Gene	Cytoband	(A) Negative	(B) Positive	(A) Negative	(B) Positive	Log2 Ratio	p-Value	q-Value	Higher expression in
ARMT1	6q25.1	-0.86	1.20	0.77	1.27	-2.07	1.28e-64	2.21e-60	(B) Positive
ESR1	6q25.1-q25.2	-1.74	3.47	1.89	1.68	-5.20	3.48e-64	2.99e-60	(B) Positive
SLC39A6	18q12.2	-1.31	1.25	0.99	1.60	-2.56	4.14e-62	2.37e-58	(B) Positive
CCDC170	6q25.1	-1.76	1.18	1.18	1.28	-2.94	1.08e-59	4.66e-56	(B) Positive
NAT1	8p22	0.21	3.73	1.43	1.95	-3.52	1.57e-59	5.41e-56	(B) Positive
AGR3	7p21.1	-2.07	4.34	2.66	2.15	-6.41	1.68e-55	4.83e-52	(B) Positive
RGS22	8q22.2	-2.81	-0.32	1.02	1.93	-2.50	6.23e-55	1.53e-51	(B) Positive
PCP2	19p13.2	-0.16	1.22	0.62	0.81	-1.38	1.83e-52	3.94e-49	(B) Positive
FSIP1	15q14	0.01	3.92	1.76	1.89	-3.91	2.92e-52	5.59e-49	(B) Positive
EVL	14q32.2	-0.42	1.16	0.71	0.81	-1.58	3.35e-52	5.76e-49	(B) Positive
SCUBE2	11p15.4	-0.92	2.58	1.59	1.83	-3.50	5.74e-52	8.96e-49	(B) Positive
TCEAL1	Xq22.2	-0.21	1.32	0.68	1.11	-1.53	8.63e-52	1.24e-48	(B) Positive
PLCD4	2q35	-1.08	0.85	0.87	1.29	-1.93	1.59e-51	2.10e-48	(B) Positive
GFRA1	10q25.3	-2.63	1.02	1.68	2.07	-3.65	3.16e-51	3.87e-48	(B) Positive
TBC1D9	4q31.21	0.05	3.26	1.47	1.47	-3.21	3.63e-51	4.16e-48	(B) Positive
CST9	20p11.21	-0.32	1.57	0.75	1.73	-1.89	6.97e-51	7.49e-48	(B) Positive
TFF1	21q22.3	-4.04	-1.60	1.03	2.06	-2.44	8.66e-51	8.76e-48	(B) Positive
SLC7A2	8p22	-2.47	-0.26	1.01	1.63	-2.20	1.46e-49	1.39e-46	(B) Positive
SERPINA11	14q32.13	-2.91	-0.78	0.96	1.67	-2.14	1.92e-49	1.74e-46	(B) Positive
PLAAT1	3q29	2.09	-0.40	1.13	1.95	2.49	6.00e-49	5.16e-46	(A) Negative
THSD4	15q23	-0.67	1.83	1.22	1.11	-2.50	5.16e-47	4.23e-44	(B) Positive
TMPRSS6	22q12.3	-0.45	0.67	0.53	0.93	-1.12	3.43e-46	2.64e-43	(B) Positive
ABAT	16p13.2	-1.25	0.76	1.00	1.23	-2.00	3.56e-46	2.64e-43	(B) Positive
STC2	5q35.2	-2.13	0.14	1.04	1.97	-2.27	3.68e-46	2.64e-43	(B) Positive
PARD6B	20q13.13	-2.51	-0.74	0.86	1.36	-1.77	3.94e-46	2.71e-43	(B) Positive
AFF3	2q11.2	-0.04	1.58	0.81	1.07	-1.62	4.46e-46	2.95e-43	(B) Positive
IL6ST	5q11.2	-0.56	1.38	0.97	1.19	-1.93	7.34e-46	4.67e-43	(B) Positive
KCTD6	3p14.3	-0.21	1.17	0.68	0.94	-1.38	7.60e-46	4.67e-43	(B) Positive
SRARP	1p36.13	-1.82	2.34	2.10	2.02	-4.17	1.12e-45	6.63e-43	(B) Positive
GRPR	Xp22.2	-0.01	2.26	1.08	1.93	-2.27	2.05e-45	1.18e-42	(B) Positive
KDM4B	19p13.3	-0.22	1.07	0.67	0.72	-1.30	8.79e-45	4.77e-42	(B) Positive
DACH1	13q21.33	1.88	5.27	1.74	1.78	-3.39	8.88e-45	4.77e-42	(B) Positive
NR2E3	15q23	-1.07	0.18	0.64	0.89	-1.25	1.77e-44	9.05e-42	(B) Positive
TRH	3q22.1	-0.33	1.71	0.82	2.15	-2.04	1.79e-44	9.05e-42	(B) Positive
SPINK4	9p13.3	-1.98	-0.05	0.89	1.82	-1.93	4.19e-44	2.06e-41	(B) Positive
ARSG	17q24.2	-0.91	0.60	0.79	0.88	-1.51	7.70e-44	3.68e-41	(B) Positive
IL20	1q32.1	-0.62	1.49	1.03	1.83	-2.11	1.09e-43	5.06e-41	(B) Positive
CA12	15q22.2	-0.82	2.59	1.76	1.17	-3.41	1.48e-43	6.71e-41	(B) Positive
ACADSB	10q26.13	-0.42	1.47	0.99	1.01	-1.88	2.04e-43	9.00e-41	(B) Positive
FAM234B	12p13.1	-0.47	1.43	1.00	1.23	-1.90	3.98e-43	1.71e-40	(B) Positive
CST9L	20p11.21	-0.82	1.67	1.09	2.56	-2.49	5.42e-43	2.27e-40	(B) Positive
DNAJC12	10q21.3	-1.77	1.34	1.65	1.88	-3.10	6.59e-43	2.70e-40	(B) Positive
ABCC8	11p15.1	-0.10	2.94	1.62	1.55	-3.03	1.39e-42	5.56e-40	(B) Positive
BCL11A	2p16.1	1.11	-1.88	1.60	1.55	2.99	1.47e-42	5.75e-40	(A) Negative
ANXA9	1q21.3	-1.30	1.71	1.62	1.34	-3.01	4.33e-42	1.65e-39	(B) Positive
KRT37	17q21.2	-1.60	0.71	1.22	1.74	-2.31	8.66e-42	3.23e-39	(B) Positive
CCDC74B	2q21.1	-0.88	1.10	1.06	1.34	-1.98	8.84e-42	3.23e-39	(B) Positive
TCEAL4	Xq22.2	0.17	1.34	0.59	1.04	-1.17	9.02e-42	3.23e-39	(B) Positive
GREB1	2p25.1	-3.13	-1.19	1.05	1.20	-1.94	1.23e-41	4.31e-39	(B) Positive
DSC2	18q12.1	3.56	1.61	1.06	1.13	1.95	1.86e-41	6.41e-39	(A) Negative
WWP1	8q21.3	0.48	1.95	0.81	0.92	-1.47	7.23e-41	2.44e-38	(B) Positive
SLC16A6	17q24.2	-1.66	0.52	1.19	1.59	-2.18	1.50e-40	4.95e-38	(B) Positive
MAGED2	Xp11.21	0.71	2.33	0.90	1.01	-1.62	1.70e-40	5.51e-38	(B) Positive
SYT9	11p15.4	0.51	1.58	0.58	0.84	-1.07	2.05e-40	6.52e-38	(B) Positive
XBP1	22q12.1	-0.03	2.35	1.33	1.09	-2.38	2.12e-40	6.61e-38	(B) Positive
KCNJ3	2q24.1	-0.66	2.23	1.43	2.82	-2.89	2.54e-40	7.81e-38	(B) Positive
CLSTN2	3q23	-0.20	2.72	1.64	1.54	-2.93	3.08e-40	9.28e-38	(B) Positive
MAPT	17q21.31	-0.08	1.43	0.84	0.93	-1.51	3.13e-40	9.28e-38	(B) Positive
CACNA2D2	3p21.31	-0.32	0.90	0.68	0.84	-1.22	6.42e-40	1.87e-37	(B) Positive
WNK4	17q21.2	-1.97	-0.09	1.03	1.49	-1.88	8.30e-40	2.38e-37	(B) Positive
EFCC1	3q21.3	1.84	3.95	1.19	1.25	-2.11	1.04e-39	2.93e-37	(B) Positive
GATA3	10p14	-1.12	1.93	1.71	1.10	-3.05	1.15e-39	3.20e-37	(B) Positive
FGD3	9q22.31	0.54	2.08	0.86	1.13	-1.54	1.67e-39	4.56e-37	(B) Positive
RABEP1	17p13.2	-0.09	1.09	0.67	0.82	-1.18	2.62e-39	7.05e-37	(B) Positive
ANKRA2	5q13.2	-0.51	0.43	0.54	0.53	-0.94	2.78e-39	7.35e-37	(B) Positive
PSAT1	9q21.2	-2.08	-4.99	1.67	1.27	2.91	4.95e-39	1.29e-36	(A) Negative
IGFALS	16p13.3	-0.13	1.99	1.21	1.44	-2.11	6.88e-39	1.77e-36	(B) Positive
UGCG	9q31.3	-0.19	1.47	0.95	1.16	-1.66	1.33e-38	3.36e-36	(B) Positive
KIF12	9q32	0.58	2.50	1.10	1.38	-1.92	1.77e-38	4.42e-36	(B) Positive
PROM1	4p15.32	3.19	-0.28	1.99	2.40	3.47	2.09e-38	5.14e-36	(A) Negative
VGLL1	Xq26.3	3.07	0.70	1.37	0.91	2.36	2.19e-38	5.30e-36	(A) Negative
B3GNT5	3q27.1	1.87	-0.56	1.41	0.98	2.44	2.40e-38	5.73e-36	(A) Negative
SUSD3	9q22.31	0.12	2.68	1.48	1.64	-2.55	2.91e-38	6.86e-36	(B) Positive
KCNK15	20q13.12	-0.42	0.93	0.78	0.94	-1.35	3.45e-38	8.01e-36	(B) Positive
CDCA7	2q31.1	-1.90	-3.91	1.17	1.15	2.00	3.56e-38	8.16e-36	(A) Negative
LAD1	1q32.1	1.97	0.61	0.75	1.21	1.36	8.07e-38	1.82e-35	(A) Negative
SLC7A8	14q11.2	0.19	1.99	1.06	0.90	-1.80	8.35e-38	1.86e-35	(B) Positive
PADI2	1p36.13	3.04	1.46	0.93	0.87	1.58	8.46e-38	1.87e-35	(A) Negative
NOVA1	14q12	-0.99	0.40	0.69	1.48	-1.39	9.36e-38	2.04e-35	(B) Positive
PGR	11q22.1	-1.98	0.93	1.68	2.23	-2.91	9.51e-38	2.04e-35	(B) Positive
DCDC1	11p14.1	0.60	1.79	0.65	1.06	-1.18	1.06e-37	2.24e-35	(B) Positive
COX6C	8q22.2	0.03	1.53	0.79	1.47	-1.50	1.15e-37	2.42e-35	(B) Positive
TCEAL6	Xq22.1	0.22	1.40	0.68	0.90	-1.18	1.32e-37	2.74e-35	(B) Positive
RAB30	11q14.1	-0.42	0.95	0.77	1.19	-1.37	1.65e-37	3.37e-35	(B) Positive
ZMYND10	3p21.31	0.35	2.45	1.25	1.05	-2.10	1.81e-37	3.65e-35	(B) Positive
NEK10	3p24.1	-0.31	1.81	1.22	1.72	-2.12	2.20e-37	4.40e-35	(B) Positive
MLPH	2q37.3	-1.38	1.47	1.69	1.01	-2.86	3.40e-37	6.71e-35	(B) Positive
UBE2E3	2q31.3	-0.28	-1.59	0.76	1.07	1.31	7.89e-37	1.54e-34	(A) Negative
RETREG1	5p15.1	0.27	2.30	1.21	1.38	-2.03	9.49e-37	1.83e-34	(B) Positive
SIAH2	3q25.1	-0.16	0.89	0.61	0.89	-1.05	1.08e-36	2.06e-34	(B) Positive
STK32B	4p16.2	-0.92	0.40	0.76	1.16	-1.32	1.36e-36	2.57e-34	(B) Positive
ATOSA	15q21.2-q21.3	-0.07	1.46	0.92	0.86	-1.53	1.39e-36	2.59e-34	(B) Positive
TCEAL3	Xq22.2	0.25	1.42	0.70	0.90	-1.18	2.57e-36	4.75e-34	(B) Positive
MACIR	5q21.1	-0.48	1.09	0.95	0.85	-1.56	2.60e-36	4.75e-34	(B) Positive
CYB5D2	17p13.2	-0.28	0.75	0.62	0.71	-1.03	2.66e-36	4.81e-34	(B) Positive
ERBB4	2q34	-0.09	2.71	1.70	1.39	-2.80	2.86e-36	5.13e-34	(B) Positive
SLC27A2	15q21.2	-2.94	-1.04	1.08	1.73	-1.90	3.21e-36	5.68e-34	(B) Positive
PPP1R14C	6q25.1	1.13	-2.30	2.09	1.46	3.43	3.30e-36	5.78e-34	(A) Negative
CSAD	12q13.13	-0.96	0.19	0.68	0.88	-1.15	3.34e-36	5.81e-34	(B) Positive
GASK1B	4q32.1	1.30	3.15	1.12	1.22	-1.84	3.80e-36	6.54e-34	(B) Positive
P4HTM	3p21.31	-0.34	1.04	0.84	0.68	-1.38	3.88e-36	6.60e-34	(B) Positive
SMCO4	11q21	1.01	0.11	0.55	0.58	0.91	4.47e-36	7.53e-34	(A) Negative
NOSTRIN	2q24.3	-0.35	1.12	0.90	0.99	-1.48	5.30e-36	8.84e-34	(B) Positive
FAM161B	14q24.3	-0.12	0.82	0.56	0.79	-0.94	6.70e-36	1.11e-33	(B) Positive
SYTL4	Xq22.1	-0.44	1.14	0.97	1.04	-1.58	9.56e-36	1.57e-33	(B) Positive
BTF3	5q13.2	-0.81	-0.06	0.46	0.48	-0.75	1.25e-35	2.02e-33	(B) Positive
PDZK1	1q21.1	-3.48	-0.72	1.60	2.52	-2.76	1.27e-35	2.03e-33	(B) Positive
PTPRN2	7q36.3	-2.00	-0.60	0.72	1.57	-1.40	2.04e-35	3.25e-33	(B) Positive
LRP8	1p32.3	-1.11	-2.77	1.03	1.07	1.66	2.97e-35	4.68e-33	(A) Negative
GAMT	19p13.3	-1.77	0.00	1.11	0.98	-1.78	5.30e-35	8.29e-33	(B) Positive
LRRC46	17q21.32	0.28	1.61	0.83	0.87	-1.33	5.45e-35	8.44e-33	(B) Positive
KLHDC1	14q21.3	0.33	1.31	0.60	0.73	-0.98	6.62e-35	1.02e-32	(B) Positive
ZNF552	19q13.43	1.32	2.99	1.05	0.93	-1.67	7.12e-35	1.08e-32	(B) Positive
PREX1	20q13.13	-0.07	1.65	1.08	1.16	-1.72	7.83e-35	1.18e-32	(B) Positive
BBS1	11q13.2	0.33	1.18	0.53	0.52	-0.85	8.92e-35	1.33e-32	(B) Positive
RUNDC1	17q21.31	0.27	1.26	0.62	0.64	-0.99	1.28e-34	1.89e-32	(B) Positive
MAG	19q13.1	-0.92	0.13	0.62	0.98	-1.05	1.51e-34	2.22e-32	(B) Positive
ABTB2	11p13	0.24	-1.15	0.88	0.85	1.39	1.73e-34	2.52e-32	(A) Negative
SLC4A8	12q13.13	-0.78	0.60	0.86	1.07	-1.38	1.84e-34	2.66e-32	(B) Positive
TMEM26	10q21.2	-0.64	1.00	0.93	1.70	-1.64	2.42e-34	3.47e-32	(B) Positive
STH	17q21.31	-0.48	1.11	0.99	1.26	-1.59	3.35e-34	4.76e-32	(B) Positive
DNALI1	1p34.3	1.03	3.96	1.87	1.29	-2.93	3.59e-34	5.06e-32	(B) Positive
PRKX	Xp22.33	1.08	-0.35	0.91	0.84	1.43	4.51e-34	6.30e-32	(A) Negative
AGTR1	3q24	1.01	3.20	1.24	2.30	-2.19	5.00e-34	6.93e-32	(B) Positive
AGR2	7p21.1	-1.68	2.50	2.67	1.59	-4.17	5.30e-34	7.29e-32	(B) Positive
MSL3	Xp22.2	0.80	0.04	0.49	0.43	0.76	8.52e-34	1.16e-31	(A) Negative
RIMS4	20q13.12	-0.58	0.92	0.94	1.23	-1.51	9.10e-34	1.23e-31	(B) Positive
TLE3	15q23	0.45	1.17	0.46	0.45	-0.72	1.36e-33	1.82e-31	(B) Positive
TMEM25	11q23.3	1.29	2.47	0.77	0.73	-1.19	1.55e-33	2.06e-31	(B) Positive
PGLYRP2	19p13.12	-0.25	1.68	1.21	1.59	-1.93	1.63e-33	2.15e-31	(B) Positive
INPP4B	4q31.21	-1.30	0.80	1.37	1.06	-2.10	3.37e-33	4.42e-31	(B) Positive
ABLIM3	5q32	-1.40	0.05	0.94	1.01	-1.45	3.98e-33	5.19e-31	(B) Positive
BCAS4	20q13.13	0.07	1.22	0.74	0.80	-1.15	4.21e-33	5.44e-31	(B) Positive
GP2	16p12.3	0.63	3.26	1.71	1.74	-2.63	4.28e-33	5.49e-31	(B) Positive
USP6NL	10p14	0.95	-0.16	0.73	0.57	1.11	5.07e-33	6.45e-31	(A) Negative
CDC20	1p34.2	-0.64	-1.89	0.81	0.80	1.24	5.17e-33	6.54e-31	(A) Negative
SLC19A2	1q24.2	-0.51	0.84	0.87	0.99	-1.35	5.35e-33	6.71e-31	(B) Positive
FBP1	9q22.32	-0.29	1.94	1.47	1.06	-2.24	5.56e-33	6.93e-31	(B) Positive
IFRD1	7q31.1	-0.47	-1.80	0.87	0.63	1.33	7.01e-33	8.67e-31	(A) Negative
CHRD	3q27.1	-0.08	0.87	0.59	0.85	-0.94	1.04e-32	1.27e-30	(B) Positive
TUBA3D	2q21.1	-0.41	0.33	0.42	0.83	-0.74	1.19e-32	1.45e-30	(B) Positive
CHAD	17q21.33	0.68	1.93	0.81	1.03	-1.26	1.30e-32	1.58e-30	(B) Positive
TPRG1	3q28	2.44	4.95	1.63	1.95	-2.51	1.40e-32	1.69e-30	(B) Positive
INPP5J	22q12.2	0.35	1.88	1.01	0.90	-1.53	1.45e-32	1.73e-30	(B) Positive
POTEB	15q11.2	-2.07	0.62	1.77	1.91	-2.70	1.60e-32	1.89e-30	(B) Positive
WFS1	4p16.1	0.30	1.42	0.74	0.63	-1.11	1.64e-32	1.93e-30	(B) Positive
KCNN4	19q13.31	1.44	-0.56	1.33	1.14	1.99	1.98e-32	2.32e-30	(A) Negative
KCNJ11	11p15.1	0.36	1.57	0.80	0.83	-1.21	2.02e-32	2.34e-30	(B) Positive
APBB2	4p14-p13	0.38	1.49	0.74	0.72	-1.11	2.75e-32	3.17e-30	(B) Positive
AMER1	Xq11.2	0.77	-0.41	0.79	0.61	1.18	2.91e-32	3.33e-30	(A) Negative
DRC3	17p11.2	0.85	2.48	1.08	1.15	-1.63	3.34e-32	3.80e-30	(B) Positive
PLCH1	3q25.31	1.31	-0.10	0.93	1.13	1.42	3.61e-32	4.08e-30	(A) Negative
TTK	6q14.1	-0.69	-2.15	0.97	0.96	1.46	4.09e-32	4.60e-30	(A) Negative
YBX1	1p34.2	-0.57	-1.57	0.67	0.57	1.00	4.15e-32	4.63e-30	(A) Negative
KIF2C	1p34.1	-1.17	-2.43	0.83	0.95	1.26	4.50e-32	4.99e-30	(A) Negative
MTHFD1L	6q25.1	-1.12	-2.25	0.77	0.61	1.14	4.58e-32	5.05e-30	(A) Negative
MAST4	5q12.3	0.13	1.32	0.79	0.73	-1.18	4.85e-32	5.31e-30	(B) Positive
BUB1	2q13	-1.56	-2.93	0.91	0.99	1.37	5.88e-32	6.39e-30	(A) Negative
CXXC5	5q31.2	-0.66	0.87	1.03	0.76	-1.52	6.12e-32	6.62e-30	(B) Positive
RMND1	6q25.1	-0.48	0.58	0.65	1.10	-1.06	6.43e-32	6.91e-30	(B) Positive
RARRES1	3q25.32	5.17	3.05	1.42	1.47	2.12	7.44e-32	7.94e-30	(A) Negative
PRKY	Yp11.2	0.64	-0.71	0.91	0.80	1.35	8.35e-32	8.86e-30	(A) Negative
NUDT12	5q21.2	-0.43	0.95	0.93	0.83	-1.38	1.01e-31	1.06e-29	(B) Positive
NCS1	9q34.11	0.08	-0.82	0.61	0.57	0.90	1.01e-31	1.06e-29	(A) Negative
BBS4	15q24.1	-0.90	0.00	0.61	0.55	-0.90	1.58e-31	1.65e-29	(B) Positive
DESI2	1q44	0.81	0.01	0.54	0.51	0.80	1.66e-31	1.72e-29	(A) Negative
CIB3	19p13.11	0.06	1.28	0.81	0.99	-1.22	1.88e-31	1.94e-29	(B) Positive
TCEAL5	Xq22.1	0.44	1.57	0.75	0.91	-1.13	1.93e-31	1.98e-29	(B) Positive
EGFR	7p11.2	0.20	-1.91	1.45	1.18	2.11	2.65e-31	2.69e-29	(A) Negative
BCAS1	20q13.2	-1.75	0.54	1.56	1.47	-2.29	3.20e-31	3.24e-29	(B) Positive
CCDC96	4p16.1	0.80	1.59	0.54	0.51	-0.79	3.29e-31	3.31e-29	(B) Positive
AKR1E2	10p15.1	1.09	-0.47	1.07	0.89	1.56	3.50e-31	3.50e-29	(A) Negative
ATP5MC2	12q13.13	-0.42	0.18	0.42	0.32	-0.61	3.72e-31	3.70e-29	(B) Positive
ADCY5	3q21.1	-0.36	0.80	0.75	1.12	-1.17	3.85e-31	3.81e-29	(B) Positive
SPMIP5	10q25.3	-1.84	0.77	1.67	2.53	-2.61	3.96e-31	3.89e-29	(B) Positive
PALS2	7p15.3	-1.88	-3.37	1.03	0.94	1.50	4.31e-31	4.21e-29	(A) Negative
UQCRH	1p33	-0.56	-1.37	0.55	0.45	0.80	4.72e-31	4.59e-29	(A) Negative
JRKL	11q21	0.71	-0.43	0.77	0.78	1.13	4.99e-31	4.82e-29	(A) Negative
PELI1	2p14	1.34	0.28	0.72	0.69	1.06	5.03e-31	4.83e-29	(A) Negative
STARD10	11q13.4	0.36	1.86	1.04	0.90	-1.50	5.50e-31	5.25e-29	(B) Positive
CNTD1	17q21.2-q21.31	0.77	2.42	1.13	1.12	-1.65	6.30e-31	5.98e-29	(B) Positive
CENPA	2p23.3	-0.73	-2.09	0.93	0.98	1.36	7.06e-31	6.67e-29	(A) Negative
RERG	12p12.3	0.54	2.84	1.59	1.23	-2.29	9.84e-31	9.24e-29	(B) Positive
RASAL1	12q24.13	0.67	-0.92	1.10	1.01	1.60	1.07e-30	1.00e-28	(A) Negative
UQCRHL	1p36.21	-0.64	-1.45	0.56	0.47	0.81	1.13e-30	1.05e-28	(A) Negative
TSPAN13	7p21.1	1.23	2.67	1.00	0.88	-1.44	1.35e-30	1.25e-28	(B) Positive
GSTP1	11q13.2	0.03	-1.52	1.05	1.26	1.55	1.41e-30	1.29e-28	(A) Negative
CENPW	6q22.32	0.02	-1.60	1.13	0.84	1.62	1.41e-30	1.29e-28	(A) Negative
NFIL3	9q22.31	0.23	-0.90	0.75	1.04	1.13	1.43e-30	1.31e-28	(A) Negative
REPS2	Xp22.2	0.74	2.12	0.91	1.27	-1.38	1.46e-30	1.32e-28	(B) Positive
KRT18	12q13.13	-1.42	0.06	1.03	0.84	-1.47	1.59e-30	1.43e-28	(B) Positive
BORCS7	10q24.32	0.38	1.36	0.68	0.63	-0.98	1.75e-30	1.57e-28	(B) Positive
TTLL4	2q35	0.39	-0.99	0.97	0.59	1.38	1.94e-30	1.73e-28	(A) Negative
H1-1	6p22.2	2.27	-0.10	1.66	1.06	2.37	2.01e-30	1.78e-28	(A) Negative
C3ORF18	3p21.31	-0.31	0.84	0.78	0.89	-1.14	2.18e-30	1.92e-28	(B) Positive
CIRBP	19p13.3	0.11	1.15	0.73	0.67	-1.04	2.47e-30	2.17e-28	(B) Positive
PIERCE1	9q34.3	-0.34	1.10	1.01	0.85	-1.44	2.68e-30	2.34e-28	(B) Positive
ELP2	18q12.2	-0.65	0.37	0.63	1.14	-1.02	2.84e-30	2.47e-28	(B) Positive
HPX	11p15.4	0.07	2.05	1.36	1.57	-1.97	2.96e-30	2.56e-28	(B) Positive
MRTFB	16p13.12	0.68	1.45	0.53	0.58	-0.77	3.64e-30	3.13e-28	(B) Positive
IZUMO4	19p13.3	-1.15	-0.35	0.53	0.80	-0.81	3.67e-30	3.14e-28	(B) Positive
BMERB1	16p13.11	-1.61	-0.06	1.06	1.26	-1.55	3.70e-30	3.15e-28	(B) Positive
FUT8	14q23.3	-0.46	0.79	0.88	0.85	-1.25	4.29e-30	3.63e-28	(B) Positive
KCNE4	2q36.1	-0.66	1.22	1.20	1.98	-1.88	4.47e-30	3.77e-28	(B) Positive
SOX11	2p25.2	1.63	-1.14	1.96	1.43	2.77	4.94e-30	4.14e-28	(A) Negative
BTG3	21q21.1	0.04	-1.37	0.99	0.92	1.40	5.13e-30	4.28e-28	(A) Negative
UCK2	1q24.1	0.12	-0.73	0.60	0.55	0.84	5.75e-30	4.78e-28	(A) Negative
CPEB2	4p15.32	-0.01	0.97	0.69	0.70	-0.98	5.97e-30	4.93e-28	(B) Positive
LRRC56	11p15.5	0.14	1.59	1.03	0.82	-1.45	6.09e-30	5.01e-28	(B) Positive
CDK2AP1	12q24.31	1.39	0.33	0.75	0.57	1.06	6.23e-30	5.10e-28	(A) Negative
ZNF703	8p11.23	0.50	1.26	0.52	0.64	-0.75	6.60e-30	5.38e-28	(B) Positive
ADGRB2	1p35.2	-0.48	0.89	0.95	1.09	-1.37	6.71e-30	5.44e-28	(B) Positive
ZNF396	18q12.2	0.93	1.91	0.68	0.80	-0.98	6.84e-30	5.52e-28	(B) Positive
CDH3	16q22.1	2.44	0.50	1.35	1.49	1.94	6.94e-30	5.57e-28	(A) Negative
TAPT1	4p15.32	0.02	0.90	0.62	0.63	-0.88	7.30e-30	5.84e-28	(B) Positive
HPDL	1p34.1	-0.78	-2.69	1.36	1.07	1.91	8.01e-30	6.37e-28	(A) Negative
SYBU	8q23.2	-0.12	2.07	1.56	1.32	-2.19	8.63e-30	6.83e-28	(B) Positive
ZFYVE16	5q14.1	-0.55	0.09	0.46	0.43	-0.65	1.09e-29	8.57e-28	(B) Positive
TFF3	21q22.3	-0.59	2.38	2.13	1.40	-2.97	1.19e-29	9.35e-28	(B) Positive
C21ORF91	21q21.1	0.64	-0.44	0.77	0.66	1.08	1.28e-29	9.97e-28	(A) Negative
CYB5R1	1q32.1	0.85	1.79	0.67	0.62	-0.94	1.34e-29	1.04e-27	(B) Positive
AKR7A3	1p36.13	0.15	1.44	0.91	1.00	-1.29	1.42e-29	1.10e-27	(B) Positive
ZNF205-AS1	16p13.3	0.11	1.46	0.96	0.89	-1.35	1.47e-29	1.14e-27	(B) Positive
CCNE1	19q12	-0.22	-1.82	1.15	0.84	1.60	1.53e-29	1.17e-27	(A) Negative
E2F3	6p22.3	0.26	-0.61	0.62	0.53	0.87	1.76e-29	1.34e-27	(A) Negative
HSPA12A	10q25.3	-0.26	1.18	1.01	1.19	-1.45	1.77e-29	1.34e-27	(B) Positive
SPATA4	4q34.2	-0.02	1.52	1.04	1.49	-1.55	1.80e-29	1.36e-27	(B) Positive
SLC22A5	5q31.1	-0.08	1.35	1.03	0.78	-1.43	1.89e-29	1.43e-27	(B) Positive
HDAC11	3p25.1	0.41	1.38	0.69	0.67	-0.97	2.51e-29	1.89e-27	(B) Positive
MICAL3	22q11.21	0.10	-0.61	0.51	0.49	0.72	2.84e-29	2.12e-27	(A) Negative
PRR15	7p14.3	0.11	2.37	1.64	1.09	-2.26	2.98e-29	2.22e-27	(B) Positive
DNAI7	12p12.1	1.51	3.23	1.23	1.19	-1.72	3.14e-29	2.33e-27	(B) Positive
DCTN4	5q33.1	0.04	0.70	0.47	0.44	-0.66	3.27e-29	2.41e-27	(B) Positive
RNASE4	14q11.2	-0.64	0.70	0.95	1.01	-1.33	3.57e-29	2.63e-27	(B) Positive
AGO2	8q24.3	0.40	-0.63	0.73	0.77	1.03	3.93e-29	2.87e-27	(A) Negative
TRIM2	4q31.3	0.99	-0.85	1.33	1.08	1.84	4.21e-29	3.07e-27	(A) Negative
MELK	9p13.2	-0.66	-2.03	0.98	1.04	1.37	4.33e-29	3.14e-27	(A) Negative
HTR7	10q23.31	-1.21	-0.41	0.50	0.94	-0.80	4.57e-29	3.29e-27	(B) Positive
ELOVL2	6p24.2	-1.89	-0.24	1.10	1.73	-1.66	4.57e-29	3.29e-27	(B) Positive
BAIAP3	16p13.3	-1.08	0.37	1.01	1.26	-1.45	4.73e-29	3.39e-27	(B) Positive
SLC44A4	6p21.33	0.17	3.28	2.27	1.29	-3.11	5.17e-29	3.69e-27	(B) Positive
UGDH	4p14	-1.17	-0.02	0.79	1.04	-1.14	5.60e-29	3.98e-27	(B) Positive
SIRT3	11p15.5	-0.13	0.53	0.46	0.51	-0.65	5.87e-29	4.15e-27	(B) Positive
WDR19	4p14	-0.17	0.47	0.46	0.48	-0.64	6.06e-29	4.27e-27	(B) Positive
PSME4	2p16.2	0.93	0.03	0.65	0.59	0.90	6.35e-29	4.46e-27	(A) Negative
BBOX1	11p14.2	5.54	3.15	1.68	2.06	2.39	6.85e-29	4.79e-27	(A) Negative
CDCA8	1p34.3	-0.82	-1.93	0.80	0.78	1.11	7.03e-29	4.87e-27	(A) Negative
F7	13q34	-0.65	0.27	0.64	0.86	-0.92	7.03e-29	4.87e-27	(B) Positive
BBOF1	14q24.3	0.82	1.94	0.81	0.84	-1.12	7.25e-29	5.01e-27	(B) Positive
DEPDC1	1p31.3	-0.91	-2.16	0.89	1.00	1.25	7.36e-29	5.06e-27	(A) Negative
FOXA1	14q21.1	-1.03	3.07	3.00	1.43	-4.10	7.94e-29	5.44e-27	(B) Positive
DAZAP2	12q13.13	0.47	1.21	0.54	0.44	-0.74	8.32e-29	5.68e-27	(B) Positive
ZNF695	1q44	-0.40	-1.97	1.14	1.06	1.57	9.34e-29	6.34e-27	(A) Negative
MCM10	10p13	-0.86	-2.34	1.07	1.07	1.48	9.42e-29	6.38e-27	(A) Negative
CCNH	5q14.3	-1.10	-0.42	0.49	0.47	-0.68	1.12e-28	7.57e-27	(B) Positive
MATN4	20q13.12	0.44	-1.26	1.25	0.72	1.70	1.27e-28	8.50e-27	(A) Negative
ATP7B	13q14.3	-0.87	0.53	1.02	1.02	-1.40	1.29e-28	8.66e-27	(B) Positive
ABRACL	6q24.1	1.33	0.19	0.83	0.76	1.14	1.35e-28	8.97e-27	(A) Negative
SFT2D2	1q24.2	2.14	1.06	0.79	0.60	1.07	1.39e-28	9.25e-27	(A) Negative
ST8SIA1	12p12.1	1.70	-0.32	1.49	1.19	2.02	1.63e-28	1.08e-26	(A) Negative
ANKRD30A	10p11.21	0.74	3.37	1.87	2.25	-2.62	1.91e-28	1.26e-26	(B) Positive
MRFAP1L1	4p16.1	-0.11	0.57	0.50	0.48	-0.68	1.91e-28	1.26e-26	(B) Positive
ACE2	Xp22.2	1.78	-0.65	1.79	1.31	2.43	1.92e-28	1.26e-26	(A) Negative
BTRC	10q24.32	0.35	1.06	0.50	0.65	-0.71	2.02e-28	1.32e-26	(B) Positive
FAM174A	5q21.1	0.31	1.48	0.87	0.67	-1.17	2.13e-28	1.38e-26	(B) Positive
EXOC6	10q23.33	-0.20	0.75	0.70	0.66	-0.95	2.17e-28	1.40e-26	(B) Positive
DNAH7	2q32.3	0.57	1.76	0.86	0.92	-1.19	2.18e-28	1.40e-26	(B) Positive
FBXL5	4p15.32	0.86	1.60	0.54	0.55	-0.75	2.18e-28	1.40e-26	(B) Positive
TP53INP1	8q22.1	0.55	1.57	0.75	0.75	-1.02	2.70e-28	1.73e-26	(B) Positive
EPB41L5	2q14.2	-0.08	0.67	0.55	0.57	-0.75	2.79e-28	1.78e-26	(B) Positive
ANLN	7p14.2	-1.31	-2.58	0.93	0.99	1.27	3.11e-28	1.97e-26	(A) Negative
IGFBP4	17q21.2	-0.57	0.73	0.96	0.86	-1.30	3.38e-28	2.13e-26	(B) Positive
FAM171A1	10p13	0.39	-1.42	1.34	0.87	1.80	3.41e-28	2.15e-26	(A) Negative
CELSR1	22q13.31	0.51	1.49	0.71	0.74	-0.98	3.63e-28	2.28e-26	(B) Positive
MPZL2	11q23.3	1.03	-0.36	1.01	1.10	1.39	3.71e-28	2.32e-26	(A) Negative
GLIPR2	9p13.3	2.22	1.06	0.86	0.79	1.16	3.79e-28	2.36e-26	(A) Negative
MAN2B2	4p16.1	0.47	1.25	0.58	0.49	-0.78	4.16e-28	2.58e-26	(B) Positive
NPRL2	3p21.31	-0.08	0.49	0.42	0.44	-0.58	4.85e-28	3.00e-26	(B) Positive
CERS6	2q24.3	0.71	1.92	0.90	0.64	-1.20	4.97e-28	3.07e-26	(B) Positive
SAG	2q37.1	0.11	1.77	1.19	1.49	-1.66	5.13e-28	3.15e-26	(B) Positive
ADGRG6	6q24.2	-1.19	-2.54	0.97	1.15	1.35	5.23e-28	3.20e-26	(A) Negative
HENMT1	1p13.3	0.54	-0.59	0.77	1.20	1.13	5.33e-28	3.25e-26	(A) Negative
IGF1R	15q26.3	-1.12	0.57	1.25	1.17	-1.69	5.35e-28	3.25e-26	(B) Positive
KRT16	17q21.2	1.95	-0.75	2.02	1.43	2.70	5.71e-28	3.46e-26	(A) Negative
DLGAP5	14q22.3	-1.41	-2.53	0.81	0.95	1.12	6.01e-28	3.63e-26	(A) Negative
LRIG1	3p14.1	0.60	1.75	0.85	0.88	-1.15	6.90e-28	4.15e-26	(B) Positive
FMO5	1q21.1	-1.46	0.22	1.21	1.49	-1.68	6.96e-28	4.17e-26	(B) Positive
IQCH	15q23	-0.40	0.65	0.78	0.72	-1.05	7.10e-28	4.24e-26	(B) Positive
PTPRT	20q12-q13.11	1.09	3.12	1.49	1.62	-2.03	7.14e-28	4.25e-26	(B) Positive
NCAM2	21q21.1	-2.60	-0.74	1.34	1.64	-1.86	7.37e-28	4.37e-26	(B) Positive
SRSF12	6q15	0.74	-1.80	1.91	0.91	2.54	7.92e-28	4.68e-26	(A) Negative
QDPR	4p15.32	-0.67	0.38	0.70	1.16	-1.04	8.04e-28	4.73e-26	(B) Positive
CEP55	10q23.33	-0.26	-1.52	0.92	1.06	1.26	8.13e-28	4.77e-26	(A) Negative
FYB2	1p32.2	-0.79	0.82	1.15	1.51	-1.61	8.17e-28	4.78e-26	(B) Positive
CHODL	21q21.1	2.45	0.08	1.79	1.00	2.37	8.31e-28	4.84e-26	(A) Negative
BEND3	6q21	0.08	-0.83	0.67	0.72	0.91	8.35e-28	4.84e-26	(A) Negative
TMEM161B	5q14.3	-1.29	-0.66	0.47	0.51	-0.64	8.37e-28	4.84e-26	(B) Positive
NDUFAF4	6q16.1	-0.24	-1.15	0.69	0.54	0.91	8.69e-28	5.01e-26	(A) Negative
DELE1	5q31.3	-0.75	-0.13	0.46	0.41	-0.62	9.62e-28	5.53e-26	(B) Positive
SPEF1	20p13	0.63	1.51	0.65	0.70	-0.88	9.66e-28	5.53e-26	(B) Positive
YBX3	12p13.2	0.23	-0.93	0.85	0.91	1.15	9.69e-28	5.53e-26	(A) Negative
KIAA0232	4p16.1	0.06	0.83	0.58	0.50	-0.77	9.94e-28	5.66e-26	(B) Positive
MRPS30	5p12	-1.09	-0.12	0.59	1.24	-0.96	1.19e-27	6.72e-26	(B) Positive
HEMK1	3p21.31	-0.96	-0.35	0.44	0.55	-0.61	1.22e-27	6.92e-26	(B) Positive
TMBIM4	12q14.3	0.48	1.24	0.57	0.48	-0.76	1.25e-27	7.07e-26	(B) Positive
HEXIM2	17q21.31	-0.48	0.33	0.60	0.62	-0.81	1.33e-27	7.47e-26	(B) Positive
CPB1	3q24	1.19	3.01	1.31	1.72	-1.83	1.35e-27	7.55e-26	(B) Positive
TRIM23	5q12.3	-0.23	0.49	0.53	0.53	-0.71	1.43e-27	7.96e-26	(B) Positive
TMEM144	4q32.1	1.01	2.17	0.86	0.81	-1.15	1.53e-27	8.51e-26	(B) Positive
MED13L	12q24.21	0.18	1.01	0.60	0.75	-0.83	1.60e-27	8.88e-26	(B) Positive
MSANTD3	9q31.1	-0.56	-1.32	0.57	0.52	0.76	1.61e-27	8.90e-26	(A) Negative
FOXC1	6p25.3	1.32	-1.26	1.97	1.14	2.58	1.82e-27	1.00e-25	(A) Negative
NCOA7	6q22.31-q22.32	1.16	-0.40	1.18	0.97	1.56	1.83e-27	1.01e-25	(A) Negative
ORC1	1p32.3	-2.13	-3.18	0.78	0.76	1.05	2.26e-27	1.23e-25	(A) Negative
CIPC	14q24.3	0.50	1.11	0.45	0.55	-0.61	2.31e-27	1.26e-25	(B) Positive
CENPN	16q23.2	-1.22	-2.14	0.69	0.68	0.92	2.32e-27	1.26e-25	(A) Negative
SRP14	15q22	0.25	0.82	0.42	0.46	-0.57	2.35e-27	1.27e-25	(B) Positive
DYNLRB2	16q23.2	0.70	3.09	1.82	1.27	-2.39	2.39e-27	1.29e-25	(B) Positive
GLS2	12q13.3	-1.35	0.04	1.05	0.99	-1.39	2.45e-27	1.32e-25	(B) Positive
INTS6L	Xq26.3	-0.24	-1.30	0.79	0.78	1.06	2.51e-27	1.35e-25	(A) Negative
ORAI3	16p11.2	-0.37	0.41	0.59	0.53	-0.78	2.54e-27	1.36e-25	(B) Positive
ATRIP	3p21.31	-0.35	0.31	0.49	0.54	-0.66	2.72e-27	1.45e-25	(B) Positive
SLC29A3	10q22.1	0.55	1.12	0.42	0.52	-0.57	2.76e-27	1.47e-25	(B) Positive
YEATS2	3q27.1	-0.35	-1.21	0.66	0.46	0.87	2.98e-27	1.58e-25	(A) Negative
MID1	Xp22	-0.05	-1.56	1.14	1.06	1.51	3.05e-27	1.61e-25	(A) Negative
MTFR2	6q23.3	-0.94	-2.19	0.93	1.01	1.25	3.31e-27	1.74e-25	(A) Negative
SERPINA5	14q32.13	-3.01	-0.79	1.64	1.92	-2.22	3.32e-27	1.74e-25	(B) Positive
RMND5B	5q35.3	-0.05	0.61	0.50	0.42	-0.66	3.50e-27	1.83e-25	(B) Positive
GATA2	3q21.3	-1.73	-0.78	0.69	0.93	-0.96	3.94e-27	2.06e-25	(B) Positive
FAM120AOS	9q22.31	0.09	0.86	0.58	0.57	-0.77	4.16e-27	2.17e-25	(B) Positive
SKP1	5q31.1	-0.20	0.49	0.53	0.48	-0.69	4.21e-27	2.19e-25	(B) Positive
SPG11	15q21.1	-0.32	0.24	0.42	0.39	-0.55	4.70e-27	2.43e-25	(B) Positive
XPA	9q22.33	-0.02	0.68	0.53	0.53	-0.70	4.81e-27	2.48e-25	(B) Positive
CCDC24	1p34.1	0.50	1.37	0.66	0.57	-0.87	5.55e-27	2.86e-25	(B) Positive
CACNA1D	3p21.1	0.15	1.35	0.90	1.00	-1.20	5.60e-27	2.87e-25	(B) Positive
TIGD6	5q32	0.28	0.94	0.49	0.49	-0.65	5.94e-27	3.04e-25	(B) Positive
RAD17	5q13.2	-0.66	-0.15	0.39	0.41	-0.51	6.02e-27	3.07e-25	(B) Positive
KAT6B	10q22.2	0.50	1.49	0.73	0.89	-0.99	7.31e-27	3.72e-25	(B) Positive
CST5	20p11.21	-0.04	0.66	0.48	0.80	-0.70	7.35e-27	3.73e-25	(B) Positive
NDUFAF1	15q15.1	-0.30	0.38	0.52	0.49	-0.68	8.01e-27	4.05e-25	(B) Positive
NDFIP1	5q31.3	0.28	0.85	0.42	0.46	-0.56	8.15e-27	4.11e-25	(B) Positive
TIGD2	4q22.1	0.58	-0.41	0.77	0.59	0.99	9.01e-27	4.53e-25	(A) Negative
CCDC82	11q21	-0.61	-1.65	0.80	0.75	1.04	9.13e-27	4.58e-25	(A) Negative
SLC36A4	11q21	-0.55	-1.59	0.80	0.78	1.04	9.18e-27	4.59e-25	(A) Negative
SMIM14	4p14	-0.11	1.23	1.04	0.73	-1.34	9.48e-27	4.73e-25	(B) Positive
TTC7A	2p21	0.18	-0.66	0.65	0.56	0.84	9.55e-27	4.75e-25	(A) Negative
KIF13B	8p12	0.41	1.24	0.60	0.80	-0.82	9.83e-27	4.87e-25	(B) Positive
SOWAHA	5q31.1	0.18	2.30	1.54	2.07	-2.12	1.02e-26	5.02e-25	(B) Positive
LBR	1q42.12	-0.44	-1.40	0.74	0.70	0.96	1.02e-26	5.02e-25	(A) Negative
ART3	4q21.1	0.48	-3.19	2.86	1.25	3.67	1.02e-26	5.02e-25	(A) Negative
PPP1R14B	11q13.1	0.12	-0.61	0.55	0.61	0.73	1.05e-26	5.12e-25	(A) Negative
HEBP1	12p13.1	0.42	1.34	0.62	1.09	-0.92	1.05e-26	5.13e-25	(B) Positive
EXO1	1q43	-1.12	-2.24	0.86	0.86	1.12	1.09e-26	5.33e-25	(A) Negative
POC5	5q13.3	-0.89	-0.31	0.44	0.46	-0.58	1.17e-26	5.66e-25	(B) Positive
IVD	15q15.1	-0.63	0.49	0.87	0.71	-1.12	1.18e-26	5.71e-25	(B) Positive
KCNK6	19q13.2	-0.68	0.26	0.72	0.73	-0.94	1.23e-26	5.96e-25	(B) Positive
SUOX	12q13.2	0.48	1.32	0.65	0.55	-0.84	1.28e-26	6.15e-25	(B) Positive
MYG1	12q13.13	-0.25	0.31	0.43	0.35	-0.55	1.28e-26	6.17e-25	(B) Positive
GLIPR1L2	12q21.2	0.72	1.86	0.85	1.02	-1.13	1.41e-26	6.76e-25	(B) Positive
KCNC2	12q21.1	0.29	1.75	0.74	2.20	-1.46	1.42e-26	6.76e-25	(B) Positive
TMEM123	11q22.2	0.47	-0.55	0.79	0.64	1.02	1.43e-26	6.79e-25	(A) Negative
CTPS1	1p34.2	-0.93	-1.90	0.75	0.67	0.97	1.46e-26	6.92e-25	(A) Negative
SSH3	11q13.2	0.18	1.12	0.73	0.62	-0.94	1.46e-26	6.92e-25	(B) Positive
TSPAN31	12q14.1	0.13	0.93	0.62	0.60	-0.80	1.61e-26	7.60e-25	(B) Positive
PDK1	2q31.1	-1.09	-2.13	0.80	0.70	1.04	1.61e-26	7.61e-25	(A) Negative
NPAS1	19q13.32	-2.05	-1.18	0.66	0.77	-0.87	1.64e-26	7.71e-25	(B) Positive
RSPH1	21q22.3	1.04	2.38	1.03	1.00	-1.35	1.71e-26	8.02e-25	(B) Positive
MYB	6q23.3	-2.10	-0.01	1.64	1.02	-2.10	1.75e-26	8.20e-25	(B) Positive
BTG2	1q32.1	0.58	1.71	0.87	0.84	-1.13	1.88e-26	8.77e-25	(B) Positive
CEBPB	20q13.13	1.38	0.48	0.69	0.69	0.90	2.01e-26	9.35e-25	(A) Negative
TMBIM6	12q13.12	0.04	0.77	0.56	0.47	-0.73	2.03e-26	9.41e-25	(B) Positive
KRT7	12q13.13	2.73	1.46	0.80	1.70	1.28	2.51e-26	1.16e-24	(A) Negative
RGMA	15q26.1	1.73	0.30	1.12	0.80	1.43	2.66e-26	1.23e-24	(A) Negative
CYP2A7	19q13.2	0.40	1.77	0.82	1.91	-1.38	2.72e-26	1.25e-24	(B) Positive
LRRC8B	1p22.2	0.76	0.07	0.53	0.54	0.69	2.74e-26	1.26e-24	(A) Negative
ATP11C	Xq27.1	0.37	-0.28	0.50	0.42	0.64	2.93e-26	1.34e-24	(A) Negative
DOK1	2p13.1	-0.05	0.69	0.56	0.72	-0.75	3.03e-26	1.38e-24	(B) Positive
PRR13	12q13.13	-0.10	0.47	0.44	0.35	-0.57	3.12e-26	1.42e-24	(B) Positive
INAVA	1q32.1	0.70	-0.89	1.21	1.34	1.58	3.18e-26	1.44e-24	(A) Negative
TICRR	15q26.1	-1.15	-2.35	0.93	0.94	1.20	3.53e-26	1.60e-24	(A) Negative
RET	10q11.21	-0.59	1.58	1.67	1.74	-2.17	3.76e-26	1.70e-24	(B) Positive
NECAB3	20q11.22	-0.75	0.17	0.70	0.74	-0.92	3.78e-26	1.70e-24	(B) Positive
IFT140	16p13.3	0.16	1.04	0.68	0.60	-0.88	3.83e-26	1.72e-24	(B) Positive
C17ORF58	17q24.2	-0.34	0.73	0.82	0.88	-1.07	3.87e-26	1.73e-24	(B) Positive
FBXL7	5p15.1	-0.34	0.51	0.65	0.72	-0.85	4.05e-26	1.81e-24	(B) Positive
CCNA2	4q27	-1.34	-2.43	0.84	0.87	1.09	4.24e-26	1.89e-24	(A) Negative
ACOT4	14q24.3	1.40	2.69	1.01	0.88	-1.29	4.30e-26	1.91e-24	(B) Positive
TSPAN1	1p34.1	0.46	2.40	1.53	0.98	-1.94	4.33e-26	1.92e-24	(B) Positive
ABCC13	21q11.2	0.11	1.41	0.87	1.62	-1.31	4.42e-26	1.95e-24	(B) Positive
ORC6	16q11.2	-1.90	-2.92	0.77	0.91	1.02	4.42e-26	1.95e-24	(A) Negative
MTMR2	11q21	-0.28	-1.03	0.59	0.49	0.75	4.67e-26	2.05e-24	(A) Negative
GCNT2	6p24.3-p24.2	0.69	-0.86	1.20	1.21	1.55	5.00e-26	2.19e-24	(A) Negative
REEP5	5q22.2	0.64	1.64	0.79	0.61	-1.00	5.13e-26	2.24e-24	(B) Positive
NKAIN1	1p35.2	-1.90	0.83	2.09	2.32	-2.73	5.36e-26	2.34e-24	(B) Positive
MAP3K12	12q13.13	-0.55	0.07	0.48	0.44	-0.62	5.42e-26	2.36e-24	(B) Positive
UBXN10	1p36.12	0.54	2.15	1.26	1.16	-1.62	5.57e-26	2.42e-24	(B) Positive
MYO10	5p15.1	-0.39	-1.50	0.87	0.75	1.10	5.83e-26	2.53e-24	(A) Negative
FMNL2	2q23.3	-0.45	-1.56	0.87	0.81	1.11	5.95e-26	2.57e-24	(A) Negative
TCTN1	12q24.11	0.30	1.12	0.64	0.59	-0.82	5.97e-26	2.57e-24	(B) Positive
MRAS	3q22.3	2.49	1.39	0.86	0.71	1.10	6.21e-26	2.67e-24	(A) Negative
POP1	8q22.2	0.10	-0.90	0.79	0.72	1.00	6.44e-26	2.76e-24	(A) Negative
KLHDC2	14q21.3	-0.55	0.14	0.53	0.57	-0.69	6.64e-26	2.84e-24	(B) Positive
LPIN1	2p25.1	-0.15	-1.31	0.92	0.60	1.16	6.72e-26	2.87e-24	(A) Negative
SAMD15	14q24.3	-0.48	0.54	0.79	0.84	-1.02	6.77e-26	2.88e-24	(B) Positive
SRPK1	6p21.31	-0.37	-1.20	0.65	0.49	0.82	7.22e-26	3.06e-24	(A) Negative
CFAP43	10q25.1	0.61	1.58	0.73	0.89	-0.97	7.49e-26	3.17e-24	(B) Positive
RHOB	2p24.1	0.63	1.81	0.94	0.69	-1.18	8.07e-26	3.41e-24	(B) Positive
NUMA1	11q13.4	0.06	0.73	0.52	0.62	-0.68	8.73e-26	3.68e-24	(B) Positive
EML4	2p21	-0.26	-1.06	0.63	0.55	0.79	8.83e-26	3.71e-24	(A) Negative
ERBB3	12q13.2	0.27	1.22	0.76	0.62	-0.96	9.24e-26	3.87e-24	(B) Positive
HEXIM1	17q21.31	0.06	0.93	0.68	0.65	-0.87	9.62e-26	4.02e-24	(B) Positive
TRMU	22q13.31	-0.51	-1.18	0.53	0.50	0.67	9.68e-26	4.03e-24	(A) Negative
TPX2	20q11.21	-0.97	-2.03	0.81	0.94	1.05	9.69e-26	4.03e-24	(A) Negative
KRT222	17q21.2	0.20	1.64	1.06	1.50	-1.44	9.70e-26	4.03e-24	(B) Positive
PEX11G	19p13.2	0.60	1.40	0.63	0.55	-0.80	9.98e-26	4.14e-24	(B) Positive
SH3BGRL	Xq21.1	0.86	2.11	0.92	1.30	-1.25	1.05e-25	4.35e-24	(B) Positive
PHGDH	1p12	-0.92	-2.45	1.20	1.14	1.53	1.15e-25	4.74e-24	(A) Negative
CMYA5	5q14.1	0.31	1.76	1.15	0.95	-1.44	1.35e-25	5.56e-24	(B) Positive
KCTD3	1q41	0.26	1.28	0.81	0.69	-1.02	1.38e-25	5.65e-24	(B) Positive
USB1	16q21	-0.04	-0.70	0.53	0.42	0.66	1.41e-25	5.77e-24	(A) Negative
HAPLN3	15q26.1	2.37	0.77	1.28	0.92	1.59	1.47e-25	6.01e-24	(A) Negative
ATP11A	13q34	-0.02	-0.86	0.68	0.49	0.84	1.50e-25	6.10e-24	(A) Negative
MS4A8	11q12.2	0.46	1.93	1.10	1.53	-1.48	1.52e-25	6.18e-24	(B) Positive
MCCC2	5q13.2	-0.55	0.51	0.83	0.89	-1.06	1.57e-25	6.35e-24	(B) Positive
CAMLG	5q31.1	0.14	0.76	0.49	0.42	-0.61	1.63e-25	6.61e-24	(B) Positive
KCNK5	6p21.2	0.26	-1.54	1.43	1.21	1.80	1.66e-25	6.71e-24	(A) Negative
PLEKHG1	6q25.1	3.06	2.02	0.83	0.71	1.04	1.87e-25	7.53e-24	(A) Negative
DNAH5	5p15.2	0.22	1.17	0.72	0.94	-0.96	1.88e-25	7.56e-24	(B) Positive
CISH	3p21.2	0.35	1.39	0.83	0.78	-1.04	1.92e-25	7.69e-24	(B) Positive
C1ORF198	1q42.2	1.68	0.90	0.62	0.60	0.78	1.96e-25	7.85e-24	(A) Negative
FOXP1	3p13	0.32	1.22	0.73	0.60	-0.91	2.06e-25	8.20e-24	(B) Positive
RAB11FIP3	16p13.3	-0.28	0.40	0.54	0.55	-0.68	2.09e-25	8.31e-24	(B) Positive
HASPIN	17p13.2	-0.86	-1.87	0.79	0.89	1.01	2.10e-25	8.35e-24	(A) Negative
CHEK1	11q24.2	-1.53	-2.84	1.05	0.97	1.32	2.14e-25	8.48e-24	(A) Negative
RNF103	2p11.2	1.28	1.99	0.57	0.49	-0.71	2.33e-25	9.23e-24	(B) Positive
LMNTD2	11p15.5	-0.14	0.65	0.62	0.64	-0.79	2.72e-25	1.07e-23	(B) Positive
FNIP1	5q31.1	-0.38	0.26	0.50	0.53	-0.64	2.82e-25	1.11e-23	(B) Positive
TTC8	14q31.3	-0.90	0.02	0.74	0.64	-0.93	2.86e-25	1.12e-23	(B) Positive
CMC2	16q23.2	-0.79	-1.49	0.55	0.56	0.70	3.14e-25	1.23e-23	(A) Negative
PDSS1	10p12.1	-0.30	-1.25	0.77	0.59	0.95	3.15e-25	1.23e-23	(A) Negative
CPLX1	4p16.3	0.20	0.69	0.39	0.44	-0.50	3.30e-25	1.29e-23	(B) Positive
CFAP61	20p11.23	1.35	2.65	1.01	1.19	-1.30	3.33e-25	1.30e-23	(B) Positive
RAD54L	1p34.1	-1.44	-2.38	0.76	0.66	0.94	3.57e-25	1.38e-23	(A) Negative
ELOVL5	6p12.1	-0.30	0.76	0.84	0.94	-1.07	4.10e-25	1.59e-23	(B) Positive
FZD9	7q11.23	0.09	-1.83	1.57	0.80	1.92	4.16e-25	1.61e-23	(A) Negative
PPM1J	1p13.2	0.24	1.50	1.01	0.98	-1.27	4.19e-25	1.62e-23	(B) Positive
TRIM29	11q23.3	1.03	-0.62	1.31	1.39	1.65	4.54e-25	1.75e-23	(A) Negative
SH3GLB2	9q34.11	-0.68	-0.07	0.49	0.54	-0.62	4.78e-25	1.83e-23	(B) Positive
SINHCAF	12p11.21	-0.32	-1.18	0.69	0.67	0.87	5.04e-25	1.93e-23	(A) Negative
ASPM	1q31.3	-0.82	-1.83	0.79	0.86	1.00	5.36e-25	2.05e-23	(A) Negative
KIF14	1q32.1	-1.20	-2.31	0.87	1.00	1.11	5.48e-25	2.09e-23	(A) Negative
LONRF2	2q11.2	-2.00	0.17	1.76	1.48	-2.18	5.50e-25	2.09e-23	(B) Positive
MEX3A	1q22	1.25	-0.37	1.29	1.19	1.61	5.55e-25	2.11e-23	(A) Negative
BCL2	18q21.33	0.37	2.21	1.49	1.30	-1.84	5.63e-25	2.13e-23	(B) Positive
SMC6	2p24.2	-0.37	-1.02	0.52	0.44	0.65	5.72e-25	2.16e-23	(A) Negative
GUSBP2	6p22.2	-1.55	-0.61	0.74	0.86	-0.94	5.77e-25	2.18e-23	(B) Positive
TPRN	9q34.3	-0.16	0.79	0.76	0.70	-0.95	6.07e-25	2.28e-23	(B) Positive
RALGPS2	1q25.2	-0.35	1.14	1.22	0.85	-1.49	6.08e-25	2.28e-23	(B) Positive
RNF145	5q33.3	-0.89	-2.01	0.89	0.85	1.11	6.44e-25	2.41e-23	(A) Negative
TMEM145	19q13.2	-1.89	-0.88	0.74	1.14	-1.01	6.53e-25	2.44e-23	(B) Positive
SLC6A14	Xq23	-0.97	-3.48	2.06	1.31	2.51	6.57e-25	2.45e-23	(A) Negative
HMGA1	6p21.31	-0.88	-1.63	0.61	0.48	0.75	7.63e-25	2.84e-23	(A) Negative
CYRIA	2p24.2	2.74	1.67	0.87	0.76	1.07	7.74e-25	2.87e-23	(A) Negative
YES1	18p11.32	0.38	-0.37	0.61	0.54	0.75	8.09e-25	2.99e-23	(A) Negative
MYRIP	3p22.1	0.10	1.96	1.51	1.35	-1.86	8.10e-25	2.99e-23	(B) Positive
PLIN5	19p13.3	0.19	1.31	0.89	0.97	-1.12	8.18e-25	3.02e-23	(B) Positive
PNPLA4	Xp22.31	0.38	1.55	0.96	0.75	-1.18	8.22e-25	3.03e-23	(B) Positive
TRPV6	7q34	3.14	1.58	1.25	1.26	1.56	8.25e-25	3.03e-23	(A) Negative
PPARA	22q13.31	0.06	-0.73	0.65	0.50	0.79	8.26e-25	3.03e-23	(A) Negative
CENPO	2p23.3	-0.70	-1.61	0.73	0.70	0.90	8.52e-25	3.12e-23	(A) Negative
PLCB4	20p12.3-p12.2	0.71	-0.65	1.03	1.44	1.36	8.81e-25	3.22e-23	(A) Negative
PLEKHF2	8q22.1	0.61	1.76	0.93	0.82	-1.15	9.15e-25	3.33e-23	(B) Positive
MICAL2	11p15.3	1.22	2.67	1.15	1.25	-1.45	9.56e-25	3.48e-23	(B) Positive
CLBA1	14q32.33	-0.01	0.80	0.66	0.65	-0.82	9.59e-25	3.48e-23	(B) Positive
AURKB	17p13.1	-1.44	-2.26	0.66	0.70	0.82	1.02e-24	3.71e-23	(A) Negative
STIL	1p33	-0.95	-1.96	0.82	0.76	1.01	1.06e-24	3.84e-23	(A) Negative
TESMIN	11q13.3	0.53	1.65	0.90	0.93	-1.13	1.08e-24	3.89e-23	(B) Positive
RALGAPA1	14q13.2	-0.26	0.34	0.49	0.43	-0.60	1.08e-24	3.89e-23	(B) Positive
LRTOMT	11q13.4	0.37	1.30	0.75	0.64	-0.92	1.08e-24	3.89e-23	(B) Positive
STOX2	4q35.1	0.73	-0.85	1.30	0.97	1.58	1.15e-24	4.13e-23	(A) Negative
POLD4	11q13.2	-0.03	0.76	0.65	0.55	-0.79	1.30e-24	4.65e-23	(B) Positive
PRRT3	3p25.3	0.52	1.65	0.93	0.80	-1.13	1.36e-24	4.86e-23	(B) Positive
PLA2G10	16p13.12	0.29	1.90	1.28	1.50	-1.61	1.38e-24	4.91e-23	(B) Positive
NHERF1	17q25.1	0.21	1.39	0.96	0.92	-1.18	1.38e-24	4.92e-23	(B) Positive
ZNF280C	Xq26.1	-0.10	-0.93	0.68	0.49	0.83	1.39e-24	4.94e-23	(A) Negative
PRKAA1	5p13.1	-0.51	-1.35	0.67	0.75	0.84	1.42e-24	5.02e-23	(A) Negative
POLR2F	22q13.1	-0.05	-0.70	0.53	0.45	0.65	1.43e-24	5.04e-23	(A) Negative
SEPHS1	10p13	0.49	-0.39	0.73	0.53	0.88	1.44e-24	5.06e-23	(A) Negative
TBX3	12q24.21	-0.53	1.05	1.28	1.30	-1.58	1.48e-24	5.20e-23	(B) Positive
RIPK4	21q22.3	-0.61	-1.69	0.84	1.07	1.08	1.48e-24	5.20e-23	(A) Negative
SLC7A13	8q21.3	0.61	1.87	0.99	1.24	-1.26	1.50e-24	5.25e-23	(B) Positive
TPBG	6q14.1	-0.32	0.82	0.93	0.81	-1.14	1.58e-24	5.51e-23	(B) Positive
CHCHD5	2q14.1	-0.13	0.58	0.59	0.48	-0.71	1.63e-24	5.69e-23	(B) Positive
SUV39H2	10p13	-0.20	-1.15	0.79	0.56	0.95	1.65e-24	5.74e-23	(A) Negative
PIGH	14q24.1	-0.58	0.15	0.60	0.57	-0.73	1.65e-24	5.74e-23	(B) Positive
FANCA	16q24.3	-1.57	-2.88	1.08	0.87	1.31	1.68e-24	5.82e-23	(A) Negative
PDHB	3p14.3	-0.67	-0.12	0.43	0.53	-0.55	1.77e-24	6.13e-23	(B) Positive
MS4A2	11q12.1	1.00	2.68	1.35	1.47	-1.68	1.78e-24	6.14e-23	(B) Positive
IL12RB2	1p31.3	2.54	0.55	1.65	1.22	1.99	1.84e-24	6.33e-23	(A) Negative
NT5DC2	3p21.1	-1.00	-2.03	0.85	0.74	1.04	1.93e-24	6.65e-23	(A) Negative
TNFRSF21	6p12.3	0.44	-0.77	0.99	0.86	1.20	1.96e-24	6.73e-23	(A) Negative
EGLN1	1q42.2	-0.70	-1.57	0.71	0.62	0.87	2.03e-24	6.95e-23	(A) Negative
LRBA	4q31.3	0.66	1.53	0.72	0.60	-0.87	2.04e-24	6.96e-23	(B) Positive
CREB3L2	7q33	1.09	0.18	0.75	0.60	0.91	2.12e-24	7.24e-23	(A) Negative
NFIB	9p23-p22.3	3.00	1.47	1.25	1.20	1.53	2.14e-24	7.28e-23	(A) Negative
AMD1	6q21	0.25	-0.76	0.83	0.70	1.00	2.22e-24	7.55e-23	(A) Negative
RBM38	20q13.31	0.18	-0.65	0.68	0.59	0.83	2.24e-24	7.59e-23	(A) Negative
GLI3	7p14.1	-0.31	1.15	1.21	1.01	-1.46	2.25e-24	7.61e-23	(B) Positive
ROPN1	3q21.1	1.12	-2.46	2.99	1.81	3.58	2.36e-24	7.98e-23	(A) Negative
EN1	2q14.2	3.45	0.95	2.10	1.21	2.51	2.72e-24	9.17e-23	(A) Negative
VAV3	1p13.3	1.80	3.56	1.46	1.14	-1.76	2.73e-24	9.19e-23	(B) Positive
RAI2	Xp22.13	1.38	2.69	1.04	1.27	-1.31	2.98e-24	1.00e-22	(B) Positive
PHOSPHO2	2q31.1	-0.00	0.97	0.79	0.81	-0.97	2.99e-24	1.00e-22	(B) Positive
ITPR1	3p26.1	-0.45	0.82	1.04	1.04	-1.28	2.99e-24	1.00e-22	(B) Positive
RAB17	2q37.3	-0.74	0.58	1.09	0.85	-1.32	3.21e-24	1.07e-22	(B) Positive
TEX10	9q31.1	-0.54	-1.17	0.53	0.43	0.63	3.26e-24	1.09e-22	(A) Negative
AKR7L	1p36.13	0.02	0.76	0.60	0.65	-0.74	3.28e-24	1.09e-22	(B) Positive
THPO	3q27.1	-0.92	-0.05	0.65	1.00	-0.87	3.36e-24	1.11e-22	(B) Positive
LMO4	1p22.3	1.63	-0.02	1.37	1.13	1.65	3.46e-24	1.15e-22	(A) Negative
RBMS1	2q24.2	0.35	-0.38	0.56	0.77	0.72	3.47e-24	1.15e-22	(A) Negative
FOXL1	16q24.1	1.00	-0.25	1.06	0.51	1.25	3.77e-24	1.24e-22	(A) Negative
TLE1	9q21.32	0.58	-0.31	0.69	0.96	0.89	4.08e-24	1.34e-22	(A) Negative
PRKD3	2p22.2	-1.20	-2.15	0.79	0.67	0.95	4.33e-24	1.42e-22	(A) Negative
DALRD3	3p21.31	-0.01	0.92	0.77	0.57	-0.92	4.53e-24	1.48e-22	(B) Positive
DNAAF1	16q24.1	0.36	1.45	0.87	1.03	-1.09	4.78e-24	1.56e-22	(B) Positive
SEZ6L	22q12.1	-1.14	-0.16	0.68	1.32	-0.99	4.94e-24	1.62e-22	(B) Positive
CDC45	22q11.21	-2.10	-3.12	0.82	0.91	1.02	5.16e-24	1.68e-22	(A) Negative
TMEM128	4p16.3	-0.07	0.54	0.50	0.50	-0.61	5.48e-24	1.78e-22	(B) Positive
CDCA5	11q13.1	-1.09	-2.05	0.77	0.94	0.96	5.85e-24	1.90e-22	(A) Negative
NAT2	8p22	0.48	2.03	1.22	1.58	-1.55	5.86e-24	1.90e-22	(B) Positive
TTC39A	1p32.3	1.23	2.86	1.36	1.10	-1.63	6.06e-24	1.96e-22	(B) Positive
TMSB10	2p11.2	1.24	0.49	0.60	0.72	0.75	6.27e-24	2.03e-22	(A) Negative
DIAPH3	13q21.2	-1.11	-2.16	0.88	0.79	1.06	7.14e-24	2.30e-22	(A) Negative
KCMF1	2p11.2	0.53	0.05	0.40	0.33	0.48	7.47e-24	2.40e-22	(A) Negative
ULK4	3p22.1	-0.22	0.56	0.63	0.73	-0.78	7.64e-24	2.45e-22	(B) Positive
MARCO	2q14.2	3.87	2.70	0.92	1.18	1.16	7.81e-24	2.50e-22	(A) Negative
PJA2	5q21.3	-0.15	0.48	0.53	0.47	-0.63	8.82e-24	2.83e-22	(B) Positive
FAAH	1p33	0.76	1.68	0.78	0.68	-0.93	1.02e-23	3.25e-22	(B) Positive
SFXN5	2p13.2	-0.29	0.31	0.47	0.65	-0.60	1.08e-23	3.45e-22	(B) Positive
EVA1B	1p34.3	1.35	2.27	0.75	0.86	-0.92	1.10e-23	3.50e-22	(B) Positive
LEMD1	1q32.1	-0.07	-3.13	2.61	1.44	3.06	1.10e-23	3.50e-22	(A) Negative
MCM7	7q22.1	-0.69	-1.30	0.52	0.47	0.62	1.15e-23	3.64e-22	(A) Negative
CEP126	11q22.1	-0.43	0.77	0.95	1.26	-1.20	1.15e-23	3.64e-22	(B) Positive
ATP11B	3q26.33	0.07	-0.73	0.64	0.79	0.80	1.19e-23	3.76e-22	(A) Negative
PTPN14	1q32.3-q41	0.72	-0.40	0.94	0.79	1.12	1.24e-23	3.91e-22	(A) Negative
SLC26A3	7q22.3-q31.1	-0.19	0.86	0.83	1.07	-1.04	1.24e-23	3.91e-22	(B) Positive
FOXM1	12p13.33	-0.74	-1.86	0.94	0.85	1.12	1.26e-23	3.96e-22	(A) Negative
NECTIN2	19q13.32	0.36	1.13	0.64	0.55	-0.76	1.26e-23	3.96e-22	(B) Positive
FAM114A2	5q33.2	0.11	0.74	0.53	0.46	-0.63	1.29e-23	4.05e-22	(B) Positive
LIN7A	12q21.31	-1.34	-0.11	0.91	1.53	-1.23	1.31e-23	4.08e-22	(B) Positive
REEP6	19p13.3	-0.86	1.11	1.67	1.24	-1.97	1.31e-23	4.08e-22	(B) Positive
CCND1	11q13.3	-0.98	0.59	1.32	1.17	-1.57	1.31e-23	4.08e-22	(B) Positive
NME3	16p13.3	0.32	1.33	0.86	0.56	-1.01	1.32e-23	4.12e-22	(B) Positive
COPZ1	12q13.13	-0.13	0.37	0.42	0.37	-0.50	1.37e-23	4.26e-22	(B) Positive
MINDY1	1q21.3	0.10	0.89	0.66	0.63	-0.79	1.38e-23	4.26e-22	(B) Positive
ENO1	1p36.23	-0.95	-1.70	0.63	0.55	0.75	1.46e-23	4.52e-22	(A) Negative
CST3	20p11.21	0.02	1.00	0.82	0.76	-0.98	1.51e-23	4.66e-22	(B) Positive
G6PC3	17q21.31	-0.13	0.35	0.39	0.49	-0.48	1.55e-23	4.76e-22	(B) Positive
MYL5	4p16.3	0.12	1.01	0.75	0.68	-0.90	1.56e-23	4.79e-22	(B) Positive
MISP	19p13.3	-1.34	0.47	1.53	1.31	-1.81	1.56e-23	4.79e-22	(B) Positive
DEFB1	8p23.1	2.63	0.76	1.55	1.58	1.87	1.64e-23	5.02e-22	(A) Negative
OCEL1	19p13.11	-0.30	0.58	0.74	0.58	-0.87	1.68e-23	5.15e-22	(B) Positive
NSMCE1	16p12.1	-0.51	0.21	0.60	0.51	-0.72	1.72e-23	5.26e-22	(B) Positive
KLF11	2p25.1	0.83	0.21	0.52	0.48	0.62	1.81e-23	5.51e-22	(A) Negative
STON2	14q31.1	-0.23	0.45	0.53	0.75	-0.68	1.81e-23	5.52e-22	(B) Positive
FANCB	Xp22.2	-1.06	-1.89	0.69	0.67	0.82	1.84e-23	5.59e-22	(A) Negative
AGBL2	11p11.2	-1.12	0.21	1.10	1.20	-1.33	1.84e-23	5.59e-22	(B) Positive
S100A9	1q21.3	2.97	0.99	1.63	1.79	1.98	1.88e-23	5.69e-22	(A) Negative
SEC14L2	22q12.2	0.76	1.89	0.87	1.30	-1.13	1.94e-23	5.86e-22	(B) Positive
SYTL2	11q14.1	-1.41	0.07	1.25	1.11	-1.48	2.01e-23	6.07e-22	(B) Positive
SIDT1	3q13.2	-0.42	1.81	1.92	1.12	-2.23	2.15e-23	6.47e-22	(B) Positive
RGS11	16p13.3	-0.22	0.61	0.69	0.76	-0.83	2.22e-23	6.68e-22	(B) Positive
PTCHD1	Xp22.11	1.45	-1.20	2.29	1.33	2.66	2.30e-23	6.91e-22	(A) Negative
ASAH1	8p22	0.95	1.94	0.81	0.95	-0.99	2.32e-23	6.94e-22	(B) Positive
CACNG1	17q24.2	-0.05	1.90	1.63	1.70	-1.95	2.59e-23	7.75e-22	(B) Positive
FBXO38	5q32	-0.08	0.41	0.41	0.42	-0.49	2.61e-23	7.78e-22	(B) Positive
PAK1IP1	6p24.2	-0.06	-0.82	0.65	0.49	0.76	2.73e-23	8.14e-22	(A) Negative
AR	Xq12	0.90	3.42	2.17	1.14	-2.51	2.76e-23	8.22e-22	(B) Positive
CENPI	Xq22.1	-0.81	-1.75	0.79	0.81	0.94	2.77e-23	8.23e-22	(A) Negative
STAC	3p22.3-p22.2	0.12	-1.72	1.60	0.69	1.84	2.81e-23	8.34e-22	(A) Negative
NXNL2	9q22.1	-1.17	-0.01	0.93	1.23	-1.16	2.82e-23	8.35e-22	(B) Positive
CROT	7q21.12	-0.59	0.66	1.05	1.06	-1.25	2.86e-23	8.44e-22	(B) Positive
ZNF688	16p11.2	0.43	1.11	0.58	0.50	-0.68	2.93e-23	8.65e-22	(B) Positive
PIGT	20q13.12	-0.11	0.65	0.63	0.68	-0.76	3.09e-23	9.10e-22	(B) Positive
AK8	9q34.13	1.28	2.46	1.00	0.86	-1.18	3.21e-23	9.42e-22	(B) Positive
PIMREG	17p13.2	-0.61	-1.72	0.94	0.95	1.12	3.40e-23	9.99e-22	(A) Negative
ANKRD42	11q14.1	0.62	1.39	0.66	0.57	-0.78	3.45e-23	1.01e-21	(B) Positive
MEIS3	19q13.32	-0.75	0.14	0.75	0.71	-0.88	3.49e-23	1.02e-21	(B) Positive
BID	22q11.21	0.20	-0.54	0.62	0.63	0.74	3.60e-23	1.05e-21	(A) Negative
GSDMC	8q24.21	2.88	1.15	1.48	1.24	1.73	3.70e-23	1.08e-21	(A) Negative
HHAT	1q32.2	1.23	2.40	1.01	0.79	-1.18	3.88e-23	1.13e-21	(B) Positive
CACNA1H	16p13.3	-0.59	0.45	0.80	1.26	-1.04	4.15e-23	1.21e-21	(B) Positive
GPM6B	Xp22.2	0.19	-1.32	1.29	1.10	1.51	4.22e-23	1.22e-21	(A) Negative
ETV6	12p13.2	1.95	1.15	0.69	0.49	0.80	4.30e-23	1.24e-21	(A) Negative
MRFAP1	4p16.1	-0.12	0.48	0.51	0.53	-0.60	4.34e-23	1.26e-21	(B) Positive
CCNB2	15q22.2	-1.22	-2.23	0.84	0.86	1.00	4.41e-23	1.27e-21	(A) Negative
STMN1	1p36.11	-0.52	-1.54	0.87	0.74	1.02	4.68e-23	1.35e-21	(A) Negative
PM20D2	6q15	-0.35	-2.19	1.58	1.24	1.84	5.13e-23	1.48e-21	(A) Negative
NIP7	16q22.1	-0.62	-1.28	0.56	0.46	0.65	5.32e-23	1.53e-21	(A) Negative
MZF1	19q13.43	-0.55	0.20	0.64	0.58	-0.75	5.46e-23	1.57e-21	(B) Positive
SKA3	13q12.11	-0.68	-1.64	0.81	0.89	0.96	5.70e-23	1.63e-21	(A) Negative
CSNK1A1	5q32	-0.02	0.52	0.47	0.38	-0.54	5.86e-23	1.67e-21	(B) Positive
IRS1	2q36.3	-0.84	0.35	1.02	0.89	-1.19	5.98e-23	1.71e-21	(B) Positive
S100A8	1q21.3	2.86	0.38	2.12	1.95	2.48	6.80e-23	1.94e-21	(A) Negative
GABRP	5q35.1	3.89	1.52	2.04	1.74	2.37	6.88e-23	1.95e-21	(A) Negative
NDC80	18p11.32	-0.74	-1.84	0.94	0.88	1.11	6.90e-23	1.96e-21	(A) Negative
LEO1	15q21.2	-0.60	0.06	0.57	0.54	-0.67	6.93e-23	1.96e-21	(B) Positive
ACOX2	3p14.3	-0.75	1.48	1.90	1.80	-2.22	6.95e-23	1.97e-21	(B) Positive
E2F2	1p36.12	-0.46	-1.13	0.57	0.55	0.67	7.16e-23	2.02e-21	(A) Negative
C1QTNF7	4p15.32	0.86	1.77	0.71	1.10	-0.91	7.36e-23	2.07e-21	(B) Positive
TMEM65	8q24.13	1.18	0.15	0.87	0.89	1.03	7.38e-23	2.08e-21	(A) Negative
NHSL1	6q24.1	-0.32	-1.35	0.87	0.85	1.02	7.53e-23	2.12e-21	(A) Negative
ROPN1L	5p15.2	-0.79	0.70	1.24	1.41	-1.49	7.56e-23	2.12e-21	(B) Positive
CRIP1	14q32.33	0.93	2.60	1.45	1.07	-1.67	7.68e-23	2.15e-21	(B) Positive
CYP2A6	19q13.2	0.46	1.63	0.78	1.72	-1.17	7.81e-23	2.18e-21	(B) Positive
CFAP52	17p13.1	0.06	0.99	0.71	1.16	-0.93	8.00e-23	2.23e-21	(B) Positive
EAPP	14q13.1	-0.03	0.58	0.52	0.41	-0.60	8.24e-23	2.30e-21	(B) Positive
CRY2	11p11.2	0.14	0.63	0.41	0.47	-0.50	8.41e-23	2.34e-21	(B) Positive
ZNF92	7q11.21	-0.12	0.55	0.54	0.74	-0.68	8.49e-23	2.36e-21	(B) Positive
CDC42EP1	22q13.1	0.63	0.14	0.42	0.42	0.49	8.61e-23	2.39e-21	(A) Negative
UGT8	4q26	1.04	-1.08	1.87	0.87	2.12	8.64e-23	2.39e-21	(A) Negative
TMEM9B	11p15.4	0.94	1.58	0.54	0.55	-0.64	8.70e-23	2.40e-21	(B) Positive
MYO5C	15q21.2	-0.00	1.07	0.94	0.69	-1.07	9.13e-23	2.52e-21	(B) Positive
LETM2	8p11.23	-0.19	0.57	0.62	0.81	-0.76	9.84e-23	2.71e-21	(B) Positive
CIB2	15q25.1	0.64	-0.52	1.01	0.74	1.15	9.87e-23	2.71e-21	(A) Negative
PTK7	6p21.1	1.20	0.41	0.64	0.87	0.79	1.01e-22	2.77e-21	(A) Negative
SPDEF	6p21.31	0.08	2.37	2.02	0.94	-2.28	1.08e-22	2.97e-21	(B) Positive
CENPF	1q41	-0.66	-1.71	0.88	0.95	1.04	1.08e-22	2.97e-21	(A) Negative
RTN4RL1	17p13.3	0.33	1.73	1.23	0.80	-1.40	1.09e-22	2.98e-21	(B) Positive
STEAP3	2q14.2	0.55	-0.38	0.80	0.73	0.93	1.09e-22	2.98e-21	(A) Negative
PSMG1	21q22.2	-0.74	-1.54	0.68	0.61	0.79	1.10e-22	3.00e-21	(A) Negative
WNT6	2q35	0.95	-0.24	1.04	0.66	1.19	1.12e-22	3.04e-21	(A) Negative
METRN	16p13.3	-0.56	1.04	1.40	1.08	-1.61	1.12e-22	3.05e-21	(B) Positive
QNG1	9q21.32	-0.35	0.48	0.72	0.60	-0.83	1.17e-22	3.17e-21	(B) Positive
FAM136A	2p13.3	-0.22	-0.89	0.58	0.43	0.67	1.19e-22	3.23e-21	(A) Negative
PTCD2	5q13.2	-1.20	-0.64	0.49	0.45	-0.57	1.21e-22	3.28e-21	(B) Positive
PFKP	10p15.2	-0.77	-1.99	1.06	0.89	1.22	1.22e-22	3.29e-21	(A) Negative
CSRP2	12q21.2	0.32	-1.14	1.27	1.03	1.46	1.23e-22	3.31e-21	(A) Negative
CERS2	1q21.3	0.16	0.90	0.64	0.63	-0.75	1.24e-22	3.32e-21	(B) Positive
SLC24A1	15q22.31	-0.00	0.61	0.52	0.52	-0.61	1.26e-22	3.38e-21	(B) Positive
TRIM8	10q24.32	0.81	1.39	0.50	0.46	-0.58	1.30e-22	3.49e-21	(B) Positive
COG7	16p12.2	-0.16	0.33	0.43	0.42	-0.50	1.34e-22	3.59e-21	(B) Positive
SEMA3F	3p21.31	0.42	1.23	0.70	0.60	-0.81	1.36e-22	3.63e-21	(B) Positive
ZSCAN32	16p13.3	-0.41	0.26	0.58	0.51	-0.67	1.37e-22	3.66e-21	(B) Positive
ADAT2	6q24.2	-1.28	-2.11	0.73	0.61	0.84	1.37e-22	3.66e-21	(A) Negative
SLC7A5	16q24.2	-0.87	-1.82	0.83	0.71	0.96	1.40e-22	3.72e-21	(A) Negative
SMOX	20p13	-0.52	-1.19	0.57	0.54	0.66	1.40e-22	3.72e-21	(A) Negative
RAB26	16p13.3	-0.69	0.43	0.96	0.93	-1.12	1.41e-22	3.74e-21	(B) Positive
TUT4	1p32.3	-0.81	-1.65	0.70	0.84	0.84	1.44e-22	3.81e-21	(A) Negative
UBE2J1	6q15	0.45	-0.23	0.60	0.49	0.69	1.50e-22	3.97e-21	(A) Negative
ZSWIM5	1p34.1	-1.98	-0.80	1.01	1.09	-1.19	1.51e-22	3.99e-21	(B) Positive
FGF10	5p12	0.68	1.75	0.70	1.62	-1.06	1.61e-22	4.25e-21	(B) Positive
COMMD10	5q23.1	-0.68	0.11	0.68	0.59	-0.78	1.62e-22	4.27e-21	(B) Positive
ZNF286A	17p12	-0.09	-0.92	0.73	0.57	0.83	1.68e-22	4.40e-21	(A) Negative
CX3CL1	16q21	1.71	0.72	0.87	0.76	1.00	1.69e-22	4.43e-21	(A) Negative
GDF15	19p13.11	-3.40	-2.02	1.17	1.30	-1.38	1.73e-22	4.53e-21	(B) Positive
GALNT3	2q24.3	3.22	1.80	1.11	1.77	1.42	1.75e-22	4.59e-21	(A) Negative
OR8B8	11q24.2	0.55	0.06	0.41	0.44	0.48	1.77e-22	4.63e-21	(A) Negative
SH2D2A	1q23.1	0.04	-1.07	0.95	1.00	1.11	1.79e-22	4.68e-21	(A) Negative
SFRP1	8p11.21	0.93	-1.90	2.46	2.15	2.83	1.82e-22	4.74e-21	(A) Negative
C5ORF15	5q31.1	-0.30	0.28	0.51	0.44	-0.58	1.91e-22	4.96e-21	(B) Positive
TMEM115	3p21.31	0.14	0.60	0.41	0.37	-0.47	1.95e-22	5.06e-21	(B) Positive
ADCY9	16p13.3	-0.43	0.42	0.73	0.71	-0.85	1.98e-22	5.15e-21	(B) Positive
FAM241A	4q25	0.10	1.37	1.11	0.94	-1.27	2.00e-22	5.18e-21	(B) Positive
KIF16B	20p12.1	1.19	2.20	0.87	0.83	-1.00	2.01e-22	5.19e-21	(B) Positive
BRD8	5q31.2	-0.65	-0.14	0.44	0.42	-0.51	2.02e-22	5.20e-21	(B) Positive
GHDC	17q21.2	-0.08	0.69	0.66	0.66	-0.77	2.02e-22	5.20e-21	(B) Positive
GPT2	16q11.2	-0.15	-1.34	1.03	0.94	1.18	2.07e-22	5.33e-21	(A) Negative
BYSL	6p21.1	-0.00	-0.60	0.51	0.53	0.59	2.08e-22	5.34e-21	(A) Negative
VLDLR	9p24.2	-0.22	-1.47	1.08	1.02	1.25	2.12e-22	5.44e-21	(A) Negative
ODC1	2p25.1	-1.28	-2.34	0.93	0.80	1.06	2.24e-22	5.75e-21	(A) Negative
ZNF385A	12q13.13	0.27	0.92	0.56	0.59	-0.65	2.25e-22	5.75e-21	(B) Positive
GTSE1	22q13.31	-0.96	-1.81	0.74	0.69	0.85	2.35e-22	6.00e-21	(A) Negative
TLE4	9q21.31	-0.08	-0.91	0.72	0.71	0.83	2.36e-22	6.03e-21	(A) Negative
PFDN5	12q13.13	-0.09	0.43	0.46	0.36	-0.52	2.44e-22	6.21e-21	(B) Positive
MCM5	22q12.3	-0.17	-0.82	0.56	0.52	0.65	2.44e-22	6.21e-21	(A) Negative
MOAP1	14q32.12	-0.45	0.29	0.62	0.71	-0.73	2.51e-22	6.37e-21	(B) Positive
HMGCL	1p36.11	-0.25	0.51	0.66	0.59	-0.76	2.53e-22	6.41e-21	(B) Positive
BLVRA	7p13	-0.55	0.38	0.81	0.79	-0.93	2.54e-22	6.44e-21	(B) Positive
AADAT	4q33	-0.13	-1.00	0.77	0.58	0.87	2.57e-22	6.50e-21	(A) Negative
CORO1C	12q24.11	-0.09	-0.76	0.58	0.57	0.67	2.62e-22	6.61e-21	(A) Negative
ZIC1	3q24	-0.47	-2.32	1.64	1.18	1.85	2.64e-22	6.66e-21	(A) Negative
IKBKB	8p11.21	0.06	0.68	0.52	0.64	-0.62	2.68e-22	6.74e-21	(B) Positive
IL22RA2	6q23.3	2.88	0.92	1.76	0.94	1.97	2.69e-22	6.76e-21	(A) Negative
RAMP2	17q21.2	0.59	1.36	0.65	0.80	-0.78	2.72e-22	6.83e-21	(B) Positive
SCAMP1	5q14.1	0.07	0.74	0.57	0.55	-0.66	2.77e-22	6.94e-21	(B) Positive
TCF7L1	2p11.2	1.81	0.13	1.47	1.32	1.68	2.93e-22	7.34e-21	(A) Negative
PEX12	17q12	-0.18	0.48	0.56	0.57	-0.65	2.96e-22	7.39e-21	(B) Positive
BPIFB1	20q11.21	0.97	3.04	1.83	1.51	-2.08	3.06e-22	7.63e-21	(B) Positive
BLM	15q26.1	-1.11	-2.06	0.83	0.83	0.96	3.38e-22	8.43e-21	(A) Negative
ATP6V1C2	2p25.1	1.61	-0.49	1.87	1.34	2.10	3.44e-22	8.56e-21	(A) Negative
GMPR2	14q12	-0.82	-0.20	0.55	0.45	-0.62	3.55e-22	8.83e-21	(B) Positive
TNS2	12q13.13	0.35	1.10	0.66	0.60	-0.75	3.62e-22	8.99e-21	(B) Positive
GPRC5B	16p12.3	1.07	0.08	0.88	0.65	0.99	3.64e-22	9.02e-21	(A) Negative
GHRH	20q11.23	-0.12	0.67	0.54	1.19	-0.80	3.72e-22	9.21e-21	(B) Positive
TIMM8A	Xq22.1	-0.57	-1.23	0.58	0.53	0.67	3.74e-22	9.24e-21	(A) Negative
DMXL1	5q23.1	-0.44	0.11	0.48	0.46	-0.55	3.75e-22	9.24e-21	(B) Positive
ELF5	11p13	4.10	1.66	2.16	1.79	2.44	3.77e-22	9.28e-21	(A) Negative
MSX2	5q35.2	-1.17	0.29	1.29	0.99	-1.45	3.77e-22	9.28e-21	(B) Positive
N4BP3	5q35.3	0.43	1.28	0.75	0.66	-0.85	4.02e-22	9.87e-21	(B) Positive
CDK17	12q23.1	-0.02	0.67	0.59	0.65	-0.69	4.07e-22	9.97e-21	(B) Positive
ASS1	9q34.11	-0.57	-1.82	1.06	1.23	1.25	4.24e-22	1.04e-20	(A) Negative
DBNDD2	20q13.12	0.80	1.68	0.76	0.80	-0.88	4.35e-22	1.06e-20	(B) Positive
LY6D	8q24.3	1.66	-0.54	1.98	1.10	2.21	4.35e-22	1.06e-20	(A) Negative
TRMT10A	4q23	-0.09	0.62	0.62	0.61	-0.71	4.52e-22	1.10e-20	(B) Positive
RAB6B	3q22.1	-0.17	-1.22	0.93	0.70	1.05	4.58e-22	1.11e-20	(A) Negative
NUS1	6q22.1	0.11	-0.67	0.68	0.61	0.78	4.60e-22	1.12e-20	(A) Negative
C3ORF52	3q13.2	0.11	1.21	0.92	1.17	-1.10	4.69e-22	1.14e-20	(B) Positive
HNRNPH2	Xq22.1	0.31	0.82	0.43	0.49	-0.50	4.76e-22	1.15e-20	(B) Positive
NASP	1p34.1	-0.86	-1.57	0.64	0.44	0.71	4.79e-22	1.16e-20	(A) Negative
AQP5	12q13.12	2.68	1.10	1.38	1.28	1.57	4.92e-22	1.19e-20	(A) Negative
RRP1B	21q22.3	-0.37	-0.98	0.55	0.40	0.61	5.08e-22	1.23e-20	(A) Negative
PHF7	3p21.1	-0.24	0.60	0.73	0.79	-0.85	5.25e-22	1.27e-20	(B) Positive
BTD	3p25.1	-0.03	0.75	0.68	0.69	-0.78	5.33e-22	1.28e-20	(B) Positive
CALU	7q32.1	0.56	-0.20	0.67	0.56	0.76	5.41e-22	1.30e-20	(A) Negative
WWTR1	3q25.1	0.62	-0.77	1.25	0.76	1.39	5.53e-22	1.33e-20	(A) Negative
CDK6	7q21.2	-1.51	-2.76	1.12	0.79	1.25	5.61e-22	1.35e-20	(A) Negative
MAP4K4	2q11.2	-0.49	-1.18	0.61	0.55	0.69	5.83e-22	1.40e-20	(A) Negative
IQUB	7q31.32	-0.01	0.84	0.69	1.00	-0.85	6.00e-22	1.43e-20	(B) Positive
DTX3	12q13.3	-0.50	0.04	0.45	0.56	-0.54	6.04e-22	1.44e-20	(B) Positive
MDP1	14q12	-0.91	-0.16	0.66	0.59	-0.75	6.06e-22	1.45e-20	(B) Positive
SERPINA6	14q32.13	-3.40	-1.76	1.02	2.65	-1.64	6.70e-22	1.59e-20	(B) Positive
DONSON	21q22.11	-1.17	-2.05	0.77	0.72	0.88	6.96e-22	1.65e-20	(A) Negative
CCDC78	16p13.3	-2.20	-1.06	0.95	1.23	-1.14	7.02e-22	1.67e-20	(B) Positive
CXCL1	4q13.3	-1.25	-3.58	2.09	1.62	2.34	7.21e-22	1.71e-20	(A) Negative
LCMT2	15q15.3	0.13	0.75	0.55	0.49	-0.62	7.41e-22	1.76e-20	(B) Positive
TLCD3B	16p11.2	-1.14	-0.35	0.65	0.92	-0.79	7.52e-22	1.78e-20	(B) Positive
APLF	2p13.3	0.80	0.12	0.57	0.73	0.68	7.84e-22	1.85e-20	(A) Negative
SEMA3B	3p21.31	-2.43	-1.21	1.05	1.17	-1.21	8.14e-22	1.92e-20	(B) Positive
CERS4	19p13.2	0.58	1.63	0.94	0.77	-1.06	8.18e-22	1.92e-20	(B) Positive
NRIP1	21q11.2-q21.1	0.08	1.18	0.97	0.88	-1.10	8.18e-22	1.92e-20	(B) Positive
GUSBP14	5q13.2	-0.95	0.55	1.32	1.27	-1.50	8.21e-22	1.93e-20	(B) Positive
PPP1R3C	10q23.32	-1.92	0.08	1.74	1.86	-2.00	8.53e-22	2.00e-20	(B) Positive
RPH3AL	17p13.3	0.13	1.25	1.00	0.85	-1.12	8.73e-22	2.05e-20	(B) Positive
UBASH3B	11q24.1	-0.10	-1.07	0.88	0.57	0.98	8.83e-22	2.07e-20	(A) Negative
ZNF446	19q13.43	0.37	0.76	0.35	0.32	-0.39	9.03e-22	2.11e-20	(B) Positive
PIGQ	16p13.3	0.07	0.70	0.56	0.52	-0.63	9.36e-22	2.18e-20	(B) Positive
ROPN1B	3q21.2	1.34	-2.12	3.14	1.84	3.46	9.62e-22	2.24e-20	(A) Negative
NUDT16L1	16p13.3	0.34	0.97	0.56	0.46	-0.63	9.70e-22	2.26e-20	(B) Positive
LZTFL1	3p21.31	-0.15	0.49	0.56	0.60	-0.64	1.01e-21	2.36e-20	(B) Positive
ARFIP2	11p15.4	0.16	0.83	0.59	0.59	-0.67	1.06e-21	2.45e-20	(B) Positive
EEF1A2	20q13.33	-2.77	-1.06	1.46	1.78	-1.71	1.07e-21	2.48e-20	(B) Positive
PLOD1	1p36.22	-0.23	-1.14	0.82	0.53	0.91	1.11e-21	2.57e-20	(A) Negative
HDAC2	6q21	0.63	-0.17	0.72	0.59	0.80	1.14e-21	2.63e-20	(A) Negative
LIMA1	12q13.12	0.01	0.97	0.87	0.63	-0.96	1.15e-21	2.66e-20	(B) Positive
RHCG	15q26.1	1.59	0.04	1.41	0.85	1.55	1.18e-21	2.72e-20	(A) Negative
APPL2	12q23.3	-0.43	0.11	0.47	0.47	-0.54	1.20e-21	2.77e-20	(B) Positive
KIF18A	11p14.1	-1.23	-2.25	0.88	0.97	1.01	1.21e-21	2.79e-20	(A) Negative
C1GALT1	7p22.1-p21.3	-0.52	-1.61	0.97	0.88	1.08	1.22e-21	2.80e-20	(A) Negative
OCIAD1	4p11	-0.36	0.21	0.51	0.46	-0.57	1.29e-21	2.96e-20	(B) Positive
ASCL1	12q23.2	-1.08	-0.04	0.61	1.75	-1.04	1.31e-21	3.00e-20	(B) Positive
RANBP1	22q11.21	-0.71	-1.42	0.64	0.51	0.71	1.33e-21	3.03e-20	(A) Negative
NCAPH	2q11.2	-1.04	-1.86	0.71	0.77	0.81	1.34e-21	3.06e-20	(A) Negative
SPCS1	3p21.1	-0.76	-0.19	0.50	0.53	-0.57	1.39e-21	3.16e-20	(B) Positive
IK	5q31.3	-0.34	0.13	0.42	0.39	-0.47	1.41e-21	3.20e-20	(B) Positive
RAMP1	2q37.3	0.47	1.86	1.20	1.39	-1.39	1.45e-21	3.29e-20	(B) Positive
CDCA2	8p21.2	-0.92	-2.02	0.99	0.73	1.09	1.45e-21	3.30e-20	(A) Negative
PLAT	8p11.21	-0.45	0.86	1.12	1.39	-1.31	1.50e-21	3.39e-20	(B) Positive
NPM2	8p21.3	-0.36	-1.60	1.13	0.69	1.24	1.50e-21	3.40e-20	(A) Negative
TENT2	5q14.1	-0.67	-0.14	0.47	0.43	-0.52	1.52e-21	3.44e-20	(B) Positive
FAAH2	Xp11.21	0.54	1.68	1.03	0.76	-1.14	1.54e-21	3.47e-20	(B) Positive
ARL3	10q24.32	0.04	0.76	0.65	0.58	-0.72	1.55e-21	3.50e-20	(B) Positive
MAP3K21	1q42.2	0.52	-0.64	1.05	0.85	1.17	1.56e-21	3.51e-20	(A) Negative
APOF	12q13.3	-2.42	-1.29	0.91	1.41	-1.13	1.57e-21	3.53e-20	(B) Positive
CYP7B1	8q12.3	3.75	2.57	1.05	0.99	1.18	1.57e-21	3.53e-20	(A) Negative
OR7E24	19p13.2	0.71	-0.10	0.73	0.62	0.81	1.59e-21	3.57e-20	(A) Negative
BHLHE40	3p26.1	-0.13	0.81	0.85	0.57	-0.94	1.64e-21	3.68e-20	(B) Positive
SLC16A10	6q21	-0.65	-1.72	0.98	0.72	1.08	1.70e-21	3.81e-20	(A) Negative
PPIP5K1	15q15.3	-0.36	0.33	0.61	0.59	-0.69	1.71e-21	3.83e-20	(B) Positive
FAM83D	20q11.23	-0.89	-2.09	1.03	1.26	1.20	1.76e-21	3.92e-20	(A) Negative
ARL9	4q12	2.39	0.51	1.70	1.31	1.87	1.77e-21	3.94e-20	(A) Negative
ABCA3	16p13.3	0.77	1.68	0.81	0.79	-0.91	1.78e-21	3.95e-20	(B) Positive
CCDC191	3q13.31	1.05	1.94	0.80	0.74	-0.89	1.80e-21	3.99e-20	(B) Positive
GPRIN2	10q11.22	2.35	0.95	1.24	1.20	1.39	1.80e-21	3.99e-20	(A) Negative
ITM2C	2q37.1	-0.65	-1.49	0.76	0.64	0.84	1.81e-21	4.00e-20	(A) Negative
RSU1	10p13	1.43	0.63	0.72	0.59	0.80	1.81e-21	4.01e-20	(A) Negative
RBM24	6p22.3	-0.99	0.42	1.14	1.77	-1.41	1.85e-21	4.09e-20	(B) Positive
WDR25	14q32.2	-0.16	0.37	0.47	0.49	-0.54	1.86e-21	4.12e-20	(B) Positive
FABP7	6q22.31	-0.02	-3.56	3.25	1.90	3.54	1.94e-21	4.28e-20	(A) Negative
CBX4	17q25.3	-0.27	0.39	0.54	0.77	-0.65	2.02e-21	4.44e-20	(B) Positive
CCNQ	Xq28	0.99	0.39	0.55	0.40	0.60	2.04e-21	4.50e-20	(A) Negative
JKAMP	14q23.1	0.08	0.78	0.63	0.52	-0.70	2.13e-21	4.67e-20	(B) Positive
HDHD2	18q21.1	-0.40	0.22	0.55	0.58	-0.62	2.13e-21	4.68e-20	(B) Positive
PCDH19	Xq22.1	0.20	0.91	0.60	0.81	-0.72	2.31e-21	5.07e-20	(B) Positive
PTP4A2	1p35.2	0.16	0.88	0.64	0.65	-0.73	2.37e-21	5.19e-20	(B) Positive
FOXD2	1p33	0.01	1.00	0.86	0.96	-0.99	2.39e-21	5.22e-20	(B) Positive
KALRN	3q21.1-q21.2	0.49	-0.38	0.80	0.58	0.87	2.47e-21	5.40e-20	(A) Negative
LRRC73	6p21.1	0.08	1.28	1.09	0.95	-1.20	2.47e-21	5.40e-20	(B) Positive
CCNYL1	2q33.3	0.14	-0.81	0.87	0.65	0.96	2.50e-21	5.44e-20	(A) Negative
CCDC18	1p22.1	-1.32	-2.24	0.83	0.74	0.92	2.59e-21	5.64e-20	(A) Negative
HAUS8	19p13.11	-0.37	-0.91	0.48	0.51	0.54	2.71e-21	5.89e-20	(A) Negative
FAH	15q25.1	-0.32	0.51	0.75	0.72	-0.84	2.74e-21	5.96e-20	(B) Positive
OSCP1	1p34.3	1.50	2.32	0.74	0.68	-0.82	2.90e-21	6.29e-20	(B) Positive
SCCPDH	1q44	-0.63	0.68	1.21	0.82	-1.32	2.94e-21	6.36e-20	(B) Positive
DNMBP	10q24.2	-1.29	-0.34	0.84	0.92	-0.95	3.01e-21	6.52e-20	(B) Positive
KITLG	12q21.32	0.52	1.84	1.17	1.19	-1.31	3.03e-21	6.54e-20	(B) Positive
ST14	11q24.3	2.18	1.60	0.51	0.58	0.59	3.03e-21	6.54e-20	(A) Negative
ACMSD	2q21.3	-0.73	0.77	1.19	1.96	-1.50	3.04e-21	6.54e-20	(B) Positive
LYPD6	2q23.2	-0.88	0.42	1.12	1.38	-1.30	3.07e-21	6.60e-20	(B) Positive
ATP1A2	1q23.2	-2.92	-1.28	1.39	1.86	-1.64	3.11e-21	6.68e-20	(B) Positive
CYP4B1	1p33	0.56	3.09	2.30	1.96	-2.53	3.16e-21	6.77e-20	(B) Positive
USP47	11p15.3	-0.06	0.55	0.55	0.55	-0.62	3.18e-21	6.82e-20	(B) Positive
PKIB	6q22.31	-0.58	1.15	1.54	1.63	-1.73	3.38e-21	7.24e-20	(B) Positive
CLSPN	1p34.3	-0.84	-1.62	0.70	0.67	0.78	3.41e-21	7.30e-20	(A) Negative
TSG101	11p15.1	0.18	0.65	0.41	0.46	-0.47	3.44e-21	7.34e-20	(B) Positive
ZNF24	18q12.2	0.51	1.10	0.53	0.51	-0.59	3.61e-21	7.70e-20	(B) Positive
TAF9	5q13.2	-1.16	-0.68	0.43	0.42	-0.48	3.67e-21	7.82e-20	(B) Positive
FBXO15	18q22.3	0.47	1.94	1.33	1.25	-1.48	3.68e-21	7.84e-20	(B) Positive
SLC43A3	11q12.1	-0.50	-1.45	0.88	0.64	0.95	3.76e-21	7.99e-20	(A) Negative
DCAF10	9p13.2	0.25	0.94	0.56	0.88	-0.69	3.80e-21	8.06e-20	(B) Positive
DCPS	11q24.2	-0.37	-1.03	0.60	0.52	0.66	3.83e-21	8.13e-20	(A) Negative
ADIRF	10q23.2	2.72	3.91	1.10	0.72	-1.19	3.93e-21	8.32e-20	(B) Positive
PHYHD1	9q34.11	0.33	1.57	1.10	1.23	-1.25	4.48e-21	9.47e-20	(B) Positive
CMBL	5p15.2	-0.90	0.82	1.60	0.92	-1.71	4.61e-21	9.74e-20	(B) Positive
LANCL3	Xp21.1	-1.14	-2.26	1.04	0.63	1.12	4.63e-21	9.77e-20	(A) Negative
ZC3H10	12q13.2	0.47	0.90	0.39	0.34	-0.43	4.97e-21	1.05e-19	(B) Positive
RAP2A	13q32.1	0.85	0.07	0.72	0.54	0.79	4.98e-21	1.05e-19	(A) Negative
LAMP3	3q27.1	3.46	1.58	1.72	1.54	1.89	5.15e-21	1.08e-19	(A) Negative
SHCBP1	16q11.2	-1.53	-2.42	0.78	0.97	0.90	5.21e-21	1.09e-19	(A) Negative
DEF8	16q24.3	-0.51	-1.16	0.59	0.51	0.65	5.27e-21	1.10e-19	(A) Negative
CYP4F22	19p13.12	-0.06	0.91	0.83	1.10	-0.97	5.34e-21	1.12e-19	(B) Positive
RAD50	5q31.1	-0.65	-0.05	0.54	0.52	-0.60	5.52e-21	1.16e-19	(B) Positive
GSTM3	1p13.3	-0.25	1.35	1.42	1.56	-1.60	5.77e-21	1.21e-19	(B) Positive
UBE3B	12q24.11	0.31	0.81	0.45	0.43	-0.49	5.78e-21	1.21e-19	(B) Positive
MZT2B	2q21.1	-0.43	-0.07	0.32	0.36	-0.36	5.97e-21	1.24e-19	(B) Positive
CHST15	10q26.13	-0.05	1.02	0.98	0.78	-1.06	6.07e-21	1.26e-19	(B) Positive
KATNA1	6q25.1	0.22	-0.37	0.54	0.47	0.59	6.16e-21	1.28e-19	(A) Negative
LDHB	12p12.1	-1.08	-2.44	1.27	0.86	1.37	6.27e-21	1.30e-19	(A) Negative
SLC34A2	4p15.2	2.70	1.26	1.32	1.08	1.44	6.71e-21	1.39e-19	(A) Negative
DNAAF3	19q13.42	-1.26	-0.27	0.88	0.97	-0.99	6.74e-21	1.40e-19	(B) Positive
EFCAB6	22q13.2-q13.31	1.06	2.15	0.99	0.91	-1.09	6.76e-21	1.40e-19	(B) Positive
NISCH	3p21.1	-0.06	0.49	0.50	0.51	-0.55	6.95e-21	1.44e-19	(B) Positive
TMEM41B	11p15.4	-0.58	-0.04	0.48	0.52	-0.54	7.14e-21	1.47e-19	(B) Positive
RPP40	6p25.1	-0.19	-0.88	0.64	0.55	0.69	7.22e-21	1.49e-19	(A) Negative
ZBTB4	17p13.1	0.67	1.30	0.57	0.54	-0.62	7.32e-21	1.51e-19	(B) Positive
MND1	4q31.3	-1.72	-2.87	1.02	1.14	1.14	7.42e-21	1.53e-19	(A) Negative
CORO6	17q11.2	-1.50	-0.59	0.60	1.48	-0.91	7.62e-21	1.57e-19	(B) Positive
TKFC	11q12.2	-0.78	-0.12	0.61	0.57	-0.67	7.77e-21	1.59e-19	(B) Positive
KIAA0825	5q15	-1.71	-1.13	0.51	0.56	-0.58	8.05e-21	1.65e-19	(B) Positive
FUT3	19p13.3	1.83	0.01	1.63	1.71	1.81	8.22e-21	1.68e-19	(A) Negative
FSCN1	7p22.1	-0.94	-1.86	0.85	0.70	0.92	8.44e-21	1.72e-19	(A) Negative
AUNIP	1p36.11	-0.79	-1.78	0.89	0.92	0.99	8.45e-21	1.73e-19	(A) Negative
TTYH3	7p22.3	0.01	-0.63	0.58	0.60	0.65	8.49e-21	1.73e-19	(A) Negative
CFAP92	3q21.3	0.45	1.92	1.30	1.54	-1.47	8.50e-21	1.73e-19	(B) Positive
CYB561D2	3p21.31	0.05	0.89	0.78	0.59	-0.84	8.54e-21	1.74e-19	(B) Positive
EPHB3	3q27.1	3.01	2.20	0.74	0.69	0.81	8.66e-21	1.76e-19	(A) Negative
DNMT3B	20q11.21	-2.74	-3.93	1.09	0.91	1.18	8.75e-21	1.78e-19	(A) Negative
DKC1	Xq28	-0.24	-0.85	0.57	0.48	0.61	8.81e-21	1.79e-19	(A) Negative
RASGEF1C	5q35.3	0.72	-0.36	1.02	0.47	1.08	8.97e-21	1.82e-19	(A) Negative
HCAR1	12q24.31	0.52	1.76	1.15	0.84	-1.23	8.99e-21	1.82e-19	(B) Positive
TES	7q31.2	1.38	0.55	0.73	0.84	0.82	9.23e-21	1.86e-19	(A) Negative
ACOT9	Xp22.11	-0.31	-1.11	0.73	0.69	0.80	9.54e-21	1.92e-19	(A) Negative
CPA6	8q13.2	-1.04	0.28	0.95	2.04	-1.32	9.82e-21	1.98e-19	(B) Positive
RFWD3	16q23.1	-0.48	-1.09	0.56	0.52	0.61	1.00e-20	2.02e-19	(A) Negative
WBP1L	10q24.32	0.92	1.47	0.50	0.49	-0.55	1.00e-20	2.02e-19	(B) Positive
CLCN4	Xp22.2	0.87	-0.37	1.17	0.73	1.24	1.01e-20	2.02e-19	(A) Negative
TEX264	3p21.2	0.19	0.74	0.49	0.52	-0.55	1.05e-20	2.10e-19	(B) Positive
BAG1	9p13.3	-0.16	0.58	0.65	0.83	-0.74	1.09e-20	2.17e-19	(B) Positive
PUM3	9p24.2	0.21	-0.66	0.81	0.50	0.87	1.10e-20	2.20e-19	(A) Negative
ASB8	12q13.11	0.48	0.95	0.43	0.38	-0.47	1.11e-20	2.21e-19	(B) Positive
COA7	1p32.3	-0.46	-1.03	0.52	0.47	0.56	1.11e-20	2.21e-19	(A) Negative
SHROOM1	5q31.1	-1.11	0.07	0.99	1.49	-1.18	1.13e-20	2.24e-19	(B) Positive
MYBL2	20q13.12	-0.95	-1.91	0.86	0.97	0.97	1.13e-20	2.26e-19	(A) Negative
NUF2	1q23.3	-0.92	-2.02	0.98	1.10	1.09	1.20e-20	2.39e-19	(A) Negative
CAPSL	5p13.2	1.02	2.41	1.18	1.68	-1.39	1.20e-20	2.39e-19	(B) Positive
C1QL2	2q14.2	1.43	0.03	1.32	0.66	1.39	1.25e-20	2.49e-19	(A) Negative
ACOT2	14q24.3	-0.44	0.38	0.74	0.75	-0.82	1.30e-20	2.59e-19	(B) Positive
CDCA3	12p13.31	-0.48	-1.35	0.80	0.73	0.87	1.34e-20	2.66e-19	(A) Negative
SIGIRR	11p15.5	0.35	1.06	0.66	0.55	-0.71	1.36e-20	2.70e-19	(B) Positive
ARL5B	10p12.31	1.06	0.19	0.81	0.62	0.86	1.39e-20	2.74e-19	(A) Negative
CTSF	11q13.2	1.11	1.97	0.79	0.78	-0.86	1.40e-20	2.76e-19	(B) Positive
DEPDC1B	5q12.1	-1.81	-2.78	0.85	1.05	0.97	1.42e-20	2.81e-19	(A) Negative
SEMA3C	7q21.11	-1.10	0.43	1.43	1.10	-1.53	1.43e-20	2.81e-19	(B) Positive
MFSD5	12q13.13	0.39	0.85	0.43	0.35	-0.46	1.46e-20	2.88e-19	(B) Positive
PRNP	20p13	-0.12	-0.78	0.60	0.61	0.66	1.53e-20	3.00e-19	(A) Negative
PNMA5	Xq28	0.56	-0.78	1.27	0.79	1.34	1.57e-20	3.07e-19	(A) Negative
TOX4	14q11.2	-0.09	0.41	0.46	0.36	-0.49	1.58e-20	3.09e-19	(B) Positive
PRSS23	11q14.2	-1.86	-0.74	0.97	1.29	-1.12	1.59e-20	3.12e-19	(B) Positive
BMPR1B	4q22.3	1.01	2.57	1.23	2.19	-1.56	1.66e-20	3.25e-19	(B) Positive
SLPI	20q13.12	0.91	-1.37	2.12	1.84	2.29	1.71e-20	3.35e-19	(A) Negative
IGDCC3	15q22.31	-3.26	-2.47	0.60	1.17	-0.79	1.80e-20	3.51e-19	(B) Positive
NUDT5	10p14	0.07	-0.69	0.72	0.48	0.76	1.82e-20	3.56e-19	(A) Negative
GPR161	1q24.2	0.45	-0.58	0.97	0.72	1.03	1.87e-20	3.65e-19	(A) Negative
GGH	8q12.3	-0.31	-1.50	1.02	1.41	1.18	1.92e-20	3.73e-19	(A) Negative
ENPP1	6q23.2	-0.83	0.60	1.34	1.05	-1.43	1.95e-20	3.79e-19	(B) Positive
KIF1B	1p36.22	0.30	-0.35	0.60	0.51	0.65	1.99e-20	3.87e-19	(A) Negative
CASD1	7q21.3	0.00	0.80	0.68	1.00	-0.80	2.04e-20	3.95e-19	(B) Positive
CHEK2	22q12.1	-0.30	-0.96	0.60	0.63	0.66	2.19e-20	4.24e-19	(A) Negative
SUGT1P3	13q14.11	-0.10	0.62	0.65	0.71	-0.72	2.25e-20	4.34e-19	(B) Positive
RHBDL2	1p34.3	2.18	1.19	0.91	0.89	0.99	2.25e-20	4.34e-19	(A) Negative
RPS23	5q14.2	-0.32	0.50	0.77	0.67	-0.82	2.33e-20	4.49e-19	(B) Positive
METTL15	11p14.1	-0.23	0.24	0.43	0.46	-0.47	2.34e-20	4.50e-19	(B) Positive
KRT81	12q13.13	1.97	0.63	1.28	0.84	1.34	2.49e-20	4.78e-19	(A) Negative
RDH10	8q21.11	1.68	0.36	1.24	0.90	1.31	2.51e-20	4.82e-19	(A) Negative
EFCAB11	14q32.11	-0.50	0.27	0.71	0.62	-0.77	2.53e-20	4.86e-19	(B) Positive
CASQ1	1q23.2	0.19	0.58	0.28	0.64	-0.40	2.55e-20	4.89e-19	(B) Positive
MALL	2q13	2.22	1.05	1.11	0.77	1.17	2.56e-20	4.90e-19	(A) Negative
JADE2	5q31.1	-0.54	0.22	0.72	0.56	-0.76	2.60e-20	4.97e-19	(B) Positive
CTR9	11p15.4	-0.03	0.49	0.49	0.47	-0.53	2.75e-20	5.26e-19	(B) Positive
KIFC1	6p21.32	-1.04	-1.96	0.84	0.88	0.92	2.78e-20	5.31e-19	(A) Negative
EMX1	2p13.2	0.67	1.43	0.61	1.07	-0.76	2.87e-20	5.47e-19	(B) Positive
SPEF2	5p13.2	1.15	2.10	0.86	0.96	-0.95	3.00e-20	5.71e-19	(B) Positive
NXN	17p13.3	1.25	0.20	0.97	0.97	1.05	3.12e-20	5.93e-19	(A) Negative
TSC22D3	Xq22.3	1.03	2.01	0.93	0.63	-0.98	3.14e-20	5.98e-19	(B) Positive
SYT17	16p12.3	0.29	2.14	1.75	1.40	-1.85	3.23e-20	6.13e-19	(B) Positive
MPP2	17q21.31	-1.09	-0.40	0.58	0.90	-0.69	3.25e-20	6.17e-19	(B) Positive
CPNE2	16q13	0.72	0.06	0.61	0.60	0.66	3.35e-20	6.34e-19	(A) Negative
PER2	2q37.3	0.48	1.15	0.63	0.52	-0.67	3.36e-20	6.36e-19	(B) Positive
RBM28	7q32.1	-0.47	-1.08	0.58	0.40	0.61	3.39e-20	6.41e-19	(A) Negative
PFKFB1	Xp11.21	-0.28	0.45	0.63	0.90	-0.73	3.41e-20	6.45e-19	(B) Positive
KIAA0040	1q25.1	1.26	2.25	0.93	0.80	-0.99	3.43e-20	6.48e-19	(B) Positive
MAML2	11q21	0.47	-0.47	0.89	0.64	0.94	3.55e-20	6.69e-19	(A) Negative
IFT88	13q12.11	0.00	0.76	0.71	0.68	-0.76	3.57e-20	6.71e-19	(B) Positive
SPRYD3	12q13.13	0.58	0.96	0.36	0.31	-0.38	3.57e-20	6.71e-19	(B) Positive
LRG1	19p13.3	-0.95	1.25	2.05	1.83	-2.19	3.67e-20	6.89e-19	(B) Positive
CYP21A2	6p21.33	0.31	1.62	1.23	1.08	-1.31	3.68e-20	6.91e-19	(B) Positive
GPR160	3q26.2	-0.29	1.35	1.57	0.96	-1.64	3.70e-20	6.94e-19	(B) Positive
SF3B3	16q22.1	-0.47	-1.00	0.50	0.42	0.53	3.78e-20	7.09e-19	(A) Negative
CENPE	4q24	-1.03	-1.87	0.76	0.85	0.84	3.81e-20	7.13e-19	(A) Negative
WBP1	2p13.1	0.07	0.62	0.51	0.45	-0.55	3.87e-20	7.24e-19	(B) Positive
LRRC17	7q22.1	-1.93	-0.20	1.62	1.46	-1.73	4.04e-20	7.55e-19	(B) Positive
FNDC3B	3q26.31	0.53	-0.29	0.78	0.61	0.82	4.06e-20	7.57e-19	(A) Negative
SMIM29	6p21.31	0.19	0.75	0.53	0.49	-0.57	4.17e-20	7.76e-19	(B) Positive
DSCC1	8q24.12	-0.74	-1.79	0.97	0.96	1.04	4.49e-20	8.36e-19	(A) Negative
SLC7A4	22q11.21	0.52	1.23	0.56	1.03	-0.71	4.88e-20	9.07e-19	(B) Positive
ASNS	7q21.3	-1.09	-2.11	0.98	0.72	1.02	4.89e-20	9.07e-19	(A) Negative
MAPK3	16p11.2	-0.36	0.07	0.37	0.51	-0.43	4.92e-20	9.13e-19	(B) Positive
STK36	2q35	-0.37	0.40	0.74	0.54	-0.77	5.10e-20	9.45e-19	(B) Positive
AMZ1	7p22.3	-0.76	0.60	1.13	1.80	-1.35	5.18e-20	9.58e-19	(B) Positive
CDC7	1p22.1	-0.92	-1.96	0.98	0.82	1.04	5.25e-20	9.71e-19	(A) Negative
BCAT2	19q13.33	-0.36	0.12	0.44	0.49	-0.48	5.28e-20	9.75e-19	(B) Positive
CTSV	9q22.33	-0.51	-2.06	1.49	1.06	1.55	5.30e-20	9.77e-19	(A) Negative
HAGH	16p13.3	-0.10	0.45	0.49	0.55	-0.54	5.32e-20	9.80e-19	(B) Positive
CYB5A	18q22.3	0.94	2.14	1.14	0.94	-1.20	5.56e-20	1.02e-18	(B) Positive
TIAM2	6q25.2-q25.3	1.22	0.09	1.08	0.83	1.13	5.75e-20	1.06e-18	(A) Negative
PNPLA7	9q34.3	0.16	0.80	0.60	0.60	-0.64	5.84e-20	1.07e-18	(B) Positive
CFAP70	10q22.2	0.83	2.14	1.22	1.23	-1.31	5.94e-20	1.09e-18	(B) Positive
SERPINI1	3q26.1	0.30	1.60	1.14	1.56	-1.30	6.04e-20	1.11e-18	(B) Positive
PROSER1	13q13.3	0.06	-0.50	0.52	0.53	0.56	6.05e-20	1.11e-18	(A) Negative
EXOC2	6p25.3	0.24	0.90	0.56	0.88	-0.66	6.08e-20	1.11e-18	(B) Positive
KIF3A	5q31.1	0.09	0.72	0.57	0.66	-0.63	6.12e-20	1.12e-18	(B) Positive
SLC40A1	2q32.2	1.32	2.85	1.42	1.48	-1.53	6.30e-20	1.15e-18	(B) Positive
TMC4	19q13.42	1.19	2.40	1.16	0.79	-1.21	6.49e-20	1.18e-18	(B) Positive
CCDC106	19q13.42	0.06	0.56	0.45	0.53	-0.50	6.50e-20	1.18e-18	(B) Positive
HACD3	15q22.31	-0.41	0.26	0.63	0.63	-0.67	6.56e-20	1.19e-18	(B) Positive
SCNN1A	12p13	0.34	1.98	1.58	1.02	-1.64	6.72e-20	1.22e-18	(B) Positive
PIF1	15q22.31	-2.05	-2.68	0.59	0.55	0.63	6.84e-20	1.24e-18	(A) Negative
GATAD1	7q21.2	-0.81	-0.36	0.41	0.46	-0.45	7.14e-20	1.29e-18	(B) Positive
SYT1	12q21.2	-0.95	0.77	1.48	2.21	-1.72	7.22e-20	1.31e-18	(B) Positive
LMNB2	19p13.3	-0.59	-1.27	0.65	0.52	0.68	7.28e-20	1.32e-18	(A) Negative
RARA	17q21.2	0.81	1.49	0.64	0.57	-0.67	7.43e-20	1.34e-18	(B) Positive
FAF1	1p32.3	-0.06	-0.58	0.50	0.37	0.52	7.63e-20	1.38e-18	(A) Negative
CEP120	5q23.2	-0.54	0.00	0.51	0.51	-0.54	7.82e-20	1.41e-18	(B) Positive
ERGIC1	5q35.1	-0.04	0.62	0.63	0.52	-0.66	7.92e-20	1.43e-18	(B) Positive
HSD17B4	5q23.1	-0.39	0.53	0.89	0.59	-0.92	7.94e-20	1.43e-18	(B) Positive
KLRG2	7q34	1.14	-0.20	1.22	1.47	1.34	8.43e-20	1.52e-18	(A) Negative
ZNF462	9q31.2	0.73	-0.66	1.31	1.15	1.38	8.45e-20	1.52e-18	(A) Negative
IFT46	11q23.3	-0.19	0.52	0.67	0.61	-0.71	8.59e-20	1.54e-18	(B) Positive
EFCAB12	3q21.3	0.31	0.82	0.45	0.63	-0.52	9.00e-20	1.61e-18	(B) Positive
TBX19	1q24.2	0.87	-0.01	0.86	0.49	0.88	9.28e-20	1.66e-18	(A) Negative
CCNG2	4q21.1	0.80	1.66	0.81	0.80	-0.86	9.56e-20	1.71e-18	(B) Positive
COG2	1q42.2	0.17	0.71	0.50	0.53	-0.54	9.79e-20	1.75e-18	(B) Positive
PERP	6q23.3	1.32	0.38	0.88	0.87	0.94	9.89e-20	1.76e-18	(A) Negative
NBR1	17q21.31	0.04	0.60	0.52	0.56	-0.56	9.97e-20	1.78e-18	(B) Positive
KCNG1	20q13.13	-0.38	-1.65	1.23	0.84	1.27	9.97e-20	1.78e-18	(A) Negative
PEX19	1q23.2	0.20	0.69	0.46	0.47	-0.49	1.01e-19	1.80e-18	(B) Positive
BECN1	17q21.31	0.14	0.69	0.53	0.50	-0.56	1.02e-19	1.82e-18	(B) Positive
THTPA	14q11.2	0.19	0.80	0.58	0.51	-0.61	1.06e-19	1.88e-18	(B) Positive
HLA-DOB	6p21.32	1.49	0.62	0.84	0.73	0.88	1.06e-19	1.89e-18	(A) Negative
MAP2	2q34	1.45	0.24	1.19	0.58	1.22	1.09e-19	1.93e-18	(A) Negative
CKS1B	1q21.3	0.05	-0.65	0.66	0.63	0.70	1.09e-19	1.93e-18	(A) Negative
FLNB	3p14.3	0.22	1.02	0.75	0.77	-0.80	1.23e-19	2.17e-18	(B) Positive
NMT2	10p13	0.17	-0.79	0.92	0.78	0.96	1.24e-19	2.18e-18	(A) Negative
AP1G2	14q11.2	-0.56	0.07	0.60	0.51	-0.63	1.25e-19	2.20e-18	(B) Positive
DOK7	4p16.3	-1.37	0.09	1.36	1.41	-1.45	1.29e-19	2.28e-18	(B) Positive
RASGEF1B	4q21.21	1.60	0.90	0.67	0.54	0.70	1.38e-19	2.44e-18	(A) Negative
STX18	4p16.3-p16.2	-0.08	0.37	0.42	0.42	-0.45	1.44e-19	2.54e-18	(B) Positive
ERICH5	8q22.2	2.19	-0.16	2.29	1.60	2.35	1.46e-19	2.57e-18	(A) Negative
PRKAB1	12q24.23	-0.69	-0.09	0.57	0.50	-0.60	1.48e-19	2.61e-18	(B) Positive
ZNF532	18q21.32	1.38	0.69	0.65	0.63	0.69	1.49e-19	2.61e-18	(A) Negative
HRC	19q13.33	-1.82	-1.26	0.49	0.72	-0.56	1.53e-19	2.68e-18	(B) Positive
TTC13	1q42.2	0.67	-0.02	0.67	0.58	0.70	1.54e-19	2.69e-18	(A) Negative
UTP4	16q22.1	-0.91	-1.50	0.56	0.47	0.59	1.63e-19	2.86e-18	(A) Negative
MREG	2q35	-0.30	0.58	0.86	0.62	-0.88	1.64e-19	2.86e-18	(B) Positive
FBXL16	16p13.3	-0.73	1.04	1.71	1.48	-1.78	1.73e-19	3.02e-18	(B) Positive
UCHL5	1q31.2	-0.59	-1.23	0.60	0.58	0.64	1.74e-19	3.04e-18	(A) Negative
TIA1	2p13.3	-0.30	-0.94	0.61	0.52	0.64	1.77e-19	3.07e-18	(A) Negative
HORMAD1	1q21.3	1.11	-2.07	3.16	1.36	3.18	1.86e-19	3.23e-18	(A) Negative
TMEM205	19p13.2	-0.17	0.70	0.83	0.68	-0.86	1.89e-19	3.28e-18	(B) Positive
NSA2	5q13.3	-0.53	-0.02	0.49	0.46	-0.52	1.93e-19	3.35e-18	(B) Positive
RNASEH1	2p25.3	-0.38	-1.01	0.62	0.42	0.63	1.94e-19	3.37e-18	(A) Negative
BCDIN3D	12q13.12	0.41	0.98	0.55	0.45	-0.57	1.94e-19	3.37e-18	(B) Positive
EMC8	16q24.1	-0.09	-0.63	0.52	0.45	0.54	1.95e-19	3.37e-18	(A) Negative
RPS6KA3	Xp22.12	-1.16	-1.82	0.62	0.67	0.66	1.98e-19	3.43e-18	(A) Negative
TTC22	1p32.3	1.08	0.45	0.62	0.50	0.64	2.03e-19	3.51e-18	(A) Negative
TBPL1	6q23.2	-0.41	-1.01	0.58	0.51	0.60	2.07e-19	3.57e-18	(A) Negative
SNHG11	20q11.23	-0.44	0.08	0.47	0.57	-0.51	2.09e-19	3.60e-18	(B) Positive
TP53BP2	1q41	1.01	0.14	0.84	0.69	0.87	2.09e-19	3.60e-18	(A) Negative
CHST3	10q22.1	0.16	-0.86	0.98	0.84	1.02	2.12e-19	3.66e-18	(A) Negative
SLC15A2	3q13.33	1.10	-0.24	1.26	1.30	1.33	2.16e-19	3.72e-18	(A) Negative
SYS1	20q13.12	0.79	1.37	0.56	0.49	-0.58	2.23e-19	3.83e-18	(B) Positive
RBKS	2p23.2	0.45	1.22	0.75	0.64	-0.78	2.23e-19	3.83e-18	(B) Positive
TMPRSS13	11q23.3	2.40	1.65	0.68	0.88	0.75	2.29e-19	3.93e-18	(A) Negative
NARF	17q25.3	-0.81	-1.40	0.57	0.50	0.59	2.30e-19	3.93e-18	(A) Negative
ACBD4	17q21.31	-0.12	0.33	0.41	0.49	-0.45	2.30e-19	3.93e-18	(B) Positive
LRFN2	6p21.2-p21.1	0.53	2.10	1.54	1.01	-1.57	2.35e-19	4.02e-18	(B) Positive
ROCK2	2p25.1	0.28	-0.22	0.47	0.54	0.50	2.42e-19	4.12e-18	(A) Negative
SLC46A1	17q11.2	0.23	0.76	0.48	0.62	-0.53	2.44e-19	4.16e-18	(B) Positive
NABP1	2q32.3	0.20	-0.61	0.76	0.83	0.81	2.52e-19	4.29e-18	(A) Negative
LGALSL	2p14	0.72	-0.09	0.77	0.74	0.81	2.53e-19	4.31e-18	(A) Negative
CBFA2T3	16q24.3	-2.27	-1.00	1.16	1.39	-1.26	2.55e-19	4.34e-18	(B) Positive
MAPK4	18q21.1-q21.2	-1.63	-3.29	1.64	0.91	1.66	2.55e-19	4.34e-18	(A) Negative
MYOZ3	5q33.1	-0.31	0.04	0.30	0.49	-0.35	2.60e-19	4.42e-18	(B) Positive
NUP93	16q13	-0.41	-0.90	0.47	0.46	0.49	2.66e-19	4.51e-18	(A) Negative
KIF11	10q23.33	-0.65	-1.27	0.58	0.64	0.62	2.68e-19	4.54e-18	(A) Negative
CCNDBP1	15q15.2	-0.33	0.34	0.64	0.66	-0.68	2.73e-19	4.61e-18	(B) Positive
UBE3A	15q11.2	-0.08	0.38	0.43	0.45	-0.45	2.74e-19	4.63e-18	(B) Positive
SNX1	15q22.31	-0.11	0.54	0.62	0.59	-0.64	2.75e-19	4.65e-18	(B) Positive
TBC1D1	4p14	0.81	0.13	0.65	0.60	0.68	2.89e-19	4.88e-18	(A) Negative
UBE2C	20q13.12	-0.37	-1.25	0.81	1.02	0.88	2.91e-19	4.90e-18	(A) Negative
IFNAR2	21q22.11	0.38	-0.27	0.63	0.51	0.65	2.96e-19	4.98e-18	(A) Negative
NMB	15q25.2	0.32	-0.75	1.02	0.98	1.07	2.99e-19	5.03e-18	(A) Negative
DOT1L	19p13.3	-0.89	-1.52	0.61	0.56	0.64	3.06e-19	5.15e-18	(A) Negative
MZT2A	2q21.1	-0.13	0.42	0.53	0.55	-0.56	3.12e-19	5.23e-18	(B) Positive
SLC25A13	7q21.3	-0.32	-0.94	0.60	0.52	0.62	3.12e-19	5.24e-18	(A) Negative
RRAS2	11p15.2	-0.52	-1.42	0.84	0.96	0.90	3.13e-19	5.25e-18	(A) Negative
EGLN2	19q13.2	0.51	1.04	0.48	0.64	-0.53	3.19e-19	5.34e-18	(B) Positive
POLD1	19q13.3	-1.15	-1.68	0.52	0.42	0.53	3.26e-19	5.45e-18	(A) Negative
TMSB15A	Xq22.1	-1.34	-3.54	2.18	1.48	2.20	3.48e-19	5.81e-18	(A) Negative
MOB3B	9p21.2	0.51	-0.70	1.19	0.87	1.21	3.51e-19	5.86e-18	(A) Negative
AIF1L	9q34.12-q34.13	0.70	-0.60	1.23	1.33	1.30	3.65e-19	6.08e-18	(A) Negative
GLUD1	10q23.2	-0.51	0.13	0.62	0.56	-0.64	3.67e-19	6.12e-18	(B) Positive
SFXN2	10q24.32	-0.45	0.33	0.74	0.78	-0.78	3.69e-19	6.14e-18	(B) Positive
DOCK7	1p31.3	0.12	-0.52	0.63	0.47	0.64	3.69e-19	6.14e-18	(A) Negative
MRPS27	5q13.2	-1.18	-0.72	0.45	0.41	-0.47	3.73e-19	6.20e-18	(B) Positive
HSPB8	12q24.23	0.02	1.24	1.11	1.46	-1.22	3.85e-19	6.39e-18	(B) Positive
EEIG1	9q34.11	0.65	1.26	0.59	0.56	-0.61	4.03e-19	6.68e-18	(B) Positive
MADD	11p11.2	-0.31	0.07	0.36	0.45	-0.39	4.05e-19	6.71e-18	(B) Positive
SERPINB6	6p25.2	-0.62	0.11	0.71	0.54	-0.73	4.05e-19	6.71e-18	(B) Positive
HOMER3	19p13.11	0.38	-0.33	0.69	0.62	0.71	4.10e-19	6.77e-18	(A) Negative
GAL	11q13.2	-2.26	-3.79	1.52	0.90	1.53	4.14e-19	6.84e-18	(A) Negative
PCSK6	15q26.3	-0.99	0.33	1.26	1.30	-1.32	4.27e-19	7.05e-18	(B) Positive
STAC2	17q12	2.58	0.91	1.63	1.39	1.67	4.30e-19	7.08e-18	(A) Negative
KIF20A	5q31.2	-1.00	-1.85	0.80	0.90	0.85	4.32e-19	7.12e-18	(A) Negative
RAP2B	3q25.2	0.33	-0.23	0.54	0.50	0.55	4.43e-19	7.29e-18	(A) Negative
CHI3L1	1q32.1	2.52	1.32	1.13	1.26	1.20	4.51e-19	7.41e-18	(A) Negative
GPSM2	1p13.3	-0.01	-1.04	1.01	0.80	1.03	4.52e-19	7.43e-18	(A) Negative
HR	8p21.3	0.79	-0.00	0.75	0.78	0.79	4.60e-19	7.55e-18	(A) Negative
TRIP13	5p15.33	-1.06	-2.06	0.96	0.96	1.00	4.61e-19	7.56e-18	(A) Negative
CNGA1	4p12	1.94	0.31	1.60	1.25	1.62	4.63e-19	7.59e-18	(A) Negative
MARVELD2	5q13.2	1.10	1.90	0.79	0.61	-0.80	4.64e-19	7.60e-18	(B) Positive
CNKSR3	6q25.2	0.76	-0.36	1.05	1.20	1.12	4.67e-19	7.63e-18	(A) Negative
CLIC6	21q22.12	0.69	2.53	1.62	2.42	-1.84	4.79e-19	7.82e-18	(B) Positive
TMEM38A	19p13.11	0.84	0.07	0.76	0.57	0.77	4.80e-19	7.83e-18	(A) Negative
SPATA20	17q21.33	-0.84	0.09	0.91	0.79	-0.93	4.83e-19	7.87e-18	(B) Positive
SGO1	3p24.3	-0.47	-1.33	0.82	0.83	0.86	4.92e-19	8.01e-18	(A) Negative
SKP2	5p13.2	-2.10	-2.95	0.83	0.62	0.84	5.06e-19	8.24e-18	(A) Negative
HSD17B2	16q23.3	-0.91	-3.01	2.05	1.76	2.10	5.15e-19	8.36e-18	(A) Negative
CREB3L4	1q21.3	1.59	2.71	1.10	0.90	-1.12	5.22e-19	8.48e-18	(B) Positive
NAB1	2q32.2	0.42	-0.30	0.70	0.65	0.72	5.34e-19	8.66e-18	(A) Negative
CHAC2	2p16.2	-0.93	-1.83	0.88	0.77	0.90	5.54e-19	8.98e-18	(A) Negative
SOD2	6q25.3	0.81	-0.28	1.09	0.75	1.10	5.65e-19	9.14e-18	(A) Negative
GTPBP4	10p15.3	0.03	-0.73	0.76	0.49	0.76	5.77e-19	9.33e-18	(A) Negative
BIRC5	17q25.3	-0.47	-1.35	0.81	1.05	0.88	5.85e-19	9.45e-18	(A) Negative
TUBA4A	2q35	-0.01	-0.59	0.55	0.57	0.58	5.85e-19	9.45e-18	(A) Negative
POTED	21q11.2	-1.47	-0.35	1.04	1.28	-1.12	6.04e-19	9.73e-18	(B) Positive
ADCY6	12q13.12	0.06	0.53	0.45	0.45	-0.47	6.23e-19	1.00e-17	(B) Positive
MED7	5q33.3	-0.41	0.11	0.51	0.43	-0.52	6.23e-19	1.00e-17	(B) Positive
GLT8D1	3p21.1	-0.45	0.08	0.52	0.44	-0.53	6.26e-19	1.01e-17	(B) Positive
NPDC1	9q34.3	-0.33	0.75	1.08	0.76	-1.08	6.34e-19	1.02e-17	(B) Positive
HRK	12q24.22	0.69	-0.34	1.01	0.86	1.03	6.57e-19	1.05e-17	(A) Negative
OSBPL3	7p15.3	-0.69	-1.59	0.89	0.77	0.90	6.68e-19	1.07e-17	(A) Negative
BCL2L12	19q13.33	-0.06	-0.67	0.58	0.62	0.61	6.76e-19	1.08e-17	(A) Negative
LAMB2	3p21.31	0.44	1.16	0.70	0.64	-0.72	6.87e-19	1.10e-17	(B) Positive
RBM5	3p21.31	-0.59	-0.15	0.40	0.49	-0.43	6.87e-19	1.10e-17	(B) Positive
SLC45A1	1p36.23	0.34	1.03	0.65	0.79	-0.69	6.87e-19	1.10e-17	(B) Positive
CPA3	3q24	3.87	5.62	1.73	1.36	-1.75	6.99e-19	1.12e-17	(B) Positive
ZNF454	5q35.3	1.02	-0.10	1.11	0.82	1.12	7.15e-19	1.14e-17	(A) Negative
MCCC1	3q27.1	0.56	-0.23	0.79	0.57	0.79	7.19e-19	1.15e-17	(A) Negative
R3HDM1	2q21.3	-0.37	-0.91	0.52	0.48	0.54	7.35e-19	1.17e-17	(A) Negative
PDCD5	19q13.11	0.07	-0.63	0.70	0.53	0.70	7.36e-19	1.17e-17	(A) Negative
SALL2	14q11.2	-1.27	-0.11	1.15	0.91	-1.16	7.83e-19	1.24e-17	(B) Positive
GLYATL2	11q12.1	3.50	1.15	2.32	1.93	2.35	8.57e-19	1.36e-17	(A) Negative
RAB27B	18q21.2	0.75	2.11	1.37	0.90	-1.37	9.02e-19	1.43e-17	(B) Positive
CFAP157	9q34.11	0.27	0.91	0.60	0.69	-0.63	9.41e-19	1.49e-17	(B) Positive
CHMP2A	19q13.43	0.28	0.87	0.59	0.49	-0.59	9.54e-19	1.51e-17	(B) Positive
NEK11	3q22.1	1.31	2.07	0.75	0.65	-0.76	9.61e-19	1.52e-17	(B) Positive
CCSAP	1q42.13	0.52	-0.12	0.62	0.56	0.64	9.62e-19	1.52e-17	(A) Negative
CBFB	16q22.1	-0.18	-0.77	0.58	0.53	0.59	9.62e-19	1.52e-17	(A) Negative
LCT	2q21.3	-0.63	-2.64	2.04	1.04	2.01	9.66e-19	1.52e-17	(A) Negative
ZNF91	19p12	0.28	1.43	1.13	0.99	-1.15	9.73e-19	1.53e-17	(B) Positive
SORD	15q21.1	-0.15	0.77	0.90	0.85	-0.92	9.98e-19	1.57e-17	(B) Positive
POLR3K	16p13.3	-0.81	-0.28	0.51	0.57	-0.54	1.05e-18	1.65e-17	(B) Positive
MTHFD2	2p13.1	-0.26	-0.95	0.67	0.64	0.69	1.08e-18	1.70e-17	(A) Negative
EFS	14q11.2	1.73	0.85	0.78	1.19	0.88	1.09e-18	1.71e-17	(A) Negative
CD82	11p11.2	1.54	0.79	0.72	0.77	0.75	1.13e-18	1.77e-17	(A) Negative
TUBB	6p21.33	-0.26	-0.77	0.50	0.47	0.51	1.17e-18	1.83e-17	(A) Negative
MRFAP1L2	4p16.1	-0.42	0.06	0.47	0.48	-0.48	1.21e-18	1.90e-17	(B) Positive
ZNF680	7q11.21	-0.14	0.44	0.57	0.57	-0.58	1.22e-18	1.91e-17	(B) Positive
TOGARAM1	14q21.2	0.16	0.88	0.72	0.64	-0.72	1.22e-18	1.91e-17	(B) Positive
TUBB6	18p11.21	-0.36	-0.96	0.60	0.52	0.60	1.24e-18	1.94e-17	(A) Negative
PLK1	16p12.2	-1.02	-1.59	0.55	0.56	0.57	1.24e-18	1.94e-17	(A) Negative
MTERF2	12q23.3	-0.07	0.59	0.65	0.63	-0.66	1.25e-18	1.95e-17	(B) Positive
TAF4B	18q11.2	-0.16	-0.98	0.82	0.65	0.82	1.26e-18	1.96e-17	(A) Negative
CBLN4	20q13.2	0.15	0.91	0.72	0.88	-0.76	1.29e-18	2.00e-17	(B) Positive
MSN	Xq12	0.19	-0.59	0.78	0.58	0.78	1.33e-18	2.06e-17	(A) Negative
UBE2B	5q31.1	0.30	0.84	0.53	0.49	-0.54	1.35e-18	2.10e-17	(B) Positive
PHF19	9q33.2	-1.52	-2.11	0.59	0.47	0.59	1.36e-18	2.10e-17	(A) Negative
GALNT6	12q13.13	1.27	2.41	1.12	1.09	-1.14	1.37e-18	2.12e-17	(B) Positive
KLHDC9	1q23.3	0.89	2.55	1.69	0.89	-1.65	1.42e-18	2.19e-17	(B) Positive
B4GALT5	20q13.13	0.40	-0.26	0.64	0.67	0.66	1.44e-18	2.22e-17	(A) Negative
SREK1IP1	5q12.3	-0.64	-0.23	0.40	0.37	-0.41	1.47e-18	2.28e-17	(B) Positive
CDC25A	3p21.31	-1.18	-1.94	0.75	0.67	0.76	1.48e-18	2.29e-17	(A) Negative
FAM81B	5q15	0.46	1.91	1.32	1.85	-1.45	1.51e-18	2.32e-17	(B) Positive
FGFBP1	4p15.32	-0.51	-2.81	2.34	1.39	2.30	1.51e-18	2.33e-17	(A) Negative
ILF2	1q21.3	0.25	-0.45	0.71	0.49	0.70	1.69e-18	2.60e-17	(A) Negative
DBF4	7q21.12	-1.03	-1.63	0.59	0.63	0.61	1.69e-18	2.60e-17	(A) Negative
MRPL2	6p21.1	-0.03	-0.57	0.54	0.43	0.54	1.72e-18	2.64e-17	(A) Negative
APPBP2	17q23.2	-1.00	-0.47	0.50	0.61	-0.53	1.72e-18	2.65e-17	(B) Positive
SLC25A33	1p36.22	-0.06	-0.83	0.77	0.60	0.77	1.76e-18	2.70e-17	(A) Negative
ATP6AP1	Xq28	0.39	0.90	0.49	0.55	-0.51	1.88e-18	2.88e-17	(B) Positive
TMEM39B	1p35.2	-0.17	-0.64	0.48	0.35	0.47	1.98e-18	3.03e-17	(A) Negative
DEUP1	11q21	0.95	-0.09	1.07	0.54	1.04	1.99e-18	3.05e-17	(A) Negative
ZNF484	9q22.31	-0.17	0.48	0.66	0.47	-0.65	2.01e-18	3.08e-17	(B) Positive
STRA8	7q33	1.96	0.24	1.76	1.02	1.72	2.01e-18	3.08e-17	(A) Negative
LIMD2	17q23.3	0.34	-0.35	0.68	0.61	0.68	2.10e-18	3.20e-17	(A) Negative
SPR	2p13.2	0.49	1.24	0.74	0.70	-0.75	2.10e-18	3.21e-17	(B) Positive
RRAGD	6q15	0.32	-0.77	1.10	0.85	1.09	2.14e-18	3.27e-17	(A) Negative
E2F1	20q11.22	-0.65	-1.34	0.66	0.75	0.69	2.17e-18	3.30e-17	(A) Negative
GPR180	13q32.1	0.03	-0.71	0.76	0.56	0.75	2.18e-18	3.32e-17	(A) Negative
PDE9A	21q22.3	0.41	-0.74	1.18	0.71	1.15	2.21e-18	3.37e-17	(A) Negative
FARP2	2q37.3	-0.02	0.46	0.48	0.44	-0.48	2.22e-18	3.37e-17	(B) Positive
ABHD2	15q26.1	-0.01	0.49	0.47	0.63	-0.50	2.25e-18	3.41e-17	(B) Positive
GCFC2	2p12	-0.21	-0.65	0.44	0.40	0.44	2.26e-18	3.43e-17	(A) Negative
ZFYVE19	15q15.1	-0.41	0.07	0.46	0.50	-0.48	2.39e-18	3.62e-17	(B) Positive
PDE6B	4p16.3	0.09	1.20	1.07	1.21	-1.11	2.40e-18	3.63e-17	(B) Positive
ABCF1	6p21.33	0.08	-0.26	0.34	0.33	0.34	2.44e-18	3.69e-17	(A) Negative
DDC	7p12.2-p12.1	-3.09	-4.90	1.81	1.60	1.81	2.48e-18	3.74e-17	(A) Negative
MON2	12q14.1	-0.37	0.03	0.40	0.41	-0.40	2.54e-18	3.84e-17	(B) Positive
DGAT2	11q13.5	1.16	0.04	1.07	1.27	1.12	2.58e-18	3.89e-17	(A) Negative
CCNYL6	19p12	0.20	-0.57	0.78	0.54	0.76	2.59e-18	3.91e-17	(A) Negative
NMU	4q12	-2.40	-4.14	1.75	1.47	1.74	2.60e-18	3.92e-17	(A) Negative
KCNF1	2p25.1	-0.57	0.40	0.86	1.37	-0.97	2.67e-18	4.02e-17	(B) Positive
CD2BP2	16p11.2	-0.19	0.35	0.54	0.51	-0.54	2.70e-18	4.06e-17	(B) Positive
KIF4A	Xq13.1	-0.99	-1.75	0.72	0.87	0.76	2.70e-18	4.06e-17	(A) Negative
IGBP1	Xq13.1	-0.55	0.05	0.61	0.48	-0.60	2.71e-18	4.06e-17	(B) Positive
HOGA1	10q24.2	-1.95	-1.00	0.88	1.17	-0.94	2.73e-18	4.10e-17	(B) Positive
CSNK1G3	5q23.2	-0.27	0.21	0.47	0.50	-0.48	2.78e-18	4.17e-17	(B) Positive
GLUL	1q25.3	1.06	1.83	0.76	0.72	-0.76	2.79e-18	4.18e-17	(B) Positive
MCM4	8q11.21	-0.94	-1.78	0.83	0.82	0.84	2.88e-18	4.30e-17	(A) Negative
C5AR2	19q13.32	0.19	0.54	0.33	0.39	-0.35	2.88e-18	4.30e-17	(B) Positive
RALGAPB	20q11.23	0.17	0.64	0.47	0.50	-0.48	2.92e-18	4.35e-17	(B) Positive
PHPT1	9q34.3	-0.37	0.17	0.54	0.49	-0.54	2.92e-18	4.36e-17	(B) Positive
ARHGEF4	2q21.1	-0.18	-1.13	0.96	0.76	0.95	2.94e-18	4.38e-17	(A) Negative
PAN2	12q13.3	-1.61	-1.04	0.57	0.50	-0.57	2.98e-18	4.43e-17	(B) Positive
CRYAB	11q23.1	3.19	2.16	1.01	1.06	1.03	3.00e-18	4.46e-17	(A) Negative
EBF4	20p13	0.88	1.72	0.85	0.73	-0.84	3.08e-18	4.58e-17	(B) Positive
CUL3	2q36.2	-0.04	0.59	0.63	0.60	-0.63	3.15e-18	4.67e-17	(B) Positive
EIF4B	12q13.13	-0.78	-0.21	0.56	0.50	-0.56	3.20e-18	4.75e-17	(B) Positive
UMOD	16p12.3	0.42	1.27	0.79	1.07	-0.85	3.40e-18	5.04e-17	(B) Positive
B3GNT3	19p13.11	0.44	-1.06	1.53	1.20	1.50	3.41e-18	5.05e-17	(A) Negative
GAK	4p16.3	-0.15	0.34	0.48	0.50	-0.48	3.43e-18	5.07e-17	(B) Positive
APEH	3p21.31	-0.89	-0.30	0.60	0.50	-0.59	3.55e-18	5.24e-17	(B) Positive
ERCC6L	Xq13.1	-0.77	-1.61	0.82	0.91	0.84	3.83e-18	5.65e-17	(A) Negative
ATL2	2p22.2-p22.1	0.68	-0.39	1.10	0.76	1.07	4.00e-18	5.90e-17	(A) Negative
LSM2	6p21.33	-0.14	-0.63	0.50	0.40	0.49	4.10e-18	6.04e-17	(A) Negative
CARD9	9q34.3	1.31	0.33	0.97	1.01	0.99	4.12e-18	6.07e-17	(A) Negative
SCPEP1	17q22	1.87	1.02	0.85	0.84	0.85	4.13e-18	6.08e-17	(A) Negative
ATF7IP	12p13.1	1.05	0.53	0.53	0.45	0.52	4.19e-18	6.16e-17	(A) Negative
SLC9A6	Xq26.3	-0.38	-1.24	0.87	0.74	0.86	4.20e-18	6.17e-17	(A) Negative
RAPGEF3	12q13.11	0.68	1.42	0.75	0.65	-0.74	4.22e-18	6.20e-17	(B) Positive
CLCN5	Xp11.23	0.60	-0.22	0.81	0.82	0.82	4.25e-18	6.23e-17	(A) Negative
MTSS2	16q22.1	0.40	-0.12	0.53	0.37	0.52	4.30e-18	6.31e-17	(A) Negative
RETREG2	2q35	0.51	0.90	0.40	0.36	-0.40	4.42e-18	6.48e-17	(B) Positive
HMGCS2	1p12	0.68	1.76	1.03	1.29	-1.08	4.45e-18	6.52e-17	(B) Positive
NME5	5q31.2	1.48	3.28	1.80	1.69	-1.79	4.48e-18	6.55e-17	(B) Positive
SRD5A1	5p15.31	0.18	-0.79	0.99	0.79	0.97	4.52e-18	6.60e-17	(A) Negative
ADAMTS15	11q24.3	0.20	0.67	0.42	0.68	-0.47	4.62e-18	6.74e-17	(B) Positive
UNC13D	17q25.3	0.18	-0.61	0.81	0.61	0.79	4.77e-18	6.95e-17	(A) Negative
KIF9	3p21.31	0.38	1.01	0.64	0.58	-0.63	4.82e-18	7.02e-17	(B) Positive
SMC1B	22q13.31	2.00	0.31	1.72	1.44	1.69	5.01e-18	7.29e-17	(A) Negative
APH1B	15q22.2	0.65	1.34	0.70	0.62	-0.69	5.08e-18	7.39e-17	(B) Positive
CACNA1F	Xp11.23	-0.17	0.18	0.31	0.52	-0.35	5.16e-18	7.51e-17	(B) Positive
STK38L	12p11.23	1.63	0.67	1.00	0.61	0.96	5.28e-18	7.67e-17	(A) Negative
TSPO	22q13.2	1.13	0.59	0.53	0.55	0.54	5.39e-18	7.82e-17	(A) Negative
IL34	16q22.1	2.33	1.23	1.14	0.78	1.10	5.41e-18	7.84e-17	(A) Negative
BLOC1S1	12q13.2	-0.06	0.36	0.43	0.39	-0.43	5.47e-18	7.92e-17	(B) Positive
CHRNA5	15q25.1	-0.78	-2.21	1.43	1.35	1.43	5.64e-18	8.17e-17	(A) Negative
PNPT1	2p16.1	-0.48	-1.12	0.65	0.54	0.64	5.67e-18	8.20e-17	(A) Negative
NUDT16L2P	3q22.1	0.39	1.40	0.99	1.12	-1.01	5.78e-18	8.36e-17	(B) Positive
GMPS	3q25.31	-0.43	-1.14	0.72	0.56	0.71	5.82e-18	8.40e-17	(A) Negative
WDR5	9q34.2	-0.47	-1.09	0.62	0.58	0.62	5.82e-18	8.40e-17	(A) Negative
RIBC1	Xp11.22	0.33	1.00	0.64	0.81	-0.67	6.01e-18	8.66e-17	(B) Positive
CCDC30	1p34.2	2.04	3.02	0.99	0.93	-0.98	6.03e-18	8.69e-17	(B) Positive
CCDC32	15q15.1	0.10	0.56	0.47	0.38	-0.45	6.04e-18	8.70e-17	(B) Positive
MFGE8	15q26.1	0.75	-0.42	1.22	0.79	1.18	6.09e-18	8.76e-17	(A) Negative
ANG	14q11.2	-1.24	-0.35	0.89	0.96	-0.90	6.14e-18	8.82e-17	(B) Positive
TUBB3	16q24.3	-0.27	-1.02	0.77	0.67	0.75	6.25e-18	8.97e-17	(A) Negative
P2RX4	12q24.31	0.81	1.51	0.72	0.60	-0.71	6.43e-18	9.22e-17	(B) Positive
SKA1	18q21.1	-0.69	-1.52	0.84	0.78	0.83	6.84e-18	9.79e-17	(A) Negative
DLG5	10q22.3	0.29	0.88	0.59	0.60	-0.59	6.89e-18	9.87e-17	(B) Positive
KLF5	13q22.1	0.96	-0.39	1.35	1.32	1.34	6.91e-18	9.88e-17	(A) Negative
TCTN2	12q24.31	0.12	0.77	0.65	0.61	-0.65	6.94e-18	9.92e-17	(B) Positive
CCDC125	5q13.2	0.37	1.37	1.02	0.84	-1.00	6.94e-18	9.92e-17	(B) Positive
SNAPC2	19p13.2	-0.04	0.46	0.50	0.49	-0.50	7.07e-18	1.01e-16	(B) Positive
GJB3	1p34.3	0.70	-0.32	1.06	0.73	1.02	7.07e-18	1.01e-16	(A) Negative
PTGR2	14q24.3	-0.62	0.12	0.74	0.70	-0.74	7.16e-18	1.02e-16	(B) Positive
KBTBD3	11q22.3	0.72	1.44	0.71	0.76	-0.71	7.17e-18	1.02e-16	(B) Positive
LRP10	14q11.2	0.36	0.93	0.59	0.46	-0.57	7.43e-18	1.06e-16	(B) Positive
LCN2	9q34.11	3.16	1.06	2.15	1.88	2.11	7.46e-18	1.06e-16	(A) Negative
ADRA2A	10q25.2	3.00	4.21	1.24	1.09	-1.21	7.53e-18	1.07e-16	(B) Positive
NPM3	10q24.32	-0.71	-1.48	0.79	0.59	0.77	7.53e-18	1.07e-16	(A) Negative
SLC1A2	11p13	-0.72	0.00	0.68	0.89	-0.72	7.70e-18	1.09e-16	(B) Positive
CDT1	16q24.3	-1.93	-2.71	0.79	0.70	0.78	7.75e-18	1.10e-16	(A) Negative
CDIN1	15q14	-0.30	-0.91	0.62	0.59	0.61	7.78e-18	1.10e-16	(A) Negative
SFI1	22q12.2	-0.69	-0.13	0.56	0.58	-0.56	7.93e-18	1.12e-16	(B) Positive
PRRT2	16p11.2	-1.84	-0.84	0.99	1.05	-1.00	8.03e-18	1.13e-16	(B) Positive
KLK6	19q13.41	1.11	-1.18	2.41	1.43	2.30	8.31e-18	1.17e-16	(A) Negative
MATN3	2p24.1	-1.89	-0.37	1.56	1.33	-1.52	8.65e-18	1.22e-16	(B) Positive
ZNF799	19p13.2	0.12	0.69	0.57	0.59	-0.57	9.10e-18	1.28e-16	(B) Positive
ABCA2	9q34.3	-0.84	-0.23	0.61	0.63	-0.61	9.33e-18	1.31e-16	(B) Positive
INPP4A	2q11.2	-0.02	-0.51	0.50	0.37	0.48	9.42e-18	1.33e-16	(A) Negative
NUCB2	11p15.1	0.01	0.83	0.80	0.95	-0.82	9.43e-18	1.33e-16	(B) Positive
FBXO36	2q36.3	-0.56	0.32	0.89	0.79	-0.88	9.61e-18	1.35e-16	(B) Positive
TMEM105	17q25.3	0.61	-0.35	0.98	0.87	0.96	1.01e-17	1.42e-16	(A) Negative
ULBP2	6q25.1	-0.08	-1.24	1.20	0.84	1.15	1.01e-17	1.42e-16	(A) Negative
SLC2A12	6q23.2	0.25	-0.71	1.01	0.61	0.96	1.05e-17	1.47e-16	(A) Negative
SNX24	5q23.2	-0.52	0.12	0.63	0.69	-0.64	1.07e-17	1.50e-16	(B) Positive
TRIT1	1p34.2	-0.65	-1.18	0.55	0.49	0.53	1.09e-17	1.52e-16	(A) Negative
PSRC1	1p13.3	-0.98	-1.72	0.76	0.65	0.74	1.10e-17	1.53e-16	(A) Negative
NFATC4	14q12	0.19	0.71	0.50	0.60	-0.51	1.10e-17	1.53e-16	(B) Positive
LRRC8D	1p22.2	0.49	-0.32	0.85	0.54	0.81	1.10e-17	1.54e-16	(A) Negative
CYBRD1	2q31.1	0.82	1.91	1.05	1.33	-1.08	1.10e-17	1.54e-16	(B) Positive
GJA1	6q22.31	0.02	1.19	1.08	1.61	-1.17	1.12e-17	1.56e-16	(B) Positive
GNPDA2	4p12	0.05	0.68	0.64	0.60	-0.62	1.14e-17	1.59e-16	(B) Positive
NINJ1	9q22.31	0.56	1.29	0.76	0.60	-0.73	1.16e-17	1.61e-16	(B) Positive
KGD4	5q13.2	-0.63	-0.09	0.56	0.49	-0.54	1.17e-17	1.62e-16	(B) Positive
NBEA	13q13.3	-0.53	0.78	1.36	1.04	-1.31	1.20e-17	1.67e-16	(B) Positive
GNB4	3q26.33	0.30	-0.47	0.78	0.75	0.77	1.22e-17	1.69e-16	(A) Negative
RNF217	6q22.31	0.84	-0.02	0.89	0.82	0.87	1.22e-17	1.69e-16	(A) Negative
C9ORF40	9q21.13	-1.00	-1.76	0.79	0.57	0.76	1.22e-17	1.69e-16	(A) Negative
UBE2S	19q13.42	-0.83	-1.44	0.60	0.67	0.61	1.22e-17	1.69e-16	(A) Negative
PTDSS1	8q22.1	0.37	-0.18	0.55	0.58	0.55	1.22e-17	1.69e-16	(A) Negative
CPEB4	5q35.2	0.23	0.88	0.66	0.64	-0.65	1.24e-17	1.71e-16	(B) Positive
KLHL7	7p15.3	-0.24	-0.85	0.63	0.60	0.62	1.25e-17	1.73e-16	(A) Negative
PDHA1	Xp22.12	-0.31	-0.87	0.60	0.39	0.57	1.27e-17	1.75e-16	(A) Negative
ASTN2	9q33.1	0.11	1.00	0.93	0.79	-0.90	1.27e-17	1.76e-16	(B) Positive
APBA2	15q13.1	-0.34	-1.30	1.00	0.75	0.96	1.30e-17	1.79e-16	(A) Negative
HRCT1	9p13.3	1.97	0.25	1.81	1.23	1.72	1.32e-17	1.82e-16	(A) Negative
KCNS1	20q13.12	0.78	-0.58	1.46	0.64	1.36	1.33e-17	1.82e-16	(A) Negative
PCBD2	5q31.1	-0.48	0.02	0.51	0.51	-0.50	1.38e-17	1.90e-16	(B) Positive
PLD1	3q26.31	-0.05	-0.88	0.86	0.76	0.83	1.40e-17	1.93e-16	(A) Negative
TIGD1	2q37.1	0.06	-0.48	0.56	0.41	0.54	1.41e-17	1.93e-16	(A) Negative
RCC2	1p36.13	0.31	-0.17	0.49	0.45	0.48	1.43e-17	1.96e-16	(A) Negative
ROGDI	16p13.3	0.56	1.24	0.70	0.63	-0.68	1.46e-17	2.00e-16	(B) Positive
SMOC1	14q24.1	-1.37	-2.65	1.35	0.76	1.28	1.47e-17	2.02e-16	(A) Negative
NDUFA2	5q31.3	0.09	0.64	0.57	0.48	-0.55	1.52e-17	2.07e-16	(B) Positive
ANKS6	9q22.33	-1.06	-1.89	0.87	0.62	0.83	1.54e-17	2.10e-16	(A) Negative
GPX7	1p32.3	0.65	-0.36	1.04	0.89	1.01	1.55e-17	2.12e-16	(A) Negative
ATAD3A	1p36.33	-0.46	-1.10	0.67	0.54	0.64	1.57e-17	2.14e-16	(A) Negative
FAM83B	6p12.1	0.56	-0.73	1.27	1.49	1.29	1.57e-17	2.15e-16	(A) Negative
FRY	13q13.1	2.47	3.47	1.03	0.90	-1.00	1.58e-17	2.16e-16	(B) Positive
GOLGB1	3q13.33	0.62	1.16	0.56	0.46	-0.54	1.58e-17	2.16e-16	(B) Positive
IFIT1B	10q23.31	0.22	0.68	0.43	0.62	-0.46	1.59e-17	2.16e-16	(B) Positive
PRDX4	Xp22.11	-0.33	-0.90	0.58	0.54	0.57	1.60e-17	2.18e-16	(A) Negative
DTWD2	5q23.1	-0.04	0.69	0.73	0.72	-0.72	1.61e-17	2.18e-16	(B) Positive
RAPGEF6	5q31.1	-0.52	-0.01	0.52	0.51	-0.51	1.65e-17	2.24e-16	(B) Positive
COQ6	14q24.3	-0.38	0.11	0.50	0.50	-0.49	1.65e-17	2.24e-16	(B) Positive
BACE2	21q22.2-q22.3	0.50	-0.42	0.94	0.93	0.92	1.70e-17	2.30e-16	(A) Negative
PSMB2	1p34.3	-0.30	-0.85	0.58	0.44	0.56	1.70e-17	2.30e-16	(A) Negative
PLAAT3	11q12.3-q13.1	0.84	2.26	1.48	1.19	-1.42	1.76e-17	2.38e-16	(B) Positive
PPP2CA	5q31.1	-0.39	0.12	0.53	0.48	-0.51	1.77e-17	2.39e-16	(B) Positive
RPL39L	3q27.3	0.44	-0.45	0.87	1.05	0.89	1.81e-17	2.44e-16	(A) Negative
BTBD3	20p12.2	0.36	-0.39	0.78	0.57	0.75	1.82e-17	2.46e-16	(A) Negative
PTTG1	5q33.3	-1.29	-2.06	0.78	0.84	0.77	1.84e-17	2.48e-16	(A) Negative
CHST4	16q22.2	-0.34	-1.96	1.73	0.85	1.62	1.85e-17	2.50e-16	(A) Negative
C1ORF56	1q21.3	-0.11	0.45	0.56	0.68	-0.57	1.86e-17	2.51e-16	(B) Positive
EFHC1	6p12.2	-0.88	-0.23	0.66	0.64	-0.65	1.92e-17	2.58e-16	(B) Positive
BOP1	8q24.3	0.12	-0.63	0.76	0.79	0.75	1.92e-17	2.58e-16	(A) Negative
ELOA	1p36.11	-0.19	-0.65	0.47	0.43	0.45	1.94e-17	2.61e-16	(A) Negative
ANKRD24	19p13.3	-0.50	-0.10	0.39	0.50	-0.40	1.94e-17	2.61e-16	(B) Positive
CHIC1	Xq13.2	-0.45	0.29	0.77	0.65	-0.74	1.95e-17	2.61e-16	(B) Positive
CFD	19p13.3	-0.00	1.32	1.35	1.34	-1.32	1.97e-17	2.64e-16	(B) Positive
EZH1	17q21.2	-0.41	0.00	0.42	0.43	-0.41	1.98e-17	2.66e-16	(B) Positive
XPC	3p25.1	-0.50	-0.00	0.51	0.46	-0.50	1.99e-17	2.66e-16	(B) Positive
PAPSS1	4q25	1.44	0.59	0.91	0.56	0.86	2.01e-17	2.69e-16	(A) Negative
BMAL2	12p11.23	-0.61	-1.78	1.24	0.80	1.17	2.09e-17	2.79e-16	(A) Negative
ETV4	17q21.31	-1.76	-2.65	0.92	0.83	0.89	2.10e-17	2.80e-16	(A) Negative
SURF1	9q34.2	-0.18	0.42	0.63	0.49	-0.60	2.14e-17	2.85e-16	(B) Positive
CACFD1	9q34.2	0.63	1.11	0.50	0.44	-0.48	2.14e-17	2.85e-16	(B) Positive
PARP3	3p21.2	-0.56	0.14	0.72	0.68	-0.70	2.16e-17	2.87e-16	(B) Positive
KPNA4	3q25.33	0.48	-0.03	0.52	0.42	0.50	2.19e-17	2.92e-16	(A) Negative
BUB1B	15q15.1	-1.42	-2.20	0.77	0.91	0.78	2.21e-17	2.94e-16	(A) Negative
SPSB1	1p36.22	1.36	0.77	0.58	0.69	0.59	2.27e-17	3.02e-16	(A) Negative
PTTG2	4p14	-1.28	-2.02	0.75	0.81	0.74	2.30e-17	3.05e-16	(A) Negative
RIPK2	8q21.3	0.94	0.30	0.66	0.58	0.64	2.33e-17	3.09e-16	(A) Negative
TMEM30B	14q23.1	0.88	1.36	0.49	0.49	-0.48	2.34e-17	3.10e-16	(B) Positive
PLAGL1	6q24.2	0.19	-0.61	0.85	0.57	0.80	2.36e-17	3.12e-16	(A) Negative
MICALL1	22q13.1	0.40	-0.45	0.90	0.68	0.86	2.42e-17	3.21e-16	(A) Negative
MCM6	2q21.3	-0.52	-1.14	0.64	0.60	0.62	2.47e-17	3.27e-16	(A) Negative
ANP32E	1q21.2	-0.29	-1.36	1.14	0.75	1.07	2.53e-17	3.34e-16	(A) Negative
PALM	19p13.3	-0.11	1.00	1.19	0.76	-1.12	2.54e-17	3.36e-16	(B) Positive
PTTG3P	8q13.1	-1.26	-2.03	0.77	0.84	0.76	2.64e-17	3.48e-16	(A) Negative
KPNA2	17q24.2	-0.69	-1.40	0.70	0.83	0.71	2.65e-17	3.49e-16	(A) Negative
SCNM1	1q21.3	0.70	0.27	0.45	0.39	0.44	2.70e-17	3.55e-16	(A) Negative
NUDT16	3q22.1	0.25	0.74	0.52	0.40	-0.50	2.77e-17	3.65e-16	(B) Positive
ADAMTSL5	19p13.3	-0.68	-0.21	0.47	0.53	-0.47	2.77e-17	3.65e-16	(B) Positive
ARHGAP21	10p12.1	0.39	-0.34	0.77	0.52	0.73	2.78e-17	3.65e-16	(A) Negative
RHOH	4p14	-1.47	-0.14	1.35	1.40	-1.32	2.78e-17	3.65e-16	(B) Positive
DHX29	5q11.2	0.11	0.53	0.43	0.41	-0.42	2.79e-17	3.67e-16	(B) Positive
RETREG3	17q21.2	0.53	0.88	0.35	0.40	-0.35	2.81e-17	3.69e-16	(B) Positive
CCNY	10p11.21	0.69	0.27	0.45	0.35	0.43	2.83e-17	3.71e-16	(A) Negative
PRPF38A	1p32.3	-0.52	-0.94	0.45	0.37	0.43	2.84e-17	3.72e-16	(A) Negative
DNAJC14	12q13.2	-0.13	0.29	0.43	0.41	-0.42	2.88e-17	3.77e-16	(B) Positive
GPR19	12p13.1	-0.66	-1.56	0.95	0.76	0.90	2.94e-17	3.85e-16	(A) Negative
LCN12	9q34.3	0.22	0.92	0.64	1.05	-0.70	2.95e-17	3.85e-16	(B) Positive
BORCS6	17p13.1	0.29	0.72	0.43	0.48	-0.43	3.06e-17	4.00e-16	(B) Positive
ZC3H12C	11q22.3	-0.37	-1.27	0.94	0.84	0.90	3.16e-17	4.12e-16	(A) Negative
ZFYVE28	4p16.3	-0.35	0.39	0.77	0.72	-0.74	3.22e-17	4.20e-16	(B) Positive
NOTCH1	9q34.3	0.28	-0.43	0.75	0.56	0.70	3.24e-17	4.22e-16	(A) Negative
SMAD3	15q22.33	-1.02	-0.35	0.69	0.63	-0.67	3.29e-17	4.28e-16	(B) Positive
CEBPG	19q13.11	0.53	-0.03	0.60	0.41	0.57	3.42e-17	4.44e-16	(A) Negative
ANTKMT	16p13.3	0.43	1.07	0.67	0.55	-0.63	3.44e-17	4.47e-16	(B) Positive
ECI2	6p25.2	-1.00	-0.07	0.99	0.69	-0.93	3.44e-17	4.47e-16	(B) Positive
FOLH1B	11q14.3	2.79	1.60	1.24	1.05	1.18	3.46e-17	4.48e-16	(A) Negative
OGFRL1	6q13	1.69	0.47	1.30	0.82	1.21	3.51e-17	4.56e-16	(A) Negative
MORC2	22q12.2	0.70	0.23	0.49	0.43	0.47	3.62e-17	4.70e-16	(A) Negative
MBD6	12q13.3	-0.10	0.29	0.40	0.40	-0.39	3.74e-17	4.85e-16	(B) Positive
NT5C2	10q24.32-q24.33	0.10	-0.57	0.71	0.57	0.67	3.80e-17	4.92e-16	(A) Negative
CEACAM19	19q13.31	0.96	0.26	0.73	0.64	0.70	3.83e-17	4.96e-16	(A) Negative
COASY	17q21.2	-0.78	-0.28	0.51	0.55	-0.50	3.85e-17	4.97e-16	(B) Positive
AMOTL1	11q21	-0.29	-1.16	0.93	0.73	0.88	3.90e-17	5.03e-16	(A) Negative
ARHGAP11A	15q13.3	-1.78	-2.60	0.84	0.85	0.82	3.95e-17	5.09e-16	(A) Negative
PNMA3	Xq28	0.26	-0.80	1.13	0.73	1.05	4.10e-17	5.28e-16	(A) Negative
RBM11	21q11.2	-0.12	1.45	1.63	1.52	-1.56	4.13e-17	5.32e-16	(B) Positive
TGM1	14q12	0.21	-1.04	1.34	0.90	1.25	4.15e-17	5.34e-16	(A) Negative
ZNF747	16p11.2	0.33	0.80	0.48	0.53	-0.48	4.20e-17	5.40e-16	(B) Positive
ACTR3	2q14.1	0.56	0.00	0.58	0.50	0.55	4.29e-17	5.51e-16	(A) Negative
DDX18	2q14.1	0.06	-0.39	0.47	0.34	0.44	4.31e-17	5.54e-16	(A) Negative
SUCLG2	3p14.1	-0.33	0.25	0.59	0.64	-0.58	4.36e-17	5.59e-16	(B) Positive
ZNF281	1q32.1	0.07	0.71	0.66	0.69	-0.64	4.45e-17	5.70e-16	(B) Positive
ZNF214	11p15.4	-0.51	0.75	1.30	1.33	-1.26	4.45e-17	5.70e-16	(B) Positive
ATP6V1E2	2p21	0.16	-0.66	0.85	0.83	0.82	4.48e-17	5.74e-16	(A) Negative
REEP1	2p11.2	-0.06	1.75	1.93	1.38	-1.81	4.54e-17	5.81e-16	(B) Positive
DTD1	20p11.23	-0.29	-0.93	0.67	0.66	0.65	4.56e-17	5.83e-16	(A) Negative
MMEL1	1p36.32	0.89	2.01	1.18	0.94	-1.12	4.68e-17	5.98e-16	(B) Positive
CPEB3	10q23.32	1.14	1.94	0.85	0.66	-0.80	4.69e-17	5.98e-16	(B) Positive
VPS37C	11q12.2	0.52	1.00	0.48	0.52	-0.47	4.96e-17	6.32e-16	(B) Positive
PWWP3B	Xq22.3	0.24	2.23	2.06	1.98	-1.99	4.97e-17	6.34e-16	(B) Positive
CCDC40	17q25.3	1.13	2.19	1.13	0.85	-1.06	5.16e-17	6.57e-16	(B) Positive
NUBPL	14q12	-0.64	-0.05	0.62	0.56	-0.59	5.17e-17	6.57e-16	(B) Positive
PTGER3	1p31.1	1.18	2.09	0.93	1.03	-0.91	5.18e-17	6.59e-16	(B) Positive
SELENBP1	1q21.3	0.53	1.45	0.97	0.76	-0.92	5.23e-17	6.64e-16	(B) Positive
AHNAK	11q12.3	-0.35	0.45	0.86	0.59	-0.80	5.25e-17	6.66e-16	(B) Positive
HSPA14	10p13	0.16	-0.50	0.71	0.49	0.66	5.29e-17	6.71e-16	(A) Negative
NPNT	4q24	1.98	3.43	1.55	1.15	-1.45	5.29e-17	6.71e-16	(B) Positive
ATP6V0A2	12q24.31	0.00	-0.47	0.50	0.45	0.47	5.30e-17	6.72e-16	(A) Negative
ADAM17	2p25.1	0.69	0.20	0.52	0.45	0.50	5.51e-17	6.97e-16	(A) Negative
HSDL2	9q32	-0.32	0.28	0.63	0.59	-0.61	5.53e-17	6.99e-16	(B) Positive
NEK9	14q24.3	-0.13	0.43	0.58	0.58	-0.56	5.56e-17	7.03e-16	(B) Positive
MEAK7	16q24.1	0.71	-0.21	0.99	0.65	0.92	5.70e-17	7.20e-16	(A) Negative
AKR7A2	1p36.13	-0.35	0.17	0.54	0.53	-0.52	5.71e-17	7.20e-16	(B) Positive
LIPG	18q21.1	0.60	-0.66	1.35	1.00	1.26	5.72e-17	7.22e-16	(A) Negative
POLI	18q21.2	-0.27	0.34	0.64	0.63	-0.61	5.76e-17	7.26e-16	(B) Positive
LRIG3	12q14.1	0.91	0.12	0.79	0.96	0.79	5.77e-17	7.27e-16	(A) Negative
CSTB	21q22.3	0.50	-0.26	0.83	0.59	0.77	5.81e-17	7.31e-16	(A) Negative
RIMS3	1p34.2	-0.09	-0.88	0.83	0.76	0.80	5.87e-17	7.39e-16	(A) Negative
WDR4	21q22.3	-0.92	-1.62	0.74	0.68	0.71	6.03e-17	7.58e-16	(A) Negative
SERPINB5	18q21.33	0.79	-0.92	1.82	1.39	1.71	6.06e-17	7.61e-16	(A) Negative
SLC35F2	11q22.3	-0.42	-1.32	0.97	0.72	0.90	6.07e-17	7.62e-16	(A) Negative
WDHD1	14q22.2-q22.3	-1.31	-1.99	0.72	0.63	0.68	6.13e-17	7.68e-16	(A) Negative
FUOM	10q26.3	-0.40	-1.19	0.81	0.83	0.79	6.22e-17	7.80e-16	(A) Negative
CERK	22q13.31	-0.22	-0.78	0.58	0.58	0.56	6.34e-17	7.94e-16	(A) Negative
LCA5L	21q22.2	0.19	1.04	0.90	0.78	-0.85	6.52e-17	8.15e-16	(B) Positive
MYLIP	6p22.3	-0.53	0.16	0.72	0.68	-0.69	6.60e-17	8.25e-16	(B) Positive
FAM86JP	3q21.2	0.12	0.51	0.41	0.38	-0.39	6.63e-17	8.28e-16	(B) Positive
CGRRF1	14q22.2	-0.14	0.43	0.61	0.49	-0.57	6.66e-17	8.32e-16	(B) Positive
PIGB	15q21.3	-0.42	0.05	0.49	0.43	-0.46	6.73e-17	8.39e-16	(B) Positive
DYNC2H1	11q22.3	-0.76	-0.06	0.73	0.68	-0.70	6.74e-17	8.40e-16	(B) Positive
GABBR2	9q22.33	-0.15	-1.48	1.46	0.70	1.34	6.80e-17	8.47e-16	(A) Negative
SLC6A2	16q12.2	1.38	-0.00	1.52	0.57	1.38	6.80e-17	8.47e-16	(A) Negative
FERMT1	20p12.3	-1.42	-2.84	1.53	1.10	1.42	6.84e-17	8.51e-16	(A) Negative
NUP50	22q13.31	0.27	-0.12	0.41	0.37	0.39	6.96e-17	8.65e-16	(A) Negative
SOX10	22q13.1	-0.34	-2.00	1.83	0.77	1.67	7.05e-17	8.76e-16	(A) Negative
ANKRD20A11P	21q11.2	-2.72	-1.21	1.53	1.77	-1.51	7.33e-17	9.10e-16	(B) Positive
KRT6A	12q13.13	0.62	-1.36	2.12	1.73	1.99	7.41e-17	9.19e-16	(A) Negative
SREK1	5q12.3	-0.87	-0.52	0.35	0.40	-0.35	7.54e-17	9.35e-16	(B) Positive
TSPAN33	7q32.1	1.37	0.53	0.88	0.80	0.83	7.58e-17	9.39e-16	(A) Negative
RPS7	2p25.3	-0.30	-0.87	0.60	0.47	0.56	7.66e-17	9.49e-16	(A) Negative
SYNCRIP	6q14.3	0.08	-0.39	0.51	0.43	0.48	7.95e-17	9.84e-16	(A) Negative
NCAPD2	12p13.31	-0.84	-1.55	0.78	0.51	0.71	8.05e-17	9.94e-16	(A) Negative
PCSK4	19p13.3	-0.46	0.40	0.91	0.78	-0.86	8.11e-17	1.00e-15	(B) Positive
CHORDC1	11q14.3	-0.48	-1.06	0.61	0.60	0.58	8.28e-17	1.02e-15	(A) Negative
HSPB1	7q11.23	-0.39	0.52	0.95	0.91	-0.91	8.34e-17	1.03e-15	(B) Positive
RCAN1	21q22.12	0.75	-0.33	1.14	0.98	1.07	8.35e-17	1.03e-15	(A) Negative
ITGB8	7p21.1	0.83	-0.09	0.97	0.89	0.92	8.40e-17	1.03e-15	(A) Negative
SNAI1	20q13.13	0.20	-0.57	0.81	0.83	0.78	8.45e-17	1.04e-15	(A) Negative
TMEFF1	9q31.1	-1.35	-2.36	1.10	0.72	1.01	8.51e-17	1.05e-15	(A) Negative
INCENP	11q12.3	-1.34	-2.06	0.76	0.73	0.72	8.59e-17	1.06e-15	(A) Negative
IL20RA	6q23.3	2.34	3.89	1.59	1.79	-1.55	8.75e-17	1.07e-15	(B) Positive
GLUD2	Xq24	-0.75	-0.14	0.65	0.58	-0.61	8.80e-17	1.08e-15	(B) Positive
CDK7	5q13.2	-0.48	-0.06	0.43	0.46	-0.42	8.90e-17	1.09e-15	(B) Positive
TCF3	19p13.3	-0.41	-0.98	0.60	0.56	0.57	8.98e-17	1.10e-15	(A) Negative
RIOK1	6p24.3	0.05	-0.59	0.70	0.46	0.64	9.22e-17	1.13e-15	(A) Negative
SMIM7	19p13.11	0.12	0.60	0.51	0.47	-0.48	9.36e-17	1.15e-15	(B) Positive
ZNF564	19p13.2	0.43	0.93	0.52	0.51	-0.49	9.45e-17	1.16e-15	(B) Positive
PPARD	6p21.31	0.58	0.13	0.48	0.42	0.45	9.61e-17	1.17e-15	(A) Negative
PDE7A	8q13.1	0.14	-0.73	0.93	0.78	0.87	9.62e-17	1.18e-15	(A) Negative
AMDHD1	12q23.1	-2.18	-1.18	0.98	1.31	-1.00	9.85e-17	1.20e-15	(B) Positive
GFRA3	5q31.2	1.03	0.16	0.97	0.36	0.87	1.00e-16	1.22e-15	(A) Negative
SNRPG	2p13.3	-0.30	-0.75	0.48	0.40	0.45	1.04e-16	1.27e-15	(A) Negative
RAB5B	12q13.2	0.58	1.05	0.50	0.41	-0.47	1.04e-16	1.27e-15	(B) Positive
GSTA2	6p12.2	0.42	-1.51	2.10	1.42	1.93	1.05e-16	1.27e-15	(A) Negative
SGMS2	4q25	0.96	0.22	0.78	0.78	0.74	1.05e-16	1.27e-15	(A) Negative
DDIAS	11q14.1	-1.15	-1.95	0.82	0.93	0.80	1.05e-16	1.28e-15	(A) Negative
PLIN2	9p22.1	-0.31	-1.16	0.88	0.90	0.85	1.05e-16	1.28e-15	(A) Negative
CETN3	5q14.3	-1.18	-0.64	0.57	0.53	-0.54	1.06e-16	1.28e-15	(B) Positive
MORN1	1p36.32	-0.06	0.51	0.59	0.58	-0.57	1.06e-16	1.29e-15	(B) Positive
NUP155	5p13.2	-0.97	-1.56	0.63	0.50	0.59	1.10e-16	1.33e-15	(A) Negative
ODR4	1q31.1	-0.27	0.27	0.58	0.51	-0.54	1.11e-16	1.34e-15	(B) Positive
LAMP5	20p12.2	0.78	2.26	1.59	1.32	-1.49	1.11e-16	1.34e-15	(B) Positive
ARL4C	2q37.1	0.14	-0.65	0.83	0.86	0.80	1.12e-16	1.35e-15	(A) Negative
MLXIP	12q21.31	-0.06	-0.54	0.51	0.46	0.48	1.13e-16	1.37e-15	(A) Negative
RGS12	4p16.3	0.14	0.48	0.36	0.35	-0.34	1.14e-16	1.38e-15	(B) Positive
PLCG2	16q24.1	1.56	0.54	1.10	0.80	1.02	1.15e-16	1.39e-15	(A) Negative
CDK8	13q12.13	-0.22	-0.74	0.56	0.49	0.52	1.16e-16	1.40e-15	(A) Negative
MIA	19q13.2	0.52	-2.19	2.97	1.90	2.71	1.20e-16	1.44e-15	(A) Negative
DUSP5	10q25.2	-0.20	0.72	0.98	0.90	-0.92	1.20e-16	1.44e-15	(B) Positive
HYCC1	7p15.3	-1.34	-2.12	0.84	0.68	0.78	1.20e-16	1.45e-15	(A) Negative
ISOC1	5q23.3	-0.56	0.24	0.72	1.24	-0.79	1.23e-16	1.48e-15	(B) Positive
TMCC2	1q32.1	-0.31	-1.24	1.01	0.64	0.92	1.25e-16	1.50e-15	(A) Negative
HSD17B8	6p21.32	-0.71	0.29	1.09	0.74	-1.00	1.27e-16	1.52e-15	(B) Positive
ANXA3	4q21.21	0.91	-0.50	1.45	1.62	1.40	1.28e-16	1.54e-15	(A) Negative
NFE2L3	7p15.2	-0.16	-1.32	1.26	0.99	1.16	1.29e-16	1.55e-15	(A) Negative
SLC22A4	5q31.1	-1.46	-0.45	1.05	1.10	-1.01	1.30e-16	1.56e-15	(B) Positive
SIL1	5q31.2	0.30	0.86	0.59	0.59	-0.56	1.38e-16	1.66e-15	(B) Positive
RNF14	5q31.3	0.23	0.66	0.45	0.42	-0.43	1.39e-16	1.67e-15	(B) Positive
INGX	Xq13.1	0.89	0.06	0.92	0.47	0.83	1.41e-16	1.69e-15	(A) Negative
KHDRBS3	8q24.23	0.91	-0.33	1.36	0.87	1.24	1.41e-16	1.69e-15	(A) Negative
B3GALNT2	1q42.3	0.66	0.04	0.65	0.63	0.62	1.41e-16	1.69e-15	(A) Negative
BORA	13q21.33	-0.75	-1.25	0.53	0.52	0.50	1.42e-16	1.70e-15	(A) Negative
ACSM1	16p12.3	0.05	1.36	1.38	1.39	-1.31	1.46e-16	1.75e-15	(B) Positive
DIPK2A	3q24	0.97	-0.01	1.07	0.81	0.98	1.48e-16	1.76e-15	(A) Negative
FANCD2	3p25.3	-0.43	-0.99	0.60	0.57	0.56	1.49e-16	1.77e-15	(A) Negative
PHF5A	22q13.2	0.19	-0.26	0.48	0.45	0.45	1.49e-16	1.78e-15	(A) Negative
FAM13A	4q22.1	-0.35	-0.88	0.56	0.54	0.53	1.55e-16	1.84e-15	(A) Negative
TGFB3	14q24.3	2.14	3.09	1.04	0.78	-0.95	1.56e-16	1.86e-15	(B) Positive
TRAF5	1q32.3	-0.20	0.57	0.81	0.82	-0.77	1.57e-16	1.86e-15	(B) Positive
RNF123	3p21.31	-0.40	-0.05	0.37	0.40	-0.35	1.57e-16	1.86e-15	(B) Positive
KCNK4	11q13.1	0.15	0.51	0.36	0.46	-0.36	1.58e-16	1.88e-15	(B) Positive
PCDHB11	5q31.3	0.92	0.05	0.92	0.93	0.87	1.61e-16	1.91e-15	(A) Negative
TPTE	21p11.2	-2.04	-1.45	0.60	0.73	-0.59	1.62e-16	1.92e-15	(B) Positive
FAM110B	8q12.1	1.58	2.62	1.12	0.98	-1.04	1.62e-16	1.92e-15	(B) Positive
ZNF563	19p13.2	-0.71	-0.11	0.62	0.74	-0.61	1.63e-16	1.92e-15	(B) Positive
TCEA3	1p36.12	1.53	2.37	0.92	0.66	-0.85	1.65e-16	1.94e-15	(B) Positive
SERINC3	20q13.12	-0.11	0.40	0.55	0.48	-0.51	1.67e-16	1.97e-15	(B) Positive
CHID1	11p15.5	-0.07	0.36	0.45	0.47	-0.43	1.67e-16	1.97e-15	(B) Positive
HDC	15q21.2	1.42	2.59	1.19	1.50	-1.18	1.70e-16	2.00e-15	(B) Positive
FOLH1	11p11.12	2.17	1.19	1.05	0.89	0.97	1.71e-16	2.01e-15	(A) Negative
DDX39A	19p13.12	-0.32	-0.88	0.58	0.60	0.55	1.72e-16	2.02e-15	(A) Negative
COLGALT1	19p13.11	-0.02	-0.53	0.54	0.54	0.51	1.75e-16	2.06e-15	(A) Negative
PPARGC1B	5q32	0.28	-0.55	0.88	0.87	0.83	1.79e-16	2.10e-15	(A) Negative
ALAD	9q32	0.17	0.71	0.58	0.50	-0.54	1.84e-16	2.16e-15	(B) Positive
LYAR	4p16.3	-0.86	-1.39	0.58	0.43	0.53	1.85e-16	2.18e-15	(A) Negative
TRIM3	11p15.4	0.23	0.99	0.80	0.81	-0.76	1.85e-16	2.18e-15	(B) Positive
HAPSTR1	16p13.2	0.18	0.65	0.52	0.42	-0.48	1.86e-16	2.18e-15	(B) Positive
RLF	1p34.2	-0.38	-0.86	0.50	0.51	0.48	1.87e-16	2.20e-15	(A) Negative
LETMD1	12q13.12	-1.26	-0.78	0.51	0.47	-0.47	1.88e-16	2.20e-15	(B) Positive
PKP1	1q32.1	1.06	-0.35	1.54	1.13	1.41	1.90e-16	2.22e-15	(A) Negative
TTYH1	19q13.42	0.64	-1.10	1.94	0.90	1.74	1.91e-16	2.23e-15	(A) Negative
SPAG8	9p13.3	-0.21	0.47	0.69	0.88	-0.68	1.91e-16	2.24e-15	(B) Positive
HTT	4p16.3	-0.34	0.08	0.43	0.51	-0.42	1.92e-16	2.24e-15	(B) Positive
UBE2T	1q32.1	-0.79	-1.56	0.79	0.94	0.77	1.95e-16	2.28e-15	(A) Negative
H2AC14	6p22.1	0.82	1.68	0.88	1.07	-0.86	1.96e-16	2.28e-15	(B) Positive
ERBIN	5q12.3	-0.18	0.23	0.44	0.37	-0.41	1.96e-16	2.29e-15	(B) Positive
KRT6C	12q13.13	0.66	-1.21	2.04	1.63	1.87	1.97e-16	2.29e-15	(A) Negative
H2AJ	12p12.3	0.40	1.22	0.83	1.07	-0.82	1.97e-16	2.29e-15	(B) Positive
PPP1R36	14q23.3	0.27	1.10	0.81	1.19	-0.83	1.97e-16	2.30e-15	(B) Positive
RPS27L	15q22.2	-0.85	-0.29	0.58	0.66	-0.56	2.00e-16	2.32e-15	(B) Positive
GABRE	Xq28	-1.56	-2.74	1.30	0.96	1.18	2.01e-16	2.33e-15	(A) Negative
IL24	1q32.1	0.05	0.54	0.46	0.76	-0.49	2.03e-16	2.36e-15	(B) Positive
MFAP1	15q15.3	-0.69	-0.16	0.58	0.44	-0.53	2.04e-16	2.36e-15	(B) Positive
HMGB3	Xq28	0.57	-0.20	0.78	0.98	0.77	2.06e-16	2.38e-15	(A) Negative
ADORA2B	17p12	-1.47	-2.55	1.17	0.96	1.08	2.08e-16	2.41e-15	(A) Negative
SPTBN4	19q13.2	0.24	0.65	0.41	0.52	-0.40	2.09e-16	2.42e-15	(B) Positive
EYA3	1p35.3	-1.01	-1.70	0.75	0.57	0.69	2.10e-16	2.42e-15	(A) Negative
NR2C2	3p25.1	-0.28	-0.83	0.59	0.47	0.54	2.11e-16	2.44e-15	(A) Negative
SEM1	7q21.3	0.40	-0.11	0.55	0.50	0.51	2.12e-16	2.44e-15	(A) Negative
C5ORF34	5p12	-1.00	-1.66	0.72	0.61	0.66	2.12e-16	2.44e-15	(A) Negative
CERT1	5q13.3	0.08	0.70	0.67	0.56	-0.62	2.18e-16	2.52e-15	(B) Positive
OLAH	10p13	0.28	-0.97	1.41	0.59	1.25	2.19e-16	2.52e-15	(A) Negative
GSC	14q32.13	-0.44	0.62	1.08	1.33	-1.06	2.19e-16	2.53e-15	(B) Positive
CCL20	2q36.3	-2.89	-4.37	1.63	1.03	1.48	2.27e-16	2.61e-15	(A) Negative
TAF9B	Xq21.1	-0.62	-0.15	0.50	0.46	-0.46	2.28e-16	2.62e-15	(B) Positive
MAN1C1	1p36.11	0.21	1.16	1.00	1.02	-0.95	2.28e-16	2.63e-15	(B) Positive
CBS	21q22.3	-1.30	-2.23	1.01	0.79	0.92	2.28e-16	2.63e-15	(A) Negative
OPRK1	8q11.23	0.43	-0.98	1.58	0.80	1.41	2.32e-16	2.67e-15	(A) Negative
FAM98A	2p22.3	0.61	0.07	0.59	0.48	0.55	2.33e-16	2.67e-15	(A) Negative
DZIP3	3q13.13	-0.39	0.16	0.57	0.68	-0.55	2.34e-16	2.68e-15	(B) Positive
HIF1A	14q23.2	-0.77	-1.50	0.73	0.97	0.73	2.36e-16	2.70e-15	(A) Negative
PERM1	1p36.33	-0.50	0.41	0.97	0.97	-0.91	2.41e-16	2.76e-15	(B) Positive
SLC26A9	1q32.1	0.71	-1.26	2.21	1.10	1.97	2.42e-16	2.77e-15	(A) Negative
MMS22L	6q16.1	-0.80	-1.57	0.85	0.61	0.77	2.43e-16	2.78e-15	(A) Negative
LIN9	1q42.12	0.07	-0.53	0.66	0.53	0.61	2.45e-16	2.80e-15	(A) Negative
RHBDF2	17q25.1	0.70	0.07	0.67	0.62	0.63	2.50e-16	2.85e-15	(A) Negative
LTBP1	2p22.3	-0.49	-1.37	0.93	1.01	0.88	2.52e-16	2.88e-15	(A) Negative
PTPRK	6q22.33	1.18	0.37	0.80	1.12	0.81	2.57e-16	2.94e-15	(A) Negative
DNAAF4	15q21.3	0.77	1.64	0.95	0.83	-0.88	2.61e-16	2.98e-15	(B) Positive
ATXN7L2	1p13.3	0.15	-0.25	0.43	0.36	0.40	2.62e-16	2.98e-15	(A) Negative
IFT43	14q24.3	0.66	1.11	0.49	0.43	-0.45	2.70e-16	3.08e-15	(B) Positive
GNPTG	16p13.3	0.44	0.96	0.56	0.50	-0.52	2.72e-16	3.10e-15	(B) Positive
ANKMY1	2q37.3	-0.22	0.42	0.69	0.66	-0.64	2.74e-16	3.12e-15	(B) Positive
CRABP1	15q25.1	0.02	-1.97	2.20	1.56	2.00	2.75e-16	3.13e-15	(A) Negative
FBXO5	6q25.2	-1.15	-1.87	0.78	0.71	0.72	2.77e-16	3.14e-15	(A) Negative
MKI67	10q26.2	-0.92	-1.84	0.98	1.02	0.92	2.79e-16	3.17e-15	(A) Negative
CRACDL	2q11.2	1.50	2.21	0.77	0.63	-0.70	2.86e-16	3.24e-15	(B) Positive
UPP1	7p12.3	-1.18	-1.94	0.83	0.62	0.76	2.90e-16	3.28e-15	(A) Negative
TMEM158	3p21.31	-1.30	-2.24	1.04	0.74	0.94	2.98e-16	3.38e-15	(A) Negative
EMC3	3p25.3	-0.08	0.44	0.58	0.47	-0.53	3.04e-16	3.44e-15	(B) Positive
SCRN2	17q21.32	-0.57	-0.03	0.58	0.60	-0.54	3.10e-16	3.50e-15	(B) Positive
CTDSP1	2q35	0.37	0.80	0.48	0.34	-0.43	3.19e-16	3.61e-15	(B) Positive
CAD	2p23.3	-0.67	-1.13	0.50	0.42	0.46	3.20e-16	3.62e-15	(A) Negative
ETS1	11q24.3	0.27	-0.47	0.81	0.65	0.74	3.22e-16	3.64e-15	(A) Negative
CCNJ	10q24.1	0.31	-0.44	0.81	0.76	0.75	3.28e-16	3.70e-15	(A) Negative
SEPTIN8	5q31.1	0.20	0.67	0.51	0.52	-0.48	3.28e-16	3.70e-15	(B) Positive
TMEM40	3p25.2	1.89	0.69	1.27	1.35	1.20	3.29e-16	3.71e-15	(A) Negative
UGP2	2p15	0.63	0.24	0.43	0.29	0.39	3.30e-16	3.72e-15	(A) Negative
ST3GAL6	3q12.1	-1.96	-2.86	1.00	0.65	0.89	3.32e-16	3.73e-15	(A) Negative
DPH2	1p34.1	-0.25	-0.74	0.53	0.45	0.49	3.33e-16	3.75e-15	(A) Negative
NAE1	16q22.1	-0.97	-1.54	0.62	0.50	0.57	3.35e-16	3.77e-15	(A) Negative
BAIAP2L2	22q13.1	-0.99	-1.97	1.10	0.61	0.98	3.44e-16	3.86e-15	(A) Negative
ZFP69B	1p34.2	-0.45	-1.12	0.73	0.62	0.67	3.46e-16	3.88e-15	(A) Negative
CA9	9p13.3	-1.96	-3.12	1.28	0.86	1.15	3.52e-16	3.95e-15	(A) Negative
ABHD14A	3p21.2	-0.20	0.34	0.58	0.60	-0.54	3.53e-16	3.96e-15	(B) Positive
IMPDH2	3p21.31	-1.45	-0.91	0.56	0.64	-0.53	3.55e-16	3.97e-15	(B) Positive
POLQ	3q13.33	-1.74	-2.43	0.73	0.79	0.69	3.56e-16	3.98e-15	(A) Negative
DPP8	15q22.31	-0.42	0.00	0.45	0.41	-0.42	3.62e-16	4.05e-15	(B) Positive
GADD45G	9q22.2	1.36	2.03	0.71	0.72	-0.67	3.63e-16	4.06e-15	(B) Positive
SLC39A9	14q24.1	0.33	0.87	0.58	0.49	-0.53	3.66e-16	4.09e-15	(B) Positive
SLC27A3	1q21.3	0.51	1.04	0.56	0.64	-0.53	3.83e-16	4.28e-15	(B) Positive
CHML	1q43	-0.25	-1.05	0.88	0.75	0.80	3.85e-16	4.30e-15	(A) Negative
ZBED4	22q13.33	0.35	-0.02	0.39	0.45	0.37	3.86e-16	4.30e-15	(A) Negative
LMX1B	9q33.3	0.61	1.25	0.70	0.61	-0.64	4.03e-16	4.49e-15	(B) Positive
LTC4S	5q35.3	1.67	2.27	0.66	0.52	-0.60	4.06e-16	4.53e-15	(B) Positive
ZNF263	16p13.3	-0.04	0.53	0.61	0.63	-0.57	4.16e-16	4.62e-15	(B) Positive
GIN1	5q21.1	-0.62	-0.16	0.50	0.46	-0.46	4.23e-16	4.70e-15	(B) Positive
PDXK	21q22.3	0.19	-0.38	0.64	0.40	0.57	4.32e-16	4.80e-15	(A) Negative
CDKL3	5q31.1	-0.48	0.08	0.61	0.55	-0.56	4.43e-16	4.92e-15	(B) Positive
CAPN9	1q42.2	-0.92	0.54	1.57	1.56	-1.46	4.51e-16	5.00e-15	(B) Positive
PITPNM2	12q24.31	-0.56	-1.04	0.52	0.51	0.48	4.52e-16	5.02e-15	(A) Negative
TXNDC5	6p24.3	-0.30	-0.87	0.62	0.55	0.57	4.65e-16	5.15e-15	(A) Negative
HPN	19q13.11	-0.74	0.66	1.55	1.23	-1.40	4.73e-16	5.24e-15	(B) Positive
RAB11A	15q22.31	0.33	0.81	0.53	0.48	-0.48	4.86e-16	5.38e-15	(B) Positive
COA3	17q21.2	0.21	0.76	0.60	0.59	-0.56	4.87e-16	5.39e-15	(B) Positive
POLK	5q13.3	-0.61	-0.21	0.43	0.45	-0.41	5.03e-16	5.56e-15	(B) Positive
LDHD	16q23.1	-0.78	0.13	0.98	0.97	-0.91	5.04e-16	5.57e-15	(B) Positive
C1ORF21	1q25.3	0.21	0.98	0.84	0.77	-0.77	5.08e-16	5.61e-15	(B) Positive
NEDD4L	18q21.31	-1.10	-0.36	0.79	0.87	-0.75	5.17e-16	5.71e-15	(B) Positive
RRP36	6p21.1	-0.05	-0.46	0.46	0.38	0.41	5.21e-16	5.75e-15	(A) Negative
NETO2	16q12.1	-0.51	-1.59	1.15	1.27	1.08	5.32e-16	5.86e-15	(A) Negative
ABCC11	16q12.1	1.29	3.42	2.38	1.65	-2.13	5.37e-16	5.92e-15	(B) Positive
FBXW4	10q24.32	0.25	0.78	0.57	0.60	-0.53	5.39e-16	5.93e-15	(B) Positive
BPI	20q11.23	1.32	0.08	1.42	0.57	1.24	5.42e-16	5.96e-15	(A) Negative
ADCY7	16q12.1	0.09	-0.61	0.77	0.69	0.71	5.53e-16	6.08e-15	(A) Negative
TUSC2	3p21.31	0.00	0.43	0.47	0.42	-0.43	5.54e-16	6.08e-15	(B) Positive
HCRTR1	1p35.2	0.44	0.06	0.42	0.36	0.38	5.54e-16	6.09e-15	(A) Negative
TNFRSF13C	22q13.2	0.30	-0.41	0.79	0.62	0.71	5.59e-16	6.13e-15	(A) Negative
CAPN13	2p23.1	1.74	3.68	2.21	1.15	-1.94	5.61e-16	6.15e-15	(B) Positive
KIF5C	2q23.1-q23.2	0.00	0.58	0.60	0.72	-0.58	5.63e-16	6.17e-15	(B) Positive
SPAST	2p22.3	0.54	0.09	0.50	0.39	0.45	5.65e-16	6.19e-15	(A) Negative
PPP2R3A	3q22.2-q22.3	1.31	0.54	0.83	0.79	0.76	5.77e-16	6.31e-15	(A) Negative
CCDC50	3q28	-0.28	-0.80	0.57	0.55	0.53	5.90e-16	6.45e-15	(A) Negative
TROAP	12q13.12	-1.16	-1.65	0.50	0.62	0.48	6.02e-16	6.58e-15	(A) Negative
CDON	11q24.2	-0.55	0.09	0.66	0.80	-0.64	6.02e-16	6.58e-15	(B) Positive
ABCG1	21q22.3	0.75	1.61	0.95	0.79	-0.86	6.07e-16	6.63e-15	(B) Positive
C15ORF39	15q24.2	-0.27	-0.87	0.65	0.66	0.60	6.10e-16	6.66e-15	(A) Negative
TIPARP	3q25.31	-0.70	-0.07	0.66	0.78	-0.63	6.14e-16	6.69e-15	(B) Positive
TYRO3	15q15.1	-1.17	-1.74	0.62	0.60	0.57	6.23e-16	6.79e-15	(A) Negative
WDR12	2q33.2	-0.84	-1.37	0.60	0.41	0.54	6.29e-16	6.85e-15	(A) Negative
SLC5A6	2p23.3	0.73	-0.14	0.98	0.69	0.87	6.46e-16	7.02e-15	(A) Negative
FLYWCH2	16p13.3	0.21	0.80	0.66	0.52	-0.59	6.47e-16	7.03e-15	(B) Positive
VEZF1	17q22	0.08	0.66	0.65	0.54	-0.59	6.51e-16	7.07e-15	(B) Positive
MEGF9	9q33.2	0.88	1.77	0.98	0.85	-0.89	6.51e-16	7.07e-15	(B) Positive
KIF23	15q23	-1.25	-2.02	0.82	0.88	0.76	6.54e-16	7.10e-15	(A) Negative
RBL1	20q11.23	-0.85	-1.49	0.70	0.61	0.64	6.72e-16	7.29e-15	(A) Negative
NPY4R	10q11.22	0.39	0.18	0.22	0.23	0.21	6.76e-16	7.33e-15	(A) Negative
CHST8	19q13.11	-1.08	0.51	1.67	1.96	-1.59	6.79e-16	7.36e-15	(B) Positive
RDX	11q22.3	-1.22	-1.87	0.71	0.68	0.65	6.81e-16	7.37e-15	(A) Negative
NELL2	12q12	0.20	1.84	1.67	2.21	-1.64	6.84e-16	7.40e-15	(B) Positive
CCL7	17q12	2.67	1.12	1.70	1.52	1.55	6.87e-16	7.43e-15	(A) Negative
TEX30	13q33.1	-0.63	-1.43	0.91	0.59	0.80	6.88e-16	7.43e-15	(A) Negative
IL32	16p13.3	0.59	-0.22	0.91	0.70	0.81	7.03e-16	7.60e-15	(A) Negative
RFC4	3q27.3	-1.17	-1.93	0.85	0.59	0.76	7.12e-16	7.69e-15	(A) Negative
GSTA5	6p12.2	0.63	-0.86	1.69	1.08	1.50	7.23e-16	7.80e-15	(A) Negative
COMMD2	3q25.1	0.03	-0.61	0.73	0.42	0.64	7.27e-16	7.84e-15	(A) Negative
EPHB6	7q34	-1.75	-2.69	1.06	0.63	0.94	7.29e-16	7.86e-15	(A) Negative
RASA1	5q14.3	-0.52	0.00	0.55	0.66	-0.53	7.33e-16	7.89e-15	(B) Positive
ECI1	16p13.3	-0.31	0.32	0.70	0.60	-0.63	7.41e-16	7.97e-15	(B) Positive
ALG3	3q27.1	-0.20	-0.63	0.47	0.46	0.43	7.47e-16	8.03e-15	(A) Negative
LY6G6C	6p21.33	-0.40	0.19	0.54	0.98	-0.59	7.63e-16	8.20e-15	(B) Positive
CARD10	22q13.1	-0.79	-0.22	0.62	0.56	-0.57	7.76e-16	8.33e-15	(B) Positive
SERTAD3	19q13.2	1.14	1.78	0.72	0.58	-0.64	7.92e-16	8.49e-15	(B) Positive
MROH8	20q11.23	-0.75	-0.27	0.48	0.64	-0.47	7.92e-16	8.50e-15	(B) Positive
DPY19L2P4	7q21.13	-0.71	0.25	0.91	1.51	-0.95	7.93e-16	8.50e-15	(B) Positive
SMURF2	17q23.3-q24.1	0.19	-0.43	0.68	0.65	0.63	7.99e-16	8.56e-15	(A) Negative
TUBA8	22q11.21	1.08	0.65	0.47	0.44	0.43	8.20e-16	8.78e-15	(A) Negative
PIGV	1p36.11	-0.47	0.07	0.59	0.56	-0.54	8.23e-16	8.80e-15	(B) Positive
MAMLD1	Xq28	-0.52	-1.64	1.27	0.86	1.12	8.23e-16	8.80e-15	(A) Negative
PRKCD	3p21.1	1.10	1.63	0.58	0.56	-0.53	8.27e-16	8.83e-15	(B) Positive
TBC1D7	6p24.1	-0.91	-1.45	0.60	0.51	0.54	8.40e-16	8.97e-15	(A) Negative
DGKG	3q27.2-q27.3	-0.44	-1.32	1.00	0.67	0.88	8.54e-16	9.11e-15	(A) Negative
TPPP3	16q22.1	1.90	2.83	1.02	0.92	-0.92	8.71e-16	9.29e-15	(B) Positive
RTN2	19q13.32	-0.25	0.60	0.94	0.78	-0.84	8.71e-16	9.29e-15	(B) Positive
PYM1	12q13.2	0.07	0.52	0.50	0.38	-0.45	8.74e-16	9.31e-15	(B) Positive
EXT1	8q24.11	0.50	-0.02	0.58	0.51	0.52	8.75e-16	9.31e-15	(A) Negative
ZNF609	15q22.1	-0.14	0.33	0.52	0.51	-0.47	8.86e-16	9.42e-15	(B) Positive
CRTAP	3p22.3	-0.55	-0.08	0.52	0.45	-0.47	8.88e-16	9.44e-15	(B) Positive
VPS39	15q15.1	0.10	0.48	0.42	0.37	-0.38	8.94e-16	9.50e-15	(B) Positive
LFNG	7p22.3	0.82	1.78	1.08	0.90	-0.97	9.16e-16	9.73e-15	(B) Positive
TAC1	7q21.3	0.07	1.00	0.93	1.34	-0.93	9.26e-16	9.82e-15	(B) Positive
RASD2	22q12.3	0.99	0.20	0.91	0.52	0.79	9.37e-16	9.94e-15	(A) Negative
PCDH1	5q31.3	0.94	1.42	0.52	0.50	-0.48	9.38e-16	9.94e-15	(B) Positive
KIF15	3p21.31	-1.60	-2.45	0.90	1.01	0.85	9.46e-16	1.00e-14	(A) Negative
DAZAP1	19p13.3	0.11	-0.21	0.34	0.36	0.32	9.51e-16	1.01e-14	(A) Negative
NOS1AP	1q23.3	-0.86	-0.11	0.77	1.01	-0.75	9.54e-16	1.01e-14	(B) Positive
MPZL1	1q24.2	1.35	0.81	0.60	0.56	0.54	9.65e-16	1.02e-14	(A) Negative
MYO1E	15q22.2	-0.00	-0.53	0.57	0.59	0.53	9.81e-16	1.04e-14	(A) Negative
KIFBP	10q22.1	0.25	0.80	0.60	0.59	-0.55	9.88e-16	1.04e-14	(B) Positive
URB2	1q42.13	0.29	-0.27	0.62	0.52	0.56	9.93e-16	1.05e-14	(A) Negative
ZIC4	3q24	0.56	-0.18	0.85	0.43	0.74	9.95e-16	1.05e-14	(A) Negative
HID1	17q25.1	0.96	1.79	0.93	0.68	-0.83	1.00e-15	1.05e-14	(B) Positive
NEURL1	10q24.33	-0.62	0.71	1.47	1.38	-1.34	1.00e-15	1.06e-14	(B) Positive
COQ5	12q24.31	-0.47	-0.03	0.49	0.40	-0.44	1.00e-15	1.06e-14	(B) Positive
TMEM141	9q34.3	-0.04	0.58	0.70	0.56	-0.63	1.02e-15	1.07e-14	(B) Positive
OTX1	2p15	0.38	-0.45	0.94	0.69	0.83	1.02e-15	1.07e-14	(A) Negative
SLC6A16	19q13.33	0.45	-0.43	0.98	0.82	0.88	1.02e-15	1.07e-14	(A) Negative
MSH3	5q14.1	-0.54	-0.03	0.55	0.55	-0.51	1.03e-15	1.08e-14	(B) Positive
ALDH1A3	15q26.3	1.61	0.54	1.17	1.15	1.07	1.03e-15	1.08e-14	(A) Negative
DZIP1	13q32.1	-1.15	-2.02	0.98	0.81	0.87	1.04e-15	1.09e-14	(A) Negative
ZMIZ2	7p13	0.98	0.55	0.48	0.44	0.44	1.06e-15	1.11e-14	(A) Negative
TSPYL5	8q22.1	3.05	1.59	1.59	1.61	1.46	1.07e-15	1.12e-14	(A) Negative
PAQR3	4q21.21	-0.52	-1.14	0.68	0.63	0.62	1.08e-15	1.13e-14	(A) Negative
CMTM7	3p22.3	0.78	-0.39	1.33	0.95	1.17	1.09e-15	1.14e-14	(A) Negative
GOPC	6q22.1	0.63	0.21	0.46	0.42	0.42	1.10e-15	1.15e-14	(A) Negative
CDC123	10p14-p13	0.05	-0.56	0.70	0.45	0.61	1.12e-15	1.17e-14	(A) Negative
SLC39A12	10p12.33	1.43	0.21	1.43	0.50	1.23	1.13e-15	1.18e-14	(A) Negative
CELF4	18q12.2	0.58	-0.19	0.86	0.67	0.76	1.14e-15	1.19e-14	(A) Negative
GBP1	1p22.2	3.26	2.01	1.38	1.23	1.24	1.17e-15	1.22e-14	(A) Negative
ELMOD3	2p11.2	0.27	0.71	0.49	0.43	-0.44	1.17e-15	1.22e-14	(B) Positive
CHI3L2	1p13.2	1.51	-0.28	2.00	1.66	1.78	1.18e-15	1.23e-14	(A) Negative
RRP1	21q22.3	-0.19	-0.63	0.50	0.41	0.44	1.19e-15	1.24e-14	(A) Negative
COQ4	9q34.11	-0.12	0.43	0.63	0.45	-0.55	1.19e-15	1.24e-14	(B) Positive
NXPH3	17q21.33	0.29	0.76	0.48	0.69	-0.48	1.19e-15	1.24e-14	(B) Positive
HAGHL	16p13.3	-0.74	0.04	0.85	0.88	-0.78	1.21e-15	1.26e-14	(B) Positive
PREP	6q21	0.29	-0.25	0.59	0.57	0.54	1.21e-15	1.26e-14	(A) Negative
FUCA1	1p36.11	0.60	1.26	0.74	0.65	-0.67	1.26e-15	1.31e-14	(B) Positive
MASTL	10p12.1	-0.99	-1.75	0.86	0.70	0.76	1.28e-15	1.33e-14	(A) Negative
STK38	6p21.31	0.45	-0.14	0.65	0.55	0.59	1.29e-15	1.34e-14	(A) Negative
AMIGO2	12q13.11	-1.44	-0.24	1.27	1.45	-1.19	1.30e-15	1.35e-14	(B) Positive
DLAT	11q23.1	-0.19	-0.62	0.48	0.40	0.43	1.34e-15	1.39e-14	(A) Negative
SMOC2	6q27	4.08	4.78	0.78	0.67	-0.70	1.34e-15	1.39e-14	(B) Positive
TEAD4	12p13.33	-0.11	-0.81	0.79	0.64	0.71	1.34e-15	1.39e-14	(A) Negative
AP3B1	5q14.1	-0.20	0.15	0.39	0.36	-0.35	1.37e-15	1.41e-14	(B) Positive
UEVLD	11p15.1	0.20	0.72	0.58	0.52	-0.52	1.37e-15	1.41e-14	(B) Positive
LIAS	4p14	-1.15	-0.62	0.59	0.52	-0.53	1.38e-15	1.42e-14	(B) Positive
SMO	7q32.1	-0.08	-1.15	1.21	0.95	1.07	1.41e-15	1.45e-14	(A) Negative
NAA38	17p13.1	-0.09	0.37	0.49	0.59	-0.46	1.42e-15	1.46e-14	(B) Positive
SPHK1	17q25.1	0.41	-0.43	0.93	0.88	0.84	1.42e-15	1.46e-14	(A) Negative
CENPL	1q25.1	-0.20	-0.77	0.61	0.65	0.56	1.42e-15	1.47e-14	(A) Negative
UCHL3	13q22.2	0.38	-0.12	0.55	0.47	0.50	1.43e-15	1.47e-14	(A) Negative
MANBAL	20q11.23	0.06	0.43	0.41	0.42	-0.37	1.44e-15	1.48e-14	(B) Positive
UGT2B15	4q13.2	-3.46	-1.92	1.61	2.05	-1.54	1.45e-15	1.49e-14	(B) Positive
PLAC9	10q22.3	-0.18	0.80	1.06	1.16	-0.98	1.47e-15	1.51e-14	(B) Positive
ALKBH1	14q24.3	-0.13	0.27	0.44	0.46	-0.41	1.47e-15	1.51e-14	(B) Positive
SREBF1	17p11.2	0.30	1.18	0.98	0.91	-0.88	1.47e-15	1.51e-14	(B) Positive
AURKA	20q13.2	-1.41	-2.08	0.70	0.89	0.67	1.50e-15	1.53e-14	(A) Negative
ELAPOR1	1p13.3	1.37	2.93	1.79	1.05	-1.55	1.50e-15	1.54e-14	(B) Positive
UPF3B	Xq24	-0.71	-1.35	0.72	0.53	0.64	1.51e-15	1.54e-14	(A) Negative
RIPK3	14q12	2.74	3.56	0.91	0.85	-0.82	1.51e-15	1.54e-14	(B) Positive
FBXL9P	16q22.1	0.14	0.57	0.46	0.54	-0.43	1.52e-15	1.55e-14	(B) Positive
SLC6A4	17q11.2	-1.80	-0.21	1.47	2.67	-1.59	1.52e-15	1.55e-14	(B) Positive
RAB40C	16p13.3	0.35	0.69	0.38	0.38	-0.34	1.54e-15	1.58e-14	(B) Positive
TOM1L2	17p11.2	0.13	0.63	0.55	0.50	-0.50	1.55e-15	1.58e-14	(B) Positive
JMJD4	1q42.13	0.91	0.36	0.61	0.56	0.55	1.55e-15	1.58e-14	(A) Negative
MTHFR	1p36.22	-0.32	0.30	0.67	0.75	-0.62	1.55e-15	1.58e-14	(B) Positive
FAM135A	6q13	0.02	-0.75	0.85	0.80	0.77	1.57e-15	1.60e-14	(A) Negative
SPATA6L	9p24.2-p24.1	0.29	1.27	1.07	1.13	-0.98	1.59e-15	1.62e-14	(B) Positive
KRR1	12q21.2	-0.27	0.17	0.49	0.44	-0.44	1.62e-15	1.65e-14	(B) Positive
SMUG1	12q13.13	-0.19	0.23	0.47	0.44	-0.42	1.63e-15	1.66e-14	(B) Positive
RPS19	19q13.2	0.23	-0.29	0.59	0.48	0.52	1.63e-15	1.66e-14	(A) Negative
ETNK2	1q32.1	-0.26	0.76	1.14	1.03	-1.02	1.64e-15	1.67e-14	(B) Positive
ANKRD11	16q24.3	-0.33	-0.95	0.69	0.56	0.61	1.65e-15	1.68e-14	(A) Negative
WNT10A	2q35	1.09	0.07	1.15	0.91	1.02	1.68e-15	1.70e-14	(A) Negative
TNFRSF10C	8p21.3	0.25	0.91	0.65	0.98	-0.65	1.70e-15	1.72e-14	(B) Positive
OLFM2	19p13.2	1.21	0.64	0.64	0.52	0.57	1.72e-15	1.75e-14	(A) Negative
TBC1D22B	6p21.2	0.26	-0.21	0.53	0.46	0.47	1.77e-15	1.79e-14	(A) Negative
LYNX1	8q24.3	1.31	0.63	0.78	0.61	0.68	1.79e-15	1.82e-14	(A) Negative
APBB3	5q31.3	-0.79	-0.25	0.60	0.56	-0.54	1.83e-15	1.86e-14	(B) Positive
DNAJB11	3q27.3	0.67	0.13	0.62	0.51	0.55	1.87e-15	1.89e-14	(A) Negative
MCTP2	15q26.2	-0.58	-1.57	1.13	0.86	0.99	1.87e-15	1.89e-14	(A) Negative
UGGT1	2q14.3	0.31	-0.27	0.65	0.56	0.58	1.94e-15	1.96e-14	(A) Negative
MFAP3L	4q33	1.41	0.57	0.93	0.88	0.84	1.97e-15	1.99e-14	(A) Negative
ARRB1	11q13.4	-0.01	0.58	0.63	0.73	-0.59	1.97e-15	1.99e-14	(B) Positive
DNAJC17	15q15.1	0.08	0.59	0.58	0.49	-0.51	1.99e-15	2.01e-14	(B) Positive
PTCH1	9q22.32	-0.74	-1.31	0.63	0.57	0.57	2.00e-15	2.01e-14	(A) Negative
TAFA3	1p13.2	1.57	-0.03	1.87	0.80	1.60	2.01e-15	2.03e-14	(A) Negative
ERICH3	1p31.1	0.50	1.29	0.77	1.24	-0.79	2.03e-15	2.04e-14	(B) Positive
ZNF546	19q13.2	-0.38	-0.03	0.39	0.37	-0.35	2.04e-15	2.06e-14	(B) Positive
A2ML1	12p13.31	1.13	0.47	0.75	0.63	0.66	2.04e-15	2.06e-14	(A) Negative
PCM1	8p22	-0.54	0.09	0.67	0.82	-0.63	2.05e-15	2.06e-14	(B) Positive
CCNP	19q13.2	0.72	1.53	0.85	1.11	-0.82	2.05e-15	2.06e-14	(B) Positive
COQ7	16p12.3	-0.09	0.41	0.57	0.50	-0.51	2.07e-15	2.08e-14	(B) Positive
ZNF599	19q13.11	-0.04	0.64	0.76	0.73	-0.68	2.14e-15	2.15e-14	(B) Positive
SH3BP1	22q13.1	0.51	0.14	0.40	0.40	0.36	2.15e-15	2.15e-14	(A) Negative
TBC1D9B	5q35.3	-0.03	0.39	0.47	0.39	-0.42	2.19e-15	2.20e-14	(B) Positive
RELT	11q13.4	-0.52	-0.96	0.48	0.50	0.44	2.21e-15	2.22e-14	(A) Negative
PFDN2	1q23.3	0.77	0.23	0.61	0.49	0.54	2.22e-15	2.22e-14	(A) Negative
ANKRD36BP1	1q24.2	1.28	0.28	1.16	0.78	1.00	2.25e-15	2.25e-14	(A) Negative
GTPBP8	3q13.2	0.02	-0.44	0.52	0.47	0.46	2.37e-15	2.37e-14	(A) Negative
POLR3G	5q14.3	-1.92	-2.72	0.93	0.66	0.81	2.38e-15	2.38e-14	(A) Negative
CIAO1	2q11.2	-0.42	-0.84	0.48	0.39	0.42	2.40e-15	2.40e-14	(A) Negative
FANCE	6p21.31	-0.77	-1.49	0.83	0.63	0.72	2.41e-15	2.41e-14	(A) Negative
PLA2G4F	15q15.1	0.33	0.85	0.55	0.65	-0.51	2.44e-15	2.43e-14	(B) Positive
IMPA2	18p11.21	-0.00	-1.11	1.27	0.92	1.11	2.49e-15	2.48e-14	(A) Negative
PUS7	7q22.3	-0.42	-1.04	0.72	0.49	0.62	2.49e-15	2.48e-14	(A) Negative
TRDMT1	10p13	-0.02	-0.83	0.93	0.59	0.81	2.51e-15	2.50e-14	(A) Negative
PIM1	6p21.2	-0.93	-1.56	0.72	0.56	0.63	2.53e-15	2.52e-14	(A) Negative
AKAP9	7q21.2	0.04	0.44	0.41	0.59	-0.40	2.53e-15	2.52e-14	(B) Positive
MOCS2	5q11.2	-0.84	-0.27	0.63	0.63	-0.57	2.53e-15	2.52e-14	(B) Positive
MUTYH	1p34.1	-0.51	-0.92	0.47	0.39	0.41	2.53e-15	2.52e-14	(A) Negative
DYSF	2p13.2	1.53	1.06	0.52	0.52	0.47	2.55e-15	2.54e-14	(A) Negative
TMEM170A	16q23.1	-0.23	-0.75	0.59	0.52	0.52	2.56e-15	2.54e-14	(A) Negative
COL9A3	20q13.33	-1.88	-3.69	2.10	1.33	1.81	2.57e-15	2.55e-14	(A) Negative
OPN3	1q43	-0.09	-0.94	0.95	0.94	0.86	2.62e-15	2.60e-14	(A) Negative
EID1	15q21.1	0.17	0.72	0.62	0.53	-0.55	2.64e-15	2.61e-14	(B) Positive
TMEM171	5q13.2	-0.38	-1.22	0.97	0.64	0.84	2.69e-15	2.66e-14	(A) Negative
ACTR3B	7q36.1-q36.2	0.43	-0.32	0.87	0.54	0.75	2.69e-15	2.66e-14	(A) Negative
ESYT3	3q22.3	0.03	-0.96	1.13	0.84	0.99	2.71e-15	2.68e-14	(A) Negative
IDUA	4p16.3	0.08	0.80	0.81	0.65	-0.71	2.71e-15	2.68e-14	(B) Positive
GALC	14q31.3	0.78	1.31	0.58	0.67	-0.53	2.75e-15	2.71e-14	(B) Positive
BAK1	6p21.31	0.39	-0.08	0.53	0.51	0.48	2.75e-15	2.72e-14	(A) Negative
RHOT2	16p13.3	-0.74	-0.35	0.42	0.50	-0.39	2.82e-15	2.79e-14	(B) Positive
SMYD2	1q32.3	0.50	0.04	0.51	0.53	0.46	2.88e-15	2.85e-14	(A) Negative
ZNF516	18q23	-0.45	0.57	1.16	0.95	-1.02	2.90e-15	2.85e-14	(B) Positive
CEP170	1q43	0.04	-0.53	0.65	0.50	0.57	2.90e-15	2.86e-14	(A) Negative
H1-5	6p22.1	-0.41	-1.45	1.14	1.26	1.04	2.92e-15	2.87e-14	(A) Negative
RNF24	20p13	-0.02	-0.60	0.62	0.74	0.58	2.92e-15	2.88e-14	(A) Negative
LSM6	4q31.22	-0.05	-0.53	0.55	0.42	0.48	2.93e-15	2.88e-14	(A) Negative
GPER1	7p22.3	-2.39	-1.34	1.08	1.55	-1.06	2.97e-15	2.92e-14	(B) Positive
NUDT4	12q22	-0.26	0.33	0.66	0.63	-0.59	2.98e-15	2.92e-14	(B) Positive
RLIM	Xq13.2	-0.03	-0.45	0.48	0.38	0.42	3.10e-15	3.04e-14	(A) Negative
KRT6B	12q13.13	4.32	2.59	1.84	2.28	1.73	3.13e-15	3.07e-14	(A) Negative
RASSF4	10q11.21	1.22	0.26	1.10	0.87	0.96	3.19e-15	3.13e-14	(A) Negative
RTN4R	22q11.21	0.79	0.11	0.77	0.68	0.68	3.22e-15	3.15e-14	(A) Negative
SIN3B	19p13.11	-0.00	-0.46	0.51	0.50	0.46	3.22e-15	3.16e-14	(A) Negative
TNRC6C	17q25.3	0.12	0.49	0.40	0.44	-0.36	3.24e-15	3.18e-14	(B) Positive
ID4	6p22.3	1.79	0.12	1.92	1.51	1.68	3.30e-15	3.23e-14	(A) Negative
UQCC1	20q11.22	-0.76	-0.28	0.53	0.52	-0.48	3.33e-15	3.25e-14	(B) Positive
KDM8	16p12.1	-0.29	0.11	0.44	0.42	-0.39	3.37e-15	3.29e-14	(B) Positive
EFNA4	1q21.3	1.62	0.98	0.67	0.91	0.64	3.39e-15	3.31e-14	(A) Negative
ATAD5	17q11.2	-1.37	-2.08	0.80	0.73	0.71	3.42e-15	3.34e-14	(A) Negative
CHIC2	4q12	0.95	0.50	0.52	0.44	0.46	3.47e-15	3.38e-14	(A) Negative
PRKAG1	12q13.12	-0.33	0.19	0.59	0.55	-0.52	3.47e-15	3.38e-14	(B) Positive
PHYKPL	5q35.3	-0.42	0.02	0.50	0.40	-0.44	3.49e-15	3.40e-14	(B) Positive
NCK2	2q12.2	0.74	0.21	0.61	0.51	0.53	3.51e-15	3.42e-14	(A) Negative
CXADR	21q21.1	0.33	-0.80	1.26	1.26	1.13	3.62e-15	3.52e-14	(A) Negative
DCAF8	1q23.2	0.41	0.83	0.46	0.46	-0.42	3.63e-15	3.53e-14	(B) Positive
TMEM121	14q32.33	0.04	1.00	1.10	0.93	-0.96	3.68e-15	3.58e-14	(B) Positive
UTP11	1p34.3	-0.18	-0.58	0.47	0.36	0.40	3.70e-15	3.60e-14	(A) Negative
RNF215	22q12.2	0.21	0.61	0.44	0.45	-0.40	3.73e-15	3.62e-14	(B) Positive
DUSP13B	10q22.2	-2.44	-1.73	0.67	1.25	-0.72	3.74e-15	3.63e-14	(B) Positive
RPP38	10p13	0.64	0.19	0.53	0.34	0.46	3.75e-15	3.64e-14	(A) Negative
ZNF441	19p13.2	0.01	0.62	0.68	0.69	-0.61	3.84e-15	3.72e-14	(B) Positive
BACH1	21q21.3	-0.04	-0.51	0.52	0.54	0.47	3.91e-15	3.79e-14	(A) Negative
CERS5	12q13.12	-0.49	-0.03	0.52	0.49	-0.46	3.93e-15	3.81e-14	(B) Positive
RASEF	9q21.32	2.20	3.41	1.38	1.21	-1.22	3.94e-15	3.81e-14	(B) Positive
CARD19	9q22.31	0.57	1.10	0.59	0.57	-0.52	3.97e-15	3.84e-14	(B) Positive
PLA2G4B	15q15.1	-0.03	0.45	0.54	0.50	-0.48	3.97e-15	3.84e-14	(B) Positive
TP53BP1	15q15.3	-0.33	0.06	0.43	0.46	-0.39	4.04e-15	3.90e-14	(B) Positive
GAN	16q23.2	0.20	-0.35	0.61	0.64	0.55	4.13e-15	3.99e-14	(A) Negative
TMEM80	11p15.5	-0.12	0.41	0.58	0.64	-0.53	4.16e-15	4.02e-14	(B) Positive
MOGS	2p13.1	-0.20	-0.59	0.45	0.39	0.39	4.17e-15	4.03e-14	(A) Negative
WDR6	3p21.31	-0.37	0.03	0.45	0.43	-0.40	4.27e-15	4.12e-14	(B) Positive
SOX8	16p13.3	0.62	-0.46	1.28	0.63	1.08	4.29e-15	4.13e-14	(A) Negative
IGF2BP3	7p15.3	-3.22	-4.19	1.16	0.50	0.97	4.29e-15	4.13e-14	(A) Negative
SLC25A37	8p21.2	-0.84	-1.53	0.81	0.54	0.69	4.32e-15	4.16e-14	(A) Negative
PAAF1	11q13.4	-1.21	-0.63	0.66	0.59	-0.58	4.32e-15	4.16e-14	(B) Positive
ZPR1	11q23.3	-0.43	-0.87	0.50	0.42	0.44	4.37e-15	4.20e-14	(A) Negative
KCTD21	11q14.1	0.38	0.84	0.49	0.64	-0.46	4.39e-15	4.22e-14	(B) Positive
EHBP1	2p15	-0.21	-0.73	0.60	0.44	0.52	4.39e-15	4.22e-14	(A) Negative
IRAK1	Xq28	0.09	-0.46	0.63	0.49	0.54	4.46e-15	4.28e-14	(A) Negative
KCNK12	2p16.3	-0.72	-1.40	0.77	0.68	0.67	4.57e-15	4.38e-14	(A) Negative
SCHIP1	3q25.33	1.18	0.15	1.20	0.83	1.03	4.60e-15	4.41e-14	(A) Negative
PLEKHA8P1	12q12	0.10	-0.37	0.53	0.52	0.47	4.60e-15	4.41e-14	(A) Negative
ZBTB16	11q23.2	0.92	2.06	1.28	1.26	-1.14	4.64e-15	4.45e-14	(B) Positive
CPA4	7q32.2	-1.45	-2.47	1.21	0.65	1.02	4.70e-15	4.50e-14	(A) Negative
FBN3	19p13.2	0.37	-0.03	0.46	0.33	0.40	4.74e-15	4.53e-14	(A) Negative
ALDH3A2	17p11.2	-0.37	0.43	0.90	0.94	-0.81	4.76e-15	4.55e-14	(B) Positive
ZNF689	16p11.2	-0.40	0.35	0.83	0.93	-0.75	4.76e-15	4.55e-14	(B) Positive
RLN2	9p24.1	-0.45	0.84	1.39	1.70	-1.29	4.79e-15	4.57e-14	(B) Positive
DIXDC1	11q23.1	0.01	0.37	0.41	0.38	-0.36	4.80e-15	4.59e-14	(B) Positive
PVALB	22q12.3	-3.37	-2.24	1.04	2.02	-1.14	4.83e-15	4.60e-14	(B) Positive
CHD1	5q15-q21.1	-0.77	-0.35	0.45	0.56	-0.42	4.84e-15	4.62e-14	(B) Positive
SLC25A38	3p22.1	-0.54	-0.04	0.56	0.51	-0.50	4.85e-15	4.62e-14	(B) Positive
PXK	3p14.3	-0.39	0.10	0.54	0.55	-0.49	4.97e-15	4.74e-14	(B) Positive
FRAT1	10q24.1	0.11	0.68	0.65	0.59	-0.57	5.06e-15	4.81e-14	(B) Positive
VPS54	2p15-p14	0.02	-0.48	0.58	0.45	0.50	5.07e-15	4.83e-14	(A) Negative
POMC	2p23.3	1.20	0.33	1.02	0.71	0.87	5.14e-15	4.89e-14	(A) Negative
DPP7	9q34.3	-0.33	0.21	0.61	0.54	-0.54	5.17e-15	4.91e-14	(B) Positive
VIPR1	3p22.1	0.63	1.35	0.82	0.73	-0.72	5.32e-15	5.05e-14	(B) Positive
VTCN1	1p13.1-p12	4.14	2.91	1.18	2.06	1.23	5.38e-15	5.11e-14	(A) Negative
ARSB	5q14.1	-0.65	-1.07	0.46	0.49	0.41	5.51e-15	5.23e-14	(A) Negative
SEMA3G	3p21.1	0.22	1.06	0.95	0.92	-0.84	5.55e-15	5.26e-14	(B) Positive
MET	7q31	-1.10	-2.01	1.06	0.75	0.91	5.62e-15	5.32e-14	(A) Negative
MEAF6	1p34.3	0.37	0.82	0.51	0.52	-0.46	5.79e-15	5.48e-14	(B) Positive
GART	21q22.11	-0.84	-1.35	0.59	0.44	0.51	5.79e-15	5.48e-14	(A) Negative
GFOD2	16q22.1	0.85	0.39	0.53	0.47	0.46	5.86e-15	5.55e-14	(A) Negative
CFAP44	3q13.2	-0.52	0.22	0.84	0.83	-0.74	5.87e-15	5.55e-14	(B) Positive
RND1	12q13.12	0.31	0.95	0.73	0.61	-0.64	5.90e-15	5.57e-14	(B) Positive
NRTN	19p13.3	0.58	-0.82	1.66	0.94	1.40	5.94e-15	5.61e-14	(A) Negative
ME2	18q21.2	-0.02	-0.64	0.72	0.59	0.62	6.03e-15	5.70e-14	(A) Negative
TRIM62	1p35.1	0.04	0.40	0.41	0.34	-0.36	6.09e-15	5.75e-14	(B) Positive
BCKDK	16p11.2	-0.59	-0.19	0.44	0.46	-0.40	6.15e-15	5.80e-14	(B) Positive
CEP57L1	6q21	-0.73	-1.30	0.65	0.55	0.57	6.18e-15	5.82e-14	(A) Negative
PISD	22q12.2	-0.20	0.31	0.55	0.69	-0.51	6.28e-15	5.91e-14	(B) Positive
H2AP	Xp11.4	-1.04	-0.55	0.51	0.71	-0.49	6.78e-15	6.38e-14	(B) Positive
CALCB	11p15.2	0.65	-0.97	1.92	1.14	1.62	6.86e-15	6.45e-14	(A) Negative
CYP39A1	6p12.3	1.26	-0.23	1.74	1.32	1.49	6.88e-15	6.47e-14	(A) Negative
PAFAH2	1p36.11	0.21	0.67	0.53	0.48	-0.46	7.05e-15	6.62e-14	(B) Positive
ARHGAP32	11q24.3	0.98	1.62	0.74	0.65	-0.64	7.06e-15	6.63e-14	(B) Positive
FAM89A	1q42.2	-0.27	-1.04	0.87	0.88	0.77	7.08e-15	6.64e-14	(A) Negative
SCN2B	11q23.3	0.34	0.87	0.56	0.76	-0.53	7.09e-15	6.65e-14	(B) Positive
PAX6	11p13	-0.59	-1.83	1.48	0.69	1.24	7.14e-15	6.69e-14	(A) Negative
RPIA	2p11.2	0.19	-0.29	0.56	0.41	0.48	7.18e-15	6.73e-14	(A) Negative
DNPEP	2q35	0.23	0.64	0.47	0.40	-0.41	7.20e-15	6.74e-14	(B) Positive
MYT1	20q13.33	-0.82	0.41	1.27	1.83	-1.22	7.23e-15	6.77e-14	(B) Positive
TAPT1-AS1	4p15.32	-1.99	-1.40	0.66	0.71	-0.59	7.33e-15	6.86e-14	(B) Positive
KIAA0319L	1p34.3	-0.34	0.16	0.55	0.59	-0.50	7.40e-15	6.92e-14	(B) Positive
HECA	6q24.1	1.87	1.36	0.59	0.47	0.51	7.44e-15	6.96e-14	(A) Negative
SLC22A18	11p15.4	-0.23	0.48	0.82	0.75	-0.71	7.45e-15	6.96e-14	(B) Positive
PIWIL4	11q21	0.94	-0.10	1.22	0.84	1.04	7.60e-15	7.10e-14	(A) Negative
RABL3	3q13.33	0.32	0.73	0.46	0.47	-0.41	7.63e-15	7.12e-14	(B) Positive
CLGN	4q31.1	-2.50	-0.79	1.94	1.88	-1.70	7.65e-15	7.14e-14	(B) Positive
TSPYL1	6q22.1	0.35	0.88	0.60	0.56	-0.53	7.67e-15	7.15e-14	(B) Positive
ZDHHC11	5p15.33	-1.78	-0.59	1.39	1.15	-1.20	7.68e-15	7.16e-14	(B) Positive
TGFA	2p13.3	0.37	-0.72	1.27	1.05	1.09	7.76e-15	7.23e-14	(A) Negative
UBXN2A	2p23.3	-0.23	-0.83	0.70	0.51	0.59	7.78e-15	7.24e-14	(A) Negative
ATOH7	10q21.3	0.24	-0.39	0.75	0.44	0.63	7.78e-15	7.24e-14	(A) Negative
MALT1	18q21.32	-0.35	-0.91	0.65	0.58	0.56	7.89e-15	7.34e-14	(A) Negative
CHST2	3q24	-0.55	-1.35	0.95	0.56	0.80	7.97e-15	7.41e-14	(A) Negative
TEAD2	19q13.33	0.98	0.24	0.80	1.01	0.74	7.98e-15	7.41e-14	(A) Negative
PWP2	21q22.3	-0.16	-0.60	0.51	0.40	0.44	8.01e-15	7.44e-14	(A) Negative
WDR54	2p13.1	-1.79	-1.15	0.74	0.67	-0.65	8.03e-15	7.45e-14	(B) Positive
TLCD3A	17p13.3	-0.48	-1.13	0.74	0.69	0.64	8.09e-15	7.50e-14	(A) Negative
GRK4	4p16.3	-0.48	0.21	0.78	0.73	-0.68	8.24e-15	7.64e-14	(B) Positive
S100B	21q22.3	-0.43	-2.30	2.22	1.37	1.86	8.39e-15	7.77e-14	(A) Negative
SLC7A1	13q12.3	-0.16	-0.72	0.65	0.57	0.57	8.41e-15	7.79e-14	(A) Negative
NDUFS4	5q11.2	-0.76	-0.29	0.55	0.47	-0.48	8.49e-15	7.85e-14	(B) Positive
FBLIM1	1p36.21	1.20	0.67	0.58	0.67	0.52	8.59e-15	7.95e-14	(A) Negative
SCRN3	2q31.1	0.09	0.55	0.53	0.51	-0.46	8.63e-15	7.98e-14	(B) Positive
PALM2AKAP2	9q31.3	0.37	-0.52	1.07	0.55	0.89	8.68e-15	8.02e-14	(A) Negative
ITPKA	15q15.1	-3.14	-2.37	0.78	1.19	-0.76	8.74e-15	8.07e-14	(B) Positive
NEK4	3p21.1	-0.01	0.36	0.40	0.49	-0.36	8.80e-15	8.12e-14	(B) Positive
PRTFDC1	10p12.1	0.63	-0.78	1.68	0.98	1.41	8.83e-15	8.14e-14	(A) Negative
KIRREL3	11q24.2	-0.42	-1.34	1.09	0.73	0.92	8.96e-15	8.26e-14	(A) Negative
FCGRT	19q13.33	1.21	1.85	0.72	0.72	-0.63	9.07e-15	8.35e-14	(B) Positive
ATG16L1	2q37.1	0.24	0.75	0.58	0.54	-0.51	9.08e-15	8.36e-14	(B) Positive
SH3GL3	15q25.2	-2.01	-3.46	1.74	0.97	1.45	9.14e-15	8.41e-14	(A) Negative
GZMB	14q12	4.08	3.18	1.01	1.07	0.90	9.18e-15	8.44e-14	(A) Negative
CST2	20p11.21	0.81	1.57	0.86	0.89	-0.76	9.19e-15	8.45e-14	(B) Positive
TP53TG1	7q21.12	0.21	1.05	1.00	0.70	-0.85	9.21e-15	8.47e-14	(B) Positive
BCL2L10	15q21.2	1.74	0.80	1.09	0.90	0.93	9.25e-15	8.49e-14	(A) Negative
CEP57	11q21	-0.67	-1.17	0.59	0.50	0.50	9.44e-15	8.66e-14	(A) Negative
NEIL3	4q34.3	-1.89	-2.72	0.92	1.05	0.83	9.45e-15	8.67e-14	(A) Negative
RGS20	8q11.23	-2.86	-3.91	1.25	0.73	1.05	9.50e-15	8.71e-14	(A) Negative
STEAP2	7q21.13	1.12	2.08	1.03	1.36	-0.96	1.02e-14	9.31e-14	(B) Positive
CALCOCO1	12q13.13	0.20	0.65	0.52	0.50	-0.45	1.02e-14	9.32e-14	(B) Positive
RGL3	19p13.2	-1.14	-0.09	1.20	1.08	-1.04	1.02e-14	9.32e-14	(B) Positive
CD38	4p15.32	-0.56	-2.13	1.81	1.68	1.58	1.03e-14	9.42e-14	(A) Negative
CCNB1IP1	14q11.2	-1.16	-1.76	0.70	0.56	0.59	1.04e-14	9.51e-14	(A) Negative
PXDC1	6p25.2	1.09	0.41	0.80	0.65	0.68	1.05e-14	9.58e-14	(A) Negative
SYNPO2L	10q22.2	-0.58	0.13	0.57	1.42	-0.70	1.05e-14	9.59e-14	(B) Positive
TRIM4	7q22.1	0.26	0.58	0.36	0.37	-0.32	1.06e-14	9.65e-14	(B) Positive
GMDS	6p25.3	0.33	-0.42	0.87	0.73	0.74	1.06e-14	9.68e-14	(A) Negative
TTF2	1p13.1	-0.90	-1.41	0.58	0.54	0.51	1.09e-14	9.94e-14	(A) Negative
CHST6	16q23.1	-0.52	-1.85	1.57	1.18	1.33	1.09e-14	9.96e-14	(A) Negative
MRPL15	8q11.23	0.24	-0.36	0.68	0.62	0.59	1.10e-14	1.00e-13	(A) Negative
FAM120C	Xp11.22	-0.05	-0.51	0.53	0.50	0.46	1.10e-14	1.01e-13	(A) Negative
PDGFD	11q22.3	1.81	2.55	0.81	0.97	-0.74	1.10e-14	1.01e-13	(B) Positive
CKAP2L	2q14.1	-0.79	-1.62	0.91	1.11	0.83	1.11e-14	1.01e-13	(A) Negative
SGO2	2q33.1	-1.02	-1.60	0.66	0.68	0.58	1.12e-14	1.02e-13	(A) Negative
NDUFB10	16p13.3	-0.18	0.28	0.52	0.48	-0.45	1.12e-14	1.02e-13	(B) Positive
ADSL	22q13.1	-0.74	-1.20	0.53	0.47	0.46	1.13e-14	1.03e-13	(A) Negative
PVR	19q13.31	-0.50	-1.10	0.70	0.60	0.60	1.13e-14	1.03e-13	(A) Negative
JOSD1	22q13.1	0.40	-0.08	0.56	0.50	0.48	1.14e-14	1.04e-13	(A) Negative
TPCN1	12q24.13	-0.66	-0.19	0.54	0.51	-0.47	1.14e-14	1.04e-13	(B) Positive
BRDT	1p22.1	0.24	1.01	0.79	1.22	-0.77	1.15e-14	1.04e-13	(B) Positive
GNL2	1p34.3	-0.22	-0.69	0.56	0.40	0.47	1.15e-14	1.04e-13	(A) Negative
ALDH6A1	14q24.3	0.14	0.77	0.72	0.71	-0.63	1.15e-14	1.04e-13	(B) Positive
ADI1	2p25.3	0.68	0.16	0.57	0.71	0.52	1.16e-14	1.05e-13	(A) Negative
PATZ1	22q12.2	0.57	1.12	0.65	0.52	-0.55	1.17e-14	1.06e-13	(B) Positive
ERMARD	6q27	-0.23	0.26	0.57	0.49	-0.49	1.18e-14	1.06e-13	(B) Positive
BAIAP2L1	7q21.3-q22.1	0.52	-0.07	0.64	0.79	0.58	1.18e-14	1.07e-13	(A) Negative
POLR1E	9p13.2	-0.33	-0.99	0.80	0.49	0.67	1.18e-14	1.07e-13	(A) Negative
KIF4B	5q33.2	-0.43	-0.93	0.56	0.61	0.50	1.20e-14	1.08e-13	(A) Negative
CADM2	3p12.1	0.46	1.16	0.69	1.17	-0.70	1.21e-14	1.09e-13	(B) Positive
OIP5	15q15.1	-1.68	-2.38	0.78	0.91	0.70	1.22e-14	1.10e-13	(A) Negative
SLC22A16	6q21	1.02	-0.12	1.36	0.92	1.14	1.22e-14	1.10e-13	(A) Negative
GPRC5A	12p13.1	-0.39	0.85	1.47	1.05	-1.24	1.22e-14	1.10e-13	(B) Positive
SCEL	13q22.3	1.53	-0.06	1.93	0.79	1.59	1.23e-14	1.11e-13	(A) Negative
ZNF540	19q13.13	0.41	1.15	0.83	0.93	-0.74	1.26e-14	1.14e-13	(B) Positive
BMS1	10q11.21	0.03	-0.36	0.46	0.36	0.39	1.28e-14	1.15e-13	(A) Negative
FZD4	11q14.2	-0.59	0.15	0.87	0.74	-0.74	1.29e-14	1.16e-13	(B) Positive
SPC25	2q31.1	-1.94	-2.64	0.76	0.94	0.69	1.29e-14	1.16e-13	(A) Negative
COL27A1	9q32	-0.04	-0.79	0.90	0.64	0.76	1.31e-14	1.18e-13	(A) Negative
GALNT4	12q21.33	0.16	0.67	0.57	0.60	-0.50	1.33e-14	1.19e-13	(B) Positive
MRPL11	11q13.2	-0.32	-0.77	0.52	0.48	0.45	1.33e-14	1.19e-13	(A) Negative
COTL1	16q24.1	0.04	-0.75	0.93	0.67	0.78	1.36e-14	1.22e-13	(A) Negative
RFX2	19p13.3	-0.17	0.36	0.59	0.64	-0.53	1.37e-14	1.22e-13	(B) Positive
UTP15	5q13.2	-0.66	-0.31	0.40	0.40	-0.35	1.39e-14	1.24e-13	(B) Positive
KLHL41	2q31.1	0.19	0.84	0.73	0.84	-0.65	1.39e-14	1.25e-13	(B) Positive
MRPS5	2q11.1	-0.42	-0.82	0.47	0.36	0.40	1.39e-14	1.25e-13	(A) Negative
TINAGL1	1p35.2	1.35	0.58	0.90	0.79	0.77	1.41e-14	1.26e-13	(A) Negative
NCAPG2	7q36.3	-1.33	-1.95	0.73	0.63	0.63	1.41e-14	1.26e-13	(A) Negative
GPN1	2p23.3	0.21	-0.24	0.54	0.34	0.45	1.43e-14	1.28e-13	(A) Negative
EPS15L1	19p13.11	-0.16	0.26	0.47	0.54	-0.42	1.43e-14	1.28e-13	(B) Positive
LTV1	6q24.2	-0.16	-0.66	0.59	0.43	0.50	1.47e-14	1.31e-13	(A) Negative
HAUS6	9p22.1	-0.96	-1.52	0.68	0.43	0.56	1.47e-14	1.31e-13	(A) Negative
MTERF4	2q37.3	-0.37	0.01	0.44	0.40	-0.38	1.47e-14	1.31e-13	(B) Positive
RNF32-DT	7q36.3	0.85	-0.18	1.19	1.17	1.03	1.53e-14	1.36e-13	(A) Negative
KCND3	1p13.2	0.20	0.60	0.44	0.60	-0.41	1.54e-14	1.37e-13	(B) Positive
ABHD14B	3p21.2	-0.32	0.17	0.57	0.51	-0.49	1.54e-14	1.37e-13	(B) Positive
CNOT8	5q33.2	-0.43	0.02	0.51	0.54	-0.45	1.58e-14	1.41e-13	(B) Positive
FDCSP	4q13.3	3.35	1.85	1.70	1.89	1.51	1.59e-14	1.41e-13	(A) Negative
PART1	5q12.1	0.89	-0.05	1.10	0.88	0.94	1.59e-14	1.41e-13	(A) Negative
PIR	Xp22.2	-1.11	-1.92	0.91	1.00	0.81	1.62e-14	1.44e-13	(A) Negative
ZDHHC17	12q21.2	-0.47	-0.10	0.44	0.39	-0.38	1.65e-14	1.46e-13	(B) Positive
SHC4	15q21.1	0.18	-1.72	2.29	1.46	1.90	1.66e-14	1.48e-13	(A) Negative
CHRM2	7q33	-0.30	-1.57	1.55	0.76	1.28	1.67e-14	1.48e-13	(A) Negative
NUDT18	8p21.3	0.11	0.72	0.71	0.67	-0.61	1.68e-14	1.49e-13	(B) Positive
PLK4	4q28.1	-1.23	-1.80	0.64	0.71	0.57	1.68e-14	1.49e-13	(A) Negative
TPSAB1	16p13.3	2.73	3.65	1.09	0.80	-0.92	1.71e-14	1.51e-13	(B) Positive
TASOR	3p14.3	-0.34	0.04	0.44	0.38	-0.37	1.72e-14	1.52e-13	(B) Positive
CABP4	11q13.2	0.20	0.56	0.36	0.60	-0.36	1.74e-14	1.54e-13	(B) Positive
FBXW4P1	22q11.23	0.21	0.69	0.55	0.59	-0.48	1.75e-14	1.54e-13	(B) Positive
DNAJC1	10p12.31	0.67	1.32	0.70	0.94	-0.65	1.76e-14	1.55e-13	(B) Positive
PRRG1	Xp21.1	0.58	-0.17	0.89	0.68	0.75	1.79e-14	1.58e-13	(A) Negative
KERA	12q21.33	0.64	1.21	0.62	0.81	-0.57	1.80e-14	1.58e-13	(B) Positive
SMG5	1q22	0.53	0.01	0.63	0.46	0.53	1.80e-14	1.59e-13	(A) Negative
FOSL1	11q13.1	-2.05	-2.52	0.56	0.39	0.46	1.83e-14	1.61e-13	(A) Negative
RUNX3	1p36.11	0.96	-0.06	1.18	1.05	1.01	1.84e-14	1.62e-13	(A) Negative
NUP205	7q33	-0.79	-1.31	0.61	0.48	0.52	1.85e-14	1.63e-13	(A) Negative
TFDP1	13q34	-0.07	-0.72	0.79	0.50	0.66	1.89e-14	1.66e-13	(A) Negative
DIO1	1p32.3	-1.10	0.82	2.20	2.28	-1.92	1.89e-14	1.67e-13	(B) Positive
AIG1	6q24.2	0.50	1.15	0.74	0.75	-0.65	1.90e-14	1.67e-13	(B) Positive
NDC1	1p32.3	-0.44	-1.04	0.68	0.67	0.59	1.91e-14	1.68e-13	(A) Negative
XPO4	13q12.11	-0.25	-0.65	0.47	0.41	0.40	1.96e-14	1.72e-13	(A) Negative
SNED1	2q37.3	-0.64	0.13	0.90	0.82	-0.77	1.97e-14	1.73e-13	(B) Positive
PGPEP1	19p13.11	-0.36	0.12	0.58	0.45	-0.48	1.98e-14	1.74e-13	(B) Positive
ANKRD45	1q25.1	0.95	-0.07	1.24	0.64	1.02	1.99e-14	1.74e-13	(A) Negative
XPO5	6p21.1	-0.28	-0.78	0.58	0.50	0.50	2.01e-14	1.76e-13	(A) Negative
RELL1	4p14	0.42	1.13	0.80	0.92	-0.71	2.03e-14	1.78e-13	(B) Positive
SLC6A11	3p25.3	-0.04	-0.71	0.78	0.69	0.67	2.03e-14	1.78e-13	(A) Negative
TJP3	19p13.3	1.38	2.03	0.78	0.58	-0.65	2.03e-14	1.78e-13	(B) Positive
WDR90	16p13.3	-0.61	-0.20	0.47	0.51	-0.41	2.06e-14	1.80e-13	(B) Positive
MUC15	11p14.2	1.33	-0.68	2.36	2.06	2.01	2.08e-14	1.82e-13	(A) Negative
CA13	8q21.2	0.64	-0.18	0.95	0.85	0.81	2.10e-14	1.83e-13	(A) Negative
E2F8	11p15.1	-0.88	-1.53	0.70	0.94	0.65	2.11e-14	1.84e-13	(A) Negative
ZNF174	16p13.3	0.15	0.54	0.45	0.44	-0.39	2.12e-14	1.85e-13	(B) Positive
ATG2B	14q32.2	0.02	0.43	0.49	0.44	-0.42	2.13e-14	1.85e-13	(B) Positive
ZNF20	19p13.2	0.35	0.90	0.65	0.55	-0.55	2.16e-14	1.89e-13	(B) Positive
ASB13	10p15.1	0.33	0.99	0.74	0.79	-0.65	2.17e-14	1.89e-13	(B) Positive
GINS1	20p11.21	-1.20	-1.89	0.79	0.78	0.69	2.18e-14	1.90e-13	(A) Negative
SLX9	21q22.3	-0.06	-0.55	0.59	0.47	0.50	2.19e-14	1.91e-13	(A) Negative
XK	Xp21.1	-2.17	-3.61	1.66	1.63	1.44	2.19e-14	1.91e-13	(A) Negative
IL20RB	3q22.3	-1.20	-2.03	0.97	0.95	0.84	2.27e-14	1.98e-13	(A) Negative
EPHB1	3q22.2	2.09	0.81	1.57	0.81	1.28	2.33e-14	2.03e-13	(A) Negative
CD46	1q32.2	0.35	0.95	0.72	0.55	-0.60	2.37e-14	2.06e-13	(B) Positive
SPAG17	1p12	0.88	1.90	1.06	1.61	-1.02	2.39e-14	2.08e-13	(B) Positive
FABP5	8q21.13	0.50	-0.64	1.34	1.23	1.14	2.45e-14	2.12e-13	(A) Negative
RNASEL	1q25.3	0.74	1.27	0.64	0.51	-0.53	2.45e-14	2.13e-13	(B) Positive
SEPTIN3	22q13.2	0.76	0.02	0.87	0.69	0.73	2.46e-14	2.13e-13	(A) Negative
PLA2G4A	1q31.1	-2.58	-3.99	1.73	0.98	1.41	2.46e-14	2.13e-13	(A) Negative
GATAD2A	19p13.11	0.13	-0.39	0.61	0.51	0.51	2.46e-14	2.13e-13	(A) Negative
RNF182	6p23	-2.99	-4.77	2.18	1.16	1.78	2.47e-14	2.14e-13	(A) Negative
SEPSECS	4p15.2	-0.54	-0.04	0.59	0.51	-0.50	2.48e-14	2.15e-13	(B) Positive
GFM2	5q13.3	-0.71	-0.36	0.39	0.42	-0.34	2.49e-14	2.16e-13	(B) Positive
SPOP	17q21.33	0.05	0.52	0.56	0.53	-0.48	2.65e-14	2.29e-13	(B) Positive
IVNS1ABP	1q25.3	-0.21	-0.64	0.50	0.44	0.43	2.71e-14	2.34e-13	(A) Negative
TPI1	12p13.31	-0.92	-1.46	0.64	0.46	0.53	2.71e-14	2.34e-13	(A) Negative
BRIP1	17q23.2	-1.50	-2.28	0.91	0.90	0.78	2.72e-14	2.35e-13	(A) Negative
PCYOX1L	5q32	-0.71	-0.15	0.66	0.57	-0.55	2.72e-14	2.35e-13	(B) Positive
STK39	2q24.3	-0.41	0.42	0.99	0.79	-0.83	2.72e-14	2.35e-13	(B) Positive
LRRFIP1	2q37.3	0.01	0.36	0.43	0.32	-0.36	2.73e-14	2.36e-13	(B) Positive
TSNAXIP1	16q22.1	0.43	1.18	0.87	0.85	-0.75	2.74e-14	2.36e-13	(B) Positive
HNMT	2q22.1	-0.03	0.60	0.74	0.70	-0.63	2.75e-14	2.37e-13	(B) Positive
C16ORF74	16q24.1	-0.81	0.21	1.22	0.93	-1.02	2.76e-14	2.37e-13	(B) Positive
SOSTDC1	7p21.2	1.32	-0.89	2.63	2.13	2.21	2.76e-14	2.38e-13	(A) Negative
ARF3	12q13.12	-0.01	0.35	0.42	0.39	-0.36	2.79e-14	2.40e-13	(B) Positive
TRAK1	3p22.1	-0.43	-0.01	0.50	0.43	-0.42	2.79e-14	2.40e-13	(B) Positive
C18ORF32	18q21.1	0.59	1.11	0.60	0.59	-0.52	2.82e-14	2.42e-13	(B) Positive
ANKMY2	7p21.1	-0.99	-0.47	0.61	0.51	-0.52	2.84e-14	2.44e-13	(B) Positive
TMEM74	8q23.1	-0.38	-1.35	1.19	0.65	0.97	2.85e-14	2.45e-13	(A) Negative
RFX6	6q22.1	0.44	1.32	0.90	1.48	-0.89	2.85e-14	2.45e-13	(B) Positive
PEX7	6q23.3	0.40	0.94	0.63	0.60	-0.54	2.85e-14	2.45e-13	(B) Positive
ZNF442	19p13.2	-0.16	0.47	0.74	0.68	-0.63	2.87e-14	2.46e-13	(B) Positive
SEC14L4	22q12.2	-1.25	-2.84	1.95	1.03	1.59	2.93e-14	2.51e-13	(A) Negative
FDXR	17q25.1	-1.07	-0.49	0.67	0.73	-0.59	2.95e-14	2.52e-13	(B) Positive
MED30	8q24.11	0.46	-0.23	0.82	0.72	0.69	2.95e-14	2.52e-13	(A) Negative
GARS1	7p14.3	-0.50	-1.02	0.63	0.51	0.52	2.95e-14	2.52e-13	(A) Negative
SCRG1	4q34.1	2.33	0.26	2.54	1.45	2.08	2.98e-14	2.54e-13	(A) Negative
B3GNT4	12q24.31	0.24	-0.54	0.91	0.87	0.78	3.00e-14	2.56e-13	(A) Negative
FEN1	11q12.2	-0.95	-1.50	0.64	0.67	0.56	3.00e-14	2.56e-13	(A) Negative
CALCOCO2	17q21.32	-0.04	0.51	0.65	0.60	-0.55	3.00e-14	2.56e-13	(B) Positive
OCA2	15q12-q13.1	-2.38	-4.26	2.32	1.18	1.88	3.08e-14	2.62e-13	(A) Negative
TSPAN15	10q22.1	1.62	2.52	1.09	0.82	-0.91	3.08e-14	2.63e-13	(B) Positive
IGFBP2	2q35	-1.53	-0.32	1.44	1.17	-1.21	3.11e-14	2.65e-13	(B) Positive
RLN1	9p24.1	0.39	1.33	1.04	1.28	-0.93	3.18e-14	2.71e-13	(B) Positive
NANOGP1	12p13.31	-2.54	-3.53	1.19	0.96	0.99	3.19e-14	2.72e-13	(A) Negative
TOMM5	9p13.2	-0.41	-0.89	0.58	0.42	0.48	3.20e-14	2.73e-13	(A) Negative
ITPK1	14q32.12	-0.06	0.43	0.58	0.50	-0.49	3.22e-14	2.74e-13	(B) Positive
CIMAP3	1p13.2	1.68	2.43	0.83	1.04	-0.75	3.25e-14	2.77e-13	(B) Positive
RASAL2	1q25.2	1.60	1.05	0.68	0.48	0.56	3.30e-14	2.81e-13	(A) Negative
HYPK	15q15.3	-0.08	0.39	0.55	0.53	-0.47	3.32e-14	2.82e-13	(B) Positive
RHOQ	2p21	0.81	0.34	0.55	0.54	0.47	3.34e-14	2.84e-13	(A) Negative
CYB5R2	11p15.4	1.89	0.96	1.09	1.07	0.93	3.34e-14	2.84e-13	(A) Negative
APP	21q21.3	1.37	0.59	0.91	0.90	0.78	3.35e-14	2.84e-13	(A) Negative
DNAJC2	7q22.1	-0.54	-1.01	0.56	0.46	0.47	3.36e-14	2.85e-13	(A) Negative
KLHL36	16q24.1	0.33	-0.21	0.65	0.51	0.54	3.40e-14	2.88e-13	(A) Negative
CHST11	12q23.3	-0.02	-0.72	0.81	0.81	0.70	3.41e-14	2.89e-13	(A) Negative
TRIM47	17q25.1	1.10	0.40	0.84	0.65	0.70	3.46e-14	2.93e-13	(A) Negative
WDFY3	4q21.23	0.67	1.05	0.45	0.40	-0.38	3.47e-14	2.93e-13	(B) Positive
KLK8	19q13.41	1.20	-1.23	2.95	2.10	2.43	3.52e-14	2.98e-13	(A) Negative
GLCCI1	7p21.3	-1.18	-0.41	0.92	0.75	-0.77	3.57e-14	3.02e-13	(B) Positive
ZMAT1	Xq22.1	0.79	1.62	0.97	0.94	-0.83	3.68e-14	3.11e-13	(B) Positive
FANCC	9q22.32	0.35	-0.19	0.64	0.56	0.54	3.69e-14	3.11e-13	(A) Negative
SYTL5	Xp11.4	-0.93	-0.39	0.62	0.72	-0.55	3.72e-14	3.14e-13	(B) Positive
NPEPPS	17q21.32	-0.26	0.12	0.42	0.52	-0.38	3.73e-14	3.14e-13	(B) Positive
KIF1A	2q37.3	0.48	-0.82	1.59	0.99	1.30	3.74e-14	3.16e-13	(A) Negative
XYLT2	17q21.33	-0.39	0.24	0.75	0.67	-0.64	3.78e-14	3.19e-13	(B) Positive
MCUR1	6p23	0.08	-0.45	0.63	0.55	0.53	3.84e-14	3.24e-13	(A) Negative
ENPP5	6p21.1	2.56	3.69	1.27	1.53	-1.13	3.85e-14	3.24e-13	(B) Positive
TM9SF1	14q12	-0.16	0.35	0.61	0.51	-0.51	3.87e-14	3.26e-13	(B) Positive
EIF4E2	2q37.1	-0.14	-0.48	0.41	0.38	0.35	3.87e-14	3.26e-13	(A) Negative
QSER1	11p13	0.15	-0.49	0.77	0.55	0.63	3.91e-14	3.29e-13	(A) Negative
MRPL37	1p32.3	-0.23	-0.66	0.52	0.42	0.43	3.94e-14	3.31e-13	(A) Negative
SLC25A19	17q25.1	-0.22	-0.68	0.53	0.58	0.46	3.97e-14	3.33e-13	(A) Negative
HSPA1L	6p21.33	0.69	1.17	0.57	0.52	-0.49	3.98e-14	3.34e-13	(B) Positive
SEC16A	9q34.3	0.48	1.05	0.68	0.52	-0.56	3.98e-14	3.34e-13	(B) Positive
SERTAD2	2p14	0.46	0.00	0.54	0.52	0.46	4.03e-14	3.38e-13	(A) Negative
CCDC87	11q13.2	0.96	1.77	0.96	0.93	-0.81	4.04e-14	3.39e-13	(B) Positive
CHD1L	1q21.1	-0.82	-1.33	0.62	0.56	0.52	4.05e-14	3.39e-13	(A) Negative
SUMF1	3p26.1	1.05	1.65	0.73	0.59	-0.61	4.09e-14	3.42e-13	(B) Positive
KLK7	19q13.41	2.87	1.08	2.19	1.57	1.80	4.14e-14	3.47e-13	(A) Negative
FANK1	10q26.2	1.11	2.10	1.16	1.14	-0.99	4.19e-14	3.51e-13	(B) Positive
PLXNA1	3q21.3	-0.09	-0.51	0.52	0.37	0.43	4.24e-14	3.54e-13	(A) Negative
BRI3	7q21.3	0.45	-0.05	0.59	0.46	0.49	4.24e-14	3.54e-13	(A) Negative
MYCBPAP	17q21.33	-0.04	1.03	1.22	1.36	-1.07	4.30e-14	3.60e-13	(B) Positive
TET3	2p13.1	0.46	-0.19	0.77	0.64	0.64	4.33e-14	3.61e-13	(A) Negative
RAD51AP1	12p13.32	-1.22	-2.08	1.04	0.82	0.86	4.35e-14	3.63e-13	(A) Negative
CEBPE	14q11.2	1.04	0.45	0.70	0.69	0.60	4.38e-14	3.65e-13	(A) Negative
MAP1A	15q15.3	-0.50	-0.09	0.48	0.51	-0.41	4.41e-14	3.68e-13	(B) Positive
OR6V1	7q34	0.86	0.56	0.35	0.32	0.30	4.42e-14	3.68e-13	(A) Negative
AGO3	1p34.3	0.33	-0.09	0.49	0.52	0.42	4.43e-14	3.69e-13	(A) Negative
PRDM13	6q16.2	-1.80	-4.10	2.86	1.33	2.29	4.47e-14	3.72e-13	(A) Negative
DOCK5	8p21.2	-0.18	-0.90	0.88	0.60	0.72	4.51e-14	3.75e-13	(A) Negative
CA14	1q21.2	-4.51	-3.79	0.76	1.14	-0.72	4.56e-14	3.79e-13	(B) Positive
WDR3	1p12	-0.25	-0.73	0.59	0.42	0.48	4.56e-14	3.79e-13	(A) Negative
STK26	Xq26.2	-0.24	-1.08	0.93	1.17	0.83	4.60e-14	3.82e-13	(A) Negative
MPHOSPH6	16q23.3	0.31	-0.40	0.83	0.80	0.70	4.72e-14	3.92e-13	(A) Negative
FNTB	14q23.3	-0.09	0.26	0.41	0.39	-0.35	4.82e-14	4.00e-13	(B) Positive
PRICKLE1	12q12	2.34	1.59	0.86	0.95	0.75	4.86e-14	4.03e-13	(A) Negative
BATF3	1q32.3	0.16	-0.45	0.72	0.69	0.61	4.88e-14	4.05e-13	(A) Negative
SPNS2	17p13.2	1.22	0.79	0.52	0.43	0.43	4.90e-14	4.06e-13	(A) Negative
PNRC2	1p36.11	-0.19	0.26	0.52	0.53	-0.45	4.95e-14	4.10e-13	(B) Positive
PANK3	5q34	0.30	0.86	0.65	0.67	-0.56	4.96e-14	4.11e-13	(B) Positive
TMEM71	8q24.22	1.15	-0.11	1.54	1.07	1.26	4.97e-14	4.11e-13	(A) Negative
NUTF2	16q22.1	-0.02	-0.45	0.52	0.49	0.44	5.01e-14	4.15e-13	(A) Negative
NUDT8	11q13.2	-0.19	-1.13	1.10	1.10	0.94	5.03e-14	4.16e-13	(A) Negative
SLCO5A1	8q13.3	0.69	-0.29	1.22	0.60	0.98	5.05e-14	4.18e-13	(A) Negative
FAM98C	19q13.2	0.62	0.99	0.45	0.36	-0.37	5.05e-14	4.18e-13	(B) Positive
GDF9	5q31.1	0.00	0.93	0.99	1.45	-0.92	5.09e-14	4.20e-13	(B) Positive
CMPK1	1p33	0.51	0.07	0.52	0.49	0.44	5.10e-14	4.21e-13	(A) Negative
TOB1	17q21.33	0.45	1.23	0.92	0.82	-0.77	5.16e-14	4.26e-13	(B) Positive
NHLRC3	13q13.3	-0.23	0.22	0.54	0.52	-0.46	5.37e-14	4.42e-13	(B) Positive
PNRC1	6q15	0.93	0.36	0.67	0.69	0.57	5.41e-14	4.46e-13	(A) Negative
UCN	2p23.3	-1.36	-0.70	0.79	0.71	-0.66	5.45e-14	4.49e-13	(B) Positive
ANOS1	Xp22.31	0.50	1.12	0.73	0.68	-0.62	5.46e-14	4.50e-13	(B) Positive
TMEM62	15q15.2	1.01	1.60	0.72	0.50	-0.59	5.49e-14	4.52e-13	(B) Positive
CTTNBP2NL	1p13.2	0.86	0.49	0.45	0.38	0.38	5.53e-14	4.55e-13	(A) Negative
THSD1	13q14.3	0.03	0.54	0.60	0.60	-0.51	5.55e-14	4.56e-13	(B) Positive
CFAP36	2p16.1	-0.06	0.42	0.58	0.46	-0.48	5.57e-14	4.58e-13	(B) Positive
PRKCA	17q24.2	-1.75	-2.38	0.79	0.42	0.64	5.57e-14	4.58e-13	(A) Negative
POU4F1	13q31.1	-0.90	-2.32	1.77	0.85	1.42	5.59e-14	4.59e-13	(A) Negative
IL2RA	10p15.1	3.11	2.29	0.96	0.96	0.81	5.64e-14	4.63e-13	(A) Negative
VPS37B	12q24.31	0.72	0.17	0.66	0.54	0.55	5.68e-14	4.66e-13	(A) Negative
ZNF671	19q13.43	-1.03	-0.08	1.12	1.11	-0.95	5.70e-14	4.67e-13	(B) Positive
EMC7	15q14	-0.14	0.23	0.44	0.44	-0.37	5.72e-14	4.69e-13	(B) Positive
CDKN2A	9p21.3	0.29	-1.30	1.99	0.90	1.59	5.75e-14	4.71e-13	(A) Negative
TOMM40	19q13.32	-0.35	-0.77	0.51	0.40	0.42	5.83e-14	4.77e-13	(A) Negative
AGPAT4	6q26	0.05	-0.61	0.80	0.66	0.67	5.84e-14	4.78e-13	(A) Negative
LYN	8q12.1	0.61	0.03	0.71	0.48	0.58	5.96e-14	4.88e-13	(A) Negative
FDX1	11q22.3	-0.17	-0.60	0.50	0.51	0.43	6.02e-14	4.92e-13	(A) Negative
CDK20	9q22.1	0.57	1.09	0.63	0.49	-0.52	6.07e-14	4.96e-13	(B) Positive
WDR77	1p13.2	-0.58	-1.00	0.50	0.42	0.41	6.11e-14	4.99e-13	(A) Negative
PTX3	3q25.32	-3.74	-5.57	2.26	1.36	1.82	6.11e-14	4.99e-13	(A) Negative
CEACAM20	19q13.31	-0.22	-0.88	0.79	0.67	0.65	6.14e-14	5.01e-13	(A) Negative
OGN	9q22.31	-0.20	1.62	2.17	1.98	-1.82	6.26e-14	5.11e-13	(B) Positive
MPHOSPH10	2p13.3	0.24	-0.13	0.45	0.37	0.37	6.35e-14	5.17e-13	(A) Negative
GPD1L	3p22.3	-0.04	0.87	1.12	0.76	-0.91	6.35e-14	5.17e-13	(B) Positive
BRWD1	21q22.2	0.04	0.46	0.51	0.42	-0.42	6.40e-14	5.21e-13	(B) Positive
TM4SF1	3q25.1	0.32	-0.70	1.19	1.29	1.02	6.49e-14	5.28e-13	(A) Negative
PNPLA2	11p15.5	0.37	0.90	0.61	0.63	-0.52	6.50e-14	5.29e-13	(B) Positive
CCDC126	7p15.3	0.92	1.56	0.72	0.90	-0.64	6.54e-14	5.32e-13	(B) Positive
SDSL	12q24.13	0.03	0.68	0.79	0.64	-0.65	6.57e-14	5.34e-13	(B) Positive
CEP128	14q31.1	-0.80	-1.28	0.58	0.47	0.47	6.61e-14	5.37e-13	(A) Negative
SLC2A10	20q13.12	0.44	1.13	0.82	0.74	-0.68	6.63e-14	5.38e-13	(B) Positive
IDH2	15q26.1	0.91	0.42	0.57	0.60	0.49	6.66e-14	5.41e-13	(A) Negative
ADD1	4p16.3	0.02	0.39	0.46	0.38	-0.38	6.80e-14	5.52e-13	(B) Positive
TMEM230	20p13-p12.3	-0.31	0.09	0.47	0.45	-0.40	6.92e-14	5.61e-13	(B) Positive
EMP2	16p13.13	-0.06	0.71	0.93	0.72	-0.76	6.95e-14	5.63e-13	(B) Positive
SNRPA	19q13.2	-0.60	-0.91	0.37	0.34	0.31	6.95e-14	5.63e-13	(A) Negative
GOLGA1	9q33.3	-0.04	0.41	0.56	0.40	-0.46	6.99e-14	5.66e-13	(B) Positive
IQGAP3	1q22	0.37	-0.26	0.73	0.80	0.63	7.08e-14	5.73e-13	(A) Negative
P2RY6	11q13.4	0.69	-0.08	0.92	0.80	0.77	7.12e-14	5.76e-13	(A) Negative
CFAP45	1q23.2	1.26	2.17	1.07	1.11	-0.91	7.20e-14	5.82e-13	(B) Positive
OVGP1	1p13.2	0.30	1.10	0.94	0.98	-0.80	7.29e-14	5.89e-13	(B) Positive
TM6SF1	15q25.2	0.05	0.56	0.61	0.53	-0.51	7.30e-14	5.90e-13	(B) Positive
CCDC65	12q13.12	0.72	1.41	0.77	1.02	-0.69	7.60e-14	6.13e-13	(B) Positive
SLCO4A1	20q13.33	-2.39	-3.02	0.77	0.62	0.63	7.62e-14	6.15e-13	(A) Negative
ZNF136	19p13.2	-0.02	0.44	0.57	0.41	-0.46	7.65e-14	6.17e-13	(B) Positive
AUH	9q22.31	-0.37	0.14	0.61	0.58	-0.51	7.70e-14	6.21e-13	(B) Positive
AGO1	1p34.3	0.24	-0.04	0.34	0.27	0.28	7.78e-14	6.27e-13	(A) Negative
FAM3D	3p14.2	2.62	1.45	1.44	1.10	1.17	7.79e-14	6.27e-13	(A) Negative
ARL6IP4	12q24.31	-0.03	0.26	0.35	0.35	-0.30	7.82e-14	6.30e-13	(B) Positive
SLC25A35	17p13.1	-0.68	-0.14	0.65	0.58	-0.54	7.99e-14	6.43e-13	(B) Positive
CATSPER2	15q15.3	-1.30	-0.81	0.57	0.66	-0.49	7.99e-14	6.43e-13	(B) Positive
ADAMTS3	4q13.3	-0.35	-1.09	0.92	0.58	0.74	8.07e-14	6.49e-13	(A) Negative
SECISBP2	9q22.2	-0.42	0.03	0.54	0.47	-0.44	8.12e-14	6.53e-13	(B) Positive
PPP4R3B	2p16.1	0.68	0.30	0.46	0.37	0.37	8.18e-14	6.57e-13	(A) Negative
PCBP4	3p21.2	0.48	-0.06	0.66	0.51	0.54	8.18e-14	6.57e-13	(A) Negative
ARHGEF3	3p14.3	0.95	1.55	0.71	0.71	-0.60	8.42e-14	6.76e-13	(B) Positive
MFSD9	2q12.1	0.03	-0.38	0.50	0.40	0.41	8.56e-14	6.86e-13	(A) Negative
NACA2	17q23.2	-0.37	-0.02	0.42	0.37	-0.35	8.61e-14	6.91e-13	(B) Positive
PNMA1	14q24.3	-0.33	0.14	0.56	0.59	-0.47	8.65e-14	6.93e-13	(B) Positive
KLK5	19q13.41	2.83	1.33	1.83	1.43	1.50	8.96e-14	7.18e-13	(A) Negative
MELTF	3q29	1.24	0.07	1.46	0.77	1.16	9.08e-14	7.27e-13	(A) Negative
MTBP	8q24.12	-0.02	-0.75	0.88	0.79	0.73	9.12e-14	7.30e-13	(A) Negative
STK17B	2q32.3	0.54	-0.14	0.81	0.78	0.68	9.12e-14	7.30e-13	(A) Negative
NTN4	12q22	-0.81	0.55	1.57	1.83	-1.36	9.23e-14	7.38e-13	(B) Positive
REXO2	11q23.2	-0.52	-1.06	0.66	0.57	0.54	9.25e-14	7.39e-13	(A) Negative
RAD51	15q15.1	-1.13	-1.80	0.76	0.97	0.67	9.29e-14	7.43e-13	(A) Negative
MIEF2	17p11.2	0.48	0.91	0.50	0.53	-0.42	9.33e-14	7.45e-13	(B) Positive
CEP170P1	4q26	-0.09	-0.67	0.71	0.57	0.58	9.43e-14	7.53e-13	(A) Negative
ITGB5	3q21.2	-0.06	0.78	1.03	0.75	-0.84	9.51e-14	7.58e-13	(B) Positive
SH3PXD2B	5q35.1	1.40	1.00	0.47	0.49	0.40	9.52e-14	7.59e-13	(A) Negative
XPO1	2p15	-0.17	-0.53	0.43	0.34	0.35	9.54e-14	7.60e-13	(A) Negative
RNGTT	6q15	-0.09	-0.52	0.52	0.46	0.43	9.67e-14	7.71e-13	(A) Negative
STX7	6q23.2	0.31	-0.20	0.60	0.57	0.50	9.69e-14	7.72e-13	(A) Negative
CCDC57	17q25.3	0.00	0.57	0.69	0.61	-0.57	9.74e-14	7.75e-13	(B) Positive
PGBD5	1q42.13	0.28	-1.13	1.77	1.10	1.42	9.92e-14	7.89e-13	(A) Negative
DHTKD1	10p14	1.06	0.45	0.74	0.57	0.60	9.92e-14	7.89e-13	(A) Negative
LYSMD3	5q14.3	-0.02	0.34	0.43	0.38	-0.36	1.01e-13	8.00e-13	(B) Positive
ROBO2	3p12.3	-0.34	0.60	1.00	1.59	-0.95	1.01e-13	8.04e-13	(B) Positive
TESK2	1p34.1	-0.01	0.69	0.82	0.89	-0.70	1.05e-13	8.35e-13	(B) Positive
ROR1	1p31.3	-0.54	-1.26	0.88	0.68	0.72	1.06e-13	8.42e-13	(A) Negative
MMP12	11q22.2	2.75	0.77	2.41	2.01	1.97	1.06e-13	8.43e-13	(A) Negative
GPR135	14q23.1	-0.63	-0.21	0.48	0.60	-0.42	1.07e-13	8.51e-13	(B) Positive
EPHA2	1p36.13	-0.62	-1.18	0.66	0.64	0.55	1.07e-13	8.51e-13	(A) Negative
NPC1	18q11.2	-0.10	-0.49	0.48	0.42	0.39	1.10e-13	8.71e-13	(A) Negative
EZH2	7q36.1	-0.92	-1.49	0.69	0.59	0.57	1.12e-13	8.90e-13	(A) Negative
NLRP12	19q13.42	-0.15	0.44	0.66	0.86	-0.59	1.14e-13	9.02e-13	(B) Positive
KRTAP8-1	21q22.1	0.68	-0.04	0.91	0.48	0.72	1.14e-13	9.04e-13	(A) Negative
MS4A14	11q12.2	2.56	3.34	0.88	1.11	-0.77	1.15e-13	9.08e-13	(B) Positive
FAM221B	9p13.3	1.25	2.03	0.89	1.09	-0.78	1.15e-13	9.08e-13	(B) Positive
ARHGEF9	Xq11.1	1.09	0.48	0.77	0.48	0.61	1.17e-13	9.22e-13	(A) Negative
USP8	15q21.2	-0.31	0.01	0.38	0.39	-0.32	1.17e-13	9.27e-13	(B) Positive
TARS1	5p13.3	-0.59	-1.05	0.57	0.46	0.46	1.18e-13	9.29e-13	(A) Negative
IGHM	14q32.33	3.48	2.77	0.82	1.01	0.71	1.18e-13	9.31e-13	(A) Negative
NAV3	12q21.2	-2.30	-1.24	1.25	1.31	-1.05	1.18e-13	9.33e-13	(B) Positive
MYO9B	19p13.11	0.14	-0.14	0.34	0.35	0.28	1.19e-13	9.35e-13	(A) Negative
IFT122	3q21.3-q22.1	0.16	0.71	0.65	0.67	-0.55	1.20e-13	9.47e-13	(B) Positive
MTMR8	Xq11.2	-0.46	-1.00	0.65	0.55	0.53	1.21e-13	9.51e-13	(A) Negative
CDKN3	14q22.2	-1.11	-1.80	0.82	0.90	0.70	1.22e-13	9.64e-13	(A) Negative
MRPL53	2p13.1	0.06	0.43	0.45	0.39	-0.37	1.22e-13	9.64e-13	(B) Positive
CFAP53	18q21.1	0.57	1.49	1.11	1.06	-0.92	1.23e-13	9.64e-13	(B) Positive
ADGRA3	4p15.2	0.03	-0.49	0.64	0.50	0.52	1.26e-13	9.89e-13	(A) Negative
ANKRD19P	9q22.31	-0.04	0.32	0.42	0.44	-0.36	1.26e-13	9.93e-13	(B) Positive
CFB	6p21.33	0.77	2.44	2.01	1.87	-1.66	1.27e-13	9.98e-13	(B) Positive
AQP9	15q21.3	3.79	2.62	1.37	1.59	1.18	1.29e-13	1.02e-12	(A) Negative
ERCC6	10q11.23	0.38	-0.15	0.66	0.44	0.53	1.30e-13	1.02e-12	(A) Negative
BCL2A1	15q25.1	0.22	-0.91	1.41	0.98	1.13	1.30e-13	1.02e-12	(A) Negative
SIKE1	1p13.2	0.27	-0.10	0.45	0.42	0.37	1.32e-13	1.03e-12	(A) Negative
CAPS2	12q21.1-q21.2	0.21	0.81	0.71	0.73	-0.60	1.32e-13	1.03e-12	(B) Positive
BSN	3p21.31	-0.45	0.19	0.73	0.94	-0.64	1.33e-13	1.04e-12	(B) Positive
PPM1A	14q23.1	0.23	0.63	0.49	0.46	-0.40	1.35e-13	1.05e-12	(B) Positive
ZFAND4	10q11.22	0.95	1.56	0.72	0.79	-0.61	1.35e-13	1.05e-12	(B) Positive
SULT1A1	16p11.2	-0.64	-0.04	0.73	0.66	-0.60	1.35e-13	1.06e-12	(B) Positive
RNF138	18q12.1	-0.33	-0.94	0.76	0.58	0.61	1.36e-13	1.06e-12	(A) Negative
PEAR1	1q23.1	0.26	0.48	0.26	0.29	-0.22	1.36e-13	1.06e-12	(B) Positive
DMRT1	9p24.3	1.03	-0.34	1.75	0.62	1.36	1.37e-13	1.07e-12	(A) Negative
FYCO1	3p21.31	0.54	1.14	0.74	0.50	-0.59	1.42e-13	1.11e-12	(B) Positive
CDC25B	20p13	-0.73	-1.42	0.84	0.75	0.69	1.43e-13	1.12e-12	(A) Negative
ABHD12B	14q22.1	-2.16	-1.09	1.13	1.86	-1.08	1.43e-13	1.12e-12	(B) Positive
SMC4	3q25.33	-0.86	-1.44	0.71	0.63	0.58	1.44e-13	1.12e-12	(A) Negative
SOX9	17q24.3	2.08	1.12	1.10	1.36	0.96	1.44e-13	1.13e-12	(A) Negative
CXCL3	4q13.3	-2.44	-3.21	0.96	0.74	0.77	1.46e-13	1.13e-12	(A) Negative
TACC3	4p16.3	-0.65	-1.26	0.71	0.77	0.60	1.46e-13	1.14e-12	(A) Negative
FRS2	12q15	0.64	1.08	0.51	0.62	-0.44	1.46e-13	1.14e-12	(B) Positive
SYT8	11p15.5	0.97	-0.36	1.67	1.12	1.33	1.47e-13	1.14e-12	(A) Negative
IDO1	8p11.21	1.32	-0.38	2.10	1.71	1.70	1.48e-13	1.15e-12	(A) Negative
RYR1	19q13.2	0.87	0.26	0.74	0.64	0.61	1.48e-13	1.15e-12	(A) Negative
SPTBN5	15q21	1.18	1.81	0.71	0.93	-0.63	1.50e-13	1.17e-12	(B) Positive
CDIPT	16p11.2	-0.25	0.22	0.54	0.64	-0.47	1.51e-13	1.17e-12	(B) Positive
HECTD2	10q23.32	-0.05	0.47	0.62	0.69	-0.53	1.51e-13	1.17e-12	(B) Positive
BOLA3	2p13.1	-0.56	-0.98	0.50	0.48	0.41	1.52e-13	1.18e-12	(A) Negative
RIN3	14q32.12	0.88	0.34	0.65	0.65	0.54	1.55e-13	1.20e-12	(A) Negative
PSME1	14q12	-0.13	0.46	0.73	0.53	-0.59	1.57e-13	1.21e-12	(B) Positive
ZCCHC24	10q22.3	-0.40	0.26	0.81	0.68	-0.66	1.58e-13	1.22e-12	(B) Positive
TLX1	10q24.31	0.94	0.04	1.14	0.63	0.90	1.58e-13	1.22e-12	(A) Negative
RGL2	6p21.32	0.17	0.63	0.55	0.57	-0.46	1.60e-13	1.24e-12	(B) Positive
TMED7	5q22.3	-0.08	0.37	0.55	0.48	-0.45	1.62e-13	1.26e-12	(B) Positive
MAPRE2	18q12.1-q12.2	-0.01	-0.70	0.86	0.71	0.70	1.63e-13	1.26e-12	(A) Negative
CPSF4	7q22.1	-0.43	-0.78	0.44	0.35	0.36	1.63e-13	1.26e-12	(A) Negative
PCBP2	12q13.13	-0.78	-0.39	0.47	0.47	-0.39	1.64e-13	1.27e-12	(B) Positive
IBTK	6q14.1	-0.16	0.23	0.47	0.42	-0.39	1.70e-13	1.31e-12	(B) Positive
QKI	6q26	0.43	-0.01	0.53	0.50	0.44	1.72e-13	1.33e-12	(A) Negative
EEF2KMT	16p13.3	0.73	1.20	0.57	0.52	-0.46	1.73e-13	1.33e-12	(B) Positive
SLC5A1	22q12.3	3.27	1.89	1.63	1.80	1.38	1.73e-13	1.33e-12	(A) Negative
HEATR1	1q43	-0.25	-0.77	0.64	0.49	0.52	1.75e-13	1.35e-12	(A) Negative
KIFC3	16q21	-0.97	-1.49	0.64	0.55	0.52	1.79e-13	1.38e-12	(A) Negative
PI3	20q13.12	0.99	-0.31	1.65	0.97	1.30	1.81e-13	1.39e-12	(A) Negative
SNX5	20p11.23	-1.40	-1.90	0.60	0.58	0.50	1.84e-13	1.41e-12	(A) Negative
AGFG1	2q36.3	0.21	-0.24	0.56	0.44	0.45	1.86e-13	1.43e-12	(A) Negative
EFNA5	5q21.3	0.71	0.08	0.78	0.67	0.63	1.86e-13	1.43e-12	(A) Negative
CREBL2	12p13.1	0.40	0.89	0.61	0.48	-0.49	1.88e-13	1.44e-12	(B) Positive
CIP2A	3q13.13	-0.64	-1.14	0.59	0.67	0.50	1.88e-13	1.45e-12	(A) Negative
CALB2	16q22.2	3.39	2.19	1.48	1.25	1.20	1.93e-13	1.48e-12	(A) Negative
OMD	9q22.31	1.84	3.01	1.43	1.28	-1.17	1.93e-13	1.48e-12	(B) Positive
LMF1	16p13.3	0.44	0.86	0.52	0.45	-0.42	1.94e-13	1.49e-12	(B) Positive
FOXK2	17q25.3	0.40	-0.02	0.50	0.54	0.42	1.94e-13	1.49e-12	(A) Negative
KNL1	15q15.1	-1.48	-2.11	0.75	0.86	0.64	1.95e-13	1.49e-12	(A) Negative
VASN	16p13.3	0.00	-0.86	1.06	0.89	0.86	1.95e-13	1.50e-12	(A) Negative
LRP2	2q31.1	1.06	2.36	1.58	1.55	-1.30	1.97e-13	1.51e-12	(B) Positive
TBC1D4	13q22.2	0.01	-0.58	0.71	0.75	0.59	1.98e-13	1.51e-12	(A) Negative
SPTBN2	11q13.2	0.14	-0.47	0.68	0.98	0.61	1.99e-13	1.53e-12	(A) Negative
KSR2	12q24.22-q24.23	-0.17	0.59	0.92	0.89	-0.76	2.01e-13	1.54e-12	(B) Positive
MMP28	17q12	0.31	0.87	0.67	0.69	-0.56	2.04e-13	1.56e-12	(B) Positive
MOCS1	6p21.2	-0.47	-0.02	0.56	0.49	-0.45	2.05e-13	1.56e-12	(B) Positive
GRAMD1B	11q24.1	-1.04	-1.39	0.43	0.37	0.35	2.07e-13	1.58e-12	(A) Negative
SCAMP4	19p13.3	0.36	0.69	0.40	0.34	-0.32	2.07e-13	1.58e-12	(B) Positive
CA6	1p36.23	1.19	0.28	1.18	0.49	0.91	2.10e-13	1.60e-12	(A) Negative
PLEKHG2	19q13.2	-0.28	-0.86	0.71	0.62	0.57	2.12e-13	1.61e-12	(A) Negative
PCDHB9	5q31.3	0.27	-0.42	0.84	0.83	0.69	2.16e-13	1.65e-12	(A) Negative
MRPL19	2p12	-0.13	-0.50	0.45	0.39	0.37	2.16e-13	1.65e-12	(A) Negative
VEZT	12q22	0.53	0.91	0.46	0.44	-0.38	2.17e-13	1.65e-12	(B) Positive
MSLN	16p13.3	-0.28	-1.94	2.14	1.10	1.67	2.18e-13	1.66e-12	(A) Negative
MRAP2	6q14.2	-1.23	-2.32	1.36	1.05	1.09	2.19e-13	1.67e-12	(A) Negative
UBALD2	17q25.1	0.24	-0.23	0.57	0.52	0.46	2.19e-13	1.67e-12	(A) Negative
MRPS34	16p13.3	-0.19	0.21	0.48	0.44	-0.39	2.20e-13	1.67e-12	(B) Positive
GRAMD2B	5q23.2	2.07	1.49	0.70	0.70	0.58	2.23e-13	1.70e-12	(A) Negative
OSBPL6	2q31.2	-0.89	0.15	1.25	1.30	-1.04	2.26e-13	1.72e-12	(B) Positive
AMN1	12p11.21	0.01	0.68	0.80	0.82	-0.66	2.27e-13	1.72e-12	(B) Positive
RIC8A	11p15.5	0.07	0.42	0.42	0.44	-0.35	2.28e-13	1.73e-12	(B) Positive
GEMIN8	Xp22.2	0.30	0.68	0.48	0.43	-0.39	2.30e-13	1.74e-12	(B) Positive
CD58	1p13.1	-0.29	-0.81	0.64	0.58	0.52	2.31e-13	1.75e-12	(A) Negative
PIEZO2	18p11.22-p11.21	-2.17	-1.24	1.05	1.43	-0.93	2.31e-13	1.75e-12	(B) Positive
SDHAF3	7q21.3	-0.80	-1.73	1.13	1.10	0.93	2.32e-13	1.76e-12	(A) Negative
ARFGAP3	22q13.2	0.32	-0.24	0.67	0.70	0.56	2.33e-13	1.76e-12	(A) Negative
CCDC9B	15q15.1	0.98	0.06	1.13	0.99	0.92	2.34e-13	1.77e-12	(A) Negative
THBS4	5q14.1	1.60	2.94	1.64	1.51	-1.34	2.34e-13	1.77e-12	(B) Positive
WDR83	19p13.13	-0.47	-0.10	0.45	0.45	-0.37	2.36e-13	1.78e-12	(B) Positive
SRSF5	14q24	-0.94	-0.55	0.46	0.56	-0.39	2.36e-13	1.79e-12	(B) Positive
RAB11FIP1	8p11.23	1.05	1.93	1.05	1.14	-0.88	2.37e-13	1.79e-12	(B) Positive
DAPK1	9q21.33	0.56	-0.24	1.01	0.75	0.81	2.38e-13	1.80e-12	(A) Negative
PEBP4	8p21.3	0.55	1.39	0.92	1.37	-0.84	2.38e-13	1.80e-12	(B) Positive
HMGB3P1	20q11.22	0.05	-0.69	0.86	1.02	0.73	2.39e-13	1.81e-12	(A) Negative
SSBP2	5q14.1	-0.76	-0.11	0.78	0.78	-0.65	2.43e-13	1.83e-12	(B) Positive
KRT8	12q13.13	-0.73	0.00	0.89	0.89	-0.73	2.43e-13	1.83e-12	(B) Positive
MTPAP	10p11.23	0.19	-0.27	0.59	0.38	0.46	2.47e-13	1.86e-12	(A) Negative
GLCE	15q23	0.41	0.96	0.63	0.83	-0.55	2.47e-13	1.86e-12	(B) Positive
HSH2D	19p13.11	-1.17	-0.14	1.21	1.38	-1.03	2.47e-13	1.86e-12	(B) Positive
MUC1	1q22	1.07	2.28	1.50	1.30	-1.21	2.49e-13	1.88e-12	(B) Positive
ZFP2	5q35.3	1.29	2.07	0.96	0.88	-0.78	2.50e-13	1.88e-12	(B) Positive
TGM3	20p13	0.39	0.92	0.58	0.90	-0.53	2.54e-13	1.91e-12	(B) Positive
EPB41L4A	5q22.1-q22.2	0.43	1.08	0.80	0.69	-0.65	2.61e-13	1.96e-12	(B) Positive
GPRC5C	17q25.1	-0.96	0.22	1.49	1.06	-1.18	2.66e-13	2.00e-12	(B) Positive
CCDC77	12p13.33	-1.06	-1.75	0.88	0.54	0.69	2.69e-13	2.02e-12	(A) Negative
DYNC2LI1	2p21	-0.04	0.50	0.67	0.55	-0.54	2.70e-13	2.03e-12	(B) Positive
DRAXIN	1p36.22	-1.34	-1.83	0.61	0.45	0.49	2.71e-13	2.03e-12	(A) Negative
LRP12	8q22.3	0.50	-0.29	0.99	0.85	0.80	2.71e-13	2.03e-12	(A) Negative
CKS2	9q22.2	-0.80	-1.44	0.78	0.79	0.64	2.73e-13	2.05e-12	(A) Negative
ZDHHC20	13q12.11	0.99	0.48	0.63	0.56	0.51	2.73e-13	2.05e-12	(A) Negative
SIRPB1	20p13	0.48	0.14	0.42	0.37	0.34	2.75e-13	2.06e-12	(A) Negative
UBXN8	8p12	-1.03	-0.37	0.80	0.82	-0.66	2.80e-13	2.10e-12	(B) Positive
CCDC93	2q14.1	-0.12	-0.47	0.43	0.40	0.35	2.81e-13	2.10e-12	(A) Negative
RNF168	3q29	-0.33	-0.79	0.58	0.41	0.46	2.83e-13	2.12e-12	(A) Negative
SF3B6	2p23.3	0.17	-0.28	0.57	0.38	0.45	2.83e-13	2.12e-12	(A) Negative
SLC2A5	1p36.23	1.17	0.71	0.56	0.56	0.46	2.84e-13	2.12e-12	(A) Negative
EDEM3	1q25.3	0.66	1.14	0.58	0.66	-0.49	2.84e-13	2.13e-12	(B) Positive
SLC35B4	7q33	-0.92	-1.29	0.47	0.35	0.37	2.85e-13	2.13e-12	(A) Negative
CYP4F8	19p13.12	-0.94	0.08	1.17	1.52	-1.02	2.87e-13	2.14e-12	(B) Positive
FTMT	5q23.1	1.00	0.41	0.77	0.32	0.59	2.92e-13	2.18e-12	(A) Negative
SARAF	8p12	0.04	0.70	0.81	0.83	-0.67	2.93e-13	2.18e-12	(B) Positive
SYTL1	1p36.11	-0.44	0.23	0.84	0.73	-0.67	2.93e-13	2.18e-12	(B) Positive
SLC38A6	14q23.1	-0.13	0.33	0.56	0.55	-0.46	2.93e-13	2.19e-12	(B) Positive
MRPL43	10q24.31	0.37	0.73	0.45	0.36	-0.36	2.94e-13	2.19e-12	(B) Positive
ZC4H2	Xq11.2	0.06	-0.51	0.72	0.56	0.58	2.94e-13	2.19e-12	(A) Negative
NDRG1	8q24.22	0.06	-0.89	1.19	0.98	0.95	2.95e-13	2.20e-12	(A) Negative
LRRC37A3	17q24.1	-0.02	0.53	0.65	0.72	-0.55	2.98e-13	2.22e-12	(B) Positive
OGFOD1	16q13	-0.56	-0.97	0.49	0.51	0.41	3.05e-13	2.27e-12	(A) Negative
GID4	17p11.2	-0.99	-1.48	0.60	0.56	0.49	3.07e-13	2.28e-12	(A) Negative
MPDU1	17p13.1	-0.27	0.11	0.45	0.52	-0.38	3.09e-13	2.30e-12	(B) Positive
NNAT	20q11.23	0.23	0.77	0.59	0.94	-0.55	3.10e-13	2.30e-12	(B) Positive
DCLK1	13q13.3	-0.93	-0.04	1.03	1.26	-0.88	3.14e-13	2.33e-12	(B) Positive
S100A2	1q21.3	-0.23	-1.77	1.91	1.67	1.54	3.22e-13	2.39e-12	(A) Negative
AKAP8	19p13.12	-0.02	-0.46	0.55	0.44	0.44	3.24e-13	2.40e-12	(A) Negative
DIS3L	15q22.31	-0.55	-0.12	0.53	0.53	-0.43	3.26e-13	2.42e-12	(B) Positive
PEX11A	15q26.1	0.34	1.16	1.03	0.81	-0.82	3.28e-13	2.43e-12	(B) Positive
NOP58	2q33.1	0.04	-0.47	0.64	0.52	0.51	3.29e-13	2.44e-12	(A) Negative
ZCCHC4	4p15.2	-0.87	-0.50	0.46	0.41	-0.37	3.30e-13	2.44e-12	(B) Positive
CXCL14	5q31.1	2.62	3.87	1.55	1.36	-1.25	3.31e-13	2.45e-12	(B) Positive
LDLRAD4	18p11.21	1.20	1.94	0.88	1.00	-0.74	3.39e-13	2.51e-12	(B) Positive
MUC16	19p13.2	-0.60	-2.04	1.83	1.36	1.44	3.40e-13	2.52e-12	(A) Negative
GLG1	16q23.1	0.21	-0.19	0.48	0.46	0.39	3.44e-13	2.55e-12	(A) Negative
NRIP3	11p15.4	-0.43	0.10	0.49	1.09	-0.53	3.45e-13	2.55e-12	(B) Positive
ATP1B3	3q23	-0.39	-0.91	0.63	0.61	0.51	3.59e-13	2.65e-12	(A) Negative
PIH1D2	11q23.1	-0.26	0.47	0.87	1.01	-0.74	3.62e-13	2.67e-12	(B) Positive
GPBP1	5q11.2	-0.19	0.18	0.46	0.40	-0.37	3.70e-13	2.73e-12	(B) Positive
CHAF1B	21q22.12-q22.13	-0.80	-1.53	0.93	0.71	0.73	3.91e-13	2.89e-12	(A) Negative
CACNG4	17q24.2	0.13	0.67	0.65	0.70	-0.54	3.93e-13	2.90e-12	(B) Positive
GDAP2	1p12	0.57	0.19	0.47	0.45	0.38	3.95e-13	2.91e-12	(A) Negative
NANOS1	10q26.11	0.79	-0.06	1.09	0.77	0.85	3.96e-13	2.92e-12	(A) Negative
ZNF678	1q42.13	-0.13	0.33	0.57	0.54	-0.46	4.03e-13	2.97e-12	(B) Positive
CARTPT	5q13.2	0.28	1.16	0.78	1.86	-0.88	4.08e-13	3.01e-12	(B) Positive
DCBLD2	3q12.1	-1.32	-1.98	0.84	0.68	0.66	4.11e-13	3.02e-12	(A) Negative
CCDC138	2q13	-1.15	-1.78	0.81	0.62	0.64	4.26e-13	3.13e-12	(A) Negative
TXNDC16	14q22.1	0.45	1.09	0.80	0.74	-0.64	4.30e-13	3.16e-12	(B) Positive
WDR31	9q32	0.33	0.82	0.59	0.66	-0.49	4.37e-13	3.21e-12	(B) Positive
ZCCHC10	5q31.1	-0.32	0.07	0.48	0.46	-0.39	4.37e-13	3.21e-12	(B) Positive
TXNL4B	16q22.2	-0.59	-1.04	0.57	0.50	0.45	4.38e-13	3.22e-12	(A) Negative
MRPL10	17q21.32	-0.85	-0.50	0.43	0.47	-0.35	4.39e-13	3.22e-12	(B) Positive
HIF1AN	10q24.31	0.19	0.59	0.49	0.48	-0.40	4.41e-13	3.24e-12	(B) Positive
CTTNBP2	7q31.31	-2.72	-1.79	1.10	1.38	-0.94	4.45e-13	3.26e-12	(B) Positive
SNRNP35	12q24.31	0.21	0.57	0.45	0.41	-0.36	4.55e-13	3.34e-12	(B) Positive
VPS72	1q21.3	0.27	-0.13	0.51	0.41	0.40	4.67e-13	3.42e-12	(A) Negative
PTPN1	20q13.13	0.01	0.50	0.54	0.87	-0.50	4.67e-13	3.42e-12	(B) Positive
AMY2A	1p21.1	2.70	1.52	1.50	1.17	1.18	4.67e-13	3.42e-12	(A) Negative
RRM2	2p25.1	-1.55	-2.34	0.94	1.07	0.78	4.69e-13	3.43e-12	(A) Negative
IL1RAP	3q28	-0.15	-0.73	0.73	0.58	0.58	4.74e-13	3.47e-12	(A) Negative
AXIN2	17q24.1	-1.06	-0.42	0.81	0.69	-0.64	4.78e-13	3.50e-12	(B) Positive
MACROH2A2	10q22.1	1.23	0.26	1.20	1.16	0.97	4.79e-13	3.50e-12	(A) Negative
EARS2	16p12.2	-0.66	-0.28	0.45	0.56	-0.39	4.80e-13	3.51e-12	(B) Positive
AQP11	11q14.1	-1.60	-0.69	1.10	1.15	-0.90	4.84e-13	3.53e-12	(B) Positive
MALAT1	11q13.1	-0.95	-0.19	0.91	1.02	-0.76	4.85e-13	3.54e-12	(B) Positive
KRT17	17q21.2	0.41	-0.99	1.75	1.57	1.40	4.98e-13	3.64e-12	(A) Negative
CRAT	9q34.11	0.18	1.10	1.16	1.01	-0.92	5.01e-13	3.66e-12	(B) Positive
ST6GAL1	3q27.3	-0.26	-0.87	0.75	0.75	0.61	5.05e-13	3.68e-12	(A) Negative
CXCL8	4q13.3	-3.03	-4.51	1.90	1.36	1.48	5.05e-13	3.68e-12	(A) Negative
METTL25B	1q23.1	-0.12	0.30	0.50	0.56	-0.42	5.14e-13	3.74e-12	(B) Positive
DLX6	7q21.3	-1.05	-2.38	1.75	0.81	1.33	5.20e-13	3.79e-12	(A) Negative
S100A10	1q21.3	0.39	-0.30	0.86	0.80	0.69	5.22e-13	3.80e-12	(A) Negative
ATP6V1G1	9q32	0.20	0.68	0.60	0.58	-0.48	5.24e-13	3.81e-12	(B) Positive
CFAP91	3q13.33	0.89	1.79	1.10	1.16	-0.90	5.28e-13	3.84e-12	(B) Positive
NUDCD1	8q23.1	0.19	-0.36	0.67	0.69	0.54	5.31e-13	3.86e-12	(A) Negative
MEX3C	18q21.2	0.65	0.13	0.65	0.54	0.51	5.32e-13	3.87e-12	(A) Negative
CNTNAP3	9p12	-1.84	-2.82	1.25	0.89	0.97	5.42e-13	3.94e-12	(A) Negative
SYNC	1p35.1	-0.74	-0.31	0.54	0.49	-0.43	5.58e-13	4.05e-12	(B) Positive
CP	3q24-q25.1	-0.83	-2.91	2.64	2.19	2.08	5.60e-13	4.07e-12	(A) Negative
NOPCHAP1	12q23.3	-0.05	-0.46	0.51	0.45	0.40	5.67e-13	4.11e-12	(A) Negative
ATP6V1G2	6p21.33	-0.61	0.20	0.99	1.01	-0.80	5.81e-13	4.21e-12	(B) Positive
PDIA6	2p25.1	-0.12	-0.65	0.68	0.52	0.53	5.94e-13	4.30e-12	(A) Negative
FETUB	3q27.3	-0.90	-1.68	1.01	0.56	0.77	5.97e-13	4.33e-12	(A) Negative
BNIPL	1q21.3	1.09	2.33	1.57	1.32	-1.24	5.99e-13	4.34e-12	(B) Positive
STAG3	7q22.1	-0.98	-1.76	1.01	0.66	0.78	6.02e-13	4.36e-12	(A) Negative
TRAF3IP1	2q37.3	0.80	1.22	0.53	0.42	-0.42	6.08e-13	4.40e-12	(B) Positive
CCNO	5q11.2	-0.64	0.35	1.16	1.47	-0.99	6.10e-13	4.41e-12	(B) Positive
LRP1B	2q22.1-q22.2	-0.60	0.47	1.09	2.05	-1.07	6.10e-13	4.41e-12	(B) Positive
CFAP20	16q21	-0.32	-0.73	0.52	0.47	0.41	6.16e-13	4.45e-12	(A) Negative
RIOK2	5q15	-0.55	-0.22	0.42	0.38	-0.33	6.34e-13	4.58e-12	(B) Positive
LASP1	17q12	0.31	0.92	0.75	0.74	-0.61	6.37e-13	4.60e-12	(B) Positive
TET1	10q21.3	-2.28	-3.07	1.03	0.67	0.79	6.38e-13	4.60e-12	(A) Negative
IL1R2	2q11.2	1.30	0.22	1.38	1.07	1.08	6.42e-13	4.63e-12	(A) Negative
DDO	6q21	-0.51	0.34	1.04	1.12	-0.85	6.46e-13	4.66e-12	(B) Positive
B4GAT1	11q13.2	-0.97	-0.53	0.53	0.56	-0.43	6.53e-13	4.70e-12	(B) Positive
EPHX2	8p21.2-p21.1	0.14	1.02	1.07	1.19	-0.88	6.57e-13	4.73e-12	(B) Positive
DKK1	10q21.1	-2.99	-5.00	2.58	1.94	2.01	6.58e-13	4.74e-12	(A) Negative
ZNF629	16p11.2	0.23	0.61	0.48	0.47	-0.39	6.60e-13	4.75e-12	(B) Positive
TCF19	6p21.33	-0.37	-0.96	0.74	0.68	0.59	6.62e-13	4.76e-12	(A) Negative
RORC	1q21.3	0.40	1.28	1.13	0.84	-0.88	6.67e-13	4.79e-12	(B) Positive
SLTM	15q22.1	-0.34	-0.02	0.39	0.43	-0.32	6.73e-13	4.84e-12	(B) Positive
PRC1	15q26.1	-0.92	-1.60	0.84	0.87	0.68	6.76e-13	4.86e-12	(A) Negative
SORCS1	10q25.1	-2.26	-1.13	1.29	1.83	-1.13	6.87e-13	4.93e-12	(B) Positive
SLC35G1	10q23.33	-0.78	-1.39	0.75	0.76	0.61	6.88e-13	4.94e-12	(A) Negative
SLC35C1	11p11.2	0.57	0.01	0.71	0.58	0.56	6.88e-13	4.94e-12	(A) Negative
BTNL9	5q35.3	0.06	0.52	0.56	0.63	-0.46	6.94e-13	4.98e-12	(B) Positive
SYNM	15q26.3	0.82	-0.28	1.42	1.06	1.10	7.06e-13	5.06e-12	(A) Negative
SLC45A3	1q32.1	0.35	-0.12	0.59	0.55	0.47	7.08e-13	5.07e-12	(A) Negative
ANAPC1	2q13	-0.43	-0.80	0.48	0.32	0.37	7.18e-13	5.14e-12	(A) Negative
LARGE2	11p11.2	1.29	0.26	1.33	0.95	1.03	7.19e-13	5.15e-12	(A) Negative
ACADS	12q24.31	-0.39	0.13	0.60	0.86	-0.53	7.24e-13	5.18e-12	(B) Positive
VEGFA	6p21.1	-0.26	-1.02	0.98	0.75	0.77	7.24e-13	5.18e-12	(A) Negative
ADM	11p15.4	-1.24	-2.30	1.33	1.23	1.06	7.25e-13	5.19e-12	(A) Negative
FGFR3	4p16.3	-1.68	-0.78	1.11	1.21	-0.91	7.26e-13	5.19e-12	(B) Positive
MAP2K4	17p12	0.14	0.61	0.50	0.83	-0.46	7.29e-13	5.21e-12	(B) Positive
BCL2L14	12p13.2	1.54	0.48	1.38	1.00	1.07	7.35e-13	5.25e-12	(A) Negative
CBLL1	7q22.3	-0.27	-0.65	0.46	0.49	0.38	7.36e-13	5.26e-12	(A) Negative
SNRPA1	15q26.3	-0.64	-1.17	0.68	0.54	0.54	7.38e-13	5.27e-12	(A) Negative
ABHD1	2p23.3	0.26	0.93	0.83	0.80	-0.67	7.39e-13	5.27e-12	(B) Positive
ARID2	12q12	-0.81	-0.31	0.64	0.49	-0.50	7.43e-13	5.30e-12	(B) Positive
SULT2B1	19q13.33	-0.14	0.87	1.28	1.11	-1.01	7.51e-13	5.36e-12	(B) Positive
PCDH8	13q14.3	0.09	-1.56	2.16	1.24	1.65	7.53e-13	5.37e-12	(A) Negative
SERPINB8	18q22.1	0.28	-0.35	0.80	0.66	0.63	7.56e-13	5.38e-12	(A) Negative
DNAAF11	8q24.22	2.14	3.10	1.20	1.20	-0.97	7.59e-13	5.40e-12	(B) Positive
ADA	20q13.12	-2.72	-3.23	0.64	0.58	0.51	7.66e-13	5.45e-12	(A) Negative
AKAP10	17p11.2	-0.27	0.11	0.46	0.54	-0.38	7.67e-13	5.46e-12	(B) Positive
CCDC88A	2p16.1	-1.07	-1.77	0.91	0.69	0.71	7.67e-13	5.46e-12	(A) Negative
YOD1	1q32.1	-0.60	-1.18	0.72	0.75	0.58	7.81e-13	5.55e-12	(A) Negative
DNA2	10q21.3	-0.92	-1.56	0.82	0.71	0.65	7.85e-13	5.58e-12	(A) Negative
YPEL2	17q22	0.75	1.34	0.74	0.66	-0.58	7.93e-13	5.64e-12	(B) Positive
RBCK1	20p13	-0.59	-0.17	0.53	0.53	-0.43	8.01e-13	5.69e-12	(B) Positive
LZTS3	20p13	0.61	-0.03	0.82	0.66	0.64	8.03e-13	5.70e-12	(A) Negative
JPT1	17q25.1	0.74	0.09	0.80	0.82	0.64	8.19e-13	5.81e-12	(A) Negative
RMDN3	15q15.1	-0.00	0.44	0.57	0.42	-0.44	8.19e-13	5.81e-12	(B) Positive
AVEN	15q14	0.10	-0.31	0.51	0.51	0.41	8.22e-13	5.83e-12	(A) Negative
RIOX2	3q11.2	0.06	-0.51	0.70	0.76	0.57	8.30e-13	5.88e-12	(A) Negative
IPO11	5q12.1	-0.12	0.23	0.43	0.49	-0.36	8.33e-13	5.90e-12	(B) Positive
PDCD4	10q25.2	0.97	1.62	0.80	0.82	-0.64	8.37e-13	5.92e-12	(B) Positive
MMP7	11q22.2	6.64	5.47	1.43	1.61	1.17	8.58e-13	6.07e-12	(A) Negative
TNIP3	4q27	1.84	0.75	1.42	0.97	1.09	8.58e-13	6.07e-12	(A) Negative
NAA10	Xq28	0.06	-0.30	0.46	0.41	0.36	8.63e-13	6.10e-12	(A) Negative
MGST2	4q31.1	-0.34	0.21	0.72	0.55	-0.56	8.75e-13	6.19e-12	(B) Positive
CIB1	15q26.1	0.28	0.82	0.70	0.54	-0.54	8.80e-13	6.22e-12	(B) Positive
DCLRE1C	10p13	0.51	0.04	0.62	0.43	0.47	8.86e-13	6.26e-12	(A) Negative
ANXA2R	5p12	0.00	-0.80	1.03	0.86	0.81	8.96e-13	6.33e-12	(A) Negative
RMND5A	2p11.2	0.37	-0.05	0.53	0.48	0.42	9.21e-13	6.50e-12	(A) Negative
ACACB	12q24.11	0.15	0.81	0.78	1.01	-0.66	9.24e-13	6.52e-12	(B) Positive
UCHL1	4p13	-0.12	-1.22	1.45	0.89	1.10	9.44e-13	6.65e-12	(A) Negative
SHPK	17p13.2	-0.76	-0.26	0.64	0.58	-0.50	9.45e-13	6.66e-12	(B) Positive
BCAM	19q13.32	0.74	1.15	0.52	0.48	-0.41	9.49e-13	6.69e-12	(B) Positive
ARFIP1	4q31.3	0.70	1.12	0.54	0.47	-0.42	9.51e-13	6.70e-12	(B) Positive
GRIK3	1p34.3	0.14	0.60	0.56	0.64	-0.46	9.55e-13	6.72e-12	(B) Positive
MYOF	10q23.33	0.25	0.87	0.79	0.67	-0.62	9.61e-13	6.76e-12	(B) Positive
PPP3CB	10q22.2	0.25	0.61	0.45	0.39	-0.36	9.72e-13	6.84e-12	(B) Positive
USP19	3p21.31	-0.64	-0.19	0.56	0.54	-0.45	9.76e-13	6.86e-12	(B) Positive
VSNL1	2p24.2	-0.92	-2.29	1.76	1.45	1.37	9.91e-13	6.97e-12	(A) Negative
LRP2BP	4q35.1	-0.37	0.08	0.55	0.58	-0.45	9.96e-13	7.00e-12	(B) Positive
UGT2B7	4q13.2	-2.39	-4.09	2.22	1.56	1.70	1.00e-12	7.03e-12	(A) Negative
SHISA4	1q32.1	0.23	0.81	0.76	0.51	-0.58	1.00e-12	7.05e-12	(B) Positive
RTKN	2p13.1	0.91	0.54	0.45	0.49	0.37	1.01e-12	7.06e-12	(A) Negative
TRPM8	2q37.1	-1.32	-2.43	1.47	0.84	1.11	1.01e-12	7.08e-12	(A) Negative
FZD7	2q33.1	1.73	0.78	1.22	1.05	0.95	1.01e-12	7.08e-12	(A) Negative
ECE2	3q27.1	0.54	0.08	0.60	0.38	0.46	1.01e-12	7.09e-12	(A) Negative
AKR1B15	7q33	-0.76	-1.70	1.24	0.78	0.94	1.02e-12	7.12e-12	(A) Negative
RIPOR3	20q13.13	-1.24	-0.67	0.59	1.09	-0.57	1.03e-12	7.19e-12	(B) Positive
FAM120B	6q27	-0.06	0.36	0.52	0.51	-0.42	1.05e-12	7.33e-12	(B) Positive
GNAI1	7q21.11	0.14	-0.51	0.78	0.94	0.65	1.05e-12	7.36e-12	(A) Negative
TTC12	11q23.2	0.60	1.32	0.90	0.85	-0.71	1.06e-12	7.41e-12	(B) Positive
FIGN	2q24.3	-0.19	-1.06	1.13	0.80	0.86	1.06e-12	7.43e-12	(A) Negative
TLE6	19p13.3	-0.03	0.83	1.08	1.04	-0.86	1.07e-12	7.48e-12	(B) Positive
FBXO8	4q34.1	0.29	0.66	0.47	0.41	-0.37	1.08e-12	7.54e-12	(B) Positive
CD7	17q25.3	0.27	-0.31	0.75	0.62	0.58	1.08e-12	7.57e-12	(A) Negative
RTKN2	10q21.2	0.12	-0.60	0.92	0.80	0.72	1.09e-12	7.62e-12	(A) Negative
CRADD	12q22	-0.92	-0.46	0.59	0.57	-0.47	1.10e-12	7.66e-12	(B) Positive
CDK19	6q21	0.65	0.09	0.71	0.62	0.56	1.10e-12	7.69e-12	(A) Negative
MS4A7	11q12.2	4.28	4.85	0.70	0.69	-0.56	1.11e-12	7.73e-12	(B) Positive
WARS1	14q32.2	-0.14	-0.86	0.95	0.58	0.72	1.12e-12	7.81e-12	(A) Negative
GRAMD2A	15q23	1.91	1.12	0.97	1.07	0.79	1.12e-12	7.82e-12	(A) Negative
PRRG2	19q13.33	1.72	2.39	0.87	0.65	-0.67	1.13e-12	7.90e-12	(B) Positive
ST6GALNAC2	17q25.1	-0.52	0.55	1.35	1.27	-1.07	1.14e-12	7.92e-12	(B) Positive
FIRRM	1q24.2	-0.56	-1.09	0.69	0.60	0.54	1.15e-12	8.00e-12	(A) Negative
LIMK2	22q12.2	1.63	1.13	0.63	0.61	0.50	1.15e-12	8.02e-12	(A) Negative
CSNK2A2	16q21	-0.28	-0.66	0.47	0.48	0.38	1.18e-12	8.23e-12	(A) Negative
GDPD3	16p11.2	-1.57	-0.71	0.90	1.63	-0.86	1.19e-12	8.27e-12	(B) Positive
DTNB	2p23.3	1.52	1.03	0.63	0.54	0.49	1.20e-12	8.37e-12	(A) Negative
TYMS	18p11.32	-1.91	-2.80	1.14	1.00	0.89	1.21e-12	8.43e-12	(A) Negative
PLEKHO1	1q21.2	1.01	0.52	0.61	0.65	0.50	1.22e-12	8.48e-12	(A) Negative
SGCG	13q12.12	-2.90	-2.21	0.61	1.50	-0.68	1.23e-12	8.54e-12	(B) Positive
HHEX	10q23.33	-2.92	-2.13	0.98	1.08	-0.80	1.24e-12	8.61e-12	(B) Positive
ZBTB5	9p13.2	0.10	-0.31	0.53	0.40	0.40	1.24e-12	8.61e-12	(A) Negative
GTDC1	2q22.3	0.71	0.49	0.28	0.26	0.22	1.25e-12	8.65e-12	(A) Negative
SNX8	7p22.3	0.46	0.02	0.56	0.55	0.44	1.26e-12	8.72e-12	(A) Negative
APMAP	20p11.21	0.06	0.51	0.56	0.64	-0.46	1.26e-12	8.75e-12	(B) Positive
MBNL3	Xq26.2	-1.50	-2.13	0.80	0.71	0.63	1.27e-12	8.80e-12	(A) Negative
SLU7	5q33.3	-0.13	0.20	0.43	0.35	-0.33	1.29e-12	8.93e-12	(B) Positive
KRT23	17q21.2	1.99	0.05	2.49	2.19	1.94	1.30e-12	8.96e-12	(A) Negative
MDH1B	2q33.3	0.15	0.80	0.82	0.77	-0.65	1.30e-12	9.00e-12	(B) Positive
CEBPZ	2p22.2	-0.21	-0.52	0.40	0.32	0.31	1.31e-12	9.03e-12	(A) Negative
C21ORF58	21q22.3	-0.86	-1.33	0.59	0.53	0.46	1.33e-12	9.19e-12	(A) Negative
ZNF530	19q13.43	-0.19	0.20	0.48	0.49	-0.39	1.34e-12	9.27e-12	(B) Positive
EHD1	11q13.1	0.89	0.47	0.52	0.55	0.42	1.35e-12	9.31e-12	(A) Negative
SLC16A1	1p13.2	-1.86	-2.80	1.23	0.95	0.94	1.36e-12	9.36e-12	(A) Negative
PTPN2	18p11.21	0.00	-0.49	0.65	0.47	0.49	1.36e-12	9.36e-12	(A) Negative
KLHDC3	6p21.1	-0.16	-0.64	0.63	0.47	0.48	1.38e-12	9.48e-12	(A) Negative
ZFR	5p13.3	0.34	0.03	0.40	0.29	0.31	1.40e-12	9.62e-12	(A) Negative
KARS1	16q23.1	-0.95	-1.40	0.58	0.55	0.46	1.40e-12	9.62e-12	(A) Negative
SLURP1	8q24.3	1.32	0.58	0.96	0.74	0.74	1.42e-12	9.79e-12	(A) Negative
ZNF181	19q13.11	0.31	0.74	0.56	0.50	-0.44	1.44e-12	9.92e-12	(B) Positive
PRAME	22q11.22	-3.08	-4.44	1.73	1.66	1.36	1.48e-12	1.02e-11	(A) Negative
MCM3	6p12.2	-0.54	-1.03	0.65	0.50	0.49	1.48e-12	1.02e-11	(A) Negative
GLS	2q32.2	0.28	-0.35	0.82	0.63	0.63	1.48e-12	1.02e-11	(A) Negative
MAP10	1q42.2	1.38	0.82	0.66	0.85	0.55	1.52e-12	1.05e-11	(A) Negative
ALCAM	3q13.11	0.16	1.23	1.43	0.88	-1.08	1.56e-12	1.07e-11	(B) Positive
TCP11L1	11p13	0.29	-0.26	0.72	0.53	0.55	1.59e-12	1.09e-11	(A) Negative
SENP5	3q29	0.41	-0.07	0.61	0.54	0.47	1.59e-12	1.09e-11	(A) Negative
DESI1	22q13.2	0.49	-0.04	0.68	0.59	0.53	1.60e-12	1.10e-11	(A) Negative
DNAH14	1q42.12	-0.91	-1.53	0.81	0.65	0.62	1.61e-12	1.10e-11	(A) Negative
ARHGAP35	19q13.32	0.29	0.68	0.49	0.51	-0.39	1.61e-12	1.10e-11	(B) Positive
KRT85	12q13.13	-0.32	-0.79	0.60	0.53	0.47	1.62e-12	1.11e-11	(A) Negative
DEPDC7	11p13	-1.40	-2.23	1.07	0.92	0.83	1.63e-12	1.12e-11	(A) Negative
CBR3	21q22.12	1.17	0.42	0.93	1.06	0.75	1.63e-12	1.12e-11	(A) Negative
OGA	10q24.32	-0.60	-0.18	0.53	0.53	-0.42	1.64e-12	1.12e-11	(B) Positive
OXCT1	5p13.1	-0.46	-1.15	0.87	0.91	0.69	1.64e-12	1.12e-11	(A) Negative
PSD4	2q14.1	0.52	0.99	0.61	0.49	-0.47	1.65e-12	1.13e-11	(B) Positive
AMPH	7p14.1	0.74	1.57	1.02	1.18	-0.83	1.66e-12	1.14e-11	(B) Positive
TGM5	15q15.2	1.26	0.32	1.22	0.97	0.94	1.66e-12	1.14e-11	(A) Negative
ZNF721	4p16.3	-0.11	0.38	0.63	0.53	-0.49	1.67e-12	1.14e-11	(B) Positive
TLR9	3p21.2	-1.00	-1.52	0.67	0.59	0.52	1.68e-12	1.15e-11	(A) Negative
PEX13	2p15	1.04	0.57	0.61	0.49	0.47	1.68e-12	1.15e-11	(A) Negative
ODAD2	10p12.1	-2.78	-1.76	1.24	1.49	-1.02	1.70e-12	1.16e-11	(B) Positive
TMEM254	10q22.3	1.48	2.01	0.68	0.56	-0.53	1.70e-12	1.16e-11	(B) Positive
ELAPOR2	7q21.12	-0.59	0.40	1.29	1.08	-1.00	1.71e-12	1.17e-11	(B) Positive
EGR3	8p21.3	-0.51	0.65	1.44	1.58	-1.16	1.72e-12	1.17e-11	(B) Positive
ADGRF1	6p12.3	1.38	0.26	1.49	0.98	1.12	1.72e-12	1.17e-11	(A) Negative
NDE1	16p13.11	-0.10	0.31	0.50	0.55	-0.41	1.74e-12	1.19e-11	(B) Positive
EVA1A	2p12	-0.62	-1.36	0.96	0.83	0.74	1.75e-12	1.19e-11	(A) Negative
SERPINH1	11q13.5	0.24	-0.22	0.56	0.66	0.46	1.76e-12	1.20e-11	(A) Negative
ATF4	22q13.1	0.11	-0.30	0.53	0.50	0.41	1.76e-12	1.20e-11	(A) Negative
ACTR2	2p14	0.63	0.24	0.50	0.41	0.39	1.76e-12	1.20e-11	(A) Negative
MAD2L1	4q27	-1.50	-2.21	0.89	0.97	0.71	1.77e-12	1.20e-11	(A) Negative
RPL18A	19p13.11	0.02	-0.45	0.60	0.57	0.47	1.77e-12	1.20e-11	(A) Negative
CCDC85A	2p16.1	1.18	2.04	1.05	1.28	-0.86	1.78e-12	1.21e-11	(B) Positive
NPHP1	2q13	0.64	1.10	0.59	0.53	-0.46	1.81e-12	1.23e-11	(B) Positive
IER3	6p21.33	-0.13	0.75	1.11	1.13	-0.88	1.86e-12	1.26e-11	(B) Positive
CELSR2	1p13.3	-0.73	-0.23	0.61	0.76	-0.50	1.88e-12	1.27e-11	(B) Positive
RLBP1	15q26.1	-1.62	-3.16	2.09	0.75	1.53	1.88e-12	1.27e-11	(A) Negative
CBL	11q23.3	-0.19	-0.54	0.44	0.39	0.34	1.88e-12	1.27e-11	(A) Negative
ANXA1	9q21.13	0.22	-0.62	1.10	0.87	0.84	1.89e-12	1.28e-11	(A) Negative
TYMSOS	18p11.32	-1.12	-2.01	1.13	1.09	0.89	1.89e-12	1.28e-11	(A) Negative
DCUN1D1	3q26.33	0.71	0.36	0.45	0.40	0.35	1.90e-12	1.29e-11	(A) Negative
SNRPC	6p21.31	-0.46	-0.80	0.43	0.39	0.34	1.91e-12	1.29e-11	(A) Negative
HOMEZ	14q11.2	0.06	0.48	0.56	0.43	-0.42	1.91e-12	1.29e-11	(B) Positive
SPIB	19q13.33	0.88	0.42	0.60	0.41	0.45	1.93e-12	1.31e-11	(A) Negative
CEACAM5	19q13.2	-1.66	-0.21	1.81	1.92	-1.45	1.94e-12	1.31e-11	(B) Positive
CSNK1A1L	13q13.3	0.19	0.59	0.51	0.50	-0.40	1.95e-12	1.32e-11	(B) Positive
HACD1	10p12.33	-1.90	-3.11	1.62	1.03	1.21	1.97e-12	1.33e-11	(A) Negative
MEX3B	15q25.2	-0.15	-0.93	1.03	0.86	0.79	1.99e-12	1.34e-11	(A) Negative
PRICKLE2	3p14.1	-0.16	0.69	1.11	0.90	-0.85	2.00e-12	1.35e-11	(B) Positive
POLR1B	2q14.1	-0.26	-0.64	0.50	0.38	0.38	2.03e-12	1.37e-11	(A) Negative
STRN3	14q12	-0.10	0.41	0.67	0.51	-0.51	2.03e-12	1.37e-11	(B) Positive
GALNT7	4q34.1	0.29	1.35	1.41	0.96	-1.06	2.05e-12	1.38e-11	(B) Positive
ZSWIM6	5q12.1	-0.30	0.09	0.48	0.56	-0.39	2.05e-12	1.38e-11	(B) Positive
BCAS3	17q23.2	-1.49	-1.11	0.49	0.43	-0.38	2.06e-12	1.39e-11	(B) Positive
PPP1R18	6p21.33	0.40	-0.11	0.67	0.58	0.51	2.07e-12	1.39e-11	(A) Negative
LRRC40	1p31.1	-0.49	-0.89	0.52	0.41	0.40	2.09e-12	1.41e-11	(A) Negative
CLDN23	8p23.1	3.14	2.27	1.13	0.96	0.87	2.10e-12	1.41e-11	(A) Negative
NDUFAF3	3p21.31	-0.46	-0.07	0.50	0.52	-0.40	2.10e-12	1.41e-11	(B) Positive
CTDSPL	3p22.2	0.05	0.50	0.58	0.56	-0.45	2.12e-12	1.42e-11	(B) Positive
TCF7L2	10q25.2-q25.3	1.33	0.79	0.69	0.71	0.55	2.14e-12	1.44e-11	(A) Negative
ADGRV1	5q14.3	-1.04	-0.21	1.04	1.12	-0.83	2.15e-12	1.45e-11	(B) Positive
BAG3	10q26.11	0.38	0.91	0.66	0.74	-0.53	2.18e-12	1.46e-11	(B) Positive
SLC30A8	8q24.11	-0.84	0.31	1.28	2.12	-1.16	2.20e-12	1.48e-11	(B) Positive
SBSN	19q13.12	0.83	-0.56	1.87	0.98	1.38	2.20e-12	1.48e-11	(A) Negative
GALNT10	5q33.2	0.20	0.80	0.79	0.60	-0.60	2.24e-12	1.50e-11	(B) Positive
SCUBE1	22q13.2	0.02	0.54	0.57	0.96	-0.52	2.24e-12	1.50e-11	(B) Positive
OTUD4	4q31.21	0.29	-0.08	0.49	0.33	0.37	2.26e-12	1.52e-11	(A) Negative
DAB2IP	9q33.2	0.91	0.50	0.51	0.50	0.40	2.29e-12	1.53e-11	(A) Negative
RPGR	Xp11.4	-0.35	0.07	0.53	0.51	-0.42	2.29e-12	1.53e-11	(B) Positive
NCBP2AS2	3q29	0.28	-0.15	0.57	0.44	0.43	2.29e-12	1.53e-11	(A) Negative
CHAC1	15q15.1	-0.06	-0.41	0.44	0.42	0.35	2.29e-12	1.53e-11	(A) Negative
CTSC	11q14.2	0.30	-0.39	0.89	0.79	0.69	2.30e-12	1.54e-11	(A) Negative
NACA	12q23-q24.1	-0.22	0.11	0.42	0.36	-0.33	2.33e-12	1.56e-11	(B) Positive
UBXN6	19p13	0.40	0.73	0.43	0.38	-0.33	2.36e-12	1.58e-11	(B) Positive
SKIC8	15q25.1	-0.61	-0.27	0.43	0.44	-0.34	2.37e-12	1.58e-11	(B) Positive
ECEL1	2q37.1	0.60	-0.28	1.16	0.86	0.88	2.40e-12	1.60e-11	(A) Negative
LYPD5	19q13.31	3.48	2.77	0.94	0.71	0.71	2.42e-12	1.61e-11	(A) Negative
SULT1A2	16p11.2	-1.00	-0.40	0.78	0.65	-0.60	2.43e-12	1.62e-11	(B) Positive
DISC1	1q42.2	0.30	-0.15	0.59	0.48	0.45	2.44e-12	1.63e-11	(A) Negative
SH3GLB1	1p22.3	0.94	0.55	0.51	0.42	0.39	2.45e-12	1.63e-11	(A) Negative
RFLNA	12q24.31	2.71	1.60	1.42	1.41	1.11	2.49e-12	1.66e-11	(A) Negative
SHISA5	3p21.31	-0.16	0.22	0.50	0.42	-0.38	2.52e-12	1.68e-11	(B) Positive
MAFG	17q25.3	-0.19	-0.56	0.46	0.47	0.36	2.56e-12	1.71e-11	(A) Negative
ARFGEF3	6q23.3-q24.1	1.20	2.21	1.36	0.83	-1.01	2.57e-12	1.71e-11	(B) Positive
VIPR2	7q36.3	-1.35	-0.49	0.93	1.64	-0.86	2.60e-12	1.73e-11	(B) Positive
XPNPEP1	10q25.1	0.22	-0.13	0.45	0.42	0.35	2.60e-12	1.73e-11	(A) Negative
TNFRSF10D	8p21.3	-0.42	-0.86	0.58	0.42	0.44	2.61e-12	1.74e-11	(A) Negative
PHF21B	22q13.31	-2.14	-1.40	0.85	1.28	-0.74	2.67e-12	1.77e-11	(B) Positive
NFKBIE	6p21.1	1.23	0.65	0.78	0.56	0.58	2.67e-12	1.77e-11	(A) Negative
IL4I1	19q13.33	3.13	2.51	0.77	0.87	0.62	2.70e-12	1.79e-11	(A) Negative
IQGAP2	5q13.3	-0.94	-0.06	1.10	1.23	-0.88	2.72e-12	1.81e-11	(B) Positive
SGSM2	17p13.3	-0.88	-0.45	0.53	0.60	-0.43	2.75e-12	1.82e-11	(B) Positive
SPATA2	20q13.13	0.17	0.50	0.42	0.46	-0.33	2.78e-12	1.84e-11	(B) Positive
MDH1	2p15	-0.01	-0.39	0.50	0.39	0.38	2.80e-12	1.85e-11	(A) Negative
NAMPT	7q22.3	-0.35	-0.99	0.83	0.75	0.64	2.81e-12	1.86e-11	(A) Negative
YPEL3	16p11.2	0.45	0.90	0.57	0.57	-0.45	2.83e-12	1.87e-11	(B) Positive
NCK1	3q22.3	0.61	0.09	0.71	0.45	0.52	2.86e-12	1.89e-11	(A) Negative
GSTCD	4q24	-0.39	0.08	0.59	0.59	-0.46	2.88e-12	1.90e-11	(B) Positive
HOXB2	17q21.32	-0.16	1.09	1.61	1.49	-1.25	2.88e-12	1.91e-11	(B) Positive
ZNF528	19q13.41	-0.37	0.32	0.91	0.76	-0.69	2.94e-12	1.94e-11	(B) Positive
RCN1	11p13	0.10	-0.48	0.74	0.77	0.58	2.95e-12	1.95e-11	(A) Negative
ZNF823	19p13.2	0.23	0.75	0.68	0.60	-0.52	2.98e-12	1.97e-11	(B) Positive
PKDREJ	22q13.31	1.12	0.35	1.05	0.55	0.77	3.02e-12	2.00e-11	(A) Negative
MRPL47	3q26.33	0.40	0.02	0.50	0.39	0.38	3.05e-12	2.02e-11	(A) Negative
DIRAS1	19p13.3	0.50	-0.06	0.74	0.64	0.56	3.05e-12	2.02e-11	(A) Negative
IP6K2	3p21.31	-0.33	0.02	0.44	0.44	-0.35	3.09e-12	2.04e-11	(B) Positive
CITED1	Xq13.1	-1.40	-0.56	0.98	1.40	-0.83	3.09e-12	2.04e-11	(B) Positive
GLRB	4q32.1	-0.70	0.21	1.10	1.48	-0.92	3.10e-12	2.04e-11	(B) Positive
FBXO10	9p13.2	0.13	-0.14	0.36	0.31	0.27	3.12e-12	2.05e-11	(A) Negative
HIVEP2	6q24.2	1.13	0.65	0.61	0.65	0.48	3.19e-12	2.10e-11	(A) Negative
DHRS12	13q14.3	1.18	1.70	0.68	0.63	-0.52	3.26e-12	2.15e-11	(B) Positive
FCHO2	5q13.2	0.58	0.98	0.52	0.43	-0.39	3.27e-12	2.16e-11	(B) Positive
PSMB4	1q21.3	0.26	-0.16	0.56	0.45	0.42	3.31e-12	2.18e-11	(A) Negative
ANKS1B	12q23.1	0.92	1.50	0.71	0.88	-0.58	3.34e-12	2.20e-11	(B) Positive
COL4A6	Xq22.3	-3.08	-2.24	0.98	1.44	-0.84	3.38e-12	2.22e-11	(B) Positive
GH1	17q23.3	0.45	0.20	0.32	0.35	0.25	3.40e-12	2.24e-11	(A) Negative
CRIPAK	4p16.3	-0.76	-0.25	0.67	0.61	-0.51	3.44e-12	2.26e-11	(B) Positive
CASP8AP2	6q15	-0.22	-0.73	0.69	0.48	0.51	3.46e-12	2.27e-11	(A) Negative
ARHGEF39	9p13.3	-0.53	-0.93	0.51	0.51	0.40	3.47e-12	2.28e-11	(A) Negative
ZNF792	19q13.11	0.38	0.80	0.55	0.52	-0.42	3.60e-12	2.36e-11	(B) Positive
CIMIP1	20q13.32	0.58	1.46	0.92	1.80	-0.89	3.60e-12	2.36e-11	(B) Positive
TMEM101	17q21.31	-0.22	0.41	0.70	1.15	-0.62	3.60e-12	2.36e-11	(B) Positive
MTUS1	8p22	0.44	1.11	0.89	0.70	-0.67	3.60e-12	2.36e-11	(B) Positive
ARL15	5q11.2	0.07	0.53	0.59	0.64	-0.47	3.61e-12	2.37e-11	(B) Positive
POLR2D	2q14.3	-0.62	-1.02	0.53	0.42	0.40	3.65e-12	2.39e-11	(A) Negative
PBX4	19p13.11	-1.08	-1.82	0.94	1.00	0.74	3.67e-12	2.40e-11	(A) Negative
ATAD3B	1p36.33	-0.85	-1.32	0.62	0.48	0.46	3.73e-12	2.44e-11	(A) Negative
E4F1	16p13.3	-0.05	0.29	0.43	0.48	-0.34	3.79e-12	2.48e-11	(B) Positive
SMIM8	6q15	0.15	-0.30	0.59	0.52	0.45	3.81e-12	2.49e-11	(A) Negative
CSTPP1	11p11.2	-0.09	0.27	0.47	0.44	-0.36	3.84e-12	2.51e-11	(B) Positive
TRIM43	2q11.1	1.27	-0.20	2.02	0.96	1.47	3.86e-12	2.52e-11	(A) Negative
ULBP3	6q25.1	0.12	-0.40	0.69	0.51	0.52	3.88e-12	2.53e-11	(A) Negative
STMN3	20q13.33	-1.51	-0.82	0.87	1.02	-0.69	3.89e-12	2.54e-11	(B) Positive
HSPA2	14q23.3	0.88	1.65	0.98	1.09	-0.77	3.95e-12	2.58e-11	(B) Positive
DHCR7	11q13.4	-0.05	-0.71	0.82	0.93	0.65	3.97e-12	2.59e-11	(A) Negative
FIGNL1	7p12.2	-0.19	-0.69	0.67	0.53	0.50	3.97e-12	2.59e-11	(A) Negative
NAA11	4q21.21	0.16	-0.22	0.50	0.44	0.38	4.02e-12	2.62e-11	(A) Negative
CGA	6q14.3	-3.56	-2.74	0.80	1.75	-0.82	4.03e-12	2.63e-11	(B) Positive
KHSRP	19p13.3	-0.22	-0.63	0.54	0.43	0.40	4.04e-12	2.64e-11	(A) Negative
PAIP2	5q31.2	-0.29	0.16	0.58	0.55	-0.44	4.11e-12	2.68e-11	(B) Positive
CALR	19p13.13	0.46	-0.00	0.61	0.52	0.46	4.12e-12	2.68e-11	(A) Negative
NEK2	1q32.3	-0.39	-1.06	0.81	1.06	0.67	4.15e-12	2.70e-11	(A) Negative
ZFYVE27	10q24.2	-0.36	0.01	0.47	0.47	-0.37	4.16e-12	2.71e-11	(B) Positive
POU2AF1	11q23.1	-1.22	-2.61	1.79	1.81	1.39	4.19e-12	2.72e-11	(A) Negative
IGF2BP2	3q27.2	-1.84	-2.78	1.30	0.66	0.95	4.19e-12	2.72e-11	(A) Negative
ZRSR2P1	5q22.2	0.18	0.51	0.43	0.42	-0.33	4.20e-12	2.73e-11	(B) Positive
L3MBTL4	18p11.31	1.00	0.16	1.14	0.72	0.84	4.31e-12	2.80e-11	(A) Negative
MPG	16p13.3	-0.14	0.26	0.52	0.43	-0.39	4.32e-12	2.80e-11	(B) Positive
SNTB1	8q24.12	-0.54	-1.43	1.20	0.90	0.89	4.40e-12	2.85e-11	(A) Negative
COL4A4	2q36.3	0.37	-0.69	1.40	1.21	1.06	4.41e-12	2.86e-11	(A) Negative
RND3	2q23.3	-0.16	-0.97	1.04	1.11	0.81	4.41e-12	2.86e-11	(A) Negative
TOX3	16q12.1	-0.17	1.43	2.15	1.60	-1.60	4.53e-12	2.94e-11	(B) Positive
STK40	1p34.3	-0.03	-0.42	0.50	0.52	0.39	4.53e-12	2.94e-11	(A) Negative
CTSG	14q12	-2.12	-1.19	1.12	1.49	-0.92	4.62e-12	2.99e-11	(B) Positive
SEH1L	18p11.21	-0.00	-0.46	0.62	0.48	0.46	4.63e-12	3.00e-11	(A) Negative
DDB2	11p11.2	-1.58	-1.16	0.56	0.54	-0.43	4.64e-12	3.00e-11	(B) Positive
PPP1CB	2p23.2	0.98	0.55	0.59	0.47	0.44	4.66e-12	3.01e-11	(A) Negative
ZW10	11q23.2	-0.56	-1.00	0.58	0.48	0.44	4.66e-12	3.01e-11	(A) Negative
SUPT5H	19q13.2	0.53	0.21	0.43	0.32	0.32	4.66e-12	3.02e-11	(A) Negative
S100A3	1q21.3	-0.28	-0.91	0.85	0.57	0.63	4.68e-12	3.03e-11	(A) Negative
ITGA6	2q31.1	1.01	-0.00	1.36	0.96	1.01	4.71e-12	3.05e-11	(A) Negative
ABCD3	1p21.3	0.01	0.52	0.65	0.75	-0.51	4.73e-12	3.06e-11	(B) Positive
ME1	6q14.2	-0.33	-1.12	0.97	1.20	0.79	4.75e-12	3.07e-11	(A) Negative
CENPP	9q22.31	-0.76	-0.27	0.60	0.78	-0.49	4.76e-12	3.07e-11	(B) Positive
MIR-16-1/16		0.21	0.60	0.52	0.44	-0.39	4.76e-12	3.07e-11	(B) Positive
MIR-16-13/16		0.21	0.60	0.52	0.44	-0.39	4.76e-12	3.07e-11	(B) Positive
MIR-16-2/16		0.21	0.60	0.52	0.44	-0.39	4.76e-12	3.07e-11	(B) Positive
MIR-16/16		0.21	0.60	0.52	0.44	-0.39	4.76e-12	3.07e-11	(B) Positive
MIR-16/3P		0.21	0.60	0.52	0.44	-0.39	4.76e-12	3.07e-11	(B) Positive
MIR-16/5P		0.21	0.60	0.52	0.44	-0.39	4.76e-12	3.07e-11	(B) Positive
GNB1L	22q11.21	-0.66	-1.13	0.61	0.64	0.47	4.86e-12	3.13e-11	(A) Negative
CCKBR	11p15.4	-0.49	-2.01	2.12	0.80	1.52	4.86e-12	3.13e-11	(A) Negative
NRG2	5q31.2	0.21	-0.73	1.28	0.89	0.94	4.91e-12	3.16e-11	(A) Negative
THBD	20p11.21	1.25	1.96	0.90	0.99	-0.71	4.91e-12	3.16e-11	(B) Positive
MDM1	12q15	-0.07	0.40	0.61	0.58	-0.47	4.93e-12	3.17e-11	(B) Positive
STXBP2	19p13.2	0.18	0.63	0.59	0.57	-0.45	5.11e-12	3.28e-11	(B) Positive
MPI	15q24.1	-1.29	-0.94	0.46	0.43	-0.35	5.12e-12	3.29e-11	(B) Positive
C3ORF62	3p21.31	-0.16	0.22	0.51	0.47	-0.39	5.22e-12	3.36e-11	(B) Positive
ABCG2	4q22.1	-2.82	-2.27	0.69	0.82	-0.55	5.24e-12	3.37e-11	(B) Positive
PDK2	17q21.33	0.01	0.54	0.71	0.61	-0.53	5.28e-12	3.39e-11	(B) Positive
SLC30A5	5q13.1-q13.2	-0.28	0.07	0.47	0.43	-0.35	5.30e-12	3.40e-11	(B) Positive
ECM1	1q21.2	0.09	1.01	1.16	1.31	-0.92	5.30e-12	3.40e-11	(B) Positive
TAF5	10q24.33	-0.41	-0.90	0.65	0.51	0.48	5.31e-12	3.40e-11	(A) Negative
PLAUR	19q13	0.09	-0.53	0.80	0.82	0.62	5.31e-12	3.40e-11	(A) Negative
SLC35A3	1p21.2	0.32	0.79	0.61	0.60	-0.47	5.31e-12	3.40e-11	(B) Positive
TTC16	9q34.11	0.36	0.93	0.73	0.78	-0.57	5.37e-12	3.44e-11	(B) Positive
WDR62	19q13.12	-0.76	-1.20	0.57	0.58	0.44	5.37e-12	3.44e-11	(A) Negative
ICE2	15q22.2	-0.75	-0.44	0.40	0.45	-0.31	5.42e-12	3.47e-11	(B) Positive
BLCAP	20q11.23	0.45	0.83	0.50	0.46	-0.38	5.43e-12	3.47e-11	(B) Positive
EPCAM	2p21	1.87	1.28	0.78	0.72	0.59	5.47e-12	3.50e-11	(A) Negative
MED29	19q13.2	0.61	0.92	0.40	0.37	-0.30	5.51e-12	3.52e-11	(B) Positive
PLAAT4	11q12.3	1.86	2.69	1.12	0.82	-0.83	5.56e-12	3.55e-11	(B) Positive
CCDC83	11q14.1-q14.2	-1.88	-1.12	0.98	1.03	-0.76	5.61e-12	3.58e-11	(B) Positive
SPDL1	5q35.1	-1.30	-1.74	0.57	0.52	0.43	5.64e-12	3.60e-11	(A) Negative
DCAF5	14q24.1	0.20	0.56	0.48	0.38	-0.36	5.67e-12	3.62e-11	(B) Positive
EIF4EBP1	8p11.23	-0.16	-0.85	0.91	0.87	0.70	5.72e-12	3.65e-11	(A) Negative
DDIT4	10q22.1	-0.14	-0.81	0.87	0.85	0.67	5.78e-12	3.68e-11	(A) Negative
H4C5	6p22.2	0.03	-0.41	0.55	0.62	0.44	5.79e-12	3.69e-11	(A) Negative
FFAR2	19q13.12	0.43	0.88	0.54	0.75	-0.45	5.80e-12	3.70e-11	(B) Positive
GNG3	11q12.3	-0.30	0.06	0.39	0.72	-0.36	5.87e-12	3.74e-11	(B) Positive
KLHL24	3q27.1	1.25	0.82	0.56	0.50	0.43	5.95e-12	3.79e-11	(A) Negative
RNF135	17q11.2	1.02	1.45	0.58	0.46	-0.43	5.97e-12	3.80e-11	(B) Positive
CAMK2B	7p13	-0.11	0.86	1.24	1.39	-0.97	6.03e-12	3.84e-11	(B) Positive
ZNF154	19q13.43	-0.08	0.35	0.56	0.55	-0.43	6.04e-12	3.84e-11	(B) Positive
PHF6	Xq26.2	0.29	-0.20	0.65	0.59	0.49	6.06e-12	3.85e-11	(A) Negative
ALDOAP2	10q26.13	-0.83	-0.27	0.73	0.72	-0.56	6.13e-12	3.90e-11	(B) Positive
NEIL1	15q24.2	0.16	0.84	0.89	0.86	-0.68	6.28e-12	3.99e-11	(B) Positive
GOLM2	15q15.3	0.84	1.30	0.61	0.51	-0.46	6.34e-12	4.02e-11	(B) Positive
SPIN4	Xq11.1	0.13	-0.41	0.73	0.51	0.54	6.62e-12	4.20e-11	(A) Negative
RHOC	1p13.2	0.44	0.86	0.55	0.48	-0.42	6.68e-12	4.24e-11	(B) Positive
IQCK	16p12.3	0.89	1.38	0.63	0.68	-0.49	6.73e-12	4.27e-11	(B) Positive
KRT19	17q21.2	1.51	2.39	1.17	0.99	-0.88	6.73e-12	4.27e-11	(B) Positive
ABRAXAS1	4q21.23	-0.55	-0.07	0.65	0.54	-0.49	6.77e-12	4.29e-11	(B) Positive
ASPA	17p13.2	0.45	1.19	0.95	1.05	-0.74	6.80e-12	4.31e-11	(B) Positive
SMPX	Xp22.12	-0.96	-2.24	1.77	1.04	1.28	6.82e-12	4.32e-11	(A) Negative
LRRC27	10q26.3	1.12	1.60	0.66	0.51	-0.49	6.87e-12	4.35e-11	(B) Positive
NPTN	15q24.1	0.49	0.96	0.61	0.59	-0.46	6.95e-12	4.40e-11	(B) Positive
USP1	1p31.3	-0.26	-0.94	0.94	0.57	0.68	7.03e-12	4.45e-11	(A) Negative
SRM	1p36.22	-0.80	-1.13	0.44	0.47	0.34	7.07e-12	4.47e-11	(A) Negative
RASGRF1	15q25.1	-0.13	-0.90	1.05	0.74	0.77	7.11e-12	4.49e-11	(A) Negative
NOXA1	9q34.3	-0.18	0.52	0.95	0.73	-0.70	7.25e-12	4.58e-11	(B) Positive
SLC7A6	16q22.1	-0.37	-0.68	0.41	0.41	0.32	7.30e-12	4.62e-11	(A) Negative
LOXL4	10q24.2	0.27	-0.82	1.51	0.80	1.09	7.31e-12	4.62e-11	(A) Negative
ODF2L	1p22.3	1.02	0.56	0.60	0.57	0.46	7.39e-12	4.67e-11	(A) Negative
UBE2K	4p14	-0.05	0.27	0.42	0.43	-0.32	7.41e-12	4.68e-11	(B) Positive
CRNKL1	20p11.23	0.29	0.73	0.59	0.51	-0.44	7.42e-12	4.68e-11	(B) Positive
TNFAIP3	6q23.3	0.69	0.10	0.78	0.77	0.59	7.44e-12	4.69e-11	(A) Negative
USP40	2q37.1	0.08	0.47	0.53	0.43	-0.39	7.50e-12	4.73e-11	(B) Positive
RASSF9	12q21.31	-1.56	-2.58	1.40	0.99	1.03	7.65e-12	4.82e-11	(A) Negative
DNAI4	1p31.3	1.46	2.21	0.98	0.99	-0.75	7.74e-12	4.87e-11	(B) Positive
SYNJ2BP	14q24.2	0.07	0.58	0.68	0.65	-0.51	7.81e-12	4.92e-11	(B) Positive
FUT4	11q21	0.26	-0.29	0.75	0.54	0.55	7.97e-12	5.02e-11	(A) Negative
ZNF772	19q13.43	0.41	1.06	0.85	0.89	-0.65	8.02e-12	5.05e-11	(B) Positive
CAMK1D	10p13	0.63	-0.08	0.96	0.83	0.72	8.02e-12	5.05e-11	(A) Negative
UQCRQ	5q31.1	-0.19	0.38	0.77	0.65	-0.57	8.08e-12	5.08e-11	(B) Positive
AHCYL1	1p13.3	-0.06	0.25	0.39	0.46	-0.31	8.13e-12	5.11e-11	(B) Positive
ATP6V0C	16p13.3	0.36	0.75	0.53	0.47	-0.39	8.13e-12	5.11e-11	(B) Positive
CLIC4	1p36.11	0.17	-0.36	0.69	0.68	0.53	8.16e-12	5.13e-11	(A) Negative
SLC44A1	9q31.1-q31.2	0.43	0.87	0.58	0.60	-0.44	8.21e-12	5.15e-11	(B) Positive
TMEM178A	2p22.1	-0.77	-0.15	0.81	0.85	-0.62	8.24e-12	5.17e-11	(B) Positive
PRDX3	10q26.11	-0.54	-0.02	0.70	0.62	-0.52	8.25e-12	5.18e-11	(B) Positive
MRS2	6p22.3	0.01	-0.42	0.57	0.50	0.42	8.26e-12	5.18e-11	(A) Negative
MTERF3	8q22.1	0.18	-0.29	0.61	0.69	0.47	8.32e-12	5.21e-11	(A) Negative
ZC3H6	2q14.1	0.38	0.88	0.65	0.72	-0.51	8.43e-12	5.28e-11	(B) Positive
GALNT13	2q23.3-q24.1	0.31	-0.91	1.71	0.93	1.22	8.43e-12	5.28e-11	(A) Negative
VRK1	14q32.2	-1.02	-1.48	0.63	0.52	0.47	8.45e-12	5.29e-11	(A) Negative
YARS1	1p35.1	-0.76	-1.14	0.50	0.47	0.38	8.46e-12	5.30e-11	(A) Negative
CLASP2	3p22.3	-0.38	-0.08	0.39	0.40	-0.30	8.65e-12	5.42e-11	(B) Positive
MRPL9	1q21.3	0.21	-0.17	0.52	0.42	0.38	8.67e-12	5.42e-11	(A) Negative
NDUFAF7	2p22.2	-0.26	-0.65	0.52	0.42	0.39	8.75e-12	5.47e-11	(A) Negative
OPA1	3q29	0.03	-0.32	0.47	0.34	0.34	8.81e-12	5.51e-11	(A) Negative
BCL11B	14q32.2	-1.84	-2.79	1.26	1.21	0.95	8.81e-12	5.51e-11	(A) Negative
GDI2	10p15.1	0.73	0.31	0.57	0.42	0.42	8.85e-12	5.53e-11	(A) Negative
GNMT	6p21.1	0.03	0.95	1.21	1.19	-0.92	8.88e-12	5.55e-11	(B) Positive
TCF20	22q13.2	0.63	0.09	0.75	0.48	0.54	8.90e-12	5.55e-11	(A) Negative
SH3D21	1p34.3	-0.36	0.24	0.78	0.85	-0.60	8.91e-12	5.56e-11	(B) Positive
ZNF548	19q13.43	0.10	0.48	0.51	0.43	-0.38	9.02e-12	5.63e-11	(B) Positive
PABPC1	8q22.3	0.49	-0.07	0.75	0.67	0.56	9.05e-12	5.64e-11	(A) Negative
RUBCNL	13q14.13	0.75	0.04	0.97	0.73	0.71	9.09e-12	5.67e-11	(A) Negative
GLDN	15q21.2	-0.66	0.32	1.29	1.27	-0.98	9.12e-12	5.68e-11	(B) Positive
SHISA2	13q12.13	-0.68	0.57	1.55	2.00	-1.25	9.14e-12	5.69e-11	(B) Positive
MBOAT7	19q13.42	-0.02	0.36	0.47	0.60	-0.38	9.18e-12	5.71e-11	(B) Positive
COCH	14q12	-2.26	-3.79	2.10	1.50	1.53	9.21e-12	5.73e-11	(A) Negative
CTRL	16q22.1	-0.46	-0.76	0.40	0.36	0.30	9.23e-12	5.74e-11	(A) Negative
MPP7	10p12.1	0.67	1.64	1.32	1.02	-0.97	9.37e-12	5.83e-11	(B) Positive
GJB6	13q12.11	1.31	0.39	1.28	0.79	0.92	9.43e-12	5.86e-11	(A) Negative
RIOK3	18q11.2	0.24	-0.14	0.52	0.44	0.39	9.47e-12	5.89e-11	(A) Negative
AFF4	5q31.1	-0.10	0.23	0.45	0.40	-0.33	9.53e-12	5.92e-11	(B) Positive
SNX25	4q35.1	-0.54	-0.02	0.69	0.65	-0.52	9.55e-12	5.93e-11	(B) Positive
LYG1	2q11.2	-0.34	-0.98	0.85	0.80	0.64	9.59e-12	5.95e-11	(A) Negative
FLOT1	6p21.33	-0.42	-0.00	0.56	0.53	-0.42	9.72e-12	6.03e-11	(B) Positive
SCMH1	1p34.2	0.46	0.04	0.56	0.53	0.42	9.72e-12	6.03e-11	(A) Negative
HOXD8	2q31.1	0.60	1.43	1.06	1.23	-0.83	9.78e-12	6.07e-11	(B) Positive
BNIP2	15q22.2	-0.06	-0.46	0.52	0.52	0.40	9.80e-12	6.08e-11	(A) Negative
GAS2L3	12q23.1	-0.11	-0.60	0.66	0.58	0.49	9.84e-12	6.10e-11	(A) Negative
S100A1	1q21.3	0.57	-0.23	1.10	0.77	0.80	9.85e-12	6.10e-11	(A) Negative
LINC00324	17p13.1	1.25	1.74	0.62	0.78	-0.49	9.98e-12	6.18e-11	(B) Positive
MTF2	1p22.1	-0.47	-0.90	0.56	0.56	0.42	9.98e-12	6.18e-11	(A) Negative
VPREB3	22q11.23	1.28	0.66	0.86	0.65	0.63	1.00e-11	6.19e-11	(A) Negative
DHRS4	14q11.2	-0.21	0.24	0.61	0.49	-0.45	1.00e-11	6.21e-11	(B) Positive
METTL8	2q31.1	0.15	-0.32	0.65	0.50	0.47	1.00e-11	6.21e-11	(A) Negative
RFC2	7q11.23	-0.47	-0.91	0.60	0.48	0.44	1.01e-11	6.23e-11	(A) Negative
PCDHB10	5q31.3	1.56	0.75	1.05	1.13	0.81	1.01e-11	6.24e-11	(A) Negative
NUDT1	7p22.3	-0.48	-0.85	0.48	0.49	0.37	1.02e-11	6.29e-11	(A) Negative
MFHAS1	8p23.1	-0.31	-0.87	0.75	0.70	0.56	1.03e-11	6.35e-11	(A) Negative
PCLO	7q21.11	0.69	1.40	0.96	0.85	-0.71	1.03e-11	6.36e-11	(B) Positive
PBLD	10q21.3	0.66	1.17	0.69	0.59	-0.51	1.03e-11	6.37e-11	(B) Positive
DDA1	19p13.11	0.32	-0.01	0.43	0.43	0.32	1.05e-11	6.49e-11	(A) Negative
DCLK2	4q31.23-q31.3	-0.16	-0.63	0.65	0.49	0.47	1.05e-11	6.50e-11	(A) Negative
ATP10B	5q34	-0.67	-1.14	0.63	0.54	0.47	1.06e-11	6.55e-11	(A) Negative
VPS13B	8q22.2	0.09	0.43	0.43	0.49	-0.34	1.07e-11	6.57e-11	(B) Positive
SMC5	9q21.12	-0.13	-0.53	0.53	0.45	0.39	1.09e-11	6.70e-11	(A) Negative
NOL9	1p36.31	-0.41	-0.86	0.61	0.41	0.44	1.09e-11	6.70e-11	(A) Negative
SLC29A4	7p22.1	-0.12	-0.63	0.71	0.48	0.51	1.09e-11	6.71e-11	(A) Negative
SESN1	6q21	-0.11	0.51	0.83	0.78	-0.62	1.10e-11	6.77e-11	(B) Positive
UPF2	10p14	0.59	0.09	0.69	0.53	0.50	1.10e-11	6.77e-11	(A) Negative
TMEM87A	15q15.1	0.39	0.74	0.47	0.46	-0.36	1.12e-11	6.86e-11	(B) Positive
SNX22	15q22.31	1.01	0.58	0.59	0.47	0.43	1.12e-11	6.88e-11	(A) Negative
HDAC4	2q37.3	-0.81	-1.17	0.49	0.41	0.36	1.13e-11	6.96e-11	(A) Negative
ZNF750	17q25.3	2.19	1.19	1.31	1.30	0.99	1.14e-11	7.03e-11	(A) Negative
MTREX	5q11.2	-1.05	-0.70	0.47	0.42	-0.35	1.16e-11	7.12e-11	(B) Positive
LEF1	4q25	-2.23	-1.59	0.79	1.06	-0.64	1.17e-11	7.19e-11	(B) Positive
MKRN3	15q11.2	-1.19	-2.05	1.19	0.88	0.87	1.17e-11	7.19e-11	(A) Negative
ACTL8	1p36.13	-1.14	-2.86	2.41	1.35	1.72	1.18e-11	7.24e-11	(A) Negative
ERLIN2	8p11.23	0.52	1.10	0.73	0.93	-0.58	1.19e-11	7.30e-11	(B) Positive
NRBF2	10q21.3	0.42	0.03	0.53	0.43	0.39	1.19e-11	7.31e-11	(A) Negative
RIF1	2q23.3	0.01	-0.44	0.63	0.48	0.46	1.22e-11	7.47e-11	(A) Negative
RAB31	18p11.22	-0.02	0.78	1.04	1.16	-0.81	1.22e-11	7.48e-11	(B) Positive
PCGF2	17q12	0.01	0.46	0.59	0.58	-0.44	1.23e-11	7.54e-11	(B) Positive
PIK3IP1	22q12.2	1.59	2.14	0.76	0.59	-0.55	1.23e-11	7.56e-11	(B) Positive
SYDE2	1p22.3	0.50	1.32	1.10	1.06	-0.83	1.25e-11	7.66e-11	(B) Positive
AMFR	16q13	0.30	0.90	0.75	0.92	-0.59	1.26e-11	7.68e-11	(B) Positive
TIMP3	22q12.3	1.12	1.89	1.05	0.87	-0.77	1.26e-11	7.70e-11	(B) Positive
IRX5	16q12.2	2.46	3.17	0.97	0.73	-0.71	1.27e-11	7.74e-11	(B) Positive
GFER	16p13.3	0.01	0.51	0.68	0.57	-0.50	1.27e-11	7.74e-11	(B) Positive
SERPINE2	2q36.1	-3.40	-4.26	1.19	0.87	0.86	1.27e-11	7.75e-11	(A) Negative
ST20	15q25.1	-0.07	-0.64	0.78	0.60	0.57	1.28e-11	7.83e-11	(A) Negative
YIPF1	1p32.3	0.87	1.30	0.59	0.52	-0.43	1.30e-11	7.94e-11	(B) Positive
CDC42EP3	2p22.2	0.42	-0.27	0.92	0.87	0.69	1.30e-11	7.95e-11	(A) Negative
GPR37	7q31.33	0.56	-0.31	1.15	1.14	0.86	1.31e-11	8.00e-11	(A) Negative
MLH3	14q24.3	0.40	0.75	0.46	0.45	-0.35	1.31e-11	8.00e-11	(B) Positive
NLRP7	19q13.42	-1.80	-3.02	1.72	1.02	1.22	1.32e-11	8.02e-11	(A) Negative
TP53I3	2p23.3	0.35	-0.15	0.67	0.66	0.50	1.33e-11	8.08e-11	(A) Negative
FUZ	19q13.33	-0.11	0.30	0.54	0.50	-0.40	1.33e-11	8.09e-11	(B) Positive
CSF2	5q31.1	-0.61	-1.34	1.00	0.69	0.72	1.33e-11	8.10e-11	(A) Negative
RBM39	20q11.22	-0.11	0.15	0.35	0.32	-0.26	1.35e-11	8.22e-11	(B) Positive
FAM13B	5q31.2	-0.45	0.01	0.62	0.57	-0.46	1.36e-11	8.30e-11	(B) Positive
SERBP1	1p31.3	0.07	-0.31	0.53	0.41	0.38	1.37e-11	8.35e-11	(A) Negative
KBTBD12	3q21.3	1.49	0.35	1.63	0.58	1.14	1.37e-11	8.36e-11	(A) Negative
BMI1	10p12.2	0.64	1.16	0.67	0.77	-0.52	1.38e-11	8.37e-11	(B) Positive
HDGF	1q23.1	0.34	-0.21	0.75	0.62	0.55	1.38e-11	8.40e-11	(A) Negative
NKRF	Xq24	-0.38	-0.77	0.53	0.41	0.39	1.38e-11	8.40e-11	(A) Negative
ZNF175	19q13.41	-1.11	-0.44	0.92	0.77	-0.67	1.43e-11	8.66e-11	(B) Positive
PDPK1	16p13.3	0.19	0.55	0.48	0.46	-0.36	1.43e-11	8.67e-11	(B) Positive
KHNYN	14q12	-0.28	0.03	0.42	0.41	-0.32	1.43e-11	8.69e-11	(B) Positive
PINX1	8p23.1	-0.52	-0.91	0.53	0.43	0.39	1.43e-11	8.70e-11	(A) Negative
MCCD1	6p21.33	0.42	1.03	0.69	1.18	-0.61	1.45e-11	8.79e-11	(B) Positive
TBCA	5q14.1	-0.75	-0.38	0.50	0.47	-0.37	1.46e-11	8.86e-11	(B) Positive
MAOA	Xp11.3	-0.76	0.22	1.25	1.52	-0.98	1.48e-11	8.95e-11	(B) Positive
STARD13	13q13.1	0.35	0.79	0.56	0.65	-0.44	1.48e-11	8.95e-11	(B) Positive
MVP	16p11.2	0.20	0.81	0.85	0.58	-0.61	1.49e-11	8.99e-11	(B) Positive
TIPIN	15q22.31	-1.30	-1.79	0.67	0.54	0.49	1.51e-11	9.11e-11	(A) Negative
MIER3	5q11.2	-0.17	0.24	0.53	0.55	-0.40	1.51e-11	9.11e-11	(B) Positive
TNFRSF11A	18q21.33	0.26	-0.38	0.89	0.61	0.64	1.52e-11	9.18e-11	(A) Negative
PLA2G7	6p12.3	4.01	3.06	1.24	1.37	0.95	1.54e-11	9.28e-11	(A) Negative
TULP1	6p21.31	0.14	-0.12	0.35	0.33	0.26	1.54e-11	9.32e-11	(A) Negative
PCNX1	14q24.2	0.17	-0.16	0.43	0.45	0.33	1.55e-11	9.34e-11	(A) Negative
EPB41L4A-AS1	5q22.1	-1.25	-0.67	0.78	0.72	-0.58	1.55e-11	9.34e-11	(B) Positive
B3GNT8	19q13.2	1.78	2.37	0.81	0.64	-0.59	1.55e-11	9.37e-11	(B) Positive
LMAN2	5q35.3	-0.17	0.23	0.53	0.53	-0.40	1.56e-11	9.41e-11	(B) Positive
TM7SF2	11q13.1	-0.90	-0.04	1.18	0.92	-0.86	1.56e-11	9.42e-11	(B) Positive
LIX1L	1q21.1	-0.79	-1.30	0.68	0.61	0.50	1.57e-11	9.50e-11	(A) Negative
RTF1	15q15.1	-0.13	0.13	0.35	0.35	-0.26	1.58e-11	9.53e-11	(B) Positive
RNF40	16p11.2	0.02	0.31	0.37	0.42	-0.29	1.59e-11	9.57e-11	(B) Positive
MAPK1	22q11.22	-0.46	-0.84	0.50	0.47	0.37	1.60e-11	9.64e-11	(A) Negative
TMPRSS5	11q23.2	-0.45	-1.40	1.36	0.61	0.95	1.60e-11	9.64e-11	(A) Negative
TBC1D12	10q23.33	0.43	0.79	0.46	0.57	-0.36	1.60e-11	9.65e-11	(B) Positive
ABCA13	7p12.3	0.87	-0.16	1.47	0.77	1.04	1.63e-11	9.80e-11	(A) Negative
YTHDC2	5q22.2	-0.25	0.22	0.62	0.60	-0.46	1.64e-11	9.86e-11	(B) Positive
QRICH1	3p21.31	-0.21	0.04	0.33	0.30	-0.25	1.65e-11	9.91e-11	(B) Positive
THAP6	4q21.1	0.00	0.46	0.61	0.58	-0.45	1.66e-11	9.96e-11	(B) Positive
MSH2	2p21-p16.3	-0.67	-1.23	0.79	0.50	0.56	1.67e-11	1.00e-10	(A) Negative
N6AMT1	21q21.3	-0.08	0.35	0.56	0.60	-0.43	1.67e-11	1.00e-10	(B) Positive
ATPAF2	17p11.2	-0.00	0.38	0.51	0.52	-0.38	1.70e-11	1.02e-10	(B) Positive
PLPP5	8p11.23	0.08	0.70	0.79	1.01	-0.62	1.72e-11	1.03e-10	(B) Positive
ZNF497	19q13.43	-0.20	0.29	0.68	0.54	-0.49	1.73e-11	1.04e-10	(B) Positive
PGM1	1p31.3	-0.48	-1.04	0.78	0.61	0.56	1.74e-11	1.04e-10	(A) Negative
HUWE1	Xp11.22	0.34	0.09	0.36	0.29	0.26	1.74e-11	1.04e-10	(A) Negative
ETV5	3q27.2	-0.95	-1.74	1.10	0.71	0.79	1.74e-11	1.05e-10	(A) Negative
NUP88	17p13.2	-0.39	-0.75	0.48	0.49	0.36	1.77e-11	1.06e-10	(A) Negative
TMC5	16p12.3	1.40	2.76	1.90	1.33	-1.36	1.78e-11	1.07e-10	(B) Positive
GRTP1	13q34	0.09	0.73	0.88	0.76	-0.64	1.80e-11	1.08e-10	(B) Positive
PTPN13	4q21.3	-0.39	0.44	1.08	1.21	-0.83	1.80e-11	1.08e-10	(B) Positive
PSMF1	20p13	0.15	0.45	0.41	0.39	-0.31	1.80e-11	1.08e-10	(B) Positive
CXCL16	17p13.2	1.35	0.83	0.72	0.47	0.51	1.81e-11	1.08e-10	(A) Negative
TMEM116	12q24.13	-0.34	0.20	0.75	0.62	-0.55	1.82e-11	1.09e-10	(B) Positive
NEGR1	1p31.1	-0.07	0.39	0.58	0.78	-0.46	1.83e-11	1.09e-10	(B) Positive
PRKCQ	10p15.1	-1.23	-2.03	1.12	0.88	0.81	1.83e-11	1.10e-10	(A) Negative
CALML5	10p15.1	2.07	0.27	2.42	2.42	1.81	1.86e-11	1.11e-10	(A) Negative
MCM2	3q21.3	-0.79	-1.32	0.73	0.65	0.53	1.86e-11	1.11e-10	(A) Negative
CYP4F12	19p13.12	-1.58	-0.95	0.82	0.94	-0.63	1.86e-11	1.11e-10	(B) Positive
NPY1R	4q32.2	-1.46	0.67	2.74	3.28	-2.13	1.86e-11	1.11e-10	(B) Positive
CCPG1	15q21.3	-0.04	0.31	0.48	0.40	-0.35	1.87e-11	1.11e-10	(B) Positive
F2RL2	5q13.3	-0.43	0.41	1.12	1.15	-0.84	1.88e-11	1.12e-10	(B) Positive
TCTA	3p21.31	0.75	1.12	0.51	0.47	-0.38	1.90e-11	1.13e-10	(B) Positive
ABCC10	6p21.1	0.08	-0.27	0.47	0.45	0.35	1.91e-11	1.14e-10	(A) Negative
SELENOP	5p12	-0.25	0.49	1.02	0.83	-0.74	1.92e-11	1.14e-10	(B) Positive
LIN54	4q21.22	-0.17	-0.60	0.60	0.44	0.43	1.92e-11	1.15e-10	(A) Negative
TRMO	9q22.33	0.15	0.57	0.58	0.46	-0.42	1.94e-11	1.15e-10	(B) Positive
PPM1F	22q11.22	-0.31	-0.73	0.55	0.56	0.41	1.94e-11	1.15e-10	(A) Negative
PITPNB	22q12.1	0.29	-0.08	0.50	0.49	0.37	1.94e-11	1.15e-10	(A) Negative
SHROOM2	Xp22.2	-0.03	0.71	1.02	0.80	-0.74	1.94e-11	1.15e-10	(B) Positive
DPH3	3p25.1	-0.87	-1.37	0.69	0.57	0.50	1.96e-11	1.17e-10	(A) Negative
C19ORF12	19q12	0.65	0.20	0.62	0.47	0.45	1.99e-11	1.18e-10	(A) Negative
CLEC4D	12p13.31	-0.36	-1.39	1.42	1.21	1.04	2.00e-11	1.19e-10	(A) Negative
TNNT2	1q32.1	-0.44	-1.19	1.02	0.85	0.74	2.01e-11	1.19e-10	(A) Negative
RPS19BP1	22q13.1	0.36	-0.00	0.50	0.42	0.36	2.03e-11	1.21e-10	(A) Negative
GAPDH	12p13.31	-0.64	-1.16	0.72	0.56	0.52	2.04e-11	1.21e-10	(A) Negative
MST1	3p21.31	-3.18	-2.83	0.43	0.57	-0.34	2.04e-11	1.21e-10	(B) Positive
NLN	5q12.3	-0.29	-0.65	0.50	0.42	0.36	2.05e-11	1.22e-10	(A) Negative
FHL3	1p34.3	-0.14	-0.54	0.53	0.56	0.40	2.06e-11	1.22e-10	(A) Negative
TRPS1	8q23.3	3.43	4.15	0.96	0.94	-0.71	2.08e-11	1.23e-10	(B) Positive
ZNF280A	22q11.22	-2.80	-3.49	0.97	0.63	0.68	2.10e-11	1.24e-10	(A) Negative
KANK2	19p13.2	-0.86	-0.38	0.66	0.56	-0.48	2.12e-11	1.25e-10	(B) Positive
HSD3B7	16p11.2	-0.01	0.43	0.58	0.62	-0.44	2.15e-11	1.27e-10	(B) Positive
CRIPT	2p21	0.10	-0.34	0.62	0.47	0.44	2.15e-11	1.28e-10	(A) Negative
NAA50	3q13.31	-0.14	-0.51	0.51	0.43	0.37	2.16e-11	1.28e-10	(A) Negative
VXN	8q13.1	0.17	-1.28	2.09	0.88	1.45	2.19e-11	1.29e-10	(A) Negative
SAP30	4q34.1	-0.15	-0.58	0.58	0.54	0.43	2.20e-11	1.30e-10	(A) Negative
ATP8B3	19p13.3	-2.28	-1.50	0.95	1.38	-0.78	2.20e-11	1.30e-10	(B) Positive
HEATR3	16q12.1	-0.34	-0.78	0.59	0.63	0.44	2.23e-11	1.32e-10	(A) Negative
NF2	22q12.2	-0.13	-0.48	0.47	0.43	0.35	2.24e-11	1.32e-10	(A) Negative
LSM7	19p13.3	0.03	-0.27	0.42	0.32	0.30	2.26e-11	1.33e-10	(A) Negative
SOS1	2p22.1	0.46	0.13	0.46	0.37	0.33	2.26e-11	1.34e-10	(A) Negative
TSC2	16p13.3	-0.08	0.25	0.44	0.48	-0.33	2.30e-11	1.36e-10	(B) Positive
KIF21B	1q32.1	-0.92	-1.25	0.44	0.42	0.33	2.32e-11	1.37e-10	(A) Negative
FANCI	15q26.1	-1.27	-1.84	0.77	0.76	0.57	2.33e-11	1.37e-10	(A) Negative
DDX21	10q22.1	-0.51	-0.90	0.53	0.47	0.39	2.33e-11	1.38e-10	(A) Negative
NR4A2	2q22-q23	0.26	1.11	1.11	1.26	-0.84	2.35e-11	1.38e-10	(B) Positive
STARD4	5q22.1	-1.91	-2.51	0.83	0.70	0.60	2.36e-11	1.39e-10	(A) Negative
RPE	2q34	-0.21	-0.62	0.58	0.40	0.41	2.36e-11	1.39e-10	(A) Negative
IDNK	9q21.32	0.10	0.65	0.75	0.69	-0.55	2.37e-11	1.40e-10	(B) Positive
ZNF100	19p13.1	-0.53	-0.12	0.55	0.57	-0.41	2.40e-11	1.41e-10	(B) Positive
FAM124A	13q14.3	0.06	-0.28	0.48	0.39	0.35	2.43e-11	1.43e-10	(A) Negative
BBS5	2q31.1	0.31	0.65	0.47	0.44	-0.34	2.44e-11	1.44e-10	(B) Positive
ZNF875	19q13.12	0.07	0.50	0.58	0.59	-0.43	2.47e-11	1.45e-10	(B) Positive
CNIH2	11q13.2	0.61	0.22	0.53	0.50	0.39	2.51e-11	1.48e-10	(A) Negative
PKIG	20q13.12	-0.26	0.15	0.55	0.58	-0.41	2.54e-11	1.49e-10	(B) Positive
HIVEP1	6p24.1	0.84	0.50	0.43	0.56	0.34	2.56e-11	1.50e-10	(A) Negative
FOXJ1	17q25.1	-0.02	0.60	0.80	0.97	-0.62	2.56e-11	1.50e-10	(B) Positive
UGT2B4	4q13.3	-1.85	-0.91	0.99	2.06	-0.94	2.62e-11	1.54e-10	(B) Positive
MTTP	4q23	-4.07	-4.76	0.97	0.74	0.69	2.63e-11	1.54e-10	(A) Negative
LSR	19q13.12	1.77	1.32	0.62	0.56	0.45	2.69e-11	1.58e-10	(A) Negative
TAGLN2	1q23.2	0.73	0.29	0.61	0.59	0.45	2.71e-11	1.59e-10	(A) Negative
SSRP1	11q12.1	-0.49	-0.84	0.48	0.40	0.35	2.71e-11	1.59e-10	(A) Negative
SLC43A1	11q12.1	-1.18	-0.54	0.84	0.92	-0.63	2.73e-11	1.60e-10	(B) Positive
CPSF3	2p25.1	-0.43	-0.82	0.56	0.35	0.39	2.74e-11	1.61e-10	(A) Negative
NOB1	16q22.1	-0.98	-1.35	0.51	0.44	0.37	2.75e-11	1.61e-10	(A) Negative
CASP2	7q34	0.18	-0.15	0.46	0.36	0.33	2.77e-11	1.62e-10	(A) Negative
HMMR	5q34	-1.44	-1.95	0.68	0.72	0.51	2.77e-11	1.62e-10	(A) Negative
BAIAP2-DT	17q25.3	0.20	0.74	0.73	0.70	-0.54	2.78e-11	1.63e-10	(B) Positive
PLEKHH3	17q21.2	0.38	0.83	0.62	0.56	-0.45	2.82e-11	1.65e-10	(B) Positive
CGAS	6q13	0.83	0.08	1.05	0.81	0.75	2.84e-11	1.66e-10	(A) Negative
FOXP4	6p21.1	0.97	0.53	0.61	0.48	0.44	2.87e-11	1.68e-10	(A) Negative
ENTPD5	14q24.3	0.03	0.51	0.58	0.86	-0.47	2.90e-11	1.69e-10	(B) Positive
TNFRSF9	1p36.23	1.15	0.33	1.12	1.06	0.82	2.90e-11	1.69e-10	(A) Negative
ESYT2	7q36.3	0.20	-0.20	0.57	0.40	0.40	2.93e-11	1.71e-10	(A) Negative
PLS3	Xq23	-0.02	-0.74	0.99	0.92	0.73	2.94e-11	1.71e-10	(A) Negative
FOXD1	5q13.2	-1.26	-2.13	1.21	0.93	0.86	2.98e-11	1.74e-10	(A) Negative
PDAP1	7q22.1	-1.10	-1.50	0.55	0.48	0.40	3.03e-11	1.77e-10	(A) Negative
CKM	19q13.32	-0.27	-0.86	0.81	0.77	0.59	3.04e-11	1.77e-10	(A) Negative
RBM8A	1q21.1	0.05	-0.28	0.46	0.36	0.33	3.06e-11	1.78e-10	(A) Negative
PTGDR2	11q12.2	-1.26	-0.93	0.44	0.55	-0.34	3.08e-11	1.79e-10	(B) Positive
DNAJC16	1p36.21	0.41	0.79	0.54	0.45	-0.39	3.09e-11	1.80e-10	(B) Positive
TPM4	19p13.12-p13.11	0.25	-0.21	0.62	0.60	0.46	3.12e-11	1.82e-10	(A) Negative
TRIM69	15q15-q21	1.09	0.66	0.61	0.45	0.43	3.13e-11	1.82e-10	(A) Negative
MYO6	6q14.1	1.74	2.34	0.84	0.74	-0.61	3.19e-11	1.85e-10	(B) Positive
ARMC9	2q37.1	-0.41	0.03	0.61	0.49	-0.43	3.22e-11	1.87e-10	(B) Positive
IL27RA	19p13.12	0.46	-0.48	1.32	1.01	0.94	3.25e-11	1.89e-10	(A) Negative
ISCU	12q23.3	-0.04	0.36	0.55	0.48	-0.40	3.26e-11	1.89e-10	(B) Positive
KCNE5	Xq23	0.22	-0.57	1.14	0.57	0.79	3.31e-11	1.92e-10	(A) Negative
KLK10	19q13.41	1.44	-0.07	2.11	1.73	1.51	3.34e-11	1.94e-10	(A) Negative
CHN2	7p14.3	-0.82	-0.12	0.93	1.00	-0.70	3.34e-11	1.94e-10	(B) Positive
ZNRF1	16q23.1	-0.53	-0.88	0.45	0.56	0.35	3.45e-11	2.00e-10	(A) Negative
ELAC1	18q21.2	0.27	-0.34	0.84	0.76	0.61	3.50e-11	2.03e-10	(A) Negative
MMP1	11q22.2	-1.00	-2.68	2.32	2.03	1.68	3.50e-11	2.03e-10	(A) Negative
WDR24	16p13.3	0.11	0.51	0.54	0.53	-0.39	3.53e-11	2.05e-10	(B) Positive
SEMA5A	5p15.31	-1.15	-0.47	0.93	0.88	-0.68	3.56e-11	2.06e-10	(B) Positive
B9D2	19q13.2	0.39	0.76	0.52	0.47	-0.37	3.59e-11	2.08e-10	(B) Positive
B4GALT2	1p34.1	-0.25	-0.67	0.59	0.49	0.42	3.61e-11	2.09e-10	(A) Negative
TCOF1	5q32-q33.1	-0.81	-1.20	0.54	0.43	0.38	3.61e-11	2.09e-10	(A) Negative
SLC41A2	12q23.3	1.31	0.63	0.94	0.90	0.68	3.62e-11	2.10e-10	(A) Negative
ASB2	14q32.12	0.32	-0.39	0.97	0.90	0.70	3.68e-11	2.13e-10	(A) Negative
C11ORF52	11q23.1	2.02	2.74	1.01	0.74	-0.71	3.70e-11	2.14e-10	(B) Positive
LURAP1L	9p23	0.99	1.93	1.31	1.14	-0.94	3.72e-11	2.15e-10	(B) Positive
TOX	8q12.1	-2.13	-2.90	1.06	0.95	0.77	3.74e-11	2.16e-10	(A) Negative
DOCK3	3p21.2	0.05	-0.84	1.24	1.03	0.89	3.74e-11	2.16e-10	(A) Negative
FAM20A	17q24.2	1.80	0.98	1.15	0.91	0.82	3.77e-11	2.17e-10	(A) Negative
TINF2	14q12	0.50	0.83	0.47	0.34	-0.33	3.85e-11	2.22e-10	(B) Positive
B3GNT7	2q37.1	0.46	0.12	0.49	0.31	0.34	4.01e-11	2.31e-10	(A) Negative
CBR1	21q22.12	-0.06	-0.79	0.97	1.10	0.73	4.05e-11	2.34e-10	(A) Negative
DHPS	19p13.13	-0.51	-0.16	0.48	0.43	-0.35	4.09e-11	2.36e-10	(B) Positive
TRMT6	20p12.3	-0.04	-0.41	0.50	0.51	0.37	4.10e-11	2.36e-10	(A) Negative
ZFP62	5q35.3	0.07	0.46	0.56	0.47	-0.40	4.13e-11	2.38e-10	(B) Positive
ST6GALNAC6	9q34.11	0.33	0.76	0.61	0.48	-0.43	4.17e-11	2.40e-10	(B) Positive
CTSO	4q32.1	2.39	3.07	0.94	0.85	-0.68	4.20e-11	2.42e-10	(B) Positive
NICN1	3p21.31	-0.46	0.00	0.61	0.68	-0.46	4.20e-11	2.42e-10	(B) Positive
KCNH6	17q23.3	-0.92	-0.62	0.33	0.63	-0.30	4.20e-11	2.42e-10	(B) Positive
CLEC7A	12p13.2	2.03	1.21	1.17	0.78	0.82	4.21e-11	2.42e-10	(A) Negative
COLEC12	18p11.32	-2.04	-1.19	1.12	1.33	-0.85	4.26e-11	2.45e-10	(B) Positive
NDUFA7	19p13.2	-0.09	0.29	0.52	0.56	-0.39	4.28e-11	2.46e-10	(B) Positive
CDCA4	14q32.33	-0.30	-0.73	0.59	0.57	0.43	4.31e-11	2.47e-10	(A) Negative
PRSS27	16p13.3	1.14	0.34	1.14	0.77	0.80	4.31e-11	2.48e-10	(A) Negative
KRTAP6-3	21q22.11	0.86	0.18	0.99	0.38	0.67	4.35e-11	2.50e-10	(A) Negative
XRCC2	7q36.1	-1.30	-1.81	0.72	0.58	0.51	4.37e-11	2.51e-10	(A) Negative
ZNF711	Xq21.1	-0.46	-1.46	1.40	1.20	1.00	4.38e-11	2.51e-10	(A) Negative
C1QTNF3	5p13.2	-0.06	1.01	1.51	1.26	-1.08	4.38e-11	2.52e-10	(B) Positive
SEMA6D	15q21.1	-1.37	-0.78	0.75	1.04	-0.59	4.41e-11	2.53e-10	(B) Positive
CRYL1	13q12.11	-0.19	0.34	0.73	0.71	-0.53	4.43e-11	2.54e-10	(B) Positive
DDX19A	16q22.1	-0.51	-0.83	0.43	0.45	0.32	4.43e-11	2.54e-10	(A) Negative
HS2ST1	1p22.3	0.10	-0.19	0.39	0.41	0.29	4.45e-11	2.55e-10	(A) Negative
IVL	1q21.3	1.16	0.30	1.22	0.86	0.85	4.45e-11	2.55e-10	(A) Negative
CATSPER3	5q31.1	-0.14	0.36	0.69	0.61	-0.49	4.45e-11	2.55e-10	(B) Positive
TRAK2	2q33.1	0.12	0.60	0.66	0.66	-0.49	4.50e-11	2.58e-10	(B) Positive
ZC3H18	16q24.2	0.25	-0.15	0.55	0.53	0.40	4.50e-11	2.58e-10	(A) Negative
HGF	7q21.11	-1.86	-1.36	0.69	0.69	-0.50	4.50e-11	2.58e-10	(B) Positive
MLKL	16q23.1	-0.32	-0.91	0.83	0.70	0.59	4.51e-11	2.58e-10	(A) Negative
POLR3D	8p21.3	-0.38	-0.74	0.50	0.47	0.36	4.51e-11	2.58e-10	(A) Negative
MDFI	6p21.1	0.51	-0.41	1.29	1.10	0.92	4.54e-11	2.60e-10	(A) Negative
ZMYND8	20q13.12	-0.78	-0.36	0.58	0.54	-0.42	4.55e-11	2.60e-10	(B) Positive
GOLT1B	12p12.1	-0.03	-0.49	0.66	0.48	0.46	4.57e-11	2.61e-10	(A) Negative
RGS5	1q23.3	1.09	1.97	1.22	1.10	-0.88	4.63e-11	2.64e-10	(B) Positive
MICU2	13q12.11	-0.14	0.32	0.64	0.56	-0.46	4.68e-11	2.67e-10	(B) Positive
COX17	3q13.33	0.15	0.50	0.46	0.52	-0.34	4.71e-11	2.69e-10	(B) Positive
FOLR1	11q13.4	-1.52	-2.37	1.22	0.79	0.85	4.73e-11	2.70e-10	(A) Negative
CDS1	4q21.23	2.09	2.63	0.75	0.64	-0.54	4.75e-11	2.71e-10	(B) Positive
RPP25	15q24.2	-0.07	-0.76	0.93	0.98	0.69	4.78e-11	2.73e-10	(A) Negative
PGLYRP4	1q21.3	-0.15	-0.94	1.13	0.81	0.79	4.87e-11	2.77e-10	(A) Negative
FAM135B	8q24.23	0.59	1.19	0.78	0.98	-0.60	4.90e-11	2.79e-10	(B) Positive
MAP2K3	17p11.2	0.36	-0.03	0.52	0.55	0.39	4.90e-11	2.79e-10	(A) Negative
AKIRIN2	6q15	0.25	-0.08	0.45	0.39	0.32	4.91e-11	2.80e-10	(A) Negative
ARFGEF1	8q13.2	0.82	1.26	0.57	0.68	-0.43	4.93e-11	2.81e-10	(B) Positive
FUNDC1	Xp11.3	-0.07	0.35	0.57	0.57	-0.42	4.94e-11	2.81e-10	(B) Positive
TENT4A	5p15.31	-0.37	-0.84	0.68	0.46	0.47	4.95e-11	2.82e-10	(A) Negative
ACTL6A	3q26.33	0.11	-0.29	0.58	0.42	0.41	4.97e-11	2.83e-10	(A) Negative
TSPAN6	Xq22.1	0.14	-0.49	0.83	1.06	0.64	5.08e-11	2.88e-10	(A) Negative
ADAMDEC1	8p21.2	5.88	4.66	1.64	1.76	1.21	5.08e-11	2.88e-10	(A) Negative
SCGB1D2	11q12.3	3.10	4.94	2.60	2.09	-1.84	5.14e-11	2.92e-10	(B) Positive
TRRAP	7q22.1	-0.11	-0.46	0.50	0.43	0.35	5.15e-11	2.92e-10	(A) Negative
CYP4Z1	1p33	3.18	4.94	2.45	2.26	-1.76	5.19e-11	2.95e-10	(B) Positive
MORF4L2	Xq22.2	-0.06	0.32	0.47	0.69	-0.38	5.19e-11	2.95e-10	(B) Positive
NSG2	5q35.2	0.31	0.88	0.75	0.95	-0.58	5.19e-11	2.95e-10	(B) Positive
AIM2	1q23.1-q23.2	1.99	0.80	1.67	1.45	1.19	5.21e-11	2.95e-10	(A) Negative
TRMT11	6q22.32	-0.39	-0.88	0.70	0.49	0.49	5.24e-11	2.97e-10	(A) Negative
ZNF141	4p16.3	-0.10	0.28	0.52	0.50	-0.38	5.26e-11	2.98e-10	(B) Positive
PARPBP	12q23.2	-1.05	-1.58	0.72	0.75	0.53	5.27e-11	2.98e-10	(A) Negative
MICOS10	1p36.13	0.22	0.52	0.40	0.44	-0.30	5.29e-11	3.00e-10	(B) Positive
TSHZ1	18q22.3	0.35	0.90	0.79	0.60	-0.55	5.37e-11	3.04e-10	(B) Positive
SIRPG	20p13	1.90	1.26	0.89	0.87	0.64	5.38e-11	3.04e-10	(A) Negative
LINC01554	5q15	0.91	0.20	1.05	0.46	0.71	5.40e-11	3.05e-10	(A) Negative
THBS1	15q14	1.91	2.55	0.90	0.69	-0.63	5.45e-11	3.08e-10	(B) Positive
PRPF18	10p13	0.89	0.47	0.59	0.44	0.41	5.48e-11	3.10e-10	(A) Negative
TRIM45	1p13.1	-0.76	-0.18	0.79	0.81	-0.58	5.52e-11	3.12e-10	(B) Positive
WDFY3-AS2	4q21.23	-0.47	0.04	0.71	0.64	-0.51	5.65e-11	3.19e-10	(B) Positive
CFAP46	10q26.3	0.26	0.65	0.49	0.69	-0.39	5.66e-11	3.20e-10	(B) Positive
CDYL2	16q23.2	-0.49	0.05	0.75	0.68	-0.54	5.66e-11	3.20e-10	(B) Positive
KIN	10p14	0.48	0.08	0.58	0.36	0.40	5.77e-11	3.26e-10	(A) Negative
ACOX3	4p16.1	0.91	1.42	0.69	0.77	-0.51	5.79e-11	3.27e-10	(B) Positive
PLEKHF1	19q12	1.27	0.66	0.89	0.62	0.61	5.79e-11	3.27e-10	(A) Negative
HSD17B7P2	10p11.1	-0.38	0.07	0.60	0.69	-0.45	5.82e-11	3.28e-10	(B) Positive
H2AC12	6p22.1	0.57	1.18	0.81	0.93	-0.61	5.82e-11	3.28e-10	(B) Positive
H4C1	6p22.2	-0.31	-0.71	0.56	0.55	0.40	5.85e-11	3.30e-10	(A) Negative
YWHAQ	2p25.1	0.19	-0.24	0.61	0.50	0.43	5.85e-11	3.30e-10	(A) Negative
SIDT2	11q23.3	0.29	0.63	0.47	0.44	-0.34	5.89e-11	3.32e-10	(B) Positive
HCFC1R1	16p13.3	0.07	0.56	0.71	0.54	-0.50	5.90e-11	3.32e-10	(B) Positive
NUP62	19q13.33	0.21	-0.04	0.35	0.35	0.26	5.92e-11	3.33e-10	(A) Negative
TIGIT	3q13.31	3.78	2.95	1.10	1.30	0.83	5.92e-11	3.33e-10	(A) Negative
SERF2	15q15.3	0.58	0.96	0.54	0.43	-0.38	5.93e-11	3.34e-10	(B) Positive
RABEP2	16p11.2	0.62	0.99	0.51	0.54	-0.37	5.93e-11	3.34e-10	(B) Positive
LENG1	19q13.42	0.26	0.57	0.45	0.39	-0.32	5.94e-11	3.34e-10	(B) Positive
ZNF22	10q11.21	0.47	-0.03	0.68	0.70	0.50	5.96e-11	3.35e-10	(A) Negative
TMEM237	2q33.1	0.04	-0.37	0.59	0.47	0.41	5.98e-11	3.36e-10	(A) Negative
NMI	2q23.3	0.96	0.37	0.82	0.74	0.59	5.99e-11	3.36e-10	(A) Negative
SPICE1	3q13.2	-0.21	0.22	0.61	0.57	-0.44	6.10e-11	3.42e-10	(B) Positive
PLPPR2	19p13.2	-0.05	0.27	0.45	0.40	-0.32	6.13e-11	3.44e-10	(B) Positive
FAM118B	11q24.2	-0.14	-0.49	0.49	0.46	0.35	6.16e-11	3.45e-10	(A) Negative
STYK1	12p13.2	2.25	1.36	1.18	1.46	0.90	6.16e-11	3.45e-10	(A) Negative
EPHA3	3p11.1	-1.61	-1.15	0.59	0.78	-0.46	6.20e-11	3.48e-10	(B) Positive
ZNF670	1q44	0.56	0.05	0.70	0.73	0.51	6.22e-11	3.49e-10	(A) Negative
ACSL4	Xq23	-1.15	-1.65	0.71	0.64	0.51	6.25e-11	3.50e-10	(A) Negative
DBP	19q13.33	0.07	0.48	0.56	0.54	-0.40	6.25e-11	3.50e-10	(B) Positive
MSMB	10q11.22	-1.32	0.12	1.90	2.31	-1.44	6.28e-11	3.51e-10	(B) Positive
SERINC1	6q22.31	0.81	1.18	0.52	0.41	-0.37	6.32e-11	3.54e-10	(B) Positive
UBE2D1	10q21.1	0.79	0.44	0.50	0.43	0.35	6.44e-11	3.60e-10	(A) Negative
WASF3	13q12.13	0.15	-0.46	0.84	0.86	0.61	6.55e-11	3.66e-10	(A) Negative
POLD3	11q13.4	-0.16	-0.59	0.61	0.53	0.43	6.62e-11	3.70e-10	(A) Negative
ICMT-DT	1p36.31	-0.65	-1.29	0.90	0.80	0.64	6.63e-11	3.71e-10	(A) Negative
PCSK1N	Xp11.23	0.51	-0.14	0.89	0.94	0.65	6.64e-11	3.71e-10	(A) Negative
GHR	5p13.1-p12	1.39	2.32	1.31	1.20	-0.94	6.68e-11	3.73e-10	(B) Positive
ADD2	2p13.3	-1.82	-2.60	1.14	0.55	0.77	6.70e-11	3.74e-10	(A) Negative
RANBP3L	5p13.2	0.45	1.36	1.23	1.34	-0.91	6.71e-11	3.75e-10	(B) Positive
EML5	14q31.3	-0.28	0.16	0.60	0.63	-0.44	6.73e-11	3.75e-10	(B) Positive
DNAH11	7p15.3	-0.22	-1.16	1.36	0.96	0.94	6.76e-11	3.77e-10	(A) Negative
ZNF226	19q13.31	-0.26	0.15	0.58	0.50	-0.41	6.86e-11	3.82e-10	(B) Positive
ZNF350	19q13.41	1.21	1.73	0.73	0.70	-0.52	6.88e-11	3.84e-10	(B) Positive
ZNF124	1q44	0.71	0.15	0.77	0.77	0.56	6.95e-11	3.87e-10	(A) Negative
PPP1R26	9q34.3	-0.70	-0.20	0.69	0.65	-0.50	7.08e-11	3.94e-10	(B) Positive
GPRIN1	5q35.2	0.30	-0.25	0.75	0.73	0.54	7.09e-11	3.95e-10	(A) Negative
KBTBD4	11p11.2	0.18	0.47	0.40	0.40	-0.29	7.09e-11	3.95e-10	(B) Positive
SHQ1	3p13	-0.06	0.27	0.44	0.48	-0.33	7.09e-11	3.95e-10	(B) Positive
ADAM19	5q33.3	0.68	0.32	0.49	0.53	0.36	7.21e-11	4.01e-10	(A) Negative
H2AZ1	4q23	-0.41	-0.83	0.57	0.56	0.41	7.24e-11	4.03e-10	(A) Negative
ZFAND6	15q25.1	-0.17	0.26	0.60	0.60	-0.43	7.25e-11	4.03e-10	(B) Positive
ICMT	1p36.31	0.14	-0.17	0.44	0.36	0.31	7.31e-11	4.07e-10	(A) Negative
SLC35F3	1q42.2	0.90	-0.43	1.87	1.70	1.33	7.32e-11	4.07e-10	(A) Negative
ATXN2	12q24.12	-0.29	-0.05	0.33	0.31	-0.23	7.43e-11	4.13e-10	(B) Positive
DDN	12q13.12	0.02	-0.21	0.33	0.28	0.23	7.44e-11	4.13e-10	(A) Negative
ILRUN	6p21.31	0.47	0.17	0.43	0.34	0.30	7.44e-11	4.13e-10	(A) Negative
GTF2F1	19p13.3	-0.26	0.01	0.38	0.34	-0.27	7.46e-11	4.14e-10	(B) Positive
SATB2	2q33.1	-2.44	-1.75	0.93	1.07	-0.69	7.47e-11	4.14e-10	(B) Positive
ARL14	3q25.33	-0.69	-1.68	1.43	0.95	0.99	7.51e-11	4.16e-10	(A) Negative
JAK3	19p13.11	0.25	-0.04	0.40	0.36	0.29	7.65e-11	4.24e-10	(A) Negative
RUSC1-AS1	1q22	-0.04	0.40	0.60	0.65	-0.44	7.71e-11	4.27e-10	(B) Positive
MCC	5q22.2	0.36	1.08	1.02	0.91	-0.72	7.84e-11	4.34e-10	(B) Positive
APC	5q22.2	0.01	0.38	0.53	0.43	-0.37	7.88e-11	4.36e-10	(B) Positive
NPC1L1	7p13	-1.17	-0.70	0.61	0.83	-0.47	7.88e-11	4.37e-10	(B) Positive
TEKT1	17p13.1	0.14	0.63	0.57	1.01	-0.49	7.89e-11	4.37e-10	(B) Positive
PPCS	1p34.2	0.75	1.09	0.49	0.43	-0.34	7.90e-11	4.37e-10	(B) Positive
GRIA2	4q32.1	0.85	1.83	1.15	2.03	-0.98	7.91e-11	4.37e-10	(B) Positive
PDZRN4	12q12	0.96	1.54	0.69	1.16	-0.58	7.91e-11	4.38e-10	(B) Positive
ENY2	8q23.1	0.16	-0.30	0.64	0.64	0.46	8.02e-11	4.44e-10	(A) Negative
B4GALNT1	12q13.3	-0.55	-1.18	0.91	0.73	0.63	8.08e-11	4.47e-10	(A) Negative
SPATA17	1q41	0.67	1.15	0.67	0.64	-0.48	8.12e-11	4.48e-10	(B) Positive
PRSS12	4q26	-0.90	-2.10	1.80	0.86	1.21	8.13e-11	4.49e-10	(A) Negative
FUT5	19p13.3	0.29	-0.60	1.23	1.27	0.89	8.13e-11	4.49e-10	(A) Negative
ULK2	17p11.2	1.25	1.73	0.65	0.76	-0.48	8.19e-11	4.52e-10	(B) Positive
ACKR3	2q37.3	-0.38	0.38	1.04	1.15	-0.77	8.19e-11	4.52e-10	(B) Positive
SMURF1	7q22.1	0.13	-0.20	0.47	0.37	0.33	8.19e-11	4.52e-10	(A) Negative
PACC1	1q32.3	0.39	-0.14	0.75	0.63	0.53	8.19e-11	4.52e-10	(A) Negative
AFTPH	2p14	1.15	1.40	0.35	0.33	-0.25	8.20e-11	4.52e-10	(B) Positive
DSC3	18q12.1	1.80	0.40	2.02	1.47	1.40	8.22e-11	4.53e-10	(A) Negative
CLEC3A	16q23.1	0.81	2.28	1.79	2.86	-1.47	8.32e-11	4.58e-10	(B) Positive
CLDN1	3q28	0.68	-0.60	1.84	1.42	1.28	8.33e-11	4.59e-10	(A) Negative
AMDHD2	16p13.3	-0.05	0.42	0.66	0.63	-0.47	8.35e-11	4.60e-10	(B) Positive
DNER	2q36.3	-3.08	-4.19	1.62	1.03	1.11	8.47e-11	4.66e-10	(A) Negative
SLAIN2	4p11	0.52	0.86	0.48	0.42	-0.34	8.52e-11	4.69e-10	(B) Positive
DHRS7	14q23.1	0.43	0.95	0.74	0.67	-0.53	8.58e-11	4.72e-10	(B) Positive
PLOD3	7q22.1	-0.69	-1.18	0.71	0.42	0.48	8.74e-11	4.80e-10	(A) Negative
EPRS1	1q41	0.05	-0.36	0.59	0.52	0.42	8.75e-11	4.81e-10	(A) Negative
COL23A1	5q35.3	-1.04	-1.73	1.01	0.64	0.69	8.86e-11	4.87e-10	(A) Negative
AGTPBP1	9q21.33	-0.28	-0.90	0.92	0.60	0.63	8.91e-11	4.89e-10	(A) Negative
CPLANE2	1p36.13	-0.47	-0.08	0.54	0.56	-0.39	8.94e-11	4.91e-10	(B) Positive
KIR3DL1	19q13.42	0.63	0.38	0.36	0.29	0.25	8.96e-11	4.92e-10	(A) Negative
C2ORF50	2p25.1	0.24	0.81	0.72	1.00	-0.57	8.99e-11	4.94e-10	(B) Positive
PSMG3-AS1	7p22.3	-0.86	-0.38	0.67	0.70	-0.48	9.14e-11	5.02e-10	(B) Positive
A1BG	19q13.43	-0.27	0.27	0.79	0.61	-0.54	9.17e-11	5.03e-10	(B) Positive
CDYL	6p25.1	-0.31	-0.72	0.58	0.53	0.41	9.18e-11	5.03e-10	(A) Negative
MIDEAS	14q24.3	0.21	0.44	0.30	0.37	-0.23	9.19e-11	5.04e-10	(B) Positive
ZFYVE26	14q24.1	-0.22	0.11	0.44	0.50	-0.33	9.33e-11	5.11e-10	(B) Positive
OTULIN	5p15.2	0.45	0.03	0.62	0.37	0.42	9.34e-11	5.11e-10	(A) Negative
ZNF839	14q32.31	-0.53	-0.21	0.44	0.49	-0.32	9.37e-11	5.13e-10	(B) Positive
SLAIN1	13q22.3	-1.10	-2.38	1.82	1.61	1.29	9.42e-11	5.16e-10	(A) Negative
PDE4B	1p31.3	0.90	0.09	1.11	1.23	0.81	9.44e-11	5.17e-10	(A) Negative
CCNB1	5q13.2	-1.58	-2.08	0.67	0.85	0.51	9.46e-11	5.18e-10	(A) Negative
PRR15L	17q21.32	1.56	2.60	1.54	0.95	-1.04	9.47e-11	5.18e-10	(B) Positive
C6ORF15	6p21.33	1.48	0.37	1.66	0.76	1.11	9.54e-11	5.22e-10	(A) Negative
GSTZ1	14q24.3	-0.38	0.15	0.77	0.63	-0.54	9.58e-11	5.24e-10	(B) Positive
PTPN4	2q14.2	-0.03	-0.34	0.44	0.38	0.31	9.64e-11	5.27e-10	(A) Negative
IMP3	15q24.2	-0.23	0.05	0.40	0.38	-0.28	9.66e-11	5.27e-10	(B) Positive
IL12A	3q25.33	0.52	-0.30	1.18	0.93	0.82	9.67e-11	5.28e-10	(A) Negative
ASGR1	17p13.1	-4.29	-4.75	0.65	0.59	0.46	9.69e-11	5.29e-10	(A) Negative
CLN5	13q22.3	0.32	0.86	0.78	0.64	-0.54	9.70e-11	5.29e-10	(B) Positive
BICD2	9q22.31	0.03	-0.39	0.60	0.55	0.43	9.71e-11	5.30e-10	(A) Negative
NAT8	2p13.1	-2.33	-1.76	0.70	1.10	-0.57	9.77e-11	5.32e-10	(B) Positive
RTN4IP1	6q21	-0.15	-0.70	0.78	0.70	0.55	9.82e-11	5.35e-10	(A) Negative
CES2	16q22.1	-0.67	-0.37	0.41	0.39	-0.29	9.94e-11	5.42e-10	(B) Positive
SSBP4	19p13.11	-0.41	-0.03	0.56	0.44	-0.39	9.98e-11	5.44e-10	(B) Positive
CAMTA2	17p13.2	-0.02	0.32	0.45	0.55	-0.34	1.01e-10	5.48e-10	(B) Positive
ZBED2	3q13.13	2.52	1.31	1.70	1.67	1.22	1.01e-10	5.49e-10	(A) Negative
DOCK1	10q26.2	0.48	0.94	0.64	0.64	-0.46	1.01e-10	5.49e-10	(B) Positive
SOCS1	16p13.13	0.68	0.22	0.66	0.56	0.46	1.01e-10	5.50e-10	(A) Negative
NYX	Xp11.4	0.81	0.41	0.59	0.39	0.40	1.01e-10	5.50e-10	(A) Negative
MIPOL1	14q13.3-q21.1	0.06	0.66	0.86	0.77	-0.61	1.02e-10	5.55e-10	(B) Positive
UFSP2	4q35.1	-0.26	0.08	0.48	0.46	-0.34	1.02e-10	5.56e-10	(B) Positive
KCNK7	11q13.1	0.23	0.04	0.27	0.28	0.20	1.03e-10	5.60e-10	(A) Negative
URI1	19q12	0.15	-0.34	0.71	0.55	0.49	1.03e-10	5.62e-10	(A) Negative
TNNT1	19q13.42	-2.30	-1.05	1.69	1.99	-1.25	1.04e-10	5.67e-10	(B) Positive
CAP2	6p22.3	-0.23	0.51	1.01	1.15	-0.74	1.05e-10	5.69e-10	(B) Positive
SNX9	6q25.3	0.10	0.50	0.57	0.50	-0.40	1.05e-10	5.70e-10	(B) Positive
SIGLEC12	19q13.41	0.75	0.26	0.73	0.52	0.50	1.05e-10	5.72e-10	(A) Negative
CDC6	17q21.2	-1.37	-2.12	1.01	1.19	0.75	1.07e-10	5.79e-10	(A) Negative
BMP4	14q22.2	-1.92	-0.98	1.32	1.25	-0.94	1.08e-10	5.85e-10	(B) Positive
SLC38A1	12q13.11	0.27	0.95	0.94	1.01	-0.68	1.09e-10	5.89e-10	(B) Positive
CFLAR	2q33.1	0.62	0.13	0.69	0.62	0.49	1.09e-10	5.92e-10	(A) Negative
P2RX5	17p13.2	-1.80	-2.37	0.81	0.78	0.57	1.10e-10	5.94e-10	(A) Negative
TSR1	17p13.3	-0.40	-0.76	0.50	0.46	0.35	1.12e-10	6.05e-10	(A) Negative
CSK	15q24.1	-0.09	-0.44	0.49	0.49	0.35	1.13e-10	6.09e-10	(A) Negative
NRDE2	14q32.11	-0.04	0.32	0.50	0.50	-0.36	1.13e-10	6.12e-10	(B) Positive
SKIC3	5q15	-0.65	-0.32	0.46	0.41	-0.32	1.13e-10	6.12e-10	(B) Positive
GINS4	8p11.21	-2.02	-2.61	0.84	0.77	0.59	1.13e-10	6.12e-10	(A) Negative
DGKZ	11p11.2	0.66	0.28	0.54	0.48	0.38	1.14e-10	6.15e-10	(A) Negative
CHRDL2	11q13.4	1.43	0.31	1.64	1.11	1.12	1.15e-10	6.22e-10	(A) Negative
ESRRA	11q13.1	-0.19	-0.49	0.43	0.39	0.30	1.15e-10	6.23e-10	(A) Negative
POM121	7q11.23	-0.26	-0.57	0.45	0.31	0.31	1.16e-10	6.25e-10	(A) Negative
PHF1	6p21.32	-0.27	0.02	0.40	0.45	-0.29	1.16e-10	6.27e-10	(B) Positive
FOXN2	2p16.3	0.62	0.02	0.86	0.75	0.60	1.17e-10	6.30e-10	(A) Negative
DUSP9	Xq28	-1.57	-1.86	0.42	0.37	0.30	1.17e-10	6.31e-10	(A) Negative
TRERF1	6p21.1	-0.49	0.25	1.07	0.87	-0.74	1.18e-10	6.36e-10	(B) Positive
RGR	10q23.1	0.53	0.14	0.59	0.25	0.39	1.20e-10	6.48e-10	(A) Negative
PRLR	5p13.2	1.85	2.52	0.96	0.85	-0.67	1.20e-10	6.49e-10	(B) Positive
SOCS2	12q22	-2.29	-1.51	1.00	1.40	-0.77	1.23e-10	6.61e-10	(B) Positive
UBL3	13q12.3	-0.09	0.40	0.71	0.61	-0.49	1.23e-10	6.63e-10	(B) Positive
FADS2	11q12.2	0.79	-0.05	1.15	1.27	0.84	1.24e-10	6.66e-10	(A) Negative
PHF20	20q11.22-q11.23	-0.26	0.05	0.46	0.35	-0.32	1.24e-10	6.68e-10	(B) Positive
POC1B	12q21.33	-0.40	0.00	0.57	0.56	-0.41	1.24e-10	6.69e-10	(B) Positive
CD79B	17q23.3	2.18	1.36	1.17	1.07	0.82	1.25e-10	6.73e-10	(A) Negative
CLRN3	10q26.2	1.06	1.60	0.70	0.95	-0.53	1.26e-10	6.77e-10	(B) Positive
NR2E1	6q21	-1.69	-2.16	0.68	0.62	0.48	1.26e-10	6.78e-10	(A) Negative
UBAP2	9p13.3	0.05	-0.39	0.63	0.50	0.43	1.26e-10	6.80e-10	(A) Negative
XPOT	12q14.2	-0.75	-1.12	0.51	0.55	0.37	1.26e-10	6.80e-10	(A) Negative
U2AF1	21q22.3	-0.55	-0.93	0.54	0.45	0.38	1.27e-10	6.84e-10	(A) Negative
MORN4	10q24.2	-0.58	-0.24	0.49	0.45	-0.35	1.29e-10	6.91e-10	(B) Positive
DNAJA4	15q25.1	1.42	2.09	0.95	0.95	-0.68	1.30e-10	6.96e-10	(B) Positive
HIRIP3	16p11.2	-0.68	-0.30	0.53	0.47	-0.37	1.30e-10	6.97e-10	(B) Positive
SPSB3	16p13.3	0.36	0.69	0.46	0.47	-0.33	1.30e-10	7.00e-10	(B) Positive
ATAD2	8q24.13	-0.50	-1.11	0.84	0.92	0.61	1.31e-10	7.00e-10	(A) Negative
CHURC1	14q23.3	-0.40	0.08	0.69	0.62	-0.48	1.32e-10	7.08e-10	(B) Positive
PPM1G	2p23.3	-0.02	-0.33	0.45	0.39	0.31	1.33e-10	7.11e-10	(A) Negative
ANXA8L1	10q11.22	0.58	-0.78	1.98	1.55	1.36	1.33e-10	7.12e-10	(A) Negative
B4GALT7	5q35.3	0.08	0.43	0.50	0.47	-0.35	1.34e-10	7.16e-10	(B) Positive
BAG2	6p12.1	-1.41	-2.29	1.31	0.81	0.88	1.34e-10	7.19e-10	(A) Negative
GSTO2	10q25.1	0.71	1.69	1.45	1.02	-0.99	1.35e-10	7.22e-10	(B) Positive
SH3KBP1	Xp22.12	-0.19	-0.75	0.80	0.69	0.56	1.36e-10	7.28e-10	(A) Negative
CBX5	12q13.13	-0.52	-1.01	0.69	0.61	0.48	1.38e-10	7.37e-10	(A) Negative
DGUOK	2p13.1	-0.09	-0.45	0.51	0.44	0.36	1.39e-10	7.43e-10	(A) Negative
IQCD	12q24.13	0.30	0.98	0.99	0.75	-0.67	1.39e-10	7.43e-10	(B) Positive
CALD1	7q33	0.73	0.11	0.89	0.82	0.62	1.39e-10	7.43e-10	(A) Negative
RTL8A	Xq26.3	0.34	-0.06	0.57	0.50	0.39	1.39e-10	7.44e-10	(A) Negative
CCT4	2p15	-0.25	-0.62	0.55	0.40	0.37	1.39e-10	7.44e-10	(A) Negative
SLC43A2	17p13.3	1.21	0.81	0.56	0.56	0.40	1.40e-10	7.46e-10	(A) Negative
CYP4F11	19p13.12	-1.03	-0.22	1.13	1.16	-0.81	1.42e-10	7.59e-10	(B) Positive
C19ORF47	19q13.2	0.59	0.13	0.69	0.47	0.46	1.44e-10	7.66e-10	(A) Negative
SMC2	9q31.1	-1.21	-1.76	0.80	0.67	0.55	1.44e-10	7.67e-10	(A) Negative
SLC18A2	10q25.3	-0.06	0.49	0.75	0.85	-0.55	1.44e-10	7.69e-10	(B) Positive
ATG14	14q22.3	-0.10	0.18	0.39	0.38	-0.28	1.45e-10	7.75e-10	(B) Positive
CYP4X1	1p33	2.75	4.38	2.31	2.24	-1.63	1.46e-10	7.77e-10	(B) Positive
MARCHF9	12q14.1	-0.42	-0.08	0.48	0.51	-0.34	1.46e-10	7.77e-10	(B) Positive
KCTD20	6p21.31	-0.24	-0.59	0.51	0.42	0.35	1.46e-10	7.77e-10	(A) Negative
KCNC4	1p13.3	0.57	0.26	0.44	0.42	0.31	1.46e-10	7.79e-10	(A) Negative
RHBDF1	16p13.3	0.28	0.68	0.57	0.53	-0.40	1.49e-10	7.92e-10	(B) Positive
ADGRG1	16q21	1.32	0.81	0.72	0.73	0.51	1.50e-10	7.96e-10	(A) Negative
NOL4	18q12.1	2.13	0.74	2.06	1.39	1.39	1.50e-10	7.96e-10	(A) Negative
TMEM129	4p16.3	-0.06	0.35	0.58	0.49	-0.40	1.50e-10	7.98e-10	(B) Positive
LRRC28	15q26.3	0.08	-0.31	0.53	0.63	0.39	1.50e-10	7.99e-10	(A) Negative
SHOC2	10q25.2	0.72	1.12	0.56	0.59	-0.40	1.50e-10	8.00e-10	(B) Positive
HNRNPA1	12q13.13	-0.59	-0.27	0.45	0.43	-0.32	1.51e-10	8.03e-10	(B) Positive
ARPC5	1q25.3	0.70	0.30	0.59	0.46	0.41	1.53e-10	8.12e-10	(A) Negative
ZNF589	3p21.31	-0.80	-0.50	0.42	0.42	-0.30	1.54e-10	8.18e-10	(B) Positive
RTCA	1p21.2	-0.04	-0.41	0.52	0.49	0.37	1.55e-10	8.23e-10	(A) Negative
CENPJ	13q12.12-q12.13	-1.07	-1.50	0.64	0.49	0.44	1.55e-10	8.24e-10	(A) Negative
KDM1B	6p22.3	0.35	-0.11	0.67	0.53	0.46	1.57e-10	8.31e-10	(A) Negative
AKAP11	13q14.11	-0.24	0.09	0.46	0.49	-0.33	1.57e-10	8.33e-10	(B) Positive
KLHDC7B	22q13.33	2.86	1.75	1.60	1.40	1.11	1.58e-10	8.40e-10	(A) Negative
ARNT2	15q25.1	0.10	1.14	1.48	1.39	-1.04	1.59e-10	8.42e-10	(B) Positive
PSD3	8p22	-0.85	0.00	1.12	1.52	-0.85	1.59e-10	8.44e-10	(B) Positive
BLVRB	19q13.2	-0.43	0.22	0.95	0.71	-0.65	1.60e-10	8.46e-10	(B) Positive
CCDC102A	16q21	0.42	-0.08	0.72	0.58	0.49	1.61e-10	8.53e-10	(A) Negative
CENPT	16q22.1	-0.84	-1.17	0.46	0.45	0.33	1.63e-10	8.61e-10	(A) Negative
CCDC167	6p21.2	0.53	0.13	0.56	0.57	0.40	1.63e-10	8.65e-10	(A) Negative
MCM8	20p12.3	-1.50	-1.91	0.57	0.60	0.41	1.64e-10	8.67e-10	(A) Negative
SUPV3L1	10q22.1	0.02	-0.35	0.54	0.45	0.37	1.64e-10	8.68e-10	(A) Negative
MAP3K1	5q11.2	0.61	1.27	0.93	0.99	-0.66	1.64e-10	8.68e-10	(B) Positive
TAFA4	3p14.1	-1.93	-2.91	1.43	1.05	0.97	1.64e-10	8.69e-10	(A) Negative
ZNF764	16p11.2	0.20	0.54	0.49	0.43	-0.34	1.65e-10	8.72e-10	(B) Positive
LRRC49	15q23	-0.34	0.28	0.88	0.88	-0.62	1.65e-10	8.74e-10	(B) Positive
SLC23A1	5q31.2	-1.97	-1.25	1.01	1.04	-0.72	1.66e-10	8.77e-10	(B) Positive
SAP18	13q12.11	0.51	0.84	0.46	0.44	-0.32	1.68e-10	8.84e-10	(B) Positive
SHC2	19p13.3	0.04	0.85	1.18	0.95	-0.81	1.68e-10	8.86e-10	(B) Positive
CBLN2	18q22.3	-0.79	0.53	1.61	2.67	-1.32	1.68e-10	8.89e-10	(B) Positive
STX17	9q31.1	0.92	0.57	0.50	0.49	0.35	1.69e-10	8.90e-10	(A) Negative
ZNF425	7q36.1	0.24	0.65	0.56	0.60	-0.40	1.71e-10	9.01e-10	(B) Positive
S100A6	1q21.3	0.75	-0.00	1.09	0.89	0.75	1.71e-10	9.02e-10	(A) Negative
KLHL34	Xp22.12	2.38	1.01	2.10	0.80	1.37	1.75e-10	9.20e-10	(A) Negative
THEMIS2	1p35.3	1.06	0.37	1.00	0.87	0.69	1.75e-10	9.22e-10	(A) Negative
GBP5	1p22.2	4.93	4.18	1.06	1.13	0.76	1.76e-10	9.26e-10	(A) Negative
ATP6V0A4	7q34	1.16	-0.25	1.92	2.29	1.41	1.77e-10	9.30e-10	(A) Negative
AKIRIN1	1p34.3	-0.20	-0.59	0.56	0.49	0.39	1.77e-10	9.31e-10	(A) Negative
SH3TC2	5q32	-0.34	-1.09	1.12	0.74	0.75	1.78e-10	9.36e-10	(A) Negative
AMTN	4q13.3	-0.21	-1.13	1.40	0.74	0.92	1.80e-10	9.44e-10	(A) Negative
CASP12	11q22.3	0.45	0.88	0.59	0.73	-0.44	1.80e-10	9.48e-10	(B) Positive
MMGT1	Xq26.3	0.13	-0.28	0.60	0.49	0.41	1.82e-10	9.55e-10	(A) Negative
MAD2L2	1p36.22	-0.95	-1.37	0.60	0.54	0.41	1.83e-10	9.59e-10	(A) Negative
NCR3	6p21.33	1.01	0.64	0.54	0.50	0.38	1.83e-10	9.63e-10	(A) Negative
PEX5L	3q26.33	-1.40	-0.96	0.49	1.00	-0.44	1.84e-10	9.64e-10	(B) Positive
SCAI	9q33.3	-0.73	-1.20	0.71	0.48	0.48	1.84e-10	9.65e-10	(A) Negative
APCDD1L	20q13.32	-0.58	-1.31	1.09	0.62	0.72	1.85e-10	9.70e-10	(A) Negative
CTDSP2	12q14.1	0.35	0.69	0.50	0.47	-0.35	1.86e-10	9.76e-10	(B) Positive
SLC39A11	17q24.3-q25.1	1.31	1.90	0.84	0.81	-0.59	1.88e-10	9.85e-10	(B) Positive
KIF3B	20q11.21	0.30	0.65	0.50	0.45	-0.34	1.89e-10	9.89e-10	(B) Positive
SKAP1	17q21.32	1.57	2.45	1.25	1.31	-0.89	1.92e-10	1.01e-9	(B) Positive
ITPRIP	10q25.1	-0.27	-0.64	0.52	0.54	0.37	1.92e-10	1.01e-9	(A) Negative
TDP1	14q32.11	-0.34	-0.74	0.57	0.52	0.40	1.94e-10	1.02e-9	(A) Negative
SCGB2A2	11q12.3	4.87	7.03	3.21	2.31	-2.17	1.96e-10	1.03e-9	(B) Positive
RGL1	1q25.3	0.43	-0.02	0.64	0.62	0.45	1.97e-10	1.03e-9	(A) Negative
PURA	5q31.3	0.47	0.96	0.71	0.64	-0.49	1.98e-10	1.04e-9	(B) Positive
IL1RAPL1	Xp21.3-p21.2	-1.35	-0.83	0.61	1.09	-0.51	1.99e-10	1.04e-9	(B) Positive
SLC66A1L	3q25.32	2.01	1.03	1.46	1.03	0.98	1.99e-10	1.04e-9	(A) Negative
DHX57	2p22.1	0.11	-0.22	0.49	0.35	0.33	2.00e-10	1.05e-9	(A) Negative
SNN	16p13.13	0.74	0.26	0.71	0.55	0.48	2.01e-10	1.05e-9	(A) Negative
ALDOA	16p11.2	-0.42	-0.02	0.57	0.57	-0.40	2.02e-10	1.05e-9	(B) Positive
DMRTA1	9p21.3	-0.00	-1.19	1.76	1.30	1.19	2.05e-10	1.07e-9	(A) Negative
RPS27A	2p16.1	-0.14	-0.50	0.53	0.48	0.36	2.05e-10	1.07e-9	(A) Negative
CD63	12q13.2	0.55	0.93	0.57	0.44	-0.38	2.07e-10	1.08e-9	(B) Positive
SGPP2	2q36.1	2.66	1.72	1.31	1.40	0.93	2.08e-10	1.09e-9	(A) Negative
BCL2L1	20q11.21	-0.15	0.10	0.36	0.35	-0.25	2.10e-10	1.09e-9	(B) Positive
TAF13	1p13.3	0.35	-0.18	0.79	0.64	0.54	2.12e-10	1.10e-9	(A) Negative
RAD54B	8q22.1	-0.37	-0.82	0.62	0.72	0.45	2.13e-10	1.11e-9	(A) Negative
ATP13A3	3q29	0.44	0.05	0.59	0.46	0.40	2.15e-10	1.12e-9	(A) Negative
DUSP22	6p25.3	-0.28	-0.64	0.53	0.47	0.36	2.16e-10	1.13e-9	(A) Negative
OR7E91P	2p13.3	1.82	1.34	0.71	0.58	0.48	2.17e-10	1.13e-9	(A) Negative
H2AX	11q23.3	-0.66	-1.06	0.56	0.58	0.40	2.20e-10	1.15e-9	(A) Negative
FOLR3	11q13.4	-1.60	-2.26	0.98	0.65	0.66	2.21e-10	1.15e-9	(A) Negative
EIF5A2	3q26.2	-0.26	-0.80	0.76	0.81	0.54	2.25e-10	1.17e-9	(A) Negative
RGS6	14q24.2	0.16	-0.42	0.87	0.63	0.59	2.27e-10	1.18e-9	(A) Negative
CDC5L	6p21.1	-0.01	-0.38	0.56	0.40	0.37	2.31e-10	1.20e-9	(A) Negative
CDK16	Xp11.3	0.05	-0.30	0.51	0.45	0.35	2.33e-10	1.21e-9	(A) Negative
SF3B5	6q24.2	0.51	0.21	0.45	0.38	0.31	2.37e-10	1.23e-9	(A) Negative
ACOT6	14q24.3	0.13	0.69	0.77	0.95	-0.57	2.37e-10	1.23e-9	(B) Positive
CABCOCO1	10q21.2	-0.84	-0.09	1.02	1.27	-0.75	2.39e-10	1.24e-9	(B) Positive
MIEF1	22q13.1	-0.30	-0.60	0.44	0.39	0.30	2.39e-10	1.24e-9	(A) Negative
ESPL1	12q13.13	-0.69	-0.93	0.32	0.46	0.24	2.40e-10	1.25e-9	(A) Negative
FAHD1	16p13.3	-0.29	0.13	0.61	0.51	-0.42	2.40e-10	1.25e-9	(B) Positive
KIAA2013	1p36.22	0.05	-0.29	0.50	0.35	0.33	2.41e-10	1.25e-9	(A) Negative
CDKAL1	6p22.3	0.25	-0.35	0.91	0.50	0.60	2.44e-10	1.27e-9	(A) Negative
C14ORF132	14q32.2	-1.26	-0.24	1.50	1.29	-1.02	2.45e-10	1.27e-9	(B) Positive
ELP6	3p21.31	-1.02	-0.75	0.39	0.37	-0.27	2.47e-10	1.28e-9	(B) Positive
UXS1	2q12.2	0.10	-0.32	0.62	0.45	0.42	2.48e-10	1.28e-9	(A) Negative
HMGN3	6q14.1	0.10	-0.35	0.65	0.60	0.45	2.50e-10	1.30e-9	(A) Negative
RXFP4	1q22	0.47	0.26	0.30	0.29	0.21	2.50e-10	1.30e-9	(A) Negative
THOC5	22q12.2	-0.21	-0.55	0.50	0.41	0.34	2.52e-10	1.30e-9	(A) Negative
DENND4B	1q21.3	-0.57	-0.88	0.44	0.42	0.30	2.54e-10	1.31e-9	(A) Negative
SEL1L	14q31	0.87	1.32	0.66	0.56	-0.45	2.54e-10	1.32e-9	(B) Positive
SIN3A	15q24.2	0.20	0.50	0.43	0.41	-0.30	2.55e-10	1.32e-9	(B) Positive
ZNF30	19q13.13	0.25	0.75	0.74	0.58	-0.50	2.57e-10	1.33e-9	(B) Positive
GTF3C6	6q21	0.14	-0.29	0.63	0.56	0.43	2.58e-10	1.33e-9	(A) Negative
MIIP	1p36.22	-0.63	-0.96	0.49	0.40	0.33	2.58e-10	1.33e-9	(A) Negative
PIP	7q34	4.26	5.62	2.03	1.44	-1.36	2.59e-10	1.34e-9	(B) Positive
BNIP3L	8p21.2	-0.88	-0.43	0.62	0.68	-0.44	2.65e-10	1.37e-9	(B) Positive
MVD	16q24.2	-0.94	-1.36	0.60	0.60	0.42	2.66e-10	1.37e-9	(A) Negative
PRKAG3	2q35	1.41	0.32	1.66	1.01	1.09	2.66e-10	1.38e-9	(A) Negative
HTRA1	10q26.13	0.77	1.46	1.01	0.92	-0.70	2.67e-10	1.38e-9	(B) Positive
RB1	13q14.2	-1.21	-0.67	0.82	0.46	-0.54	2.69e-10	1.39e-9	(B) Positive
LRSAM1	9q33.3-q34.11	-0.09	0.26	0.50	0.53	-0.35	2.70e-10	1.39e-9	(B) Positive
RAB3D	19p13.2	1.14	1.55	0.59	0.57	-0.41	2.71e-10	1.40e-9	(B) Positive
SLC12A6	15q14	0.35	-0.00	0.50	0.50	0.35	2.72e-10	1.40e-9	(A) Negative
MRPS17	7p11.2	-0.01	-0.58	0.86	0.58	0.57	2.78e-10	1.43e-9	(A) Negative
PAGR1	16p11.2	0.25	0.64	0.57	0.52	-0.39	2.79e-10	1.44e-9	(B) Positive
CCNJL	5q33.3	-0.15	-0.84	1.01	0.88	0.69	2.81e-10	1.45e-9	(A) Negative
ZNF44	19p13.2	-0.19	0.12	0.44	0.49	-0.31	2.81e-10	1.45e-9	(B) Positive
GRINA	8q24.3	0.85	1.27	0.58	0.64	-0.41	2.84e-10	1.46e-9	(B) Positive
PNO1	2p14	-0.37	-0.73	0.52	0.41	0.35	2.86e-10	1.47e-9	(A) Negative
CYSTM1	5q31.3	-0.30	0.12	0.60	0.60	-0.42	2.87e-10	1.48e-9	(B) Positive
C1ORF116	1q32.1	3.26	2.42	1.08	1.63	0.84	2.87e-10	1.48e-9	(A) Negative
HNRNPLL	2p22.1	-0.42	-0.81	0.57	0.49	0.39	2.88e-10	1.48e-9	(A) Negative
FBXO11	2p16.3	0.35	0.06	0.42	0.35	0.28	2.88e-10	1.48e-9	(A) Negative
HAO1	20p12.3	1.19	0.18	1.58	0.63	1.02	2.89e-10	1.48e-9	(A) Negative
RACGAP1	12q13.12	-1.10	-1.54	0.60	0.76	0.44	2.92e-10	1.50e-9	(A) Negative
CYFIP2	5q33.3	-1.07	-0.41	0.94	0.99	-0.66	2.92e-10	1.50e-9	(B) Positive
PSIP1	9p22.3	-0.83	-1.45	0.93	0.65	0.62	2.92e-10	1.50e-9	(A) Negative
FBXL3	13q22.3	0.63	1.13	0.74	0.61	-0.50	2.93e-10	1.50e-9	(B) Positive
C1ORF52	1p22.3	-0.24	-0.59	0.51	0.42	0.34	2.96e-10	1.52e-9	(A) Negative
SNRPN	15q11.2	-2.52	-2.00	0.72	0.81	-0.51	3.02e-10	1.55e-9	(B) Positive
CDC42BPG	11q13.1	0.66	0.39	0.40	0.37	0.27	3.04e-10	1.56e-9	(A) Negative
DMD	Xp21.2-p21.1	0.33	-0.12	0.67	0.50	0.45	3.05e-10	1.56e-9	(A) Negative
DISP1	1q41	0.61	1.08	0.68	0.62	-0.47	3.09e-10	1.58e-9	(B) Positive
LRPAP1	4p16.3	-0.06	0.28	0.49	0.43	-0.33	3.11e-10	1.59e-9	(B) Positive
CHRM3	1q43	-0.90	-1.52	0.95	0.58	0.62	3.13e-10	1.60e-9	(A) Negative
MAB21L1	13q13.3	0.82	1.34	0.73	0.88	-0.53	3.14e-10	1.61e-9	(B) Positive
LDLRAD1	1p32.3	-2.72	-1.59	1.65	1.49	-1.13	3.14e-10	1.61e-9	(B) Positive
GATA6	18q11.2	1.16	0.19	1.44	1.13	0.97	3.15e-10	1.61e-9	(A) Negative
USP39	2p11.2	0.01	-0.28	0.43	0.31	0.28	3.15e-10	1.61e-9	(A) Negative
KLRD1	12p13.2	2.90	2.06	1.23	1.12	0.84	3.16e-10	1.62e-9	(A) Negative
KLF2	19p13.11	1.73	2.18	0.64	0.65	-0.45	3.19e-10	1.63e-9	(B) Positive
SLC18B1	6q23.2	0.32	-0.39	1.05	0.89	0.71	3.22e-10	1.64e-9	(A) Negative
RNF150	4q31.21	0.14	-0.93	1.61	1.08	1.06	3.24e-10	1.65e-9	(A) Negative
TUBA1B	12q13.12	-0.41	-0.73	0.45	0.47	0.32	3.26e-10	1.67e-9	(A) Negative
TOMM22	22q13.1	-0.08	-0.42	0.50	0.45	0.34	3.27e-10	1.67e-9	(A) Negative
NAA25	12q24.13	-0.73	-1.09	0.54	0.46	0.36	3.28e-10	1.67e-9	(A) Negative
ZNHIT3	17q12	-0.54	-0.20	0.46	0.57	-0.34	3.34e-10	1.70e-9	(B) Positive
TIMM44	19p13.2	-0.41	-0.75	0.50	0.46	0.34	3.34e-10	1.70e-9	(A) Negative
CXCL2	4q13.3	-0.30	-1.27	1.41	1.31	0.97	3.36e-10	1.72e-9	(A) Negative
TRAPPC6A	19q13.32	0.36	0.76	0.59	0.51	-0.40	3.38e-10	1.72e-9	(B) Positive
ZMYND12	1p34.2	2.25	2.93	0.97	1.01	-0.68	3.38e-10	1.72e-9	(B) Positive
GNG10	9q31.3	-0.47	-0.01	0.66	0.63	-0.45	3.39e-10	1.73e-9	(B) Positive
TRAFD1	12q24.13	-0.10	0.23	0.48	0.53	-0.34	3.39e-10	1.73e-9	(B) Positive
CREB5	7p15.1-p14.3	-0.89	-1.61	1.08	0.81	0.72	3.40e-10	1.73e-9	(A) Negative
ZNF217	20q13.2	0.01	0.50	0.69	0.79	-0.49	3.42e-10	1.74e-9	(B) Positive
ABCC4	13q32.1	-1.12	-1.78	0.98	0.82	0.66	3.48e-10	1.77e-9	(A) Negative
PLAGL2	20q11.21	-0.02	-0.48	0.68	0.61	0.47	3.56e-10	1.81e-9	(A) Negative
PTGR1	9q31.3	-0.72	-0.24	0.67	0.84	-0.49	3.57e-10	1.82e-9	(B) Positive
HARS2	5q31.3	-0.14	0.21	0.52	0.42	-0.35	3.57e-10	1.82e-9	(B) Positive
PITPNA	17p13.3	0.09	-0.25	0.50	0.44	0.34	3.64e-10	1.85e-9	(A) Negative
CLEC3B	3p21.31	0.68	1.33	0.97	0.87	-0.66	3.65e-10	1.86e-9	(B) Positive
ASRGL1	11q12.3	-0.63	-1.57	1.34	1.41	0.94	3.66e-10	1.86e-9	(A) Negative
TRIM15	6p22.1	-2.70	-3.29	0.92	0.46	0.60	3.68e-10	1.87e-9	(A) Negative
NXT1	20p11.21	0.30	-0.05	0.53	0.39	0.35	3.71e-10	1.88e-9	(A) Negative
ANAPC13	3q22.2	-0.06	0.31	0.55	0.44	-0.37	3.71e-10	1.88e-9	(B) Positive
ALYREF	17q25.3	0.08	-0.50	0.84	0.84	0.58	3.72e-10	1.89e-9	(A) Negative
SIGMAR1	9p13.3	-0.15	-0.39	0.35	0.32	0.24	3.72e-10	1.89e-9	(A) Negative
CX3CR1	3p22.2	-2.30	-1.50	1.15	1.23	-0.80	3.72e-10	1.89e-9	(B) Positive
WDR73	15q25.2	-0.47	-0.14	0.48	0.45	-0.33	3.77e-10	1.91e-9	(B) Positive
DHRS2	14q11.2	-3.59	-2.51	1.44	2.00	-1.08	3.80e-10	1.93e-9	(B) Positive
HDAC7	12q13.11	-0.24	0.06	0.43	0.41	-0.29	3.82e-10	1.94e-9	(B) Positive
SLC10A3	Xq28	0.50	0.13	0.55	0.45	0.37	3.85e-10	1.95e-9	(A) Negative
PXN	12q24.23	-0.76	-0.50	0.38	0.34	-0.26	3.86e-10	1.96e-9	(B) Positive
FAM83E	19q13.33	0.09	0.78	0.95	1.20	-0.69	3.86e-10	1.96e-9	(B) Positive
ZNF438	10p11.23	1.26	0.89	0.56	0.46	0.38	3.93e-10	1.99e-9	(A) Negative
EIF2AK4	15q15.1	0.17	0.56	0.57	0.54	-0.39	3.95e-10	2.00e-9	(B) Positive
SOX12	20p13	-0.72	-0.25	0.69	0.65	-0.47	3.96e-10	2.00e-9	(B) Positive
HIGD1B	17q21.31	3.32	3.95	0.94	0.72	-0.63	3.97e-10	2.01e-9	(B) Positive
RCCD1	15q26.1	-1.05	-1.49	0.66	0.55	0.44	4.02e-10	2.03e-9	(A) Negative
ICA1	7p21.3	1.08	1.59	0.75	0.63	-0.51	4.04e-10	2.04e-9	(B) Positive
FRMD6	14q22.1	-0.50	0.06	0.81	0.82	-0.56	4.06e-10	2.05e-9	(B) Positive
PDZK1IP1	1p33	3.70	3.16	0.64	1.21	0.54	4.06e-10	2.05e-9	(A) Negative
NQO1	16q22.1	-1.75	-0.79	1.43	1.19	-0.96	4.08e-10	2.06e-9	(B) Positive
PRPF3	1q21.2	0.12	-0.33	0.68	0.55	0.45	4.10e-10	2.07e-9	(A) Negative
PSEN1	14q24.2	0.31	0.64	0.48	0.51	-0.33	4.13e-10	2.09e-9	(B) Positive
ICOSLG	21q22.3	0.49	0.17	0.47	0.42	0.32	4.14e-10	2.09e-9	(A) Negative
PRSS33	16p13.3	-0.30	-1.28	1.53	0.58	0.98	4.15e-10	2.10e-9	(A) Negative
BPNT2	8q12.1	0.83	0.42	0.61	0.57	0.42	4.18e-10	2.11e-9	(A) Negative
AP1M2	19p13.2	1.30	1.75	0.67	0.58	-0.45	4.23e-10	2.13e-9	(B) Positive
HDHD5	22q11.1	-0.28	-0.66	0.56	0.52	0.38	4.28e-10	2.16e-9	(A) Negative
NDUFS5	1p34.3	0.22	-0.16	0.57	0.44	0.38	4.30e-10	2.17e-9	(A) Negative
ACAD10	12q24.12	-0.49	-0.22	0.36	0.47	-0.27	4.34e-10	2.19e-9	(B) Positive
C8G	9q34.3	-1.09	-1.63	0.81	0.58	0.53	4.40e-10	2.21e-9	(A) Negative
MYO15A	17p11.2	-0.23	0.27	0.71	0.85	-0.51	4.41e-10	2.22e-9	(B) Positive
FCRL5	1q23.1	1.33	0.56	1.17	0.87	0.77	4.45e-10	2.24e-9	(A) Negative
SLC35E2A	1p36.33	-0.27	0.01	0.40	0.47	-0.29	4.48e-10	2.25e-9	(B) Positive
FAM219A	9p13.3	0.44	0.21	0.34	0.27	0.23	4.50e-10	2.27e-9	(A) Negative
E2F4	16q22.1	-0.84	-1.14	0.46	0.38	0.31	4.53e-10	2.28e-9	(A) Negative
CCK	3p22.1	-0.84	-1.98	1.73	1.21	1.14	4.53e-10	2.28e-9	(A) Negative
PTCH2	1p34.1	0.42	0.58	0.23	0.29	-0.17	4.55e-10	2.29e-9	(B) Positive
SLC25A32	8q22.3	0.08	-0.33	0.60	0.59	0.41	4.59e-10	2.31e-9	(A) Negative
REPS1	6q24.1	0.09	-0.34	0.66	0.50	0.43	4.61e-10	2.31e-9	(A) Negative
RRBP1	20p12.1	0.88	0.42	0.67	0.59	0.45	4.61e-10	2.31e-9	(A) Negative
MCOLN2	1p22.3	1.24	0.45	1.17	1.03	0.79	4.61e-10	2.31e-9	(A) Negative
LRRC59	17q21.33	-0.06	-0.44	0.55	0.58	0.38	4.65e-10	2.33e-9	(A) Negative
KCNH1	1q32.2	0.36	0.66	0.42	0.47	-0.30	4.67e-10	2.34e-9	(B) Positive
ARID4A	14q23.1	-0.03	0.27	0.44	0.43	-0.30	4.70e-10	2.36e-9	(B) Positive
KIF3C	2p23.3	0.59	0.07	0.76	0.76	0.52	4.71e-10	2.36e-9	(A) Negative
SLC16A5	17q25.1	-0.19	0.49	0.98	1.05	-0.68	4.71e-10	2.36e-9	(B) Positive
TSC1	9q34	-0.36	-0.08	0.41	0.40	-0.28	4.73e-10	2.37e-9	(B) Positive
NHSL3	1p35.1	0.88	1.27	0.56	0.56	-0.39	4.76e-10	2.39e-9	(B) Positive
ZNF597	16p13.3	-0.06	0.67	1.13	0.68	-0.73	4.77e-10	2.39e-9	(B) Positive
RAX	18q21.32	0.69	0.04	1.03	0.44	0.66	4.79e-10	2.40e-9	(A) Negative
TAF7L	Xq22.1	0.42	-0.07	0.77	0.43	0.49	4.79e-10	2.40e-9	(A) Negative
CKAP2	13q14.3	-0.63	-1.08	0.65	0.64	0.45	4.81e-10	2.41e-9	(A) Negative
KIF5B	10p11.22	0.53	0.14	0.59	0.43	0.39	4.82e-10	2.41e-9	(A) Negative
MAN2A1	5q21.3	-0.47	0.01	0.68	0.72	-0.47	4.83e-10	2.41e-9	(B) Positive
EGFL6	Xp22.2	3.61	2.78	1.22	1.12	0.83	4.84e-10	2.42e-9	(A) Negative
EOLA2	Xq28	0.43	0.84	0.57	0.68	-0.41	4.84e-10	2.42e-9	(B) Positive
PWWP3A	19p13.3	-0.20	0.10	0.44	0.39	-0.29	4.86e-10	2.43e-9	(B) Positive
ATP1A1	1p13.1	0.38	-0.04	0.62	0.53	0.42	4.87e-10	2.43e-9	(A) Negative
EED	11q14.2	-0.62	-1.01	0.58	0.55	0.40	4.88e-10	2.44e-9	(A) Negative
CNNM3	2q11.2	-0.02	0.32	0.50	0.52	-0.35	4.90e-10	2.45e-9	(B) Positive
DHCR24	1p32.3	-0.01	0.71	1.10	0.72	-0.72	4.94e-10	2.46e-9	(B) Positive
ALX3	1p13.3	0.78	0.23	0.87	0.43	0.56	4.94e-10	2.47e-9	(A) Negative
CLDN14	21q22.13	0.53	-0.33	1.26	1.19	0.86	5.01e-10	2.50e-9	(A) Negative
NUDT13	10q22.2	-1.64	-1.16	0.71	0.70	-0.49	5.03e-10	2.51e-9	(B) Positive
MIR1915HG	10p12.31	0.19	-0.87	1.62	1.09	1.05	5.06e-10	2.52e-9	(A) Negative
SHTN1	10q25.3	0.53	1.00	0.71	0.57	-0.47	5.08e-10	2.53e-9	(B) Positive
HEBP2	6q24.1	1.75	1.24	0.78	0.58	0.51	5.12e-10	2.55e-9	(A) Negative
F11R	1q23.3	1.29	0.86	0.63	0.61	0.43	5.14e-10	2.56e-9	(A) Negative
RNF38	9p13.2	0.65	0.28	0.57	0.44	0.38	5.19e-10	2.58e-9	(A) Negative
RTN4	2p16.1	-0.36	0.07	0.62	0.70	-0.44	5.19e-10	2.58e-9	(B) Positive
VGF	7q22.1	-0.88	-1.38	0.72	0.74	0.50	5.20e-10	2.59e-9	(A) Negative
KRT32	17q21.2	0.62	1.36	1.03	1.28	-0.74	5.20e-10	2.59e-9	(B) Positive
DGKD	2q37.1	-0.38	0.15	0.76	0.77	-0.52	5.21e-10	2.59e-9	(B) Positive
TPGS2	18q12.2	-0.07	-0.52	0.69	0.56	0.46	5.28e-10	2.62e-9	(A) Negative
DLX5	7q21.3	0.75	-0.20	1.48	0.78	0.95	5.28e-10	2.62e-9	(A) Negative
POLG	15q26.1	-1.33	-1.81	0.71	0.68	0.48	5.35e-10	2.66e-9	(A) Negative
EPOR	19p13.2	-1.08	-0.75	0.49	0.47	-0.34	5.35e-10	2.66e-9	(B) Positive
NDUFV2	18p11.22	-0.47	-0.10	0.55	0.48	-0.37	5.36e-10	2.66e-9	(B) Positive
MAGI1	3p14.1	-0.11	0.36	0.70	0.70	-0.48	5.43e-10	2.70e-9	(B) Positive
TIMM50	19q13.2	-0.12	-0.44	0.47	0.41	0.31	5.45e-10	2.70e-9	(A) Negative
NUDT3	6p21.31	0.68	0.31	0.56	0.45	0.37	5.46e-10	2.71e-9	(A) Negative
U2SURP	3q23	-0.25	-0.55	0.44	0.35	0.29	5.48e-10	2.72e-9	(A) Negative
WDR74	11q12.3	-0.50	-0.80	0.45	0.42	0.30	5.48e-10	2.72e-9	(A) Negative
BLOC1S4	4p16.1	-0.39	-0.09	0.44	0.39	-0.30	5.55e-10	2.75e-9	(B) Positive
CNNM4	2q11.2	0.71	1.11	0.56	0.66	-0.39	5.62e-10	2.78e-9	(B) Positive
VAMP2	17p13.1	0.31	0.60	0.42	0.45	-0.29	5.62e-10	2.79e-9	(B) Positive
SEPTIN11	4q21.1	0.53	0.15	0.56	0.53	0.38	5.63e-10	2.79e-9	(A) Negative
ABHD4	14q11.2	-0.12	0.28	0.60	0.51	-0.40	5.63e-10	2.79e-9	(B) Positive
RNH1	11p15.5	-0.18	0.14	0.49	0.42	-0.33	5.63e-10	2.79e-9	(B) Positive
PDCD2L	19q13.11	-0.11	-0.56	0.68	0.50	0.45	5.64e-10	2.79e-9	(A) Negative
ZNF621	3p22.1	-0.05	0.27	0.47	0.45	-0.32	5.64e-10	2.79e-9	(B) Positive
STOM	9q33.2	0.26	0.81	0.78	0.85	-0.54	5.83e-10	2.88e-9	(B) Positive
KIR2DL4	19q13.42	0.93	0.50	0.66	0.36	0.42	5.90e-10	2.92e-9	(A) Negative
LY6K	8q24.3	-0.12	-1.18	1.60	1.26	1.06	5.90e-10	2.92e-9	(A) Negative
CENPM	22q13.2	-0.76	-1.22	0.64	0.78	0.46	5.91e-10	2.92e-9	(A) Negative
FLNA	Xq28	-0.37	-0.91	0.80	0.77	0.54	5.99e-10	2.96e-9	(A) Negative
ARG2	14q24.1	-1.75	-2.48	1.10	0.84	0.72	6.04e-10	2.98e-9	(A) Negative
GGNBP2	17q12	0.25	0.51	0.38	0.44	-0.27	6.05e-10	2.99e-9	(B) Positive
NACC2	9q34.3	-0.35	-0.93	0.88	0.69	0.58	6.14e-10	3.03e-9	(A) Negative
SPOCK2	10q22.1	1.05	0.29	1.12	1.04	0.75	6.18e-10	3.05e-9	(A) Negative
ZBTB41	1q31.3	1.09	1.45	0.50	0.58	-0.35	6.24e-10	3.08e-9	(B) Positive
KIAA1755	20q11.23	2.20	1.55	1.00	0.72	0.65	6.27e-10	3.09e-9	(A) Negative
MDC1	6p21.33	-0.68	-1.08	0.62	0.45	0.40	6.31e-10	3.11e-9	(A) Negative
TMEM45A	3q12.2	0.03	-0.89	1.38	1.26	0.93	6.34e-10	3.13e-9	(A) Negative
ADAMTS1	21q21.3	-1.26	-2.03	1.10	1.24	0.77	6.34e-10	3.13e-9	(A) Negative
GMNN	6p22.3	-1.19	-1.70	0.77	0.63	0.51	6.37e-10	3.14e-9	(A) Negative
DNAI3	1p22.3	0.24	0.75	0.70	0.94	-0.51	6.39e-10	3.15e-9	(B) Positive
PAXBP1	21q22.11	-0.69	-1.03	0.51	0.42	0.34	6.40e-10	3.15e-9	(A) Negative
GLT1D1	12q24.33	-2.01	-2.57	0.86	0.60	0.56	6.42e-10	3.16e-9	(A) Negative
SLC1A1	9p24.2	0.21	1.32	1.51	2.03	-1.10	6.43e-10	3.16e-9	(B) Positive
LOXL1	15q24.1	-0.74	-0.03	1.03	1.04	-0.70	6.46e-10	3.18e-9	(B) Positive
FCN3	1p36.11	2.53	2.07	0.68	0.69	0.46	6.50e-10	3.19e-9	(A) Negative
SAPCD2	9q34.3	-0.57	-1.06	0.71	0.75	0.49	6.50e-10	3.20e-9	(A) Negative
SEPHS2	16p11.2	0.01	0.50	0.71	0.71	-0.49	6.52e-10	3.21e-9	(B) Positive
TNFRSF8	1p36.22	-1.32	-1.77	0.67	0.60	0.45	6.55e-10	3.22e-9	(A) Negative
COL4A5	Xq22.3	-0.46	0.03	0.71	0.77	-0.49	6.66e-10	3.27e-9	(B) Positive
MIR9-1HG	1q22	-1.42	-2.11	1.08	0.62	0.69	6.67e-10	3.28e-9	(A) Negative
TFDP3	Xq26.2	0.20	-0.38	0.90	0.67	0.59	6.77e-10	3.32e-9	(A) Negative
RUFY1	5q35.3	0.48	0.84	0.54	0.48	-0.36	6.77e-10	3.32e-9	(B) Positive
CLK4	5q35.3	0.04	0.48	0.65	0.60	-0.44	6.78e-10	3.33e-9	(B) Positive
ZC3H15	2q32.1	-0.15	-0.46	0.47	0.37	0.31	6.80e-10	3.33e-9	(A) Negative
SACS	13q12.12	-1.74	-2.32	0.88	0.65	0.58	6.80e-10	3.33e-9	(A) Negative
PPARGC1A	4p15.2	-1.15	-2.08	1.46	0.85	0.93	6.81e-10	3.34e-9	(A) Negative
PPDPF	20q13.33	0.20	0.63	0.64	0.58	-0.43	6.95e-10	3.41e-9	(B) Positive
ZFYVE1	14q24.2	0.31	0.57	0.38	0.38	-0.26	6.97e-10	3.42e-9	(B) Positive
RELB	19q13.32	1.60	1.06	0.82	0.65	0.54	6.98e-10	3.42e-9	(A) Negative
RPS6KA5	14q32.11	-0.04	0.55	0.90	0.69	-0.59	6.99e-10	3.42e-9	(B) Positive
GALNT5	2q24.1	-2.39	-1.67	0.99	1.31	-0.72	7.08e-10	3.47e-9	(B) Positive
CIAPIN1	16q21	-0.25	-0.53	0.40	0.45	0.28	7.10e-10	3.48e-9	(A) Negative
GALNT2	1q42.13	-0.22	-0.55	0.48	0.54	0.33	7.13e-10	3.49e-9	(A) Negative
SIRPA	20p13	0.68	0.15	0.82	0.60	0.53	7.15e-10	3.50e-9	(A) Negative
ADGRL2	1p31.1	0.67	-0.10	1.18	0.87	0.77	7.16e-10	3.50e-9	(A) Negative
RASL11B	4q12	-0.15	0.66	1.23	1.04	-0.82	7.16e-10	3.50e-9	(B) Positive
SPAG7	17p13.2	-0.34	-0.01	0.47	0.49	-0.32	7.20e-10	3.52e-9	(B) Positive
C10ORF90	10q26.2	-1.07	-1.92	1.35	0.61	0.85	7.30e-10	3.57e-9	(A) Negative
ARHGAP1	11p11.2	0.57	0.87	0.46	0.43	-0.31	7.32e-10	3.57e-9	(B) Positive
GRHL1	2p25.1	1.69	1.07	0.95	0.71	0.62	7.35e-10	3.59e-9	(A) Negative
SLC26A11	17q25.3	0.52	0.91	0.57	0.64	-0.40	7.38e-10	3.60e-9	(B) Positive
MTIF2	2p16.1	-0.32	-0.66	0.51	0.38	0.33	7.39e-10	3.61e-9	(A) Negative
HIGD1A	3p22.1	-0.33	0.21	0.77	0.89	-0.54	7.43e-10	3.62e-9	(B) Positive
KRT4	12q13.13	1.43	0.56	1.38	0.62	0.87	7.44e-10	3.63e-9	(A) Negative
LRRIQ3	1p31.1	-0.30	0.46	1.09	1.17	-0.75	7.45e-10	3.63e-9	(B) Positive
DCAF13	8q22.3	-0.07	-0.54	0.70	0.70	0.48	7.45e-10	3.63e-9	(A) Negative
HINT3	6q22.32	0.58	0.04	0.81	0.71	0.54	7.46e-10	3.64e-9	(A) Negative
PDE4A	19p13.2	-0.08	0.40	0.69	0.76	-0.48	7.49e-10	3.65e-9	(B) Positive
UHMK1	1q23.3	0.65	1.07	0.61	0.69	-0.42	7.51e-10	3.66e-9	(B) Positive
TMOD2	15q21.2	1.09	0.55	0.83	0.67	0.54	7.57e-10	3.68e-9	(A) Negative
C5	9q33.2	-2.66	-2.16	0.74	0.74	-0.50	7.62e-10	3.71e-9	(B) Positive
NEURL3	2q11.2	1.64	0.84	1.20	1.07	0.80	7.67e-10	3.73e-9	(A) Negative
SNAP29	22q11.21	0.17	0.49	0.47	0.48	-0.32	7.73e-10	3.76e-9	(B) Positive
GSTM1	1p13.3	-0.84	-0.00	1.20	1.36	-0.84	7.77e-10	3.78e-9	(B) Positive
ZNF423	16q12.1	-0.23	0.41	0.93	0.96	-0.64	7.93e-10	3.85e-9	(B) Positive
GPR162	12p13	-1.09	-0.68	0.53	0.83	-0.41	8.00e-10	3.89e-9	(B) Positive
BHLHA15	7q21.3	0.41	0.23	0.26	0.28	0.18	8.00e-10	3.89e-9	(A) Negative
CSRNP1	3p22.2	0.45	0.85	0.57	0.67	-0.40	8.06e-10	3.92e-9	(B) Positive
CANT1	17q25.3	0.50	1.00	0.74	0.72	-0.50	8.13e-10	3.95e-9	(B) Positive
ORMDL2	12q13.2	0.49	0.90	0.62	0.52	-0.41	8.14e-10	3.95e-9	(B) Positive
ELMOD2	4q31.1	0.57	0.95	0.58	0.53	-0.38	8.16e-10	3.96e-9	(B) Positive
HPS6	10q24.32	0.44	0.76	0.48	0.39	-0.31	8.19e-10	3.97e-9	(B) Positive
DNAJB14	4q23	-0.04	0.31	0.53	0.49	-0.36	8.20e-10	3.98e-9	(B) Positive
ZRSR2	Xp22.2	0.22	0.51	0.44	0.43	-0.30	8.24e-10	4.00e-9	(B) Positive
TPPP2	14q11.2	-0.04	-0.57	0.86	0.36	0.54	8.26e-10	4.00e-9	(A) Negative
FAM204A	10q26.11	0.60	0.92	0.48	0.43	-0.32	8.29e-10	4.02e-9	(B) Positive
ZNF354C	5q35.3	0.19	-0.02	0.32	0.32	0.21	8.33e-10	4.04e-9	(A) Negative
NAGS	17q21.31	0.37	0.90	0.74	0.95	-0.53	8.35e-10	4.04e-9	(B) Positive
RPRML	17q21.32	-0.46	-1.76	2.06	1.10	1.30	8.48e-10	4.11e-9	(A) Negative
FMO2	1q24.3	2.79	2.08	1.09	0.91	0.71	8.55e-10	4.14e-9	(A) Negative
RUNX1	21q22.12	0.16	0.78	0.89	1.02	-0.62	8.65e-10	4.19e-9	(B) Positive
ROR2	9q22.31	0.67	1.20	0.78	0.81	-0.53	8.66e-10	4.19e-9	(B) Positive
CNGA3	2q11.2	0.10	0.70	0.84	1.06	-0.60	8.72e-10	4.22e-9	(B) Positive
HOXC5	12q13.13	0.04	0.45	0.59	0.65	-0.41	8.85e-10	4.28e-9	(B) Positive
C12ORF4	12p13.32	0.61	0.22	0.60	0.42	0.39	8.97e-10	4.34e-9	(A) Negative
CPLX3	15q24.1	0.61	0.05	0.87	0.57	0.56	9.03e-10	4.37e-9	(A) Negative
SNX2	5q23.2	-0.52	-0.15	0.57	0.46	-0.37	9.06e-10	4.38e-9	(B) Positive
KIT	4q12	1.84	0.66	1.80	1.57	1.19	9.08e-10	4.38e-9	(A) Negative
PAK3	Xq23	1.24	0.33	1.42	0.98	0.91	9.13e-10	4.41e-9	(A) Negative
PRSS16	6p22.1	1.04	-0.05	1.60	1.67	1.09	9.14e-10	4.41e-9	(A) Negative
ZFYVE21	14q32.33	0.39	0.77	0.57	0.52	-0.38	9.24e-10	4.46e-9	(B) Positive
KRT5	12q13.13	0.20	-1.02	1.83	1.68	1.22	9.27e-10	4.47e-9	(A) Negative
ZDHHC24	11q13.2	0.14	0.59	0.66	0.62	-0.44	9.32e-10	4.50e-9	(B) Positive
MDH2	7q11.23	0.18	-0.08	0.38	0.40	0.26	9.47e-10	4.57e-9	(A) Negative
CCP110	16p12.3	-0.68	-0.30	0.57	0.54	-0.38	9.48e-10	4.57e-9	(B) Positive
SFXN3	10q24.31	-0.43	-0.12	0.48	0.39	-0.31	9.60e-10	4.63e-9	(B) Positive
PPP3R1	2p14	0.03	-0.27	0.44	0.41	0.29	9.89e-10	4.76e-9	(A) Negative
METTL4	18p11.32	-0.05	-0.49	0.68	0.52	0.44	9.90e-10	4.77e-9	(A) Negative
B3GAT1	11q25	-2.01	-3.08	1.66	1.19	1.07	9.91e-10	4.77e-9	(A) Negative
MAX	14q23.3	0.39	0.65	0.38	0.38	-0.26	9.97e-10	4.80e-9	(B) Positive
GTF3C1	16p12.1	-0.02	0.31	0.48	0.53	-0.33	9.98e-10	4.80e-9	(B) Positive
ZBTB7A	19p13.3	0.45	0.90	0.68	0.55	-0.44	1.00e-9	4.83e-9	(B) Positive
CEP290	12q21.32	-0.43	0.15	0.87	0.83	-0.58	1.01e-9	4.84e-9	(B) Positive
PIGG	4p16.3	-0.41	-0.06	0.53	0.45	-0.35	1.01e-9	4.84e-9	(B) Positive
SLC4A11	20p13	-0.27	-0.97	1.07	0.87	0.70	1.01e-9	4.84e-9	(A) Negative
SHMT2	12q13.3	-0.70	-1.10	0.60	0.57	0.40	1.01e-9	4.87e-9	(A) Negative
PCK2	14q11.2-q12	-0.76	-0.29	0.73	0.57	-0.47	1.02e-9	4.88e-9	(B) Positive
PABIR1	9q21.11	0.11	-0.21	0.49	0.41	0.32	1.02e-9	4.90e-9	(A) Negative
KCNQ4	1p34.2	0.31	-0.04	0.53	0.48	0.35	1.03e-9	4.96e-9	(A) Negative
USP35	11q14.1	-0.19	0.24	0.59	0.82	-0.43	1.04e-9	4.99e-9	(B) Positive
HS6ST3	13q32.1	-0.48	0.67	1.69	1.81	-1.15	1.05e-9	5.02e-9	(B) Positive
CAMKV	3p21.31	-2.48	-3.09	0.96	0.54	0.61	1.05e-9	5.04e-9	(A) Negative
SLFN11	17q12	-0.33	-0.98	0.99	0.88	0.65	1.05e-9	5.05e-9	(A) Negative
LRFN4	11q13.2	-0.09	-0.58	0.72	0.78	0.49	1.06e-9	5.06e-9	(A) Negative
AREG	4q13.3	-2.92	-1.54	1.89	2.58	-1.37	1.06e-9	5.09e-9	(B) Positive
ATRNL1	10q25.3	-1.78	-0.87	1.28	1.58	-0.90	1.07e-9	5.13e-9	(B) Positive
SEC62	3q26.2	0.24	0.61	0.57	0.48	-0.37	1.07e-9	5.13e-9	(B) Positive
FAM111B	11q12.1	0.56	-0.30	1.28	1.25	0.86	1.08e-9	5.16e-9	(A) Negative
KTI12	1p32.3	0.11	-0.16	0.41	0.35	0.27	1.08e-9	5.16e-9	(A) Negative
RNF144A	2p25.1	-0.15	-0.57	0.64	0.62	0.42	1.10e-9	5.26e-9	(A) Negative
GFI1	1p22.1	-1.51	-2.21	1.06	0.95	0.70	1.11e-9	5.34e-9	(A) Negative
ANP32B	9q22.33	-0.28	-0.63	0.54	0.36	0.34	1.12e-9	5.35e-9	(A) Negative
ZNF117	7q11.21	-0.35	0.13	0.71	0.68	-0.47	1.12e-9	5.36e-9	(B) Positive
POLR1G	19q13.32	0.45	-0.02	0.72	0.56	0.47	1.12e-9	5.37e-9	(A) Negative
PDK4	7q21.3	-1.49	-0.59	1.30	1.50	-0.90	1.13e-9	5.41e-9	(B) Positive
PTBP3	9q32	0.55	0.26	0.44	0.40	0.29	1.14e-9	5.45e-9	(A) Negative
ZNF134	19q13.43	-0.05	0.30	0.53	0.50	-0.35	1.14e-9	5.45e-9	(B) Positive
DCUN1D5	11q22.3	-0.80	-1.29	0.75	0.65	0.49	1.14e-9	5.45e-9	(A) Negative
CYP2A13	19q13.2	0.73	1.30	0.70	1.27	-0.57	1.15e-9	5.47e-9	(B) Positive
MIS18A	21q22.11	-0.12	-0.48	0.55	0.52	0.37	1.15e-9	5.50e-9	(A) Negative
LAG3	12p13.31	1.50	0.56	1.44	1.26	0.95	1.15e-9	5.51e-9	(A) Negative
CSDE1	1p13.2	-0.17	-0.45	0.43	0.37	0.28	1.16e-9	5.54e-9	(A) Negative
CKLF	16q21	-0.29	-0.65	0.53	0.47	0.35	1.20e-9	5.70e-9	(A) Negative
NAIP	5q13.2	-0.34	0.17	0.77	0.75	-0.51	1.20e-9	5.74e-9	(B) Positive
AZIN2	1p35.1	0.88	1.23	0.53	0.45	-0.35	1.22e-9	5.79e-9	(B) Positive
PGRMC1	Xq24	0.69	0.23	0.70	0.64	0.46	1.22e-9	5.80e-9	(A) Negative
PAICS	4q12	-0.94	-1.33	0.60	0.46	0.39	1.22e-9	5.81e-9	(A) Negative
GSDMD	8q24.3	0.23	0.74	0.77	0.70	-0.51	1.22e-9	5.83e-9	(B) Positive
SLC1A4	2p14	-0.44	0.10	0.81	0.74	-0.53	1.23e-9	5.88e-9	(B) Positive
KLHL12	1q32.1	-0.12	0.20	0.48	0.47	-0.32	1.24e-9	5.90e-9	(B) Positive
GDAP1	8q21.11	-0.25	0.40	0.86	1.31	-0.64	1.25e-9	5.95e-9	(B) Positive
EIF3B	7p22.3	0.04	-0.27	0.50	0.35	0.32	1.26e-9	5.97e-9	(A) Negative
MRPL12	17q25.3	-0.04	-0.46	0.64	0.61	0.42	1.26e-9	5.97e-9	(A) Negative
STARD5	15q25.1	-0.11	0.22	0.48	0.54	-0.33	1.28e-9	6.08e-9	(B) Positive
JPT2	16p13.3	0.35	0.69	0.51	0.49	-0.34	1.29e-9	6.16e-9	(B) Positive
ICAM1	19p13.2	0.14	-0.59	1.15	0.82	0.73	1.30e-9	6.16e-9	(A) Negative
COL9A1	6q13	-0.49	-2.09	2.60	1.10	1.60	1.30e-9	6.17e-9	(A) Negative
TEKT2	1p34.3	0.35	1.15	1.17	1.37	-0.81	1.30e-9	6.17e-9	(B) Positive
SNRPD1	18q11.2	-0.48	-0.85	0.56	0.48	0.36	1.31e-9	6.22e-9	(A) Negative
LCK	1p35.2	-1.21	-2.02	1.21	1.20	0.81	1.32e-9	6.25e-9	(A) Negative
ARSD	Xp22.33	0.71	1.12	0.61	0.66	-0.41	1.33e-9	6.29e-9	(B) Positive
TRIM58	1q44	-1.59	-0.61	1.47	1.51	-0.99	1.33e-9	6.33e-9	(B) Positive
LRRC8C	1p22.2	0.26	-0.37	1.00	0.72	0.64	1.34e-9	6.33e-9	(A) Negative
SPAG5	17q11.2	-1.51	-2.09	0.83	0.99	0.58	1.34e-9	6.35e-9	(A) Negative
ZNF740	12q13.13	-0.26	-0.01	0.37	0.35	-0.24	1.35e-9	6.42e-9	(B) Positive
THUMPD1	16p12.3	0.17	0.49	0.49	0.47	-0.33	1.35e-9	6.42e-9	(B) Positive
COX6A1	12q24.31	0.22	0.53	0.45	0.52	-0.31	1.36e-9	6.45e-9	(B) Positive
DNTTIP2	1p22.1	0.06	-0.26	0.50	0.38	0.32	1.36e-9	6.47e-9	(A) Negative
EML2	19q13.32	-0.58	-0.06	0.77	0.79	-0.52	1.37e-9	6.47e-9	(B) Positive
RIMS1	6q13	0.28	0.68	0.46	0.95	-0.40	1.37e-9	6.48e-9	(B) Positive
CDAN1	15q15.2	-0.63	-0.27	0.54	0.51	-0.36	1.38e-9	6.53e-9	(B) Positive
CAVIN2	2q32.3	-1.68	-0.83	1.23	1.49	-0.86	1.39e-9	6.55e-9	(B) Positive
CLDN12	7q21.13	-0.06	0.33	0.54	0.71	-0.39	1.39e-9	6.55e-9	(B) Positive
DCAF4	14q24.2	0.44	0.01	0.67	0.55	0.43	1.39e-9	6.56e-9	(A) Negative
CARD6	5p13.1	0.42	-0.21	0.97	0.81	0.63	1.39e-9	6.59e-9	(A) Negative
PML	15q24.1	0.89	0.48	0.64	0.45	0.41	1.39e-9	6.59e-9	(A) Negative
GAR1	4q25	-0.09	-0.48	0.63	0.35	0.39	1.40e-9	6.62e-9	(A) Negative
UBR1	15q15.2	0.04	0.41	0.58	0.40	-0.37	1.42e-9	6.71e-9	(B) Positive
NAGLU	17q21.2	-0.40	-0.04	0.54	0.55	-0.36	1.43e-9	6.75e-9	(B) Positive
NANP	20p11.21	-0.27	-0.63	0.56	0.49	0.36	1.43e-9	6.76e-9	(A) Negative
PHAX	5q23.2	-0.31	-0.07	0.35	0.40	-0.24	1.44e-9	6.79e-9	(B) Positive
CCDC22	Xp11.23	-0.08	0.19	0.41	0.40	-0.27	1.44e-9	6.80e-9	(B) Positive
LAMA3	18q11.2	0.39	1.10	1.05	1.17	-0.72	1.45e-9	6.84e-9	(B) Positive
SULT4A1	22q13.31	-0.38	-1.08	1.10	0.81	0.70	1.45e-9	6.85e-9	(A) Negative
DOC2A	16p11.2	-0.35	-0.03	0.45	0.58	-0.32	1.46e-9	6.89e-9	(B) Positive
DHRS7B	17p11.2	0.44	0.77	0.47	0.59	-0.33	1.48e-9	6.98e-9	(B) Positive
IGFBP5	2q35	0.53	1.27	1.05	1.34	-0.74	1.48e-9	6.99e-9	(B) Positive
RAB29	1q32.1	0.59	0.07	0.77	0.82	0.52	1.52e-9	7.17e-9	(A) Negative
OMA1	1p32.2-p32.1	0.19	0.55	0.54	0.54	-0.36	1.53e-9	7.20e-9	(B) Positive
OPTN	10p13	1.52	0.95	0.90	0.61	0.57	1.53e-9	7.22e-9	(A) Negative
TTC29	4q31.22	-0.67	0.11	1.11	1.42	-0.78	1.55e-9	7.30e-9	(B) Positive
RALGPS1	9q33.3	0.27	0.69	0.65	0.52	-0.42	1.56e-9	7.34e-9	(B) Positive
EDN1	6p24.1	1.64	0.80	1.25	1.32	0.84	1.57e-9	7.39e-9	(A) Negative
EDF1	9q34.3	-0.01	0.27	0.41	0.40	-0.27	1.58e-9	7.42e-9	(B) Positive
CYB5D1	17p13.1	-0.04	0.34	0.55	0.64	-0.38	1.58e-9	7.42e-9	(B) Positive
COL4A3	2q36.3	-0.28	-0.68	0.61	0.52	0.39	1.58e-9	7.43e-9	(A) Negative
ACTR10	14q23.1	-0.14	0.21	0.55	0.47	-0.36	1.59e-9	7.46e-9	(B) Positive
POLL	10q24.32	-0.14	0.07	0.31	0.32	-0.21	1.60e-9	7.52e-9	(B) Positive
NUBP1	16p13.13	0.05	0.39	0.54	0.39	-0.34	1.63e-9	7.65e-9	(B) Positive
EPN3	17q21.33	1.91	2.55	0.98	0.84	-0.64	1.63e-9	7.65e-9	(B) Positive
RRAGB	Xp11.21	0.50	1.01	0.78	0.65	-0.50	1.63e-9	7.67e-9	(B) Positive
KIR2DS2	19q13.4 alternate reference locus	0.79	0.41	0.60	0.43	0.38	1.65e-9	7.75e-9	(A) Negative
SRFBP1	5q23.1	-0.27	0.04	0.46	0.45	-0.31	1.68e-9	7.88e-9	(B) Positive
CCL18	17q12	4.19	3.63	0.79	0.98	0.55	1.68e-9	7.90e-9	(A) Negative
DUSP16	12p13.2	0.53	0.94	0.60	0.69	-0.41	1.69e-9	7.93e-9	(B) Positive
ANKRD29	18q11.2	-1.69	-1.07	0.87	1.20	-0.62	1.70e-9	7.98e-9	(B) Positive
FLYWCH1	16p13.3	-0.57	-0.32	0.39	0.34	-0.25	1.71e-9	8.01e-9	(B) Positive
CEACAM6	19q13.2	-0.11	2.12	3.47	2.85	-2.23	1.72e-9	8.05e-9	(B) Positive
SEC14L1	17q25.2-q25.3	-0.22	-0.57	0.55	0.42	0.35	1.72e-9	8.06e-9	(A) Negative
DNAI1	9p13.3	0.18	0.53	0.47	0.72	-0.35	1.74e-9	8.14e-9	(B) Positive
TBK1	12q14.2	0.01	0.32	0.48	0.42	-0.31	1.74e-9	8.17e-9	(B) Positive
SNW1	14q24.3	-0.36	-0.15	0.31	0.36	-0.21	1.75e-9	8.21e-9	(B) Positive
CC2D1B	1p32.3	-0.10	-0.34	0.37	0.34	0.24	1.76e-9	8.25e-9	(A) Negative
MSH6	2p16.3	-0.42	-0.86	0.70	0.47	0.44	1.77e-9	8.26e-9	(A) Negative
H4C2	6p22.2	-0.40	-0.91	0.79	0.72	0.51	1.77e-9	8.29e-9	(A) Negative
OTUD7B	1q21.2	0.76	1.15	0.58	0.55	-0.38	1.78e-9	8.30e-9	(B) Positive
SQSTM1	5q35.3	0.61	1.05	0.68	0.55	-0.43	1.78e-9	8.30e-9	(B) Positive
BCAT1	12p12.1	-2.22	-2.96	1.18	0.79	0.74	1.78e-9	8.31e-9	(A) Negative
ERRFI1	1p36.23	-0.41	-0.99	0.90	0.77	0.58	1.78e-9	8.33e-9	(A) Negative
CAPN6	Xq23	0.64	-0.86	2.43	1.30	1.50	1.79e-9	8.36e-9	(A) Negative
EXTL3	8p21.1	0.03	-0.33	0.56	0.47	0.36	1.80e-9	8.40e-9	(A) Negative
KRT86	12q13	0.57	-0.54	1.80	0.92	1.11	1.81e-9	8.46e-9	(A) Negative
SLC35E3	12q15	0.04	0.52	0.74	0.69	-0.48	1.81e-9	8.46e-9	(B) Positive
SHANK3	22q13.33	1.16	0.88	0.41	0.44	0.27	1.81e-9	8.47e-9	(A) Negative
TRMT1L	1q25.3	0.09	0.47	0.58	0.50	-0.37	1.82e-9	8.50e-9	(B) Positive
WDR20	14q32.31	0.21	0.48	0.43	0.37	-0.28	1.84e-9	8.56e-9	(B) Positive
COPB1	11p15.2	-0.17	0.14	0.47	0.49	-0.31	1.87e-9	8.69e-9	(B) Positive
MXD4	4p16.3	0.61	0.95	0.52	0.45	-0.34	1.88e-9	8.76e-9	(B) Positive
RBM15	1p13.3	-0.50	-0.82	0.48	0.44	0.31	1.90e-9	8.83e-9	(A) Negative
TREX2	Xq28	0.36	0.06	0.46	0.37	0.29	1.90e-9	8.83e-9	(A) Negative
AKR1B1	7q33	-1.35	-1.91	0.88	0.66	0.56	1.90e-9	8.84e-9	(A) Negative
ITGB1BP2	Xq13.1	-1.13	-1.60	0.74	0.61	0.47	1.90e-9	8.84e-9	(A) Negative
USP28	11q23.2	-0.70	-1.12	0.64	0.63	0.42	1.92e-9	8.93e-9	(A) Negative
NUDT21	16q13	-0.60	-0.91	0.47	0.46	0.31	1.92e-9	8.95e-9	(A) Negative
PKNOX1	21q22.3	0.20	0.39	0.30	0.28	-0.20	1.96e-9	9.12e-9	(B) Positive
S100A11	1q21.3	1.14	0.64	0.78	0.64	0.50	2.00e-9	9.31e-9	(A) Negative
EXD2	14q24.1	0.58	0.94	0.55	0.50	-0.36	2.00e-9	9.31e-9	(B) Positive
ABCE1	4q31.21	-0.08	-0.45	0.59	0.39	0.37	2.01e-9	9.34e-9	(A) Negative
TIPRL	1q24.2	0.10	-0.27	0.58	0.50	0.37	2.01e-9	9.35e-9	(A) Negative
CR1L	1q32.2	-2.76	-3.42	1.05	0.76	0.66	2.02e-9	9.36e-9	(A) Negative
PABPC3	13q12.13	0.40	-0.10	0.76	0.70	0.50	2.02e-9	9.37e-9	(A) Negative
NUAK1	12q23.3	0.50	0.95	0.70	0.61	-0.45	2.02e-9	9.39e-9	(B) Positive
MAGI2	7q21.11	1.33	1.96	0.89	1.15	-0.62	2.02e-9	9.39e-9	(B) Positive
RCAN3	1p36.11	1.24	0.85	0.59	0.58	0.39	2.04e-9	9.48e-9	(A) Negative
ATP2C1	3q22.1	0.97	0.58	0.63	0.42	0.39	2.04e-9	9.48e-9	(A) Negative
TBCCD1	3q27.3	0.52	0.20	0.50	0.38	0.31	2.05e-9	9.50e-9	(A) Negative
DCAKD	17q21.31	-0.08	0.24	0.46	0.54	-0.32	2.06e-9	9.56e-9	(B) Positive
RHEB	7q36.1	0.08	-0.28	0.56	0.41	0.35	2.06e-9	9.57e-9	(A) Negative
TUBGCP3	13q34	-0.26	-0.68	0.68	0.46	0.42	2.07e-9	9.61e-9	(A) Negative
MPV17L	16p13.11	-0.31	0.50	1.26	1.13	-0.81	2.09e-9	9.68e-9	(B) Positive
MYO1H	12q24.11	0.67	0.27	0.65	0.42	0.41	2.10e-9	9.75e-9	(A) Negative
TEKT5	16p13.13	0.58	1.19	0.98	0.72	-0.62	2.13e-9	9.85e-9	(B) Positive
PPRC1	10q24.32	-0.11	-0.42	0.49	0.36	0.31	2.14e-9	9.90e-9	(A) Negative
LARGE1	22q12.3	0.07	0.78	1.12	0.86	-0.71	2.14e-9	9.93e-9	(B) Positive
AZI2	3p24.1	-0.06	0.22	0.44	0.38	-0.28	2.17e-9	1.01e-8	(B) Positive
DDX28	16q22.1	0.04	-0.29	0.51	0.44	0.33	2.19e-9	1.01e-8	(A) Negative
ARHGAP22	10q11.22-q11.23	-0.25	-0.90	1.01	0.92	0.65	2.20e-9	1.02e-8	(A) Negative
PARK7	1p36.23	0.23	0.53	0.47	0.42	-0.30	2.20e-9	1.02e-8	(B) Positive
CXCL13	4q21.1	5.24	3.93	1.97	2.13	1.32	2.20e-9	1.02e-8	(A) Negative
ZNF311	6p22.1	-0.67	0.10	1.21	1.02	-0.77	2.21e-9	1.02e-8	(B) Positive
DIAPH2	Xq21.33	-0.10	-0.55	0.69	0.64	0.45	2.23e-9	1.03e-8	(A) Negative
PRECSIT	13q34	0.37	-0.25	0.95	0.90	0.62	2.24e-9	1.03e-8	(A) Negative
CYTH3	7p22.1	0.61	0.18	0.65	0.65	0.43	2.27e-9	1.05e-8	(A) Negative
BIN1	2q14.3	0.14	-0.31	0.72	0.55	0.45	2.28e-9	1.05e-8	(A) Negative
FOXE3	1p33	0.21	0.43	0.32	0.36	-0.22	2.28e-9	1.05e-8	(B) Positive
HAUS7	Xq28	-0.57	-0.88	0.51	0.34	0.32	2.29e-9	1.06e-8	(A) Negative
TLR6	4p14	0.91	0.42	0.77	0.64	0.49	2.30e-9	1.06e-8	(A) Negative
MTMR9	8p23.1	-0.42	-0.06	0.56	0.49	-0.36	2.31e-9	1.06e-8	(B) Positive
ARMC5	16p11.2	-0.11	0.23	0.52	0.48	-0.33	2.31e-9	1.07e-8	(B) Positive
PKMYT1	16p13.3	-0.73	-1.12	0.57	0.75	0.40	2.33e-9	1.07e-8	(A) Negative
CD70	19p13.3	-1.55	-2.11	0.87	0.78	0.56	2.33e-9	1.07e-8	(A) Negative
NRXN3	14q24.3-q31.1	0.16	1.04	1.28	1.54	-0.88	2.33e-9	1.07e-8	(B) Positive
SLC9A1	1p36.11	0.11	0.35	0.37	0.34	-0.24	2.34e-9	1.08e-8	(B) Positive
LRRC8E	19p13.2	1.28	1.75	0.76	0.53	-0.48	2.34e-9	1.08e-8	(B) Positive
PDIK1L	1p36.11	0.31	0.67	0.57	0.47	-0.36	2.35e-9	1.08e-8	(B) Positive
FOXQ1	6p25.3	-0.95	-1.52	0.91	0.65	0.57	2.35e-9	1.08e-8	(A) Negative
SNRK	3p22.1	0.50	0.83	0.50	0.47	-0.33	2.35e-9	1.08e-8	(B) Positive
IFNGR1	6q23.3	1.60	1.12	0.75	0.57	0.47	2.36e-9	1.09e-8	(A) Negative
COL11A2	6p21.32	-0.55	-1.19	1.04	0.55	0.64	2.38e-9	1.10e-8	(A) Negative
MRPS9	2q12.1	0.02	-0.35	0.61	0.38	0.38	2.39e-9	1.10e-8	(A) Negative
ABCA8	17q24.2	-0.05	0.71	1.09	1.42	-0.76	2.39e-9	1.10e-8	(B) Positive
PFN1P2	1p11.2	0.28	-0.00	0.43	0.41	0.28	2.40e-9	1.10e-8	(A) Negative
HINT2	9p13.3	0.01	0.36	0.54	0.48	-0.35	2.40e-9	1.10e-8	(B) Positive
URGCP	7p13	-0.44	-0.12	0.48	0.50	-0.31	2.40e-9	1.10e-8	(B) Positive
AK7	14q32.2	-1.99	-1.30	1.07	1.01	-0.69	2.41e-9	1.11e-8	(B) Positive
CARF	2q33.2	-0.08	0.24	0.48	0.53	-0.32	2.41e-9	1.11e-8	(B) Positive
PLIN1	15q26.1	1.57	2.51	1.43	1.45	-0.94	2.41e-9	1.11e-8	(B) Positive
STRN	2p22.2	0.95	0.55	0.62	0.58	0.40	2.42e-9	1.11e-8	(A) Negative
PSMA7	20q13.33	0.68	0.30	0.58	0.63	0.39	2.42e-9	1.11e-8	(A) Negative
SLC2A1	1p34.2	-0.29	-0.86	0.90	0.78	0.58	2.43e-9	1.11e-8	(A) Negative
SAC3D1	11q13.1	0.16	-0.14	0.44	0.51	0.30	2.43e-9	1.11e-8	(A) Negative
RPAP2	1p22.1	-0.16	-0.42	0.41	0.34	0.26	2.43e-9	1.11e-8	(A) Negative
FGF18	5q35.1	0.20	0.95	1.15	1.08	-0.75	2.44e-9	1.12e-8	(B) Positive
MARK1	1q41	0.64	-0.10	1.11	1.23	0.74	2.46e-9	1.12e-8	(A) Negative
RTL8C	Xq26.3	0.27	-0.10	0.56	0.50	0.36	2.46e-9	1.13e-8	(A) Negative
IQCG	3q29	1.65	1.14	0.81	0.64	0.51	2.48e-9	1.14e-8	(A) Negative
EDARADD	1q42.3-q43	-0.03	0.68	1.07	1.12	-0.71	2.49e-9	1.14e-8	(B) Positive
PTCD3	2p11.2	-0.25	-0.53	0.44	0.37	0.28	2.49e-9	1.14e-8	(A) Negative
NAPA	19q13.33	0.76	1.23	0.72	0.64	-0.46	2.51e-9	1.15e-8	(B) Positive
PIK3AP1	10q24.1	2.01	1.42	0.94	0.76	0.60	2.52e-9	1.15e-8	(A) Negative
GJB5	1p34.3	0.71	-0.65	2.15	1.69	1.36	2.52e-9	1.15e-8	(A) Negative
ACTN4	19q13.2	0.40	0.04	0.58	0.45	0.36	2.52e-9	1.15e-8	(A) Negative
CCT6A	7p11.2	-0.58	-1.09	0.83	0.46	0.51	2.54e-9	1.16e-8	(A) Negative
GINS3	16q21	-0.68	-1.09	0.63	0.61	0.41	2.55e-9	1.16e-8	(A) Negative
FBXO4	5p13.1	-0.11	0.42	0.83	0.67	-0.52	2.56e-9	1.17e-8	(B) Positive
MLIP	6p12.1	0.50	-0.50	1.62	1.01	1.00	2.62e-9	1.19e-8	(A) Negative
MSI1	12q24.31	-0.13	-0.41	0.42	0.47	0.28	2.64e-9	1.20e-8	(A) Negative
SDC4	20q13.12	0.49	1.01	0.81	0.71	-0.52	2.64e-9	1.20e-8	(B) Positive
GNA14	9q21.2	0.05	0.91	1.32	1.32	-0.86	2.64e-9	1.20e-8	(B) Positive
PSMG3	7p22.3	-0.46	-0.79	0.52	0.42	0.33	2.65e-9	1.21e-8	(A) Negative
IGLL3P	22q11.23	-0.71	-1.90	1.87	1.59	1.19	2.66e-9	1.21e-8	(A) Negative
EFCAB2	1q44	-0.77	-0.18	0.90	0.89	-0.59	2.66e-9	1.21e-8	(B) Positive
TMEM190	19q13.42	-0.94	-0.26	0.90	1.53	-0.69	2.69e-9	1.22e-8	(B) Positive
ZFAND5	9q21.13	0.69	0.40	0.46	0.38	0.29	2.69e-9	1.23e-8	(A) Negative
MED17	11q21	0.33	0.03	0.45	0.46	0.29	2.69e-9	1.23e-8	(A) Negative
RRAGC	1p34.3	0.91	0.63	0.43	0.41	0.28	2.70e-9	1.23e-8	(A) Negative
QSOX2	9q34.3	-1.33	-1.64	0.46	0.51	0.31	2.71e-9	1.23e-8	(A) Negative
SDHAF4	6q13	-0.31	-0.71	0.61	0.58	0.40	2.73e-9	1.24e-8	(A) Negative
CHMP4A	14q12	-0.15	0.31	0.73	0.56	-0.46	2.75e-9	1.25e-8	(B) Positive
FGF9	13q12.11	-0.88	-1.91	1.69	0.85	1.03	2.76e-9	1.25e-8	(A) Negative
RNF122	8p12	0.70	0.18	0.79	0.84	0.52	2.76e-9	1.25e-8	(A) Negative
SVBP	1p34.2	0.72	0.35	0.59	0.52	0.38	2.78e-9	1.26e-8	(A) Negative
SNX33	15q24.2	0.45	0.74	0.45	0.41	-0.29	2.79e-9	1.27e-8	(B) Positive
BOD1	5q35.2	-0.50	-0.17	0.48	0.56	-0.32	2.81e-9	1.27e-8	(B) Positive
SRCIN1	17q12	0.68	1.33	1.04	0.77	-0.65	2.81e-9	1.28e-8	(B) Positive
ENOX2	Xq26.1	0.59	0.18	0.65	0.52	0.41	2.82e-9	1.28e-8	(A) Negative
SLC4A7	3p24.1	-0.04	0.52	0.81	1.03	-0.56	2.83e-9	1.28e-8	(B) Positive
CSTF3	11p13	-0.20	-0.52	0.51	0.38	0.32	2.83e-9	1.28e-8	(A) Negative
CNIH3	1q42.12	-0.35	0.21	0.86	0.82	-0.55	2.83e-9	1.29e-8	(B) Positive
YIPF6	Xq12-q13.1	0.12	0.42	0.44	0.54	-0.30	2.86e-9	1.30e-8	(B) Positive
GHITM	10q23.1	0.14	0.41	0.41	0.43	-0.27	2.87e-9	1.30e-8	(B) Positive
KCNC1	11p15.1	-0.98	-0.09	1.26	1.73	-0.89	2.90e-9	1.32e-8	(B) Positive
CASK	Xp11.4	1.14	0.72	0.63	0.69	0.42	2.91e-9	1.32e-8	(A) Negative
MAP7D3	Xq26.3	-0.68	-1.15	0.75	0.51	0.47	2.91e-9	1.32e-8	(A) Negative
MGAT3	22q13.1	-0.19	-0.93	1.21	0.76	0.74	2.91e-9	1.32e-8	(A) Negative
MED16	19p13.3	-0.04	0.25	0.44	0.41	-0.28	2.91e-9	1.32e-8	(B) Positive
ZNF521	18q11.2	0.66	-0.23	1.41	1.13	0.89	2.91e-9	1.32e-8	(A) Negative
NUSAP1	15q14	-1.54	-2.02	0.71	0.87	0.49	2.92e-9	1.32e-8	(A) Negative
ESPN	1p36.31	-0.43	0.09	0.78	0.84	-0.52	2.92e-9	1.32e-8	(B) Positive
RSPH4A	6q22.1	0.28	0.79	0.71	1.01	-0.51	2.92e-9	1.32e-8	(B) Positive
TMEM59	1p32.3	0.55	0.90	0.53	0.51	-0.34	2.93e-9	1.32e-8	(B) Positive
RHOBTB2	8p21.3	-0.78	-0.40	0.58	0.57	-0.38	2.94e-9	1.33e-8	(B) Positive
SCGB1D1	11q12.3	2.71	4.06	2.17	1.60	-1.35	2.97e-9	1.34e-8	(B) Positive
GEMIN4	17p13.3	-0.36	-0.68	0.50	0.43	0.32	2.97e-9	1.34e-8	(A) Negative
MTAP	9p21.3	0.18	-0.40	0.95	0.55	0.58	3.00e-9	1.35e-8	(A) Negative
LIPE	19q13.2	0.96	1.77	1.22	1.28	-0.80	3.01e-9	1.36e-8	(B) Positive
IL15RA	10p15.1	0.90	0.27	1.01	0.73	0.63	3.04e-9	1.37e-8	(A) Negative
OSGEPL1	2q32.2	-0.39	-0.03	0.56	0.52	-0.36	3.05e-9	1.38e-8	(B) Positive
NR2F2	15q26.2	-0.08	0.53	0.89	1.13	-0.61	3.05e-9	1.38e-8	(B) Positive
WDR91	7q33	0.08	-0.30	0.60	0.42	0.37	3.06e-9	1.38e-8	(A) Negative
IGKV1-5	2p11.2	4.29	3.59	0.98	1.40	0.70	3.07e-9	1.38e-8	(A) Negative
OR7C2	19p13.12	1.63	1.25	0.59	0.54	0.38	3.10e-9	1.40e-8	(A) Negative
GPX4	19p13.3	0.24	0.62	0.60	0.49	-0.38	3.12e-9	1.41e-8	(B) Positive
COMMD3	10p12.2	0.34	0.70	0.55	0.60	-0.36	3.15e-9	1.42e-8	(B) Positive
RNF41	12q13.3	0.18	0.50	0.51	0.37	-0.32	3.16e-9	1.42e-8	(B) Positive
FKTN	9q31.2	-0.66	-0.31	0.56	0.45	-0.35	3.19e-9	1.44e-8	(B) Positive
KIF19	17q25.1	1.43	0.91	0.83	0.66	0.52	3.20e-9	1.44e-8	(A) Negative
CNOT9	2q35	-0.15	-0.56	0.67	0.50	0.42	3.20e-9	1.44e-8	(A) Negative
SMPD3	16q22.1	0.02	0.51	0.73	0.80	-0.49	3.20e-9	1.44e-8	(B) Positive
LGI1	10q23.33	-1.90	-1.25	0.74	1.64	-0.65	3.22e-9	1.45e-8	(B) Positive
DYNLT2	6q27	0.22	-0.08	0.47	0.35	0.29	3.26e-9	1.47e-8	(A) Negative
CD83	6p23	1.16	0.65	0.81	0.69	0.51	3.28e-9	1.47e-8	(A) Negative
BCOR	Xp11.4	-0.87	-0.58	0.44	0.51	-0.29	3.28e-9	1.48e-8	(B) Positive
TIMP4	3p25.2	-1.97	-1.02	1.41	1.64	-0.95	3.29e-9	1.48e-8	(B) Positive
PGM5	9q21.11	0.09	0.40	0.47	0.54	-0.32	3.31e-9	1.49e-8	(B) Positive
NECAP1	12p13.31	0.29	0.53	0.36	0.39	-0.24	3.32e-9	1.49e-8	(B) Positive
PF4V1	4q13.3	1.23	0.55	1.11	0.63	0.68	3.33e-9	1.49e-8	(A) Negative
USP7	16p13.2	0.24	0.53	0.45	0.42	-0.29	3.33e-9	1.49e-8	(B) Positive
TBC1D2	9q22.33	1.07	1.47	0.63	0.51	-0.40	3.33e-9	1.50e-8	(B) Positive
QRSL1	6q21	0.12	-0.34	0.73	0.62	0.46	3.34e-9	1.50e-8	(A) Negative
BZW1	2q33.1	-0.53	-0.17	0.56	0.51	-0.36	3.34e-9	1.50e-8	(B) Positive
SLFN13	17q12	1.44	0.47	1.55	1.20	0.97	3.39e-9	1.52e-8	(A) Negative
MINDY2	15q21.3-q22.1	-0.27	0.16	0.68	0.58	-0.43	3.39e-9	1.52e-8	(B) Positive
CLPB	11q13.4	-0.34	-0.75	0.64	0.62	0.41	3.41e-9	1.53e-8	(A) Negative
CDCA7L	7p15.3	-1.21	-1.73	0.80	0.82	0.52	3.41e-9	1.53e-8	(A) Negative
CCDC127	5p15.33	0.19	0.55	0.57	0.44	-0.36	3.43e-9	1.54e-8	(B) Positive
TNNI2	11p15.5	-1.80	-2.57	1.26	0.78	0.77	3.44e-9	1.54e-8	(A) Negative
CYP4F2	19p13.12	-1.47	-0.82	0.95	1.23	-0.65	3.45e-9	1.54e-8	(B) Positive
NEDD4	15q21.3	-0.78	-0.35	0.69	0.54	-0.43	3.45e-9	1.54e-8	(B) Positive
PITRM1	10p15.2	0.62	0.19	0.70	0.46	0.43	3.45e-9	1.55e-8	(A) Negative
ZNF429	19p12	-0.86	-0.43	0.68	0.65	-0.44	3.46e-9	1.55e-8	(B) Positive
SF3A3	1p34.3	-0.50	-0.80	0.48	0.33	0.30	3.47e-9	1.55e-8	(A) Negative
UTP6	17q11.2	-0.49	-0.82	0.51	0.42	0.32	3.47e-9	1.55e-8	(A) Negative
SOX4	6p22.3	1.15	0.67	0.74	0.72	0.48	3.49e-9	1.56e-8	(A) Negative
ALKBH7	19p13.3	0.61	0.88	0.41	0.38	-0.26	3.51e-9	1.57e-8	(B) Positive
ELF1	13q14.11	0.15	0.56	0.65	0.60	-0.42	3.51e-9	1.57e-8	(B) Positive
ABCC6	16p13.11	-1.59	-1.09	0.70	1.00	-0.50	3.54e-9	1.58e-8	(B) Positive
TMEM217	6p21.2	0.48	-0.00	0.78	0.50	0.48	3.54e-9	1.58e-8	(A) Negative
RECQL4	8q24.3	-0.74	-1.25	0.77	0.85	0.51	3.55e-9	1.59e-8	(A) Negative
PPP1R8	1p35.3	-0.01	-0.33	0.51	0.46	0.32	3.56e-9	1.59e-8	(A) Negative
NPB	17q25.3	0.64	0.21	0.69	0.54	0.43	3.59e-9	1.60e-8	(A) Negative
CMSS1	3q12.1	-0.69	-1.14	0.74	0.52	0.45	3.65e-9	1.63e-8	(A) Negative
CHD6	20q12	-0.26	0.17	0.68	0.63	-0.43	3.65e-9	1.63e-8	(B) Positive
PDE1C	7p14.3	-1.26	-1.92	1.10	0.60	0.66	3.67e-9	1.64e-8	(A) Negative
ATP5F1C	10p14	0.01	-0.39	0.66	0.46	0.41	3.68e-9	1.64e-8	(A) Negative
RAB37	17q25.1	0.04	0.51	0.75	0.61	-0.47	3.70e-9	1.65e-8	(B) Positive
PPIL1	6p21.2	-0.53	-0.85	0.50	0.49	0.32	3.71e-9	1.65e-8	(A) Negative
SNRNP25	16p13.3	-0.38	-0.01	0.57	0.57	-0.37	3.73e-9	1.66e-8	(B) Positive
PCMTD2	20q13.33	-0.38	-0.05	0.51	0.54	-0.33	3.74e-9	1.67e-8	(B) Positive
SLC16A8	22q13.1	1.05	0.43	1.04	0.56	0.63	3.76e-9	1.67e-8	(A) Negative
KCNMA1	10q22.3	-1.17	-0.48	1.09	1.00	-0.70	3.79e-9	1.69e-8	(B) Positive
LIMS1	2q12.3	0.81	0.33	0.75	0.70	0.48	3.82e-9	1.70e-8	(A) Negative
CCDC183	9q34.3	-1.62	-1.35	0.41	0.44	-0.27	3.85e-9	1.71e-8	(B) Positive
CCN6	6q21	2.57	1.15	2.28	1.68	1.42	3.87e-9	1.72e-8	(A) Negative
SYAP1	Xp22.2	0.11	0.46	0.52	0.62	-0.35	3.88e-9	1.73e-8	(B) Positive
TWF1	12q12	0.09	0.43	0.53	0.46	-0.33	3.90e-9	1.73e-8	(B) Positive
SERHL	22q13.2	1.19	2.04	1.35	1.16	-0.85	3.90e-9	1.74e-8	(B) Positive
ZNF500	16p13.3	-0.41	-0.07	0.52	0.55	-0.34	3.97e-9	1.76e-8	(B) Positive
ZNF639	3q26.33	0.10	-0.29	0.58	0.65	0.39	3.97e-9	1.76e-8	(A) Negative
SPATA18	4q12	0.69	1.17	0.70	0.91	-0.48	4.00e-9	1.78e-8	(B) Positive
CIAO2B	16q22.1	-0.23	-0.56	0.51	0.49	0.33	4.03e-9	1.79e-8	(A) Negative
SPEG	2q35	0.55	0.05	0.80	0.54	0.49	4.04e-9	1.79e-8	(A) Negative
KAT8	16p11.2	-0.28	0.02	0.46	0.48	-0.30	4.04e-9	1.79e-8	(B) Positive
IFT22	7q22.1	0.20	0.52	0.52	0.43	-0.33	4.05e-9	1.80e-8	(B) Positive
MYCN	2p24.3	-0.45	-0.89	0.69	0.63	0.44	4.05e-9	1.80e-8	(A) Negative
ADCY1	7p12.3	-0.05	0.18	0.34	0.45	-0.23	4.11e-9	1.82e-8	(B) Positive
ANO9	11p15.5	-0.78	-0.28	0.77	0.80	-0.50	4.14e-9	1.83e-8	(B) Positive
DGLUCY	14q32.11	0.25	0.66	0.65	0.53	-0.41	4.14e-9	1.84e-8	(B) Positive
RAP1GDS1	4q23	0.26	0.65	0.57	0.72	-0.39	4.15e-9	1.84e-8	(B) Positive
TRPM6	9q21.13	0.73	0.18	0.92	0.49	0.55	4.16e-9	1.84e-8	(A) Negative
ZNF789	7q22.1	-0.78	-1.22	0.71	0.59	0.45	4.17e-9	1.84e-8	(A) Negative
MIA3	1q41	0.73	1.17	0.69	0.63	-0.44	4.19e-9	1.85e-8	(B) Positive
GRP	18q21.32	4.16	5.48	2.07	1.93	-1.32	4.20e-9	1.86e-8	(B) Positive
GNPDA1	5q31.3	-0.73	-0.44	0.45	0.47	-0.30	4.21e-9	1.86e-8	(B) Positive
CPE	4q32.3	-0.31	0.41	1.14	1.04	-0.72	4.27e-9	1.89e-8	(B) Positive
PLPPR5	1p21.3	-1.55	-1.19	0.56	0.56	-0.36	4.29e-9	1.90e-8	(B) Positive
TRIM63	1p36.11	-3.49	-2.82	1.02	1.15	-0.67	4.33e-9	1.92e-8	(B) Positive
CYP26A1	10q23.33	-2.53	-1.53	1.52	1.67	-1.00	4.35e-9	1.93e-8	(B) Positive
KDM2B	12q24.31	-0.41	-0.85	0.70	0.55	0.43	4.38e-9	1.93e-8	(A) Negative
FLRT3	20p12.1	-1.51	-0.02	2.38	2.05	-1.49	4.39e-9	1.94e-8	(B) Positive
CTC1	17p13.1	-0.12	0.24	0.56	0.54	-0.36	4.42e-9	1.95e-8	(B) Positive
ING2	4q35.1	-0.31	0.03	0.53	0.54	-0.34	4.43e-9	1.96e-8	(B) Positive
NPFFR2	4q13.3	-1.26	-0.49	1.13	1.48	-0.77	4.47e-9	1.97e-8	(B) Positive
SEPTIN12	16p13.3	0.43	0.88	0.67	0.83	-0.45	4.48e-9	1.98e-8	(B) Positive
TPSD1	16p13.3	0.06	0.32	0.38	0.47	-0.26	4.49e-9	1.98e-8	(B) Positive
MED8	1p34.2	0.22	-0.06	0.45	0.35	0.28	4.51e-9	1.99e-8	(A) Negative
CBR4	4q32.3	-0.67	-0.25	0.69	0.57	-0.43	4.52e-9	1.99e-8	(B) Positive
SSTR2	17q25.1	2.12	2.78	1.02	1.11	-0.66	4.53e-9	2.00e-8	(B) Positive
TTC19	17p12	-0.14	0.18	0.45	0.66	-0.32	4.56e-9	2.01e-8	(B) Positive
SLC2A6	9q34.2	-0.65	-1.19	0.87	0.70	0.54	4.57e-9	2.01e-8	(A) Negative
IRF4	6p25.3	-1.43	-2.19	1.23	0.89	0.76	4.57e-9	2.01e-8	(A) Negative
DDX11	12p11.21	-1.44	-1.84	0.66	0.43	0.40	4.59e-9	2.02e-8	(A) Negative
LNX1	4q12	0.31	0.80	0.80	0.57	-0.49	4.60e-9	2.03e-8	(B) Positive
UBE2Q1	1q21.3	0.81	0.56	0.40	0.37	0.25	4.61e-9	2.03e-8	(A) Negative
CNIH4	1q42.11	0.25	-0.14	0.57	0.73	0.39	4.62e-9	2.03e-8	(A) Negative
NCL	2q37.1	0.10	-0.19	0.46	0.35	0.29	4.62e-9	2.03e-8	(A) Negative
PPIP5K2	5q21.1	-0.60	-0.22	0.60	0.49	-0.37	4.70e-9	2.07e-8	(B) Positive
BBS10	12q21.2	0.08	0.43	0.56	0.46	-0.35	4.70e-9	2.07e-8	(B) Positive
COX4I1	16q24.1	-0.17	-0.48	0.49	0.42	0.31	4.77e-9	2.10e-8	(A) Negative
TNFRSF25	1p36.31	-0.16	-0.89	1.15	1.03	0.72	4.79e-9	2.10e-8	(A) Negative
ADGRE5	19p13.12	-0.68	-1.16	0.74	0.70	0.47	4.79e-9	2.10e-8	(A) Negative
ALKAL2	2p25.3	1.03	-0.21	2.04	1.34	1.24	4.81e-9	2.11e-8	(A) Negative
SAA4	11p15.1	-2.37	-3.30	1.53	0.99	0.93	4.81e-9	2.11e-8	(A) Negative
USP32	17q23.3	-0.96	-0.57	0.53	0.80	-0.38	4.85e-9	2.13e-8	(B) Positive
PUS10	2p16.1-p15	0.11	-0.35	0.76	0.55	0.46	4.86e-9	2.13e-8	(A) Negative
CDK5R1	17q11.2	0.24	-0.13	0.59	0.49	0.37	4.86e-9	2.13e-8	(A) Negative
ZNF107	7q11.21	-0.20	0.13	0.51	0.53	-0.33	4.87e-9	2.14e-8	(B) Positive
CIMAP2	1p32.3	0.65	0.29	0.56	0.54	0.36	4.88e-9	2.14e-8	(A) Negative
CCDC14	3q21.1	-0.75	-1.25	0.82	0.57	0.50	4.88e-9	2.14e-8	(A) Negative
PTGS2	1q31.1	-2.04	-3.11	1.77	1.05	1.07	4.90e-9	2.15e-8	(A) Negative
MAPK9	5q35.3	-0.11	0.34	0.72	0.63	-0.45	4.91e-9	2.15e-8	(B) Positive
ICAM5	19p13.2	-2.45	-2.90	0.74	0.54	0.45	4.92e-9	2.16e-8	(A) Negative
PPT1	1p34.2	0.09	0.55	0.69	0.75	-0.45	4.94e-9	2.16e-8	(B) Positive
NEK8	17q11.2	-0.39	-0.10	0.45	0.42	-0.28	4.95e-9	2.17e-8	(B) Positive
BAHCC1	17q25.3	-0.00	-0.56	0.87	0.80	0.55	4.97e-9	2.18e-8	(A) Negative
GSTA3	6p12.2	0.54	-0.61	1.87	1.37	1.15	4.97e-9	2.18e-8	(A) Negative
MAP7D2	Xp22.12	-0.86	-1.60	1.22	0.77	0.74	5.01e-9	2.19e-8	(A) Negative
MYO18B	22q12.1	-1.20	-0.65	0.82	0.97	-0.55	5.02e-9	2.20e-8	(B) Positive
PF4	4q13.3	0.82	0.41	0.68	0.45	0.42	5.08e-9	2.22e-8	(A) Negative
MAP3K7	6q15	0.09	-0.22	0.49	0.48	0.32	5.10e-9	2.23e-8	(A) Negative
ISCA2	14q24.3	-0.38	-0.07	0.49	0.46	-0.31	5.13e-9	2.24e-8	(B) Positive
TK1	17q25.3	-0.60	-1.15	0.83	0.96	0.55	5.18e-9	2.26e-8	(A) Negative
RAMP3	7p13	0.29	0.96	1.02	1.15	-0.67	5.22e-9	2.28e-8	(B) Positive
FASN	17q25.3	-0.20	0.51	1.12	1.07	-0.71	5.23e-9	2.28e-8	(B) Positive
NUBP2	16p13.3	0.03	0.30	0.43	0.45	-0.28	5.28e-9	2.31e-8	(B) Positive
SAR1B	5q31.1	0.18	0.60	0.66	0.57	-0.41	5.31e-9	2.32e-8	(B) Positive
KCNB2	8q21.11	1.10	0.63	0.78	0.51	0.47	5.31e-9	2.32e-8	(A) Negative
S1PR2	19p13.2	0.47	0.32	0.25	0.21	0.16	5.31e-9	2.32e-8	(A) Negative
GORASP2	2q31.1	0.37	0.13	0.38	0.30	0.24	5.36e-9	2.34e-8	(A) Negative
HSPA12B	20p13	1.77	2.10	0.51	0.52	-0.33	5.38e-9	2.35e-8	(B) Positive
GPR137	11q13.1	-0.06	0.21	0.42	0.43	-0.27	5.40e-9	2.35e-8	(B) Positive
FAM30A	14q32.33	2.94	1.95	1.55	1.45	0.98	5.41e-9	2.36e-8	(A) Negative
RNF112	17p11.2	-1.60	-2.18	0.94	0.79	0.58	5.45e-9	2.38e-8	(A) Negative
ENOX1	13q14.11	-0.26	0.41	1.03	1.10	-0.67	5.46e-9	2.38e-8	(B) Positive
ILDR2	1q24.1	0.68	0.38	0.50	0.29	0.30	5.47e-9	2.38e-8	(A) Negative
PTEN	10q23.31	0.26	0.77	0.84	0.53	-0.51	5.52e-9	2.40e-8	(B) Positive
SLC25A20	3p21.31	-0.02	0.40	0.65	0.64	-0.42	5.59e-9	2.43e-8	(B) Positive
SLC12A1	15q21.1	1.06	0.46	1.01	0.57	0.60	5.61e-9	2.44e-8	(A) Negative
TFR2	7q22.1	-0.92	-1.24	0.48	0.50	0.31	5.64e-9	2.46e-8	(A) Negative
TPI1P2	7q32.1	-0.69	-1.05	0.58	0.41	0.35	5.74e-9	2.50e-8	(A) Negative
OVOL2	20p11.23	3.46	3.86	0.67	0.50	-0.41	5.80e-9	2.52e-8	(B) Positive
MAGEA4	Xq28	-2.26	-3.76	2.53	1.21	1.50	5.85e-9	2.54e-8	(A) Negative
CYBA	16q24.2	-0.22	-0.75	0.83	0.87	0.53	5.85e-9	2.55e-8	(A) Negative
ATP5ME	4p16.3	0.05	0.39	0.56	0.48	-0.35	5.87e-9	2.55e-8	(B) Positive
CD274	9p24.1	1.41	0.74	1.11	0.80	0.68	5.89e-9	2.56e-8	(A) Negative
SORCS2	4p16.1	0.56	1.38	1.31	1.24	-0.83	5.90e-9	2.56e-8	(B) Positive
NECTIN1	11q23.3	0.70	0.32	0.59	0.61	0.38	5.91e-9	2.57e-8	(A) Negative
NKX2-5	5q34	-0.03	-0.89	1.43	0.84	0.85	5.93e-9	2.58e-8	(A) Negative
HIF3A	19q13.32	0.14	-0.22	0.60	0.26	0.36	5.94e-9	2.58e-8	(A) Negative
KIR2DL1	19q13.42	0.79	0.49	0.46	0.45	0.29	5.96e-9	2.59e-8	(A) Negative
TRAF1	9q33.2	0.28	-0.21	0.79	0.61	0.49	5.96e-9	2.59e-8	(A) Negative
HOXC6	12q13.13	0.38	0.77	0.61	0.62	-0.39	5.99e-9	2.60e-8	(B) Positive
EEF2	19p13.3	-0.67	-0.36	0.47	0.52	-0.31	6.08e-9	2.63e-8	(B) Positive
DUSP4	8p12	-0.50	0.36	1.35	1.34	-0.86	6.08e-9	2.64e-8	(B) Positive
PDE1A	2q32.1	-1.30	-0.82	0.71	0.87	-0.47	6.15e-9	2.67e-8	(B) Positive
MRPS25	3p25.1	-0.42	-0.82	0.66	0.51	0.41	6.16e-9	2.67e-8	(A) Negative
ADAMTS9	3p14.1	0.53	-0.02	0.88	0.77	0.55	6.24e-9	2.70e-8	(A) Negative
TRIM16L	17p11.2	-0.73	-0.39	0.53	0.58	-0.34	6.26e-9	2.71e-8	(B) Positive
SQOR	15q21.1	1.66	2.16	0.82	0.63	-0.50	6.29e-9	2.72e-8	(B) Positive
GPR63	6q16.1	0.02	-0.36	0.62	0.44	0.38	6.35e-9	2.75e-8	(A) Negative
MTCL2	20q11.23	-0.89	-0.67	0.32	0.42	-0.22	6.43e-9	2.78e-8	(B) Positive
LY6G5C	6p21.33	-0.11	0.14	0.37	0.41	-0.24	6.44e-9	2.79e-8	(B) Positive
SPIN3	Xp11.21	0.04	0.41	0.57	0.61	-0.37	6.57e-9	2.84e-8	(B) Positive
EMILIN2	18p11.32-p11.31	1.27	0.72	0.87	0.87	0.55	6.58e-9	2.85e-8	(A) Negative
SNX12	Xq13.1	0.37	0.08	0.48	0.41	0.30	6.59e-9	2.85e-8	(A) Negative
KDM4D	11q21	-0.60	-1.05	0.73	0.64	0.45	6.59e-9	2.85e-8	(A) Negative
LENEP	1q21.3	0.06	-0.13	0.31	0.30	0.20	6.62e-9	2.86e-8	(A) Negative
ODAM	4q13.3	-0.74	-2.03	2.21	0.77	1.29	6.67e-9	2.88e-8	(A) Negative
POLR3E	16p12.2	-1.64	-1.33	0.48	0.54	-0.31	6.68e-9	2.89e-8	(B) Positive
CAB39L	13q14.2	1.25	1.85	0.98	0.74	-0.60	6.71e-9	2.90e-8	(B) Positive
SPAG6	10p12.2	0.55	1.35	0.97	2.06	-0.81	6.76e-9	2.92e-8	(B) Positive
ZNF667	19q13.43	0.12	-0.66	1.24	1.18	0.78	6.81e-9	2.94e-8	(A) Negative
GRIK4	11q23.3	0.41	0.86	0.67	0.85	-0.45	6.86e-9	2.96e-8	(B) Positive
MAGOH	1p32.3	0.32	-0.24	0.90	0.87	0.57	6.91e-9	2.98e-8	(A) Negative
CCL5	17q12	3.36	2.72	1.01	1.00	0.64	6.93e-9	2.99e-8	(A) Negative
ANKRD30BP2	21q11.2	-0.23	0.15	0.43	1.00	-0.38	6.95e-9	3.00e-8	(B) Positive
GSTM2	1p13.3	-0.95	-0.38	0.89	0.97	-0.57	6.95e-9	3.00e-8	(B) Positive
DFFB	1p36.32	-0.10	-0.42	0.52	0.34	0.31	7.01e-9	3.02e-8	(A) Negative
RASGRP3	2p22.3	3.97	3.46	0.84	0.63	0.51	7.01e-9	3.02e-8	(A) Negative
MCF2L	13q34	1.11	1.47	0.58	0.49	-0.36	7.05e-9	3.04e-8	(B) Positive
EPS8L1	19q13.42	0.84	1.50	1.09	0.79	-0.66	7.07e-9	3.05e-8	(B) Positive
SSBP1	7q34	-0.41	-0.75	0.56	0.41	0.34	7.08e-9	3.05e-8	(A) Negative
FIS1	7q22.1	-0.16	0.15	0.50	0.47	-0.31	7.10e-9	3.06e-8	(B) Positive
CCHCR1	6p21.33	-0.41	-0.79	0.64	0.48	0.39	7.11e-9	3.06e-8	(A) Negative
LYRM1	16p12.3	-0.20	0.18	0.58	0.60	-0.37	7.18e-9	3.09e-8	(B) Positive
CALHM2	10q24.33	1.22	1.64	0.70	0.55	-0.43	7.22e-9	3.11e-8	(B) Positive
AMY2B	1p21.1	0.53	-0.03	0.91	0.80	0.56	7.24e-9	3.11e-8	(A) Negative
DARS1	2q21.3	-0.35	-0.61	0.42	0.35	0.26	7.25e-9	3.12e-8	(A) Negative
FBXO21	12q24.22	0.33	0.66	0.55	0.39	-0.33	7.30e-9	3.14e-8	(B) Positive
MYO19	17q12	-1.25	-1.65	0.63	0.62	0.40	7.35e-9	3.16e-8	(A) Negative
SNX21	20q13.12	-0.29	-0.01	0.45	0.45	-0.28	7.48e-9	3.21e-8	(B) Positive
PTMA	2q37.1	0.62	0.31	0.51	0.41	0.31	7.53e-9	3.24e-8	(A) Negative
LAMTOR3	4q23	0.42	0.77	0.55	0.49	-0.34	7.56e-9	3.24e-8	(B) Positive
RACK1	5q35.3	-0.68	-0.35	0.53	0.47	-0.33	7.59e-9	3.26e-8	(B) Positive
ORC2	2q33.1	-0.75	-1.08	0.54	0.48	0.34	7.61e-9	3.27e-8	(A) Negative
YTHDC1	4q13.2	0.36	0.56	0.32	0.29	-0.20	7.64e-9	3.28e-8	(B) Positive
ZNF319	16q21	0.49	0.15	0.55	0.46	0.34	7.66e-9	3.29e-8	(A) Negative
IL36RN	2q14.1	0.86	0.27	0.99	0.60	0.59	7.68e-9	3.29e-8	(A) Negative
LINC01140	1p22.3	1.57	0.94	1.04	0.77	0.63	7.71e-9	3.31e-8	(A) Negative
GNRH1	8p21.2	-0.92	-1.54	1.02	0.73	0.62	7.76e-9	3.33e-8	(A) Negative
PRDM4	12q23.3	0.05	0.33	0.44	0.42	-0.28	7.79e-9	3.34e-8	(B) Positive
MMACHC	1p34.1	0.08	-0.31	0.63	0.56	0.39	7.82e-9	3.35e-8	(A) Negative
MTMR12	5p13.3	0.68	0.31	0.62	0.44	0.37	7.84e-9	3.36e-8	(A) Negative
ZNF385B	2q31.2-q31.3	0.04	0.79	1.10	1.49	-0.75	7.85e-9	3.36e-8	(B) Positive
HPRT1	Xq26.2-q26.3	-0.42	-0.83	0.65	0.57	0.40	7.90e-9	3.38e-8	(A) Negative
CSRNP2	12q13.12	0.54	0.90	0.56	0.56	-0.36	7.91e-9	3.38e-8	(B) Positive
HELLS	10q23.33	-1.35	-1.79	0.70	0.68	0.44	7.96e-9	3.41e-8	(A) Negative
MAP2K5	15q23	-1.06	-0.72	0.54	0.53	-0.34	7.97e-9	3.41e-8	(B) Positive
PBX1	1q23.3	1.73	2.24	0.83	0.74	-0.52	8.00e-9	3.42e-8	(B) Positive
SLC52A2	8q24.3	0.69	0.33	0.56	0.63	0.36	8.05e-9	3.44e-8	(A) Negative
BMP2	20p12.3	-1.52	-2.31	1.31	0.91	0.78	8.08e-9	3.46e-8	(A) Negative
LIMK1	7q11.23	0.65	0.12	0.83	0.82	0.53	8.12e-9	3.47e-8	(A) Negative
ESS2	22q11.21	0.07	-0.14	0.31	0.35	0.20	8.15e-9	3.48e-8	(A) Negative
TRAM1L1	4q26	1.45	2.05	0.96	0.90	-0.60	8.20e-9	3.50e-8	(B) Positive
SNX20	16q12.1	0.72	0.43	0.46	0.41	0.29	8.22e-9	3.51e-8	(A) Negative
BEND7	10p13	0.17	-0.77	1.51	1.40	0.94	8.28e-9	3.53e-8	(A) Negative
SLC6A15	12q21.31	-2.60	-3.50	1.54	0.68	0.90	8.30e-9	3.54e-8	(A) Negative
NACA4P	8q22.3	-0.18	0.09	0.44	0.37	-0.27	8.34e-9	3.56e-8	(B) Positive
LRGUK	7q33	-0.57	-0.10	0.72	0.84	-0.47	8.36e-9	3.56e-8	(B) Positive
HSD17B7	1q23.3	-0.40	-0.00	0.60	0.69	-0.39	8.37e-9	3.57e-8	(B) Positive
DUSP28	2q37.3	-0.24	0.13	0.60	0.54	-0.37	8.41e-9	3.59e-8	(B) Positive
PDCD1	2q37.3	1.01	0.27	1.20	1.02	0.74	8.44e-9	3.60e-8	(A) Negative
IL21R	16p12.1	0.71	0.04	1.07	0.97	0.66	8.46e-9	3.61e-8	(A) Negative
RARB	3p24.2	0.99	0.28	1.16	0.92	0.70	8.51e-9	3.63e-8	(A) Negative
CHRNA6	8p11.21	0.62	1.10	0.75	0.81	-0.48	8.53e-9	3.63e-8	(B) Positive
RRM2B	8q22.3	0.20	0.61	0.64	0.69	-0.41	8.53e-9	3.63e-8	(B) Positive
GPC1	2q37.3	-0.06	0.44	0.83	0.62	-0.50	8.56e-9	3.64e-8	(B) Positive
CDC20B	5q11.2	0.16	0.56	0.55	0.90	-0.40	8.63e-9	3.67e-8	(B) Positive
WDFY2	13q14.3	-0.33	-0.65	0.52	0.47	0.32	8.78e-9	3.74e-8	(A) Negative
MRPL54	19p13.3	-0.07	0.27	0.55	0.45	-0.34	8.79e-9	3.74e-8	(B) Positive
BRCA2	13q13.1	-0.37	-0.99	1.01	0.84	0.62	8.79e-9	3.74e-8	(A) Negative
RSRC1	3q25.32	-0.04	-0.37	0.54	0.45	0.33	8.81e-9	3.75e-8	(A) Negative
SSR4P1	21q22.3	0.22	-0.21	0.71	0.50	0.43	8.86e-9	3.77e-8	(A) Negative
CDC14B	9q22.32-q22.33	-0.66	-1.01	0.56	0.57	0.35	8.87e-9	3.77e-8	(A) Negative
FAM120A	9q22.31	0.40	0.68	0.47	0.38	-0.28	8.98e-9	3.81e-8	(B) Positive
TTC9C	11q12.3	-0.06	-0.33	0.43	0.45	0.27	9.02e-9	3.83e-8	(A) Negative
ATP6V0A1	17q21.2	-0.38	-0.10	0.44	0.46	-0.28	9.11e-9	3.87e-8	(B) Positive
FCRL2	1q23.1	0.62	-0.10	1.19	0.93	0.72	9.11e-9	3.87e-8	(A) Negative
DNMT1	19p13.2	-0.60	-0.95	0.58	0.45	0.35	9.12e-9	3.87e-8	(A) Negative
VASH2	1q32.3	-0.05	-0.55	0.83	0.63	0.50	9.21e-9	3.91e-8	(A) Negative
NDNF	4q27	-0.95	-0.16	1.26	1.22	-0.79	9.21e-9	3.91e-8	(B) Positive
HOOK2	19p13.13	-0.07	0.32	0.61	0.65	-0.39	9.24e-9	3.92e-8	(B) Positive
KRT83	12q13.13	0.70	-0.36	1.83	0.89	1.07	9.33e-9	3.96e-8	(A) Negative
ANKAR	2q32.2	0.26	0.69	0.68	0.68	-0.43	9.36e-9	3.97e-8	(B) Positive
RNPEP	1q32.1	0.17	0.58	0.64	0.69	-0.41	9.44e-9	4.00e-8	(B) Positive
ZC3HAV1L	7q34	0.19	-0.11	0.48	0.46	0.30	9.48e-9	4.02e-8	(A) Negative
SLC20A1	2q14.1	-1.21	-0.87	0.55	0.52	-0.34	9.49e-9	4.02e-8	(B) Positive
PCNX4	14q23.1	-0.43	-0.19	0.39	0.37	-0.24	9.51e-9	4.03e-8	(B) Positive
SH3BGRL3	1p36.11	0.14	-0.15	0.47	0.46	0.29	9.59e-9	4.06e-8	(A) Negative
FBL	19q13.2	-0.44	-0.85	0.70	0.45	0.41	9.62e-9	4.07e-8	(A) Negative
METTL21A	2q33.3	-0.81	-1.20	0.65	0.50	0.39	9.63e-9	4.08e-8	(A) Negative
RPUSD3	3p25.3	-0.20	-0.58	0.63	0.47	0.38	9.65e-9	4.08e-8	(A) Negative
SNAPC1	14q23.2	-0.98	-1.31	0.53	0.53	0.33	9.72e-9	4.11e-8	(A) Negative
TMEM135	11q14.2	-0.49	-0.03	0.75	0.69	-0.46	9.73e-9	4.11e-8	(B) Positive
WDR75	2q32.2	-0.37	-0.68	0.49	0.47	0.31	9.74e-9	4.12e-8	(A) Negative
GNG4	1q42.3	-1.15	-2.02	1.45	1.02	0.87	9.80e-9	4.14e-8	(A) Negative
RTL9	Xq23	-0.29	0.10	0.59	0.73	-0.39	9.86e-9	4.17e-8	(B) Positive
TAF1D	11q21	-1.09	-1.52	0.71	0.63	0.44	1.01e-8	4.29e-8	(A) Negative
MRPL4	19p13.2	-0.21	-0.50	0.48	0.44	0.30	1.02e-8	4.30e-8	(A) Negative
ICOS	2q33.2	2.14	1.36	1.27	1.12	0.78	1.02e-8	4.30e-8	(A) Negative
CIMAP1A	11p15.5	0.31	0.52	0.35	0.33	-0.22	1.05e-8	4.44e-8	(B) Positive
SUSD6	14q24.1	1.53	1.85	0.53	0.42	-0.32	1.05e-8	4.44e-8	(B) Positive
COPS9	2q37.3	0.48	0.74	0.42	0.42	-0.26	1.06e-8	4.46e-8	(B) Positive
BARX1	9q22.32	-0.80	-1.61	1.40	0.67	0.81	1.06e-8	4.48e-8	(A) Negative
GNLY	2p11.2	3.63	2.82	1.32	1.21	0.82	1.07e-8	4.49e-8	(A) Negative
TRAPPC4	11q23.3	-0.69	-0.37	0.53	0.49	-0.33	1.07e-8	4.53e-8	(B) Positive
MDGA1	6p21.2	0.55	1.00	0.74	0.71	-0.46	1.07e-8	4.53e-8	(B) Positive
NUDT15	13q14.2	-0.55	-0.93	0.63	0.52	0.38	1.08e-8	4.53e-8	(A) Negative
SLX4	16p13.3	-0.49	-0.18	0.51	0.47	-0.31	1.08e-8	4.54e-8	(B) Positive
DEPP1	10q11.21	2.00	1.45	0.85	0.97	0.55	1.08e-8	4.56e-8	(A) Negative
NDUFA10	2q37.3	-0.07	0.28	0.57	0.54	-0.35	1.09e-8	4.60e-8	(B) Positive
ABTB1	3q21.3	0.39	0.70	0.51	0.46	-0.31	1.10e-8	4.62e-8	(B) Positive
BEX1	Xq22.1	-3.38	-2.56	1.10	1.93	-0.82	1.10e-8	4.62e-8	(B) Positive
ZNF782	9q22.33	-0.03	0.29	0.53	0.49	-0.32	1.10e-8	4.63e-8	(B) Positive
FAM234A	16p13.3	-0.02	0.32	0.55	0.42	-0.33	1.10e-8	4.63e-8	(B) Positive
TTC39B	9p22.3	1.36	0.80	0.89	0.95	0.57	1.10e-8	4.64e-8	(A) Negative
NSUN4	1p33	0.08	-0.21	0.47	0.40	0.29	1.10e-8	4.64e-8	(A) Negative
DOK5	20q13.2	0.23	-0.58	1.37	0.87	0.81	1.11e-8	4.66e-8	(A) Negative
RBM17	10p15.1	0.43	0.07	0.60	0.39	0.36	1.11e-8	4.66e-8	(A) Negative
NEBL	10p12.31	2.02	2.75	1.23	0.73	-0.72	1.13e-8	4.74e-8	(B) Positive
HDGFL3	15q25.2	-0.71	0.00	1.19	0.91	-0.71	1.13e-8	4.76e-8	(B) Positive
CBX7	22q13.1	0.59	0.96	0.60	0.59	-0.38	1.15e-8	4.81e-8	(B) Positive
PWWP2A	5q33.3	-0.40	-0.05	0.56	0.55	-0.35	1.15e-8	4.82e-8	(B) Positive
H2AC15	6p22.1	0.23	0.64	0.63	0.74	-0.41	1.15e-8	4.82e-8	(B) Positive
LYSMD4	15q26.3	-0.54	-0.94	0.64	0.64	0.40	1.15e-8	4.84e-8	(A) Negative
DNAJC19	3q26.33	0.10	0.40	0.45	0.61	-0.30	1.16e-8	4.85e-8	(B) Positive
FSTL3	19p13.3	-1.06	-0.55	0.84	0.71	-0.51	1.16e-8	4.86e-8	(B) Positive
TMCO1	1q24.1	0.41	0.73	0.52	0.50	-0.32	1.16e-8	4.87e-8	(B) Positive
CSGALNACT1	8p21.3	-0.42	-0.98	0.92	0.83	0.56	1.17e-8	4.89e-8	(A) Negative
MARF1	16p13.11	0.51	0.76	0.42	0.39	-0.26	1.17e-8	4.89e-8	(B) Positive
NMNAT3	3q23	1.14	1.81	1.05	1.10	-0.66	1.17e-8	4.90e-8	(B) Positive
SNHG12	1p35.3	-1.03	-1.54	0.82	0.74	0.50	1.17e-8	4.91e-8	(A) Negative
SLC25A27	6p12.3	-0.98	-1.62	1.06	0.89	0.64	1.17e-8	4.91e-8	(A) Negative
CYP4V2	4q35.1-q35.2	0.51	1.07	0.91	0.88	-0.57	1.18e-8	4.93e-8	(B) Positive
ADAMTS19	5q23.3	-1.73	-0.83	1.40	1.59	-0.90	1.18e-8	4.94e-8	(B) Positive
POU2F2	19q13.2	1.18	0.79	0.64	0.51	0.39	1.18e-8	4.95e-8	(A) Negative
RUSF1	16p11.2	-0.11	0.13	0.40	0.36	-0.25	1.19e-8	4.97e-8	(B) Positive
CMAS	12p12.1	-0.11	-0.57	0.77	0.49	0.45	1.19e-8	4.98e-8	(A) Negative
GOLM1	9q21.33	0.88	1.47	0.89	1.09	-0.58	1.19e-8	4.98e-8	(B) Positive
MTARC2	1q41	0.77	1.47	1.17	0.88	-0.70	1.19e-8	4.99e-8	(B) Positive
KLHL1	13q21.33	-0.69	-0.02	0.66	1.96	-0.67	1.19e-8	4.99e-8	(B) Positive
MARCHF10	17q23.2	-0.02	0.19	0.28	0.47	-0.21	1.20e-8	5.00e-8	(B) Positive
NCAPD3	11q25	-0.99	-1.34	0.57	0.52	0.35	1.21e-8	5.05e-8	(A) Negative
ZBTB40	1p36.12	-0.18	-0.00	0.28	0.31	-0.18	1.21e-8	5.05e-8	(B) Positive
MAN2C1	15q24.2	-1.15	-0.88	0.43	0.47	-0.27	1.21e-8	5.05e-8	(B) Positive
PRG2	11q12.1	-0.97	-0.53	0.72	0.65	-0.44	1.22e-8	5.11e-8	(B) Positive
UBE3D	6q14.1	0.25	-0.22	0.76	0.65	0.46	1.22e-8	5.11e-8	(A) Negative
ZNF526	19q13.2	0.85	0.63	0.36	0.33	0.22	1.23e-8	5.12e-8	(A) Negative
CXCL11	4q21.1	5.08	4.03	1.69	1.66	1.05	1.23e-8	5.15e-8	(A) Negative
PSMD7	16q23.1	-0.62	-0.97	0.55	0.56	0.35	1.24e-8	5.17e-8	(A) Negative
CD6	11q12.2	0.54	0.05	0.80	0.75	0.49	1.24e-8	5.17e-8	(A) Negative
FAM167B	1p35.2	1.23	0.87	0.59	0.48	0.35	1.24e-8	5.18e-8	(A) Negative
H1-10	3q21.3	-0.09	0.31	0.67	0.59	-0.41	1.24e-8	5.18e-8	(B) Positive
NHERF2	16p13.3	0.97	1.57	0.97	0.89	-0.60	1.26e-8	5.27e-8	(B) Positive
PAFAH1B3	19q13.1	0.57	0.90	0.52	0.59	-0.33	1.27e-8	5.31e-8	(B) Positive
PRND	20p13	1.61	2.25	1.00	1.12	-0.64	1.27e-8	5.31e-8	(B) Positive
ARSF	Xp22.33	0.71	0.25	0.78	0.50	0.46	1.28e-8	5.33e-8	(A) Negative
PRX	19q13.2	-0.08	0.17	0.41	0.37	-0.25	1.28e-8	5.33e-8	(B) Positive
ARHGAP5-AS1	14q12	0.16	-0.41	0.95	0.73	0.57	1.29e-8	5.38e-8	(A) Negative
GPI	19q13.11	-0.45	-0.83	0.62	0.50	0.38	1.30e-8	5.39e-8	(A) Negative
PDE8B	5q13.3	-1.79	-0.87	1.44	1.59	-0.92	1.30e-8	5.39e-8	(B) Positive
VAC14	16q22.1-q22.2	-0.02	-0.33	0.50	0.53	0.31	1.30e-8	5.41e-8	(A) Negative
GLYR1	16p13.3	0.24	0.52	0.44	0.50	-0.28	1.31e-8	5.45e-8	(B) Positive
STBD1	4q21.1	-0.10	0.45	0.91	0.74	-0.55	1.32e-8	5.50e-8	(B) Positive
HPSE	4q21.23	1.02	0.44	0.96	0.85	0.58	1.34e-8	5.55e-8	(A) Negative
SLC30A3	2p23.3	-1.52	-1.89	0.62	0.51	0.37	1.34e-8	5.57e-8	(A) Negative
NCBP1	9q22.33	-0.23	-0.52	0.49	0.41	0.30	1.34e-8	5.58e-8	(A) Negative
BPIFC	22q12.3	-0.08	0.16	0.38	0.43	-0.24	1.34e-8	5.58e-8	(B) Positive
INA	10q24.33	-2.21	-3.04	1.42	0.93	0.83	1.35e-8	5.59e-8	(A) Negative
ZNF395	8p21.1	-0.56	-0.18	0.59	0.68	-0.38	1.35e-8	5.60e-8	(B) Positive
AARS1	16q22.1	-0.67	-1.00	0.52	0.56	0.33	1.36e-8	5.63e-8	(A) Negative
MYO15B	17q25.1	-0.41	-0.05	0.56	0.65	-0.36	1.36e-8	5.65e-8	(B) Positive
SETD1B	12q24.31	0.19	0.44	0.40	0.37	-0.25	1.36e-8	5.65e-8	(B) Positive
FOXG1	14q12	-1.32	-2.33	1.77	0.77	1.01	1.36e-8	5.66e-8	(A) Negative
SH3BP4	2q37.2	0.42	0.98	0.92	0.77	-0.56	1.38e-8	5.71e-8	(B) Positive
KLHDC8B	3p21.31	0.20	0.55	0.58	0.52	-0.36	1.38e-8	5.71e-8	(B) Positive
RBP1	3q23	2.54	1.83	1.11	1.26	0.71	1.38e-8	5.72e-8	(A) Negative
RETSAT	2p11.2	0.18	0.69	0.86	0.60	-0.51	1.39e-8	5.74e-8	(B) Positive
DNAJC25	9q31.3	-0.35	-0.03	0.53	0.49	-0.32	1.39e-8	5.75e-8	(B) Positive
ANKS1A	6p21.31	0.38	0.09	0.47	0.39	0.29	1.39e-8	5.75e-8	(A) Negative
TTC14	3q26.33	-0.72	-0.31	0.68	0.58	-0.41	1.43e-8	5.91e-8	(B) Positive
ZNF83	19q13.41	-0.36	0.01	0.60	0.57	-0.37	1.43e-8	5.91e-8	(B) Positive
GTF3C5	9q34.13	-0.23	-0.55	0.53	0.37	0.31	1.43e-8	5.93e-8	(A) Negative
CHIA	1p13.2	0.96	0.41	0.95	0.42	0.55	1.44e-8	5.95e-8	(A) Negative
GALNT16	14q24.1	-0.52	0.39	1.49	1.33	-0.91	1.44e-8	5.95e-8	(B) Positive
RASGEF1A	10q11.21	1.55	0.65	1.50	1.21	0.90	1.45e-8	6.00e-8	(A) Negative
KANK4	1p31.3	1.56	0.68	1.49	1.04	0.88	1.46e-8	6.05e-8	(A) Negative
SNAP23	15q15.1-q15.2	-0.36	0.10	0.74	0.71	-0.46	1.47e-8	6.06e-8	(B) Positive
WDR59	16q23.1	-0.51	-0.76	0.42	0.34	0.25	1.47e-8	6.07e-8	(A) Negative
GTF2H4	6p21.33	-0.35	-0.65	0.50	0.44	0.30	1.47e-8	6.09e-8	(A) Negative
INTS13	12p11.23	-1.21	-1.76	0.95	0.61	0.55	1.48e-8	6.09e-8	(A) Negative
LEAP2	5q31.1	-2.98	-2.53	0.72	0.73	-0.45	1.50e-8	6.19e-8	(B) Positive
ARID1B	6q25.3	0.58	0.30	0.48	0.35	0.28	1.50e-8	6.19e-8	(A) Negative
TEAD3	6p21.31	0.80	0.57	0.38	0.36	0.23	1.50e-8	6.21e-8	(A) Negative
FBXO28	1q42.11	0.80	0.45	0.58	0.54	0.35	1.52e-8	6.27e-8	(A) Negative
CD79A	19q13.2	1.63	0.95	1.13	0.86	0.67	1.52e-8	6.28e-8	(A) Negative
HPS3	3q24	-0.81	-1.67	1.44	1.17	0.86	1.53e-8	6.29e-8	(A) Negative
FSTL4	5q31.1	0.00	0.46	0.73	0.76	-0.46	1.53e-8	6.31e-8	(B) Positive
ARB2A	5q15	0.43	0.82	0.64	0.57	-0.39	1.53e-8	6.32e-8	(B) Positive
HERC1	15q22.31	-0.29	-0.00	0.44	0.53	-0.29	1.54e-8	6.36e-8	(B) Positive
RECK	9p13.3	0.00	-0.39	0.61	0.71	0.39	1.55e-8	6.39e-8	(A) Negative
ICA1L	2q33.2	-0.50	-0.03	0.75	0.77	-0.47	1.56e-8	6.42e-8	(B) Positive
LTA	6p21.33	0.68	0.43	0.41	0.36	0.25	1.58e-8	6.51e-8	(A) Negative
USP31	16p12.2	0.20	-0.12	0.51	0.49	0.31	1.59e-8	6.53e-8	(A) Negative
SPARCL1	4q22.1	4.45	4.82	0.59	0.62	-0.37	1.61e-8	6.64e-8	(B) Positive
PTPRB	12q15	1.01	1.48	0.76	0.73	-0.47	1.61e-8	6.65e-8	(B) Positive
ACY1	3p21.2	-0.81	-0.45	0.59	0.50	-0.36	1.63e-8	6.72e-8	(B) Positive
RAB21	12q21.1	-0.05	0.29	0.56	0.52	-0.34	1.65e-8	6.79e-8	(B) Positive
FYN	6q21	-0.26	-0.68	0.69	0.66	0.42	1.65e-8	6.79e-8	(A) Negative
UMODL1-AS1	21q22.3	0.39	0.01	0.63	0.50	0.38	1.66e-8	6.84e-8	(A) Negative
FGFBP3	10q23.32	-0.73	-1.31	0.96	0.83	0.58	1.66e-8	6.84e-8	(A) Negative
SCN4B	11q23.3	0.36	1.02	1.07	1.07	-0.66	1.67e-8	6.85e-8	(B) Positive
MIGA1	1p31.1	0.70	1.09	0.64	0.65	-0.40	1.67e-8	6.86e-8	(B) Positive
HK3	5q35.2	2.00	1.47	0.87	0.84	0.54	1.68e-8	6.89e-8	(A) Negative
DAPP1	4q23	0.93	0.14	1.31	1.08	0.78	1.69e-8	6.95e-8	(A) Negative
PTPN22	1p13.2	-0.31	-0.87	0.95	0.79	0.57	1.69e-8	6.95e-8	(A) Negative
KCNJ2	17q24.3	3.82	3.39	0.71	0.63	0.43	1.70e-8	6.99e-8	(A) Negative
ERICH2	2q31.1	-0.18	0.84	1.71	1.42	-1.02	1.71e-8	7.01e-8	(B) Positive
FPR2	19q13.41	1.16	0.56	1.02	0.73	0.60	1.72e-8	7.04e-8	(A) Negative
LAMTOR2	1q22	0.61	0.90	0.46	0.50	-0.29	1.73e-8	7.09e-8	(B) Positive
CFAP97	4q35.1	-0.14	0.11	0.40	0.41	-0.25	1.74e-8	7.15e-8	(B) Positive
MIR17HG	13q31.3	-3.23	-3.73	0.86	0.65	0.51	1.75e-8	7.19e-8	(A) Negative
ZNF146	19q13.1	0.42	0.08	0.58	0.46	0.35	1.76e-8	7.20e-8	(A) Negative
SPHK2	19q13.33	0.22	0.49	0.46	0.38	-0.27	1.77e-8	7.26e-8	(B) Positive
ATP5MF	7q22.1	-0.21	-0.50	0.48	0.39	0.29	1.77e-8	7.26e-8	(A) Negative
ZSCAN22	19q13.43	0.38	0.67	0.47	0.47	-0.29	1.78e-8	7.28e-8	(B) Positive
OR52A1	11p15.4	0.42	0.15	0.46	0.36	0.27	1.78e-8	7.28e-8	(A) Negative
RECQL	12p12.1	-0.41	-0.81	0.68	0.47	0.40	1.78e-8	7.30e-8	(A) Negative
IGLL1	22q11.23	-0.55	-1.08	0.88	0.79	0.53	1.79e-8	7.32e-8	(A) Negative
ATP13A5	3q29	1.80	0.84	1.60	1.25	0.96	1.81e-8	7.41e-8	(A) Negative
COG1	17q25.1	0.33	0.60	0.44	0.45	-0.27	1.82e-8	7.43e-8	(B) Positive
C12ORF60	12p12.3	-0.79	-0.30	0.73	1.04	-0.50	1.83e-8	7.47e-8	(B) Positive
ONECUT2	18q21.31	-1.78	-2.59	1.34	1.26	0.82	1.85e-8	7.57e-8	(A) Negative
PPP2R5D	6p21.1	0.06	-0.23	0.48	0.40	0.29	1.86e-8	7.60e-8	(A) Negative
TNF	6p21.33	2.19	1.58	1.03	0.77	0.60	1.86e-8	7.61e-8	(A) Negative
PTP4A3	8q24.3	0.77	0.37	0.66	0.63	0.40	1.86e-8	7.61e-8	(A) Negative
PTPRF	1p34.2	1.67	1.35	0.52	0.56	0.33	1.86e-8	7.61e-8	(A) Negative
IPO13	1p34.1	0.37	0.14	0.38	0.36	0.23	1.88e-8	7.69e-8	(A) Negative
CDC73	1q31.2	0.13	-0.24	0.61	0.58	0.37	1.89e-8	7.71e-8	(A) Negative
IL23A	12q13.3	-0.77	-1.55	1.34	0.89	0.78	1.89e-8	7.73e-8	(A) Negative
PPM1M	3p21.2	0.29	0.66	0.60	0.57	-0.37	1.90e-8	7.75e-8	(B) Positive
RPS20	8q12.1	0.39	-0.03	0.70	0.62	0.42	1.91e-8	7.80e-8	(A) Negative
NFU1	2p13.3	0.06	0.33	0.42	0.50	-0.27	1.91e-8	7.81e-8	(B) Positive
DCDC2	6p22.3	-3.64	-2.56	1.70	2.02	-1.09	1.92e-8	7.82e-8	(B) Positive
PRKDC	8q11.21	-0.21	-0.61	0.67	0.58	0.40	1.92e-8	7.82e-8	(A) Negative
NUAK2	1q32.1	-0.18	0.34	0.88	0.71	-0.52	1.92e-8	7.82e-8	(B) Positive
CDC23	5q31.2	-0.80	-0.55	0.41	0.41	-0.25	1.93e-8	7.87e-8	(B) Positive
GRHL3	1p36.11	1.29	0.42	1.46	1.18	0.87	1.94e-8	7.89e-8	(A) Negative
SLC22A15	1p13.1	0.22	0.75	0.86	0.89	-0.53	1.94e-8	7.89e-8	(B) Positive
BDKRB2	14q32.2	1.11	1.52	0.68	0.63	-0.41	1.95e-8	7.93e-8	(B) Positive
PLPP1	5q11.2	0.31	0.75	0.72	0.69	-0.44	1.96e-8	7.99e-8	(B) Positive
TCFL5	20q13.33	-0.65	-0.93	0.47	0.42	0.28	1.98e-8	8.07e-8	(A) Negative
BOD1L2	18q21.31	-0.24	0.00	0.38	0.47	-0.25	2.00e-8	8.13e-8	(B) Positive
MRPS12	19q13.2	0.10	-0.24	0.57	0.44	0.34	2.01e-8	8.18e-8	(A) Negative
POP7	7q22.1	0.33	0.06	0.45	0.42	0.27	2.01e-8	8.19e-8	(A) Negative
NSRP1	17q11.2	0.05	0.33	0.45	0.50	-0.28	2.02e-8	8.23e-8	(B) Positive
TP53I11	11p11.2	1.20	1.63	0.72	0.57	-0.43	2.03e-8	8.24e-8	(B) Positive
DCXR	17q25.3	0.19	0.69	0.83	0.72	-0.50	2.03e-8	8.27e-8	(B) Positive
CALML4	15q23	-0.31	-0.88	0.94	0.92	0.57	2.04e-8	8.30e-8	(A) Negative
MTA3	2p21	-0.01	0.33	0.57	0.47	-0.34	2.05e-8	8.31e-8	(B) Positive
LRRC32	11q13.5	2.51	2.90	0.64	0.59	-0.39	2.05e-8	8.33e-8	(B) Positive
TSEN15	1q25.3	0.01	-0.32	0.55	0.53	0.33	2.05e-8	8.34e-8	(A) Negative
ACR	22q13.33	1.02	0.63	0.67	0.44	0.39	2.06e-8	8.35e-8	(A) Negative
LCLAT1	2p23.1	0.37	0.07	0.49	0.51	0.30	2.07e-8	8.42e-8	(A) Negative
ITGA9	3p22.2	1.08	0.57	0.88	0.58	0.51	2.08e-8	8.45e-8	(A) Negative
SEC24C	10q22.2	-0.24	0.02	0.40	0.47	-0.26	2.08e-8	8.45e-8	(B) Positive
CIT	12q24.23	-1.34	-1.80	0.74	0.79	0.46	2.08e-8	8.46e-8	(A) Negative
ATAD2B	2p24.1-p23.3	0.59	0.28	0.51	0.40	0.30	2.09e-8	8.49e-8	(A) Negative
SDR16C5	8q12.1	1.30	2.66	2.25	2.06	-1.36	2.10e-8	8.54e-8	(B) Positive
SLC6A9	1p34.1	0.32	-0.10	0.69	0.71	0.42	2.11e-8	8.55e-8	(A) Negative
NSL1	1q32.3	-0.59	-0.20	0.65	0.52	-0.39	2.11e-8	8.56e-8	(B) Positive
PNPO	17q21.32	-0.03	0.34	0.62	0.54	-0.37	2.12e-8	8.58e-8	(B) Positive
FOXH1	8q24.3	0.17	-0.04	0.33	0.38	0.21	2.13e-8	8.62e-8	(A) Negative
SDR42E1	16q23.3	1.35	0.62	1.18	1.20	0.73	2.14e-8	8.67e-8	(A) Negative
ATP9B	18q23	0.80	1.14	0.56	0.51	-0.34	2.15e-8	8.69e-8	(B) Positive
MIF4GD	17q25.1	-0.02	0.34	0.59	0.58	-0.36	2.15e-8	8.71e-8	(B) Positive
SAV1	14q22.1	0.82	0.43	0.66	0.52	0.39	2.16e-8	8.75e-8	(A) Negative
PYCARD	16p11.2	0.70	1.37	1.11	1.04	-0.67	2.17e-8	8.79e-8	(B) Positive
CCDC107	9p13.3	0.95	0.56	0.66	0.53	0.39	2.18e-8	8.81e-8	(A) Negative
MARS2	2q33.1	0.26	-0.12	0.62	0.61	0.38	2.18e-8	8.83e-8	(A) Negative
DUSP1	5q35.1	0.64	1.22	0.91	1.05	-0.58	2.19e-8	8.86e-8	(B) Positive
L3MBTL1	20q13.12	-1.80	-1.36	0.72	0.74	-0.44	2.20e-8	8.88e-8	(B) Positive
RTL5	Xq13.1	0.03	0.56	0.83	0.97	-0.52	2.21e-8	8.92e-8	(B) Positive
VPS52	6p21.32	-0.26	0.05	0.51	0.55	-0.31	2.21e-8	8.94e-8	(B) Positive
SRCAP	16p11.2	0.48	0.71	0.36	0.41	-0.23	2.23e-8	8.99e-8	(B) Positive
MATR3	5q31.2	0.14	0.34	0.32	0.32	-0.20	2.23e-8	9.00e-8	(B) Positive
FBH1	10p15.1	0.36	0.03	0.56	0.44	0.33	2.25e-8	9.09e-8	(A) Negative
HSPB6	19q13.12	-0.16	0.03	0.30	0.35	-0.19	2.27e-8	9.14e-8	(B) Positive
P3H4	17q21.2	-0.58	-0.09	0.81	0.72	-0.48	2.27e-8	9.16e-8	(B) Positive
CHAF1A	19p13.3	-1.20	-1.55	0.59	0.52	0.35	2.27e-8	9.17e-8	(A) Negative
FANCG	9p13.3	-0.74	-1.13	0.65	0.54	0.38	2.28e-8	9.19e-8	(A) Negative
SYCN	19q13.2	0.26	0.12	0.23	0.24	0.14	2.29e-8	9.24e-8	(A) Negative
DENND2D	1p13.3-p13.2	1.75	2.22	0.80	0.58	-0.47	2.30e-8	9.29e-8	(B) Positive
PCBP3	21q22.3	-0.03	-0.49	0.80	0.55	0.46	2.32e-8	9.34e-8	(A) Negative
LRP6	12p13.2	0.69	0.21	0.81	0.61	0.47	2.32e-8	9.36e-8	(A) Negative
GSTM5	1p13.3	0.33	0.89	0.89	1.02	-0.56	2.34e-8	9.44e-8	(B) Positive
LINC01558	6q27	1.68	0.99	1.21	0.70	0.69	2.37e-8	9.55e-8	(A) Negative
FBXL15	10q24.32	-0.04	0.21	0.42	0.34	-0.25	2.38e-8	9.57e-8	(B) Positive
TRAM2	6p12.2	-0.51	-0.76	0.41	0.38	0.25	2.38e-8	9.59e-8	(A) Negative
HMG20B	19p13.3	-0.26	0.06	0.51	0.50	-0.31	2.38e-8	9.59e-8	(B) Positive
TMEM45B	11q24.3	-2.40	-1.15	2.14	1.53	-1.24	2.39e-8	9.60e-8	(B) Positive
AFAP1L2	10q25.3	0.46	0.97	0.79	1.01	-0.51	2.39e-8	9.63e-8	(B) Positive
PLEKHB1	11q13.4	1.00	0.29	1.21	0.99	0.71	2.42e-8	9.75e-8	(A) Negative
SCAMP2	15q24.1	-0.19	0.09	0.45	0.42	-0.27	2.44e-8	9.82e-8	(B) Positive
BATF	14q24.3	1.21	2.00	1.34	1.00	-0.78	2.45e-8	9.83e-8	(B) Positive
FKBP4	12p13.33	-0.36	0.03	0.66	0.61	-0.40	2.45e-8	9.85e-8	(B) Positive
NOM1	7q36.3	-0.54	-0.85	0.51	0.43	0.30	2.47e-8	9.92e-8	(A) Negative
GHRL	3p25.3	2.29	1.68	1.03	0.87	0.61	2.47e-8	9.94e-8	(A) Negative
RPS16	19q13.2	0.08	-0.23	0.52	0.46	0.31	2.50e-8	1.00e-7	(A) Negative
SYNE4	19q13.12	1.68	2.28	1.05	0.65	-0.60	2.51e-8	1.01e-7	(B) Positive
HTR1E	6q14.3	-0.81	-0.38	0.62	1.00	-0.43	2.54e-8	1.02e-7	(B) Positive
RPF1	1p22.3	-0.24	0.05	0.49	0.45	-0.29	2.55e-8	1.02e-7	(B) Positive
XPO7	8p21.3	-0.46	-0.80	0.56	0.49	0.33	2.56e-8	1.03e-7	(A) Negative
REL	2p16.1	0.74	1.16	0.67	0.76	-0.42	2.56e-8	1.03e-7	(B) Positive
SLC27A1	19p13.11	0.54	0.85	0.52	0.42	-0.31	2.57e-8	1.03e-7	(B) Positive
NUP160	11p11.2	-0.95	-1.29	0.59	0.43	0.34	2.57e-8	1.03e-7	(A) Negative
STOML2	9p13.3	-0.36	-0.70	0.58	0.41	0.34	2.58e-8	1.03e-7	(A) Negative
ELP3	8p21.1	-0.59	-0.30	0.45	0.53	-0.29	2.58e-8	1.03e-7	(B) Positive
ILF3	19p13.2	-0.34	-0.54	0.35	0.27	0.20	2.60e-8	1.04e-7	(A) Negative
PDE11A	2q31.2	-1.17	-0.66	0.86	0.73	-0.51	2.61e-8	1.05e-7	(B) Positive
OXGR1	13q32.1	2.32	1.17	2.01	1.33	1.16	2.64e-8	1.06e-7	(A) Negative
TASOR2	10p15.1	0.90	0.50	0.68	0.51	0.40	2.64e-8	1.06e-7	(A) Negative
SKI	1p36.33-p36.32	0.98	0.65	0.57	0.43	0.33	2.66e-8	1.06e-7	(A) Negative
SRR	17p13.3	-0.11	0.31	0.69	0.71	-0.42	2.69e-8	1.08e-7	(B) Positive
ARHGAP26	5q31.3	-0.46	-0.96	0.84	0.82	0.51	2.70e-8	1.08e-7	(A) Negative
NOP53	19q13.33	0.03	0.38	0.59	0.56	-0.36	2.71e-8	1.08e-7	(B) Positive
VARS1	6p21.33	-0.84	-1.15	0.51	0.51	0.31	2.72e-8	1.09e-7	(A) Negative
NSF	17q21.31	0.03	0.32	0.47	0.53	-0.29	2.74e-8	1.10e-7	(B) Positive
BUD13	11q23.3	-0.28	-0.57	0.51	0.38	0.30	2.75e-8	1.10e-7	(A) Negative
GCM1	6p12.1	0.32	0.54	0.35	0.41	-0.22	2.77e-8	1.11e-7	(B) Positive
NEFL	8p21.2	-2.73	-2.18	0.87	1.04	-0.55	2.78e-8	1.11e-7	(B) Positive
MRTO4	1p36.13	-0.80	-1.05	0.44	0.34	0.26	2.78e-8	1.11e-7	(A) Negative
METTL5	2q31.1	-0.53	-0.80	0.45	0.36	0.27	2.80e-8	1.12e-7	(A) Negative
DKK2	4q25	0.95	1.47	0.84	0.98	-0.53	2.81e-8	1.12e-7	(B) Positive
CCNG1	5q34	-1.84	-1.45	0.65	0.66	-0.40	2.81e-8	1.12e-7	(B) Positive
CAMK2N1	1p36.12	0.07	0.75	1.17	0.90	-0.68	2.84e-8	1.13e-7	(B) Positive
GALNT14	2p23.1	0.04	-1.14	2.01	1.66	1.18	2.86e-8	1.14e-7	(A) Negative
GPR137B	1q42.3	1.43	1.96	0.88	0.82	-0.53	2.88e-8	1.15e-7	(B) Positive
SLC38A3	3p21.31	-0.62	-1.15	0.92	0.57	0.53	2.90e-8	1.16e-7	(A) Negative
VAPA	18p11.22	0.22	0.50	0.49	0.42	-0.29	2.92e-8	1.16e-7	(B) Positive
HERC5	4q22.1	0.31	-0.48	1.33	1.15	0.79	2.93e-8	1.17e-7	(A) Negative
CAMKMT	2p21	0.18	-0.13	0.52	0.43	0.31	2.95e-8	1.18e-7	(A) Negative
PLAC1	Xq26.3	-1.17	-0.27	1.52	1.35	-0.90	2.96e-8	1.18e-7	(B) Positive
NUP153	6p22.3	-0.37	-0.75	0.65	0.47	0.37	2.97e-8	1.18e-7	(A) Negative
ADTRP	6p24.1	-2.51	-3.46	1.61	1.37	0.95	2.99e-8	1.19e-7	(A) Negative
ITGB7	12q13.13	-3.34	-3.64	0.49	0.45	0.29	3.00e-8	1.20e-7	(A) Negative
TPGS1	19p13.3	0.13	0.47	0.56	0.54	-0.33	3.01e-8	1.20e-7	(B) Positive
INSM1	20p11.23	-0.40	0.43	1.26	1.79	-0.83	3.01e-8	1.20e-7	(B) Positive
LRRC42	1p32.3	-0.23	-0.61	0.63	0.58	0.37	3.02e-8	1.20e-7	(A) Negative
EP400P1	12q24.33	-0.63	-1.03	0.68	0.60	0.40	3.02e-8	1.20e-7	(A) Negative
IL18RAP	2q12.1	3.01	2.26	1.26	1.16	0.75	3.02e-8	1.20e-7	(A) Negative
NDUFA5	7q31.32	-0.20	0.06	0.43	0.45	-0.26	3.03e-8	1.21e-7	(B) Positive
DBN1	5q35.3	0.25	-0.09	0.55	0.63	0.34	3.04e-8	1.21e-7	(A) Negative
RAB5C	17q21.2	-0.43	-0.14	0.46	0.50	-0.29	3.05e-8	1.21e-7	(B) Positive
ZNF595	4p16.3	0.04	0.48	0.74	0.63	-0.44	3.05e-8	1.21e-7	(B) Positive
HSPA1A	6p21.33	1.22	1.88	1.10	1.03	-0.66	3.05e-8	1.21e-7	(B) Positive
SLC26A7	8q21.3	1.37	0.59	1.39	0.67	0.78	3.06e-8	1.21e-7	(A) Negative
VPS11	11q23.3	0.19	0.45	0.41	0.42	-0.25	3.07e-8	1.22e-7	(B) Positive
DSCAML1	11q23.3	-0.14	0.44	0.90	1.15	-0.58	3.08e-8	1.22e-7	(B) Positive
HSPD1	2q33.1	-0.57	-0.87	0.50	0.55	0.31	3.10e-8	1.23e-7	(A) Negative
DUSP2	2q11.2	0.44	-0.02	0.77	0.76	0.46	3.10e-8	1.23e-7	(A) Negative
C2ORF15	2q11.2	0.61	1.16	0.93	0.81	-0.55	3.10e-8	1.23e-7	(B) Positive
CLTB	5q35.2	0.33	0.62	0.47	0.46	-0.28	3.13e-8	1.24e-7	(B) Positive
COQ3	6q16.2	-0.47	-0.93	0.78	0.60	0.45	3.13e-8	1.24e-7	(A) Negative
FSD1	19p13.3	-1.35	-1.78	0.77	0.43	0.44	3.15e-8	1.25e-7	(A) Negative
RDH16	12q13.3	0.12	0.58	0.69	1.00	-0.46	3.16e-8	1.25e-7	(B) Positive
VAX2	2p13.3	0.72	0.08	1.09	0.95	0.64	3.18e-8	1.26e-7	(A) Negative
ABI1	10p12.1	0.66	0.32	0.58	0.45	0.34	3.19e-8	1.26e-7	(A) Negative
OLFML3	1p13.2	0.78	1.34	0.95	0.86	-0.56	3.19e-8	1.27e-7	(B) Positive
FAM27E2	9p11.2	-1.88	-2.46	1.01	0.72	0.58	3.22e-8	1.27e-7	(A) Negative
PATJ	1p31.3	1.16	1.55	0.64	0.71	-0.40	3.22e-8	1.27e-7	(B) Positive
ATP7A	Xq21.1	0.46	0.86	0.68	0.58	-0.40	3.22e-8	1.28e-7	(B) Positive
SLC28A1	15q25.3	0.19	-0.14	0.57	0.39	0.33	3.24e-8	1.28e-7	(A) Negative
KRT15	17q21.2	2.13	1.02	1.77	2.10	1.11	3.27e-8	1.29e-7	(A) Negative
CEACAM8	19q13.2	0.11	0.54	0.72	0.70	-0.43	3.27e-8	1.29e-7	(B) Positive
ZNF490	19p13.2-p13.13	0.50	0.78	0.46	0.44	-0.27	3.27e-8	1.29e-7	(B) Positive
IFT70B	2q31.2	0.92	1.31	0.67	0.55	-0.39	3.29e-8	1.30e-7	(B) Positive
ECHDC2	1p32.3	1.37	1.68	0.48	0.58	-0.30	3.29e-8	1.30e-7	(B) Positive
NRAS	1p13.2	-1.10	-1.61	0.91	0.56	0.52	3.29e-8	1.30e-7	(A) Negative
PPIH	1p34.2	-0.24	-0.61	0.63	0.51	0.37	3.29e-8	1.30e-7	(A) Negative
PIGA	Xp22.2	0.07	-0.27	0.58	0.48	0.34	3.31e-8	1.31e-7	(A) Negative
ZNF213	16p13.3	0.67	0.97	0.51	0.47	-0.30	3.34e-8	1.32e-7	(B) Positive
NOTUM	17q25.3	-2.40	-2.63	0.40	0.32	0.23	3.34e-8	1.32e-7	(A) Negative
UMODL1	21q22.3	-0.18	-0.89	1.23	0.88	0.71	3.37e-8	1.33e-7	(A) Negative
POPDC3	6q21	-2.71	-3.52	1.42	1.05	0.82	3.38e-8	1.33e-7	(A) Negative
COQ10B	2q33.1	0.19	0.52	0.57	0.44	-0.33	3.38e-8	1.33e-7	(B) Positive
RNF208	9q34.3	0.11	0.37	0.45	0.35	-0.26	3.41e-8	1.35e-7	(B) Positive
NFKBIB	19q13.2	0.40	0.08	0.56	0.42	0.32	3.43e-8	1.35e-7	(A) Negative
IRX1	5p15.33	0.82	0.16	1.18	0.68	0.66	3.44e-8	1.36e-7	(A) Negative
SYP	Xp11.23	-0.15	0.15	0.43	0.71	-0.30	3.44e-8	1.36e-7	(B) Positive
CCDC124	19p13.11	-0.27	-0.54	0.44	0.44	0.27	3.45e-8	1.36e-7	(A) Negative
ZNF17	19q13.43	0.38	0.67	0.49	0.45	-0.29	3.45e-8	1.36e-7	(B) Positive
LCA5	6q14.1	0.63	1.09	0.78	0.70	-0.46	3.47e-8	1.37e-7	(B) Positive
DSG2	18q12.1	1.30	0.81	0.82	0.71	0.48	3.49e-8	1.37e-7	(A) Negative
IFT70A	2q31.2	1.01	1.51	0.85	0.70	-0.49	3.52e-8	1.38e-7	(B) Positive
CPAMD8	19p13.11	1.87	1.03	1.40	1.31	0.83	3.52e-8	1.39e-7	(A) Negative
ZDHHC18	1p36.11	0.40	0.07	0.57	0.45	0.33	3.53e-8	1.39e-7	(A) Negative
JRK	8q24.3	0.26	-0.06	0.54	0.45	0.32	3.53e-8	1.39e-7	(A) Negative
ZUP1	6q22.1	-0.15	-0.42	0.46	0.43	0.27	3.53e-8	1.39e-7	(A) Negative
TUBA1C	12q13.12	-0.61	-0.92	0.52	0.50	0.31	3.54e-8	1.39e-7	(A) Negative
ZNF624	17p11.2	0.60	0.91	0.51	0.53	-0.31	3.55e-8	1.40e-7	(B) Positive
MAPKBP1	15q15.1	0.15	0.37	0.39	0.31	-0.23	3.57e-8	1.40e-7	(B) Positive
EPG5	18q12.3-q21.1	-0.45	-0.19	0.42	0.43	-0.26	3.57e-8	1.40e-7	(B) Positive
MFN1	3q26.33	0.17	-0.14	0.53	0.44	0.31	3.57e-8	1.40e-7	(A) Negative
PLEKHG6	12p13.31	1.15	0.80	0.61	0.49	0.35	3.57e-8	1.40e-7	(A) Negative
SDF2	17q11.2	0.41	0.77	0.63	0.48	-0.36	3.58e-8	1.41e-7	(B) Positive
AVPR2	Xq28	0.26	0.49	0.36	0.42	-0.23	3.60e-8	1.41e-7	(B) Positive
PHF10	6q27	-0.44	-0.85	0.70	0.65	0.41	3.61e-8	1.42e-7	(A) Negative
LY75	2q24.2	2.74	1.98	1.27	1.18	0.76	3.62e-8	1.42e-7	(A) Negative
TEX261	2p13.3	0.27	0.04	0.40	0.35	0.23	3.68e-8	1.44e-7	(A) Negative
CALHM1	10q24.33	0.14	0.39	0.36	0.58	-0.25	3.69e-8	1.45e-7	(B) Positive
VNN1	6q23.2	-0.09	-0.87	1.40	0.71	0.78	3.69e-8	1.45e-7	(A) Negative
PANX1	11q21	0.74	0.42	0.52	0.59	0.32	3.71e-8	1.45e-7	(A) Negative
IGLV2-14	22q11.22	-0.04	-1.05	1.73	1.47	1.01	3.72e-8	1.46e-7	(A) Negative
GDPD5	11q13.4-q13.5	-0.19	-0.69	0.83	0.84	0.50	3.74e-8	1.46e-7	(A) Negative
OR7A5	19p13.1	0.91	0.45	0.80	0.58	0.46	3.75e-8	1.47e-7	(A) Negative
CDC25C	5q31.2	-1.12	-1.56	0.68	0.90	0.44	3.80e-8	1.49e-7	(A) Negative
ZNF280B	22q11.22	-0.87	-1.38	0.87	0.71	0.51	3.80e-8	1.49e-7	(A) Negative
NCALD	8q22.3	2.20	1.50	1.22	0.89	0.70	3.80e-8	1.49e-7	(A) Negative
FAM90A1	12p13.31	0.22	-0.65	1.49	1.27	0.87	3.80e-8	1.49e-7	(A) Negative
LMO1	11p15.4	-0.74	-1.59	1.51	0.98	0.86	3.81e-8	1.49e-7	(A) Negative
ZER1	9q34.11	0.27	0.52	0.42	0.36	-0.25	3.82e-8	1.49e-7	(B) Positive
PLXNB1	3p21.31	-0.16	0.25	0.67	0.70	-0.41	3.82e-8	1.49e-7	(B) Positive
MTIF3	13q12.2	0.26	0.55	0.48	0.47	-0.29	3.83e-8	1.50e-7	(B) Positive
BAZ1A	14q13.1-q13.2	0.40	0.08	0.55	0.48	0.32	3.83e-8	1.50e-7	(A) Negative
ECE1	1p36.12	0.12	0.41	0.48	0.49	-0.29	3.84e-8	1.50e-7	(B) Positive
BOC	3q13.2	2.42	1.80	1.05	0.92	0.62	3.86e-8	1.51e-7	(A) Negative
ZNF486	19p12	0.02	0.45	0.72	0.71	-0.43	3.87e-8	1.51e-7	(B) Positive
PYY	17q21.31	0.58	0.82	0.33	0.63	-0.25	3.87e-8	1.51e-7	(B) Positive
PLOD2	3q24	-0.39	-1.00	1.01	1.05	0.61	3.87e-8	1.51e-7	(A) Negative
CD59	11p13	1.14	0.65	0.84	0.66	0.49	3.88e-8	1.51e-7	(A) Negative
SGTB	5q12.3	-0.48	-0.74	0.44	0.45	0.26	3.90e-8	1.52e-7	(A) Negative
MFAP3	5q33.2	0.13	0.49	0.61	0.51	-0.35	3.91e-8	1.53e-7	(B) Positive
ZNF496	1q44	0.22	-0.07	0.50	0.40	0.29	3.94e-8	1.54e-7	(A) Negative
PGGHG	11p15.5	-1.33	-0.68	1.03	1.30	-0.65	3.97e-8	1.55e-7	(B) Positive
SYCP2L	6p24.2	-2.30	-3.01	1.25	0.73	0.70	4.02e-8	1.57e-7	(A) Negative
RPS6KA4	11q13.1	0.44	0.09	0.61	0.46	0.35	4.02e-8	1.57e-7	(A) Negative
ZNF85	19p12	-0.34	0.09	0.73	0.68	-0.43	4.02e-8	1.57e-7	(B) Positive
ITGBL1	13q33.1	1.51	2.29	1.33	1.23	-0.78	4.03e-8	1.57e-7	(B) Positive
INTS12	4q24	0.06	0.37	0.54	0.47	-0.31	4.03e-8	1.57e-7	(B) Positive
INPP5B	1p34.3	-0.24	-0.60	0.63	0.45	0.36	4.04e-8	1.57e-7	(A) Negative
PROK2	3p13	-0.95	-1.56	1.07	0.76	0.61	4.08e-8	1.59e-7	(A) Negative
GPR27	3p13	0.04	0.51	0.78	0.78	-0.47	4.09e-8	1.59e-7	(B) Positive
MT1X	16q13	-0.05	-0.46	0.69	0.63	0.41	4.14e-8	1.61e-7	(A) Negative
E2F7	12q21.2	-1.47	-1.98	0.86	0.79	0.51	4.15e-8	1.61e-7	(A) Negative
GUCY1A1	4q32.1	4.21	3.70	0.85	0.83	0.51	4.18e-8	1.63e-7	(A) Negative
PIP5KL1	9q34.11	-0.21	0.18	0.64	0.76	-0.40	4.19e-8	1.63e-7	(B) Positive
NME4	16p13.3	-0.44	-0.10	0.58	0.55	-0.35	4.20e-8	1.63e-7	(B) Positive
ZNF567	19q13.12	0.55	0.19	0.65	0.46	0.37	4.22e-8	1.64e-7	(A) Negative
ETS2	21q22.2	-0.01	-0.37	0.59	0.64	0.36	4.22e-8	1.64e-7	(A) Negative
FBXO30	6q24.3	0.55	0.17	0.66	0.57	0.38	4.23e-8	1.64e-7	(A) Negative
FRMPD3	Xq22.3	0.58	0.82	0.39	0.41	-0.24	4.23e-8	1.64e-7	(B) Positive
SOD3	4p15.2	0.37	-0.34	1.22	1.03	0.71	4.23e-8	1.64e-7	(A) Negative
PRKAG2	7q36.1	1.49	1.13	0.64	0.48	0.37	4.24e-8	1.65e-7	(A) Negative
TMEM108	3q22.1	0.74	0.04	1.21	1.04	0.70	4.25e-8	1.65e-7	(A) Negative
TLR1	4p14	2.57	1.98	1.03	0.83	0.60	4.27e-8	1.66e-7	(A) Negative
WASHC5	8q24.13	0.26	0.65	0.62	0.75	-0.39	4.28e-8	1.66e-7	(B) Positive
CFAP410	21q22.3	-0.48	-0.22	0.44	0.43	-0.26	4.28e-8	1.66e-7	(B) Positive
GNPTAB	12q23.2	0.08	-0.25	0.57	0.47	0.33	4.28e-8	1.66e-7	(A) Negative
CLCNKA	1p36.13	-0.04	0.13	0.27	0.31	-0.17	4.31e-8	1.67e-7	(B) Positive
GPR158	10p12.1	-0.17	-1.35	2.00	1.84	1.18	4.33e-8	1.68e-7	(A) Negative
LAMC2	1q25.3	1.51	0.60	1.53	1.51	0.91	4.35e-8	1.69e-7	(A) Negative
LINGO4	1q21.3	0.48	0.30	0.30	0.32	0.18	4.35e-8	1.69e-7	(A) Negative
LAMA2	6q22.33	3.19	3.88	1.16	1.13	-0.69	4.42e-8	1.71e-7	(B) Positive
BAD	11q13.1	0.57	0.83	0.43	0.44	-0.26	4.45e-8	1.72e-7	(B) Positive
JMJD6	17q25.1	0.00	-0.24	0.39	0.45	0.24	4.48e-8	1.73e-7	(A) Negative
CYYR1	21q21.3	2.08	1.38	1.23	0.81	0.70	4.48e-8	1.73e-7	(A) Negative
CPNE8	12q12	-0.17	-0.74	1.00	0.71	0.57	4.50e-8	1.74e-7	(A) Negative
DNM1L	12p11.21	-0.37	-0.71	0.60	0.44	0.34	4.54e-8	1.76e-7	(A) Negative
ITPRIPL1	2q11.2	-1.28	-1.76	0.85	0.54	0.48	4.55e-8	1.76e-7	(A) Negative
ZRANB2	1p31.1	-0.58	-0.81	0.39	0.32	0.23	4.60e-8	1.78e-7	(A) Negative
DCLRE1B	1p13.2	-0.19	-0.52	0.56	0.53	0.33	4.69e-8	1.81e-7	(A) Negative
PODN	1p32.3	2.18	2.60	0.73	0.67	-0.43	4.73e-8	1.83e-7	(B) Positive
FOXRED2	22q12.3	-0.45	-0.89	0.76	0.62	0.44	4.75e-8	1.84e-7	(A) Negative
PMAIP1	18q21.32	-1.96	-1.28	1.13	1.25	-0.69	4.77e-8	1.84e-7	(B) Positive
ZNG1E	9q21.11	-0.98	-0.66	0.50	0.69	-0.32	4.78e-8	1.85e-7	(B) Positive
YWHAB	20q13.12	0.20	0.48	0.48	0.44	-0.28	4.80e-8	1.85e-7	(B) Positive
OR4D5	11q24.1	0.65	0.41	0.41	0.30	0.23	4.82e-8	1.86e-7	(A) Negative
PROX1	1q32.3	-1.32	-1.98	1.17	0.77	0.66	4.83e-8	1.86e-7	(A) Negative
CSN3	4q13.3	1.24	0.25	1.80	0.91	0.99	4.88e-8	1.88e-7	(A) Negative
TULP2	19q13.33	-0.47	-0.65	0.29	0.32	0.18	4.91e-8	1.89e-7	(A) Negative
ZBTB24	6q21	-0.07	-0.39	0.55	0.54	0.32	4.91e-8	1.90e-7	(A) Negative
EIF5B	2q11.2	0.13	-0.04	0.27	0.26	0.16	4.93e-8	1.90e-7	(A) Negative
ENTREP3	1q22	0.28	-0.09	0.64	0.54	0.37	4.95e-8	1.91e-7	(A) Negative
CRYZL1	21q22.11	-0.50	-0.20	0.50	0.46	-0.29	5.00e-8	1.93e-7	(B) Positive
SLC25A25	9q34.11	-0.34	-0.03	0.50	0.65	-0.32	5.01e-8	1.93e-7	(B) Positive
RXYLT1	12q14.2	-0.53	-0.22	0.51	0.52	-0.31	5.03e-8	1.94e-7	(B) Positive
PHC3	3q26.2	-0.03	0.26	0.52	0.42	-0.30	5.04e-8	1.94e-7	(B) Positive
PODXL	7q32.3	-1.24	-1.72	0.82	0.79	0.48	5.06e-8	1.95e-7	(A) Negative
DNAJC6	1p31.3	-0.36	-0.70	0.57	0.58	0.34	5.06e-8	1.95e-7	(A) Negative
ABCD1	Xq28	0.49	0.11	0.65	0.54	0.38	5.07e-8	1.95e-7	(A) Negative
PAH	12q23.2	-5.03	-4.41	0.94	1.40	-0.62	5.08e-8	1.96e-7	(B) Positive
PPM1L	3q25.33-q26.1	0.56	0.21	0.61	0.53	0.35	5.11e-8	1.97e-7	(A) Negative
GLIDR	9p12	-0.32	0.15	0.79	0.74	-0.46	5.12e-8	1.97e-7	(B) Positive
ZNF182	Xp11.23	-0.63	-0.32	0.53	0.56	-0.32	5.13e-8	1.97e-7	(B) Positive
PRXL2B	1p36.32	0.38	0.79	0.71	0.62	-0.41	5.13e-8	1.97e-7	(B) Positive
HDDC3	15q26.1	-0.26	0.00	0.44	0.41	-0.26	5.17e-8	1.99e-7	(B) Positive
SLC9A8	20q13.13	-0.01	0.23	0.39	0.43	-0.24	5.18e-8	1.99e-7	(B) Positive
DNAJB12	10q22.1	0.69	0.97	0.48	0.36	-0.27	5.18e-8	1.99e-7	(B) Positive
TRIP6	7q22.1	0.12	-0.26	0.63	0.65	0.38	5.23e-8	2.01e-7	(A) Negative
KDM3B	5q31.2	-0.01	0.25	0.45	0.40	-0.26	5.24e-8	2.01e-7	(B) Positive
ARHGEF12	11q23.3	0.36	0.63	0.47	0.40	-0.27	5.24e-8	2.01e-7	(B) Positive
PLA2R1	2q23-q24	1.12	1.54	0.72	0.70	-0.43	5.24e-8	2.01e-7	(B) Positive
RPP21	6p22.1	0.15	-0.15	0.51	0.46	0.30	5.26e-8	2.02e-7	(A) Negative
LARP4B	10p15.3	0.72	0.44	0.50	0.40	0.29	5.27e-8	2.03e-7	(A) Negative
RNMT	18p11.21	-0.28	-0.56	0.49	0.39	0.28	5.33e-8	2.05e-7	(A) Negative
UBTF	17q21.31	0.02	0.22	0.34	0.33	-0.20	5.39e-8	2.07e-7	(B) Positive
H4C13	6p22.1	-0.54	-1.22	1.18	1.02	0.68	5.42e-8	2.08e-7	(A) Negative
NPCDR1	3p21.1	0.39	0.69	0.48	0.63	-0.30	5.44e-8	2.09e-7	(B) Positive
CDH19	18q22.1	-0.71	-2.12	2.58	1.11	1.41	5.46e-8	2.09e-7	(A) Negative
VPS28	8q24.3	0.65	1.00	0.60	0.53	-0.35	5.46e-8	2.09e-7	(B) Positive
UGT2B17	4q13.2	-1.71	-0.84	1.34	1.92	-0.87	5.47e-8	2.10e-7	(B) Positive
STON1	2p16.3	0.57	-0.06	1.07	0.96	0.62	5.49e-8	2.11e-7	(A) Negative
ADGRG2	Xp22.13	0.21	-1.01	2.23	1.13	1.22	5.56e-8	2.13e-7	(A) Negative
RPL39	Xq24	0.06	-0.30	0.62	0.53	0.36	5.56e-8	2.13e-7	(A) Negative
ZNF675	19p12	-0.52	-0.11	0.70	0.65	-0.41	5.61e-8	2.15e-7	(B) Positive
PI4KA	22q11.21	-0.93	-0.69	0.38	0.45	-0.24	5.65e-8	2.16e-7	(B) Positive
FGD4	12p11.21	0.70	0.25	0.80	0.62	0.45	5.68e-8	2.17e-7	(A) Negative
GNRH2	20p13	0.15	0.01	0.23	0.25	0.14	5.69e-8	2.18e-7	(A) Negative
RAB12	18p11.22	-0.07	-0.56	0.85	0.74	0.49	5.72e-8	2.19e-7	(A) Negative
CRYBB3	22q11.23	0.28	0.14	0.23	0.24	0.13	5.73e-8	2.19e-7	(A) Negative
CCNC	6q16.2	0.12	-0.28	0.69	0.60	0.40	5.74e-8	2.20e-7	(A) Negative
RGS2	1q31.2	1.24	0.36	1.52	1.30	0.88	5.78e-8	2.21e-7	(A) Negative
CRYBG2	1p36.11	0.20	-0.23	0.72	0.81	0.44	5.79e-8	2.22e-7	(A) Negative
RNF157	17q25.1	-1.30	-0.94	0.58	0.66	-0.35	5.80e-8	2.22e-7	(B) Positive
PLEKHA6	1q32.1	1.13	1.71	1.04	0.72	-0.58	5.81e-8	2.22e-7	(B) Positive
FEM1C	5q22.3	-0.01	0.45	0.81	0.70	-0.47	5.87e-8	2.24e-7	(B) Positive
ZNF43	19p12	-0.26	0.18	0.76	0.69	-0.44	5.87e-8	2.24e-7	(B) Positive
ULK1	12q24.33	-0.44	-0.16	0.50	0.42	-0.29	5.90e-8	2.25e-7	(B) Positive
CAMK1G	1q32.2	-0.17	-0.40	0.39	0.42	0.23	5.91e-8	2.26e-7	(A) Negative
CSNK1G1	15q22.31	-0.19	0.06	0.41	0.46	-0.25	5.92e-8	2.26e-7	(B) Positive
RNF220	1p34.1	0.02	-0.21	0.39	0.34	0.23	5.93e-8	2.27e-7	(A) Negative
DDR1	6p21.33	1.36	1.77	0.69	0.66	-0.41	5.94e-8	2.27e-7	(B) Positive
FAM219B	15q24.1-q24.2	-0.48	-0.18	0.49	0.51	-0.29	5.94e-8	2.27e-7	(B) Positive
ZNF287	17p11.2	0.61	1.07	0.78	0.79	-0.46	5.97e-8	2.28e-7	(B) Positive
SLC23A2	20p13	-0.25	-0.50	0.43	0.35	0.25	6.00e-8	2.29e-7	(A) Negative
RSAD1	17q21.33	-0.37	0.02	0.68	0.58	-0.39	6.01e-8	2.29e-7	(B) Positive
RANBP2	2q13	0.33	0.06	0.47	0.42	0.27	6.01e-8	2.29e-7	(A) Negative
IQCN	19p13.11	-1.04	-0.59	0.76	0.79	-0.45	6.02e-8	2.29e-7	(B) Positive
PRSS3	9p13.3	-2.10	-2.62	0.91	0.74	0.52	6.03e-8	2.30e-7	(A) Negative
DNASE1L2	16p13.3	-1.77	-1.30	0.79	0.78	-0.47	6.04e-8	2.30e-7	(B) Positive
GGTLC1	20p11.21	0.63	-0.03	1.08	1.32	0.67	6.06e-8	2.31e-7	(A) Negative
PPP2R5A	1q32.3	0.86	1.30	0.77	0.59	-0.44	6.06e-8	2.31e-7	(B) Positive
TDG	12q23.3	0.03	-0.25	0.49	0.43	0.28	6.10e-8	2.32e-7	(A) Negative
RHBDD2	7q11.23	0.39	0.70	0.53	0.50	-0.31	6.11e-8	2.33e-7	(B) Positive
ACYP2	2p16.2	0.59	0.21	0.65	0.60	0.38	6.12e-8	2.33e-7	(A) Negative
ASPN	9q22.31	6.68	7.55	1.52	1.30	-0.87	6.14e-8	2.34e-7	(B) Positive
LYPD1	2q21.2	-1.11	-1.67	1.01	0.71	0.57	6.19e-8	2.35e-7	(A) Negative
DDRGK1	20p13	0.37	0.63	0.45	0.39	-0.26	6.20e-8	2.36e-7	(B) Positive
COPS3	17p11.2	-0.58	-0.85	0.46	0.45	0.27	6.20e-8	2.36e-7	(A) Negative
GPHN	14q23.3	-0.75	-0.36	0.64	0.76	-0.39	6.20e-8	2.36e-7	(B) Positive
DYNC2I1	7q36.3	-0.26	0.02	0.48	0.51	-0.29	6.26e-8	2.38e-7	(B) Positive
VPS16	20p13	-0.01	0.29	0.53	0.42	-0.30	6.31e-8	2.40e-7	(B) Positive
PFN1	17p13.2	-0.16	-0.42	0.46	0.44	0.27	6.34e-8	2.41e-7	(A) Negative
PRIM2	6p11.2	-1.02	-1.49	0.84	0.64	0.47	6.35e-8	2.41e-7	(A) Negative
RFC3	13q13.2	-0.82	-1.23	0.73	0.57	0.41	6.39e-8	2.43e-7	(A) Negative
NKG7	19q13.41	2.05	1.50	0.96	0.80	0.55	6.41e-8	2.43e-7	(A) Negative
ALDH3B2	11q13.2	0.97	1.61	1.07	1.10	-0.63	6.47e-8	2.46e-7	(B) Positive
JPH2	20q13.12	0.78	0.42	0.66	0.41	0.37	6.50e-8	2.47e-7	(A) Negative
CEP85L	6q22.31	-0.26	-0.74	0.85	0.67	0.48	6.54e-8	2.48e-7	(A) Negative
GNAT2	1p13.3	-0.35	-0.76	0.68	0.69	0.40	6.57e-8	2.49e-7	(A) Negative
ZCCHC14	16q24.2	0.17	-0.12	0.51	0.45	0.29	6.60e-8	2.50e-7	(A) Negative
ADAMTS13	9q34.2	-0.78	-0.50	0.47	0.48	-0.28	6.62e-8	2.51e-7	(B) Positive
YAP1	11q22.1	0.08	-0.25	0.56	0.54	0.33	6.63e-8	2.51e-7	(A) Negative
C1ORF174	1p36.32	-0.22	-0.50	0.50	0.37	0.28	6.64e-8	2.52e-7	(A) Negative
C9ORF163	9q34.3	-0.24	-0.44	0.34	0.32	0.20	6.68e-8	2.53e-7	(A) Negative
MAGED4B	Xp11.22	-0.94	-1.81	1.55	1.10	0.87	6.68e-8	2.53e-7	(A) Negative
GLMN	1p22.1	-0.92	-1.29	0.65	0.56	0.37	6.71e-8	2.54e-7	(A) Negative
RGMB	5q15	-0.01	0.33	0.61	0.50	-0.35	6.73e-8	2.55e-7	(B) Positive
CASP7	10q25.3	0.64	1.04	0.68	0.65	-0.40	6.74e-8	2.55e-7	(B) Positive
ATP5IF1	1p35.3	-0.63	-0.26	0.63	0.59	-0.37	6.75e-8	2.56e-7	(B) Positive
FAXDC2	5q33.2	-0.84	-0.28	0.89	1.20	-0.56	6.85e-8	2.59e-7	(B) Positive
CAMK2D	4q26	0.22	-0.23	0.74	0.85	0.45	6.86e-8	2.59e-7	(A) Negative
BACH2	6q15	0.11	-0.45	0.97	0.92	0.56	6.87e-8	2.60e-7	(A) Negative
DEPTOR	8q24.12	0.48	1.33	1.51	1.03	-0.84	6.87e-8	2.60e-7	(B) Positive
USP45	6q16.2	-0.85	-1.17	0.56	0.49	0.32	6.92e-8	2.62e-7	(A) Negative
BAZ1B	7q11.23	0.44	0.15	0.50	0.48	0.29	6.92e-8	2.62e-7	(A) Negative
CNOT1	16q21	-0.26	-0.54	0.47	0.47	0.28	6.96e-8	2.63e-7	(A) Negative
RTN1	14q23.1	1.28	1.71	0.71	0.83	-0.43	7.00e-8	2.64e-7	(B) Positive
SLC19A1	21q22.3	-0.24	-0.65	0.71	0.68	0.41	7.00e-8	2.65e-7	(A) Negative
TTC5	14q11.2	-0.36	-0.05	0.55	0.49	-0.32	7.01e-8	2.65e-7	(B) Positive
CCL13	17q12	4.31	3.54	1.29	1.40	0.77	7.03e-8	2.65e-7	(A) Negative
SORL1	11q24.1	0.48	0.99	0.87	0.84	-0.51	7.04e-8	2.66e-7	(B) Positive
IGFBP6	12q13.13	-1.38	-0.99	0.65	0.73	-0.39	7.04e-8	2.66e-7	(B) Positive
MAN2B1	19p13.13	1.05	0.74	0.52	0.52	0.31	7.15e-8	2.70e-7	(A) Negative
GRAMD1C	3q13.31	0.46	0.95	0.85	0.76	-0.49	7.15e-8	2.70e-7	(B) Positive
ADPRH	3q13.33	1.48	1.16	0.54	0.52	0.32	7.15e-8	2.70e-7	(A) Negative
PRR34	22q13.31	0.08	0.39	0.53	0.52	-0.31	7.20e-8	2.71e-7	(B) Positive
MRPS18A	6p21.1	0.21	-0.05	0.45	0.40	0.26	7.23e-8	2.73e-7	(A) Negative
PIP4K2C	12q13.3	0.67	0.96	0.49	0.51	-0.29	7.30e-8	2.75e-7	(B) Positive
PCGF3	4p16.3	-0.08	0.20	0.49	0.43	-0.28	7.36e-8	2.77e-7	(B) Positive
CLTRN	Xp22.2	0.36	-0.29	1.14	0.99	0.65	7.37e-8	2.78e-7	(A) Negative
ZNF208	19p12	-0.46	-0.08	0.64	0.63	-0.38	7.39e-8	2.78e-7	(B) Positive
CRLF3	17q11.2	-0.10	-0.47	0.65	0.51	0.36	7.40e-8	2.79e-7	(A) Negative
PAF1	19q13.2	0.45	0.69	0.42	0.35	-0.24	7.50e-8	2.82e-7	(B) Positive
DECR2	16p13.3	-0.20	0.17	0.64	0.54	-0.37	7.50e-8	2.82e-7	(B) Positive
HMBS	11q23.3	-1.69	-2.02	0.57	0.50	0.33	7.51e-8	2.83e-7	(A) Negative
RNF166	16q24.2-q24.3	-0.40	-0.71	0.53	0.47	0.30	7.52e-8	2.83e-7	(A) Negative
RNF8	6p21.2	-0.20	-0.48	0.49	0.39	0.28	7.56e-8	2.85e-7	(A) Negative
RAP2C	Xq26.2	0.19	0.58	0.64	0.74	-0.39	7.58e-8	2.85e-7	(B) Positive
CCDC115	2q21.1	1.00	1.31	0.55	0.44	-0.31	7.60e-8	2.86e-7	(B) Positive
TMTC2	12q21.31	1.26	1.83	0.98	0.93	-0.57	7.63e-8	2.87e-7	(B) Positive
MYH7B	20q11.22	-0.14	0.22	0.59	0.66	-0.35	7.63e-8	2.87e-7	(B) Positive
THAP10	15q23	-0.79	-0.36	0.76	0.68	-0.44	7.66e-8	2.88e-7	(B) Positive
ZMAT4	8p11.21	-2.96	-1.99	1.54	2.06	-0.97	7.68e-8	2.89e-7	(B) Positive
NEDD8	14q12	-0.29	-0.04	0.46	0.36	-0.26	7.74e-8	2.91e-7	(B) Positive
MIPEP	13q12.12	-0.22	0.21	0.75	0.65	-0.43	7.77e-8	2.92e-7	(B) Positive
TMEM268	9q32	0.53	0.91	0.68	0.52	-0.38	7.79e-8	2.93e-7	(B) Positive
FXN	9q21.11	-0.32	-0.63	0.57	0.41	0.32	7.83e-8	2.94e-7	(A) Negative
CAMK1	3p25.3	-0.59	-0.26	0.55	0.60	-0.33	7.94e-8	2.98e-7	(B) Positive
INO80	15q15.1	-0.05	0.14	0.33	0.29	-0.19	7.96e-8	2.99e-7	(B) Positive
WDR7	18q21.31	0.66	0.92	0.46	0.45	-0.27	8.00e-8	3.00e-7	(B) Positive
GABPB2	1q21.3	-0.49	-0.79	0.50	0.53	0.30	8.06e-8	3.02e-7	(A) Negative
ADCK2	7q34	0.30	0.59	0.49	0.51	-0.29	8.11e-8	3.04e-7	(B) Positive
SMR3A	4q13.3	1.32	0.70	1.13	0.57	0.61	8.14e-8	3.05e-7	(A) Negative
KCNA7	19q13.33	-0.06	-0.45	0.68	0.60	0.39	8.16e-8	3.06e-7	(A) Negative
HTR1F	3p12	-0.78	-0.34	0.69	0.95	-0.44	8.23e-8	3.08e-7	(B) Positive
ATP1A3	19q13.2	0.42	0.03	0.69	0.66	0.40	8.25e-8	3.09e-7	(A) Negative
APOBEC3B	22q13.1	-0.53	-1.42	1.62	1.07	0.90	8.26e-8	3.09e-7	(A) Negative
COL24A1	1p22.3	0.19	0.78	1.05	0.78	-0.59	8.27e-8	3.10e-7	(B) Positive
CCDC68	18q21.2	-1.07	-0.60	0.73	1.08	-0.48	8.30e-8	3.11e-7	(B) Positive
HDAC9	7p21.1	0.36	-0.04	0.72	0.57	0.41	8.32e-8	3.12e-7	(A) Negative
MTHFSD	16q24.1	0.13	-0.22	0.63	0.49	0.35	8.37e-8	3.13e-7	(A) Negative
DDX23	12q13.12	-0.14	0.08	0.38	0.36	-0.22	8.38e-8	3.14e-7	(B) Positive
NSMAF	8q12.1	-0.18	-0.53	0.60	0.58	0.35	8.42e-8	3.15e-7	(A) Negative
PTGFR	1p31.1	-0.75	-1.42	1.23	0.75	0.67	8.45e-8	3.16e-7	(A) Negative
C2ORF49	2q12.2	-0.26	-0.55	0.51	0.42	0.29	8.50e-8	3.18e-7	(A) Negative
ECHDC1	6q22.33	-0.40	-1.02	1.10	0.92	0.62	8.54e-8	3.19e-7	(A) Negative
AFMID	17q25.3	-0.87	-0.44	0.72	0.78	-0.43	8.56e-8	3.20e-7	(B) Positive
GPR39	2q21.2	0.02	0.21	0.34	0.35	-0.20	8.59e-8	3.21e-7	(B) Positive
ASF1B	19p13.12	-0.92	-1.28	0.60	0.69	0.36	8.65e-8	3.23e-7	(A) Negative
ANKLE1	19p13.11	-0.68	-1.03	0.61	0.46	0.34	8.69e-8	3.25e-7	(A) Negative
CXCR4	2q22.1	0.91	0.29	1.06	0.98	0.61	8.77e-8	3.27e-7	(A) Negative
DNPH1	6p21.1	0.11	-0.21	0.55	0.56	0.32	8.80e-8	3.29e-7	(A) Negative
GK5	3q23	0.18	-0.18	0.64	0.48	0.36	8.81e-8	3.29e-7	(A) Negative
KDM1A	1p36.12	-0.39	-0.70	0.56	0.43	0.31	8.85e-8	3.30e-7	(A) Negative
ADIPOR1	1q32.1	0.23	0.52	0.51	0.51	-0.30	8.86e-8	3.31e-7	(B) Positive
TRIP10	19p13.3	-0.01	-0.36	0.62	0.51	0.35	8.87e-8	3.31e-7	(A) Negative
AKAP3	12p13.32	0.18	-0.36	0.97	0.76	0.54	8.87e-8	3.31e-7	(A) Negative
ANKH	5p15.2	-0.05	-0.59	0.95	0.81	0.54	8.93e-8	3.33e-7	(A) Negative
ZNF776	19q13.43	0.41	0.72	0.54	0.50	-0.31	9.04e-8	3.37e-7	(B) Positive
EIF2B3	1p34.1	-0.67	-0.99	0.56	0.48	0.32	9.13e-8	3.40e-7	(A) Negative
IPPK	9q22.31	0.24	0.63	0.68	0.60	-0.39	9.14e-8	3.40e-7	(B) Positive
GRK6	5q35.3	0.09	-0.17	0.46	0.34	0.26	9.31e-8	3.47e-7	(A) Negative
PIGO	9p13.3	0.24	0.58	0.59	0.55	-0.34	9.35e-8	3.48e-7	(B) Positive
ATP2A1	16p11.2	0.07	-0.13	0.33	0.38	0.20	9.38e-8	3.49e-7	(A) Negative
CALHM6	6q22.1	0.46	-0.42	1.56	1.28	0.88	9.48e-8	3.53e-7	(A) Negative
SRF	6p21.1	0.44	0.14	0.53	0.42	0.30	9.49e-8	3.53e-7	(A) Negative
FAM110C	2p25.3	0.47	1.17	1.28	0.83	-0.70	9.53e-8	3.54e-7	(B) Positive
H4C3	6p22.2	-0.59	-1.25	1.16	0.98	0.66	9.53e-8	3.55e-7	(A) Negative
CDKL1	14q21.3	0.25	-0.14	0.70	0.52	0.39	9.61e-8	3.57e-7	(A) Negative
RAB3A	19p13.11	-0.40	-0.11	0.51	0.49	-0.29	9.81e-8	3.65e-7	(B) Positive
ZNF219	14q11	-0.22	0.27	0.89	0.62	-0.49	9.85e-8	3.66e-7	(B) Positive
SEC23IP	10q26.11-q26.12	0.43	0.73	0.53	0.45	-0.30	9.92e-8	3.69e-7	(B) Positive
MSX1	4p16.2	-0.85	-0.49	0.61	0.64	-0.36	9.93e-8	3.69e-7	(B) Positive
CABLES2	20q13.33	0.18	-0.21	0.66	0.65	0.38	1.00e-7	3.72e-7	(A) Negative
TOP2A	17q21.2	-1.53	-2.07	0.87	1.12	0.54	1.00e-7	3.73e-7	(A) Negative
CXCL10	4q21.1	3.89	3.52	0.62	0.67	0.36	1.01e-7	3.73e-7	(A) Negative
SLC25A51P4	11p15.1	-0.14	-0.51	0.66	0.58	0.37	1.01e-7	3.74e-7	(A) Negative
SUV39H1	Xp11.23	-0.67	-0.96	0.50	0.48	0.29	1.01e-7	3.75e-7	(A) Negative
MFSD2A	1p34.2	0.67	0.04	1.10	0.95	0.62	1.02e-7	3.78e-7	(A) Negative
C18ORF21	18q12.2	0.24	-0.09	0.59	0.42	0.33	1.02e-7	3.79e-7	(A) Negative
ASAP1	8q24.21-q24.22	0.23	-0.10	0.60	0.51	0.34	1.02e-7	3.79e-7	(A) Negative
CD3E	11q23.3	-0.16	-0.41	0.43	0.41	0.25	1.03e-7	3.81e-7	(A) Negative
ESX1	Xq22.2	-2.71	-3.33	1.15	0.62	0.62	1.03e-7	3.82e-7	(A) Negative
MLH1	3p22.2	-0.69	-0.33	0.64	0.51	-0.36	1.03e-7	3.83e-7	(B) Positive
BET1L	11p15.5	0.34	0.58	0.44	0.39	-0.25	1.03e-7	3.83e-7	(B) Positive
TEK	9p21.2	0.74	1.10	0.61	0.67	-0.36	1.04e-7	3.84e-7	(B) Positive
EXO5	1p34.2	0.61	0.29	0.58	0.45	0.32	1.04e-7	3.84e-7	(A) Negative
ANGEL2	1q32.3	0.11	0.37	0.45	0.46	-0.26	1.04e-7	3.85e-7	(B) Positive
DSCR9	21q22.13	-0.34	-0.82	0.85	0.76	0.48	1.04e-7	3.86e-7	(A) Negative
DOLK	9q34.11	0.20	0.50	0.54	0.42	-0.30	1.04e-7	3.86e-7	(B) Positive
TAF11	6p21.31	-0.39	-0.75	0.64	0.52	0.36	1.06e-7	3.91e-7	(A) Negative
C14ORF28	14q21.2	0.06	0.39	0.60	0.43	-0.33	1.06e-7	3.94e-7	(B) Positive
EPB41L2	6q23.1-q23.2	-0.16	-0.68	0.94	0.68	0.52	1.07e-7	3.94e-7	(A) Negative
PSORS1C2	6p21.33	0.61	0.39	0.41	0.23	0.22	1.07e-7	3.94e-7	(A) Negative
SLC25A5	Xq24	-0.40	-0.76	0.64	0.51	0.35	1.07e-7	3.94e-7	(A) Negative
ANKRD50	4q28.1	0.95	1.45	0.86	0.88	-0.50	1.07e-7	3.96e-7	(B) Positive
ZNF625	19p13.2	-0.42	-0.13	0.51	0.47	-0.29	1.07e-7	3.97e-7	(B) Positive
TBC1D13	9q34.11	-0.28	0.03	0.55	0.53	-0.32	1.08e-7	3.99e-7	(B) Positive
ETV7	6p21.31	3.56	3.01	0.94	0.94	0.54	1.08e-7	3.99e-7	(A) Negative
GALNT12	9q22.33	-2.13	-2.87	1.33	1.04	0.74	1.08e-7	3.99e-7	(A) Negative
EDNRA	4q31.22-q31.23	1.71	2.26	0.95	0.91	-0.54	1.08e-7	3.99e-7	(B) Positive
UFD1	22q11.21	-0.20	-0.48	0.49	0.47	0.28	1.08e-7	3.99e-7	(A) Negative
SOAT1	1q25.2	-0.37	-0.88	0.92	0.77	0.52	1.08e-7	4.00e-7	(A) Negative
PLEKHA8	7p14.3	0.09	-0.25	0.60	0.59	0.35	1.09e-7	4.01e-7	(A) Negative
PBK	8p21.1	-2.22	-2.84	1.04	1.17	0.62	1.09e-7	4.02e-7	(A) Negative
PGK1	Xq21.1	-0.93	-1.27	0.59	0.52	0.34	1.09e-7	4.04e-7	(A) Negative
VMP1	17q23.1	-1.26	-0.83	0.75	0.77	-0.43	1.10e-7	4.07e-7	(B) Positive
MOGAT1	2q36.1	0.37	-0.35	1.34	0.74	0.72	1.11e-7	4.09e-7	(A) Negative
ANAPC2	9q34.3	-0.43	-0.15	0.49	0.49	-0.28	1.12e-7	4.11e-7	(B) Positive
KBTBD8	3p14.1	-0.79	-1.27	0.85	0.78	0.48	1.12e-7	4.12e-7	(A) Negative
SLC5A10	17p11.2	-0.07	0.22	0.46	0.64	-0.29	1.12e-7	4.12e-7	(B) Positive
CRBN	3p26.2	0.05	0.39	0.61	0.49	-0.34	1.12e-7	4.12e-7	(B) Positive
CLEC4E	12p13.31	3.99	3.33	1.15	1.14	0.66	1.12e-7	4.13e-7	(A) Negative
USP24	1p32.3	-0.16	-0.46	0.54	0.41	0.30	1.12e-7	4.13e-7	(A) Negative
PHKG2	16p11.2	-0.20	0.07	0.48	0.46	-0.28	1.12e-7	4.14e-7	(B) Positive
CYP2R1	11p15.2	-0.45	-0.12	0.57	0.52	-0.33	1.14e-7	4.18e-7	(B) Positive
TBC1D19	4p15.2	-0.79	-0.46	0.61	0.50	-0.34	1.14e-7	4.20e-7	(B) Positive
KTN1	14q22.1	-0.01	0.32	0.55	0.58	-0.32	1.14e-7	4.21e-7	(B) Positive
ATP6V1H	8q11.23	0.26	0.58	0.55	0.59	-0.32	1.15e-7	4.22e-7	(B) Positive
CHM	Xq21.2	-0.13	0.16	0.49	0.50	-0.28	1.15e-7	4.23e-7	(B) Positive
AAAS	12q13.13	-0.83	-0.61	0.37	0.41	-0.22	1.15e-7	4.24e-7	(B) Positive
ZNF479	7p11.2	-0.25	0.07	0.55	0.53	-0.32	1.16e-7	4.26e-7	(B) Positive
PTGR3	18q22.3	-0.30	0.02	0.54	0.58	-0.32	1.16e-7	4.27e-7	(B) Positive
KLHL30	2q37.3	0.30	0.19	0.19	0.22	0.12	1.16e-7	4.27e-7	(A) Negative
RBM12	20q11.22	-0.54	-0.22	0.58	0.43	-0.32	1.17e-7	4.28e-7	(B) Positive
SLC45A4	8q24.3	1.66	1.16	0.88	0.81	0.50	1.17e-7	4.30e-7	(A) Negative
S100A12	1q21.3	0.90	0.35	0.99	0.82	0.55	1.17e-7	4.31e-7	(A) Negative
FNBP1	9q34.11	-0.04	-0.42	0.68	0.63	0.39	1.17e-7	4.31e-7	(A) Negative
RGS9BP	19q13.11	0.39	-0.29	1.17	1.25	0.68	1.18e-7	4.33e-7	(A) Negative
XDH	2p23.1	0.83	-0.13	1.79	1.01	0.96	1.18e-7	4.33e-7	(A) Negative
MPC1	6q27	0.39	0.03	0.66	0.53	0.37	1.18e-7	4.34e-7	(A) Negative
UBD	6p22.1	2.30	1.16	1.99	1.89	1.14	1.18e-7	4.34e-7	(A) Negative
YWHAZ	8q22.3	0.79	0.48	0.52	0.60	0.31	1.18e-7	4.35e-7	(A) Negative
EBNA1BP2	1p34.2	-0.36	-0.63	0.49	0.37	0.27	1.19e-7	4.35e-7	(A) Negative
TCIM	8p11.21	0.53	1.39	1.44	1.68	-0.86	1.19e-7	4.35e-7	(B) Positive
GCSH	16q23.2	-0.91	-1.36	0.81	0.60	0.45	1.19e-7	4.37e-7	(A) Negative
TRMT1	19p13.13	-0.80	-1.07	0.48	0.42	0.27	1.20e-7	4.39e-7	(A) Negative
RASSF2	20p13	0.88	0.56	0.56	0.52	0.32	1.20e-7	4.39e-7	(A) Negative
SIRT5	6p23	-0.15	-0.46	0.56	0.42	0.31	1.21e-7	4.44e-7	(A) Negative
CGN	1q21.3	1.74	2.26	0.93	0.81	-0.52	1.21e-7	4.45e-7	(B) Positive
LPO	17q22	0.49	0.10	0.71	0.49	0.39	1.22e-7	4.46e-7	(A) Negative
ZNF768	16p11.2	-0.10	0.22	0.55	0.60	-0.32	1.22e-7	4.46e-7	(B) Positive
NXPH1	7p21.3	-0.76	0.46	2.01	2.57	-1.23	1.22e-7	4.48e-7	(B) Positive
DEFA5	8p23.1	0.58	0.26	0.54	0.55	0.31	1.22e-7	4.48e-7	(A) Negative
CXXC4	4q24	0.25	1.16	1.63	1.32	-0.91	1.23e-7	4.50e-7	(B) Positive
TAF7	5q31.3	0.15	0.42	0.44	0.58	-0.27	1.24e-7	4.53e-7	(B) Positive
CCDC66	3p14.3	-0.29	0.07	0.61	0.66	-0.36	1.25e-7	4.56e-7	(B) Positive
SLC22A1	6q25.3	0.07	-0.20	0.45	0.53	0.27	1.25e-7	4.59e-7	(A) Negative
ODAPH	4q21.1	0.05	-0.45	0.88	0.78	0.50	1.26e-7	4.60e-7	(A) Negative
FAM184A	6q22.31	-0.54	-1.13	1.05	0.90	0.59	1.26e-7	4.61e-7	(A) Negative
TNFSF13B	13q33.3	3.55	2.92	1.13	0.90	0.63	1.26e-7	4.62e-7	(A) Negative
YIPF5	5q31.3	0.30	0.60	0.54	0.49	-0.31	1.26e-7	4.62e-7	(B) Positive
LINC01600	6p25.2	0.47	0.02	0.79	0.75	0.45	1.27e-7	4.65e-7	(A) Negative
TAF1C	16q24.1	-0.58	-0.81	0.41	0.37	0.23	1.27e-7	4.66e-7	(A) Negative
TAGAP	6q25.3	2.25	1.61	1.15	0.94	0.64	1.29e-7	4.71e-7	(A) Negative
FANCL	2p16.1	-0.62	-1.06	0.81	0.54	0.44	1.30e-7	4.73e-7	(A) Negative
PRR12	19q13.33	0.29	0.53	0.42	0.41	-0.24	1.30e-7	4.74e-7	(B) Positive
DHX38	16q22.2	-0.41	-0.67	0.46	0.47	0.27	1.30e-7	4.75e-7	(A) Negative
MMAB	12q24.11	-1.06	-0.77	0.50	0.52	-0.29	1.31e-7	4.76e-7	(B) Positive
PYCR2	1q42.12	-0.44	-0.17	0.49	0.47	-0.28	1.32e-7	4.81e-7	(B) Positive
WDR5B	3q21.1	0.76	1.10	0.60	0.55	-0.34	1.34e-7	4.88e-7	(B) Positive
FKBP1A	20p13	-0.31	-0.61	0.53	0.46	0.30	1.34e-7	4.89e-7	(A) Negative
FAF2	5q35.2	0.17	0.46	0.52	0.44	-0.29	1.34e-7	4.89e-7	(B) Positive
TMEM260	14q22.3	0.42	0.75	0.58	0.58	-0.33	1.34e-7	4.90e-7	(B) Positive
RAB42	1p35.3	-0.44	-0.94	0.89	0.76	0.50	1.34e-7	4.90e-7	(A) Negative
C1ORF159	1p36.33	-0.15	-0.44	0.51	0.51	0.29	1.35e-7	4.93e-7	(A) Negative
NCR1	19q13.42	-0.54	-1.18	1.15	0.95	0.64	1.35e-7	4.93e-7	(A) Negative
TOMM40L	1q23.3	0.57	0.21	0.64	0.54	0.36	1.36e-7	4.94e-7	(A) Negative
C9ORF85	9q21.13	-0.48	-0.82	0.61	0.50	0.34	1.36e-7	4.95e-7	(A) Negative
SLC4A3	2q35	0.75	0.30	0.77	0.88	0.45	1.36e-7	4.96e-7	(A) Negative
RPS21	20q13.33	-0.54	-0.83	0.49	0.55	0.29	1.37e-7	4.97e-7	(A) Negative
ANXA5	4q27	0.10	-0.18	0.49	0.43	0.28	1.38e-7	5.00e-7	(A) Negative
MGAM	7q34	0.37	0.89	0.79	1.26	-0.52	1.38e-7	5.01e-7	(B) Positive
RHPN1	8q24.3	-0.26	0.05	0.53	0.52	-0.30	1.39e-7	5.04e-7	(B) Positive
AQP8	16p12.1	-0.18	0.01	0.31	0.39	-0.19	1.39e-7	5.07e-7	(B) Positive
JAM3	11q25	-1.49	-1.02	0.83	0.75	-0.47	1.40e-7	5.09e-7	(B) Positive
GKAP1	9q21.32	-0.36	0.06	0.75	0.65	-0.42	1.40e-7	5.09e-7	(B) Positive
SPATA7	14q31.3	-0.05	0.26	0.55	0.50	-0.31	1.41e-7	5.11e-7	(B) Positive
RBM23	14q11.2	-0.23	0.10	0.58	0.53	-0.33	1.41e-7	5.13e-7	(B) Positive
TCF7	5q31.1	-2.20	-2.60	0.71	0.68	0.40	1.41e-7	5.13e-7	(A) Negative
EHBP1L1	11q13.1	-0.44	-0.78	0.61	0.51	0.34	1.42e-7	5.14e-7	(A) Negative
GLRX3	10q26.3	-0.58	-0.90	0.58	0.45	0.32	1.42e-7	5.15e-7	(A) Negative
HELZ2	20q13.33	0.36	0.20	0.29	0.32	0.17	1.42e-7	5.15e-7	(A) Negative
NUDCD3	7p13	0.17	0.40	0.42	0.35	-0.23	1.42e-7	5.17e-7	(B) Positive
TONSL	8q24.3	-0.18	-0.41	0.38	0.48	0.23	1.42e-7	5.17e-7	(A) Negative
DUSP7	3p21.2	0.18	-0.10	0.48	0.48	0.28	1.42e-7	5.17e-7	(A) Negative
ITGA3	17q21.33	-1.17	-0.64	0.95	0.74	-0.52	1.43e-7	5.17e-7	(B) Positive
MEI1	22q13.2	1.09	0.65	0.79	0.67	0.44	1.43e-7	5.19e-7	(A) Negative
CHRNG	2q37.1	0.32	0.53	0.36	0.37	-0.21	1.43e-7	5.19e-7	(B) Positive
CHMP1A	16q24.3	0.16	-0.11	0.47	0.50	0.27	1.45e-7	5.26e-7	(A) Negative
ANGPTL4	19p13.2	0.12	-0.82	1.69	1.44	0.94	1.46e-7	5.28e-7	(A) Negative
TXN	9q31.3	-0.34	-0.66	0.57	0.48	0.32	1.46e-7	5.28e-7	(A) Negative
UBXN11	1p36.11	-0.01	0.25	0.45	0.50	-0.26	1.46e-7	5.30e-7	(B) Positive
ATRX	Xq21.1	0.02	0.23	0.36	0.38	-0.21	1.47e-7	5.31e-7	(B) Positive
ENPP6	4q35.1	1.50	0.90	1.12	0.71	0.60	1.47e-7	5.32e-7	(A) Negative
SLITRK6	13q31.1	1.96	3.41	2.52	2.58	-1.45	1.49e-7	5.40e-7	(B) Positive
PSPH	7p11.2	-0.65	-1.05	0.72	0.59	0.40	1.50e-7	5.42e-7	(A) Negative
IRX6	16q12.2	0.53	0.15	0.72	0.44	0.39	1.50e-7	5.42e-7	(A) Negative
IFI16	1q23.1	-0.11	-0.65	0.97	0.83	0.54	1.50e-7	5.43e-7	(A) Negative
SIAE	11q24.2	0.44	0.85	0.71	0.74	-0.41	1.51e-7	5.45e-7	(B) Positive
PDE2A	11q13.4	-2.05	-1.67	0.65	0.77	-0.38	1.51e-7	5.45e-7	(B) Positive
FBXW8	12q24.22	-0.02	0.24	0.45	0.45	-0.26	1.51e-7	5.45e-7	(B) Positive
DERL3	22q11.23	0.04	-0.50	0.98	0.82	0.54	1.51e-7	5.45e-7	(A) Negative
TEKT3	17p12	0.71	1.30	0.98	1.18	-0.59	1.52e-7	5.48e-7	(B) Positive
CUL2	10p11.21	0.40	0.08	0.59	0.42	0.32	1.52e-7	5.49e-7	(A) Negative
MTCP1	Xq28	-0.04	-0.32	0.51	0.45	0.28	1.52e-7	5.50e-7	(A) Negative
SFTPD	10q22.3	1.02	1.62	1.07	0.98	-0.60	1.52e-7	5.51e-7	(B) Positive
GTF2IRD2	7q11.23	0.44	-0.01	0.84	0.60	0.45	1.53e-7	5.51e-7	(A) Negative
CTLA4	2q33.2	0.80	0.30	0.89	0.76	0.49	1.53e-7	5.52e-7	(A) Negative
TK2	16q21	0.17	0.44	0.49	0.37	-0.27	1.53e-7	5.54e-7	(B) Positive
DENND1B	1q31.3	1.13	1.64	0.78	1.24	-0.51	1.54e-7	5.54e-7	(B) Positive
PTOV1	19q13.33	0.03	0.31	0.49	0.51	-0.28	1.54e-7	5.55e-7	(B) Positive
HACL1	3p25.1	-0.84	-0.51	0.58	0.51	-0.33	1.54e-7	5.55e-7	(B) Positive
FLT3	13q12.2	1.96	2.74	1.31	1.57	-0.78	1.55e-7	5.57e-7	(B) Positive
DHX40	17q23.1	-0.52	-0.13	0.66	0.70	-0.38	1.55e-7	5.60e-7	(B) Positive
OGDHL	10q11.23	-2.50	-3.33	1.53	1.06	0.83	1.56e-7	5.62e-7	(A) Negative
MYRF	11q12.2	-1.51	-1.84	0.58	0.48	0.32	1.56e-7	5.62e-7	(A) Negative
THUMPD2	2p22.1	0.16	-0.13	0.52	0.40	0.28	1.58e-7	5.71e-7	(A) Negative
MYCBP	1p34.3	-0.09	0.22	0.56	0.54	-0.32	1.59e-7	5.71e-7	(B) Positive
POLR2H	3q27.1	-0.28	-0.55	0.50	0.41	0.28	1.59e-7	5.72e-7	(A) Negative
NFATC3	16q22.1	-0.53	-0.79	0.47	0.45	0.26	1.59e-7	5.73e-7	(A) Negative
SLAMF7	1q23.3	3.03	2.24	1.40	1.29	0.79	1.62e-7	5.82e-7	(A) Negative
MTMR1	Xq28	0.62	0.32	0.55	0.38	0.30	1.62e-7	5.82e-7	(A) Negative
NELFE	6p21.33	-0.17	-0.41	0.43	0.36	0.24	1.62e-7	5.84e-7	(A) Negative
CD101	1p13.1	0.80	0.49	0.56	0.55	0.32	1.63e-7	5.87e-7	(A) Negative
SENP7	3q12.3	-0.32	-0.02	0.55	0.45	-0.30	1.64e-7	5.89e-7	(B) Positive
ZNF19	16q22.2	0.25	0.58	0.59	0.56	-0.33	1.64e-7	5.89e-7	(B) Positive
ADRM1	20q13.33	-0.14	-0.41	0.47	0.54	0.28	1.64e-7	5.89e-7	(A) Negative
ZNF33A	10p11.1	0.59	0.28	0.58	0.45	0.31	1.65e-7	5.92e-7	(A) Negative
IL19	1q32.1	0.64	1.33	1.13	1.49	-0.69	1.65e-7	5.93e-7	(B) Positive
PRPS2	Xp22.2	0.33	-0.12	0.82	0.65	0.45	1.67e-7	5.99e-7	(A) Negative
TCP1	6q25.3	-0.74	-1.10	0.67	0.52	0.37	1.67e-7	5.99e-7	(A) Negative
PANK1	10q23.31	-0.59	-1.16	0.98	1.07	0.57	1.68e-7	6.03e-7	(A) Negative
ITM2B	13q14.2	0.89	1.27	0.68	0.53	-0.37	1.69e-7	6.06e-7	(B) Positive
AOC3	17q21.31	0.86	1.36	0.85	0.91	-0.49	1.69e-7	6.07e-7	(B) Positive
SLC41A1	1q32.1	-0.00	-0.28	0.47	0.60	0.28	1.69e-7	6.08e-7	(A) Negative
TNFRSF17	16p13.13	-0.65	-1.57	1.62	1.52	0.91	1.70e-7	6.09e-7	(A) Negative
EXT2	11p11.2	0.34	0.01	0.59	0.47	0.32	1.70e-7	6.11e-7	(A) Negative
CHKA	11q13.2	-0.46	-0.92	0.84	0.71	0.47	1.71e-7	6.12e-7	(A) Negative
LRATD2	8q24.21	1.08	1.54	0.84	0.73	-0.47	1.72e-7	6.17e-7	(B) Positive
FAM89B	11q13.1	1.30	1.04	0.45	0.47	0.26	1.72e-7	6.18e-7	(A) Negative
KYNU	2q22.2	-1.14	-1.90	1.39	1.08	0.76	1.72e-7	6.18e-7	(A) Negative
GFOD1	6p24.1-p23	0.68	0.12	1.02	0.78	0.55	1.74e-7	6.23e-7	(A) Negative
NLRP5	19q13.43	-0.67	-0.13	0.75	1.48	-0.54	1.74e-7	6.23e-7	(B) Positive
TMEM86B	19q13.42	-0.81	-1.08	0.46	0.52	0.27	1.74e-7	6.24e-7	(A) Negative
FGFBP2	4p15.32	0.92	0.09	1.54	1.16	0.84	1.75e-7	6.26e-7	(A) Negative
TDO2	4q32.1	2.89	2.20	1.21	1.24	0.69	1.75e-7	6.26e-7	(A) Negative
TOPBP1	3q22.1	-0.53	-0.85	0.57	0.45	0.31	1.76e-7	6.30e-7	(A) Negative
PLAC8	4q21.22	-2.72	-3.59	1.56	1.42	0.87	1.76e-7	6.30e-7	(A) Negative
PGRMC2	4q28.2	0.17	0.47	0.53	0.58	-0.30	1.78e-7	6.36e-7	(B) Positive
RPL41	12q13	0.23	0.55	0.59	0.48	-0.33	1.80e-7	6.43e-7	(B) Positive
KIAA1549L	11p13	0.59	-0.08	1.25	0.82	0.67	1.80e-7	6.44e-7	(A) Negative
STXBP4	17q22	-0.22	0.17	0.67	0.69	-0.38	1.82e-7	6.50e-7	(B) Positive
ITGB4	17q25.1	1.10	0.51	1.03	1.02	0.58	1.82e-7	6.50e-7	(A) Negative
RAB14	9q33.2	0.52	0.77	0.47	0.34	-0.25	1.83e-7	6.54e-7	(B) Positive
FXYD5	19q13.12	0.18	-0.35	0.98	0.76	0.53	1.84e-7	6.57e-7	(A) Negative
H4C4	6p22.2	-0.23	-0.83	1.09	0.95	0.60	1.86e-7	6.65e-7	(A) Negative
WNK2	9q22.31	0.20	-0.18	0.70	0.56	0.38	1.86e-7	6.65e-7	(A) Negative
SSTR5	16p13.3	0.25	0.57	0.50	0.76	-0.32	1.87e-7	6.67e-7	(B) Positive
PIGS	17q11.2	-0.42	-0.05	0.67	0.64	-0.38	1.88e-7	6.70e-7	(B) Positive
LYRM7	5q23.3-q31.1	-1.42	-1.18	0.44	0.40	-0.25	1.88e-7	6.72e-7	(B) Positive
MFSD4A	1q32.1	1.96	1.21	1.39	0.99	0.75	1.89e-7	6.75e-7	(A) Negative
KIAA1191	5q35.2	0.26	0.58	0.59	0.40	-0.32	1.89e-7	6.75e-7	(B) Positive
SLC15A1	13q32.2-q32.3	0.28	-0.03	0.59	0.31	0.31	1.90e-7	6.80e-7	(A) Negative
UBC	12q24.3	0.41	0.66	0.44	0.40	-0.25	1.91e-7	6.82e-7	(B) Positive
CHFR	12q24.33	0.11	-0.16	0.50	0.44	0.28	1.91e-7	6.83e-7	(A) Negative
PHKG1	7p11.2	0.31	-0.14	0.83	0.56	0.44	1.91e-7	6.83e-7	(A) Negative
PDIA5	3q21.1	0.12	-0.24	0.64	0.60	0.36	1.92e-7	6.85e-7	(A) Negative
LUZP2	11p14.3	-2.42	-1.54	1.58	1.44	-0.88	1.92e-7	6.86e-7	(B) Positive
LY6E	8q24.3	1.02	0.52	0.89	0.86	0.50	1.95e-7	6.95e-7	(A) Negative
NCAPH2	22q13.33	-0.28	-0.57	0.52	0.50	0.29	1.95e-7	6.96e-7	(A) Negative
TCTN3	10q24.1	0.10	0.35	0.46	0.38	-0.25	1.96e-7	6.98e-7	(B) Positive
CD99L2	Xq28	-0.18	0.14	0.59	0.56	-0.33	1.98e-7	7.05e-7	(B) Positive
RASA2	3q23	0.38	0.01	0.69	0.47	0.37	2.00e-7	7.14e-7	(A) Negative
FLVCR2	14q24.3	0.35	-0.12	0.86	0.68	0.47	2.01e-7	7.17e-7	(A) Negative
CD163L1	12p13.31	0.42	-0.19	1.06	1.10	0.60	2.02e-7	7.19e-7	(A) Negative
KIRREL2	19q13.12	-0.79	-1.46	1.25	0.88	0.67	2.05e-7	7.28e-7	(A) Negative
ORAI1	12q24.31	0.16	-0.15	0.57	0.45	0.31	2.05e-7	7.31e-7	(A) Negative
ATMIN	16q23.2	0.32	0.11	0.38	0.36	0.21	2.06e-7	7.34e-7	(A) Negative
SLITRK5	13q31.2	-1.24	-2.26	1.89	1.38	1.02	2.06e-7	7.34e-7	(A) Negative
TMEM106B	7p21.3	-0.07	0.26	0.59	0.49	-0.32	2.07e-7	7.36e-7	(B) Positive
CALCR	7q21.3	-4.07	-3.61	0.75	1.04	-0.46	2.08e-7	7.41e-7	(B) Positive
TRAF3IP3	1q32.2	1.09	0.53	1.03	0.80	0.56	2.09e-7	7.44e-7	(A) Negative
MRPL45	17q12	-0.67	-0.30	0.65	0.66	-0.37	2.10e-7	7.45e-7	(B) Positive
CEACAM4	19q13.2	0.84	0.54	0.56	0.44	0.30	2.12e-7	7.55e-7	(A) Negative
MRPL1	4q21.1	0.22	-0.12	0.62	0.45	0.33	2.14e-7	7.59e-7	(A) Negative
MGMT	10q26.3	0.56	0.99	0.79	0.62	-0.43	2.14e-7	7.59e-7	(B) Positive
LAPTM4B	8q22.1	0.10	-0.50	0.99	1.33	0.60	2.14e-7	7.61e-7	(A) Negative
SPATA32	17q21.31	0.51	0.29	0.40	0.38	0.22	2.14e-7	7.61e-7	(A) Negative
ADIPOR2	12p13.33	0.19	0.57	0.64	0.85	-0.39	2.15e-7	7.63e-7	(B) Positive
ABCA9	17q24.2	1.07	1.53	0.74	1.04	-0.46	2.15e-7	7.63e-7	(B) Positive
POM121L8P	22q11.21	-0.41	-0.94	0.97	0.75	0.53	2.16e-7	7.67e-7	(A) Negative
SEMA7A	15q24.1	-0.57	-0.99	0.75	0.69	0.42	2.17e-7	7.68e-7	(A) Negative
ZSCAN18	19q13.43	0.20	0.71	0.87	1.04	-0.51	2.18e-7	7.72e-7	(B) Positive
COL6A3	2q37.3	1.05	1.56	0.91	0.89	-0.51	2.18e-7	7.73e-7	(B) Positive
CFAP206	6q15	2.00	2.61	1.06	1.18	-0.61	2.19e-7	7.76e-7	(B) Positive
DPCD	10q24.32	0.15	0.51	0.66	0.54	-0.36	2.22e-7	7.86e-7	(B) Positive
FAIM	3q22.3	0.62	0.27	0.64	0.51	0.35	2.22e-7	7.88e-7	(A) Negative
IL2RG	Xq13.1	0.06	-0.52	1.05	0.88	0.58	2.23e-7	7.91e-7	(A) Negative
PSMD14	2q24.2	-0.29	-0.53	0.42	0.40	0.24	2.24e-7	7.94e-7	(A) Negative
MYH7	14q11.2	0.10	-0.44	1.02	0.67	0.54	2.24e-7	7.94e-7	(A) Negative
SETBP1	18q12.3	0.66	1.25	1.03	1.14	-0.59	2.25e-7	7.97e-7	(B) Positive
ELK4	1q32.1	-0.12	-0.39	0.47	0.49	0.27	2.26e-7	8.00e-7	(A) Negative
SYK	9q22.2	1.83	1.35	0.88	0.79	0.48	2.26e-7	8.01e-7	(A) Negative
SLC13A3	20q13.12	-0.77	-1.35	1.04	1.03	0.59	2.27e-7	8.03e-7	(A) Negative
ATG9A	2q35	-0.31	-0.57	0.48	0.38	0.26	2.28e-7	8.08e-7	(A) Negative
CANX	5q35.3	0.01	0.27	0.47	0.45	-0.26	2.28e-7	8.08e-7	(B) Positive
TBC1D31	8q24.13	-0.48	-0.85	0.62	0.83	0.37	2.30e-7	8.13e-7	(A) Negative
ZNF99	19p12	-0.12	0.20	0.59	0.54	-0.32	2.31e-7	8.17e-7	(B) Positive
VPS4A	16q23.1	-0.19	-0.40	0.38	0.35	0.21	2.32e-7	8.20e-7	(A) Negative
BIK	22q13.2	1.69	2.40	1.34	0.90	-0.71	2.32e-7	8.20e-7	(B) Positive
MDN1	6q15	-0.64	-0.97	0.61	0.48	0.33	2.34e-7	8.27e-7	(A) Negative
DNMT3A	2p23.3	0.71	0.42	0.53	0.47	0.29	2.34e-7	8.27e-7	(A) Negative
PLXDC1	17q12	3.60	4.01	0.75	0.62	-0.41	2.36e-7	8.32e-7	(B) Positive
ERC2	3p14.3	-0.11	-0.63	0.98	0.71	0.52	2.37e-7	8.36e-7	(A) Negative
IFI35	17q21.31	0.18	0.70	0.96	0.76	-0.52	2.37e-7	8.36e-7	(B) Positive
GSTM4	1p13.3	-0.34	0.15	0.88	0.78	-0.49	2.38e-7	8.40e-7	(B) Positive
FLAD1	1q21.3	0.84	0.53	0.55	0.51	0.30	2.39e-7	8.42e-7	(A) Negative
NXPH4	12q13.3	0.02	-0.38	0.75	0.53	0.40	2.39e-7	8.42e-7	(A) Negative
MINPP1	10q23.2	-0.88	-0.41	0.85	0.75	-0.47	2.42e-7	8.53e-7	(B) Positive
EPHX3	19p13.12	0.65	0.22	0.82	0.42	0.43	2.42e-7	8.54e-7	(A) Negative
SRP54	14q13.2	-0.38	-0.11	0.50	0.43	-0.27	2.42e-7	8.54e-7	(B) Positive
RNASEH2A	19p13.13	-0.89	-1.20	0.56	0.54	0.31	2.43e-7	8.55e-7	(A) Negative
ZNF25	10p11.21	1.08	1.38	0.55	0.47	-0.30	2.43e-7	8.56e-7	(B) Positive
R3HDM2	12q13.3	-0.15	0.05	0.35	0.34	-0.20	2.43e-7	8.58e-7	(B) Positive
NFYA	6p21.1	0.76	0.36	0.74	0.57	0.40	2.44e-7	8.58e-7	(A) Negative
LRRC36	16q22.1	-0.31	0.13	0.78	0.80	-0.44	2.45e-7	8.64e-7	(B) Positive
KCNMB1	5q35.1	2.38	2.08	0.54	0.53	0.30	2.46e-7	8.66e-7	(A) Negative
KCNJ1	11q24.3	0.65	0.36	0.54	0.46	0.30	2.46e-7	8.66e-7	(A) Negative
BIRC2	11q22.2	-0.38	-0.68	0.57	0.42	0.31	2.47e-7	8.71e-7	(A) Negative
PUS1	12q24.33	-0.45	-0.75	0.54	0.46	0.30	2.48e-7	8.74e-7	(A) Negative
HNRNPDL	4q21.22	-0.42	-0.17	0.45	0.40	-0.25	2.48e-7	8.74e-7	(B) Positive
HROB	17q21.31	-0.94	-1.26	0.56	0.62	0.32	2.51e-7	8.83e-7	(A) Negative
KRT10-AS1	17q21.2	0.01	0.44	0.77	0.79	-0.44	2.51e-7	8.84e-7	(B) Positive
TXLNG	Xp22.2	0.14	-0.27	0.76	0.57	0.41	2.53e-7	8.90e-7	(A) Negative
PSEN2	1q42.13	0.86	1.19	0.59	0.52	-0.32	2.53e-7	8.91e-7	(B) Positive
RNF175	4q31.3	0.18	-0.28	0.84	0.77	0.46	2.55e-7	8.97e-7	(A) Negative
LMNB1	5q23.2	-1.53	-2.19	1.13	1.34	0.66	2.56e-7	9.00e-7	(A) Negative
CHMP5	9p13.3	0.16	0.48	0.59	0.50	-0.32	2.57e-7	9.04e-7	(B) Positive
TAGLN3	3q13.2	-0.45	-0.93	0.91	0.63	0.48	2.57e-7	9.05e-7	(A) Negative
HTR3A	11q23.2	-0.24	-0.73	0.97	0.43	0.50	2.58e-7	9.05e-7	(A) Negative
BRD7	16q12.1	-0.05	-0.31	0.47	0.46	0.26	2.58e-7	9.06e-7	(A) Negative
TCN2	22q12.2	0.72	0.29	0.79	0.66	0.43	2.59e-7	9.09e-7	(A) Negative
DHX58	17q21.2	0.99	1.57	1.09	0.81	-0.58	2.61e-7	9.16e-7	(B) Positive
OR10H2	19p13.12	0.62	0.46	0.28	0.25	0.15	2.61e-7	9.17e-7	(A) Negative
TFAP2C	20q13.31	1.44	0.87	1.02	0.99	0.57	2.63e-7	9.23e-7	(A) Negative
MOB1A	2p13.1	0.32	0.01	0.57	0.49	0.31	2.65e-7	9.31e-7	(A) Negative
HYOU1	11q23.3	-0.12	-0.38	0.48	0.48	0.27	2.66e-7	9.33e-7	(A) Negative
AP4B1	1p13.2	-0.48	-0.70	0.40	0.35	0.22	2.66e-7	9.33e-7	(A) Negative
TTC21A	3p22.2	0.17	0.58	0.72	0.70	-0.40	2.67e-7	9.36e-7	(B) Positive
TEX14	17q22	-0.58	0.04	1.04	1.39	-0.62	2.69e-7	9.42e-7	(B) Positive
FTCD	21q22.3	-2.69	-3.15	0.86	0.56	0.45	2.69e-7	9.44e-7	(A) Negative
MLLT10	10p12.31	-0.21	-0.54	0.64	0.40	0.33	2.70e-7	9.47e-7	(A) Negative
MRPL22	5q33.2	-0.37	-0.13	0.44	0.39	-0.24	2.71e-7	9.50e-7	(B) Positive
ABLIM1	10q25.3	0.84	0.46	0.69	0.62	0.38	2.71e-7	9.51e-7	(A) Negative
CRTC2	1q21.3	0.71	0.47	0.44	0.40	0.24	2.72e-7	9.52e-7	(A) Negative
RAB1B	11q13.2	-0.23	0.12	0.61	0.62	-0.34	2.72e-7	9.53e-7	(B) Positive
SETD9	5q11.2	-0.26	0.18	0.79	0.77	-0.44	2.74e-7	9.59e-7	(B) Positive
LGI3	8p21.3	0.16	-0.01	0.31	0.26	0.17	2.75e-7	9.64e-7	(A) Negative
KCND2	7q31.31	2.78	3.54	1.35	1.40	-0.76	2.78e-7	9.72e-7	(B) Positive
L1CAM	Xq28	-1.10	-1.44	0.65	0.47	0.35	2.80e-7	9.79e-7	(A) Negative
NME6	3p21.31	0.17	0.40	0.39	0.42	-0.22	2.80e-7	9.79e-7	(B) Positive
SBF1	22q13.33	-0.50	-0.84	0.62	0.60	0.34	2.81e-7	9.83e-7	(A) Negative
WDR53	3q29	0.12	-0.16	0.53	0.38	0.28	2.81e-7	9.83e-7	(A) Negative
CRHBP	5q13.3	-0.44	0.02	0.81	0.82	-0.45	2.81e-7	9.84e-7	(B) Positive
UBTD2	5q35.1	0.24	0.55	0.57	0.54	-0.31	2.82e-7	9.85e-7	(B) Positive
C9	5p13.1	0.03	-0.13	0.28	0.30	0.16	2.82e-7	9.87e-7	(A) Negative
DCBLD1	6q22.1	0.96	0.42	1.02	0.75	0.54	2.83e-7	9.89e-7	(A) Negative
SGSH	17q25.3	0.04	0.35	0.56	0.54	-0.31	2.84e-7	9.92e-7	(B) Positive
DLX2	2q31.1	-2.56	-1.84	1.16	1.69	-0.72	2.84e-7	9.92e-7	(B) Positive
LAX1	1q32.1	1.42	0.70	1.33	1.13	0.72	2.85e-7	9.94e-7	(A) Negative
STOX1	10q22.1	0.12	0.82	1.22	1.35	-0.69	2.86e-7	9.98e-7	(B) Positive
MRPL41	9q34.3	-0.15	0.22	0.69	0.55	-0.37	2.86e-7	9.98e-7	(B) Positive
PREPL	2p21	0.13	0.39	0.47	0.40	-0.25	2.86e-7	9.98e-7	(B) Positive
SMPD1	11p15.4	-0.13	0.20	0.60	0.52	-0.33	2.86e-7	9.98e-7	(B) Positive
TNFRSF12A	16p13.3	-0.52	-0.99	0.83	0.87	0.47	2.87e-7	1.002e-6	(A) Negative
ICE1	5p15.32	-0.32	-0.61	0.54	0.39	0.29	2.88e-7	1.004e-6	(A) Negative
INTU	4q28.1	-0.12	0.30	0.78	0.69	-0.42	2.89e-7	1.007e-6	(B) Positive
GPR146	7p22.3	-0.38	-0.04	0.59	0.71	-0.34	2.89e-7	1.008e-6	(B) Positive
CCZ1B	7p22.1	0.22	-0.05	0.50	0.43	0.27	2.92e-7	1.018e-6	(A) Negative
IFNL1	19q13.2	0.27	-0.01	0.50	0.50	0.28	2.94e-7	1.026e-6	(A) Negative
EPHA10	1p34.3	0.48	0.79	0.59	0.41	-0.31	2.98e-7	1.039e-6	(B) Positive
KLF14	7q32.2	0.36	0.13	0.42	0.41	0.23	3.00e-7	1.045e-6	(A) Negative
HIRA	22q11.21	-2.27	-2.80	0.96	0.93	0.53	3.01e-7	1.048e-6	(A) Negative
COX16	14q24.2	0.08	0.33	0.45	0.43	-0.25	3.01e-7	1.049e-6	(B) Positive
ZNF280D	15q21.3	0.66	0.96	0.54	0.52	-0.30	3.02e-7	1.052e-6	(B) Positive
RHOBTB3	5q15	-1.97	-1.52	0.75	1.05	-0.46	3.02e-7	1.052e-6	(B) Positive
SPACA4	19q13.33	0.00	0.21	0.35	0.46	-0.21	3.03e-7	1.053e-6	(B) Positive
SASS6	1p21.2	-0.36	-0.72	0.66	0.58	0.36	3.03e-7	1.053e-6	(A) Negative
PLPP6	9p24.1	0.27	0.65	0.71	0.59	-0.38	3.06e-7	1.065e-6	(B) Positive
CNTNAP2	7q35-q36.1	-0.34	0.60	1.71	1.62	-0.94	3.10e-7	1.079e-6	(B) Positive
APEX2	Xp11.21	0.34	0.10	0.42	0.41	0.23	3.10e-7	1.079e-6	(A) Negative
C14ORF93	14q11.2	-0.34	-0.13	0.38	0.37	-0.21	3.10e-7	1.079e-6	(B) Positive
MKNK2	19p13.3	-0.06	0.28	0.63	0.58	-0.34	3.11e-7	1.080e-6	(B) Positive
WDR27	6q27	-1.11	-0.74	0.67	0.67	-0.37	3.12e-7	1.084e-6	(B) Positive
LDHC	11p15.1	0.28	-0.63	1.63	1.73	0.92	3.12e-7	1.085e-6	(A) Negative
PRKAR1B	7p22.3	-0.58	-0.86	0.52	0.48	0.28	3.15e-7	1.094e-6	(A) Negative
AP2B1	17q12	-0.53	-0.15	0.68	0.67	-0.38	3.15e-7	1.094e-6	(B) Positive
IWS1	2q14.3	-0.14	-0.37	0.45	0.34	0.24	3.15e-7	1.095e-6	(A) Negative
PRMT2	21q22.3	0.69	0.37	0.60	0.39	0.32	3.16e-7	1.095e-6	(A) Negative
CCN5	20q13.12	-1.35	-0.58	1.38	1.48	-0.78	3.16e-7	1.096e-6	(B) Positive
GLA	Xq22.1	-0.41	-0.01	0.62	1.05	-0.40	3.16e-7	1.097e-6	(B) Positive
KCNJ10	1q23.2	-0.10	-0.33	0.42	0.40	0.23	3.17e-7	1.099e-6	(A) Negative
PLXDC2	10p12.31	3.61	3.12	0.89	0.79	0.48	3.18e-7	1.101e-6	(A) Negative
HCN1	5p12	-0.64	-0.35	0.48	0.66	-0.29	3.19e-7	1.108e-6	(B) Positive
HTATIP2	11p15.1	-0.14	-0.60	0.83	0.79	0.46	3.22e-7	1.115e-6	(A) Negative
PAQR8	6p12.2	-0.59	-1.10	0.96	0.60	0.50	3.22e-7	1.116e-6	(A) Negative
ZNF365	10q21.2	0.52	1.29	1.43	1.20	-0.77	3.23e-7	1.120e-6	(B) Positive
ILK	11p15.4	-0.15	0.13	0.52	0.48	-0.28	3.23e-7	1.120e-6	(B) Positive
C6ORF136	6p21.33	-0.21	-0.44	0.43	0.41	0.23	3.24e-7	1.122e-6	(A) Negative
TMPO	12q23.1	-0.80	-1.15	0.64	0.61	0.35	3.25e-7	1.125e-6	(A) Negative
OTOR	20p12.1	0.56	1.11	0.99	1.05	-0.55	3.27e-7	1.131e-6	(B) Positive
PRPF40A	2q23.3	-0.10	-0.33	0.43	0.41	0.24	3.28e-7	1.134e-6	(A) Negative
HK1	10q22.1	-0.04	0.17	0.38	0.36	-0.21	3.28e-7	1.136e-6	(B) Positive
SERPINA3	14q32.13	0.49	1.58	2.03	1.62	-1.08	3.29e-7	1.137e-6	(B) Positive
MUSTN1	3p21.1	0.03	0.35	0.56	0.61	-0.32	3.30e-7	1.140e-6	(B) Positive
MAP3K6	1p36.11	0.71	0.41	0.54	0.55	0.30	3.30e-7	1.140e-6	(A) Negative
C12ORF43	12q24.31	-0.28	-0.08	0.36	0.33	-0.20	3.30e-7	1.141e-6	(B) Positive
HSPBAP1	3q21.1	0.02	-0.31	0.62	0.43	0.32	3.31e-7	1.143e-6	(A) Negative
NBR2	17q21.31	-0.66	-0.33	0.60	0.57	-0.33	3.31e-7	1.143e-6	(B) Positive
MGRN1	16p13.3	0.11	0.35	0.43	0.40	-0.23	3.31e-7	1.144e-6	(B) Positive
CASP5	11q22.3	0.78	0.39	0.72	0.61	0.39	3.35e-7	1.156e-6	(A) Negative
CYP11B1	8q24.3	0.68	0.52	0.27	0.28	0.15	3.37e-7	1.163e-6	(A) Negative
ATF5	19q13.33	0.53	0.13	0.75	0.61	0.40	3.39e-7	1.171e-6	(A) Negative
MARCKS	6q21	1.51	1.12	0.65	0.83	0.38	3.40e-7	1.174e-6	(A) Negative
CFTR	7q31.2	-0.17	-1.04	1.65	1.27	0.88	3.41e-7	1.176e-6	(A) Negative
KCNV1	8q23.2	0.55	0.02	1.03	0.48	0.52	3.41e-7	1.178e-6	(A) Negative
PTTG1IP	21q22.3	0.35	0.06	0.55	0.43	0.29	3.41e-7	1.178e-6	(A) Negative
HGD	3q13.33	-2.60	-1.59	1.83	1.78	-1.01	3.43e-7	1.184e-6	(B) Positive
BCAP29	7q22.3	-0.17	0.11	0.53	0.45	-0.28	3.45e-7	1.190e-6	(B) Positive
CYREN	7q33	-0.46	-0.74	0.53	0.36	0.28	3.45e-7	1.192e-6	(A) Negative
GARNL3	9q33.3	0.64	1.09	0.84	0.74	-0.45	3.46e-7	1.193e-6	(B) Positive
PSTPIP1	15q24.3	1.29	0.77	0.95	0.81	0.51	3.48e-7	1.201e-6	(A) Negative
SMTNL2	17p13.2	-0.37	-1.23	1.65	1.02	0.86	3.48e-7	1.201e-6	(A) Negative
SMIM3	5q33.1	-0.54	-0.10	0.79	0.80	-0.44	3.49e-7	1.202e-6	(B) Positive
CIB4	2p23.3	0.69	0.25	0.82	0.66	0.44	3.49e-7	1.202e-6	(A) Negative
SDK2	17q25.1	0.35	0.07	0.52	0.49	0.28	3.50e-7	1.205e-6	(A) Negative
ZMAT2	5q31.3	0.02	0.26	0.42	0.45	-0.23	3.51e-7	1.210e-6	(B) Positive
LGR6	1q32.1	2.65	1.71	1.74	1.53	0.94	3.51e-7	1.210e-6	(A) Negative
TRIM6-TRIM34	11p15.4	1.58	2.04	0.87	0.69	-0.46	3.52e-7	1.212e-6	(B) Positive
LMAN1	18q21.32	-0.25	-0.59	0.62	0.61	0.34	3.53e-7	1.215e-6	(A) Negative
LPAR6	13q14.2	0.53	1.01	0.90	0.68	-0.48	3.54e-7	1.217e-6	(B) Positive
LNX2	13q12.2	0.48	0.83	0.65	0.52	-0.35	3.55e-7	1.222e-6	(B) Positive
NDRG4	16q21	1.16	0.52	1.18	1.08	0.64	3.56e-7	1.223e-6	(A) Negative
BCR	22q11.23	0.79	0.53	0.47	0.49	0.26	3.57e-7	1.227e-6	(A) Negative
EFCAB14	1p33	0.84	1.12	0.50	0.48	-0.27	3.58e-7	1.231e-6	(B) Positive
PTK6	20q13.33	0.88	1.53	1.23	0.81	-0.64	3.58e-7	1.231e-6	(B) Positive
ZKSCAN1	7q22.1	-0.29	-0.03	0.46	0.53	-0.26	3.58e-7	1.231e-6	(B) Positive
CD22	19q13.12	0.51	1.03	0.97	0.82	-0.52	3.59e-7	1.233e-6	(B) Positive
FOS	14q24.3	-0.23	0.54	1.37	1.52	-0.77	3.61e-7	1.241e-6	(B) Positive
HEATR5B	2p22.2	0.64	0.89	0.46	0.40	-0.25	3.62e-7	1.243e-6	(B) Positive
VRTN	14q24.3	-2.99	-3.56	1.13	0.46	0.57	3.64e-7	1.250e-6	(A) Negative
IGSF3	1p13.1	0.89	0.49	0.71	0.80	0.40	3.65e-7	1.252e-6	(A) Negative
BBS2	16q13	-0.34	-0.01	0.62	0.55	-0.33	3.69e-7	1.268e-6	(B) Positive
IGHD	14q32.33	0.65	0.43	0.40	0.36	0.22	3.70e-7	1.269e-6	(A) Negative
TRIM7	5q35.3	-2.01	-1.55	0.80	0.97	-0.46	3.70e-7	1.271e-6	(B) Positive
MAL	2q11.1	-4.42	-4.97	1.04	0.77	0.55	3.71e-7	1.271e-6	(A) Negative
TMEM177	2q14.2	-0.07	-0.36	0.55	0.43	0.29	3.72e-7	1.276e-6	(A) Negative
PAOX	10q26.3	0.99	1.34	0.66	0.50	-0.35	3.74e-7	1.282e-6	(B) Positive
RAB35	12q24.23	0.10	-0.13	0.43	0.44	0.24	3.78e-7	1.298e-6	(A) Negative
TTC39C	18q11.2	-0.10	0.35	0.81	0.79	-0.45	3.79e-7	1.301e-6	(B) Positive
THAP12	11q13.5	-0.32	-0.68	0.63	0.75	0.36	3.83e-7	1.313e-6	(A) Negative
CST1	20p11.21	1.19	1.95	1.37	1.40	-0.76	3.85e-7	1.320e-6	(B) Positive
OBP2B	9q34.2	1.93	1.17	1.38	1.35	0.76	3.87e-7	1.326e-6	(A) Negative
CLUH	17p13.3	-0.19	-0.49	0.55	0.54	0.30	3.88e-7	1.330e-6	(A) Negative
DNAAF6	Xq22.3	0.27	0.68	0.67	0.95	-0.40	3.89e-7	1.333e-6	(B) Positive
XIRP1	3p22.2	0.70	0.30	0.73	0.70	0.40	3.90e-7	1.337e-6	(A) Negative
CIAO3	16p13.3	0.44	0.73	0.54	0.49	-0.29	3.92e-7	1.342e-6	(B) Positive
COLQ	3p25.1	0.16	0.38	0.38	0.47	-0.22	3.94e-7	1.349e-6	(B) Positive
LILRB3	19q13.42	2.74	2.38	0.65	0.68	0.36	3.95e-7	1.350e-6	(A) Negative
CCNE2	8q22.1	-0.41	-1.01	1.08	1.06	0.59	3.96e-7	1.354e-6	(A) Negative
TXNDC15	5q31.1	0.16	0.45	0.55	0.45	-0.29	3.97e-7	1.359e-6	(B) Positive
DEDD	1q23.3	0.72	0.53	0.36	0.32	0.20	3.97e-7	1.359e-6	(A) Negative
KRTAP5-9	11q13.4	0.20	-0.03	0.40	0.43	0.22	4.01e-7	1.371e-6	(A) Negative
CEP78	9q21.2	-0.90	-1.21	0.60	0.47	0.32	4.03e-7	1.378e-6	(A) Negative
C6	5p13.1	1.12	1.85	1.27	1.50	-0.73	4.07e-7	1.390e-6	(B) Positive
SEMA4B	15q26.1	0.33	0.71	0.71	0.62	-0.38	4.07e-7	1.392e-6	(B) Positive
GIPC1	19p13.12	0.52	0.25	0.47	0.49	0.26	4.07e-7	1.392e-6	(A) Negative
IRAK2	3p25.3	-0.30	-0.48	0.33	0.38	0.19	4.07e-7	1.392e-6	(A) Negative
SLC9B1	4q24	-0.07	0.37	0.81	0.74	-0.44	4.09e-7	1.396e-6	(B) Positive
LHX2	9q33.3	-2.51	-3.41	1.69	1.37	0.90	4.10e-7	1.399e-6	(A) Negative
KRT35	17q21.2	0.45	0.76	0.47	0.87	-0.32	4.13e-7	1.411e-6	(B) Positive
PCGF6	10q24.33	-0.56	-0.86	0.56	0.45	0.30	4.13e-7	1.411e-6	(A) Negative
ANXA10	4q32.3	-1.73	-1.16	1.00	1.19	-0.57	4.15e-7	1.416e-6	(B) Positive
GRIA1	5q33.2	0.01	0.27	0.25	0.90	-0.26	4.15e-7	1.417e-6	(B) Positive
MGA	15q15	0.10	-0.09	0.36	0.36	0.20	4.16e-7	1.421e-6	(A) Negative
ZNF444	19q13.43	0.13	0.40	0.48	0.48	-0.27	4.18e-7	1.426e-6	(B) Positive
ZNF391	6p22.1	-0.40	-0.80	0.76	0.62	0.40	4.19e-7	1.428e-6	(A) Negative
NRM	6p21.33	-0.57	-0.89	0.60	0.54	0.32	4.21e-7	1.437e-6	(A) Negative
WNK3	Xp11.22	-0.44	-1.02	1.08	0.94	0.58	4.23e-7	1.444e-6	(A) Negative
RCN2	15q24.3	-0.30	-0.65	0.68	0.48	0.35	4.24e-7	1.446e-6	(A) Negative
CLDN10	13q32.1	-1.74	-2.91	2.34	0.81	1.17	4.25e-7	1.448e-6	(A) Negative
PARP1	1q42.12	-0.19	-0.51	0.59	0.59	0.32	4.25e-7	1.449e-6	(A) Negative
MPZL3	11q23.3	0.93	0.57	0.67	0.59	0.36	4.27e-7	1.455e-6	(A) Negative
CATSPERE	1q44	0.81	1.24	0.76	0.87	-0.43	4.27e-7	1.456e-6	(B) Positive
CLDN4	7q11.23	2.24	1.89	0.63	0.63	0.35	4.28e-7	1.456e-6	(A) Negative
UTP14C	13q14.3	0.43	0.64	0.38	0.33	-0.20	4.29e-7	1.460e-6	(B) Positive
TIMM8B	11q23.1	0.25	-0.07	0.60	0.56	0.32	4.30e-7	1.463e-6	(A) Negative
PRRC1	5q23.2	0.45	0.71	0.49	0.45	-0.26	4.34e-7	1.477e-6	(B) Positive
CNTLN	9p22.2	-0.12	-0.64	0.99	0.76	0.52	4.38e-7	1.489e-6	(A) Negative
HS3ST1	4p15.33	2.75	2.24	0.94	0.84	0.50	4.38e-7	1.490e-6	(A) Negative
SGK3	8q13.1	0.50	1.07	0.99	1.23	-0.57	4.38e-7	1.490e-6	(B) Positive
MED11	17p13.2	0.10	0.33	0.43	0.44	-0.24	4.39e-7	1.494e-6	(B) Positive
APOBEC3A	22q13.1	2.33	1.45	1.66	1.41	0.88	4.43e-7	1.506e-6	(A) Negative
B9D1	17p11.2	-0.44	-0.07	0.66	0.76	-0.37	4.45e-7	1.512e-6	(B) Positive
SLC6A8	Xq28	-1.21	-1.54	0.60	0.59	0.33	4.47e-7	1.520e-6	(A) Negative
LRRC23	12p13.31	0.27	0.62	0.66	0.56	-0.35	4.48e-7	1.521e-6	(B) Positive
BNC2	9p22.3-p22.2	-0.71	-0.21	0.92	0.93	-0.50	4.48e-7	1.521e-6	(B) Positive
ISG20	15q26.1	0.72	0.19	0.96	0.94	0.52	4.49e-7	1.525e-6	(A) Negative
KRT75	12q13.13	0.85	0.14	1.33	1.12	0.71	4.52e-7	1.534e-6	(A) Negative
GDPD1	17q22	0.09	0.49	0.70	0.89	-0.41	4.53e-7	1.537e-6	(B) Positive
NANS	9q22.33	-0.20	0.15	0.66	0.58	-0.35	4.54e-7	1.540e-6	(B) Positive
BRAF	7q34	0.51	0.14	0.68	0.67	0.37	4.54e-7	1.541e-6	(A) Negative
SERPINB3	18q21.33	-2.89	-4.07	2.30	1.48	1.19	4.55e-7	1.542e-6	(A) Negative
VPS13C	15q22.2	-0.17	0.27	0.81	0.74	-0.43	4.55e-7	1.545e-6	(B) Positive
LONRF3	Xq24	-1.13	-1.71	1.09	0.91	0.58	4.56e-7	1.545e-6	(A) Negative
GPR143	Xp22.2	0.80	1.48	1.28	1.09	-0.68	4.56e-7	1.547e-6	(B) Positive
CISD1	10q21.1	-0.36	-0.71	0.63	0.66	0.35	4.59e-7	1.555e-6	(A) Negative
UNC5B	10q22.1	1.16	1.70	0.99	0.94	-0.54	4.61e-7	1.561e-6	(B) Positive
SCML2	Xp22.13	-1.21	-1.64	0.82	0.64	0.43	4.63e-7	1.571e-6	(A) Negative
ADAMTS4	1q23.3	1.25	0.90	0.64	0.60	0.35	4.68e-7	1.587e-6	(A) Negative
MPO	17q22	0.88	0.42	0.88	0.64	0.46	4.72e-7	1.598e-6	(A) Negative
FKBP1B	2p23.3	-1.94	-1.48	0.82	0.90	-0.46	4.75e-7	1.608e-6	(B) Positive
CCDC88C	14q32.11-q32.12	0.26	0.55	0.53	0.58	-0.29	4.75e-7	1.609e-6	(B) Positive
ZNF596	8p23.3	0.01	0.44	0.79	0.74	-0.43	4.75e-7	1.609e-6	(B) Positive
YWHAG	7q11.23	0.32	0.05	0.50	0.48	0.27	4.77e-7	1.615e-6	(A) Negative
MRPL39	21q21.3	-0.67	-0.97	0.57	0.43	0.30	4.78e-7	1.619e-6	(A) Negative
VEPH1	3q25.31-q25.32	-1.54	-2.12	1.09	1.01	0.59	4.79e-7	1.620e-6	(A) Negative
OSBPL9	1p32.3	-0.53	-0.85	0.61	0.51	0.32	4.79e-7	1.620e-6	(A) Negative
KLHL26	19p13.11	0.23	0.46	0.43	0.42	-0.23	4.82e-7	1.631e-6	(B) Positive
CENPU	4q35.1	-0.74	-1.20	0.82	0.96	0.46	4.85e-7	1.639e-6	(A) Negative
ABHD17B	9q21.13	-0.25	-0.59	0.62	0.60	0.34	4.85e-7	1.640e-6	(A) Negative
CSF2RB	22q12.3	0.56	0.26	0.59	0.33	0.30	4.87e-7	1.645e-6	(A) Negative
SMARCC2	12q13.2	0.25	0.46	0.41	0.36	-0.22	4.88e-7	1.649e-6	(B) Positive
MAST1	19p13.13	-0.11	-0.53	0.76	0.80	0.42	4.88e-7	1.649e-6	(A) Negative
ZNF778	16q24.3	0.11	-0.19	0.56	0.54	0.30	4.89e-7	1.652e-6	(A) Negative
CCDC71	3p21.31	-0.93	-0.64	0.53	0.51	-0.29	4.90e-7	1.656e-6	(B) Positive
FAM27E3	9q21.11	-1.64	-2.21	1.10	0.79	0.57	4.91e-7	1.658e-6	(A) Negative
SAMD4A	14q22.2	-0.05	-0.50	0.88	0.63	0.46	4.95e-7	1.670e-6	(A) Negative
ZNF701	19q13.41	0.89	1.25	0.67	0.62	-0.36	4.95e-7	1.670e-6	(B) Positive
CHST14	15q15.1	-0.10	0.16	0.49	0.44	-0.26	4.98e-7	1.681e-6	(B) Positive
CYP2D6	22q13.2	-0.23	-0.50	0.52	0.41	0.27	4.98e-7	1.681e-6	(A) Negative
ZNF676	19p12	-0.77	-0.42	0.64	0.68	-0.35	5.01e-7	1.689e-6	(B) Positive
RAB5IF	20q11.23	-0.16	-0.48	0.59	0.57	0.32	5.06e-7	1.706e-6	(A) Negative
SMIM11	21q22.11-q22.12	-0.20	0.05	0.44	0.44	-0.24	5.08e-7	1.713e-6	(B) Positive
NCOA4	10q11.22	-0.25	0.07	0.58	0.56	-0.32	5.08e-7	1.713e-6	(B) Positive
P2RY2	11q13.4	1.54	2.33	1.52	1.15	-0.79	5.10e-7	1.720e-6	(B) Positive
RAB23	6p12.1-p11.2	0.38	-0.03	0.80	0.58	0.42	5.11e-7	1.723e-6	(A) Negative
CEP76	18p11.21	-0.18	-0.48	0.58	0.49	0.31	5.11e-7	1.723e-6	(A) Negative
GLRX2	1q31.2	0.25	0.00	0.46	0.41	0.25	5.13e-7	1.727e-6	(A) Negative
CALCA	11p15.2	0.45	-0.08	1.05	0.44	0.52	5.16e-7	1.736e-6	(A) Negative
NCBP2	3q29	0.19	-0.10	0.56	0.42	0.29	5.17e-7	1.740e-6	(A) Negative
ZMIZ1	10q22.3	0.56	0.84	0.52	0.43	-0.28	5.20e-7	1.751e-6	(B) Positive
HTR2B	2q37.1	1.94	2.63	1.29	1.18	-0.69	5.20e-7	1.751e-6	(B) Positive
ZNF12	7p22.1	-0.09	0.17	0.47	0.43	-0.25	5.21e-7	1.754e-6	(B) Positive
AGMAT	1p36.21	-2.74	-3.13	0.73	0.67	0.39	5.23e-7	1.760e-6	(A) Negative
RNF139	8q24.13	0.67	1.05	0.71	0.59	-0.38	5.23e-7	1.761e-6	(B) Positive
SLC37A3	7q34	0.28	-0.03	0.58	0.53	0.31	5.24e-7	1.762e-6	(A) Negative
FZD6	8q22.3	0.65	0.10	0.94	1.26	0.55	5.27e-7	1.772e-6	(A) Negative
KRT33A	17q21.2	1.39	1.91	0.98	0.91	-0.53	5.29e-7	1.778e-6	(B) Positive
SOX30	5q33.3	0.27	-0.03	0.58	0.36	0.29	5.30e-7	1.780e-6	(A) Negative
LOX	5q23.1	-1.08	-1.65	1.06	1.09	0.58	5.34e-7	1.795e-6	(A) Negative
SLC4A1AP	2p23.3	0.14	-0.08	0.43	0.29	0.22	5.35e-7	1.796e-6	(A) Negative
TIMM29	19p13.2	0.16	-0.08	0.45	0.39	0.24	5.38e-7	1.808e-6	(A) Negative
KCNH8	3p24.3	0.75	-0.05	1.55	1.07	0.80	5.40e-7	1.813e-6	(A) Negative
ZNF443	19p13.2	0.32	0.66	0.63	0.61	-0.34	5.43e-7	1.825e-6	(B) Positive
PCNA	20p12.3	-1.14	-1.50	0.65	0.68	0.36	5.49e-7	1.843e-6	(A) Negative
SLC30A6	2p22.3	0.30	-0.00	0.57	0.44	0.30	5.50e-7	1.846e-6	(A) Negative
CORO2A	9q22.33	-0.13	0.36	0.92	0.86	-0.49	5.50e-7	1.846e-6	(B) Positive
TF	3q22.1	-3.05	-3.60	1.06	0.69	0.54	5.50e-7	1.846e-6	(A) Negative
TRAPPC2	Xp22.2	0.35	0.66	0.57	0.51	-0.31	5.50e-7	1.847e-6	(B) Positive
ZMYND15	17p13.2	1.63	1.20	0.83	0.56	0.42	5.54e-7	1.857e-6	(A) Negative
SPRY2	13q31.1	-1.57	-2.10	0.98	1.01	0.53	5.56e-7	1.864e-6	(A) Negative
OLFML1	11p15.4	1.38	1.63	0.46	0.44	-0.25	5.57e-7	1.867e-6	(B) Positive
CD19	16p11.2	0.36	-0.44	1.53	1.26	0.81	5.58e-7	1.869e-6	(A) Negative
MAP3K5	6q23.3	1.04	0.55	0.90	0.85	0.48	5.58e-7	1.870e-6	(A) Negative
VPS25	17q21.31	-0.31	-0.05	0.49	0.48	-0.26	5.59e-7	1.874e-6	(B) Positive
IFNG	12q15	2.94	1.93	1.95	1.50	1.01	5.64e-7	1.888e-6	(A) Negative
NDUFA9	12p13.3	-0.02	-0.37	0.70	0.44	0.36	5.64e-7	1.890e-6	(A) Negative
ADCY3	2p23.3	0.12	-0.31	0.84	0.61	0.43	5.67e-7	1.899e-6	(A) Negative
ARL6IP6	2q23.3	-0.98	-1.36	0.73	0.55	0.38	5.68e-7	1.902e-6	(A) Negative
ADAM15	1q21.3	0.16	-0.21	0.68	0.64	0.37	5.82e-7	1.948e-6	(A) Negative
CAVIN3	11p15.4	0.63	0.21	0.79	0.72	0.42	5.87e-7	1.966e-6	(A) Negative
JUND	19p13.11	0.84	1.25	0.79	0.66	-0.41	5.89e-7	1.971e-6	(B) Positive
GLYATL1	11q12.1	0.26	1.39	2.07	2.17	-1.13	5.90e-7	1.975e-6	(B) Positive
MRPS10	6p21.1	-0.23	-0.47	0.46	0.38	0.24	5.92e-7	1.981e-6	(A) Negative
LTA4H	12q23.1	-0.53	-0.26	0.52	0.47	-0.28	5.95e-7	1.990e-6	(B) Positive
RBM34	1q42.3	0.18	-0.11	0.56	0.47	0.29	5.96e-7	1.993e-6	(A) Negative
ZAN	7q22.1	0.48	0.33	0.26	0.27	0.14	5.97e-7	1.995e-6	(A) Negative
RHOA	3p21.31	-0.07	0.24	0.59	0.52	-0.31	5.97e-7	1.995e-6	(B) Positive
HEATR6	17q23.1	-1.24	-0.88	0.66	0.68	-0.36	5.99e-7	2.001e-6	(B) Positive
CWC15	11q21	-0.06	-0.31	0.47	0.47	0.26	6.02e-7	2.012e-6	(A) Negative
YIF1B	19q13.2	-0.62	-0.85	0.43	0.41	0.23	6.05e-7	2.020e-6	(A) Negative
BTN2A2	6p22.2	-0.30	-0.66	0.68	0.55	0.36	6.06e-7	2.024e-6	(A) Negative
ZKSCAN2	16p12.1	-0.43	-0.16	0.52	0.46	-0.27	6.12e-7	2.045e-6	(B) Positive
CHST9	18q11.2	-0.62	-1.65	1.99	1.47	1.02	6.13e-7	2.048e-6	(A) Negative
PRIMPOL	4q35.1	-0.59	-0.24	0.65	0.56	-0.34	6.14e-7	2.051e-6	(B) Positive
POU5F1P4	1q22	-4.33	-4.70	0.74	0.49	0.38	6.15e-7	2.052e-6	(A) Negative
DYNC1I1	7q21.3	-0.01	-0.87	1.69	0.99	0.85	6.15e-7	2.052e-6	(A) Negative
CSAG3	Xq28	-3.07	-4.10	2.00	1.38	1.02	6.15e-7	2.052e-6	(A) Negative
FXYD2	11q23.3	-1.63	-1.80	0.32	0.29	0.17	6.17e-7	2.058e-6	(A) Negative
OR2T11	1q44	0.37	0.52	0.25	0.40	-0.15	6.17e-7	2.059e-6	(B) Positive
CLIP2	7q11.23	-0.39	-0.68	0.56	0.51	0.30	6.19e-7	2.065e-6	(A) Negative
BST2	19p13.11	-0.20	0.53	1.38	1.25	-0.73	6.25e-7	2.084e-6	(B) Positive
IPO5	13q32.2	-0.63	-0.99	0.70	0.49	0.36	6.27e-7	2.088e-6	(A) Negative
LHB	19q13.33	0.12	-0.03	0.27	0.32	0.15	6.27e-7	2.091e-6	(A) Negative
TOLLIP	11p15.5	0.44	0.64	0.37	0.37	-0.20	6.28e-7	2.094e-6	(B) Positive
NAA80	3p21.31	-0.92	-0.63	0.54	0.51	-0.29	6.29e-7	2.094e-6	(B) Positive
EHD2	19q13.33	-0.66	-0.26	0.76	0.65	-0.40	6.29e-7	2.095e-6	(B) Positive
NXPE3	3q12.3	0.34	0.85	0.94	0.94	-0.51	6.32e-7	2.104e-6	(B) Positive
PLCL1	2q33.1	-0.20	0.31	0.88	1.13	-0.51	6.33e-7	2.106e-6	(B) Positive
MLLT11	1q21.3	-1.21	-1.87	1.29	0.85	0.65	6.35e-7	2.112e-6	(A) Negative
LRRC31	3q26.2	0.99	2.00	1.88	1.90	-1.02	6.35e-7	2.113e-6	(B) Positive
ZBTB7C-AS2	18q21.1	0.64	0.49	0.29	0.31	0.16	6.36e-7	2.115e-6	(A) Negative
TMEM131L	4q31.3	0.18	-0.19	0.69	0.70	0.37	6.36e-7	2.116e-6	(A) Negative
VPS41	7p14.1	0.04	0.29	0.48	0.44	-0.26	6.40e-7	2.127e-6	(B) Positive
MNAT1	14q23.1	-0.54	-0.34	0.37	0.42	-0.20	6.42e-7	2.136e-6	(B) Positive
FRMD3	9q21.32	-0.21	-0.90	1.37	0.85	0.69	6.46e-7	2.148e-6	(A) Negative
TTLL7	1p31.1	0.03	-0.43	0.87	0.75	0.46	6.48e-7	2.154e-6	(A) Negative
EBF2	8p21.2	0.40	0.54	0.25	0.30	-0.14	6.49e-7	2.155e-6	(B) Positive
DMWD	19q13.32	0.41	0.27	0.25	0.28	0.14	6.49e-7	2.156e-6	(A) Negative
RPL29	3p21.2	-0.85	-0.58	0.48	0.55	-0.27	6.50e-7	2.161e-6	(B) Positive
LDB3	10q23.2	0.13	0.33	0.32	0.48	-0.19	6.53e-7	2.169e-6	(B) Positive
SHD	19p13.3	-0.42	-0.65	0.43	0.46	0.23	6.53e-7	2.169e-6	(A) Negative
MCAM	11q23.3	0.51	0.17	0.64	0.58	0.34	6.54e-7	2.173e-6	(A) Negative
DLL3	19q13.2	-0.99	-1.48	0.96	0.67	0.49	6.60e-7	2.191e-6	(A) Negative
TPPP	5p15.33	0.40	0.78	0.67	0.81	-0.38	6.60e-7	2.191e-6	(B) Positive
PPP1R1B	17q12	2.89	2.17	1.29	1.55	0.72	6.61e-7	2.193e-6	(A) Negative
MIR155HG	21q21.3	1.65	1.12	1.00	0.83	0.52	6.61e-7	2.194e-6	(A) Negative
KRTAP1-1	17q21.2	0.12	-0.15	0.54	0.25	0.27	6.61e-7	2.194e-6	(A) Negative
OLIG1	21q22.11	-1.60	-2.25	1.26	0.88	0.64	6.61e-7	2.194e-6	(A) Negative
KCNK1	1q42.2	1.19	0.33	1.42	2.18	0.86	6.64e-7	2.202e-6	(A) Negative
LCMT1	16p12.1	0.29	0.57	0.50	0.51	-0.27	6.66e-7	2.206e-6	(B) Positive
SLAMF1	1q23.3	2.80	2.09	1.37	1.19	0.72	6.68e-7	2.216e-6	(A) Negative
ARPC5L	9q33.3	0.16	-0.12	0.53	0.43	0.27	6.71e-7	2.223e-6	(A) Negative
LINC00311	16q24.1	0.16	0.03	0.25	0.27	0.14	6.73e-7	2.228e-6	(A) Negative
MTCL1	18p11.22	-0.84	-0.48	0.65	0.74	-0.36	6.73e-7	2.229e-6	(B) Positive
HPCA	1p35.1	-0.62	-0.93	0.58	0.57	0.31	6.74e-7	2.232e-6	(A) Negative
CEP152	15q21.1	-1.81	-2.06	0.48	0.47	0.26	6.79e-7	2.247e-6	(A) Negative
SAMD12	8q24.11-q24.12	1.28	1.73	0.85	0.76	-0.45	6.79e-7	2.249e-6	(B) Positive
PLCB2	15q15.1	0.55	0.26	0.54	0.53	0.29	6.83e-7	2.259e-6	(A) Negative
MB	22q12.3	1.37	2.09	1.39	0.97	-0.71	6.90e-7	2.283e-6	(B) Positive
MCEMP1	19p13.2	0.61	-0.02	1.21	0.98	0.63	6.91e-7	2.287e-6	(A) Negative
PFAS	17p13.1	-1.71	-1.48	0.45	0.42	-0.24	6.91e-7	2.287e-6	(B) Positive
ST3GAL4	11q24.2	-0.35	-0.79	0.85	0.62	0.44	6.94e-7	2.295e-6	(A) Negative
ADIPOQ	3q27.3	1.38	2.12	1.33	1.58	-0.74	6.94e-7	2.295e-6	(B) Positive
BIN2	12q13.13	0.36	-0.14	0.96	0.81	0.50	6.95e-7	2.298e-6	(A) Negative
MFSD14CP	9q22.33	-0.29	-0.60	0.61	0.42	0.31	6.95e-7	2.298e-6	(A) Negative
COX7C	5q14.3	0.18	0.49	0.59	0.56	-0.31	6.96e-7	2.300e-6	(B) Positive
RNF25	2q35	0.03	0.26	0.47	0.31	-0.24	6.97e-7	2.303e-6	(B) Positive
CYP2D7	22q13.2	-0.26	-0.45	0.35	0.32	0.19	6.99e-7	2.308e-6	(A) Negative
SLAMF8	1q23.2	3.38	2.97	0.77	0.73	0.41	7.00e-7	2.311e-6	(A) Negative
ACTRT3	3q26.2	1.26	0.81	0.87	0.67	0.45	7.00e-7	2.311e-6	(A) Negative
NUP54	4q21.1	-0.27	-0.55	0.56	0.40	0.29	7.05e-7	2.328e-6	(A) Negative
INTS8	8q22.1	0.05	-0.27	0.59	0.62	0.32	7.06e-7	2.330e-6	(A) Negative
TMIE	3p21.31	0.48	0.14	0.65	0.50	0.33	7.07e-7	2.333e-6	(A) Negative
ATG16L2	11q13.4	-1.32	-0.97	0.65	0.69	-0.35	7.10e-7	2.341e-6	(B) Positive
ZNF224	19q13.31	-0.22	0.06	0.54	0.43	-0.28	7.10e-7	2.342e-6	(B) Positive
FADS1	11q12.2	-2.06	-2.54	0.89	1.00	0.49	7.16e-7	2.361e-6	(A) Negative
ZNF584	19q13.43	-0.40	-0.17	0.43	0.36	-0.23	7.16e-7	2.361e-6	(B) Positive
LUZP1	1p36.12	0.11	-0.08	0.34	0.35	0.19	7.16e-7	2.362e-6	(A) Negative
PPP1R1A	12q13.2	1.44	0.48	1.83	1.59	0.96	7.17e-7	2.362e-6	(A) Negative
KMT5A	12q24.31	-0.16	-0.42	0.48	0.47	0.26	7.18e-7	2.367e-6	(A) Negative
VRK3	19q13.33	0.16	0.39	0.41	0.45	-0.22	7.22e-7	2.378e-6	(B) Positive
LRRC4C	11p12	1.91	2.60	1.28	1.31	-0.69	7.22e-7	2.380e-6	(B) Positive
ZNF771	16p11.2	0.06	0.29	0.45	0.41	-0.24	7.23e-7	2.383e-6	(B) Positive
ZNF22-AS1	10q11.21	-0.44	-0.77	0.63	0.47	0.33	7.24e-7	2.384e-6	(A) Negative
WASHC3	12q23.2	0.12	0.40	0.53	0.46	-0.28	7.25e-7	2.386e-6	(B) Positive
VPS35	16q11.2	0.45	0.17	0.53	0.53	0.28	7.26e-7	2.389e-6	(A) Negative
FOXK1	7p22.1	-0.46	-0.69	0.45	0.38	0.24	7.28e-7	2.397e-6	(A) Negative
COLEC11	2p25.3	-0.36	-0.98	1.20	1.00	0.62	7.35e-7	2.420e-6	(A) Negative
PLXNB3	Xq28	0.72	0.37	0.68	0.59	0.35	7.36e-7	2.421e-6	(A) Negative
PRR4	12p13.2	0.47	-0.33	1.61	0.94	0.81	7.40e-7	2.436e-6	(A) Negative
KDELR3	22q13.1	0.77	0.23	0.99	1.07	0.54	7.43e-7	2.445e-6	(A) Negative
OLIG2	21q22.11	-1.51	-1.82	0.55	0.63	0.30	7.48e-7	2.461e-6	(A) Negative
SEC13	3p25.3	0.05	-0.20	0.49	0.40	0.26	7.49e-7	2.462e-6	(A) Negative
TSGA10	2q11.2	1.44	2.01	1.04	1.09	-0.56	7.49e-7	2.463e-6	(B) Positive
BANP	16q24.2	0.28	0.09	0.36	0.36	0.19	7.55e-7	2.483e-6	(A) Negative
FRMD4A	10p13	0.58	0.35	0.45	0.35	0.23	7.62e-7	2.502e-6	(A) Negative
SNX3	6q21	0.41	0.09	0.61	0.54	0.32	7.66e-7	2.515e-6	(A) Negative
FUT9	6q16.1	0.71	-0.15	1.59	1.69	0.86	7.68e-7	2.521e-6	(A) Negative
SERPINC1	1q25.1	-4.64	-4.30	0.61	0.69	-0.34	7.78e-7	2.556e-6	(B) Positive
NPPC	2q37.1	1.10	0.24	1.66	1.47	0.87	7.78e-7	2.556e-6	(A) Negative
SUPT6H	17q11.2	-0.18	0.11	0.56	0.48	-0.29	7.80e-7	2.560e-6	(B) Positive
WNT5B	12p13.33	-0.18	-0.84	1.28	0.98	0.66	7.81e-7	2.562e-6	(A) Negative
TMEM117	12q12	0.04	-0.38	0.80	0.68	0.42	7.81e-7	2.562e-6	(A) Negative
ANKDD1A	15q22.31	-0.28	-0.52	0.47	0.39	0.24	7.83e-7	2.569e-6	(A) Negative
POR	7q11.23	0.29	-0.05	0.67	0.50	0.34	7.85e-7	2.577e-6	(A) Negative
PTPRA	20p13	-0.16	0.08	0.46	0.42	-0.24	7.91e-7	2.594e-6	(B) Positive
SRSF6	20q13.11	-0.22	0.20	0.81	0.73	-0.42	7.91e-7	2.594e-6	(B) Positive
SIX3	2p21	0.88	0.51	0.74	0.49	0.37	7.92e-7	2.597e-6	(A) Negative
PRXL2C	9q22.33	-0.23	-0.58	0.67	0.55	0.35	7.93e-7	2.599e-6	(A) Negative
CXCL6	4q13.3	0.48	-0.14	1.24	0.83	0.63	7.98e-7	2.614e-6	(A) Negative
LSMEM1	7q31.1	-0.48	-0.93	0.88	0.75	0.46	8.01e-7	2.625e-6	(A) Negative
FGF21	19q13.33	0.47	0.22	0.51	0.29	0.25	8.05e-7	2.638e-6	(A) Negative
ZNF582	19q13.43	0.31	0.77	0.86	0.88	-0.46	8.08e-7	2.646e-6	(B) Positive
RIC8B	12q23.3	-0.31	0.01	0.62	0.55	-0.32	8.13e-7	2.664e-6	(B) Positive
HOMER1	5q14.1	-0.62	-1.13	0.91	1.10	0.51	8.15e-7	2.670e-6	(A) Negative
PPA1	10q22.1	0.02	-0.28	0.56	0.58	0.30	8.16e-7	2.671e-6	(A) Negative
CLDN8	21q22.11	4.45	3.48	1.80	1.85	0.97	8.19e-7	2.679e-6	(A) Negative
ZNF644	1p22.2	0.85	0.49	0.70	0.59	0.36	8.19e-7	2.680e-6	(A) Negative
ETFDH	4q32.1	0.02	0.30	0.53	0.51	-0.28	8.20e-7	2.681e-6	(B) Positive
TEDC2	16p13.3	-1.35	-1.74	0.70	0.80	0.38	8.20e-7	2.681e-6	(A) Negative
FAM76B	11q21	-0.28	-0.57	0.57	0.49	0.30	8.22e-7	2.689e-6	(A) Negative
CD36	7q21.11	2.23	2.96	1.32	1.56	-0.73	8.23e-7	2.692e-6	(B) Positive
TNFSF15	9q32	0.89	0.40	0.97	0.80	0.50	8.28e-7	2.707e-6	(A) Negative
RC3H2	9q33.2	-0.27	-0.51	0.49	0.37	0.25	8.30e-7	2.713e-6	(A) Negative
DYRK4	12p13.32	0.58	0.17	0.80	0.62	0.41	8.30e-7	2.713e-6	(A) Negative
CATSPERG	19q13.2	0.05	0.25	0.36	0.40	-0.20	8.34e-7	2.726e-6	(B) Positive
FAR1	11p15.3	-0.42	-0.05	0.71	0.63	-0.37	8.37e-7	2.735e-6	(B) Positive
ALK	2p23.2-p23.1	-0.81	-1.40	1.14	0.89	0.58	8.41e-7	2.747e-6	(A) Negative
SETDB2	13q14.2	-0.19	0.15	0.66	0.51	-0.34	8.42e-7	2.751e-6	(B) Positive
ZDHHC14	6q25.3	-0.17	-0.58	0.79	0.65	0.41	8.53e-7	2.785e-6	(A) Negative
TP53TG5	20q13.12	0.28	0.51	0.38	0.56	-0.23	8.56e-7	2.795e-6	(B) Positive
ORM2	9q32	-3.13	-4.05	1.85	1.03	0.92	8.57e-7	2.795e-6	(A) Negative
MAP9	4q32.1	1.22	1.78	1.01	1.15	-0.55	8.58e-7	2.799e-6	(B) Positive
UGT1A6	2q37.1	-0.42	-1.11	1.37	0.87	0.68	8.61e-7	2.809e-6	(A) Negative
SCN1B	19q13.11	-0.33	-0.11	0.41	0.50	-0.23	8.62e-7	2.812e-6	(B) Positive
TCEA2	20q13.33	-0.02	0.32	0.65	0.60	-0.34	8.64e-7	2.818e-6	(B) Positive
SPTY2D1	11p15.1	0.70	0.93	0.45	0.42	-0.24	8.68e-7	2.831e-6	(B) Positive
DDX10	11q22.3	-0.53	-0.82	0.55	0.46	0.29	8.72e-7	2.842e-6	(A) Negative
NAP1L2	Xq13.2	-1.27	-0.41	1.62	1.60	-0.86	8.76e-7	2.856e-6	(B) Positive
PARP16	15q22.31	-0.46	-0.20	0.48	0.48	-0.26	8.81e-7	2.870e-6	(B) Positive
PIK3C2G	12p12.3	2.56	1.65	1.75	1.52	0.91	8.81e-7	2.871e-6	(A) Negative
RPL15	3p24.2	-0.61	-0.37	0.47	0.44	-0.25	8.83e-7	2.875e-6	(B) Positive
FCAR	19q13.42	0.43	0.23	0.37	0.36	0.20	8.85e-7	2.881e-6	(A) Negative
C1QTNF1	17q25.3	0.70	0.33	0.72	0.59	0.37	8.86e-7	2.885e-6	(A) Negative
MRPS15	1p34.3	-0.15	-0.41	0.51	0.40	0.26	8.94e-7	2.910e-6	(A) Negative
DTX4	11q12.1	0.94	0.48	0.89	0.71	0.45	8.95e-7	2.912e-6	(A) Negative
HTR7P1	12p13.1	0.22	0.48	0.42	0.67	-0.26	8.99e-7	2.924e-6	(B) Positive
ZNF236	18q23	0.27	0.53	0.50	0.49	-0.26	9.01e-7	2.930e-6	(B) Positive
ROBO1	3p12.3	-0.46	-0.92	0.89	0.74	0.46	9.02e-7	2.934e-6	(A) Negative
UQCRC2	16p12.2	-0.34	-0.07	0.51	0.44	-0.26	9.03e-7	2.938e-6	(B) Positive
VNN2	6q23.2	2.52	1.82	1.36	1.10	0.70	9.04e-7	2.940e-6	(A) Negative
MAPK14	6p21.31	-0.25	-0.49	0.45	0.39	0.24	9.05e-7	2.941e-6	(A) Negative
SVIL	10p11.23	0.71	0.27	0.85	0.71	0.44	9.09e-7	2.953e-6	(A) Negative
TNFSF12	17p13.1	1.78	2.15	0.71	0.62	-0.37	9.10e-7	2.959e-6	(B) Positive
BEX4	Xq22.1	-0.04	0.37	0.77	0.78	-0.41	9.14e-7	2.969e-6	(B) Positive
BUB3	10q26.13	-0.40	-0.09	0.59	0.49	-0.30	9.14e-7	2.970e-6	(B) Positive
RPP38-DT	10p13	0.08	-0.35	0.85	0.65	0.43	9.16e-7	2.974e-6	(A) Negative
RNF170	8p11.21	-0.28	0.06	0.64	0.65	-0.34	9.16e-7	2.974e-6	(B) Positive
SCNN1D	1p36.33	-1.01	-0.81	0.37	0.44	-0.21	9.16e-7	2.974e-6	(B) Positive
LRRN3	7q31.1	-0.28	0.16	0.78	0.99	-0.44	9.25e-7	3.001e-6	(B) Positive
CCDC117	22q12.1	0.25	0.53	0.43	0.82	-0.28	9.26e-7	3.006e-6	(B) Positive
CREB3L1	11p11.2	0.58	1.02	0.83	0.78	-0.44	9.33e-7	3.027e-6	(B) Positive
PTS	11q23.1	-0.02	-0.39	0.73	0.48	0.37	9.36e-7	3.037e-6	(A) Negative
RIC1	9p24.1	0.53	0.10	0.84	0.66	0.43	9.37e-7	3.040e-6	(A) Negative
MACROH2A1	5q31.1	0.44	0.71	0.52	0.50	-0.28	9.40e-7	3.048e-6	(B) Positive
CHD7	8q12.2	-0.17	-0.74	1.09	1.00	0.57	9.50e-7	3.080e-6	(A) Negative
SMARCA5	4q31.21	-0.09	-0.34	0.48	0.39	0.25	9.50e-7	3.080e-6	(A) Negative
ASL	7q11.21	-0.47	-0.13	0.66	0.53	-0.34	9.53e-7	3.088e-6	(B) Positive
KYAT1	9q34.11	-1.54	-1.30	0.46	0.45	-0.24	9.55e-7	3.095e-6	(B) Positive
UNKL	16p13.3	-0.38	-0.08	0.59	0.48	-0.30	9.70e-7	3.144e-6	(B) Positive
HYI	1p34.2	0.30	0.62	0.63	0.58	-0.33	9.74e-7	3.155e-6	(B) Positive
ZBTB32	19q13.12	1.80	1.26	1.05	0.88	0.54	9.74e-7	3.156e-6	(A) Negative
DCTD	4q35.1	-0.55	-0.29	0.51	0.48	-0.27	9.76e-7	3.160e-6	(B) Positive
SUMO3	21q22.3	0.27	-0.05	0.62	0.51	0.32	9.81e-7	3.178e-6	(A) Negative
GPR68	14q32.11	0.47	0.81	0.66	0.53	-0.34	9.83e-7	3.181e-6	(B) Positive
LMTK2	7q21.3	0.15	-0.09	0.44	0.47	0.24	9.86e-7	3.191e-6	(A) Negative
SLC2A8	9q33.3	-0.24	0.06	0.56	0.50	-0.29	9.86e-7	3.191e-6	(B) Positive
BIRC3	11q22.2	0.15	-0.62	1.49	1.23	0.76	9.87e-7	3.193e-6	(A) Negative
TRIM13	13q14.2	0.02	0.32	0.59	0.44	-0.30	9.94e-7	3.217e-6	(B) Positive
RHOF	12q24.31	-0.41	-0.74	0.64	0.58	0.33	9.97e-7	3.224e-6	(A) Negative
COPS4	4q21.22	-0.30	-0.01	0.56	0.50	-0.29	9.98e-7	3.228e-6	(B) Positive
MAPK7	17p11.2	-0.12	-0.31	0.37	0.38	0.20	1.000e-6	3.233e-6	(A) Negative
HBP1	7q22.3	0.61	0.89	0.51	0.52	-0.27	1.014e-6	3.279e-6	(B) Positive
FMR1	Xq27.3	0.61	0.33	0.54	0.47	0.28	1.023e-6	3.307e-6	(A) Negative
CR2	1q32.2	-0.60	-1.13	1.04	0.85	0.53	1.026e-6	3.314e-6	(A) Negative
TSNAX	1q42.2	0.18	0.45	0.51	0.53	-0.27	1.029e-6	3.324e-6	(B) Positive
UBA52	19p13.1-p12	-0.18	-0.42	0.47	0.40	0.24	1.034e-6	3.339e-6	(A) Negative
PCYT2	17q25.3	0.04	-0.28	0.62	0.53	0.32	1.042e-6	3.366e-6	(A) Negative
COA6	1q42.2	-0.14	-0.45	0.61	0.51	0.31	1.046e-6	3.376e-6	(A) Negative
HARS1	5q31.3	-0.36	-0.15	0.41	0.31	-0.21	1.051e-6	3.393e-6	(B) Positive
FXYD6	11q23.3	1.74	1.28	0.92	0.66	0.46	1.058e-6	3.414e-6	(A) Negative
ACAA1	3p22.2	0.17	0.45	0.55	0.50	-0.28	1.059e-6	3.417e-6	(B) Positive
SATB1	3p24.3	0.30	-0.31	1.18	1.09	0.61	1.059e-6	3.417e-6	(A) Negative
PLEKHA3	2q31.2	0.45	0.67	0.44	0.33	-0.22	1.060e-6	3.419e-6	(B) Positive
RARS1	5q34	-0.63	-0.40	0.44	0.37	-0.22	1.061e-6	3.420e-6	(B) Positive
CPD	17q11.2	0.28	0.69	0.81	0.71	-0.42	1.062e-6	3.423e-6	(B) Positive
UHRF2	9p24.1	-0.45	-0.78	0.67	0.44	0.33	1.063e-6	3.427e-6	(A) Negative
GPC3	Xq26.2	-4.44	-3.86	1.04	1.29	-0.58	1.080e-6	3.480e-6	(B) Positive
IGKC	2p11.2	4.02	3.26	1.40	1.63	0.76	1.080e-6	3.481e-6	(A) Negative
HUS1	7p12.3	0.04	-0.25	0.58	0.43	0.29	1.081e-6	3.484e-6	(A) Negative
PCED1A	20p13	-0.58	-0.41	0.32	0.32	-0.17	1.085e-6	3.495e-6	(B) Positive
NRN1	6p25.1	-1.54	-2.09	1.12	0.70	0.55	1.092e-6	3.516e-6	(A) Negative
OR4D2	17q22	0.45	0.33	0.23	0.26	0.12	1.093e-6	3.519e-6	(A) Negative
TGFB2	1q41	0.84	0.06	1.52	1.30	0.78	1.095e-6	3.525e-6	(A) Negative
CCDC110	4q35.1	1.79	2.31	0.98	1.04	-0.52	1.098e-6	3.535e-6	(B) Positive
MX2	21q22.3	0.18	-0.35	1.02	0.87	0.52	1.100e-6	3.541e-6	(A) Negative
PUSL1	1p36.33	0.01	-0.30	0.61	0.57	0.32	1.104e-6	3.552e-6	(A) Negative
PCCA	13q32.3	-0.85	-0.44	0.82	0.60	-0.41	1.105e-6	3.555e-6	(B) Positive
PNMA2	8p21.2	-1.67	-1.32	0.60	0.80	-0.34	1.107e-6	3.561e-6	(B) Positive
BBC3	19q13.32	0.16	0.44	0.53	0.48	-0.27	1.118e-6	3.595e-6	(B) Positive
FOXP3	Xp11.23	0.50	0.30	0.39	0.38	0.21	1.127e-6	3.625e-6	(A) Negative
SWSAP1	19p13.2	0.22	0.51	0.57	0.46	-0.29	1.129e-6	3.629e-6	(B) Positive
PHACTR2	6q24.2	0.54	0.21	0.64	0.65	0.34	1.129e-6	3.630e-6	(A) Negative
BAIAP2	17q25.3	0.23	0.51	0.53	0.51	-0.28	1.132e-6	3.636e-6	(B) Positive
DCTN2	12q13.3	-0.26	-0.06	0.37	0.38	-0.20	1.133e-6	3.639e-6	(B) Positive
MYC	8q24.21	-0.87	-1.38	0.99	0.87	0.51	1.134e-6	3.642e-6	(A) Negative
FAS	10q23.31	0.82	0.24	1.15	0.87	0.58	1.138e-6	3.656e-6	(A) Negative
XRCC3	14q32.33	-0.51	-0.69	0.33	0.36	0.18	1.144e-6	3.675e-6	(A) Negative
DERA	12p12.3	-0.51	-0.87	0.73	0.44	0.36	1.145e-6	3.675e-6	(A) Negative
CTSW	11q13.1	1.38	0.93	0.89	0.72	0.45	1.151e-6	3.694e-6	(A) Negative
UCP1	4q31.1	-0.53	-0.11	0.61	1.24	-0.41	1.151e-6	3.695e-6	(B) Positive
TMEM143	19q13.32	-0.22	-0.09	0.26	0.26	-0.14	1.153e-6	3.700e-6	(B) Positive
TMT1B	12q13.2	-0.24	-0.58	0.66	0.57	0.34	1.158e-6	3.714e-6	(A) Negative
NDUFAF5	20p12.1	-0.35	-0.59	0.45	0.47	0.24	1.167e-6	3.744e-6	(A) Negative
GRIN3A	9q31.1	1.48	1.03	0.88	0.76	0.45	1.174e-6	3.764e-6	(A) Negative
EIF4G1	3q27.1	-0.02	-0.25	0.43	0.47	0.23	1.176e-6	3.771e-6	(A) Negative
SLC1A6	19p13.12	-0.90	-1.59	1.41	0.79	0.69	1.179e-6	3.779e-6	(A) Negative
SLC12A8	3q21.2	1.71	1.34	0.69	0.73	0.37	1.179e-6	3.780e-6	(A) Negative
PLD4	14q32.33	0.07	0.48	0.78	0.77	-0.41	1.181e-6	3.783e-6	(B) Positive
ATP8B2	1q21.3	-1.07	-0.73	0.67	0.62	-0.35	1.183e-6	3.791e-6	(B) Positive
C1ORF94	1p35.1	-1.24	-1.88	1.31	0.60	0.64	1.185e-6	3.795e-6	(A) Negative
PRKAR1A	17q24.2	-0.15	0.15	0.57	0.57	-0.30	1.186e-6	3.797e-6	(B) Positive
SCIN	7p21.3	2.03	2.63	1.10	1.33	-0.60	1.186e-6	3.798e-6	(B) Positive
NOD1	7p14.3	0.20	-0.06	0.51	0.50	0.27	1.186e-6	3.798e-6	(A) Negative
SMARCB1	22q11.23	-0.05	-0.33	0.53	0.54	0.28	1.191e-6	3.811e-6	(A) Negative
DLG1	3q29	0.19	-0.08	0.54	0.39	0.27	1.193e-6	3.817e-6	(A) Negative
LTK	15q15.1	-1.36	-1.83	0.93	0.74	0.47	1.210e-6	3.873e-6	(A) Negative
PFN2	3q25.1	0.10	-0.47	1.09	1.01	0.56	1.211e-6	3.875e-6	(A) Negative
TAS1R1	1p36.31	0.04	-0.28	0.64	0.45	0.32	1.211e-6	3.875e-6	(A) Negative
PNOC	8p21.1	-0.16	-1.04	1.73	1.48	0.88	1.217e-6	3.893e-6	(A) Negative
UBQLN4	1q22	0.30	-0.09	0.74	0.69	0.38	1.223e-6	3.909e-6	(A) Negative
TRIM26	6p22.1	0.58	0.37	0.39	0.40	0.21	1.228e-6	3.927e-6	(A) Negative
PSKH1	16q22.1	0.06	-0.14	0.38	0.38	0.20	1.232e-6	3.938e-6	(A) Negative
PSMD9	12q24.31	-0.45	-0.20	0.48	0.45	-0.25	1.233e-6	3.941e-6	(B) Positive
TRPV4	12q24.11	0.76	0.22	1.08	0.75	0.54	1.235e-6	3.947e-6	(A) Negative
ZNF571	19q13.12	0.56	0.88	0.61	0.54	-0.31	1.236e-6	3.947e-6	(B) Positive
NUP42	7p15.3	-0.56	-0.85	0.55	0.54	0.29	1.241e-6	3.962e-6	(A) Negative
PRF1	10q22.1	1.63	1.11	1.04	0.84	0.53	1.242e-6	3.967e-6	(A) Negative
LINC00602	6q27	-1.07	-1.39	0.62	0.55	0.32	1.245e-6	3.974e-6	(A) Negative
KCNIP2	10q24.32	-0.31	-0.06	0.42	0.64	-0.25	1.248e-6	3.984e-6	(B) Positive
GSTA4	6p12.2	1.09	0.61	0.91	0.93	0.48	1.252e-6	3.995e-6	(A) Negative
HEATR4	14q24.3	0.37	0.74	0.68	0.79	-0.37	1.252e-6	3.995e-6	(B) Positive
CRLF1	19p12	-2.41	-3.43	2.11	1.11	1.02	1.265e-6	4.036e-6	(A) Negative
INSR	19p13.2	1.29	1.60	0.59	0.59	-0.31	1.266e-6	4.038e-6	(B) Positive
CHCHD3	7q32.3-q33	-0.64	-0.89	0.50	0.40	0.25	1.269e-6	4.048e-6	(A) Negative
ARL1	12q23.2	0.43	0.69	0.51	0.43	-0.26	1.270e-6	4.051e-6	(B) Positive
ZNF519	18p11.21	-0.67	-1.10	0.87	0.64	0.43	1.276e-6	4.066e-6	(A) Negative
ADRA1D	20p13	0.44	0.27	0.34	0.31	0.17	1.276e-6	4.067e-6	(A) Negative
TAF5L	1q42.13	-0.50	-0.90	0.77	0.73	0.40	1.280e-6	4.078e-6	(A) Negative
ZDHHC9	Xq26.1	1.17	0.83	0.67	0.56	0.34	1.280e-6	4.078e-6	(A) Negative
PSMC2	7q22.1	-0.15	-0.39	0.48	0.38	0.24	1.285e-6	4.094e-6	(A) Negative
CASP14	19p13.12	0.26	-0.09	0.69	0.51	0.35	1.286e-6	4.096e-6	(A) Negative
CNBD2	20q11.23	0.18	0.43	0.43	0.61	-0.25	1.293e-6	4.118e-6	(B) Positive
DENND1C	19p13.3	0.28	-0.26	1.07	0.93	0.55	1.295e-6	4.124e-6	(A) Negative
CNN3	1p21.3	1.20	0.79	0.73	0.89	0.40	1.297e-6	4.130e-6	(A) Negative
KDELR2	7p22.1	0.59	0.31	0.55	0.50	0.28	1.300e-6	4.136e-6	(A) Negative
ECT2	3q26.31	-0.43	-0.85	0.82	0.76	0.42	1.301e-6	4.139e-6	(A) Negative
CLTC	17q23.1	-0.22	0.16	0.69	0.79	-0.37	1.308e-6	4.163e-6	(B) Positive
CARS2	13q34	0.44	0.12	0.63	0.55	0.32	1.310e-6	4.166e-6	(A) Negative
CD8B	2p11.2	-2.42	-2.89	0.93	0.79	0.47	1.313e-6	4.177e-6	(A) Negative
SYNGR2	17q25.3	0.55	0.94	0.74	0.76	-0.39	1.318e-6	4.191e-6	(B) Positive
ZDHHC4	7p22.1	-0.68	-0.36	0.64	0.51	-0.32	1.327e-6	4.218e-6	(B) Positive
TOP1MT	8q24.3	-0.06	-0.46	0.79	0.65	0.40	1.337e-6	4.250e-6	(A) Negative
TFCP2L1	2q14.2	3.96	3.03	1.85	1.46	0.93	1.341e-6	4.262e-6	(A) Negative
PGGT1B	5q22.3	-0.40	0.05	0.89	0.69	-0.45	1.342e-6	4.263e-6	(B) Positive
ZNF337	20p11.21	-0.23	0.02	0.50	0.40	-0.25	1.343e-6	4.266e-6	(B) Positive
ATP6V1D	14q23.3	-0.18	0.07	0.49	0.41	-0.25	1.344e-6	4.270e-6	(B) Positive
ZNF250	8q24.3	0.68	0.33	0.67	0.59	0.34	1.349e-6	4.284e-6	(A) Negative
APOBEC3D	22q13.1	-0.67	-1.45	1.61	1.01	0.79	1.351e-6	4.290e-6	(A) Negative
SYCE1	10q26.3	0.35	0.82	0.80	1.18	-0.46	1.354e-6	4.298e-6	(B) Positive
AFF1	4q21.3-q22.1	-0.06	0.33	0.78	0.52	-0.39	1.360e-6	4.317e-6	(B) Positive
AGXT2	5p13.2	0.12	0.38	0.43	0.67	-0.25	1.361e-6	4.318e-6	(B) Positive
GPRC5D	12p13.1	0.34	0.56	0.41	0.50	-0.22	1.365e-6	4.329e-6	(B) Positive
ABCC2	10q24.2	-4.06	-4.53	0.96	0.65	0.47	1.372e-6	4.352e-6	(A) Negative
ANGPT1	8q23.1	-1.65	-2.14	1.00	0.56	0.48	1.373e-6	4.354e-6	(A) Negative
UBE3C	7q36.3	-0.03	-0.30	0.55	0.41	0.27	1.380e-6	4.374e-6	(A) Negative
ZAP70	2q11.2	-2.33	-2.80	0.92	0.76	0.47	1.380e-6	4.374e-6	(A) Negative
GPD1	12q13.12	-0.00	0.60	1.09	1.35	-0.60	1.381e-6	4.378e-6	(B) Positive
GCLM	1p22.1	-0.15	-0.48	0.66	0.50	0.33	1.388e-6	4.400e-6	(A) Negative
CELF3	1q21.3	-0.15	0.14	0.47	0.79	-0.29	1.391e-6	4.406e-6	(B) Positive
GTPBP1	22q13.1	-0.13	-0.29	0.29	0.32	0.15	1.392e-6	4.410e-6	(A) Negative
GTPBP2	6p21.1	-0.24	-0.48	0.49	0.34	0.24	1.405e-6	4.449e-6	(A) Negative
DGKH	13q14.11	0.47	0.07	0.77	0.72	0.40	1.405e-6	4.449e-6	(A) Negative
DCP1A	3p21.1	-0.31	-0.11	0.38	0.38	-0.20	1.406e-6	4.451e-6	(B) Positive
SYT15	10q11.22	0.08	-0.39	0.95	0.63	0.47	1.412e-6	4.471e-6	(A) Negative
CCL2	17q12	1.53	0.93	1.18	1.08	0.61	1.416e-6	4.482e-6	(A) Negative
ZNF74	22q11.21	-0.45	-0.75	0.60	0.53	0.31	1.422e-6	4.500e-6	(A) Negative
PEDS1	20q13.13	0.02	-0.29	0.58	0.72	0.32	1.423e-6	4.501e-6	(A) Negative
SRSF4	1p35.3	-0.34	-0.64	0.58	0.51	0.30	1.425e-6	4.507e-6	(A) Negative
SLC5A3	21q22.11	-0.20	-0.52	0.62	0.57	0.32	1.430e-6	4.524e-6	(A) Negative
TANK	2q24.2	0.67	0.34	0.65	0.52	0.33	1.435e-6	4.537e-6	(A) Negative
SHROOM3	4q21.1	1.99	2.38	0.75	0.81	-0.40	1.441e-6	4.556e-6	(B) Positive
HIKESHI	11q14.2	-0.19	-0.47	0.55	0.53	0.28	1.443e-6	4.561e-6	(A) Negative
CEACAM7	19q13.2	0.63	1.30	1.33	1.06	-0.67	1.446e-6	4.571e-6	(B) Positive
ZNF652	17q21.32	-1.30	-0.83	0.89	0.99	-0.48	1.456e-6	4.601e-6	(B) Positive
RRP8	11p15.4	-0.46	-0.23	0.45	0.38	-0.23	1.456e-6	4.601e-6	(B) Positive
CTNND2	5p15.2	-1.23	-0.10	2.18	2.15	-1.13	1.459e-6	4.608e-6	(B) Positive
TNNT3	11p15.5	0.47	0.90	0.79	1.00	-0.43	1.463e-6	4.621e-6	(B) Positive
SRA1	5q31.3	0.06	0.30	0.49	0.37	-0.24	1.469e-6	4.638e-6	(B) Positive
CCDC59	12q21.31	-0.44	-0.70	0.53	0.43	0.26	1.474e-6	4.652e-6	(A) Negative
CCZ1	7p22.1	0.21	-0.04	0.50	0.41	0.25	1.474e-6	4.653e-6	(A) Negative
INTS10	8p21.3	-0.29	-0.61	0.63	0.53	0.32	1.476e-6	4.657e-6	(A) Negative
CDC14A	1p21.2	-0.42	-0.10	0.52	0.86	-0.32	1.479e-6	4.668e-6	(B) Positive
ASIC2	17q11.2-q12	0.22	0.60	0.68	0.96	-0.39	1.482e-6	4.674e-6	(B) Positive
ECM2	9q22.31	3.36	3.95	1.15	1.10	-0.59	1.493e-6	4.710e-6	(B) Positive
ECPAS	9q31.3	-0.42	-0.13	0.57	0.48	-0.29	1.494e-6	4.711e-6	(B) Positive
PABPN1	14q11.2	-0.03	-0.25	0.44	0.40	0.22	1.501e-6	4.732e-6	(A) Negative
CD96	3q13.13-q13.2	-0.51	-1.12	1.17	1.09	0.60	1.504e-6	4.741e-6	(A) Negative
NEU1	6p21.33	0.44	0.69	0.47	0.51	-0.25	1.505e-6	4.744e-6	(B) Positive
SERPINB4	18q21.33	-2.69	-3.75	2.15	1.38	1.05	1.507e-6	4.749e-6	(A) Negative
UBE2V2	8q11.21	-0.34	-0.66	0.61	0.62	0.32	1.517e-6	4.778e-6	(A) Negative
ZFHX4	8q21.13	0.35	0.98	1.26	1.03	-0.63	1.522e-6	4.793e-6	(B) Positive
SPSB4	3q23	0.83	0.56	0.52	0.57	0.28	1.526e-6	4.805e-6	(A) Negative
FAM81A	15q22.2	-0.61	-1.19	1.19	0.82	0.59	1.527e-6	4.807e-6	(A) Negative
CACNA2D3	3p21.1-p14.3	-1.70	-1.27	0.78	1.00	-0.43	1.530e-6	4.816e-6	(B) Positive
GNG11	7q21.3	-1.11	-0.67	0.84	0.89	-0.44	1.538e-6	4.840e-6	(B) Positive
NADSYN1	11q13.4	-0.23	0.07	0.56	0.64	-0.30	1.546e-6	4.865e-6	(B) Positive
ATF7	12q13.13	0.55	0.76	0.41	0.38	-0.21	1.546e-6	4.865e-6	(B) Positive
ZEB1	10p11.22	-0.24	0.29	1.03	0.96	-0.53	1.547e-6	4.867e-6	(B) Positive
PLIN4	19p13.3	1.45	2.14	1.33	1.39	-0.70	1.548e-6	4.870e-6	(B) Positive
RFX3	9p24.2	0.35	-0.02	0.75	0.62	0.38	1.551e-6	4.877e-6	(A) Negative
SMNDC1	10q25.2	-0.17	-0.42	0.49	0.41	0.25	1.557e-6	4.895e-6	(A) Negative
MDK	11p11.2	0.05	-0.42	0.90	0.95	0.47	1.561e-6	4.907e-6	(A) Negative
NPAS2	2q11.2	-0.02	-0.55	1.07	0.79	0.53	1.561e-6	4.907e-6	(A) Negative
FCHO1	19p13.11	-1.10	-1.66	1.06	1.10	0.55	1.562e-6	4.910e-6	(A) Negative
GNS	12q14.3	0.45	0.73	0.53	0.58	-0.28	1.565e-6	4.918e-6	(B) Positive
RANGAP1	22q13.2	-0.47	-0.80	0.62	0.63	0.32	1.569e-6	4.928e-6	(A) Negative
SFRP2	4q31.3	2.04	2.78	1.39	1.56	-0.74	1.570e-6	4.931e-6	(B) Positive
CACNB4	2q23.3	-0.77	-0.25	0.99	1.06	-0.52	1.577e-6	4.951e-6	(B) Positive
TRIP4	15q22.31	0.20	0.42	0.43	0.39	-0.22	1.585e-6	4.977e-6	(B) Positive
SYTL3	6q25.3	2.42	2.04	0.75	0.73	0.39	1.616e-6	5.074e-6	(A) Negative
CCDC51	3p21.31	-0.35	-0.11	0.48	0.46	-0.25	1.620e-6	5.083e-6	(B) Positive
UBR7	14q32.12	-0.21	0.08	0.59	0.47	-0.29	1.621e-6	5.087e-6	(B) Positive
SLC30A9	4p13	-0.00	0.28	0.55	0.47	-0.28	1.630e-6	5.113e-6	(B) Positive
KRT13	17q21.2	1.78	0.86	1.72	1.94	0.92	1.632e-6	5.119e-6	(A) Negative
CRELD1	3p25.3	-0.25	0.08	0.65	0.57	-0.33	1.635e-6	5.126e-6	(B) Positive
CLPSL2	6p21.31	0.68	1.21	0.99	1.13	-0.53	1.635e-6	5.126e-6	(B) Positive
RGN	Xp11.3	-1.33	-1.97	1.29	1.07	0.65	1.636e-6	5.128e-6	(A) Negative
PIK3CD	1p36.22	0.25	-0.16	0.82	0.66	0.41	1.649e-6	5.170e-6	(A) Negative
IGFBP3	7p12.3	-1.80	-2.18	0.77	0.59	0.38	1.650e-6	5.172e-6	(A) Negative
ATPAF1	1p33	-0.41	-0.15	0.51	0.50	-0.26	1.653e-6	5.178e-6	(B) Positive
YPEL5	2p23.1	1.22	1.48	0.52	0.41	-0.26	1.658e-6	5.195e-6	(B) Positive
CFDP1	16q23.1	-0.50	-0.83	0.66	0.54	0.33	1.660e-6	5.199e-6	(A) Negative
HPS5	11p15.1	-0.09	-0.34	0.50	0.41	0.25	1.680e-6	5.261e-6	(A) Negative
OR51G2	11p15.4	0.73	0.57	0.33	0.27	0.16	1.686e-6	5.280e-6	(A) Negative
FBXO17	19q13.2	-1.00	-1.43	0.88	0.68	0.44	1.687e-6	5.282e-6	(A) Negative
TMEM170B	6p24.2	-0.98	-0.51	0.92	0.81	-0.47	1.693e-6	5.297e-6	(B) Positive
RILP	17p13.3	0.06	-0.26	0.63	0.60	0.32	1.693e-6	5.297e-6	(A) Negative
AKAP5	14q23.3	-0.84	-0.37	0.88	1.05	-0.48	1.706e-6	5.337e-6	(B) Positive
COP1	1q25.1-q25.2	0.78	0.53	0.50	0.41	0.25	1.709e-6	5.347e-6	(A) Negative
ZNF264	19q13.43	0.63	0.90	0.53	0.43	-0.26	1.711e-6	5.351e-6	(B) Positive
MAGEB1	Xp21.2	-0.47	-0.98	1.06	0.64	0.51	1.712e-6	5.354e-6	(A) Negative
ZNF48	16p11.2	0.23	0.52	0.57	0.48	-0.29	1.717e-6	5.368e-6	(B) Positive
PSMA4	15q25.1	-0.14	-0.38	0.46	0.44	0.23	1.733e-6	5.416e-6	(A) Negative
EID2B	19q13.2	-1.25	-0.89	0.73	0.66	-0.37	1.743e-6	5.448e-6	(B) Positive
UTP20	12q23.2	0.14	-0.32	0.94	0.68	0.46	1.744e-6	5.450e-6	(A) Negative
FAM218A	4q32.3	0.67	0.03	1.27	1.19	0.65	1.748e-6	5.461e-6	(A) Negative
NOP16	5q35.2	-0.64	-0.93	0.58	0.48	0.29	1.748e-6	5.461e-6	(A) Negative
KCNA2	1p13.3	0.19	-0.16	0.72	0.48	0.35	1.752e-6	5.472e-6	(A) Negative
KANK1	9p24.3	-0.08	-0.61	1.07	0.83	0.53	1.753e-6	5.474e-6	(A) Negative
BRMS1L	14q13.2	-0.28	-0.62	0.69	0.52	0.34	1.755e-6	5.480e-6	(A) Negative
TANC2	17q23.2-q23.3	-0.68	-0.30	0.72	0.72	-0.37	1.766e-6	5.513e-6	(B) Positive
POLA2	11q13.1	-0.99	-1.24	0.48	0.46	0.25	1.771e-6	5.526e-6	(A) Negative
POLN	4p16.3	0.34	0.68	0.64	0.70	-0.34	1.771e-6	5.526e-6	(B) Positive
ADGRG3	16q21	0.06	-0.11	0.29	0.42	0.17	1.773e-6	5.531e-6	(A) Negative
ANKRD27	19q13.11	0.17	-0.19	0.74	0.53	0.37	1.774e-6	5.534e-6	(A) Negative
HMGB2	4q34.1	-0.63	-1.03	0.78	0.80	0.41	1.780e-6	5.550e-6	(A) Negative
ZNF619	3p22.1	-0.11	0.18	0.57	0.51	-0.29	1.798e-6	5.605e-6	(B) Positive
GPAT4	8p11.21	-0.36	0.04	0.73	0.87	-0.39	1.799e-6	5.608e-6	(B) Positive
REPIN1	7q36.1	-0.46	-0.20	0.52	0.50	-0.27	1.822e-6	5.677e-6	(B) Positive
AVL9	7p14.3	-0.19	-0.51	0.64	0.59	0.33	1.822e-6	5.677e-6	(A) Negative
APBA3	19p13.3	0.18	-0.06	0.49	0.39	0.24	1.826e-6	5.688e-6	(A) Negative
CSTL1	20p11.21	0.06	0.44	0.66	0.97	-0.38	1.827e-6	5.691e-6	(B) Positive
EOGT	3p14.1	0.41	0.08	0.66	0.56	0.33	1.833e-6	5.709e-6	(A) Negative
PNLIPRP2	10q25.3	-0.74	0.34	2.10	2.11	-1.08	1.835e-6	5.713e-6	(B) Positive
TREM1	6p21.1	2.34	1.88	0.88	0.93	0.46	1.844e-6	5.740e-6	(A) Negative
TTLL11	9q33.2	0.37	0.65	0.55	0.51	-0.28	1.857e-6	5.780e-6	(B) Positive
HOXA3	7p15.2	-0.15	-0.61	0.94	0.71	0.46	1.857e-6	5.780e-6	(A) Negative
THRB	3p24.2	0.09	0.48	0.80	0.64	-0.40	1.864e-6	5.800e-6	(B) Positive
CCDC134	22q13.2	0.15	-0.13	0.54	0.51	0.27	1.865e-6	5.801e-6	(A) Negative
DFFA	1p36.22	-0.40	-0.64	0.49	0.33	0.24	1.871e-6	5.820e-6	(A) Negative
ZNF620	3p22.1	-0.67	-0.26	0.82	0.71	-0.41	1.872e-6	5.821e-6	(B) Positive
HEXB	5q13.3	-0.41	-0.10	0.61	0.55	-0.31	1.873e-6	5.823e-6	(B) Positive
MBTPS1	16q23.3-q24.1	-0.09	0.18	0.51	0.53	-0.26	1.881e-6	5.848e-6	(B) Positive
AZU1	19p13.3	-0.36	-0.09	0.53	0.56	-0.28	1.885e-6	5.860e-6	(B) Positive
POLR1C	6p21.1	0.12	-0.16	0.58	0.45	0.29	1.887e-6	5.864e-6	(A) Negative
ABCG4	11q23.3	-0.38	-0.61	0.47	0.37	0.23	1.887e-6	5.864e-6	(A) Negative
TBRG4	7p13	-0.60	-0.81	0.41	0.38	0.21	1.895e-6	5.886e-6	(A) Negative
AZGP1	7q22.1	2.67	3.40	1.49	1.04	-0.73	1.895e-6	5.886e-6	(B) Positive
OBP2A	9q34.3	2.19	1.39	1.57	1.56	0.81	1.900e-6	5.901e-6	(A) Negative
MFSD12	19p13.3	-0.90	-1.17	0.55	0.46	0.27	1.904e-6	5.912e-6	(A) Negative
RBMS2	12q13.3	0.52	0.31	0.43	0.33	0.21	1.914e-6	5.941e-6	(A) Negative
COL4A2	13q34	1.83	1.44	0.77	0.71	0.39	1.914e-6	5.941e-6	(A) Negative
TRIB2	2p24.3	-0.41	-0.86	0.87	0.87	0.45	1.917e-6	5.948e-6	(A) Negative
PDS5B	13q13.1	0.17	0.41	0.49	0.44	-0.25	1.926e-6	5.975e-6	(B) Positive
GPR84	12q13.13	2.69	2.16	1.07	0.87	0.53	1.927e-6	5.978e-6	(A) Negative
ZBP1	20q13.31	1.62	1.01	1.23	1.07	0.62	1.931e-6	5.987e-6	(A) Negative
LBH	2p23.1	1.46	1.15	0.62	0.56	0.31	1.931e-6	5.987e-6	(A) Negative
PDIA4	7q36.1	0.06	-0.28	0.68	0.54	0.34	1.933e-6	5.994e-6	(A) Negative
MTA2	11q12.3	0.50	0.21	0.55	0.57	0.29	1.935e-6	5.998e-6	(A) Negative
TCF15	20p13	-0.47	-1.08	1.23	0.93	0.60	1.936e-6	6.000e-6	(A) Negative
MFAP2	1p36.13	0.93	0.47	0.87	0.96	0.46	1.939e-6	6.009e-6	(A) Negative
APBA1	9q21.12	0.77	0.42	0.72	0.43	0.34	1.943e-6	6.019e-6	(A) Negative
CD247	1q24.2	-0.42	-1.17	1.47	1.38	0.75	1.943e-6	6.019e-6	(A) Negative
ACSL6	5q31.1	0.55	-0.00	1.15	0.69	0.55	1.955e-6	6.054e-6	(A) Negative
RBM43	2q23.3	-0.26	0.09	0.69	0.68	-0.35	1.962e-6	6.075e-6	(B) Positive
NPAS4	11q13.2	0.08	-0.06	0.29	0.23	0.14	1.965e-6	6.084e-6	(A) Negative
PRSS35	6q14.2	-0.35	0.07	0.82	0.86	-0.42	1.967e-6	6.090e-6	(B) Positive
GPAT3	4q21.23	-0.86	-1.41	1.10	0.92	0.55	1.970e-6	6.098e-6	(A) Negative
SMN1	5q13.2	-1.05	-0.78	0.54	0.50	-0.28	1.984e-6	6.140e-6	(B) Positive
SPA17	11q24.2	-0.38	0.07	0.88	0.89	-0.45	1.989e-6	6.153e-6	(B) Positive
SORT1	1p13.3	0.45	0.09	0.74	0.50	0.36	1.991e-6	6.159e-6	(A) Negative
FARSB	2q36.1	-0.49	-0.72	0.45	0.39	0.23	1.999e-6	6.181e-6	(A) Negative
PMP22	17p12	1.00	1.48	0.95	0.89	-0.48	2.009e-6	6.211e-6	(B) Positive
GLRA3	4q34.1	-1.40	-0.64	1.30	1.98	-0.75	2.009e-6	6.211e-6	(B) Positive
CCDC86	11q12.2	-0.89	-1.17	0.55	0.58	0.29	2.016e-6	6.233e-6	(A) Negative
SSR1	6p24.3	0.65	0.31	0.68	0.57	0.34	2.025e-6	6.259e-6	(A) Negative
SESN2	1p35.3	-0.97	-0.69	0.55	0.48	-0.27	2.037e-6	6.295e-6	(B) Positive
CCS	11q13.2	-0.18	0.07	0.49	0.48	-0.25	2.044e-6	6.314e-6	(B) Positive
USP18	22q11.2	1.51	1.05	0.90	0.91	0.46	2.044e-6	6.314e-6	(A) Negative
TYSND1	10q22.1	0.16	0.44	0.57	0.51	-0.28	2.045e-6	6.316e-6	(B) Positive
GATC	12q24.31	-1.03	-1.35	0.63	0.59	0.32	2.046e-6	6.319e-6	(A) Negative
ADRA2C	4p16.3	-2.28	-1.64	1.22	1.32	-0.64	2.057e-6	6.349e-6	(B) Positive
TRAPPC2B	19q13.43	0.26	0.52	0.51	0.48	-0.26	2.070e-6	6.390e-6	(B) Positive
LPAR2	19p13.11	1.10	0.83	0.51	0.54	0.27	2.076e-6	6.406e-6	(A) Negative
GLMP	1q22	0.52	0.23	0.60	0.50	0.30	2.081e-6	6.419e-6	(A) Negative
PRDX2	19p13.13	-0.18	0.12	0.61	0.50	-0.30	2.084e-6	6.429e-6	(B) Positive
MTFR1	8q13.1	0.14	-0.25	0.74	0.83	0.39	2.088e-6	6.441e-6	(A) Negative
NRDC	1p32.3	-0.23	-0.45	0.43	0.39	0.22	2.102e-6	6.483e-6	(A) Negative
KRTAP19-1	21q22.11	-0.07	-0.26	0.39	0.30	0.19	2.103e-6	6.484e-6	(A) Negative
RBM22	5q33.1	0.67	0.94	0.54	0.47	-0.27	2.130e-6	6.568e-6	(B) Positive
KLHL15	Xp22.11	-0.35	-0.61	0.54	0.45	0.27	2.144e-6	6.609e-6	(A) Negative
AMPD2	1p13.3	-0.84	-1.10	0.50	0.47	0.25	2.148e-6	6.620e-6	(A) Negative
C19ORF18	19q13.43	1.11	1.63	1.00	1.05	-0.52	2.151e-6	6.626e-6	(B) Positive
CEP63	3q22.2	-0.13	0.10	0.44	0.40	-0.22	2.159e-6	6.652e-6	(B) Positive
GTF3C2	2p23.3	-0.86	-1.19	0.67	0.53	0.33	2.164e-6	6.665e-6	(A) Negative
SURF6	9q34.2	-0.43	-0.67	0.47	0.42	0.24	2.185e-6	6.729e-6	(A) Negative
AMHR2	12q13.13	-2.41	-2.13	0.49	0.70	-0.28	2.188e-6	6.735e-6	(B) Positive
PDCD6IP	3p22.3	-0.17	0.11	0.56	0.45	-0.27	2.195e-6	6.756e-6	(B) Positive
PODXL2	3q21.3	-0.08	-0.56	0.91	1.03	0.48	2.195e-6	6.756e-6	(A) Negative
BSND	1p32.3	-2.00	-2.36	0.74	0.59	0.37	2.199e-6	6.766e-6	(A) Negative
RYK	3q22.2	0.74	0.48	0.55	0.39	0.27	2.199e-6	6.766e-6	(A) Negative
CRIP2	14q32.33	1.06	1.50	0.87	0.85	-0.44	2.200e-6	6.766e-6	(B) Positive
FBXW7	4q31.3	0.51	0.20	0.64	0.43	0.31	2.209e-6	6.794e-6	(A) Negative
POU5F1P3	12p13.31	-4.50	-4.85	0.73	0.48	0.35	2.221e-6	6.829e-6	(A) Negative
PYROXD1	12p12.1	0.49	0.13	0.72	0.59	0.36	2.226e-6	6.845e-6	(A) Negative
TMEM245	9q31.3	-0.28	-0.07	0.41	0.39	-0.21	2.233e-6	6.865e-6	(B) Positive
KCTD2	17q25.1	0.06	0.29	0.45	0.51	-0.24	2.238e-6	6.879e-6	(B) Positive
SPRTN	1q42.2	0.93	0.66	0.53	0.49	0.27	2.240e-6	6.882e-6	(A) Negative
C1QL4	12q13.12	0.33	-0.05	0.80	0.43	0.38	2.246e-6	6.900e-6	(A) Negative
BDP1	5q13.2	-0.18	0.19	0.75	0.66	-0.38	2.247e-6	6.902e-6	(B) Positive
MOCOS	18q12.2	-1.23	-1.89	1.33	1.13	0.66	2.267e-6	6.963e-6	(A) Negative
SPINK1	5q32	0.17	-0.67	1.68	1.43	0.83	2.271e-6	6.972e-6	(A) Negative
CSAG1	Xq28	-2.88	-3.61	1.49	1.03	0.72	2.271e-6	6.973e-6	(A) Negative
FMC1	7q34	0.11	-0.22	0.65	0.63	0.33	2.274e-6	6.981e-6	(A) Negative
LSM14B	20q13.33	0.45	0.12	0.65	0.63	0.33	2.280e-6	6.997e-6	(A) Negative
SMIM30	7q31.1	-0.32	-0.67	0.71	0.58	0.35	2.282e-6	7.003e-6	(A) Negative
SSH2	17q11.2	-1.09	-1.42	0.65	0.67	0.33	2.292e-6	7.031e-6	(A) Negative
GAPT	5q11.2	2.92	3.53	1.22	1.14	-0.61	2.309e-6	7.083e-6	(B) Positive
GRIK1	21q21.3	-0.28	0.10	0.56	1.21	-0.38	2.311e-6	7.086e-6	(B) Positive
SLC6A17	1p13.3	0.73	0.51	0.44	0.41	0.22	2.327e-6	7.136e-6	(A) Negative
EIF3L	22q13.1	0.22	-0.03	0.48	0.48	0.25	2.332e-6	7.148e-6	(A) Negative
HIC2	22q11.21	-2.30	-2.57	0.53	0.53	0.27	2.348e-6	7.196e-6	(A) Negative
PRPF6	20q13.33	0.09	0.33	0.46	0.48	-0.24	2.348e-6	7.196e-6	(B) Positive
KCTD14	11q14.1	0.10	-0.78	1.83	1.31	0.89	2.352e-6	7.205e-6	(A) Negative
CST4	20p11.21	0.80	1.41	1.19	1.22	-0.61	2.360e-6	7.230e-6	(B) Positive
LTB	6p21.33	3.70	3.00	1.39	1.38	0.71	2.366e-6	7.247e-6	(A) Negative
ZNF346	5q35.2	-0.37	-0.19	0.36	0.33	-0.18	2.368e-6	7.250e-6	(B) Positive
EFHD1	2q37.1	2.19	2.66	0.96	0.76	-0.47	2.370e-6	7.258e-6	(B) Positive
ATP6AP2	Xp11.4	0.23	0.49	0.51	0.54	-0.26	2.373e-6	7.266e-6	(B) Positive
SEMA5B	3q21.1	-0.05	-0.57	1.09	0.67	0.52	2.384e-6	7.296e-6	(A) Negative
MARCHF2	19p13.2	1.33	1.56	0.45	0.43	-0.23	2.389e-6	7.312e-6	(B) Positive
HTRA3	4p16.1	1.52	2.02	0.98	1.00	-0.50	2.392e-6	7.318e-6	(B) Positive
ZFHX3	16q22.2-q22.3	-0.09	0.30	0.78	0.63	-0.38	2.394e-6	7.324e-6	(B) Positive
ZSCAN26	6p22.1	-0.01	0.24	0.51	0.45	-0.25	2.408e-6	7.364e-6	(B) Positive
ZNF488	10q11.22	-0.41	-0.83	0.87	0.61	0.42	2.410e-6	7.368e-6	(A) Negative
AP3S2	15q26.1	0.24	0.49	0.50	0.48	-0.25	2.418e-6	7.392e-6	(B) Positive
TMTC3	12q21.32	0.57	0.85	0.56	0.56	-0.29	2.423e-6	7.405e-6	(B) Positive
SAMD4B	19q13.2	0.56	0.34	0.44	0.35	0.22	2.429e-6	7.424e-6	(A) Negative
RACGAP1P1	12q12	-1.55	-2.01	0.90	0.99	0.47	2.433e-6	7.435e-6	(A) Negative
ALG11	13q14.3	-0.54	-0.25	0.59	0.50	-0.29	2.433e-6	7.435e-6	(B) Positive
DDX49	19p13.11	0.31	0.06	0.50	0.40	0.25	2.434e-6	7.436e-6	(A) Negative
FAM86C1P	11q13.4	-0.42	-0.22	0.40	0.34	-0.20	2.436e-6	7.440e-6	(B) Positive
SPRED2	2p14	-0.14	0.30	0.92	0.58	-0.44	2.443e-6	7.459e-6	(B) Positive
LTB4R2	14q12	0.53	0.32	0.41	0.31	0.20	2.450e-6	7.479e-6	(A) Negative
PLPBP	8p11.23	0.19	0.53	0.65	0.77	-0.34	2.457e-6	7.500e-6	(B) Positive
CUEDC1	17q22	0.54	1.02	0.98	0.78	-0.48	2.460e-6	7.508e-6	(B) Positive
COL14A1	8q24.12	-0.38	0.29	1.32	1.37	-0.68	2.473e-6	7.547e-6	(B) Positive
PPIE	1p34.2	0.04	-0.19	0.45	0.46	0.23	2.476e-6	7.553e-6	(A) Negative
TOR1AIP2	1q25.2	0.75	0.48	0.53	0.48	0.27	2.485e-6	7.581e-6	(A) Negative
LINS1	15q26.3	-0.14	0.11	0.49	0.47	-0.25	2.503e-6	7.632e-6	(B) Positive
GPR34	Xp11.4	4.08	4.73	1.30	1.24	-0.66	2.509e-6	7.650e-6	(B) Positive
CNNM1	10q24.2	-0.19	-0.55	0.75	0.56	0.36	2.524e-6	7.695e-6	(A) Negative
TOM1L1	17q22	0.04	0.46	0.83	0.87	-0.43	2.538e-6	7.736e-6	(B) Positive
SLC16A13	17p13.1	0.18	-0.02	0.42	0.36	0.21	2.541e-6	7.743e-6	(A) Negative
CD27	12p13.31	3.47	3.02	0.86	0.98	0.45	2.557e-6	7.792e-6	(A) Negative
TSR3	16p13.3	0.29	0.52	0.47	0.47	-0.24	2.570e-6	7.830e-6	(B) Positive
ABCC5	3q27.1	0.07	0.41	0.62	0.83	-0.34	2.576e-6	7.847e-6	(B) Positive
TOR1AIP1	1q25.2	0.36	0.59	0.46	0.45	-0.23	2.581e-6	7.860e-6	(B) Positive
INTS7	1q32.3	0.02	-0.22	0.48	0.54	0.25	2.594e-6	7.898e-6	(A) Negative
CCNL2	1p36.33	-1.13	-0.92	0.42	0.45	-0.22	2.595e-6	7.901e-6	(B) Positive
GPR108	19p13.3	0.28	0.51	0.47	0.42	-0.23	2.609e-6	7.941e-6	(B) Positive
ZNF254	19p13	-0.21	0.14	0.71	0.59	-0.35	2.610e-6	7.942e-6	(B) Positive
S100A7	1q21.3	1.55	0.19	2.73	2.52	1.36	2.613e-6	7.950e-6	(A) Negative
FZD5	2q33.3	-1.24	-1.66	0.88	0.69	0.43	2.615e-6	7.956e-6	(A) Negative
SYN2	3p25.2	0.08	-0.41	1.05	0.58	0.50	2.635e-6	8.016e-6	(A) Negative
TAP2	6p21.32	0.47	0.14	0.69	0.54	0.34	2.639e-6	8.027e-6	(A) Negative
EDN2	1p34.2	2.97	2.17	1.57	1.63	0.80	2.650e-6	8.057e-6	(A) Negative
IL17RD	3p14.3	0.46	-0.17	1.29	0.96	0.62	2.660e-6	8.086e-6	(A) Negative
LINC01711	20q13.32	-0.46	0.05	1.03	0.96	-0.51	2.674e-6	8.128e-6	(B) Positive
TLR2	4q31.3	3.65	3.22	0.86	0.75	0.43	2.687e-6	8.166e-6	(A) Negative
GJD4	10p11.21	0.31	0.16	0.30	0.27	0.15	2.699e-6	8.200e-6	(A) Negative
SRRM1	1p36.11	-0.07	-0.32	0.51	0.45	0.25	2.708e-6	8.227e-6	(A) Negative
TMEM39A	3q13.33	0.61	0.38	0.49	0.37	0.24	2.714e-6	8.245e-6	(A) Negative
FGF20	8p22	0.44	0.86	0.84	0.76	-0.42	2.720e-6	8.259e-6	(B) Positive
RIT2	18q12.3	-0.22	0.03	0.49	0.50	-0.25	2.726e-6	8.277e-6	(B) Positive
PABPC4	1p34.3	-0.71	-1.07	0.72	0.75	0.37	2.730e-6	8.289e-6	(A) Negative
RAPGEFL1	17q21.1	-0.58	0.00	1.12	1.22	-0.58	2.733e-6	8.295e-6	(B) Positive
WFIKKN1	16p13.3	-2.14	-1.67	0.89	1.02	-0.47	2.738e-6	8.309e-6	(B) Positive
TRMT9B	8p22	0.37	0.84	0.88	1.12	-0.47	2.754e-6	8.357e-6	(B) Positive
KNTC1	12q24.31	-1.84	-2.16	0.64	0.65	0.32	2.756e-6	8.362e-6	(A) Negative
VCAM1	1p21.2	2.01	1.46	1.12	0.89	0.55	2.757e-6	8.362e-6	(A) Negative
CNTNAP1	17q21.2	-1.68	-1.48	0.37	0.43	-0.20	2.759e-6	8.368e-6	(B) Positive
SERF1A	5q13.2	-0.27	0.05	0.64	0.60	-0.32	2.766e-6	8.388e-6	(B) Positive
ZNF8	19q13.43	0.31	0.05	0.53	0.45	0.26	2.773e-6	8.408e-6	(A) Negative
WASF1	6q21	-0.99	-1.53	1.09	1.03	0.55	2.775e-6	8.411e-6	(A) Negative
FERD3L	7p21.1	0.16	0.01	0.30	0.27	0.15	2.784e-6	8.435e-6	(A) Negative
TAF1A	1q41	-0.73	-1.03	0.61	0.54	0.30	2.784e-6	8.435e-6	(A) Negative
NDUFC2	11q14.1	0.54	0.89	0.68	0.74	-0.35	2.792e-6	8.459e-6	(B) Positive
NUTM1	15q14	0.19	-0.22	0.87	0.53	0.41	2.803e-6	8.490e-6	(A) Negative
XRCC6	22q13.2	-0.05	-0.29	0.49	0.40	0.24	2.810e-6	8.509e-6	(A) Negative
SAXO4	11q12.2	0.15	0.43	0.55	0.56	-0.28	2.814e-6	8.520e-6	(B) Positive
MIR7-3HG	19p13.3	-0.11	0.16	0.42	0.83	-0.27	2.818e-6	8.532e-6	(B) Positive
ZC2HC1C	14q24.3	0.60	0.88	0.55	0.59	-0.28	2.825e-6	8.552e-6	(B) Positive
DYNLT3	Xp11.4	-0.52	-0.21	0.62	0.55	-0.31	2.841e-6	8.596e-6	(B) Positive
MAGI3	1p13.2	1.29	1.74	0.89	0.86	-0.45	2.871e-6	8.685e-6	(B) Positive
CHDH	3p21.1	-0.01	0.38	0.72	0.88	-0.38	2.871e-6	8.685e-6	(B) Positive
POSTN	13q13.3	4.03	4.69	1.30	1.33	-0.66	2.876e-6	8.698e-6	(B) Positive
DPYS	8q22.3	0.86	0.58	0.56	0.53	0.28	2.885e-6	8.723e-6	(A) Negative
ATP8B1	18q21.31	1.16	1.54	0.77	0.66	-0.38	2.890e-6	8.737e-6	(B) Positive
FIGLA	2p13.3	0.60	0.21	0.81	0.63	0.40	2.902e-6	8.773e-6	(A) Negative
C8ORF34	8q13.2	0.76	1.19	0.67	1.32	-0.43	2.903e-6	8.774e-6	(B) Positive
OR10A2	11p15.4	0.35	0.20	0.32	0.29	0.16	2.904e-6	8.774e-6	(A) Negative
PABPC5	Xq21.31	0.43	0.76	0.59	0.88	-0.33	2.904e-6	8.774e-6	(B) Positive
EIF2S2	20q11.22	-0.39	-0.66	0.57	0.50	0.28	2.918e-6	8.814e-6	(A) Negative
ARAP2	4p14	1.14	0.71	0.87	0.81	0.43	2.920e-6	8.820e-6	(A) Negative
MR1	1q25.3	0.06	0.41	0.71	0.68	-0.36	2.928e-6	8.842e-6	(B) Positive
OTOA	16p12.2	0.70	0.98	0.57	0.46	-0.28	2.934e-6	8.857e-6	(B) Positive
RNF214	11q23.3	-0.48	-0.72	0.50	0.44	0.25	2.940e-6	8.876e-6	(A) Negative
PSMD2	3q27.1	-0.23	-0.51	0.57	0.50	0.28	2.941e-6	8.877e-6	(A) Negative
RASL10B	17q12	-1.16	-1.49	0.68	0.51	0.33	2.951e-6	8.904e-6	(A) Negative
MAGEA5P	Xq28	-1.52	-2.06	1.14	0.70	0.54	2.959e-6	8.928e-6	(A) Negative
ARL8B	3p26.1	0.33	0.58	0.52	0.42	-0.25	2.960e-6	8.931e-6	(B) Positive
AGER	6p21.32	-1.05	-1.22	0.34	0.38	0.18	2.967e-6	8.948e-6	(A) Negative
LDB2	4p15.32	0.47	0.84	0.74	0.71	-0.37	2.970e-6	8.955e-6	(B) Positive
USP12	13q12.13	-0.12	-0.40	0.58	0.50	0.28	2.972e-6	8.960e-6	(A) Negative
ARHGAP27	17q21.31	0.41	0.15	0.51	0.54	0.26	2.985e-6	8.998e-6	(A) Negative
SART1	11q13.1	-0.21	-0.42	0.40	0.41	0.20	2.985e-6	8.998e-6	(A) Negative
PTPN21	14q31.3	0.18	-0.16	0.67	0.63	0.33	2.991e-6	9.013e-6	(A) Negative
SH3BP2	4p16.3	0.82	0.66	0.32	0.29	0.16	3.014e-6	9.082e-6	(A) Negative
CHRNA9	4p14	-3.71	-3.15	0.79	1.89	-0.56	3.019e-6	9.094e-6	(B) Positive
ZNF407	18q23	0.80	1.02	0.40	0.51	-0.21	3.025e-6	9.112e-6	(B) Positive
IL6	7p15.3	-0.78	-1.50	1.38	1.57	0.72	3.034e-6	9.135e-6	(A) Negative
TMEM249	8q24.3	0.31	-0.17	0.96	0.88	0.48	3.037e-6	9.142e-6	(A) Negative
NECTIN4	1q23.3	3.65	3.23	0.82	0.83	0.41	3.037e-6	9.142e-6	(A) Negative
RHBDL3	17q11.2	-1.45	-0.77	1.35	1.41	-0.69	3.041e-6	9.152e-6	(B) Positive
RFXAP	13q13.3	-0.82	-1.17	0.72	0.62	0.35	3.067e-6	9.229e-6	(A) Negative
SH3BP5L	1q44	0.50	0.22	0.56	0.54	0.28	3.081e-6	9.269e-6	(A) Negative
GSE1	16q24.1	-0.45	-0.11	0.70	0.61	-0.34	3.081e-6	9.269e-6	(B) Positive
BSCL2	11q12.3	0.19	0.49	0.61	0.57	-0.30	3.083e-6	9.273e-6	(B) Positive
KCNN3	1q21.3	-0.68	-1.15	0.99	0.71	0.48	3.087e-6	9.282e-6	(A) Negative
TUBA3FP	22q11.21	-1.84	-1.58	0.48	0.62	-0.26	3.088e-6	9.284e-6	(B) Positive
CEP192	18p11.21	-0.47	-0.75	0.59	0.47	0.28	3.092e-6	9.294e-6	(A) Negative
FNBP4	11p11.2	-0.85	-1.08	0.47	0.41	0.23	3.093e-6	9.295e-6	(A) Negative
PAPOLG	2p16.1	0.57	0.34	0.47	0.41	0.23	3.103e-6	9.325e-6	(A) Negative
IGSF21	1p36.13	0.36	1.02	1.28	1.46	-0.66	3.110e-6	9.343e-6	(B) Positive
KIR2DS4	19q13.42	0.52	0.35	0.34	0.26	0.17	3.116e-6	9.361e-6	(A) Negative
CIRBP-AS1	19p13.3	0.71	0.45	0.55	0.40	0.26	3.137e-6	9.422e-6	(A) Negative
SEC61G	7p11.2	-0.43	-0.86	0.88	0.66	0.42	3.142e-6	9.436e-6	(A) Negative
CRELD2	22q13.33	0.82	0.52	0.60	0.58	0.30	3.151e-6	9.460e-6	(A) Negative
TNFRSF4	1p36.33	3.08	2.67	0.83	0.71	0.41	3.154e-6	9.469e-6	(A) Negative
OSR1	2p24.1	0.88	0.05	1.73	1.33	0.83	3.162e-6	9.491e-6	(A) Negative
TOX2	20q13.12	-2.28	-2.74	0.95	0.85	0.47	3.163e-6	9.491e-6	(A) Negative
TINCR	19p13.3	0.58	-0.31	1.78	1.67	0.89	3.167e-6	9.501e-6	(A) Negative
IKZF5	10q26.13	0.20	0.51	0.64	0.47	-0.31	3.183e-6	9.548e-6	(B) Positive
ADRA2B	2q11.2	0.33	0.02	0.64	0.47	0.31	3.209e-6	9.623e-6	(A) Negative
AIFM3	22q11.21	-0.51	-0.18	0.64	0.76	-0.33	3.209e-6	9.623e-6	(B) Positive
GOLGA2P5	12q23.1	-0.04	0.24	0.56	0.50	-0.27	3.221e-6	9.657e-6	(B) Positive
ARMH3	10q24.32	0.28	0.44	0.33	0.27	-0.16	3.229e-6	9.681e-6	(B) Positive
ZNF700	19p13.2	-0.92	-0.64	0.57	0.54	-0.28	3.245e-6	9.725e-6	(B) Positive
PSMC6	14q22.1	-0.61	-0.37	0.49	0.43	-0.24	3.250e-6	9.740e-6	(B) Positive
LIN37	19q13.12	0.66	0.44	0.44	0.44	0.22	3.257e-6	9.758e-6	(A) Negative
CENPV	17p11.2	-2.00	-2.60	1.20	1.12	0.60	3.263e-6	9.774e-6	(A) Negative
CCL15	17q12	1.04	1.40	0.71	0.69	-0.35	3.264e-6	9.775e-6	(B) Positive
SAPCD1	6p21.33	-2.13	-2.43	0.60	0.58	0.30	3.266e-6	9.781e-6	(A) Negative
PTH1R	3p21.31	-1.75	-1.38	0.73	0.77	-0.37	3.281e-6	9.824e-6	(B) Positive
BLNK	10q24.1	0.97	1.39	0.88	0.73	-0.43	3.315e-6	9.923e-6	(B) Positive
ANKFN1	17q22	-1.03	-0.74	0.50	0.82	-0.29	3.316e-6	9.924e-6	(B) Positive
FRMD5	15q15.3	-1.61	-2.32	1.50	0.96	0.71	3.318e-6	9.929e-6	(A) Negative
LSM5	7p14.3	-0.70	-0.96	0.53	0.45	0.26	3.319e-6	9.932e-6	(A) Negative
COPS7B	2q37.1	-0.23	-0.46	0.48	0.41	0.24	3.328e-6	9.956e-6	(A) Negative
CARD17P	11q22.3	0.98	0.46	1.07	0.89	0.52	3.329e-6	9.958e-6	(A) Negative
ARPC2	2q35	0.39	0.17	0.44	0.41	0.22	3.336e-6	9.974e-6	(A) Negative
E2F5	8q21.2	0.30	-0.16	0.94	0.87	0.46	3.336e-6	9.974e-6	(A) Negative
NAP1L3	Xq21.32	-0.73	-0.21	1.05	1.00	-0.52	3.343e-6	9.994e-6	(B) Positive
RUNDC3A	17q21.31	0.21	0.45	0.37	0.73	-0.24	3.347e-6	1.000e-5	(B) Positive
TMCO5A	15q14	0.57	0.33	0.52	0.36	0.25	3.352e-6	1.002e-5	(A) Negative
SERPINB2	18q21.33-q22.1	-4.05	-4.79	1.59	0.83	0.74	3.371e-6	1.007e-5	(A) Negative
RANGRF	17p13.1	-0.74	-0.41	0.66	0.68	-0.33	3.400e-6	1.016e-5	(B) Positive
GPC4	Xq26.2	-0.16	0.51	1.35	1.33	-0.67	3.404e-6	1.017e-5	(B) Positive
USP20	9q34.2	-0.93	-0.74	0.37	0.39	-0.19	3.408e-6	1.018e-5	(B) Positive
P4HA3	11q13.4	2.38	2.86	0.99	0.85	-0.48	3.417e-6	1.020e-5	(B) Positive
SLC2A3	12p13.31	-2.59	-2.93	0.68	0.63	0.34	3.418e-6	1.020e-5	(A) Negative
AP1AR	4q25	0.28	0.60	0.65	0.58	-0.32	3.427e-6	1.023e-5	(B) Positive
KL	13q13.1	1.44	1.82	0.71	0.96	-0.38	3.434e-6	1.025e-5	(B) Positive
DPH6	15q14	-0.43	-0.16	0.54	0.55	-0.27	3.438e-6	1.026e-5	(B) Positive
PRKCI	3q26.2	0.58	0.23	0.73	0.65	0.36	3.438e-6	1.026e-5	(A) Negative
HAUS4	14q11.2	-0.74	-0.46	0.57	0.45	-0.27	3.442e-6	1.027e-5	(B) Positive
SNRPD3	22q11.23	0.07	-0.17	0.49	0.50	0.25	3.457e-6	1.031e-5	(A) Negative
SMCHD1	18p11.32	-0.11	-0.42	0.62	0.56	0.31	3.469e-6	1.034e-5	(A) Negative
UNC119	17q11.2	-0.03	0.26	0.58	0.54	-0.29	3.487e-6	1.039e-5	(B) Positive
LIME1	20q13.33	-0.71	-0.97	0.54	0.49	0.27	3.489e-6	1.040e-5	(A) Negative
PRDM15	21q22.3	-0.56	-0.74	0.36	0.34	0.18	3.499e-6	1.043e-5	(A) Negative
ERI3	1p34.1	-0.24	-0.55	0.61	0.61	0.31	3.508e-6	1.045e-5	(A) Negative
HSF2	6q22.31	-0.39	-0.71	0.67	0.46	0.32	3.512e-6	1.046e-5	(A) Negative
AQP7P2	9q13	0.18	0.64	0.85	1.18	-0.46	3.539e-6	1.054e-5	(B) Positive
SELENOT	3q25.1	-0.11	0.20	0.62	0.51	-0.30	3.539e-6	1.054e-5	(B) Positive
BTF3L4	1p32.3	-0.04	-0.24	0.41	0.42	0.21	3.553e-6	1.058e-5	(A) Negative
FAN1	15q13.3	-0.23	-0.03	0.41	0.40	-0.20	3.556e-6	1.059e-5	(B) Positive
SLC25A24	1p13.3	-0.06	0.29	0.70	0.64	-0.34	3.557e-6	1.059e-5	(B) Positive
COL13A1	10q22.1	-0.26	-0.80	1.14	0.86	0.54	3.557e-6	1.059e-5	(A) Negative
TANGO2	22q11.21	-0.41	-0.14	0.52	0.60	-0.27	3.584e-6	1.067e-5	(B) Positive
GRIPAP1	Xp11.23	0.03	0.25	0.44	0.40	-0.22	3.587e-6	1.067e-5	(B) Positive
GFPT1	2p13.3	0.48	0.17	0.63	0.58	0.31	3.598e-6	1.070e-5	(A) Negative
IQCB1	3q13.33	-0.37	-0.68	0.66	0.49	0.31	3.602e-6	1.071e-5	(A) Negative
TFRC	3q29	-1.47	-2.02	1.13	0.98	0.55	3.632e-6	1.080e-5	(A) Negative
WDR64	1q43	0.44	0.15	0.59	0.54	0.29	3.647e-6	1.084e-5	(A) Negative
EPB41L1	20q11.23	0.51	0.87	0.73	0.66	-0.36	3.674e-6	1.092e-5	(B) Positive
TNN	1q25.1	2.79	3.64	1.73	1.56	-0.85	3.680e-6	1.094e-5	(B) Positive
STN1	10q24.33	-0.16	0.13	0.60	0.44	-0.29	3.701e-6	1.100e-5	(B) Positive
SPNS3	17p13.2	-0.86	-1.14	0.58	0.52	0.28	3.703e-6	1.100e-5	(A) Negative
CLK1	2q33.1	-0.02	0.28	0.61	0.61	-0.31	3.705e-6	1.101e-5	(B) Positive
IPO8	12p11.21	0.36	0.09	0.56	0.43	0.27	3.718e-6	1.104e-5	(A) Negative
CYTH2	19q13.33	0.53	0.82	0.60	0.59	-0.30	3.725e-6	1.106e-5	(B) Positive
TMEM204	16p13.3	4.19	4.60	0.82	0.77	-0.40	3.730e-6	1.107e-5	(B) Positive
EPB41L3	18p11.31	-0.61	-0.07	1.11	1.05	-0.55	3.737e-6	1.109e-5	(B) Positive
PDIA2	16p13.3	-2.71	-3.34	1.39	0.72	0.64	3.743e-6	1.111e-5	(A) Negative
CRABP2	1q23.1	0.83	1.53	1.47	1.05	-0.70	3.749e-6	1.112e-5	(B) Positive
FAXC	6q16.2	1.08	0.56	1.09	0.83	0.52	3.753e-6	1.113e-5	(A) Negative
SPRED1	15q14	0.28	-0.05	0.64	0.72	0.33	3.759e-6	1.115e-5	(A) Negative
FOXD3	1p31.3	0.76	0.55	0.42	0.44	0.21	3.763e-6	1.116e-5	(A) Negative
CTNNA1	5q31.2	0.41	0.63	0.45	0.38	-0.22	3.782e-6	1.121e-5	(B) Positive
NUP85	17q25.1	-0.27	-0.51	0.47	0.53	0.24	3.783e-6	1.121e-5	(A) Negative
LIPA	10q23.31	0.64	0.99	0.72	0.67	-0.35	3.809e-6	1.129e-5	(B) Positive
POM121L9P	22q11.23	-0.46	-0.27	0.38	0.43	-0.19	3.815e-6	1.131e-5	(B) Positive
KRTAP3-3	17q21.2	0.38	0.79	0.72	1.13	-0.41	3.820e-6	1.132e-5	(B) Positive
DPYSL2	8p21.2	-0.06	-0.42	0.74	0.65	0.36	3.827e-6	1.134e-5	(A) Negative
CCDC137	17q25.3	-0.31	-0.64	0.67	0.62	0.33	3.855e-6	1.142e-5	(A) Negative
GOLGA2P2Y	Yq11.23	-0.74	-1.14	0.82	0.69	0.40	3.875e-6	1.148e-5	(A) Negative
MT1G	16q13	-0.07	-0.60	1.09	0.93	0.53	3.879e-6	1.148e-5	(A) Negative
RHOT1	17q11.2	-0.02	0.17	0.38	0.39	-0.19	3.884e-6	1.150e-5	(B) Positive
TMEM179	14q32.33	0.11	-0.09	0.42	0.34	0.20	3.910e-6	1.157e-5	(A) Negative
TCAF2	7q35	0.54	0.18	0.74	0.62	0.36	3.917e-6	1.159e-5	(A) Negative
GPR88	1p21.2	0.46	0.81	0.56	1.07	-0.35	3.918e-6	1.159e-5	(B) Positive
BNIP1	5q35.1	0.41	0.65	0.49	0.41	-0.24	3.935e-6	1.164e-5	(B) Positive
F13A1	6p25.1	4.01	4.51	1.03	0.91	-0.50	3.942e-6	1.166e-5	(B) Positive
SLC25A40	7q21.12	-0.75	-1.05	0.60	0.60	0.30	3.963e-6	1.172e-5	(A) Negative
NCKIPSD	3p21.31	-0.84	-0.63	0.44	0.43	-0.22	3.963e-6	1.172e-5	(B) Positive
TCEAL7	Xq22.2	2.16	2.66	0.98	1.12	-0.50	3.969e-6	1.173e-5	(B) Positive
RPRM	2q23.3	-1.93	-2.48	1.19	0.76	0.56	3.972e-6	1.174e-5	(A) Negative
RMI2	16p13.13	-0.96	-1.41	0.89	0.94	0.45	3.972e-6	1.174e-5	(A) Negative
CRYZ	1p31.1	-0.62	-0.24	0.75	0.76	-0.37	3.986e-6	1.178e-5	(B) Positive
MTFP1	22q12.2	-0.29	-0.61	0.63	0.61	0.31	4.003e-6	1.183e-5	(A) Negative
BAG6	6p21.33	-0.24	-0.45	0.43	0.35	0.20	4.013e-6	1.185e-5	(A) Negative
GAL3ST1	22q12.2	-1.26	-1.70	0.92	0.62	0.43	4.035e-6	1.192e-5	(A) Negative
CLCN7	16p13.3	-0.08	0.20	0.56	0.57	-0.28	4.068e-6	1.201e-5	(B) Positive
CLPS	6p21.31	0.89	0.52	0.80	0.51	0.37	4.070e-6	1.202e-5	(A) Negative
HECTD4	12q24.13	0.24	0.63	0.79	0.77	-0.39	4.117e-6	1.215e-5	(B) Positive
ANXA6	5q33.1	-1.06	-0.62	0.90	0.87	-0.44	4.149e-6	1.224e-5	(B) Positive
SULF2	20q13.12	-0.50	0.09	1.19	1.17	-0.59	4.154e-6	1.226e-5	(B) Positive
SLC7A11	4q28.3	-1.90	-2.36	0.92	0.98	0.46	4.157e-6	1.227e-5	(A) Negative
WDR46	6p21.32	-0.62	-0.79	0.36	0.33	0.17	4.159e-6	1.227e-5	(A) Negative
DZANK1	20p11.23	0.86	1.21	0.73	0.53	-0.34	4.176e-6	1.232e-5	(B) Positive
BCLAF3	Xp22.12	0.89	1.15	0.53	0.45	-0.26	4.189e-6	1.235e-5	(B) Positive
UBA7	3p21.31	0.94	1.35	0.86	0.72	-0.41	4.245e-6	1.252e-5	(B) Positive
PPP1R21	2p16.3	0.13	-0.10	0.50	0.35	0.24	4.263e-6	1.257e-5	(A) Negative
COX4I2	20q11.21	1.52	1.81	0.58	0.59	-0.29	4.277e-6	1.261e-5	(B) Positive
NUDT22	11q13.1	-0.28	-0.04	0.49	0.46	-0.24	4.287e-6	1.263e-5	(B) Positive
ITGB1BP1	2p25.1	-0.58	-0.88	0.61	0.52	0.29	4.307e-6	1.269e-5	(A) Negative
SLC22A10	11q12.3	0.15	0.32	0.28	0.49	-0.16	4.317e-6	1.272e-5	(B) Positive
SANBR	2p15	0.34	-0.06	0.85	0.60	0.40	4.328e-6	1.275e-5	(A) Negative
PPEF1	Xp22.13	1.76	2.37	1.28	1.04	-0.61	4.337e-6	1.277e-5	(B) Positive
ARMCX3	Xq22.1	0.71	1.01	0.61	0.61	-0.30	4.338e-6	1.277e-5	(B) Positive
TAT	16q22.2	0.33	0.68	0.57	1.07	-0.35	4.338e-6	1.277e-5	(B) Positive
ZNF615	19q13.41	0.95	1.29	0.70	0.65	-0.34	4.363e-6	1.284e-5	(B) Positive
GOLGA2P7	15q25.2	-0.31	-0.82	1.08	0.88	0.52	4.371e-6	1.286e-5	(A) Negative
ADAL	15q15.3	-1.14	-0.81	0.68	0.60	-0.33	4.400e-6	1.295e-5	(B) Positive
VSTM2A	7p11.2	0.32	0.76	0.66	1.44	-0.44	4.406e-6	1.296e-5	(B) Positive
DHDH	19q13.33	0.15	-0.47	1.31	0.99	0.62	4.442e-6	1.307e-5	(A) Negative
STXBP6	14q11.2	-1.66	-2.48	1.80	0.96	0.82	4.448e-6	1.308e-5	(A) Negative
ADPRHL1	13q34	0.66	1.10	0.89	0.83	-0.44	4.453e-6	1.309e-5	(B) Positive
DHX33	17p13.2	-0.69	-1.01	0.68	0.44	0.32	4.472e-6	1.315e-5	(A) Negative
PES1	22q12.2	-0.19	-0.42	0.45	0.48	0.23	4.487e-6	1.319e-5	(A) Negative
OR6X1	11q24.1	1.14	0.58	1.22	0.75	0.56	4.515e-6	1.327e-5	(A) Negative
RPS6KB1	17q23.1	-1.08	-0.79	0.58	0.66	-0.30	4.533e-6	1.332e-5	(B) Positive
KXD1	19p13.11	-0.24	-0.45	0.45	0.32	0.21	4.545e-6	1.335e-5	(A) Negative
FKBP14	7p14.3	-0.54	-0.87	0.65	0.73	0.33	4.549e-6	1.336e-5	(A) Negative
PIM2	Xp11.23	-1.29	-1.77	1.01	0.74	0.47	4.585e-6	1.346e-5	(A) Negative
CNOT2	12q15	0.23	0.45	0.45	0.39	-0.22	4.589e-6	1.347e-5	(B) Positive
ELAVL2	9p21.3	1.12	0.48	1.37	0.91	0.64	4.590e-6	1.348e-5	(A) Negative
TFEB	6p21.1	1.72	1.39	0.71	0.53	0.33	4.597e-6	1.349e-5	(A) Negative
IL6-AS1	7p15.3	0.26	0.08	0.35	0.38	0.18	4.600e-6	1.350e-5	(A) Negative
S100G	Xp22.2	0.13	0.73	1.03	1.76	-0.60	4.648e-6	1.364e-5	(B) Positive
STC1	8p21.2	-0.20	0.35	0.99	1.44	-0.54	4.656e-6	1.366e-5	(B) Positive
IGHMBP2	11q13.3	-0.77	-0.50	0.51	0.70	-0.27	4.684e-6	1.374e-5	(B) Positive
HOXB3	17q21.32	-0.07	0.58	1.33	1.22	-0.64	4.700e-6	1.378e-5	(B) Positive
DHX30	3p21.31	-0.49	-0.29	0.39	0.38	-0.19	4.715e-6	1.383e-5	(B) Positive
ERG	21q22.2	0.36	0.60	0.50	0.47	-0.24	4.745e-6	1.391e-5	(B) Positive
ZNF148	3q21.2	0.28	0.54	0.55	0.39	-0.26	4.760e-6	1.395e-5	(B) Positive
PIK3R4	3q22.1	0.03	0.26	0.48	0.38	-0.23	4.766e-6	1.397e-5	(B) Positive
RBM33	7q36.3	-0.22	-0.47	0.53	0.46	0.25	4.777e-6	1.400e-5	(A) Negative
SLC2A14	12p13.31	-0.96	-1.21	0.49	0.50	0.24	4.799e-6	1.406e-5	(A) Negative
TRMT61A	14q32.33	0.39	0.16	0.46	0.44	0.22	4.810e-6	1.409e-5	(A) Negative
MKX	10p12.1	-0.39	0.35	1.33	2.01	-0.74	4.844e-6	1.419e-5	(B) Positive
TAF6L	11q12.3	0.14	-0.08	0.44	0.40	0.21	4.864e-6	1.424e-5	(A) Negative
ASAP2	2p25.1	-0.10	-0.43	0.70	0.61	0.34	4.894e-6	1.433e-5	(A) Negative
CMTM5	14q11.2	0.61	0.05	1.25	0.56	0.56	4.898e-6	1.434e-5	(A) Negative
ARAF	Xp11.3	-0.38	-0.09	0.58	0.65	-0.29	4.963e-6	1.453e-5	(B) Positive
EMCN	4q24	3.97	4.37	0.82	0.83	-0.40	4.984e-6	1.458e-5	(B) Positive
FPGT	1p31.1	1.09	1.37	0.58	0.50	-0.28	4.997e-6	1.462e-5	(B) Positive
PCOLCE2	3q23	-2.61	-3.55	1.90	1.93	0.94	5.009e-6	1.465e-5	(A) Negative
NFIX	19p13.13	0.92	0.45	0.96	0.93	0.47	5.014e-6	1.466e-5	(A) Negative
IFT172	2p23.3	0.63	0.35	0.58	0.52	0.28	5.017e-6	1.467e-5	(A) Negative
STX6	1q25.3	1.06	0.72	0.72	0.55	0.34	5.019e-6	1.468e-5	(A) Negative
DEAF1	11p15.5	-0.15	0.09	0.47	0.48	-0.23	5.026e-6	1.469e-5	(B) Positive
LCE1A	1q21.3	0.92	0.70	0.45	0.47	0.22	5.031e-6	1.471e-5	(A) Negative
FAM210B	20q13.2	0.48	0.17	0.63	0.60	0.31	5.039e-6	1.473e-5	(A) Negative
MUL1	1p36.12	-0.16	0.07	0.47	0.48	-0.23	5.041e-6	1.473e-5	(B) Positive
SMPDL3B	1p35.3	1.42	0.99	0.85	0.92	0.43	5.044e-6	1.473e-5	(A) Negative
RSPH6A	19q13.3	0.41	0.25	0.33	0.28	0.16	5.060e-6	1.478e-5	(A) Negative
TMUB2	17q21.31	0.09	0.28	0.37	0.43	-0.19	5.064e-6	1.479e-5	(B) Positive
STX8	17p13.1	-0.11	0.11	0.46	0.45	-0.23	5.078e-6	1.483e-5	(B) Positive
PDCL2	4q12	-0.56	-1.02	0.99	0.62	0.45	5.096e-6	1.488e-5	(A) Negative
PRELID3A	18p11.21	-0.03	-0.49	0.97	0.77	0.46	5.104e-6	1.490e-5	(A) Negative
GRM4	6p21.31	0.30	0.57	0.48	0.74	-0.27	5.123e-6	1.495e-5	(B) Positive
EIF3D	22q12.3	0.19	-0.00	0.40	0.39	0.20	5.135e-6	1.498e-5	(A) Negative
APBB1	11p15.4	-0.06	0.23	0.57	0.62	-0.28	5.186e-6	1.513e-5	(B) Positive
SLC44A5	1p31.1	-0.10	0.52	1.26	1.34	-0.63	5.195e-6	1.515e-5	(B) Positive
INSL5	1p31.3	0.39	0.68	0.55	0.71	-0.29	5.199e-6	1.516e-5	(B) Positive
DHX36	3q25.2	-0.44	-0.71	0.58	0.38	0.27	5.200e-6	1.516e-5	(A) Negative
RAB3IP	12q15	0.17	0.58	0.85	0.79	-0.41	5.208e-6	1.518e-5	(B) Positive
EXOSC8	13q13.3	-1.23	-1.53	0.64	0.48	0.30	5.210e-6	1.519e-5	(A) Negative
APOBEC3C	22q13.1	-1.06	-1.45	0.82	0.73	0.39	5.217e-6	1.521e-5	(A) Negative
SERINC2	1p35.2	0.83	1.17	0.71	0.60	-0.34	5.233e-6	1.525e-5	(B) Positive
PMVK	1q21.3	0.77	1.02	0.52	0.51	-0.25	5.234e-6	1.525e-5	(B) Positive
ZBTB21	21q22.3	-0.03	-0.26	0.48	0.41	0.23	5.237e-6	1.525e-5	(A) Negative
ANKEF1	20p12.2	0.63	1.04	0.88	0.69	-0.41	5.241e-6	1.526e-5	(B) Positive
LIF	22q12.2	-0.53	-0.87	0.73	0.47	0.34	5.246e-6	1.528e-5	(A) Negative
YRDC	1p34.3	-0.30	-0.58	0.60	0.48	0.28	5.249e-6	1.528e-5	(A) Negative
NHEJ1	2q35	-0.26	-0.48	0.46	0.42	0.22	5.261e-6	1.531e-5	(A) Negative
XRCC4	5q14.2	-0.98	-0.72	0.54	0.51	-0.26	5.271e-6	1.534e-5	(B) Positive
PTPRZ1	7q31.32	-2.54	-3.38	1.82	1.24	0.84	5.280e-6	1.536e-5	(A) Negative
USP10	16q24.1	-0.53	-0.78	0.51	0.49	0.25	5.280e-6	1.536e-5	(A) Negative
PCMTD1	8q11.23	1.50	1.81	0.63	0.63	-0.31	5.283e-6	1.537e-5	(B) Positive
NIT1	1q23.3	0.28	0.46	0.38	0.38	-0.19	5.301e-6	1.542e-5	(B) Positive
TTC9B	19q13.2	0.20	0.43	0.45	0.56	-0.23	5.301e-6	1.542e-5	(B) Positive
PHACTR1	6p24.1	-1.91	-2.25	0.73	0.49	0.34	5.310e-6	1.544e-5	(A) Negative
SMAD9	13q13.3	-0.87	-1.28	0.84	0.76	0.41	5.328e-6	1.549e-5	(A) Negative
FRA10AC1	10q23.33	-0.13	0.12	0.53	0.41	-0.25	5.334e-6	1.550e-5	(B) Positive
PPFIA4	1q32.1	-2.80	-3.17	0.75	0.82	0.38	5.342e-6	1.552e-5	(A) Negative
ZNF491	19p13.2	-0.09	0.24	0.70	0.54	-0.33	5.361e-6	1.558e-5	(B) Positive
LRATD1	2p24.3	2.51	1.97	1.09	1.15	0.54	5.369e-6	1.560e-5	(A) Negative
POMGNT1	1p34.1	0.11	0.33	0.43	0.50	-0.22	5.371e-6	1.560e-5	(B) Positive
CPNE5	6p21.2	1.23	0.90	0.70	0.62	0.33	5.371e-6	1.560e-5	(A) Negative
LYRM4	6p25.1	-0.26	-0.51	0.54	0.39	0.25	5.378e-6	1.562e-5	(A) Negative
MOSPD1	Xq26.3	-0.33	-0.56	0.48	0.45	0.23	5.385e-6	1.563e-5	(A) Negative
FAIM2	12q13.12	0.22	0.43	0.34	0.62	-0.20	5.396e-6	1.566e-5	(B) Positive
TTC31	2p13.1	-0.41	-0.24	0.32	0.34	-0.16	5.402e-6	1.568e-5	(B) Positive
SLCO1A2	12p12.1	-1.29	-1.94	1.44	0.67	0.65	5.461e-6	1.585e-5	(A) Negative
PLAAT5	11q12.3	1.34	1.80	0.92	1.00	-0.46	5.486e-6	1.592e-5	(B) Positive
HEPH	Xq12	-0.36	-0.85	1.05	0.86	0.50	5.502e-6	1.596e-5	(A) Negative
DDX46	5q31.1	-0.61	-0.41	0.42	0.38	-0.20	5.551e-6	1.610e-5	(B) Positive
TENM3	4q34.3-q35.1	-1.27	-0.91	0.73	0.83	-0.37	5.559e-6	1.612e-5	(B) Positive
P3H2	3q28	-2.48	-3.03	1.20	0.73	0.55	5.571e-6	1.615e-5	(A) Negative
PSMA2	7p14.1	-0.50	-0.26	0.50	0.39	-0.23	5.581e-6	1.618e-5	(B) Positive
RWDD3	1p21.3	0.04	-0.20	0.52	0.47	0.25	5.612e-6	1.627e-5	(A) Negative
FXYD3	19q13.12	1.48	2.05	1.22	0.97	-0.58	5.637e-6	1.633e-5	(B) Positive
PRDM1	6q21	0.91	0.53	0.78	0.71	0.38	5.648e-6	1.636e-5	(A) Negative
TRIM59	3q25.33	0.27	-0.09	0.76	0.59	0.36	5.651e-6	1.637e-5	(A) Negative
PROZ	13q34	-1.54	-1.25	0.54	0.80	-0.29	5.651e-6	1.637e-5	(B) Positive
MAGEB4	Xp21.2	0.69	0.21	1.06	0.59	0.48	5.661e-6	1.639e-5	(A) Negative
CLDN9	16p13.3	0.30	0.13	0.37	0.24	0.17	5.665e-6	1.640e-5	(A) Negative
ZP4	1q43	0.43	-0.06	1.10	0.38	0.49	5.671e-6	1.642e-5	(A) Negative
PARP9	3q21.1	2.27	2.72	0.98	0.65	-0.45	5.690e-6	1.647e-5	(B) Positive
ABHD3	18q11.2	-0.71	-0.32	0.76	0.94	-0.39	5.695e-6	1.648e-5	(B) Positive
NBL1	1p36.13	0.51	0.94	0.87	0.88	-0.43	5.706e-6	1.651e-5	(B) Positive
LSM14A	19q13.11	0.59	0.33	0.56	0.36	0.26	5.711e-6	1.652e-5	(A) Negative
PFKL	21q22.3	-0.18	-0.45	0.54	0.57	0.27	5.720e-6	1.654e-5	(A) Negative
GAPVD1	9q33.3	0.01	0.24	0.48	0.41	-0.23	5.733e-6	1.658e-5	(B) Positive
CABP2	11q13.2	0.28	0.02	0.57	0.38	0.26	5.791e-6	1.674e-5	(A) Negative
ANKRD7	7q31.31	-0.96	-1.52	1.23	0.71	0.56	5.796e-6	1.675e-5	(A) Negative
KANK3	19p13.2	1.03	1.22	0.39	0.38	-0.19	5.797e-6	1.675e-5	(B) Positive
EFNB1	Xq13.1	0.37	0.04	0.69	0.62	0.33	5.802e-6	1.677e-5	(A) Negative
RUFY2	10q21.3	-0.02	0.20	0.45	0.45	-0.22	5.808e-6	1.678e-5	(B) Positive
TMEM33	4p13	0.21	0.44	0.48	0.39	-0.23	5.812e-6	1.679e-5	(B) Positive
TREML2	6p21.1	-0.04	-0.43	0.83	0.65	0.39	5.838e-6	1.686e-5	(A) Negative
IL1A	2q14.1	-1.86	-2.31	0.96	0.71	0.45	5.867e-6	1.694e-5	(A) Negative
SMYD3	1q44	-0.54	-0.12	0.86	0.87	-0.42	5.882e-6	1.698e-5	(B) Positive
MAP4K2	11q13.1	0.16	-0.12	0.58	0.52	0.28	5.882e-6	1.698e-5	(A) Negative
KRT14	17q21.2	0.64	-0.03	1.35	1.44	0.67	5.886e-6	1.699e-5	(A) Negative
EIF4E3	3p13	0.99	1.39	0.87	0.63	-0.40	5.907e-6	1.705e-5	(B) Positive
SH2D1B	1q23.3	-0.20	-0.65	0.95	0.77	0.45	5.926e-6	1.710e-5	(A) Negative
TM2D1	1p31.3	-0.17	0.11	0.58	0.58	-0.28	5.932e-6	1.711e-5	(B) Positive
RAPGEF4	2q31.1	0.39	0.79	0.81	0.86	-0.40	5.944e-6	1.714e-5	(B) Positive
MCFD2	2p21	-0.83	-1.07	0.52	0.41	0.24	5.948e-6	1.715e-5	(A) Negative
NGRN	15q26.1	0.30	0.57	0.59	0.49	-0.28	5.955e-6	1.717e-5	(B) Positive
LGR4	11p14.1	-0.15	-0.58	0.86	0.91	0.43	5.969e-6	1.721e-5	(A) Negative
NAV1	1q32.1	-0.32	0.06	0.80	0.72	-0.38	5.981e-6	1.724e-5	(B) Positive
FOXN4	12q24.11	-2.33	-1.70	1.13	1.78	-0.63	6.018e-6	1.735e-5	(B) Positive
EIF5A	17p13.1	-1.17	-1.47	0.61	0.64	0.30	6.029e-6	1.737e-5	(A) Negative
DET1	15q26.1	-0.15	0.14	0.61	0.56	-0.29	6.089e-6	1.754e-5	(B) Positive
IL18R1	2q12.1	1.59	1.13	0.97	0.84	0.46	6.097e-6	1.756e-5	(A) Negative
TRIM52	5q35.3	-1.26	-0.99	0.57	0.51	-0.27	6.102e-6	1.757e-5	(B) Positive
ESCO2	8p21.1	-1.49	-1.90	0.79	1.00	0.41	6.114e-6	1.761e-5	(A) Negative
MPST	22q12.3	0.32	0.11	0.45	0.39	0.21	6.130e-6	1.765e-5	(A) Negative
KAZALD1	10q24.31	-0.86	-0.35	1.01	1.19	-0.51	6.160e-6	1.773e-5	(B) Positive
CIDEC	3p25.3	0.34	0.69	0.66	0.87	-0.35	6.165e-6	1.775e-5	(B) Positive
F2R	5q13.3	-0.51	-0.05	0.95	0.87	-0.45	6.186e-6	1.780e-5	(B) Positive
CLDN5	22q11.21	3.10	3.40	0.62	0.52	-0.29	6.212e-6	1.787e-5	(B) Positive
TEF	22q13.2	0.45	0.70	0.52	0.49	-0.25	6.214e-6	1.788e-5	(B) Positive
SHLD2	10q23.2	-0.24	0.00	0.50	0.43	-0.24	6.218e-6	1.789e-5	(B) Positive
PYDC1	16p11.2	1.11	1.72	1.25	1.27	-0.61	6.224e-6	1.790e-5	(B) Positive
PSMC5	17q23.3	-0.57	-0.29	0.56	0.61	-0.28	6.227e-6	1.790e-5	(B) Positive
SFRP4	7p14.1	4.63	5.34	1.47	1.34	-0.70	6.256e-6	1.799e-5	(B) Positive
PTPRCAP	11q13.2	0.40	-0.06	0.98	0.81	0.46	6.270e-6	1.802e-5	(A) Negative
ALX1	12q21.31	-3.11	-3.59	1.09	0.58	0.49	6.277e-6	1.804e-5	(A) Negative
REXO4	9q34.2	-0.49	-0.72	0.50	0.41	0.24	6.281e-6	1.805e-5	(A) Negative
GALT	9p13.3	-0.17	-0.45	0.59	0.58	0.29	6.285e-6	1.806e-5	(A) Negative
ERICH6	3q25.1	0.09	0.31	0.46	0.45	-0.22	6.298e-6	1.809e-5	(B) Positive
EIF1	17q21.2	-0.42	-0.17	0.53	0.45	-0.25	6.320e-6	1.815e-5	(B) Positive
POGK	1q24.1	0.86	0.58	0.60	0.51	0.28	6.326e-6	1.817e-5	(A) Negative
TMEM199	17q11.2	0.46	0.74	0.57	0.54	-0.28	6.398e-6	1.837e-5	(B) Positive
PSMA5	1p13.3	-0.05	-0.25	0.42	0.40	0.20	6.450e-6	1.852e-5	(A) Negative
ZNF696	8q24.3	0.42	0.13	0.61	0.59	0.29	6.473e-6	1.858e-5	(A) Negative
ZMYND19	9q34.3	-0.28	-0.48	0.44	0.38	0.21	6.480e-6	1.859e-5	(A) Negative
COQ2	4q21.23	-0.26	-0.56	0.62	0.58	0.30	6.497e-6	1.864e-5	(A) Negative
OLFM1	9q34.3	-0.81	-0.26	1.16	1.00	-0.55	6.523e-6	1.871e-5	(B) Positive
CACNA1G	17q21.33	-0.16	0.02	0.36	0.43	-0.18	6.568e-6	1.884e-5	(B) Positive
LCN1	9q34.3	-0.13	-0.32	0.39	0.44	0.19	6.574e-6	1.885e-5	(A) Negative
OR11L1	1q44	0.63	0.50	0.28	0.27	0.13	6.589e-6	1.889e-5	(A) Negative
PEX26	22q11.21	0.44	0.24	0.41	0.34	0.19	6.625e-6	1.899e-5	(A) Negative
ACTN1	14q24.1	0.96	0.62	0.74	0.60	0.35	6.640e-6	1.903e-5	(A) Negative
TECPR1	7q21.3	-0.04	-0.31	0.57	0.52	0.27	6.682e-6	1.915e-5	(A) Negative
CCR1	3p21.31	0.10	-0.36	0.98	0.83	0.46	6.753e-6	1.935e-5	(A) Negative
CDK5RAP3	17q21.32	-0.72	-0.47	0.53	0.49	-0.25	6.779e-6	1.942e-5	(B) Positive
HAAO	2p21	0.47	0.20	0.56	0.52	0.27	6.810e-6	1.951e-5	(A) Negative
DCN	12q21.33	1.72	2.37	1.34	1.34	-0.65	6.819e-6	1.953e-5	(B) Positive
TXNRD2	22q11.21	-1.02	-0.80	0.42	0.56	-0.22	6.826e-6	1.954e-5	(B) Positive
MED15	22q11.21	-0.54	-0.71	0.33	0.40	0.17	6.853e-6	1.962e-5	(A) Negative
LILRA5	19q13.42	0.74	0.43	0.65	0.58	0.31	6.866e-6	1.965e-5	(A) Negative
PHF24	9p13.3	0.57	0.10	1.07	0.54	0.48	6.878e-6	1.969e-5	(A) Negative
LALBA	12q13.11	0.85	0.18	1.52	0.66	0.68	6.889e-6	1.971e-5	(A) Negative
AKAP12	6q25.1	-2.03	-1.53	1.04	1.01	-0.50	6.901e-6	1.974e-5	(B) Positive
HOXD1	2q31.1	-0.57	-0.02	1.16	1.03	-0.55	6.908e-6	1.976e-5	(B) Positive
FOXC2	16q24.1	0.34	0.04	0.64	0.56	0.30	6.937e-6	1.984e-5	(A) Negative
SFPQ	1p34.3	0.32	0.15	0.36	0.31	0.17	6.970e-6	1.993e-5	(A) Negative
NUP62CL	Xq22.3	-1.63	-1.02	1.26	1.18	-0.60	7.012e-6	2.005e-5	(B) Positive
TPP1	11p15.4	0.32	0.58	0.54	0.45	-0.25	7.035e-6	2.011e-5	(B) Positive
TECPR2	14q32.33	0.20	0.41	0.44	0.39	-0.21	7.062e-6	2.018e-5	(B) Positive
ASB6	9q34.11	-0.12	-0.34	0.45	0.41	0.22	7.082e-6	2.024e-5	(A) Negative
C1QTNF6	22q12.3	-0.17	0.19	0.75	0.72	-0.36	7.091e-6	2.026e-5	(B) Positive
FNDC11	20q13.33	-0.22	0.12	0.72	0.68	-0.34	7.133e-6	2.038e-5	(B) Positive
FAT2	5q33.1	0.94	0.35	1.20	1.22	0.58	7.137e-6	2.038e-5	(A) Negative
RBM3	Xp11.23	0.19	0.45	0.54	0.55	-0.26	7.186e-6	2.052e-5	(B) Positive
MAPK10	4q21.3	0.56	1.01	0.89	1.05	-0.45	7.189e-6	2.053e-5	(B) Positive
KATNB1	16q21	-0.58	-0.80	0.45	0.45	0.22	7.238e-6	2.066e-5	(A) Negative
MXRA8	1p36.33	2.20	2.72	1.10	0.95	-0.52	7.247e-6	2.068e-5	(B) Positive
COPZ2	17q21.32	-0.28	0.18	0.96	0.90	-0.46	7.266e-6	2.074e-5	(B) Positive
PARS2	1p32.3	0.35	0.12	0.49	0.42	0.23	7.295e-6	2.082e-5	(A) Negative
FRYL	4p11	-0.03	0.25	0.59	0.49	-0.28	7.305e-6	2.084e-5	(B) Positive
FBXW11	5q35.1	-0.73	-0.52	0.42	0.49	-0.21	7.334e-6	2.092e-5	(B) Positive
BVES	6q21	-0.38	-0.71	0.72	0.49	0.33	7.346e-6	2.095e-5	(A) Negative
RNF111	15q22.1-q22.2	-0.19	0.06	0.56	0.42	-0.26	7.402e-6	2.111e-5	(B) Positive
OSBPL5	11p15.4	1.13	1.46	0.70	0.56	-0.33	7.407e-6	2.112e-5	(B) Positive
PIAS3	1q21.1	0.22	0.44	0.45	0.47	-0.22	7.416e-6	2.114e-5	(B) Positive
ARK2N	18q21.1	0.60	0.38	0.45	0.41	0.21	7.419e-6	2.114e-5	(A) Negative
MYL6	12q13.2	0.69	0.94	0.56	0.38	-0.25	7.420e-6	2.114e-5	(B) Positive
ALG5	13q13.3	-0.06	0.23	0.62	0.52	-0.29	7.490e-6	2.134e-5	(B) Positive
ZYG11A	1p32.3	-0.52	-1.18	1.38	1.26	0.65	7.500e-6	2.137e-5	(A) Negative
RASSF8	12p12.1	-0.88	-0.51	0.76	0.82	-0.37	7.502e-6	2.137e-5	(B) Positive
TTC28	22q12.1	-0.63	-0.42	0.45	0.39	-0.21	7.510e-6	2.139e-5	(B) Positive
MRPL24	1q23.1	0.38	0.68	0.63	0.60	-0.30	7.516e-6	2.140e-5	(B) Positive
TATDN2	3p25.3	0.41	0.18	0.50	0.39	0.23	7.518e-6	2.140e-5	(A) Negative
SRGAP3	3p25.3	0.48	0.72	0.50	0.53	-0.24	7.526e-6	2.142e-5	(B) Positive
ZNF75A	16p13.3	0.23	0.52	0.55	0.70	-0.28	7.531e-6	2.143e-5	(B) Positive
GSAP	7q11.23	0.71	1.10	0.83	0.73	-0.39	7.531e-6	2.143e-5	(B) Positive
AP2A2	11p15.5	0.31	0.49	0.38	0.36	-0.18	7.560e-6	2.151e-5	(B) Positive
CDH4	20q13.33	-1.69	-2.26	1.30	0.69	0.58	7.575e-6	2.155e-5	(A) Negative
CEACAM1	19q13.2	0.90	0.25	1.41	1.10	0.65	7.627e-6	2.169e-5	(A) Negative
CMA1	14q12	0.47	0.83	0.73	0.83	-0.36	7.669e-6	2.181e-5	(B) Positive
SERPINB1	6p25.2	-0.28	0.12	0.88	0.57	-0.40	7.734e-6	2.199e-5	(B) Positive
PTPRG	3p14.2	-1.03	-0.64	0.80	0.79	-0.38	7.737e-6	2.199e-5	(B) Positive
SCARA3	8p21.1	-0.18	-0.72	1.18	0.82	0.54	7.742e-6	2.200e-5	(A) Negative
ANKRD12	18p11.22	0.16	0.42	0.56	0.48	-0.26	7.762e-6	2.206e-5	(B) Positive
CETN2	Xq28	0.59	0.85	0.54	0.41	-0.25	7.768e-6	2.207e-5	(B) Positive
NFKBID	19q13.12	0.03	-0.16	0.42	0.35	0.20	7.772e-6	2.208e-5	(A) Negative
CARMIL1	6p22.2	0.79	0.47	0.69	0.61	0.32	7.788e-6	2.212e-5	(A) Negative
SLAMF6	1q23.2-q23.3	0.63	0.25	0.81	0.72	0.38	7.794e-6	2.213e-5	(A) Negative
P3H1	1p34.2	-0.30	-0.58	0.58	0.60	0.28	7.819e-6	2.220e-5	(A) Negative
ZNF543	19q13.43	0.91	1.16	0.53	0.43	-0.25	7.844e-6	2.227e-5	(B) Positive
MMP20	11q22.2	0.76	0.18	1.27	0.80	0.57	7.845e-6	2.227e-5	(A) Negative
COL1A1	17q21.33	4.16	4.69	1.10	1.12	-0.53	7.852e-6	2.228e-5	(B) Positive
H2AC6	6p22.2	0.54	0.95	0.85	0.84	-0.41	7.875e-6	2.234e-5	(B) Positive
SH2D4A	8p21.3	-0.55	-0.02	1.03	1.33	-0.53	7.882e-6	2.236e-5	(B) Positive
CAPN11	6p21.1	0.04	0.32	0.53	0.73	-0.28	7.897e-6	2.240e-5	(B) Positive
PCDHB15	5q31.3	-0.13	-0.51	0.81	0.71	0.38	7.907e-6	2.243e-5	(A) Negative
RPS14	5q33.1	0.09	0.35	0.56	0.52	-0.26	7.928e-6	2.248e-5	(B) Positive
FLJ44635	Xq13.1	0.10	0.37	0.56	0.56	-0.27	7.929e-6	2.248e-5	(B) Positive
ABCD4	14q24.3	-0.64	-0.40	0.53	0.43	-0.24	7.976e-6	2.261e-5	(B) Positive
FAM107A	3p14.3-p14.2	1.81	1.12	1.52	0.88	0.68	7.981e-6	2.262e-5	(A) Negative
TM2D2	8p11.22	0.52	0.84	0.62	0.79	-0.31	7.981e-6	2.262e-5	(B) Positive
SGCB	4q12	-0.01	-0.41	0.84	0.76	0.40	7.987e-6	2.263e-5	(A) Negative
TXNIP	1q21.1	0.30	0.69	0.82	0.80	-0.39	7.998e-6	2.266e-5	(B) Positive
TKT	3p21.1	-1.16	-1.47	0.67	0.59	0.32	8.011e-6	2.269e-5	(A) Negative
ACVR2A	2q22.3-q23.1	0.78	0.47	0.64	0.60	0.31	8.017e-6	2.270e-5	(A) Negative
BTBD10	11p15.3	0.41	0.61	0.42	0.41	-0.20	8.043e-6	2.277e-5	(B) Positive
IL7	8q21.13	0.59	-0.02	1.29	1.13	0.61	8.065e-6	2.283e-5	(A) Negative
TMEM37	2q14.2	-0.41	-0.04	0.76	0.88	-0.38	8.085e-6	2.288e-5	(B) Positive
NDRG2	14q11.2	1.56	0.97	1.33	0.82	0.60	8.086e-6	2.288e-5	(A) Negative
PRORP	14q13.2	-0.04	0.15	0.41	0.37	-0.19	8.094e-6	2.290e-5	(B) Positive
TTC1	5q33.3	-0.26	-0.02	0.51	0.37	-0.23	8.121e-6	2.298e-5	(B) Positive
IFI30	19p13.11	1.65	1.27	0.79	0.82	0.38	8.126e-6	2.298e-5	(A) Negative
ZNF137P	19q13.41	0.13	0.36	0.49	0.44	-0.23	8.138e-6	2.301e-5	(B) Positive
SRSF3	6p21.31-p21.2	-0.17	-0.35	0.38	0.34	0.18	8.152e-6	2.305e-5	(A) Negative
RHEBL1	12q13.12	-0.74	-1.10	0.78	0.63	0.36	8.157e-6	2.306e-5	(A) Negative
MAP4K1	19q13.2	-0.09	-0.43	0.73	0.61	0.34	8.163e-6	2.307e-5	(A) Negative
PHC2	1p35.1	0.27	0.10	0.36	0.35	0.17	8.186e-6	2.314e-5	(A) Negative
QPCT	2p22.2	-2.15	-2.84	1.51	1.05	0.69	8.188e-6	2.314e-5	(A) Negative
RPL37	5p13.1	-0.18	-0.48	0.65	0.55	0.30	8.193e-6	2.315e-5	(A) Negative
TRA2B	3q27.2	-0.35	-0.57	0.46	0.39	0.22	8.202e-6	2.317e-5	(A) Negative
DDX20	1p13.2	-0.12	-0.31	0.40	0.37	0.19	8.224e-6	2.323e-5	(A) Negative
AOX1	2q33.1	-1.51	-1.05	0.94	0.98	-0.46	8.235e-6	2.326e-5	(B) Positive
ARRB2	17p13.2	0.12	-0.09	0.44	0.42	0.21	8.237e-6	2.326e-5	(A) Negative
MAP3K14	17q21.31	0.57	0.27	0.66	0.54	0.30	8.255e-6	2.330e-5	(A) Negative
ATOX1	5q33.1	-0.10	0.22	0.68	0.52	-0.31	8.294e-6	2.341e-5	(B) Positive
ACOT13	6p22.3	-0.42	-0.72	0.64	0.55	0.30	8.296e-6	2.341e-5	(A) Negative
MGST1	12p12.3	0.39	-0.17	1.09	1.43	0.56	8.297e-6	2.341e-5	(A) Negative
ST18	8q11.23	0.44	0.14	0.67	0.44	0.30	8.301e-6	2.342e-5	(A) Negative
IER3IP1	18q21.1	0.18	0.46	0.57	0.61	-0.28	8.355e-6	2.357e-5	(B) Positive
MESP1	15q26.1	0.97	0.33	1.31	1.46	0.64	8.357e-6	2.357e-5	(A) Negative
CCNI	4q21.1	0.49	0.71	0.47	0.44	-0.22	8.362e-6	2.358e-5	(B) Positive
SLC66A3	2p25.1	0.87	1.26	0.81	0.83	-0.39	8.382e-6	2.363e-5	(B) Positive
MLST8	16p13.3	-0.32	-0.08	0.48	0.49	-0.23	8.423e-6	2.374e-5	(B) Positive
EPHB4	7q22.1	0.49	0.13	0.72	0.85	0.36	8.432e-6	2.376e-5	(A) Negative
TNPO1	5q13.2	-0.53	-0.35	0.40	0.36	-0.19	8.464e-6	2.385e-5	(B) Positive
ANXA11	10q22.3	0.27	0.54	0.60	0.47	-0.28	8.505e-6	2.396e-5	(B) Positive
LMAN2L	2q11.2	0.33	0.61	0.61	0.51	-0.28	8.539e-6	2.405e-5	(B) Positive
NUDT2	9p13.3	-0.18	0.11	0.60	0.54	-0.28	8.539e-6	2.405e-5	(B) Positive
ZWINT	10q21.1	-0.78	-1.11	0.67	0.72	0.33	8.541e-6	2.405e-5	(A) Negative
ADAP1	7p22.3	-0.09	0.20	0.62	0.53	-0.29	8.551e-6	2.408e-5	(B) Positive
EEF1G	11q12.3	-0.06	-0.32	0.56	0.51	0.27	8.600e-6	2.421e-5	(A) Negative
NOLC1	10q24.32	-0.30	-0.52	0.48	0.36	0.22	8.643e-6	2.433e-5	(A) Negative
USP34	2p15	0.10	-0.08	0.39	0.31	0.18	8.657e-6	2.436e-5	(A) Negative
CLUAP1	16p13.3	0.47	0.80	0.71	0.60	-0.33	8.669e-6	2.439e-5	(B) Positive
NCAN	19p12	0.91	0.22	1.58	0.48	0.68	8.681e-6	2.442e-5	(A) Negative
ATG4C	1p31.3	-0.83	-1.09	0.56	0.48	0.26	8.708e-6	2.449e-5	(A) Negative
ELOVL1	1p34.2	0.47	0.18	0.62	0.51	0.29	8.709e-6	2.449e-5	(A) Negative
HAUS2	15q15.2	-1.27	-1.52	0.53	0.45	0.25	8.712e-6	2.450e-5	(A) Negative
RPL5	1p22.1	-0.34	-0.58	0.51	0.49	0.24	8.722e-6	2.452e-5	(A) Negative
PARP11	12p13.32	0.21	0.62	0.92	0.60	-0.41	8.727e-6	2.453e-5	(B) Positive
ALG10B	12q12	-0.67	-0.42	0.55	0.43	-0.25	8.744e-6	2.457e-5	(B) Positive
CD80	3q13.33	1.33	0.97	0.79	0.63	0.36	8.782e-6	2.468e-5	(A) Negative
C2CD2L	11q23.3	-0.11	0.19	0.65	0.57	-0.31	8.818e-6	2.478e-5	(B) Positive
MRAP	21q22.11	0.62	1.20	1.16	1.37	-0.58	8.881e-6	2.495e-5	(B) Positive
PIP5K1A	1q21.3	0.04	-0.23	0.57	0.55	0.27	8.884e-6	2.495e-5	(A) Negative
MAT2A	2p11.2	-0.19	0.00	0.40	0.39	-0.19	8.906e-6	2.501e-5	(B) Positive
MPPE1	18p11.21	0.19	0.49	0.64	0.53	-0.29	8.910e-6	2.502e-5	(B) Positive
MAFF	22q13.1	0.19	-0.15	0.71	0.69	0.34	8.929e-6	2.507e-5	(A) Negative
HCCS	Xp22.2	0.01	-0.25	0.56	0.50	0.26	8.942e-6	2.510e-5	(A) Negative
CSTA	3q21.1	2.29	1.56	1.51	1.57	0.73	8.952e-6	2.512e-5	(A) Negative
FOSB	19q13.32	0.68	1.18	1.03	1.16	-0.50	8.979e-6	2.520e-5	(B) Positive
BFSP1	20p12.1	0.23	-0.26	1.02	1.06	0.49	8.992e-6	2.522e-5	(A) Negative
PLTP	20q13.12	0.77	0.33	0.94	0.88	0.44	8.992e-6	2.522e-5	(A) Negative
CNRIP1	2p14	-1.10	-0.72	0.80	0.79	-0.38	9.037e-6	2.535e-5	(B) Positive
POLR2A	17p13.1	0.19	0.35	0.34	0.38	-0.17	9.078e-6	2.546e-5	(B) Positive
PLGRKT	9p24.1	0.69	1.07	0.80	0.68	-0.37	9.088e-6	2.548e-5	(B) Positive
TMC8	17q25.3	-0.46	-0.63	0.36	0.36	0.17	9.106e-6	2.552e-5	(A) Negative
CDH16	16q22.1	-1.33	-1.65	0.70	0.54	0.32	9.107e-6	2.552e-5	(A) Negative
PPWD1	5q12.3	-1.29	-1.08	0.46	0.40	-0.21	9.117e-6	2.555e-5	(B) Positive
IL7R	5p13.2	1.17	0.40	1.61	1.61	0.77	9.119e-6	2.555e-5	(A) Negative
MDFIC	7q31.1-q31.2	0.48	0.14	0.72	0.67	0.34	9.137e-6	2.560e-5	(A) Negative
SMTN	22q12.2	0.16	-0.15	0.66	0.58	0.31	9.169e-6	2.568e-5	(A) Negative
CSH1	17q23.3	0.29	0.18	0.22	0.24	0.11	9.174e-6	2.569e-5	(A) Negative
ZNF410	14q24.3	0.22	0.39	0.36	0.36	-0.17	9.236e-6	2.586e-5	(B) Positive
NR5A2	1q32.1	0.02	0.17	0.31	0.36	-0.15	9.246e-6	2.588e-5	(B) Positive
OR8S1	12q13.11	0.84	0.60	0.52	0.47	0.24	9.256e-6	2.591e-5	(A) Negative
STAG1	3q22.3	0.05	-0.22	0.58	0.47	0.27	9.266e-6	2.593e-5	(A) Negative
REM2	14q11.2	0.31	0.64	0.65	0.85	-0.33	9.279e-6	2.596e-5	(B) Positive
RFX7	15q21.3	-0.39	-0.20	0.40	0.38	-0.19	9.300e-6	2.602e-5	(B) Positive
ECHS1	10q26.3	0.42	0.66	0.53	0.41	-0.24	9.369e-6	2.621e-5	(B) Positive
ADH1B	4q23	1.70	2.38	1.42	1.46	-0.68	9.410e-6	2.632e-5	(B) Positive
PPAT	4q12	-0.62	-1.01	0.84	0.71	0.39	9.476e-6	2.650e-5	(A) Negative
ME3	11q14.2	0.58	0.96	0.76	0.93	-0.38	9.522e-6	2.662e-5	(B) Positive
CD180	5q12.3	1.03	0.48	1.21	0.82	0.54	9.538e-6	2.666e-5	(A) Negative
HSD17B12	11p11.2	-0.09	-0.46	0.80	0.72	0.37	9.577e-6	2.677e-5	(A) Negative
GOLPH3L	1q21.3	0.84	1.16	0.65	0.72	-0.32	9.604e-6	2.684e-5	(B) Positive
POLR1A	2p11.2	-0.18	-0.38	0.43	0.37	0.20	9.681e-6	2.705e-5	(A) Negative
LCAT	16q22.1	-1.27	-1.48	0.45	0.42	0.21	9.727e-6	2.717e-5	(A) Negative
SDE2	1q42.12	0.37	0.14	0.49	0.43	0.23	9.786e-6	2.734e-5	(A) Negative
OPN4	10q23.2	0.22	0.34	0.25	0.28	-0.12	9.825e-6	2.744e-5	(B) Positive
SH2D4B	10q23.1	0.60	0.35	0.54	0.48	0.25	9.845e-6	2.749e-5	(A) Negative
COL12A1	6q13-q14.1	1.84	2.42	1.25	1.20	-0.59	9.873e-6	2.756e-5	(B) Positive
CCDC33	15q24.1	0.42	0.24	0.36	0.35	0.17	9.874e-6	2.756e-5	(A) Negative
SLCO4C1	5q21.1	0.03	-0.28	0.66	0.52	0.30	9.953e-6	2.778e-5	(A) Negative
SYT13	11p11.2	0.12	1.52	2.87	3.24	-1.40	1.007e-5	2.810e-5	(B) Positive
COQ9	16q21	-0.02	-0.26	0.53	0.47	0.24	1.007e-5	2.810e-5	(A) Negative
COQ10A	12q13.3	-1.07	-0.76	0.65	0.67	-0.31	1.008e-5	2.813e-5	(B) Positive
STX4	16p11.2	0.26	0.48	0.47	0.40	-0.22	1.010e-5	2.818e-5	(B) Positive
USP6	17p13.2	-0.70	-0.48	0.43	0.61	-0.22	1.015e-5	2.831e-5	(B) Positive
ALG6	1p31.3	0.05	-0.22	0.60	0.52	0.28	1.025e-5	2.857e-5	(A) Negative
GSK3B	3q13.33	0.25	0.02	0.50	0.44	0.23	1.027e-5	2.862e-5	(A) Negative
MRPL48	11q13.4	-0.29	-0.52	0.49	0.54	0.24	1.027e-5	2.863e-5	(A) Negative
ITCH	20q11.22	0.18	-0.03	0.44	0.38	0.20	1.029e-5	2.868e-5	(A) Negative
TAL2	9q31.2	-0.79	-0.45	0.63	0.98	-0.34	1.035e-5	2.885e-5	(B) Positive
AKIP1	11p15.4	-0.52	-0.25	0.58	0.47	-0.27	1.038e-5	2.891e-5	(B) Positive
EHMT2	6p21.33	-0.38	-0.58	0.42	0.37	0.19	1.039e-5	2.894e-5	(A) Negative
HOXB6	17q21.32	-0.31	0.42	1.50	1.61	-0.72	1.043e-5	2.905e-5	(B) Positive
ERP44	9q31.1	0.21	0.03	0.40	0.32	0.18	1.044e-5	2.906e-5	(A) Negative
FBXO32	8q24.13	2.16	1.67	1.07	0.88	0.49	1.044e-5	2.908e-5	(A) Negative
PTPRM	18p11.23	-0.60	-0.24	0.79	0.63	-0.36	1.045e-5	2.908e-5	(B) Positive
PHLDA1	12q21.2	-1.51	-2.03	1.13	0.91	0.52	1.046e-5	2.911e-5	(A) Negative
LY6H	8q24.3	0.57	1.01	0.94	0.90	-0.44	1.050e-5	2.921e-5	(B) Positive
LPCAT2	16q12.2	-0.04	-0.54	1.09	0.97	0.51	1.058e-5	2.944e-5	(A) Negative
VEGFB	11q13.1	-0.38	-0.14	0.49	0.45	-0.23	1.059e-5	2.945e-5	(B) Positive
DDOST	1p36.12	-0.03	-0.24	0.44	0.43	0.21	1.061e-5	2.952e-5	(A) Negative
LYPD3	19q13.31	0.40	0.91	1.07	1.09	-0.51	1.067e-5	2.967e-5	(B) Positive
HHIPL1	14q32.2	0.87	0.65	0.48	0.41	0.22	1.070e-5	2.975e-5	(A) Negative
SIGLEC8	19q13.33-q13.41	1.05	1.40	0.77	0.66	-0.35	1.086e-5	3.019e-5	(B) Positive
PHLDA2	11p15.4	-0.78	-1.25	1.02	0.92	0.47	1.086e-5	3.019e-5	(A) Negative
GK2	4q21.21	0.10	-0.06	0.32	0.37	0.16	1.090e-5	3.029e-5	(A) Negative
METTL3	14q11.2	-0.81	-0.58	0.49	0.47	-0.23	1.091e-5	3.031e-5	(B) Positive
NLRC5	16q13	0.96	0.62	0.73	0.59	0.33	1.095e-5	3.043e-5	(A) Negative
TACR2	10q22.1	0.45	0.63	0.38	0.42	-0.18	1.096e-5	3.043e-5	(B) Positive
CUL1	7q36.1	-0.13	-0.35	0.49	0.40	0.23	1.097e-5	3.046e-5	(A) Negative
ELP1	9q31.3	-1.33	-1.09	0.51	0.48	-0.24	1.109e-5	3.079e-5	(B) Positive
SLC35A4	5q31.3	0.31	0.49	0.40	0.32	-0.18	1.111e-5	3.084e-5	(B) Positive
SMARCE1	17q21.2	-0.09	0.13	0.46	0.51	-0.22	1.111e-5	3.085e-5	(B) Positive
RAB13	1q21.3	0.27	0.48	0.44	0.46	-0.21	1.120e-5	3.109e-5	(B) Positive
FABP4	8q21.13	3.87	4.70	1.78	1.69	-0.83	1.120e-5	3.109e-5	(B) Positive
STARD7	2q11.2	0.06	-0.17	0.49	0.39	0.22	1.121e-5	3.109e-5	(A) Negative
CORO2B	15q23	-1.88	-1.64	0.50	0.53	-0.24	1.123e-5	3.114e-5	(B) Positive
LANCL2	7p11.2	0.76	0.40	0.81	0.46	0.36	1.123e-5	3.114e-5	(A) Negative
OSM	22q12.2	2.85	2.36	1.04	1.01	0.49	1.123e-5	3.114e-5	(A) Negative
ATM	11q22.3	-1.33	-1.56	0.49	0.52	0.23	1.124e-5	3.115e-5	(A) Negative
MED27	9q34.13	-0.42	-0.63	0.48	0.40	0.22	1.137e-5	3.153e-5	(A) Negative
OIT3	10q22.1	1.05	0.64	0.90	0.83	0.42	1.143e-5	3.169e-5	(A) Negative
MICALL2	7p22.3	-0.57	-0.24	0.72	0.54	-0.33	1.144e-5	3.172e-5	(B) Positive
GTF2F2	13q14.12-q14.13	-0.16	-0.40	0.50	0.50	0.24	1.148e-5	3.182e-5	(A) Negative
TMEM259	19p13.3	-0.40	-0.21	0.43	0.36	-0.20	1.151e-5	3.190e-5	(B) Positive
PLA2G12A	4q25	0.05	0.30	0.55	0.44	-0.25	1.156e-5	3.202e-5	(B) Positive
SNCB	5q35.2	0.08	-0.08	0.33	0.37	0.16	1.161e-5	3.214e-5	(A) Negative
SPRR2F	1q21.3	-0.73	-1.13	0.89	0.73	0.41	1.161e-5	3.215e-5	(A) Negative
NUMBL	19q13.2	-0.06	-0.27	0.46	0.38	0.21	1.168e-5	3.233e-5	(A) Negative
MALSU1	7p15.3	-0.70	-0.92	0.47	0.43	0.22	1.172e-5	3.243e-5	(A) Negative
FANCF	11p14.3	0.86	1.18	0.70	0.52	-0.31	1.173e-5	3.248e-5	(B) Positive
SOBP	6q21	0.34	0.09	0.53	0.53	0.25	1.176e-5	3.254e-5	(A) Negative
SFTA2	6p21.33	0.84	0.55	0.64	0.49	0.29	1.179e-5	3.263e-5	(A) Negative
HAR1A	20q13.33	-1.02	-0.65	0.70	1.04	-0.37	1.184e-5	3.275e-5	(B) Positive
POMT2	14q24.3	-0.30	-0.08	0.45	0.45	-0.21	1.188e-5	3.286e-5	(B) Positive
FBXL2	3p22.3	1.10	1.48	0.84	0.71	-0.39	1.188e-5	3.286e-5	(B) Positive
GPR87	3q25.1	-0.47	-1.35	1.93	1.61	0.88	1.190e-5	3.291e-5	(A) Negative
CYP2C8	10q23.33	0.19	0.57	0.76	1.03	-0.39	1.193e-5	3.297e-5	(B) Positive
DUOXA1	15q21.1	1.22	0.86	0.78	0.66	0.36	1.195e-5	3.304e-5	(A) Negative
TMPRSS9	19p13.3	0.45	0.21	0.51	0.50	0.24	1.196e-5	3.306e-5	(A) Negative
SLFN5	17q12	1.10	0.61	1.04	1.04	0.49	1.197e-5	3.309e-5	(A) Negative
FICD	12q23.3	0.20	0.51	0.66	0.66	-0.31	1.199e-5	3.313e-5	(B) Positive
DNM3	1q24.3	1.75	1.33	0.91	0.73	0.41	1.201e-5	3.319e-5	(A) Negative
PUF60	8q24.3	0.71	0.43	0.58	0.60	0.27	1.206e-5	3.331e-5	(A) Negative
ANKRD35	1q21.1	2.08	1.43	1.43	1.06	0.64	1.207e-5	3.334e-5	(A) Negative
KRT72	12q13.13	0.55	0.23	0.72	0.48	0.32	1.208e-5	3.337e-5	(A) Negative
FAM162B	6q22.1	0.85	1.27	0.87	0.96	-0.42	1.212e-5	3.346e-5	(B) Positive
ALG14	1p21.3	0.46	0.69	0.50	0.49	-0.23	1.216e-5	3.357e-5	(B) Positive
SERPINB7	18q21.33	0.43	-0.15	1.31	0.70	0.57	1.217e-5	3.358e-5	(A) Negative
SV2C	5q13.3	0.73	0.19	1.22	0.83	0.54	1.218e-5	3.362e-5	(A) Negative
UBE2E2	3p24.3	0.56	0.12	0.94	0.92	0.44	1.231e-5	3.396e-5	(A) Negative
EPHB2	1p36.12	0.23	-0.19	0.93	0.67	0.41	1.235e-5	3.406e-5	(A) Negative
CCL25	19p13.2	0.70	0.53	0.36	0.35	0.17	1.235e-5	3.407e-5	(A) Negative
MAPK8IP2	22q13.33	0.79	1.28	1.09	0.92	-0.50	1.237e-5	3.411e-5	(B) Positive
NOP9	14q12	0.29	0.06	0.52	0.46	0.24	1.244e-5	3.429e-5	(A) Negative
BLOC1S2	10q24.31	0.29	0.55	0.57	0.46	-0.26	1.245e-5	3.432e-5	(B) Positive
KRBOX5	16p11.2	-0.24	0.05	0.61	0.62	-0.29	1.246e-5	3.435e-5	(B) Positive
RNF185	22q12.2	0.73	0.91	0.39	0.42	-0.19	1.253e-5	3.452e-5	(B) Positive
SPMIP9	2p11.2	-0.05	-0.19	0.32	0.27	0.15	1.253e-5	3.452e-5	(A) Negative
SLC22A23	6p25.2	0.04	0.27	0.51	0.42	-0.23	1.259e-5	3.469e-5	(B) Positive
IFT25	1p32.3	-0.41	-0.71	0.63	0.57	0.29	1.260e-5	3.471e-5	(A) Negative
IGFBPL1	9p13.1	-0.35	-0.65	0.66	0.59	0.30	1.260e-5	3.471e-5	(A) Negative
GALK1	17q25.1	-0.41	-0.72	0.66	0.68	0.31	1.272e-5	3.503e-5	(A) Negative
FBXL19	16p11.2	-0.26	-0.44	0.38	0.41	0.18	1.272e-5	3.503e-5	(A) Negative
FBXO16	8p21.1	0.31	0.84	1.13	1.19	-0.54	1.273e-5	3.503e-5	(B) Positive
ACRV1	11q24.2	-0.22	-0.49	0.62	0.43	0.28	1.278e-5	3.517e-5	(A) Negative
CCDC15	11q24.2	-1.03	-0.62	0.89	0.73	-0.41	1.280e-5	3.524e-5	(B) Positive
MAK	6p24.2	0.50	0.94	0.93	1.03	-0.45	1.282e-5	3.527e-5	(B) Positive
SAAL1	11p15.1	-1.03	-1.35	0.71	0.58	0.32	1.282e-5	3.527e-5	(A) Negative
ZNRF3	22q12.1	-0.22	0.07	0.59	0.72	-0.29	1.283e-5	3.529e-5	(B) Positive
DSTN	20p12.1	0.72	1.06	0.75	0.63	-0.34	1.284e-5	3.532e-5	(B) Positive
ABCC1	16p13.11	-0.94	-1.23	0.60	0.60	0.28	1.287e-5	3.539e-5	(A) Negative
AGL	1p21.2	0.39	0.85	0.92	1.13	-0.45	1.287e-5	3.539e-5	(B) Positive
CHRDL1	Xq23	0.80	0.29	1.13	0.94	0.51	1.290e-5	3.545e-5	(A) Negative
SH2D5	1p36.12	-1.20	-1.41	0.46	0.35	0.21	1.290e-5	3.547e-5	(A) Negative
DMAC2L	14q21.3	-0.27	-0.01	0.53	0.56	-0.25	1.296e-5	3.561e-5	(B) Positive
MFSD3	8q24.3	0.17	0.51	0.73	0.75	-0.34	1.298e-5	3.565e-5	(B) Positive
BEST4	1p34.1	0.38	0.12	0.58	0.54	0.27	1.298e-5	3.566e-5	(A) Negative
TBX21	17q21.32	3.87	3.24	1.35	1.32	0.63	1.299e-5	3.568e-5	(A) Negative
AGGF1	5q13.3	-0.36	-0.13	0.51	0.43	-0.23	1.301e-5	3.572e-5	(B) Positive
TECR	19p13.12	-0.33	-0.08	0.53	0.51	-0.25	1.305e-5	3.583e-5	(B) Positive
TSHZ3	19q12	1.64	2.09	0.97	0.89	-0.45	1.307e-5	3.589e-5	(B) Positive
CD3D	11q23.3	-2.31	-2.84	1.17	1.05	0.54	1.311e-5	3.597e-5	(A) Negative
POGLUT3	11q22.3	-0.54	-0.87	0.71	0.60	0.32	1.312e-5	3.600e-5	(A) Negative
FBXO3	11p13	0.44	0.76	0.70	0.56	-0.32	1.321e-5	3.625e-5	(B) Positive
ST3GAL1	8q24.22	0.33	0.77	0.93	0.93	-0.43	1.327e-5	3.640e-5	(B) Positive
LRPPRC	2p21	0.03	-0.20	0.52	0.40	0.23	1.328e-5	3.644e-5	(A) Negative
PUS3	11q24.2	-0.02	-0.29	0.58	0.53	0.27	1.333e-5	3.657e-5	(A) Negative
STXBP5	6q24.3	-0.51	-0.82	0.66	0.56	0.30	1.338e-5	3.671e-5	(A) Negative
ZNF681	19p12	-0.34	-0.01	0.72	0.69	-0.33	1.349e-5	3.699e-5	(B) Positive
GUK1	1q42.13	0.68	0.47	0.47	0.41	0.21	1.350e-5	3.700e-5	(A) Negative
GNAL	18p11.21	-0.27	-0.62	0.81	0.57	0.36	1.356e-5	3.717e-5	(A) Negative
CDC42BPA	1q42.13	0.26	-0.08	0.70	0.78	0.34	1.361e-5	3.729e-5	(A) Negative
ZNF420	19q13.12	0.65	1.03	0.81	0.73	-0.37	1.362e-5	3.732e-5	(B) Positive
NCDN	1p34.3	-0.12	0.13	0.54	0.53	-0.25	1.365e-5	3.740e-5	(B) Positive
ZBTB47	3p22.1	0.35	0.59	0.51	0.42	-0.23	1.368e-5	3.747e-5	(B) Positive
TRAPPC3	1p34.3	0.01	-0.25	0.57	0.50	0.26	1.375e-5	3.767e-5	(A) Negative
NFIC	19p13.3	0.49	0.79	0.66	0.61	-0.30	1.377e-5	3.771e-5	(B) Positive
TUBGCP2	10q26.3	0.30	0.54	0.50	0.51	-0.24	1.385e-5	3.793e-5	(B) Positive
ZNF131	5p12	-0.28	-0.53	0.56	0.41	0.25	1.391e-5	3.808e-5	(A) Negative
ARHGEF17	11q13.4	0.51	0.70	0.42	0.45	-0.20	1.398e-5	3.825e-5	(B) Positive
NFS1	20q11.22	-0.69	-0.47	0.46	0.46	-0.21	1.400e-5	3.831e-5	(B) Positive
SPDYA	2p23.2	-0.02	-0.37	0.80	0.50	0.35	1.400e-5	3.832e-5	(A) Negative
PCF11	11q14.1	-0.48	-0.20	0.59	0.60	-0.28	1.404e-5	3.840e-5	(B) Positive
TAF2	8q24.12	0.50	0.19	0.68	0.63	0.31	1.415e-5	3.869e-5	(A) Negative
AQP6	12q13.12	0.61	0.20	0.92	0.67	0.41	1.417e-5	3.876e-5	(A) Negative
AKR1B10	7q33	-2.03	-2.95	2.07	1.41	0.91	1.421e-5	3.884e-5	(A) Negative
ARL13A	Xq22.1	0.16	-0.29	1.04	0.64	0.45	1.423e-5	3.891e-5	(A) Negative
ALDH4A1	1p36.13	-0.72	-0.37	0.78	0.65	-0.35	1.427e-5	3.902e-5	(B) Positive
HPCAL1	2p25.1	-0.34	-0.58	0.51	0.55	0.24	1.441e-5	3.939e-5	(A) Negative
COPS8	2q37.3	-0.52	-0.31	0.48	0.41	-0.22	1.444e-5	3.945e-5	(B) Positive
XYLB	3p22.2	-0.31	-0.61	0.65	0.52	0.29	1.444e-5	3.946e-5	(A) Negative
ZNF570	19q13.12	0.26	-0.02	0.64	0.52	0.29	1.446e-5	3.950e-5	(A) Negative
ZNF343	20p13	-0.12	0.08	0.44	0.45	-0.21	1.448e-5	3.956e-5	(B) Positive
OXCT2	1p34.2	0.05	-0.36	0.88	0.81	0.40	1.455e-5	3.973e-5	(A) Negative
SLC24A2	9p22.1	0.50	0.75	0.53	0.51	-0.25	1.455e-5	3.973e-5	(B) Positive
BLOC1S6	15q21.1	-0.36	-0.11	0.55	0.47	-0.25	1.464e-5	3.996e-5	(B) Positive
HSPA4L	4q28.1	-1.52	-2.20	1.52	1.25	0.69	1.464e-5	3.997e-5	(A) Negative
PROCA1	17q11.2	-2.02	-1.72	0.63	0.65	-0.30	1.469e-5	4.009e-5	(B) Positive
HMGCR	5q13.3	-0.75	-0.53	0.52	0.35	-0.23	1.470e-5	4.011e-5	(B) Positive
EIF3E	8q23.1	-0.18	-0.50	0.69	0.64	0.32	1.471e-5	4.012e-5	(A) Negative
SIT1	9p13.3	-0.21	-0.84	1.35	1.28	0.62	1.474e-5	4.021e-5	(A) Negative
AREL1	14q24.3	0.10	-0.05	0.32	0.32	0.15	1.474e-5	4.021e-5	(A) Negative
ACSL5	10q25.2	0.15	-0.36	1.13	1.01	0.51	1.477e-5	4.029e-5	(A) Negative
TM4SF4	3q25.1	0.58	-0.01	1.36	0.76	0.59	1.480e-5	4.035e-5	(A) Negative
TAS2R31	12p13.2	0.55	0.38	0.38	0.36	0.17	1.481e-5	4.037e-5	(A) Negative
SLC28A2	15q21.1	-0.27	0.01	0.53	0.74	-0.27	1.482e-5	4.041e-5	(B) Positive
PTH2R	2q34	2.52	1.78	1.71	1.06	0.75	1.483e-5	4.041e-5	(A) Negative
AP3M1	10q22.2	-0.21	0.04	0.55	0.52	-0.25	1.484e-5	4.044e-5	(B) Positive
C19ORF48P	19q13.33	-0.81	-1.09	0.60	0.60	0.28	1.490e-5	4.060e-5	(A) Negative
TMPRSS12	12q13.12	0.48	0.21	0.62	0.38	0.27	1.494e-5	4.070e-5	(A) Negative
DKK3	11p15.3	-0.57	-0.10	1.05	0.90	-0.47	1.503e-5	4.093e-5	(B) Positive
ZBTB2	6q25.1	0.33	0.56	0.47	0.58	-0.23	1.514e-5	4.122e-5	(B) Positive
MAP6	11q13.5	1.44	1.86	0.90	0.93	-0.42	1.515e-5	4.126e-5	(B) Positive
ABCA6	17q24.2-q24.3	2.11	2.59	1.01	1.08	-0.48	1.516e-5	4.127e-5	(B) Positive
DPM3	1q22	0.07	-0.17	0.50	0.47	0.23	1.517e-5	4.129e-5	(A) Negative
OLFM4	13q14.3	4.07	2.96	2.45	2.15	1.11	1.522e-5	4.142e-5	(A) Negative
ELAVL1	19p13.2	-0.04	-0.25	0.47	0.39	0.21	1.525e-5	4.149e-5	(A) Negative
FAT3	11q14.3	-0.31	-0.09	0.48	0.43	-0.22	1.529e-5	4.161e-5	(B) Positive
BICD1	12p11.21	-0.19	-0.54	0.77	0.71	0.35	1.530e-5	4.162e-5	(A) Negative
SNU13	22q13.2	-0.17	-0.36	0.40	0.40	0.19	1.535e-5	4.175e-5	(A) Negative
PIN1	19p13	-0.38	-0.21	0.37	0.39	-0.17	1.539e-5	4.185e-5	(B) Positive
SLC35A1	6q15	0.48	0.75	0.57	0.56	-0.26	1.539e-5	4.185e-5	(B) Positive
SCN7A	2q24.3	0.25	0.50	0.47	0.73	-0.25	1.540e-5	4.187e-5	(B) Positive
JAM2	21q21.3	0.49	0.92	0.91	0.94	-0.43	1.544e-5	4.197e-5	(B) Positive
APOO	Xp22.11	-0.25	-0.59	0.77	0.59	0.34	1.549e-5	4.210e-5	(A) Negative
TRPM4	19q13.33	1.10	1.60	1.14	0.64	-0.49	1.551e-5	4.215e-5	(B) Positive
ZNF433	19p13.2	-0.07	0.31	0.85	0.68	-0.38	1.553e-5	4.219e-5	(B) Positive
TNFSF9	19p13.3	-1.64	-1.83	0.37	0.48	0.18	1.557e-5	4.229e-5	(A) Negative
HMGB1P1	20q13.31	0.10	-0.25	0.79	0.60	0.35	1.558e-5	4.232e-5	(A) Negative
HACD2	3q21.1	0.79	0.46	0.74	0.51	0.33	1.561e-5	4.239e-5	(A) Negative
CCT8	21q21.3	-0.41	-0.61	0.43	0.37	0.19	1.562e-5	4.240e-5	(A) Negative
C6ORF89	6p21.2	0.01	0.21	0.44	0.36	-0.20	1.563e-5	4.243e-5	(B) Positive
IGFLR1	19q13.12	0.90	0.49	0.90	0.84	0.41	1.568e-5	4.255e-5	(A) Negative
MTRF1L	6q25.2	-0.76	-0.99	0.50	0.44	0.23	1.573e-5	4.270e-5	(A) Negative
IRF2BPL	14q24.3	0.89	1.17	0.60	0.54	-0.27	1.583e-5	4.297e-5	(B) Positive
PDXP	22q13.1	-1.17	-1.37	0.45	0.45	0.21	1.588e-5	4.307e-5	(A) Negative
SLC22A17	14q11.2	0.80	1.13	0.72	0.73	-0.33	1.588e-5	4.307e-5	(B) Positive
POU5F1	6p21.33	-4.19	-4.47	0.65	0.44	0.28	1.589e-5	4.310e-5	(A) Negative
ZNF436-AS1	1p36.12	-1.79	-2.12	0.71	0.66	0.33	1.591e-5	4.314e-5	(A) Negative
OR10G7	11q24.2	0.35	0.24	0.22	0.32	0.11	1.592e-5	4.317e-5	(A) Negative
ADRB2	5q32	-0.56	-0.00	1.25	1.02	-0.56	1.595e-5	4.323e-5	(B) Positive
CA4	17q23.1	-2.04	-1.61	0.84	1.17	-0.43	1.595e-5	4.323e-5	(B) Positive
ZSCAN5A	19q13.43	-0.09	-0.44	0.80	0.62	0.36	1.599e-5	4.334e-5	(A) Negative
LSM10	1p34.3	0.04	-0.16	0.43	0.40	0.20	1.600e-5	4.335e-5	(A) Negative
CMKLR2	2q33.3	-0.68	-0.27	0.87	0.92	-0.41	1.613e-5	4.369e-5	(B) Positive
SMIM19	8p11.21	0.11	0.43	0.67	0.76	-0.32	1.619e-5	4.384e-5	(B) Positive
HOXB5	17q21.32	-0.68	-0.09	1.22	1.38	-0.58	1.620e-5	4.386e-5	(B) Positive
SVEP1	9q31.3	0.08	0.37	0.63	0.66	-0.29	1.625e-5	4.400e-5	(B) Positive
CDK4	12q14.1	-0.35	-0.55	0.44	0.45	0.21	1.628e-5	4.408e-5	(A) Negative
TMEM43	3p25.1	0.05	-0.17	0.50	0.39	0.22	1.628e-5	4.408e-5	(A) Negative
XCL1	1q24.2	1.07	0.60	1.02	1.00	0.47	1.633e-5	4.420e-5	(A) Negative
OVOL1	11q13.1	0.85	1.27	0.94	0.76	-0.42	1.637e-5	4.430e-5	(B) Positive
CCL17	16q21	2.02	1.48	1.17	1.11	0.53	1.638e-5	4.433e-5	(A) Negative
AKR1C1	10p15.1	-1.88	-2.58	1.59	1.23	0.71	1.644e-5	4.446e-5	(A) Negative
MTHFS	15q25.1	-0.32	-0.07	0.55	0.43	-0.24	1.649e-5	4.461e-5	(B) Positive
CITED2	6q24.1	0.14	0.45	0.64	0.78	-0.31	1.654e-5	4.473e-5	(B) Positive
DMRT3	9p24.3	1.59	1.11	1.09	0.68	0.47	1.655e-5	4.476e-5	(A) Negative
NDP	Xp11.3	-2.26	-1.58	1.24	2.10	-0.68	1.657e-5	4.480e-5	(B) Positive
IGF2R	6q25.3	0.25	-0.03	0.61	0.51	0.27	1.657e-5	4.480e-5	(A) Negative
FIBP	11q13.1	-0.00	0.18	0.39	0.40	-0.18	1.664e-5	4.497e-5	(B) Positive
ZNF587	19q13.43	0.01	0.23	0.45	0.59	-0.22	1.666e-5	4.502e-5	(B) Positive
GZMM	19p13.3	-0.18	-0.58	0.87	0.80	0.40	1.676e-5	4.528e-5	(A) Negative
TTC27	2p22.3	-0.28	-0.51	0.51	0.39	0.23	1.676e-5	4.529e-5	(A) Negative
C19ORF25	19p13.3	0.15	0.36	0.46	0.43	-0.21	1.678e-5	4.533e-5	(B) Positive
TXNRD1	12q23.3	-0.91	-1.25	0.75	0.69	0.34	1.679e-5	4.533e-5	(A) Negative
ZCCHC9	5q14.1	-0.95	-0.76	0.42	0.38	-0.19	1.680e-5	4.535e-5	(B) Positive
BBS7	4q27	-0.34	-0.60	0.59	0.49	0.26	1.694e-5	4.573e-5	(A) Negative
ZNF430	19p12	-0.39	-0.09	0.68	0.56	-0.30	1.694e-5	4.573e-5	(B) Positive
ADAM11	17q21.31	-0.98	-1.20	0.50	0.38	0.22	1.701e-5	4.590e-5	(A) Negative
TNFRSF10B	8p21.3	-0.91	-1.23	0.69	0.66	0.32	1.703e-5	4.595e-5	(A) Negative
TRIM10	6p22.1	-0.45	-0.60	0.34	0.29	0.15	1.720e-5	4.640e-5	(A) Negative
UQCR11	19p13.3	-0.31	-0.12	0.43	0.37	-0.19	1.733e-5	4.674e-5	(B) Positive
THRA	17q21.1	0.03	0.49	1.03	0.82	-0.46	1.736e-5	4.683e-5	(B) Positive
LOC401052	3p25.3	0.74	1.20	1.02	0.89	-0.46	1.737e-5	4.685e-5	(B) Positive
MRPL14	6p21.1	-0.02	-0.25	0.50	0.50	0.23	1.739e-5	4.688e-5	(A) Negative
CHD3	17p13.1	-0.62	-0.36	0.57	0.56	-0.26	1.741e-5	4.695e-5	(B) Positive
SERHL2	22q13.2	0.82	1.24	0.93	0.83	-0.42	1.744e-5	4.700e-5	(B) Positive
FBXO42	1p36.13	0.30	0.13	0.37	0.34	0.17	1.749e-5	4.714e-5	(A) Negative
CYP27C1	2q14.3	0.26	0.00	0.57	0.46	0.25	1.755e-5	4.729e-5	(A) Negative
CNFN	19q13.2	1.14	0.91	0.50	0.53	0.23	1.755e-5	4.729e-5	(A) Negative
CEP68	2p14	0.46	0.73	0.60	0.47	-0.27	1.756e-5	4.731e-5	(B) Positive
DUS2	16q22.1	-0.40	-0.61	0.44	0.48	0.21	1.757e-5	4.732e-5	(A) Negative
REV3L	6q21	-0.62	-0.92	0.67	0.55	0.30	1.761e-5	4.743e-5	(A) Negative
FCRL3	1q23.1	1.51	1.06	1.00	0.83	0.45	1.762e-5	4.744e-5	(A) Negative
RCSD1	1q24.2	-0.25	-0.77	1.18	0.94	0.52	1.773e-5	4.773e-5	(A) Negative
KLHL3	5q31.2	-0.26	-0.01	0.53	0.57	-0.25	1.774e-5	4.776e-5	(B) Positive
TNPO2	19p13.13	-0.69	-0.91	0.48	0.39	0.21	1.775e-5	4.776e-5	(A) Negative
RBL2	16q12.2	0.03	0.28	0.56	0.50	-0.25	1.775e-5	4.777e-5	(B) Positive
MRGBP	20q13.33	-0.64	-0.90	0.54	0.65	0.26	1.777e-5	4.781e-5	(A) Negative
RABGGTA	14q12	0.19	0.39	0.45	0.43	-0.21	1.779e-5	4.786e-5	(B) Positive
CDS2	20p12.3	0.43	0.69	0.55	0.54	-0.25	1.793e-5	4.822e-5	(B) Positive
ZDHHC22	14q24.3	-1.48	-1.27	0.36	0.69	-0.21	1.795e-5	4.826e-5	(B) Positive
MMRN1	4q22.1	1.27	1.74	0.96	1.21	-0.47	1.799e-5	4.837e-5	(B) Positive
PICALM	11q14.2	0.06	-0.18	0.54	0.47	0.24	1.810e-5	4.866e-5	(A) Negative
TEX15	8p12	-2.14	-2.71	1.35	0.69	0.58	1.812e-5	4.872e-5	(A) Negative
C1ORF43	1q21.3	0.33	0.58	0.53	0.58	-0.25	1.818e-5	4.887e-5	(B) Positive
TMEM9	1q32.1	0.22	0.48	0.56	0.58	-0.26	1.819e-5	4.889e-5	(B) Positive
LPAR3	1p22.3	-0.01	-0.55	1.23	0.97	0.54	1.839e-5	4.940e-5	(A) Negative
DYNLRB1	20q11.22	0.40	0.60	0.42	0.43	-0.19	1.839e-5	4.940e-5	(B) Positive
DEFA6	8p23.1	0.16	0.06	0.22	0.26	0.10	1.844e-5	4.953e-5	(A) Negative
NOL10	2p25.1	0.10	-0.13	0.54	0.40	0.24	1.849e-5	4.965e-5	(A) Negative
NOSIP	19q13.33	0.08	0.28	0.41	0.45	-0.19	1.851e-5	4.969e-5	(B) Positive
MRPL27	17q21.33	-0.13	0.16	0.65	0.62	-0.29	1.851e-5	4.970e-5	(B) Positive
NUDT9	4q22.1	0.21	0.48	0.61	0.47	-0.27	1.855e-5	4.980e-5	(B) Positive
CA5A	16q24.2	-3.93	-4.27	0.78	0.47	0.33	1.859e-5	4.989e-5	(A) Negative
CLIC3	9q34.3	-0.27	-0.89	1.40	1.09	0.62	1.860e-5	4.990e-5	(A) Negative
SLF2	10q24.31	-0.26	-0.06	0.45	0.41	-0.20	1.862e-5	4.996e-5	(B) Positive
BMP7	20q13.31	-1.75	-2.45	1.58	1.30	0.70	1.866e-5	5.005e-5	(A) Negative
ZNF763	19p13.2	-0.20	0.06	0.55	0.57	-0.26	1.866e-5	5.005e-5	(B) Positive
UBAP2L	1q21.3	-0.08	-0.31	0.51	0.44	0.23	1.867e-5	5.006e-5	(A) Negative
MBNL2	13q32.1	0.50	0.19	0.66	0.72	0.31	1.873e-5	5.022e-5	(A) Negative
DCAF7	17q23.3	-0.24	-0.48	0.54	0.47	0.24	1.878e-5	5.034e-5	(A) Negative
KMT2B	19q13.12	-0.08	-0.33	0.58	0.48	0.26	1.881e-5	5.041e-5	(A) Negative
LGMN	14q32.12	0.20	-0.03	0.50	0.44	0.22	1.884e-5	5.049e-5	(A) Negative
IKZF3	17q12-q21.1	0.85	0.45	0.88	0.79	0.40	1.885e-5	5.051e-5	(A) Negative
OR2W1	6p22.1	0.05	0.33	0.64	0.53	-0.28	1.888e-5	5.059e-5	(B) Positive
KDM5A	12p13.33	0.49	0.23	0.60	0.42	0.26	1.891e-5	5.065e-5	(A) Negative
KIZ	20p11.23	-1.47	-1.21	0.59	0.49	-0.26	1.893e-5	5.070e-5	(B) Positive
ZNF627	19p13.2	0.48	0.72	0.56	0.47	-0.25	1.893e-5	5.070e-5	(B) Positive
SPACA5	Xp11.23	-0.03	0.13	0.35	0.39	-0.16	1.896e-5	5.076e-5	(B) Positive
ELOVL4	6q14.1	-0.78	-1.31	1.22	0.85	0.53	1.907e-5	5.105e-5	(A) Negative
GABRG3	15q12	-1.43	-1.97	1.25	0.74	0.54	1.909e-5	5.110e-5	(A) Negative
PCK1	20q13.31	-2.30	-1.91	0.80	1.02	-0.39	1.910e-5	5.110e-5	(B) Positive
ABCB8	7q36.1	-0.18	0.07	0.55	0.52	-0.25	1.916e-5	5.126e-5	(B) Positive
HINFP	11q23.3	-0.47	-0.68	0.47	0.42	0.21	1.916e-5	5.126e-5	(A) Negative
COX5A	15q24.2	-0.55	-0.79	0.55	0.43	0.24	1.917e-5	5.128e-5	(A) Negative
CSTF2	Xq22.1	-0.53	-0.72	0.43	0.41	0.20	1.926e-5	5.152e-5	(A) Negative
MOG	6p22.1	0.20	-0.26	1.08	0.55	0.46	1.932e-5	5.165e-5	(A) Negative
PRCC	1q23.1	0.78	0.58	0.45	0.43	0.20	1.932e-5	5.166e-5	(A) Negative
KCNE3	11q13.4	2.65	2.34	0.69	0.63	0.31	1.934e-5	5.169e-5	(A) Negative
EBF1	5q33.3	0.21	0.66	0.97	1.04	-0.45	1.934e-5	5.169e-5	(B) Positive
ARHGAP31	3q13.32-q13.33	1.62	1.28	0.75	0.71	0.34	1.935e-5	5.171e-5	(A) Negative
GPR119	Xq26.1	0.49	0.32	0.39	0.32	0.17	1.942e-5	5.190e-5	(A) Negative
ARV1	1q42.2	0.26	0.54	0.61	0.57	-0.27	1.943e-5	5.190e-5	(B) Positive
DBNDD1	16q24.3	0.25	-0.06	0.69	0.69	0.32	1.945e-5	5.195e-5	(A) Negative
DCAF11	14q12	-0.11	0.16	0.63	0.49	-0.28	1.948e-5	5.202e-5	(B) Positive
OR2W3	1q44	-0.43	-0.10	0.74	0.71	-0.34	1.950e-5	5.206e-5	(B) Positive
TLCD4	1p21.3	-0.19	-0.70	1.13	1.06	0.51	1.955e-5	5.220e-5	(A) Negative
SEC61B	9q22.33	0.46	0.26	0.43	0.36	0.19	1.957e-5	5.224e-5	(A) Negative
FAM177A1	14q13.2	0.47	0.70	0.51	0.47	-0.23	1.962e-5	5.237e-5	(B) Positive
KHDC4	1q22	-0.97	-1.20	0.51	0.47	0.23	1.964e-5	5.241e-5	(A) Negative
ZBTB8OS	1p35.1	-0.25	-0.50	0.55	0.47	0.25	1.965e-5	5.242e-5	(A) Negative
FPR3	19q13.41	3.93	3.56	0.80	0.90	0.38	1.977e-5	5.275e-5	(A) Negative
TMEM139	7q34	1.27	0.65	1.40	1.20	0.62	1.978e-5	5.276e-5	(A) Negative
LRP3	19q13.11	0.98	0.75	0.49	0.50	0.22	1.980e-5	5.281e-5	(A) Negative
PDCD1LG2	9p24.1	0.73	0.34	0.88	0.73	0.39	1.997e-5	5.324e-5	(A) Negative
MYOG	1q32.1	0.41	0.32	0.19	0.21	0.09	1.997e-5	5.324e-5	(A) Negative
LCTL	15q22.31	-1.40	-1.90	1.15	0.73	0.49	1.997e-5	5.324e-5	(A) Negative
IRF2BP2	1q42.3	0.90	0.61	0.64	0.55	0.28	1.999e-5	5.329e-5	(A) Negative
LINC00158	21q21.2	0.63	0.25	0.88	0.64	0.38	2.012e-5	5.362e-5	(A) Negative
FCMR	1q32.1	0.26	0.58	0.71	0.70	-0.32	2.012e-5	5.362e-5	(B) Positive
STK17A	7p13	-0.63	-0.88	0.55	0.55	0.25	2.017e-5	5.375e-5	(A) Negative
MYCT1	6q25.2	1.84	2.16	0.70	0.68	-0.32	2.018e-5	5.376e-5	(B) Positive
SPDYE1	7p13	-0.18	0.03	0.46	0.44	-0.21	2.020e-5	5.380e-5	(B) Positive
GLYAT	11q12.1	0.24	0.57	0.65	0.92	-0.33	2.024e-5	5.390e-5	(B) Positive
ZNF233	19q13.31	0.68	1.14	1.02	0.97	-0.46	2.028e-5	5.401e-5	(B) Positive
MGAT5	2q21.2-q21.3	0.17	-0.05	0.51	0.46	0.23	2.030e-5	5.405e-5	(A) Negative
NELL1	11p15.1	0.64	1.26	1.16	1.86	-0.61	2.032e-5	5.409e-5	(B) Positive
NANOG	12p13.31	-4.29	-3.97	0.67	0.69	-0.31	2.040e-5	5.430e-5	(B) Positive
TRIM6	11p15.4	-0.22	0.29	1.17	0.92	-0.51	2.067e-5	5.501e-5	(B) Positive
MARK2	11q13.1	0.79	0.58	0.44	0.45	0.20	2.070e-5	5.507e-5	(A) Negative
IBA57	1q42.13	-0.44	-0.59	0.34	0.29	0.15	2.076e-5	5.521e-5	(A) Negative
LCOR	10q24.1	0.04	-0.22	0.59	0.47	0.26	2.083e-5	5.539e-5	(A) Negative
BRIX1	5p13.2	-0.88	-1.19	0.71	0.55	0.31	2.090e-5	5.558e-5	(A) Negative
BTLA	3q13.2	2.30	1.68	1.39	1.21	0.62	2.094e-5	5.567e-5	(A) Negative
ASXL1	20q11.21	-0.49	-0.67	0.39	0.34	0.17	2.115e-5	5.622e-5	(A) Negative
CASP10	2q33.1	-0.17	-0.51	0.77	0.58	0.34	2.123e-5	5.642e-5	(A) Negative
RUNDC3B	7q21.12	1.13	1.61	1.03	1.03	-0.47	2.123e-5	5.642e-5	(B) Positive
XRN1	3q23	0.45	0.23	0.51	0.39	0.22	2.136e-5	5.675e-5	(A) Negative
SLC12A5	20q13.12	-0.93	-0.73	0.39	0.60	-0.20	2.137e-5	5.679e-5	(B) Positive
USP4	3p21.31	0.30	0.48	0.41	0.38	-0.18	2.148e-5	5.706e-5	(B) Positive
ACY3	11q13.2	-0.02	-0.44	0.96	0.79	0.42	2.156e-5	5.727e-5	(A) Negative
ANKRD1	10q23.31	-2.17	-2.71	1.25	0.85	0.54	2.168e-5	5.756e-5	(A) Negative
LPXN	11q12.1	-0.23	-0.64	0.91	0.74	0.40	2.188e-5	5.809e-5	(A) Negative
CASP3	4q35.1	0.36	0.14	0.50	0.40	0.22	2.194e-5	5.824e-5	(A) Negative
RBMS3	3p24.1	0.05	0.48	0.93	0.91	-0.42	2.195e-5	5.824e-5	(B) Positive
GNE	9p13.3	-0.83	-1.28	1.05	0.67	0.45	2.195e-5	5.824e-5	(A) Negative
ETNPPL	4q25	-2.49	-1.83	1.38	1.73	-0.66	2.200e-5	5.837e-5	(B) Positive
S100A4	1q21.3	-0.33	-0.77	1.01	0.80	0.44	2.201e-5	5.840e-5	(A) Negative
KRTAP2-4	17q21.2	0.18	0.07	0.24	0.25	0.11	2.203e-5	5.843e-5	(A) Negative
CCNA1	13q13.3	0.47	-0.31	1.82	1.24	0.78	2.213e-5	5.870e-5	(A) Negative
XCL2	1q24.2	1.31	0.79	1.15	1.09	0.52	2.214e-5	5.871e-5	(A) Negative
INVS	9q31.1	-0.52	-0.77	0.56	0.48	0.25	2.214e-5	5.871e-5	(A) Negative
ZNF580	19q13.42	-0.12	0.17	0.64	0.60	-0.29	2.217e-5	5.878e-5	(B) Positive
ADSS1	14q32.33	-1.13	-0.67	1.07	0.77	-0.46	2.228e-5	5.905e-5	(B) Positive
SLC17A3	6p22.2	0.25	-0.02	0.62	0.46	0.27	2.238e-5	5.931e-5	(A) Negative
PI4K2B	4p15.2	0.07	-0.22	0.66	0.50	0.29	2.239e-5	5.933e-5	(A) Negative
MRPS24	7p13	-0.52	-0.72	0.47	0.39	0.21	2.241e-5	5.938e-5	(A) Negative
FAM193A	4p16.3	-0.02	0.19	0.47	0.39	-0.21	2.242e-5	5.940e-5	(B) Positive
IQCC	1p35.2	-0.78	-0.49	0.65	0.55	-0.29	2.249e-5	5.956e-5	(B) Positive
SCAF11	12q12	0.26	0.50	0.52	0.47	-0.23	2.252e-5	5.964e-5	(B) Positive
FADD	11q13.3	-0.16	0.13	0.56	0.83	-0.28	2.264e-5	5.995e-5	(B) Positive
ARMC8	3q22.3	-0.10	-0.31	0.47	0.39	0.21	2.271e-5	6.012e-5	(A) Negative
NPR3	5p13.3	0.63	-0.27	2.11	1.40	0.90	2.283e-5	6.042e-5	(A) Negative
SPAG9	17q21.33	-0.55	-0.82	0.60	0.53	0.27	2.285e-5	6.047e-5	(A) Negative
PDCD11	10q24.33	-0.32	-0.53	0.50	0.38	0.22	2.294e-5	6.070e-5	(A) Negative
VIRMA	8q22.1	0.45	0.69	0.52	0.60	-0.24	2.304e-5	6.096e-5	(B) Positive
ZNF417	19q13.43	0.13	0.34	0.49	0.45	-0.22	2.318e-5	6.131e-5	(B) Positive
MAGEA3	Xq28	-3.18	-3.95	1.81	1.14	0.77	2.326e-5	6.151e-5	(A) Negative
GPRASP1	Xq22.1	0.03	0.48	1.01	0.86	-0.45	2.326e-5	6.151e-5	(B) Positive
STYX	14q22.1	0.19	-0.08	0.62	0.49	0.27	2.327e-5	6.152e-5	(A) Negative
ELMO3	16q22.1	0.98	1.39	0.96	0.65	-0.41	2.335e-5	6.173e-5	(B) Positive
FAM118A	22q13.31	-0.46	-0.78	0.71	0.62	0.32	2.336e-5	6.175e-5	(A) Negative
IQSEC1	3p25.2	0.04	0.26	0.50	0.43	-0.22	2.337e-5	6.176e-5	(B) Positive
GMEB1	1p35.3	0.38	0.18	0.45	0.38	0.20	2.338e-5	6.177e-5	(A) Negative
PRR27	4q13.3	0.68	0.12	1.37	0.43	0.56	2.349e-5	6.206e-5	(A) Negative
SYNDIG1	20p11.21	0.08	0.82	1.63	1.54	-0.73	2.359e-5	6.232e-5	(B) Positive
RCOR3	1q32.2-q32.3	0.04	0.25	0.43	0.55	-0.21	2.376e-5	6.276e-5	(B) Positive
CD34	1q32.2	3.78	4.03	0.56	0.58	-0.26	2.381e-5	6.289e-5	(B) Positive
ELL2	5q15	-0.97	-0.62	0.76	0.74	-0.34	2.390e-5	6.311e-5	(B) Positive
IDI2	10p15.3	0.22	0.04	0.43	0.35	0.19	2.392e-5	6.316e-5	(A) Negative
ARPP19	15q21.2	-0.20	0.06	0.57	0.58	-0.26	2.393e-5	6.316e-5	(B) Positive
PTPN7	1q32.1	-0.20	-0.57	0.84	0.70	0.37	2.399e-5	6.331e-5	(A) Negative
MTO1	6q13	-0.71	-0.95	0.54	0.44	0.24	2.399e-5	6.331e-5	(A) Negative
SEC63	6q21	0.78	0.47	0.69	0.58	0.30	2.423e-5	6.392e-5	(A) Negative
ZFYVE9	1p32.3	-0.19	-0.50	0.66	0.78	0.31	2.440e-5	6.436e-5	(A) Negative
PAFAH1B2	11q23.3	0.10	-0.15	0.56	0.49	0.25	2.445e-5	6.448e-5	(A) Negative
GALNT15	3p25.1	0.97	1.33	0.80	0.74	-0.36	2.447e-5	6.452e-5	(B) Positive
WNT4	1p36.12	2.35	2.89	1.20	1.12	-0.54	2.455e-5	6.472e-5	(B) Positive
PRCP	11q14	0.65	0.95	0.64	0.74	-0.30	2.455e-5	6.473e-5	(B) Positive
OLFML2A	9q33.3	0.77	1.05	0.65	0.51	-0.28	2.465e-5	6.497e-5	(B) Positive
CELF6	15q23	-0.08	0.07	0.31	0.40	-0.15	2.465e-5	6.497e-5	(B) Positive
PIP5K1B	9q21.11	-0.14	-0.76	1.37	1.35	0.62	2.465e-5	6.497e-5	(A) Negative
GJE1	6q24.1	1.73	2.24	1.14	0.99	-0.50	2.466e-5	6.497e-5	(B) Positive
KCTD7	7q11.21	0.05	-0.10	0.33	0.34	0.15	2.469e-5	6.505e-5	(A) Negative
CYRIB	8q24.21	0.48	0.17	0.67	0.71	0.31	2.469e-5	6.505e-5	(A) Negative
PTGES3	12q13.3	-0.73	-0.51	0.50	0.40	-0.22	2.479e-5	6.529e-5	(B) Positive
GRB2	17q25.1	0.13	0.35	0.45	0.59	-0.22	2.492e-5	6.561e-5	(B) Positive
YEATS4	12q15	-0.94	-0.65	0.63	0.73	-0.29	2.493e-5	6.563e-5	(B) Positive
ZNFX1	20q13.13	0.52	0.81	0.65	0.59	-0.29	2.504e-5	6.592e-5	(B) Positive
SIRT1	10q21.3	0.11	0.32	0.48	0.47	-0.22	2.514e-5	6.616e-5	(B) Positive
YJU2	19p13.3	-0.18	0.03	0.47	0.41	-0.21	2.514e-5	6.616e-5	(B) Positive
F5	1q24.2	-2.08	-2.55	1.06	0.90	0.47	2.515e-5	6.618e-5	(A) Negative
ACAN	15q26.1	1.82	1.35	1.09	0.85	0.47	2.523e-5	6.636e-5	(A) Negative
LTBP2	14q24.3	2.04	2.36	0.70	0.71	-0.32	2.523e-5	6.636e-5	(B) Positive
MMP10	11q22.2	1.55	2.41	1.87	1.99	-0.86	2.530e-5	6.654e-5	(B) Positive
DYRK2	12q15	0.96	0.72	0.49	0.62	0.24	2.531e-5	6.657e-5	(A) Negative
AP1S3	2q36.1	0.54	0.14	0.92	0.70	0.40	2.532e-5	6.657e-5	(A) Negative
CYGB	17q25.1	-0.01	0.23	0.52	0.58	-0.24	2.544e-5	6.688e-5	(B) Positive
FCRLA	1q23.3	-0.66	-1.26	1.37	1.13	0.60	2.563e-5	6.735e-5	(A) Negative
C7	5p13.1	1.52	2.13	1.31	1.53	-0.61	2.564e-5	6.737e-5	(B) Positive
TNFRSF13B	17p11.2	-1.72	-1.99	0.60	0.52	0.27	2.568e-5	6.747e-5	(A) Negative
YKT6	7p13	-0.26	-0.47	0.49	0.44	0.22	2.576e-5	6.768e-5	(A) Negative
TPP2	13q33.1	-0.36	-0.63	0.61	0.51	0.27	2.578e-5	6.772e-5	(A) Negative
IRF9	14q12	1.71	2.06	0.80	0.69	-0.35	2.581e-5	6.778e-5	(B) Positive
WAS	Xp11.23	0.53	0.31	0.51	0.41	0.22	2.588e-5	6.795e-5	(A) Negative
UPK1B	3q13.32	0.21	-0.30	1.22	0.63	0.51	2.590e-5	6.800e-5	(A) Negative
PRRC2A	6p21.33	-0.47	-0.67	0.44	0.46	0.20	2.604e-5	6.835e-5	(A) Negative
PTGES	9q34.11	0.55	0.98	0.94	1.05	-0.44	2.612e-5	6.857e-5	(B) Positive
SLC46A3	13q12.3	1.16	1.57	0.92	0.87	-0.41	2.619e-5	6.874e-5	(B) Positive
EML3	11q12.3	-0.83	-0.61	0.49	0.54	-0.23	2.625e-5	6.889e-5	(B) Positive
UNC93A	6q27	-2.81	-3.11	0.70	0.50	0.30	2.652e-5	6.958e-5	(A) Negative
ZNF71	19q13.4	0.92	0.68	0.55	0.45	0.24	2.656e-5	6.968e-5	(A) Negative
CYB5R3	22q13.2	0.28	0.08	0.46	0.38	0.20	2.673e-5	7.010e-5	(A) Negative
PDE6H	12p12.3	-0.65	-0.98	0.75	0.70	0.34	2.679e-5	7.026e-5	(A) Negative
WIF1	12q14.3	1.68	0.99	1.62	1.18	0.69	2.684e-5	7.039e-5	(A) Negative
TMEM38B	9q31.2	-1.28	-1.75	1.04	1.10	0.48	2.692e-5	7.056e-5	(A) Negative
USP30	12q24.11	0.18	0.37	0.43	0.42	-0.19	2.705e-5	7.089e-5	(B) Positive
MSH5	6p21.33	-1.74	-1.97	0.52	0.45	0.23	2.708e-5	7.098e-5	(A) Negative
NR5A1	9q33.3	0.02	-0.09	0.25	0.29	0.12	2.710e-5	7.102e-5	(A) Negative
EPSTI1	13q14.11	1.45	1.01	1.01	0.85	0.44	2.712e-5	7.105e-5	(A) Negative
ZNF133	20p11.23	0.17	-0.09	0.60	0.50	0.26	2.712e-5	7.105e-5	(A) Negative
DLC1	8p22	-0.21	0.12	0.73	0.74	-0.33	2.715e-5	7.111e-5	(B) Positive
MRPS22	3q23	-0.61	-0.80	0.45	0.35	0.19	2.727e-5	7.141e-5	(A) Negative
ZC3H7A	16p13.13	-0.22	-0.03	0.44	0.32	-0.19	2.727e-5	7.141e-5	(B) Positive
STIMATE	3p21.1	0.13	0.43	0.68	0.63	-0.30	2.735e-5	7.159e-5	(B) Positive
SEC22C	3p22.1	-0.31	-0.09	0.52	0.42	-0.23	2.750e-5	7.197e-5	(B) Positive
ZNF304	19q13.43	0.80	1.05	0.59	0.49	-0.26	2.755e-5	7.212e-5	(B) Positive
CNOT6	5q35.3	0.05	0.26	0.49	0.43	-0.22	2.757e-5	7.214e-5	(B) Positive
GPR83	11q21	0.40	0.23	0.39	0.37	0.17	2.757e-5	7.214e-5	(A) Negative
PDCD6	5p15.33	-0.32	-0.07	0.57	0.47	-0.25	2.759e-5	7.219e-5	(B) Positive
LRRC15	3q29	0.03	0.54	1.13	1.14	-0.51	2.760e-5	7.219e-5	(B) Positive
ISCA1	9q21.33	0.09	0.28	0.45	0.38	-0.19	2.762e-5	7.224e-5	(B) Positive
C11ORF24	11q13.2	-0.01	-0.25	0.54	0.52	0.24	2.779e-5	7.266e-5	(A) Negative
REG1A	2p12	0.31	0.09	0.47	0.54	0.22	2.790e-5	7.294e-5	(A) Negative
PCNX2	1q42.2	0.34	0.09	0.56	0.54	0.25	2.791e-5	7.294e-5	(A) Negative
ZNF626	19p12	0.19	0.49	0.68	0.58	-0.30	2.793e-5	7.300e-5	(B) Positive
LUC7L	16p13.3	-0.91	-0.61	0.68	0.58	-0.30	2.811e-5	7.346e-5	(B) Positive
FCER1A	1q23.2	3.39	4.00	1.40	1.14	-0.61	2.813e-5	7.348e-5	(B) Positive
APOBR	16p12.1	1.95	2.26	0.70	0.71	-0.31	2.813e-5	7.348e-5	(B) Positive
KANSL1	17q21.31	0.16	0.40	0.52	0.50	-0.23	2.816e-5	7.355e-5	(B) Positive
IL2RB	22q12.3	1.69	1.29	0.89	0.88	0.40	2.818e-5	7.359e-5	(A) Negative
KAT14	20p11.23	0.08	0.31	0.54	0.47	-0.24	2.824e-5	7.375e-5	(B) Positive
SLC39A4	8q24.3	0.22	-0.16	0.82	1.00	0.39	2.825e-5	7.375e-5	(A) Negative
GATM	15q21.1	2.50	3.06	1.22	1.29	-0.55	2.832e-5	7.392e-5	(B) Positive
ZNF547	19q13.43	0.52	0.82	0.65	0.66	-0.29	2.837e-5	7.404e-5	(B) Positive
CRTC3	15q26.1	0.33	0.54	0.48	0.49	-0.22	2.839e-5	7.409e-5	(B) Positive
GPR171	3q25.1	3.23	2.62	1.39	1.27	0.61	2.846e-5	7.426e-5	(A) Negative
ENPP4	6p21.1	1.53	1.93	0.87	0.98	-0.40	2.848e-5	7.431e-5	(B) Positive
NXT2	Xq23	0.63	0.29	0.78	0.63	0.34	2.850e-5	7.434e-5	(A) Negative
TUBB8	10p15.3	-0.28	-0.49	0.46	0.41	0.20	2.857e-5	7.450e-5	(A) Negative
CHRNB4	15q25.1	0.33	0.15	0.41	0.39	0.18	2.863e-5	7.465e-5	(A) Negative
CCL26	7q11.23	-1.05	-1.43	0.86	0.74	0.38	2.870e-5	7.484e-5	(A) Negative
GNG5	1p22.3	0.00	-0.28	0.65	0.59	0.29	2.884e-5	7.518e-5	(A) Negative
ANAPC16	10q22.1	0.17	0.38	0.48	0.42	-0.21	2.900e-5	7.557e-5	(B) Positive
GNG8	19q13.32	0.52	0.32	0.47	0.37	0.20	2.900e-5	7.557e-5	(A) Negative
RUNX1T1	8q21.3	2.11	2.64	1.21	1.08	-0.53	2.907e-5	7.574e-5	(B) Positive
DLX4	17q21.33	-0.99	-1.42	0.98	0.91	0.43	2.907e-5	7.574e-5	(A) Negative
SMU1	9p21.1	0.14	-0.06	0.47	0.40	0.20	2.912e-5	7.586e-5	(A) Negative
REX1BD	19p13.11	0.29	0.01	0.64	0.56	0.28	2.921e-5	7.607e-5	(A) Negative
TRPM7	15q21.2	-0.48	-0.24	0.54	0.46	-0.24	2.923e-5	7.611e-5	(B) Positive
TRANK1	3p22.2	0.49	0.75	0.60	0.50	-0.26	2.925e-5	7.615e-5	(B) Positive
CNTN3	3p12.3	1.65	2.10	0.95	1.14	-0.44	2.925e-5	7.615e-5	(B) Positive
ZYG11B	1p32.3	-0.14	-0.37	0.53	0.45	0.23	2.926e-5	7.616e-5	(A) Negative
SPTBN1	2p16.2	0.28	0.01	0.60	0.54	0.26	2.932e-5	7.630e-5	(A) Negative
GRB10	7p12.1	0.14	-0.20	0.77	0.73	0.34	2.932e-5	7.630e-5	(A) Negative
CSNK1D	17q25.3	-0.50	-0.70	0.48	0.39	0.21	2.940e-5	7.650e-5	(A) Negative
PLEKHA1	10q26.13	0.80	0.54	0.60	0.55	0.27	2.944e-5	7.658e-5	(A) Negative
ZNF75D	Xq26.3	0.18	0.38	0.45	0.42	-0.20	2.949e-5	7.669e-5	(B) Positive
ACKR2	3p22.1	0.51	0.05	1.10	0.66	0.46	2.956e-5	7.687e-5	(A) Negative
AMACR	5p13.2	-0.13	0.24	0.89	0.56	-0.37	2.958e-5	7.691e-5	(B) Positive
CCM2L	20q11.21	1.49	1.81	0.73	0.66	-0.32	2.964e-5	7.706e-5	(B) Positive
ATP13A4	3q29	1.86	1.16	1.60	1.33	0.69	2.984e-5	7.757e-5	(A) Negative
TRGV5	7p14.1	0.63	0.50	0.30	0.29	0.13	2.988e-5	7.765e-5	(A) Negative
DXO	6p21.33	0.11	-0.08	0.44	0.39	0.19	2.991e-5	7.771e-5	(A) Negative
C4ORF36	4q21.3	0.02	0.30	0.63	0.70	-0.29	2.991e-5	7.771e-5	(B) Positive
NSDHL	Xq28	0.01	-0.20	0.49	0.39	0.21	3.027e-5	7.864e-5	(A) Negative
ISG20L2	1q23.1	0.50	0.27	0.52	0.46	0.23	3.029e-5	7.868e-5	(A) Negative
EEF1D	8q24.3	0.52	0.78	0.58	0.57	-0.26	3.030e-5	7.870e-5	(B) Positive
POGLUT2	13q33.1	-1.18	-1.57	0.91	0.74	0.39	3.039e-5	7.890e-5	(A) Negative
COMMD4	15q24.2	-0.67	-0.46	0.48	0.45	-0.21	3.044e-5	7.903e-5	(B) Positive
LAIR2	19q13.42	0.06	-0.51	1.29	1.15	0.57	3.051e-5	7.920e-5	(A) Negative
WAC	10p12.1	0.54	0.34	0.47	0.30	0.20	3.058e-5	7.936e-5	(A) Negative
GSKIP	14q32.2	0.05	0.33	0.65	0.50	-0.28	3.065e-5	7.952e-5	(B) Positive
LHFPL6	13q13.3-q14.11	1.00	1.32	0.70	0.77	-0.32	3.065e-5	7.952e-5	(B) Positive
CFAP57	1p34.2	0.60	0.80	0.43	0.53	-0.20	3.079e-5	7.987e-5	(B) Positive
PLK2	5q11.2	0.47	0.94	1.04	1.10	-0.47	3.079e-5	7.987e-5	(B) Positive
MC2R	18p11.2	0.14	0.29	0.34	0.34	-0.15	3.094e-5	8.025e-5	(B) Positive
GNL3L	Xp11.22	-1.31	-1.53	0.49	0.46	0.22	3.104e-5	8.048e-5	(A) Negative
WDR17	4q34.2	-0.59	-0.23	0.78	0.94	-0.36	3.111e-5	8.065e-5	(B) Positive
BTN2A3P	6p22.2	0.00	-0.14	0.31	0.28	0.14	3.114e-5	8.073e-5	(A) Negative
ZYX	7q34	0.37	0.09	0.64	0.64	0.29	3.142e-5	8.144e-5	(A) Negative
C1ORF74	1q32.2	0.61	0.34	0.63	0.57	0.27	3.152e-5	8.168e-5	(A) Negative
MAP3K19	2q21.3	0.15	0.49	0.72	0.90	-0.34	3.152e-5	8.168e-5	(B) Positive
RAB10	2p23.3	0.40	0.22	0.41	0.34	0.18	3.162e-5	8.192e-5	(A) Negative
RHNO1	12p13.33	-0.51	-0.80	0.69	0.44	0.29	3.172e-5	8.218e-5	(A) Negative
DYNC1LI2	16q22.1	0.28	0.06	0.51	0.47	0.22	3.196e-5	8.276e-5	(A) Negative
DERL1	8q24.13	0.64	0.40	0.51	0.61	0.24	3.214e-5	8.322e-5	(A) Negative
CEP70	3q22.3	0.04	-0.24	0.67	0.56	0.29	3.217e-5	8.330e-5	(A) Negative
CLIP4	2p23.2	0.17	-0.35	1.15	1.22	0.52	3.228e-5	8.355e-5	(A) Negative
SLC16A3	17q25.3	-1.64	-2.05	0.94	0.88	0.41	3.234e-5	8.371e-5	(A) Negative
CYTIP	2q24.1	1.10	0.55	1.25	1.26	0.56	3.243e-5	8.394e-5	(A) Negative
IGF1	12q23.2	1.94	2.59	1.49	1.36	-0.65	3.245e-5	8.397e-5	(B) Positive
ZNF18	17p12	0.10	0.32	0.46	0.60	-0.22	3.248e-5	8.403e-5	(B) Positive
RNF141	11p15.3	0.39	0.63	0.58	0.45	-0.25	3.258e-5	8.428e-5	(B) Positive
IRF3	19q13.33	-0.40	-0.62	0.51	0.50	0.23	3.269e-5	8.455e-5	(A) Negative
RNASE2	14q11.2	0.54	0.15	0.91	0.71	0.39	3.274e-5	8.467e-5	(A) Negative
XRCC1	19q13.31	-0.24	-0.05	0.42	0.39	-0.18	3.277e-5	8.474e-5	(B) Positive
RNF34	12q24.31	0.02	0.27	0.59	0.49	-0.25	3.292e-5	8.510e-5	(B) Positive
TOR1B	9q34.11	-0.31	-0.08	0.54	0.46	-0.23	3.312e-5	8.560e-5	(B) Positive
IFIH1	2q24.2	2.40	1.92	1.10	0.91	0.47	3.315e-5	8.566e-5	(A) Negative
TPMT	6p22.3	-0.61	-0.89	0.65	0.56	0.28	3.319e-5	8.577e-5	(A) Negative
FDPS	1q22	-0.15	-0.41	0.59	0.56	0.26	3.322e-5	8.583e-5	(A) Negative
DRC1	2p23.3	0.28	0.66	0.75	1.15	-0.38	3.322e-5	8.583e-5	(B) Positive
SDCBP2	20p13	1.57	1.03	1.24	1.06	0.54	3.333e-5	8.609e-5	(A) Negative
ZCCHC3	20p13	-0.73	-0.55	0.38	0.40	-0.17	3.336e-5	8.614e-5	(B) Positive
USHBP1	19p13.11	0.87	1.08	0.47	0.47	-0.21	3.340e-5	8.624e-5	(B) Positive
RAB4A	1q42.13	0.90	0.64	0.59	0.56	0.26	3.351e-5	8.652e-5	(A) Negative
MCRS1	12q13.12	-0.40	-0.23	0.39	0.39	-0.17	3.354e-5	8.658e-5	(B) Positive
CAPN2	1q41	0.58	0.20	0.86	0.83	0.38	3.366e-5	8.687e-5	(A) Negative
LAMA5	20q13.33	-0.71	-0.39	0.73	0.63	-0.32	3.369e-5	8.694e-5	(B) Positive
TAS1R3	1p36.33	0.29	0.16	0.28	0.33	0.13	3.374e-5	8.705e-5	(A) Negative
TFAM	10q21.1	-0.25	-0.50	0.61	0.39	0.26	3.379e-5	8.716e-5	(A) Negative
ZNF225	19q13.31	-0.13	0.08	0.49	0.47	-0.22	3.379e-5	8.717e-5	(B) Positive
ZNF197	3p21.31	-0.37	-0.15	0.50	0.42	-0.21	3.383e-5	8.724e-5	(B) Positive
EXOSC4	8q24.3	0.42	0.15	0.60	0.65	0.27	3.386e-5	8.732e-5	(A) Negative
RAVER2	1p31.3	0.43	-0.05	1.13	0.88	0.48	3.397e-5	8.757e-5	(A) Negative
LRP5	11q13.2	-0.20	-0.48	0.64	0.63	0.28	3.407e-5	8.784e-5	(A) Negative
CDKN2AIPNL	5q31.1	-1.31	-1.05	0.57	0.62	-0.26	3.417e-5	8.807e-5	(B) Positive
RBM45	2q31.2	0.09	0.20	0.23	0.26	-0.11	3.422e-5	8.819e-5	(B) Positive
MED14	Xp11.4	0.04	-0.13	0.39	0.38	0.17	3.425e-5	8.826e-5	(A) Negative
OARD1	6p21.1	-0.68	-0.45	0.53	0.47	-0.23	3.431e-5	8.839e-5	(B) Positive
SLC39A14	8p21.3	-0.68	-0.96	0.67	0.46	0.28	3.450e-5	8.887e-5	(A) Negative
MRTFA	22q13.1-q13.2	0.72	0.57	0.32	0.36	0.15	3.456e-5	8.901e-5	(A) Negative
DNAJC11	1p36.31	-0.28	-0.52	0.55	0.49	0.24	3.484e-5	8.972e-5	(A) Negative
FHIT	3p14.2	0.22	0.45	0.53	0.56	-0.24	3.491e-5	8.990e-5	(B) Positive
RBM6	3p21.31	-0.83	-0.62	0.47	0.47	-0.21	3.499e-5	9.009e-5	(B) Positive
CEP164	11q23.3	-0.09	-0.28	0.45	0.37	0.19	3.510e-5	9.035e-5	(A) Negative
CDK18	1q32.1	0.19	-0.05	0.55	0.50	0.24	3.512e-5	9.039e-5	(A) Negative
NEK1	4q33	0.14	0.39	0.58	0.46	-0.25	3.518e-5	9.054e-5	(B) Positive
DKKL1	19q13.33	0.31	-0.12	0.97	0.91	0.42	3.524e-5	9.066e-5	(A) Negative
PCDHB13	5q31.3	0.47	0.22	0.56	0.55	0.25	3.534e-5	9.091e-5	(A) Negative
ACADVL	17p13.1	-0.70	-0.46	0.53	0.53	-0.24	3.567e-5	9.176e-5	(B) Positive
KCTD9	8p21.2	-0.20	-0.57	0.87	0.61	0.37	3.575e-5	9.194e-5	(A) Negative
NALCN	13q32.3-q33.1	0.38	0.07	0.76	0.41	0.31	3.598e-5	9.251e-5	(A) Negative
DQX1	2p13.1	-2.49	-1.92	1.25	1.43	-0.57	3.605e-5	9.268e-5	(B) Positive
CPT1A	11q13.3	-0.18	0.18	0.82	0.79	-0.36	3.607e-5	9.272e-5	(B) Positive
NDUFC1	4q31.1	0.14	0.41	0.64	0.51	-0.27	3.608e-5	9.274e-5	(B) Positive
LAMTOR1	11q13.4	0.31	0.45	0.33	0.33	-0.15	3.611e-5	9.279e-5	(B) Positive
ZNF618	9q32	0.92	0.67	0.59	0.49	0.25	3.617e-5	9.292e-5	(A) Negative
VASP	19q13.32	1.29	0.96	0.75	0.68	0.33	3.617e-5	9.292e-5	(A) Negative
PIGP	21q22.13	-0.12	0.13	0.55	0.58	-0.25	3.617e-5	9.292e-5	(B) Positive
ACTR8	3p21.1	-0.17	-0.01	0.36	0.36	-0.16	3.621e-5	9.299e-5	(B) Positive
FRAT2	10q24.1	0.62	0.37	0.58	0.45	0.25	3.627e-5	9.313e-5	(A) Negative
LAMB3	1q32.2	0.19	-0.50	1.62	1.37	0.69	3.661e-5	9.399e-5	(A) Negative
WDR72	15q21.3	-2.13	-1.60	1.11	1.48	-0.53	3.669e-5	9.419e-5	(B) Positive
COLGALT2	1q25.3	-1.71	-2.15	1.04	0.78	0.44	3.676e-5	9.435e-5	(A) Negative
PAG1	8q21.13	0.17	-0.24	0.95	0.79	0.41	3.684e-5	9.455e-5	(A) Negative
CD244	1q23.3	0.97	0.62	0.81	0.60	0.34	3.685e-5	9.455e-5	(A) Negative
SLC35B2	6p21.1	0.20	-0.03	0.54	0.46	0.23	3.686e-5	9.458e-5	(A) Negative
H2AC13	6p22.1	0.03	0.37	0.73	0.96	-0.35	3.711e-5	9.520e-5	(B) Positive
ZNF14	19p13.11	0.71	0.97	0.57	0.63	-0.26	3.766e-5	9.658e-5	(B) Positive
SLC26A2	5q32	0.58	0.14	1.06	0.68	0.44	3.768e-5	9.663e-5	(A) Negative
OR2T2	1q44	0.43	0.20	0.55	0.41	0.23	3.769e-5	9.663e-5	(A) Negative
ENTHD1	22q13.1	1.22	0.71	1.21	1.01	0.52	3.803e-5	9.750e-5	(A) Negative
CLDN16	3q28	0.67	0.34	0.75	0.65	0.32	3.804e-5	9.750e-5	(A) Negative
METAP1D	2q31.1	-0.99	-1.32	0.76	0.65	0.33	3.807e-5	9.757e-5	(A) Negative
PSMB7	9q33.3	-0.41	-0.61	0.47	0.43	0.21	3.810e-5	9.763e-5	(A) Negative
ROBO3	11q24.2	-0.59	-0.80	0.48	0.43	0.21	3.829e-5	9.808e-5	(A) Negative
RBPMS	8p12	-0.24	0.11	0.80	0.71	-0.35	3.829e-5	9.808e-5	(B) Positive
RMDN2	2p22.2	0.13	0.45	0.74	0.67	-0.32	3.848e-5	9.857e-5	(B) Positive
OS9	12q13.3-q14.1	0.21	0.44	0.50	0.53	-0.22	3.852e-5	9.865e-5	(B) Positive
PCSK9	1p32.3	-2.91	-3.29	0.90	0.72	0.38	3.854e-5	9.869e-5	(A) Negative
OR10W1	11q12.1	0.12	0.29	0.31	0.54	-0.17	3.861e-5	9.885e-5	(B) Positive
COMP	19p13.11	3.84	4.35	1.23	0.74	-0.51	3.877e-5	9.923e-5	(B) Positive
ZBTB45	19q13.43	0.61	0.81	0.49	0.42	-0.21	3.879e-5	9.927e-5	(B) Positive
RAB11FIP5	2p13.2	0.17	0.40	0.52	0.43	-0.22	3.881e-5	9.931e-5	(B) Positive
CST11	20p11.21	0.42	0.77	0.72	1.00	-0.35	3.902e-5	9.983e-5	(B) Positive
GLIS3-AS1	9p24.2	0.30	0.10	0.45	0.42	0.19	3.929e-5	1.005e-4	(A) Negative
BBLN	9q34.11	0.15	-0.05	0.47	0.45	0.20	3.931e-5	1.006e-4	(A) Negative
TMEM222	1p36.11	0.34	0.52	0.41	0.39	-0.18	3.933e-5	1.006e-4	(B) Positive
AVIL	12q14.1	0.39	0.72	0.75	0.74	-0.33	3.949e-5	1.010e-4	(B) Positive
NSUN5P2	7q11.23	-0.63	-0.84	0.48	0.41	0.20	3.972e-5	1.016e-4	(A) Negative
ACOT7	1p36.31	-0.83	-1.12	0.63	0.71	0.29	3.984e-5	1.019e-4	(A) Negative
SLIT3	5q34-q35.1	2.64	2.94	0.72	0.57	-0.30	3.987e-5	1.019e-4	(B) Positive
ACTB	7p22.1	0.72	0.51	0.46	0.48	0.21	3.998e-5	1.022e-4	(A) Negative
ZNF2	2q11.1	0.29	0.48	0.45	0.41	-0.19	4.005e-5	1.023e-4	(B) Positive
CSNK1G2	19p13.3	0.05	-0.16	0.49	0.36	0.21	4.013e-5	1.025e-4	(A) Negative
EIF4EBP2	10q22.1	0.62	0.44	0.44	0.38	0.19	4.030e-5	1.030e-4	(A) Negative
NDN	15q11.2	-1.04	-0.57	1.11	0.98	-0.48	4.043e-5	1.033e-4	(B) Positive
C15ORF48	15q21.1	4.18	4.71	1.19	1.22	-0.53	4.044e-5	1.033e-4	(B) Positive
PBX3	9q33.3	-0.34	0.06	0.89	0.98	-0.40	4.047e-5	1.033e-4	(B) Positive
SLC12A2	5q23.3	0.94	1.46	1.22	1.05	-0.52	4.066e-5	1.038e-4	(B) Positive
AGBL5	2p23.3	-0.25	-0.47	0.52	0.38	0.22	4.084e-5	1.042e-4	(A) Negative
SUCLA2	13q14.2	-0.60	-0.34	0.61	0.52	-0.26	4.093e-5	1.045e-4	(B) Positive
TRPV5	7q34	0.41	0.24	0.37	0.42	0.17	4.095e-5	1.045e-4	(A) Negative
SNAP91	6q14.2	0.38	0.17	0.51	0.43	0.22	4.104e-5	1.047e-4	(A) Negative
NIPA1	15q11.2	-0.46	-0.19	0.62	0.67	-0.28	4.110e-5	1.048e-4	(B) Positive
LCN6	9q34.3	0.89	1.15	0.57	0.70	-0.27	4.148e-5	1.058e-4	(B) Positive
UMPS	3q21.2	0.18	0.01	0.39	0.33	0.17	4.154e-5	1.059e-4	(A) Negative
CTTN	11q13.3	0.33	0.62	0.60	0.77	-0.28	4.155e-5	1.060e-4	(B) Positive
GORASP1	3p22.2	0.35	0.57	0.50	0.44	-0.21	4.164e-5	1.062e-4	(B) Positive
SNX14	6q14.3	-0.02	0.24	0.61	0.51	-0.26	4.187e-5	1.067e-4	(B) Positive
ZNF322	6p22.2	0.24	0.47	0.53	0.43	-0.23	4.187e-5	1.067e-4	(B) Positive
BLZF1	1q24.2	0.61	0.85	0.56	0.46	-0.24	4.194e-5	1.069e-4	(B) Positive
MGLL	3q21.3	-0.31	0.16	1.07	1.01	-0.46	4.219e-5	1.075e-4	(B) Positive
ZFP1	16q23.1	-0.18	-0.40	0.50	0.49	0.22	4.248e-5	1.082e-4	(A) Negative
LARP4	12q13.12	-0.11	0.10	0.47	0.48	-0.21	4.254e-5	1.084e-4	(B) Positive
GCNT1	9q21.13	1.01	0.46	1.28	1.10	0.55	4.274e-5	1.089e-4	(A) Negative
SHC3	9q22.1	-0.44	-1.02	1.40	0.86	0.57	4.283e-5	1.091e-4	(A) Negative
KRT34	17q21.2	-1.35	-1.77	1.04	0.64	0.43	4.284e-5	1.091e-4	(A) Negative
RIT1	1q22	0.48	0.21	0.63	0.53	0.27	4.285e-5	1.091e-4	(A) Negative
IFNB1	9p21.3	0.19	-0.10	0.69	0.53	0.29	4.293e-5	1.093e-4	(A) Negative
GAS7	17p13.1	-0.31	0.01	0.74	0.71	-0.32	4.295e-5	1.093e-4	(B) Positive
EPHA4	2q36.1	-0.41	-0.91	1.14	1.10	0.50	4.308e-5	1.096e-4	(A) Negative
IRX2-DT	5p15.33	0.24	0.71	1.04	1.16	-0.47	4.321e-5	1.099e-4	(B) Positive
MYO5B	18q21.1	1.87	1.55	0.77	0.64	0.32	4.339e-5	1.104e-4	(A) Negative
ARHGEF1	19q13.2	0.16	-0.05	0.48	0.43	0.21	4.351e-5	1.107e-4	(A) Negative
CIBAR1	8q22.1	-0.88	-1.37	1.14	1.07	0.49	4.353e-5	1.107e-4	(A) Negative
PYGB	20p11.21	0.08	-0.24	0.77	0.59	0.32	4.364e-5	1.110e-4	(A) Negative
FHIP1B	11p15.4	0.05	0.20	0.34	0.36	-0.15	4.368e-5	1.111e-4	(B) Positive
RGP1	9p13.3	0.87	0.58	0.68	0.67	0.30	4.389e-5	1.116e-4	(A) Negative
TMA7	3p21.31	-0.03	0.19	0.52	0.47	-0.22	4.390e-5	1.116e-4	(B) Positive
SDC1	2p24.1	1.85	1.41	1.01	1.02	0.44	4.404e-5	1.119e-4	(A) Negative
CSNK2A1	20p13	0.04	-0.15	0.44	0.43	0.19	4.413e-5	1.121e-4	(A) Negative
RNF19B	1p35.1	1.33	1.06	0.64	0.50	0.27	4.416e-5	1.122e-4	(A) Negative
ARHGAP36	Xq26.1	-3.95	-3.15	1.63	2.46	-0.80	4.471e-5	1.136e-4	(B) Positive
TCL1B	14q32.13	-0.72	-0.19	1.17	1.29	-0.52	4.479e-5	1.137e-4	(B) Positive
MFAP4	17p11.2	-1.28	-0.73	1.23	1.38	-0.55	4.497e-5	1.142e-4	(B) Positive
DHRS1	14q12	0.33	0.58	0.59	0.51	-0.25	4.505e-5	1.144e-4	(B) Positive
TMEM181	6q25.3	-0.06	0.27	0.76	0.77	-0.33	4.506e-5	1.144e-4	(B) Positive
SSC4D	7q11.23	-0.81	-1.10	0.63	0.79	0.29	4.508e-5	1.144e-4	(A) Negative
PHF23	17p13.1	-0.11	0.05	0.37	0.38	-0.16	4.512e-5	1.145e-4	(B) Positive
TRABD	22q13.33	0.38	0.18	0.45	0.50	0.20	4.516e-5	1.146e-4	(A) Negative
AP1G1	16q22.2	0.12	-0.07	0.44	0.47	0.19	4.519e-5	1.146e-4	(A) Negative
ZNF554	19p13.3	0.40	0.66	0.61	0.47	-0.25	4.532e-5	1.150e-4	(B) Positive
ECT2L	6q24.1	0.67	1.01	0.72	0.97	-0.34	4.542e-5	1.152e-4	(B) Positive
TAOK2	16p11.2	0.14	0.33	0.43	0.40	-0.19	4.545e-5	1.153e-4	(B) Positive
POLM	7p13	0.81	0.66	0.34	0.36	0.15	4.560e-5	1.156e-4	(A) Negative
NOL7	6p23	-0.18	-0.33	0.36	0.29	0.15	4.561e-5	1.156e-4	(A) Negative
GEMIN6	2p22.1	-0.06	-0.30	0.58	0.46	0.24	4.572e-5	1.159e-4	(A) Negative
COQ8B	19q13.2	-0.15	0.07	0.50	0.49	-0.22	4.595e-5	1.165e-4	(B) Positive
AEBP1	7p13	1.40	1.83	0.98	0.98	-0.43	4.612e-5	1.169e-4	(B) Positive
GTF2E2	8p12	-0.38	-0.64	0.60	0.55	0.26	4.617e-5	1.170e-4	(A) Negative
UVSSA	4p16.3	-0.82	-0.55	0.62	0.60	-0.27	4.626e-5	1.172e-4	(B) Positive
PINK1	1p36.12	0.32	0.49	0.40	0.37	-0.17	4.642e-5	1.176e-4	(B) Positive
THADA	2p21	0.10	-0.12	0.54	0.31	0.22	4.654e-5	1.179e-4	(A) Negative
RXFP1	4q32.1	0.53	0.19	0.75	0.79	0.33	4.656e-5	1.179e-4	(A) Negative
DYNC1I2	2q31.1	0.40	0.57	0.38	0.42	-0.17	4.675e-5	1.184e-4	(B) Positive
EPM2AIP1	3p22.2	-0.43	-0.17	0.58	0.57	-0.25	4.679e-5	1.185e-4	(B) Positive
RYR3	15q13.3-q14	-0.17	-0.74	1.41	0.77	0.57	4.698e-5	1.189e-4	(A) Negative
MANBA	4q24	0.25	0.57	0.75	0.64	-0.32	4.703e-5	1.190e-4	(B) Positive
NOXO1	16p13.3	2.40	1.72	1.57	1.50	0.68	4.703e-5	1.190e-4	(A) Negative
AAR2	20q11.23	0.23	0.41	0.43	0.39	-0.19	4.710e-5	1.192e-4	(B) Positive
EXOSC2	9q34.12	-1.08	-1.30	0.55	0.41	0.23	4.732e-5	1.197e-4	(A) Negative
ANXA4	2p13.3	0.25	-0.00	0.60	0.45	0.25	4.742e-5	1.199e-4	(A) Negative
SSR2	1q22	1.07	0.85	0.49	0.49	0.21	4.757e-5	1.203e-4	(A) Negative
KATNIP	16p12.1	0.22	0.39	0.41	0.33	-0.17	4.761e-5	1.204e-4	(B) Positive
EBP	Xp11.23	-0.63	-0.89	0.61	0.53	0.26	4.768e-5	1.205e-4	(A) Negative
TFF2	21q22.3	0.78	0.14	1.58	0.84	0.64	4.776e-5	1.207e-4	(A) Negative
NTHL1	16p13.3	-0.24	-0.01	0.52	0.61	-0.24	4.784e-5	1.209e-4	(B) Positive
C11ORF58	11p15.2	0.21	0.42	0.48	0.50	-0.21	4.784e-5	1.209e-4	(B) Positive
ARFGAP2	11p11.2	-0.48	-0.23	0.55	0.61	-0.25	4.789e-5	1.210e-4	(B) Positive
ARRDC5	19p13.3	1.11	0.83	0.65	0.68	0.28	4.792e-5	1.211e-4	(A) Negative
SLC31A1	9q32	-0.22	-0.47	0.57	0.59	0.25	4.808e-5	1.214e-4	(A) Negative
RNF167	17p13.2	-0.16	0.02	0.42	0.44	-0.18	4.820e-5	1.217e-4	(B) Positive
ARAP1	11q13.4	0.09	0.32	0.51	0.50	-0.22	4.821e-5	1.217e-4	(B) Positive
VILL	3p22.2	-0.28	0.06	0.78	0.77	-0.34	4.841e-5	1.222e-4	(B) Positive
ITSN1	21q22.11	-0.46	-0.23	0.54	0.45	-0.23	4.850e-5	1.224e-4	(B) Positive
TMEM150A	2p11.2	0.32	0.56	0.61	0.37	-0.25	4.852e-5	1.225e-4	(B) Positive
SEPTIN6	Xq24	-0.56	-0.84	0.66	0.59	0.28	4.853e-5	1.225e-4	(A) Negative
H2BC21	1q21.2	0.03	0.42	0.86	0.94	-0.38	4.854e-5	1.225e-4	(B) Positive
LHFPL5	6p21.31	0.86	0.66	0.47	0.42	0.20	4.858e-5	1.226e-4	(A) Negative
CHPT1	12q23.2	-0.35	0.14	1.11	1.10	-0.48	4.864e-5	1.227e-4	(B) Positive
SLMAP	3p14.3	0.29	0.51	0.51	0.46	-0.22	4.865e-5	1.227e-4	(B) Positive
DNASE2B	1p31.1-p22.3	1.06	1.60	1.19	1.45	-0.54	4.867e-5	1.227e-4	(B) Positive
BLTP1	4q27	0.43	0.68	0.60	0.56	-0.26	4.888e-5	1.233e-4	(B) Positive
PHLDA3	1q32.1	0.16	0.59	1.03	0.84	-0.43	4.897e-5	1.235e-4	(B) Positive
PRMT1	19q13.33	-0.85	-1.07	0.51	0.49	0.22	4.930e-5	1.243e-4	(A) Negative
HOXB9	17q21.32	-3.64	-4.17	1.26	0.94	0.52	4.935e-5	1.244e-4	(A) Negative
SLCO1C1	12p12.2	-0.05	0.15	0.44	0.52	-0.20	4.938e-5	1.244e-4	(B) Positive
RBBP7	Xp22.2	0.03	0.32	0.62	0.77	-0.28	4.942e-5	1.245e-4	(B) Positive
LILRA2	19q13.42	-0.31	0.00	0.73	0.66	-0.31	4.950e-5	1.247e-4	(B) Positive
ACTN2	1q43	0.57	-0.33	2.10	1.95	0.90	4.973e-5	1.253e-4	(A) Negative
ALPI	2q37.1	0.19	0.09	0.22	0.21	0.10	4.987e-5	1.256e-4	(A) Negative
MBOAT1	6p22.3	0.67	1.24	1.41	0.95	-0.58	4.989e-5	1.256e-4	(B) Positive
SOCS7	17q12	0.63	0.33	0.69	0.68	0.30	5.028e-5	1.266e-4	(A) Negative
STAT6	12q13.3	0.24	0.61	0.85	0.76	-0.36	5.031e-5	1.266e-4	(B) Positive
PIH1D1	19q13.33	-0.29	-0.11	0.44	0.42	-0.19	5.058e-5	1.273e-4	(B) Positive
NDUFB4	3q13.33	0.10	0.31	0.49	0.48	-0.21	5.075e-5	1.277e-4	(B) Positive
OXA1L	14q11.2	-0.86	-0.66	0.48	0.39	-0.20	5.083e-5	1.279e-4	(B) Positive
SSR4	Xq28	0.35	0.09	0.60	0.53	0.26	5.089e-5	1.280e-4	(A) Negative
SLC17A5	6q13	0.16	-0.18	0.81	0.71	0.34	5.104e-5	1.284e-4	(A) Negative
CEP295	11q21	-0.47	-0.72	0.57	0.52	0.24	5.129e-5	1.290e-4	(A) Negative
PARVB	22q13.31	-0.57	-0.89	0.74	0.70	0.32	5.130e-5	1.290e-4	(A) Negative
ANO1	11q13.3	3.62	3.93	0.73	0.59	-0.31	5.135e-5	1.291e-4	(B) Positive
TNFAIP8L3	15q21.2	0.62	0.93	0.71	0.74	-0.31	5.144e-5	1.293e-4	(B) Positive
GOLGA5	14q32.12	0.61	0.83	0.54	0.42	-0.22	5.171e-5	1.300e-4	(B) Positive
GLOD4	17p13.3	-0.01	0.17	0.42	0.44	-0.19	5.187e-5	1.304e-4	(B) Positive
SPRING1	12q24.22	0.90	0.60	0.72	0.56	0.30	5.189e-5	1.304e-4	(A) Negative
D2HGDH	2q37.3	-0.39	-0.19	0.46	0.43	-0.20	5.189e-5	1.304e-4	(B) Positive
AIRIM	1p34.3	-0.15	-0.39	0.57	0.46	0.24	5.202e-5	1.307e-4	(A) Negative
RNF130	5q35.3	1.09	0.87	0.51	0.44	0.22	5.209e-5	1.308e-4	(A) Negative
OR8J1	11q12.1	0.54	0.36	0.41	0.37	0.17	5.213e-5	1.309e-4	(A) Negative
TRPT1	11q13.1	-0.40	-0.19	0.48	0.46	-0.21	5.227e-5	1.313e-4	(B) Positive
CTBP2	10q26.13	1.15	1.38	0.55	0.48	-0.23	5.235e-5	1.314e-4	(B) Positive
TREM2	6p21.1	3.40	3.68	0.67	0.50	-0.28	5.252e-5	1.319e-4	(B) Positive
PPDPFL	8q11.21	-3.53	-3.89	0.89	0.60	0.36	5.267e-5	1.322e-4	(A) Negative
ASCC3	6q16.3	0.18	-0.06	0.55	0.53	0.24	5.271e-5	1.323e-4	(A) Negative
IDO2	8p11.21	0.36	-0.11	1.12	0.89	0.47	5.294e-5	1.329e-4	(A) Negative
FASTKD2	2q33.3	0.07	-0.14	0.51	0.39	0.21	5.302e-5	1.330e-4	(A) Negative
TRA2A	7p15.3	-0.05	0.13	0.43	0.40	-0.18	5.317e-5	1.334e-4	(B) Positive
SLC38A5	Xp11.23	-2.18	-2.51	0.77	0.77	0.33	5.326e-5	1.336e-4	(A) Negative
MAST3	19p13.11	-0.46	-0.25	0.48	0.47	-0.21	5.330e-5	1.337e-4	(B) Positive
HEATR9	17q12	0.33	0.17	0.38	0.35	0.16	5.349e-5	1.341e-4	(A) Negative
CDKN1B	12p13.1	0.02	0.35	0.73	0.84	-0.33	5.349e-5	1.341e-4	(B) Positive
FAM162A	3q21.1	-0.89	-0.62	0.62	0.65	-0.27	5.363e-5	1.344e-4	(B) Positive
GALK2	15q21.1-q21.2	-0.54	-0.77	0.53	0.49	0.23	5.366e-5	1.345e-4	(A) Negative
PCYT1A	3q29	0.61	0.35	0.62	0.54	0.26	5.378e-5	1.348e-4	(A) Negative
RAD1	5p13.2	-0.43	-0.66	0.57	0.44	0.24	5.408e-5	1.355e-4	(A) Negative
GCNT4	5q13.3	0.10	0.28	0.40	0.53	-0.19	5.413e-5	1.356e-4	(B) Positive
KLHDC8A	1q32.1	1.08	0.76	0.76	0.57	0.31	5.445e-5	1.364e-4	(A) Negative
SRC	20q11.23	0.58	0.32	0.62	0.55	0.26	5.448e-5	1.365e-4	(A) Negative
THNSL2	2p11.2	1.56	1.99	0.98	1.10	-0.43	5.464e-5	1.368e-4	(B) Positive
QSOX1	1q25.2	0.03	0.43	0.97	0.80	-0.41	5.486e-5	1.374e-4	(B) Positive
CMTM1	16q21	0.58	0.32	0.62	0.52	0.26	5.523e-5	1.383e-4	(A) Negative
ANGPTL1	1q25.2	0.60	1.03	0.98	1.07	-0.43	5.543e-5	1.387e-4	(B) Positive
CKAP5	11p11.2	-0.41	-0.63	0.53	0.46	0.22	5.549e-5	1.389e-4	(A) Negative
HDAC6	Xp11.23	-0.47	-0.62	0.36	0.28	0.15	5.564e-5	1.392e-4	(A) Negative
TUBA3C	13q12.11	-0.40	-0.61	0.48	0.56	0.21	5.576e-5	1.395e-4	(A) Negative
CERCAM	9q34.11	-0.27	0.02	0.68	0.65	-0.29	5.580e-5	1.396e-4	(B) Positive
SHLD1	20p12.3	-0.59	-0.30	0.71	0.60	-0.30	5.616e-5	1.405e-4	(B) Positive
SULT1E1	4q13.3	0.17	-0.34	1.27	0.74	0.51	5.618e-5	1.405e-4	(A) Negative
TIMM10B	11p15.4	0.24	0.47	0.53	0.48	-0.22	5.623e-5	1.406e-4	(B) Positive
PEX16	11p11.2	0.09	0.29	0.49	0.43	-0.21	5.632e-5	1.408e-4	(B) Positive
POMGNT2	3p22.1	0.26	0.49	0.56	0.46	-0.23	5.633e-5	1.408e-4	(B) Positive
TARBP2	12q13.13	-0.60	-0.39	0.49	0.39	-0.20	5.654e-5	1.413e-4	(B) Positive
CXCL12	10q11.21	1.77	2.24	1.11	1.05	-0.47	5.656e-5	1.414e-4	(B) Positive
TCEAL9	Xq22.2	0.23	-0.17	0.91	0.91	0.39	5.675e-5	1.418e-4	(A) Negative
FAM200A	7q22.1	-0.06	0.14	0.44	0.51	-0.20	5.687e-5	1.421e-4	(B) Positive
RSPH9	6p21.1	0.79	1.04	0.51	0.71	-0.24	5.691e-5	1.422e-4	(B) Positive
MAK16	8p12	-0.76	-1.04	0.66	0.57	0.28	5.705e-5	1.425e-4	(A) Negative
CTU1	19q13.41	0.34	0.12	0.53	0.50	0.22	5.723e-5	1.429e-4	(A) Negative
IARS1	9q22.31	-1.03	-1.27	0.56	0.51	0.24	5.724e-5	1.429e-4	(A) Negative
RNASEH2C	11q13.1	-0.40	-0.17	0.53	0.57	-0.23	5.727e-5	1.430e-4	(B) Positive
BAX	19q13.33	-0.68	-0.90	0.51	0.50	0.22	5.745e-5	1.434e-4	(A) Negative
CRLS1	20p12.3	-0.44	-0.66	0.52	0.45	0.22	5.804e-5	1.449e-4	(A) Negative
ACTN3	11q13.2	0.71	0.42	0.70	0.64	0.30	5.809e-5	1.449e-4	(A) Negative
HNRNPCL1	1p36.21	0.30	0.49	0.44	0.45	-0.19	5.809e-5	1.449e-4	(B) Positive
PNPLA6	19p13.2	0.20	0.04	0.38	0.41	0.17	5.825e-5	1.453e-4	(A) Negative
HIPK4	19q13.2	0.06	0.30	0.57	0.56	-0.24	5.832e-5	1.455e-4	(B) Positive
SLC32A1	20q11.23	-0.70	-0.88	0.43	0.46	0.19	5.841e-5	1.457e-4	(A) Negative
KLK4	19q13.41	0.80	1.07	0.63	0.69	-0.28	5.845e-5	1.458e-4	(B) Positive
DHODH	16q22.2	-0.78	-1.05	0.64	0.52	0.27	5.852e-5	1.459e-4	(A) Negative
RIPPLY2	6q14.2	-0.66	-1.20	1.32	1.04	0.54	5.854e-5	1.459e-4	(A) Negative
ZBED10P	7q36.1	-1.24	-1.63	0.93	0.76	0.39	5.856e-5	1.459e-4	(A) Negative
CCL24	7q11.23	0.44	0.26	0.41	0.38	0.17	5.856e-5	1.459e-4	(A) Negative
CCL8	17q12	4.45	4.02	0.96	1.11	0.43	5.858e-5	1.460e-4	(A) Negative
ASB9	Xp22.2	-2.00	-2.46	1.08	1.00	0.46	5.861e-5	1.460e-4	(A) Negative
C2CD4A	15q22.2	1.13	0.83	0.69	0.69	0.30	5.893e-5	1.468e-4	(A) Negative
XKRX	Xq22.1	0.55	0.08	1.15	0.94	0.48	5.922e-5	1.475e-4	(A) Negative
LPA	6q25.3-q26	-0.17	-0.29	0.27	0.31	0.12	5.944e-5	1.480e-4	(A) Negative
ADAM20	14q24.2	-0.08	0.10	0.41	0.46	-0.18	5.951e-5	1.482e-4	(B) Positive
TOR2A	9q34.11	-0.06	0.04	0.23	0.22	-0.10	5.962e-5	1.485e-4	(B) Positive
TPT1	13q14.13	0.46	0.70	0.54	0.54	-0.23	5.988e-5	1.491e-4	(B) Positive
GPN2	1p36.11	-0.15	-0.33	0.45	0.38	0.19	6.008e-5	1.495e-4	(A) Negative
BRINP2	1q25.2	0.22	0.81	1.22	1.79	-0.59	6.010e-5	1.496e-4	(B) Positive
RPL7L1	6p21.1	-0.34	-0.55	0.49	0.39	0.20	6.012e-5	1.496e-4	(A) Negative
CLEC14A	14q21.1	4.99	5.24	0.60	0.54	-0.25	6.024e-5	1.499e-4	(B) Positive
EFHB	3p24.3	0.33	0.73	0.87	1.08	-0.39	6.081e-5	1.513e-4	(B) Positive
IL1RL2	2q12.1	0.57	0.38	0.43	0.43	0.19	6.088e-5	1.514e-4	(A) Negative
CAPNS1	19q13.12	0.01	0.24	0.54	0.49	-0.23	6.097e-5	1.516e-4	(B) Positive
L3HYPDH	14q23.1	-0.71	-0.99	0.70	0.49	0.28	6.121e-5	1.522e-4	(A) Negative
PTBP2	1p21.3	-0.37	-0.71	0.82	0.56	0.33	6.122e-5	1.522e-4	(A) Negative
ALG8	11q14.1	-0.51	-0.17	0.77	0.84	-0.34	6.132e-5	1.524e-4	(B) Positive
DBI	2q14.2	1.07	0.72	0.84	0.74	0.35	6.175e-5	1.535e-4	(A) Negative
SMDT1	22q13.2	-0.16	0.06	0.51	0.53	-0.22	6.179e-5	1.536e-4	(B) Positive
CRISP2	6p12.3	1.21	0.55	1.63	1.17	0.66	6.185e-5	1.537e-4	(A) Negative
STEAP4	7q21.12	0.72	1.42	1.58	1.82	-0.70	6.195e-5	1.539e-4	(B) Positive
FNDC4	2p23.3	0.64	0.25	0.92	0.84	0.39	6.201e-5	1.540e-4	(A) Negative
NR1I2	3q13.33	-1.85	-2.19	0.85	0.53	0.34	6.207e-5	1.542e-4	(A) Negative
NMRAL1	16p13.3	0.43	0.64	0.48	0.43	-0.20	6.221e-5	1.545e-4	(B) Positive
ORC3	6q15	-0.14	-0.39	0.63	0.49	0.26	6.223e-5	1.545e-4	(A) Negative
CNR2	1p36.11	0.68	0.45	0.54	0.45	0.22	6.225e-5	1.545e-4	(A) Negative
GCNT3	15q22.2	-1.48	-2.25	1.94	1.17	0.77	6.239e-5	1.549e-4	(A) Negative
AK9	6q21	0.52	0.83	0.72	0.72	-0.31	6.251e-5	1.552e-4	(B) Positive
ATP6V0E2	7q36.1	0.53	0.92	0.94	0.79	-0.39	6.262e-5	1.554e-4	(B) Positive
ZNF45	19q13.31	0.12	0.32	0.49	0.41	-0.20	6.264e-5	1.554e-4	(B) Positive
CD14	5q31.3	4.27	4.00	0.64	0.52	0.26	6.282e-5	1.558e-4	(A) Negative
C1S	12p13.31	3.50	2.97	1.23	1.25	0.53	6.355e-5	1.576e-4	(A) Negative
URB1	21q22.11	-0.28	-0.49	0.51	0.37	0.21	6.375e-5	1.581e-4	(A) Negative
CHMP4C	8q21.13	1.99	1.51	1.14	0.97	0.48	6.406e-5	1.588e-4	(A) Negative
SUGCT	7p14.1	0.09	-0.22	0.74	0.67	0.31	6.406e-5	1.588e-4	(A) Negative
ATP2A3	17p13.2	-0.15	0.26	0.95	1.00	-0.41	6.424e-5	1.593e-4	(B) Positive
TIGD3	11q13.1	-0.07	0.29	0.88	0.73	-0.36	6.439e-5	1.596e-4	(B) Positive
AHCTF1	1q44	0.22	-0.06	0.67	0.56	0.28	6.460e-5	1.601e-4	(A) Negative
AKAP14	Xq24	0.14	0.50	0.73	1.14	-0.36	6.473e-5	1.604e-4	(B) Positive
MYBPC3	11p11.2	0.68	0.50	0.44	0.37	0.18	6.475e-5	1.604e-4	(A) Negative
CYP2E1	10q26.3	-0.83	-0.51	0.78	0.71	-0.33	6.516e-5	1.614e-4	(B) Positive
KRBA1	7q36.1	-0.49	-0.75	0.60	0.65	0.26	6.523e-5	1.616e-4	(A) Negative
ZNF177	19p13.2	-0.40	0.06	1.07	1.14	-0.46	6.530e-5	1.617e-4	(B) Positive
PLRG1	4q31.3	-0.18	-0.40	0.53	0.34	0.21	6.535e-5	1.618e-4	(A) Negative
PPM1H	12q14.1-q14.2	-0.02	0.45	1.13	0.99	-0.47	6.551e-5	1.622e-4	(B) Positive
OR5M11	11q12.1	0.36	0.20	0.38	0.41	0.16	6.570e-5	1.626e-4	(A) Negative
TGS1	8q12.1	-0.09	-0.37	0.67	0.59	0.28	6.574e-5	1.627e-4	(A) Negative
WIPF1	2q31.1	0.58	0.26	0.78	0.68	0.32	6.599e-5	1.633e-4	(A) Negative
FAHD2A	2q11.1	-0.28	-0.52	0.57	0.48	0.24	6.612e-5	1.636e-4	(A) Negative
SPIN2A	Xp11.21	-0.03	0.20	0.54	0.54	-0.23	6.618e-5	1.637e-4	(B) Positive
SMYD1	2p11.2	0.62	0.29	0.81	0.66	0.33	6.634e-5	1.641e-4	(A) Negative
RNF43	17q22	-0.44	-0.04	0.93	0.87	-0.39	6.643e-5	1.643e-4	(B) Positive
TSPAN32	11p15.5	0.46	0.24	0.51	0.50	0.22	6.662e-5	1.647e-4	(A) Negative
EMILIN3	20q12	-0.03	-0.22	0.47	0.31	0.19	6.674e-5	1.650e-4	(A) Negative
CDH7	18q22.1	-1.11	-0.72	0.81	1.24	-0.39	6.676e-5	1.650e-4	(B) Positive
RPS10	6p21.31	0.24	0.02	0.51	0.47	0.21	6.698e-5	1.656e-4	(A) Negative
PLSCR1	3q24	1.03	0.59	1.07	0.84	0.44	6.717e-5	1.660e-4	(A) Negative
PSMD6	3p14.1	-1.75	-1.56	0.44	0.44	-0.19	6.738e-5	1.665e-4	(B) Positive
CPS1-IT1	2q34	0.33	0.87	1.30	1.14	-0.54	6.748e-5	1.667e-4	(B) Positive
LRR1	14q21.3	-0.84	-1.10	0.62	0.55	0.26	6.750e-5	1.668e-4	(A) Negative
CCT5	5p15.2	-0.09	-0.35	0.62	0.60	0.26	6.759e-5	1.670e-4	(A) Negative
ABCG5	2p21	-4.15	-4.45	0.73	0.61	0.30	6.762e-5	1.670e-4	(A) Negative
FEM1B	15q23	-0.16	-0.41	0.61	0.50	0.25	6.772e-5	1.672e-4	(A) Negative
ZNF232	17p13.2	-0.04	-0.35	0.76	0.51	0.30	6.784e-5	1.675e-4	(A) Negative
VSIG2	11q24.2	0.33	0.87	1.22	1.45	-0.54	6.798e-5	1.678e-4	(B) Positive
SCUBE3	6p21.3	0.85	0.41	1.07	0.84	0.44	6.805e-5	1.680e-4	(A) Negative
SRGAP1	12q14.2	-0.13	0.22	0.80	0.87	-0.35	6.844e-5	1.689e-4	(B) Positive
MMP27	11q22.2	0.58	0.93	0.81	0.87	-0.35	6.858e-5	1.692e-4	(B) Positive
PAX9	14q13.3	-0.10	0.64	1.85	1.19	-0.74	6.881e-5	1.698e-4	(B) Positive
NDUFB9	8q24.13	0.67	0.37	0.70	0.69	0.30	6.893e-5	1.700e-4	(A) Negative
TSPY26P	20q11.21	0.09	0.36	0.65	0.61	-0.27	6.912e-5	1.705e-4	(B) Positive
WRNIP1	6p25.2	0.40	0.24	0.40	0.31	0.16	6.937e-5	1.711e-4	(A) Negative
IYD	6q25.1	1.09	1.71	1.45	1.44	-0.62	6.941e-5	1.711e-4	(B) Positive
HFM1	1p22.2	-1.25	-1.59	0.82	0.67	0.34	6.948e-5	1.713e-4	(A) Negative
MYBPC2	19q13.33	-1.01	-1.40	0.96	0.75	0.39	6.960e-5	1.716e-4	(A) Negative
MKS1	17q22	-0.27	-0.03	0.58	0.53	-0.24	6.971e-5	1.718e-4	(B) Positive
RAB24	5q35.3	-0.74	-0.51	0.57	0.47	-0.23	6.985e-5	1.721e-4	(B) Positive
SACM1L	3p21.31	-0.94	-0.64	0.72	0.67	-0.30	6.995e-5	1.724e-4	(B) Positive
ANKRD40CL	17q21.33	0.37	0.27	0.24	0.25	0.10	7.004e-5	1.726e-4	(A) Negative
SH2D1A	Xq25	-2.04	-2.66	1.50	1.36	0.63	7.035e-5	1.733e-4	(A) Negative
ZFP14	19q13.12	-0.14	0.24	0.93	0.72	-0.38	7.037e-5	1.733e-4	(B) Positive
DCAF16	4p15.31	-0.75	-0.44	0.75	0.72	-0.32	7.041e-5	1.734e-4	(B) Positive
LHPP	10q26.13	0.59	0.35	0.58	0.55	0.24	7.045e-5	1.735e-4	(A) Negative
TRIR	19p13.13	0.34	0.20	0.33	0.32	0.14	7.055e-5	1.737e-4	(A) Negative
KLHL13	Xq24	-1.15	-1.79	1.51	1.38	0.63	7.066e-5	1.739e-4	(A) Negative
PLCE1	10q23.33	0.25	-0.31	1.29	1.42	0.56	7.074e-5	1.741e-4	(A) Negative
SNRPD2	19q13.2-q13.3	0.17	-0.00	0.40	0.42	0.17	7.079e-5	1.742e-4	(A) Negative
SGCD	5q33.2-q33.3	-1.01	-0.60	0.94	1.00	-0.41	7.085e-5	1.743e-4	(B) Positive
B4GALT3	1q23.3	0.86	0.63	0.54	0.56	0.23	7.089e-5	1.744e-4	(A) Negative
RAPSN	11p11.2	0.41	0.24	0.41	0.30	0.16	7.118e-5	1.751e-4	(A) Negative
RPL3	22q13.1	0.12	0.32	0.46	0.50	-0.20	7.122e-5	1.752e-4	(B) Positive
CMTM4	16q22.1-q22.3	0.52	0.22	0.71	0.64	0.30	7.126e-5	1.752e-4	(A) Negative
INTS2	17q23.2	-1.07	-0.83	0.53	0.67	-0.24	7.134e-5	1.754e-4	(B) Positive
LYSET	14q32.12	-0.04	0.23	0.66	0.56	-0.27	7.146e-5	1.757e-4	(B) Positive
DHX16	6p21.33	-0.18	-0.34	0.38	0.35	0.16	7.159e-5	1.760e-4	(A) Negative
UBL4B	1p13.3	0.44	0.24	0.49	0.36	0.20	7.160e-5	1.760e-4	(A) Negative
TPD52	8q21.13	1.15	1.50	0.83	0.82	-0.35	7.170e-5	1.762e-4	(B) Positive
NAV2	11p15.1	-0.57	-0.89	0.78	0.71	0.32	7.171e-5	1.762e-4	(A) Negative
JARID2	6p22.3	-0.39	-0.65	0.65	0.50	0.26	7.178e-5	1.763e-4	(A) Negative
SLC24A4	14q32.12	0.84	0.62	0.52	0.48	0.22	7.222e-5	1.774e-4	(A) Negative
CAND2	3p25.2	-0.35	-0.92	1.40	1.10	0.57	7.251e-5	1.781e-4	(A) Negative
LRRC75A	17p11.2	0.17	0.55	0.90	0.79	-0.37	7.264e-5	1.784e-4	(B) Positive
NCR2	6p21.1	0.27	0.12	0.33	0.41	0.15	7.267e-5	1.784e-4	(A) Negative
AP3M2	8p11.21	-0.05	0.24	0.67	0.74	-0.29	7.274e-5	1.786e-4	(B) Positive
ZNF593	1p36.11	0.27	0.05	0.52	0.49	0.22	7.290e-5	1.789e-4	(A) Negative
NFYC	1p34.2	0.61	0.44	0.41	0.39	0.17	7.290e-5	1.789e-4	(A) Negative
STRBP	9q33.1-q33.3	0.04	0.23	0.46	0.48	-0.20	7.325e-5	1.797e-4	(B) Positive
MMP24	20q11.22	0.14	0.30	0.41	0.34	-0.17	7.325e-5	1.797e-4	(B) Positive
SLC1A3	5p13.2	0.89	0.47	1.02	0.82	0.42	7.339e-5	1.801e-4	(A) Negative
RPS15	19p13.3	-0.12	0.10	0.54	0.49	-0.22	7.359e-5	1.805e-4	(B) Positive
LINC01587	4p16.2	0.11	-0.37	1.19	0.79	0.47	7.364e-5	1.806e-4	(A) Negative
TRUB1	10q25.3	0.39	0.54	0.37	0.32	-0.15	7.384e-5	1.811e-4	(B) Positive
ESF1	20p12.1	-0.19	-0.40	0.51	0.48	0.21	7.388e-5	1.811e-4	(A) Negative
LYZ	12q15	0.24	-0.51	1.79	1.65	0.75	7.397e-5	1.813e-4	(A) Negative
SYF2	1p36.11	-0.10	0.10	0.49	0.46	-0.20	7.409e-5	1.816e-4	(B) Positive
DENND4A	15q22.31	-0.83	-0.62	0.51	0.47	-0.21	7.449e-5	1.826e-4	(B) Positive
PMS1	2q32.2	-0.73	-0.91	0.43	0.35	0.18	7.451e-5	1.826e-4	(A) Negative
KCNJ15	21q22.13-q22.2	1.52	1.03	1.16	1.17	0.49	7.457e-5	1.827e-4	(A) Negative
ZNF655	7q22.1	-0.79	-0.46	0.80	0.62	-0.33	7.469e-5	1.829e-4	(B) Positive
APOBEC3F	22q13.1	-1.05	-1.43	0.91	0.80	0.38	7.469e-5	1.829e-4	(A) Negative
SPOUT1	9q34.11	-0.67	-0.46	0.50	0.48	-0.21	7.487e-5	1.834e-4	(B) Positive
MYADML	2p22.3	0.37	0.29	0.20	0.22	0.09	7.489e-5	1.834e-4	(A) Negative
EHF	11p13	6.38	5.64	1.67	1.97	0.74	7.521e-5	1.841e-4	(A) Negative
PIGX	3q29	-0.13	0.14	0.66	0.54	-0.27	7.524e-5	1.842e-4	(B) Positive
WDR45B	17q25.3	0.36	0.11	0.60	0.59	0.25	7.554e-5	1.849e-4	(A) Negative
TNR	1q25.1	0.46	0.30	0.39	0.32	0.16	7.560e-5	1.850e-4	(A) Negative
GSS	20q11.22	-0.38	-0.16	0.52	0.46	-0.22	7.575e-5	1.854e-4	(B) Positive
PLSCR4	3q24	1.52	1.90	0.93	0.83	-0.38	7.582e-5	1.855e-4	(B) Positive
PRELID3B	20q13.32	-0.02	-0.24	0.49	0.59	0.22	7.587e-5	1.856e-4	(A) Negative
CLN3	16p12.1	-0.47	-0.29	0.41	0.47	-0.18	7.593e-5	1.857e-4	(B) Positive
ATP1A4	1q23.2	0.26	-0.06	0.76	0.74	0.32	7.622e-5	1.864e-4	(A) Negative
IFT27	22q12.3	0.77	1.10	0.83	0.55	-0.33	7.622e-5	1.864e-4	(B) Positive
TMEM176A	7q36.1	3.89	3.67	0.50	0.58	0.22	7.629e-5	1.865e-4	(A) Negative
TUBB4B	9q34.3	-0.44	-0.21	0.54	0.55	-0.23	7.642e-5	1.868e-4	(B) Positive
C4BPA	1q32.2	-2.78	-3.44	1.67	0.83	0.65	7.651e-5	1.870e-4	(A) Negative
SLC25A46	5q22.1	-0.74	-0.54	0.47	0.43	-0.20	7.656e-5	1.871e-4	(B) Positive
CCT3	1q22	0.22	0.02	0.45	0.47	0.19	7.680e-5	1.877e-4	(A) Negative
CFAP126	1q23.3	0.50	0.85	0.79	1.00	-0.35	7.720e-5	1.886e-4	(B) Positive
ZNHIT6	1p22.3	0.26	-0.01	0.67	0.57	0.28	7.771e-5	1.898e-4	(A) Negative
KLRC1	12p13	-0.72	-1.21	1.22	0.90	0.49	7.786e-5	1.902e-4	(A) Negative
RANBP17	5q35.1	0.62	0.13	1.16	1.13	0.49	7.819e-5	1.909e-4	(A) Negative
SLC30A1	1q32.3	-0.45	-0.17	0.63	0.74	-0.28	7.832e-5	1.912e-4	(B) Positive
ATP8A1	4p13	1.39	0.97	1.03	0.80	0.42	7.846e-5	1.915e-4	(A) Negative
UPK2	11q23.3	0.08	-0.06	0.33	0.38	0.14	7.865e-5	1.920e-4	(A) Negative
MCMDC2	8q13.1	0.98	0.56	0.99	1.05	0.42	7.889e-5	1.925e-4	(A) Negative
SLA2	20q11.23	0.22	-0.27	1.17	1.03	0.48	7.905e-5	1.929e-4	(A) Negative
SGK2	20q13.12	-1.38	-0.97	0.98	0.92	-0.41	7.925e-5	1.934e-4	(B) Positive
RGPD4	2q12.3	0.39	0.09	0.74	0.66	0.30	7.938e-5	1.937e-4	(A) Negative
PANX2	22q13.33	0.13	-0.07	0.49	0.46	0.20	7.957e-5	1.941e-4	(A) Negative
NES	1q23.1	-0.76	-1.25	1.26	0.69	0.49	7.991e-5	1.949e-4	(A) Negative
MVB12A	19p13.11	-0.23	-0.02	0.53	0.44	-0.22	7.997e-5	1.950e-4	(B) Positive
TMEM67	8q22.1	0.02	0.33	0.74	0.68	-0.31	8.001e-5	1.951e-4	(B) Positive
FKBP3	14q21.2	-0.54	-0.28	0.63	0.48	-0.25	8.004e-5	1.951e-4	(B) Positive
CACNA2D4	12p13.33	-1.33	-1.09	0.57	0.63	-0.25	8.046e-5	1.961e-4	(B) Positive
OR2T8	1q44	-0.08	0.11	0.44	0.51	-0.19	8.077e-5	1.968e-4	(B) Positive
ALPP	2q37.1	-0.39	-0.62	0.58	0.33	0.23	8.093e-5	1.972e-4	(A) Negative
CSMD3	8q23.3	-0.63	-0.45	0.32	0.64	-0.17	8.094e-5	1.972e-4	(B) Positive
ZNF598	16p13.3	-0.45	-0.65	0.48	0.50	0.20	8.114e-5	1.977e-4	(A) Negative
ILDR1	3q13.33	-1.26	-1.08	0.41	0.51	-0.18	8.192e-5	1.995e-4	(B) Positive
SPIN2B	Xp11.21	-0.12	0.11	0.53	0.54	-0.22	8.219e-5	2.002e-4	(B) Positive
ERAP1	5q15	-0.24	0.10	0.80	0.72	-0.33	8.234e-5	2.005e-4	(B) Positive
FRMD8	11q13.1	0.81	0.56	0.61	0.55	0.25	8.241e-5	2.006e-4	(A) Negative
TMEM87B	2q13	0.98	1.30	0.80	0.55	-0.32	8.284e-5	2.017e-4	(B) Positive
UCP3	11q13.4	0.47	0.29	0.41	0.47	0.18	8.291e-5	2.018e-4	(A) Negative
MYBL1	8q13.1	-0.83	-1.42	1.44	1.23	0.59	8.305e-5	2.021e-4	(A) Negative
THG1L	5q33.3	-0.83	-0.60	0.56	0.48	-0.23	8.306e-5	2.021e-4	(B) Positive
GRK3	22q12.1	0.86	1.15	0.69	0.65	-0.29	8.310e-5	2.022e-4	(B) Positive
WDCP	2p23.3	-0.40	-0.62	0.56	0.38	0.22	8.322e-5	2.025e-4	(A) Negative
FDPSP2	7q11.23	-0.13	-0.39	0.63	0.58	0.26	8.324e-5	2.025e-4	(A) Negative
TUFT1	1q21.3	0.82	1.13	0.75	0.68	-0.31	8.372e-5	2.036e-4	(B) Positive
KDM7A	7q34	0.24	-0.08	0.77	0.72	0.32	8.384e-5	2.039e-4	(A) Negative
FOXA2	20p11.21	-3.12	-3.51	0.99	0.52	0.39	8.398e-5	2.042e-4	(A) Negative
HTATSF1	Xq26.3	0.49	0.26	0.57	0.39	0.23	8.418e-5	2.046e-4	(A) Negative
HKDC1	10q22.1	-2.54	-2.80	0.66	0.49	0.26	8.448e-5	2.053e-4	(A) Negative
ERC1	12p13.33	0.74	0.44	0.75	0.59	0.30	8.469e-5	2.058e-4	(A) Negative
ABL2	1q25.2	-0.11	-0.27	0.40	0.34	0.16	8.569e-5	2.082e-4	(A) Negative
NDUFAF6	8q22.1	0.37	0.69	0.72	0.85	-0.31	8.622e-5	2.095e-4	(B) Positive
RPA4	Xq21.33	-0.22	-0.63	0.98	0.95	0.41	8.643e-5	2.100e-4	(A) Negative
ZNF573	19q13.12	0.24	0.50	0.65	0.55	-0.26	8.650e-5	2.101e-4	(B) Positive
GPR15LG	10q23.1	0.44	0.27	0.40	0.36	0.16	8.679e-5	2.108e-4	(A) Negative
FES	15q26.1	0.31	0.01	0.73	0.63	0.30	8.681e-5	2.108e-4	(A) Negative
MYO1C	17p13.3	-0.34	-0.15	0.46	0.43	-0.19	8.789e-5	2.134e-4	(B) Positive
IARS2	1q41	-0.30	-0.08	0.53	0.53	-0.22	8.816e-5	2.140e-4	(B) Positive
CDK9	9q34.11	-0.01	0.19	0.49	0.42	-0.20	8.897e-5	2.160e-4	(B) Positive
SPIRE2	16q24.3	-0.02	-0.21	0.43	0.46	0.18	8.902e-5	2.160e-4	(A) Negative
ARMC7	17q25.1	0.43	0.67	0.59	0.51	-0.24	8.919e-5	2.164e-4	(B) Positive
ERMAP	1p34.2	0.22	0.50	0.68	0.59	-0.28	8.945e-5	2.170e-4	(B) Positive
ADH1C	4q23	2.48	3.20	1.74	1.69	-0.73	8.953e-5	2.172e-4	(B) Positive
CD40	20q13.12	0.98	0.58	1.01	0.80	0.40	8.960e-5	2.173e-4	(A) Negative
UBE2U	1p31.3	0.47	0.22	0.63	0.48	0.25	9.004e-5	2.184e-4	(A) Negative
AK5	1p31.1	0.54	1.14	1.37	1.57	-0.59	9.025e-5	2.188e-4	(B) Positive
TUSC3	8p22	-0.36	-0.82	1.14	1.02	0.47	9.070e-5	2.199e-4	(A) Negative
ZNF292	6q14.3	0.38	0.11	0.66	0.60	0.27	9.076e-5	2.200e-4	(A) Negative
ZCRB1	12q12	-0.10	0.06	0.40	0.39	-0.17	9.103e-5	2.206e-4	(B) Positive
HCST	19q13.12	2.15	1.84	0.74	0.63	0.30	9.126e-5	2.212e-4	(A) Negative
TRIM65	17q25.1	0.13	-0.09	0.55	0.42	0.22	9.133e-5	2.213e-4	(A) Negative
ARSJ	4q26	-0.54	-1.09	1.37	1.12	0.55	9.143e-5	2.215e-4	(A) Negative
TTLL5	14q24.3	-0.64	-0.49	0.35	0.41	-0.15	9.150e-5	2.216e-4	(B) Positive
CD3G	11q23.3	-1.31	-1.90	1.42	1.35	0.59	9.167e-5	2.220e-4	(A) Negative
ZNF79	9q33.3	0.56	0.74	0.44	0.42	-0.18	9.188e-5	2.225e-4	(B) Positive
C12ORF56	12q14.2	-0.97	-1.64	1.60	1.62	0.67	9.189e-5	2.225e-4	(A) Negative
IFI44	1p31.1	1.17	0.63	1.34	1.16	0.54	9.215e-5	2.231e-4	(A) Negative
HEXD	17q25.3	-0.02	0.24	0.61	0.56	-0.25	9.226e-5	2.233e-4	(B) Positive
BAZ2B	2q24.2	0.80	1.06	0.67	0.52	-0.27	9.231e-5	2.234e-4	(B) Positive
EBF3	10q26.3	2.35	2.74	0.95	0.86	-0.39	9.253e-5	2.239e-4	(B) Positive
PCP4	21q22.2	-1.94	-2.54	1.53	1.09	0.61	9.260e-5	2.241e-4	(A) Negative
SCLT1	4q28.2	0.58	0.25	0.80	0.70	0.33	9.284e-5	2.246e-4	(A) Negative
ARHGAP6	Xp22.2	-1.30	-1.03	0.66	0.59	-0.27	9.294e-5	2.248e-4	(B) Positive
AARS2	6p21.1	-0.23	-0.35	0.32	0.27	0.13	9.335e-5	2.258e-4	(A) Negative
CCL1	17q12	-0.96	-1.20	0.53	0.66	0.23	9.343e-5	2.259e-4	(A) Negative
PRIMA1	14q32.12	0.74	0.39	0.87	0.73	0.35	9.352e-5	2.261e-4	(A) Negative
OR52N2	11p15.4	0.43	0.27	0.40	0.29	0.16	9.402e-5	2.273e-4	(A) Negative
HNRNPA0	5q31.2	-0.51	-0.32	0.45	0.46	-0.19	9.442e-5	2.282e-4	(B) Positive
NUFIP1	13q14.12	-0.26	-0.47	0.53	0.40	0.21	9.539e-5	2.306e-4	(A) Negative
TDRKH	1q21.3	0.50	0.20	0.73	0.65	0.30	9.542e-5	2.306e-4	(A) Negative
ABCA11P	4p16.3	-0.40	-0.15	0.62	0.60	-0.26	9.570e-5	2.312e-4	(B) Positive
SLC35G5	8p23.1	-0.84	-0.62	0.51	0.55	-0.22	9.611e-5	2.322e-4	(B) Positive
STYXL1	7q11.23	-0.18	0.07	0.61	0.52	-0.25	9.612e-5	2.322e-4	(B) Positive
RPRD1B	20q11.23	-0.20	-0.02	0.42	0.43	-0.18	9.623e-5	2.324e-4	(B) Positive
SRSF9	12q24.31	-0.32	-0.13	0.47	0.41	-0.19	9.639e-5	2.328e-4	(B) Positive
GABARAPL3	15q26.1	0.13	-0.13	0.61	0.67	0.26	9.646e-5	2.329e-4	(A) Negative
CDC34	19p13.3	-0.16	-0.36	0.47	0.46	0.20	9.685e-5	2.338e-4	(A) Negative
OXER1	2p21	0.17	0.03	0.35	0.28	0.14	9.689e-5	2.339e-4	(A) Negative
OCLN	5q13.2	1.04	1.42	0.93	0.84	-0.38	9.726e-5	2.348e-4	(B) Positive
FOXD4L4	9q21.11	0.44	0.83	0.95	0.90	-0.39	9.793e-5	2.363e-4	(B) Positive
ZHX3	20q12	-0.37	-0.17	0.51	0.46	-0.21	9.794e-5	2.363e-4	(B) Positive
DHX34	19q13.32	0.01	-0.11	0.29	0.34	0.12	9.832e-5	2.372e-4	(A) Negative
KRTAP13-2	21q22.11	0.07	-0.11	0.39	0.51	0.18	9.838e-5	2.373e-4	(A) Negative
CYP1B1	2p22.2	1.41	0.76	1.62	1.34	0.65	9.847e-5	2.375e-4	(A) Negative
ZNF211	19q13.4	0.04	0.29	0.61	0.56	-0.25	9.848e-5	2.375e-4	(B) Positive
LAMP2	Xq24	0.96	0.72	0.61	0.48	0.24	9.849e-5	2.375e-4	(A) Negative
HPS1	10q24.2	0.62	0.46	0.38	0.40	0.16	9.868e-5	2.379e-4	(A) Negative
SLC35E4	22q12.2	-1.27	-1.09	0.43	0.53	-0.19	9.883e-5	2.382e-4	(B) Positive
GLDC	9p24.1	-1.58	-2.11	1.29	1.18	0.53	9.920e-5	2.391e-4	(A) Negative
IKZF1	7p12.2	-1.20	-1.60	0.99	0.87	0.40	9.956e-5	2.399e-4	(A) Negative
RBM7	11q23.1-q23.2	-0.43	-0.76	0.82	0.76	0.34	9.960e-5	2.400e-4	(A) Negative
BTN2A1	6p22.2	-0.20	-0.41	0.53	0.43	0.21	1.002e-4	2.414e-4	(A) Negative
POU4F3	5q32	-0.07	-0.35	0.70	0.57	0.28	1.003e-4	2.416e-4	(A) Negative
POU3F1	1p34.3	-1.05	-1.25	0.50	0.40	0.20	1.004e-4	2.419e-4	(A) Negative
PRKG1	10q11.23-q21.1	0.88	1.10	0.54	0.51	-0.22	1.005e-4	2.420e-4	(B) Positive
TCERG1L	10q26.3	-1.60	-1.22	0.91	0.96	-0.38	1.006e-4	2.422e-4	(B) Positive
FAM3A	Xq28	-0.10	-0.28	0.46	0.40	0.19	1.006e-4	2.422e-4	(A) Negative
ENOSF1	18p11.32	-0.66	-0.39	0.67	0.66	-0.28	1.007e-4	2.425e-4	(B) Positive
NCF2	1q25.3	3.23	2.87	0.88	0.87	0.37	1.009e-4	2.427e-4	(A) Negative
SLC9B2	4q24	-0.66	-1.01	0.86	0.77	0.35	1.009e-4	2.427e-4	(A) Negative
N4BP2L1	13q13.1	0.31	0.76	1.12	0.82	-0.44	1.009e-4	2.428e-4	(B) Positive
HOXD13	2q31.1	-1.48	-1.86	0.94	0.80	0.38	1.010e-4	2.431e-4	(A) Negative
BIN3-IT1	8p21.3	-0.99	-0.85	0.33	0.38	-0.14	1.012e-4	2.434e-4	(B) Positive
BCKDHA	19q13.2	0.38	0.59	0.52	0.41	-0.21	1.014e-4	2.439e-4	(B) Positive
ARMC6	19p13.11	-0.18	-0.35	0.43	0.39	0.18	1.015e-4	2.440e-4	(A) Negative
NCF1	7q11.23	2.29	1.89	0.99	0.83	0.40	1.015e-4	2.440e-4	(A) Negative
HAUS3	4p16.3	-0.29	-0.10	0.48	0.44	-0.20	1.017e-4	2.445e-4	(B) Positive
NHP2	5q35.3	-0.31	-0.11	0.49	0.41	-0.20	1.020e-4	2.451e-4	(B) Positive
MAT2B	5q34	-0.06	0.21	0.65	0.59	-0.27	1.020e-4	2.453e-4	(B) Positive
TIFA	4q25	0.67	0.34	0.81	0.67	0.33	1.029e-4	2.472e-4	(A) Negative
GABRA5	15q12	-1.82	-2.32	1.29	0.88	0.51	1.030e-4	2.474e-4	(A) Negative
MTPN	7q33	-0.08	-0.36	0.68	0.56	0.27	1.030e-4	2.475e-4	(A) Negative
ATP6V0E1	5q35.1	1.29	1.51	0.54	0.42	-0.22	1.034e-4	2.484e-4	(B) Positive
LIFR	5p13.1	-1.63	-1.15	1.22	0.91	-0.48	1.035e-4	2.486e-4	(B) Positive
PCDH11Y	Yp11.2	0.11	-0.20	0.77	0.66	0.31	1.036e-4	2.487e-4	(A) Negative
SARM1	17q11.2	-0.11	0.23	0.80	0.93	-0.34	1.037e-4	2.489e-4	(B) Positive
AGPAT5	8p23.1	-0.91	-1.19	0.68	0.57	0.27	1.038e-4	2.492e-4	(A) Negative
KIF6	6p21.2	-0.33	0.00	0.79	0.83	-0.33	1.039e-4	2.494e-4	(B) Positive
MAP4K3	2p22.1	-0.00	0.17	0.45	0.34	-0.18	1.039e-4	2.494e-4	(B) Positive
POC1A	3p21.2	-0.57	-0.82	0.58	0.66	0.25	1.044e-4	2.505e-4	(A) Negative
BMP6	6p24.3	-1.92	-2.46	1.38	0.86	0.53	1.044e-4	2.506e-4	(A) Negative
SLC27A4	9q34.11	0.09	0.36	0.64	0.67	-0.27	1.048e-4	2.515e-4	(B) Positive
UIMC1	5q35.2	-0.69	-0.49	0.51	0.38	-0.20	1.052e-4	2.523e-4	(B) Positive
CRYBB2	22q11.23	-0.50	-0.82	0.81	0.65	0.32	1.060e-4	2.542e-4	(A) Negative
NKIRAS1	3p24.2	0.07	0.32	0.61	0.62	-0.25	1.060e-4	2.542e-4	(B) Positive
FCN1	9q34.3	2.15	1.75	1.00	0.89	0.40	1.061e-4	2.543e-4	(A) Negative
ZBTB39	12q13.3	-0.24	-0.45	0.51	0.47	0.21	1.064e-4	2.551e-4	(A) Negative
S1PR4	19p13.3	2.35	1.87	1.17	1.08	0.48	1.067e-4	2.557e-4	(A) Negative
SESN3	11q21	0.91	0.43	1.13	1.24	0.48	1.072e-4	2.570e-4	(A) Negative
SLC28A3	9q21.32-q21.33	1.59	1.06	1.28	1.29	0.53	1.072e-4	2.570e-4	(A) Negative
FCF1	14q24.3	0.10	0.28	0.43	0.43	-0.18	1.073e-4	2.570e-4	(B) Positive
DUS1L	17q25.3	0.57	0.32	0.60	0.60	0.25	1.073e-4	2.571e-4	(A) Negative
TIMP2	17q25.3	0.09	-0.20	0.69	0.64	0.28	1.075e-4	2.574e-4	(A) Negative
SMARCA1	Xq25-q26.1	-0.85	-0.35	1.19	1.22	-0.50	1.078e-4	2.583e-4	(B) Positive
ZFP42	4q35.2	-0.42	-1.18	2.01	0.88	0.76	1.080e-4	2.585e-4	(A) Negative
H1-2	6p22.2	-1.34	-0.73	1.43	1.64	-0.61	1.081e-4	2.588e-4	(B) Positive
PRKRA	2q31.2	0.11	-0.05	0.39	0.37	0.16	1.083e-4	2.592e-4	(A) Negative
GAD1	2q31.1	-2.91	-2.47	0.88	1.51	-0.43	1.083e-4	2.593e-4	(B) Positive
RGS14	5q35.3	-0.37	-0.14	0.52	0.66	-0.23	1.083e-4	2.593e-4	(B) Positive
RETN	19p13.2	0.59	0.16	1.07	0.82	0.42	1.084e-4	2.595e-4	(A) Negative
POLR3GL	1q21.1	-0.22	0.01	0.55	0.59	-0.23	1.090e-4	2.609e-4	(B) Positive
KEAP1	19p13.2	0.20	0.38	0.45	0.38	-0.18	1.091e-4	2.610e-4	(B) Positive
CORO1B	11q13.2	0.20	0.45	0.57	0.64	-0.24	1.093e-4	2.614e-4	(B) Positive
RPL22L1	3q26.2	-1.56	-1.91	0.87	0.73	0.35	1.094e-4	2.615e-4	(A) Negative
CD5	11q12.2	-0.13	-0.58	1.12	1.03	0.46	1.096e-4	2.621e-4	(A) Negative
SCAND2P	15q25.2	-0.66	-0.48	0.44	0.44	-0.18	1.105e-4	2.642e-4	(B) Positive
ALPK1	4q25	1.67	1.39	0.69	0.63	0.28	1.107e-4	2.646e-4	(A) Negative
VSX1	20p11.21	1.64	1.16	1.27	0.62	0.48	1.108e-4	2.650e-4	(A) Negative
IREB2	15q25.1	-0.70	-0.86	0.41	0.35	0.17	1.115e-4	2.665e-4	(A) Negative
OPA3	19q13.32	0.51	0.35	0.40	0.41	0.17	1.115e-4	2.665e-4	(A) Negative
FGD6	12q22	1.14	1.41	0.64	0.79	-0.28	1.116e-4	2.666e-4	(B) Positive
KAT5	11q13.1	0.21	0.38	0.41	0.39	-0.17	1.117e-4	2.669e-4	(B) Positive
ACSS1	20p11.21	0.04	0.46	1.03	0.98	-0.42	1.119e-4	2.672e-4	(B) Positive
DPF1	19q13.2	-1.31	-1.58	0.67	0.50	0.26	1.119e-4	2.672e-4	(A) Negative
CCDC12	3p21.31	-0.31	-0.15	0.38	0.36	-0.16	1.128e-4	2.694e-4	(B) Positive
RAC3	17q25.3	-0.26	-0.53	0.69	0.54	0.27	1.129e-4	2.697e-4	(A) Negative
CTSE	1q32.1	0.26	0.01	0.65	0.36	0.25	1.130e-4	2.698e-4	(A) Negative
RNFT2	12q24.22	-0.45	-0.85	1.03	0.75	0.40	1.133e-4	2.704e-4	(A) Negative
LYSMD2	15q21.2	0.57	0.21	0.85	0.86	0.35	1.135e-4	2.708e-4	(A) Negative
CHCT1	17q23.2	0.54	0.20	0.89	0.54	0.34	1.136e-4	2.710e-4	(A) Negative
LONP2	16q12.1	0.34	0.64	0.73	0.64	-0.29	1.142e-4	2.725e-4	(B) Positive
CIBAR1P2	4q35.1	-0.42	-0.74	0.75	0.81	0.31	1.143e-4	2.727e-4	(A) Negative
DLGAP4	20q11.23	0.86	0.57	0.72	0.61	0.29	1.144e-4	2.729e-4	(A) Negative
EPN2	17p11.2	0.04	0.27	0.57	0.51	-0.23	1.151e-4	2.745e-4	(B) Positive
MMP9	20q13.12	3.82	3.44	0.88	0.99	0.37	1.151e-4	2.745e-4	(A) Negative
RPN1	3q21.3	0.78	0.56	0.56	0.44	0.22	1.153e-4	2.750e-4	(A) Negative
TLL1	4q32.3	1.30	1.60	0.73	0.78	-0.30	1.155e-4	2.754e-4	(B) Positive
UNC50	2q11.2	-0.33	-0.09	0.60	0.48	-0.24	1.158e-4	2.761e-4	(B) Positive
ADAMTS5	21q21.3	2.42	1.98	1.03	1.13	0.43	1.161e-4	2.768e-4	(A) Negative
LGALS7	19q13.13	1.64	0.92	1.80	1.49	0.72	1.163e-4	2.772e-4	(A) Negative
KHK	2p23.3	-0.93	-1.22	0.68	0.70	0.28	1.164e-4	2.773e-4	(A) Negative
DGAT1	8q24.3	0.34	0.59	0.63	0.62	-0.26	1.169e-4	2.786e-4	(B) Positive
SAP30BP	17q25.1	0.21	0.03	0.44	0.45	0.18	1.170e-4	2.787e-4	(A) Negative
SP5	2q31.1	-2.99	-2.43	1.33	1.44	-0.56	1.171e-4	2.789e-4	(B) Positive
CD300LG	17q21.31	0.40	0.52	0.24	0.36	-0.11	1.173e-4	2.794e-4	(B) Positive
CCDC81	11q14.2	-0.08	-0.27	0.49	0.40	0.19	1.174e-4	2.795e-4	(A) Negative
PHLDB2	3q13.2	-0.93	-0.53	0.97	0.94	-0.40	1.176e-4	2.800e-4	(B) Positive
CDCP1	3p21.31	1.77	1.45	0.75	0.88	0.32	1.176e-4	2.800e-4	(A) Negative
IQSEC2	Xp11.22	0.43	0.59	0.38	0.38	-0.16	1.181e-4	2.810e-4	(B) Positive
NT5DC3	12q23.3	-0.79	-1.06	0.69	0.48	0.27	1.182e-4	2.814e-4	(A) Negative
MRPL16	11q12.1	-0.72	-0.89	0.41	0.41	0.17	1.184e-4	2.816e-4	(A) Negative
USP13	3q26.33	-0.48	-0.82	0.86	0.70	0.34	1.185e-4	2.819e-4	(A) Negative
TSC22D1	13q14.11	0.34	0.64	0.77	0.59	-0.30	1.187e-4	2.824e-4	(B) Positive
FMOD	1q32.1	4.57	4.93	0.87	0.84	-0.35	1.191e-4	2.833e-4	(B) Positive
CD209	19p13.2	0.59	0.42	0.44	0.32	0.17	1.194e-4	2.840e-4	(A) Negative
THRSP	11q14.1	2.61	3.34	1.77	1.72	-0.72	1.196e-4	2.845e-4	(B) Positive
KAT6A	8p11.21	0.68	0.94	0.63	0.67	-0.26	1.197e-4	2.846e-4	(B) Positive
ANXA7	10q22.2	0.68	0.87	0.47	0.41	-0.19	1.204e-4	2.862e-4	(B) Positive
OR1L6	9q33.2	0.41	0.28	0.33	0.26	0.13	1.208e-4	2.871e-4	(A) Negative
PIP4P1	14q11.2	-0.19	-0.03	0.41	0.37	-0.17	1.211e-4	2.878e-4	(B) Positive
SIK2	11q23.1	0.03	-0.20	0.54	0.63	0.23	1.215e-4	2.888e-4	(A) Negative
GKN1	2p13.3	0.34	0.16	0.40	0.48	0.17	1.216e-4	2.890e-4	(A) Negative
ORM1	9q32	-3.37	-4.05	1.79	1.02	0.68	1.221e-4	2.900e-4	(A) Negative
RGS10	10q26.11	1.29	0.95	0.85	0.67	0.33	1.222e-4	2.903e-4	(A) Negative
CXCL9	4q21.1	6.25	5.75	1.21	1.30	0.51	1.226e-4	2.912e-4	(A) Negative
OSBPL11	3q21.2	0.49	0.32	0.43	0.39	0.17	1.227e-4	2.912e-4	(A) Negative
STAP1	4q13.2	1.96	1.43	1.32	1.16	0.53	1.230e-4	2.921e-4	(A) Negative
BMPR1A	10q23.2	0.38	0.13	0.63	0.59	0.26	1.232e-4	2.925e-4	(A) Negative
KIR2DL2	19q13.4 alternate reference locus	0.41	0.19	0.53	0.48	0.21	1.236e-4	2.933e-4	(A) Negative
ITLN1	1q23.3	0.24	-0.16	0.98	0.98	0.40	1.239e-4	2.940e-4	(A) Negative
CSH2	17q23.3	0.18	-0.01	0.46	0.46	0.19	1.239e-4	2.941e-4	(A) Negative
DNAJA3	16p13.3	-0.37	-0.18	0.45	0.48	-0.19	1.241e-4	2.945e-4	(B) Positive
CRACR2A	12p13.32	-0.28	-0.06	0.54	0.58	-0.23	1.246e-4	2.956e-4	(B) Positive
HNRNPK	9q21.32	0.27	0.38	0.27	0.28	-0.11	1.249e-4	2.963e-4	(B) Positive
AKT3	1q43-q44	-0.04	-0.49	1.18	0.78	0.46	1.249e-4	2.963e-4	(A) Negative
LRRC41	1p34.1-p33	0.44	0.27	0.42	0.41	0.17	1.250e-4	2.965e-4	(A) Negative
TCP11L2	12q23.3	-0.43	-0.21	0.55	0.48	-0.22	1.256e-4	2.978e-4	(B) Positive
MORN5	9q33.2	0.70	1.07	0.84	1.12	-0.37	1.258e-4	2.983e-4	(B) Positive
PTGES3P1	1p22.2	-0.56	-0.38	0.45	0.40	-0.18	1.258e-4	2.983e-4	(B) Positive
CKAP4	12q23.3	0.32	0.02	0.75	0.66	0.30	1.259e-4	2.984e-4	(A) Negative
DCANP1	5q31.1	1.87	1.53	0.84	0.75	0.34	1.261e-4	2.988e-4	(A) Negative
ZNF324	19q13.43	0.29	0.46	0.43	0.39	-0.17	1.264e-4	2.995e-4	(B) Positive
C5ORF24	5q31.1	0.24	0.46	0.54	0.50	-0.22	1.267e-4	3.000e-4	(B) Positive
CD72	9p13.3	2.26	1.82	1.09	1.00	0.44	1.267e-4	3.001e-4	(A) Negative
SYT14	1q32.2	-0.48	-0.73	0.64	0.55	0.25	1.271e-4	3.010e-4	(A) Negative
MCUB	4q25	0.53	0.21	0.80	0.70	0.32	1.275e-4	3.019e-4	(A) Negative
HNRNPUL1	19q13.2	0.34	0.18	0.42	0.32	0.16	1.275e-4	3.019e-4	(A) Negative
ENO2	12p13.31	-2.27	-1.92	0.85	0.89	-0.35	1.280e-4	3.031e-4	(B) Positive
CD2	1p13.1	4.06	3.43	1.54	1.49	0.63	1.280e-4	3.031e-4	(A) Negative
TRPM2	21q22.3	1.80	1.44	0.86	0.98	0.36	1.282e-4	3.034e-4	(A) Negative
ZNF407-AS1	18q22.3	-0.25	0.03	0.71	0.66	-0.29	1.284e-4	3.039e-4	(B) Positive
CCR5	3p21.31	3.98	3.61	0.93	0.84	0.37	1.285e-4	3.041e-4	(A) Negative
GDI1	Xq28	0.25	0.46	0.50	0.54	-0.21	1.286e-4	3.042e-4	(B) Positive
ATP2C2	16q24.1	1.20	1.88	1.74	1.30	-0.68	1.286e-4	3.043e-4	(B) Positive
SPARC	5q33.1	1.24	1.61	0.92	0.90	-0.37	1.288e-4	3.047e-4	(B) Positive
CRHR1	17q21.31	0.46	0.35	0.26	0.21	0.10	1.290e-4	3.051e-4	(A) Negative
RCBTB1	13q14.2	0.04	0.29	0.64	0.52	-0.25	1.291e-4	3.053e-4	(B) Positive
KIF1C	17p13.2	0.18	-0.04	0.55	0.49	0.22	1.293e-4	3.056e-4	(A) Negative
IL12RB1	19p13.11	0.67	0.50	0.44	0.33	0.17	1.294e-4	3.058e-4	(A) Negative
DTX2	7q11.23	0.53	0.34	0.47	0.48	0.19	1.295e-4	3.061e-4	(A) Negative
POFUT2	21q22.3	-0.21	-0.37	0.42	0.33	0.16	1.296e-4	3.064e-4	(A) Negative
CGB7	19q13.33	0.45	0.58	0.30	0.33	-0.13	1.297e-4	3.065e-4	(B) Positive
GMIP	19p13.11	1.09	0.89	0.51	0.47	0.21	1.301e-4	3.073e-4	(A) Negative
TAX1BP3	17p13.2	-0.12	-0.46	0.83	0.80	0.34	1.308e-4	3.089e-4	(A) Negative
SETD6	16q21	-0.55	-0.87	0.78	0.69	0.31	1.313e-4	3.102e-4	(A) Negative
CD226	18q22.2	1.36	1.00	0.90	0.76	0.36	1.314e-4	3.103e-4	(A) Negative
STRADA	17q23.3	-0.49	-0.31	0.44	0.39	-0.18	1.322e-4	3.122e-4	(B) Positive
BTBD9	6p21.2	0.71	0.90	0.49	0.40	-0.19	1.326e-4	3.131e-4	(B) Positive
TXK	4p12	-0.03	-0.37	0.86	0.70	0.34	1.331e-4	3.142e-4	(A) Negative
SIMC1	5q35.2	-0.66	-1.06	0.97	1.01	0.40	1.337e-4	3.155e-4	(A) Negative
COL22A1	8q24.23-q24.3	1.07	0.76	0.82	0.53	0.31	1.343e-4	3.168e-4	(A) Negative
C1QTNF9	13q12.12	0.75	1.08	0.80	0.90	-0.34	1.348e-4	3.182e-4	(B) Positive
TENT5C	1p12	-0.73	-0.25	1.22	0.91	-0.47	1.349e-4	3.182e-4	(B) Positive
TFCP2	12q13.12-q13.13	0.01	0.26	0.63	0.52	-0.25	1.350e-4	3.185e-4	(B) Positive
SPCS3	4q34.2	-0.59	-0.89	0.75	0.64	0.30	1.351e-4	3.186e-4	(A) Negative
DHRS3	1p36.21	0.51	0.14	0.91	0.80	0.36	1.357e-4	3.200e-4	(A) Negative
ZDHHC8	22q11.21	0.22	0.08	0.33	0.31	0.13	1.357e-4	3.201e-4	(A) Negative
ZNF132	19q13.43	0.51	0.79	0.73	0.60	-0.29	1.358e-4	3.201e-4	(B) Positive
IL18BP	11q13.4	1.22	0.97	0.65	0.51	0.25	1.359e-4	3.204e-4	(A) Negative
PCDHA3	5q31.3	1.02	1.50	1.18	1.22	-0.48	1.361e-4	3.208e-4	(B) Positive
PRPF19	11q12.2	-0.82	-1.06	0.55	0.66	0.23	1.362e-4	3.210e-4	(A) Negative
SP1	12q13.13	0.71	0.91	0.49	0.44	-0.19	1.362e-4	3.210e-4	(B) Positive
NR1I3	1q23.3	0.53	0.31	0.53	0.47	0.21	1.364e-4	3.212e-4	(A) Negative
VHL	3p25.3	-0.38	-0.66	0.71	0.59	0.28	1.364e-4	3.212e-4	(A) Negative
GABARAPL1	12p13.2	0.08	-0.20	0.67	0.76	0.28	1.364e-4	3.212e-4	(A) Negative
CCT7	2p13.2	-0.51	-0.66	0.39	0.35	0.15	1.367e-4	3.220e-4	(A) Negative
RABEPK	9q33.3	-0.64	-0.41	0.58	0.46	-0.23	1.375e-4	3.238e-4	(B) Positive
GMPPB	3p21.31	0.24	0.54	0.74	0.72	-0.30	1.376e-4	3.240e-4	(B) Positive
OXSR1	3p22.2	-0.11	-0.27	0.41	0.35	0.16	1.377e-4	3.241e-4	(A) Negative
SUN2	22q13.1	0.32	-0.04	0.90	0.83	0.36	1.384e-4	3.257e-4	(A) Negative
DPH7	9q34.3	-0.61	-0.78	0.43	0.39	0.17	1.385e-4	3.259e-4	(A) Negative
BLK	8p23.1	-1.83	-2.33	1.26	1.05	0.50	1.389e-4	3.269e-4	(A) Negative
ACKR1	1q23.2	1.86	2.36	1.22	1.29	-0.50	1.390e-4	3.270e-4	(B) Positive
EDA2R	Xq12	-0.12	0.06	0.43	0.41	-0.18	1.397e-4	3.287e-4	(B) Positive
INPPL1	11q13.4	-0.86	-0.64	0.55	0.58	-0.23	1.398e-4	3.288e-4	(B) Positive
RPL9	4p14	-0.22	0.02	0.60	0.51	-0.24	1.402e-4	3.297e-4	(B) Positive
FAM167A	8p23.1	-1.51	-1.07	1.03	1.19	-0.44	1.402e-4	3.297e-4	(B) Positive
MCM3AP	21q22.3	0.04	0.25	0.50	0.55	-0.21	1.407e-4	3.308e-4	(B) Positive
MRPS21	1q21.2	0.14	-0.12	0.65	0.58	0.26	1.409e-4	3.312e-4	(A) Negative
SNRNP27	2p13.3	-0.12	-0.28	0.40	0.36	0.16	1.415e-4	3.327e-4	(A) Negative
NLRP8	19q13.43	0.22	0.46	0.54	0.72	-0.24	1.417e-4	3.330e-4	(B) Positive
ALDH1B1	9p13.1	0.18	-0.10	0.74	0.56	0.29	1.418e-4	3.332e-4	(A) Negative
RGS4	1q23.3	-0.14	0.27	1.01	1.04	-0.42	1.423e-4	3.342e-4	(B) Positive
SMAD5	5q31.1	0.08	0.42	0.85	0.76	-0.34	1.424e-4	3.346e-4	(B) Positive
BOLA1	1q21.2	0.84	0.60	0.61	0.57	0.25	1.428e-4	3.353e-4	(A) Negative
ZNF622	5p15.1	-0.28	-0.07	0.55	0.41	-0.21	1.428e-4	3.353e-4	(B) Positive
ARHGAP42	11q22.1	0.26	-0.07	0.79	0.83	0.33	1.430e-4	3.358e-4	(A) Negative
PNLIP	10q25.3	0.08	0.32	0.53	0.76	-0.24	1.433e-4	3.365e-4	(B) Positive
OSBPL7	17q21.32	-0.87	-0.69	0.42	0.53	-0.18	1.436e-4	3.371e-4	(B) Positive
OGG1	3p25.3	-0.26	-0.11	0.37	0.31	-0.15	1.441e-4	3.384e-4	(B) Positive
CEP89	19q13.11	0.82	0.61	0.56	0.38	0.21	1.444e-4	3.390e-4	(A) Negative
SYVN1	11q13.1	0.02	0.19	0.41	0.44	-0.17	1.448e-4	3.398e-4	(B) Positive
ALKBH8	11q22.3	-0.07	0.20	0.67	0.64	-0.27	1.449e-4	3.400e-4	(B) Positive
LACC1	13q14.11	1.75	1.51	0.58	0.60	0.24	1.451e-4	3.403e-4	(A) Negative
TMEM258	11q12.2	-0.05	-0.24	0.46	0.44	0.18	1.452e-4	3.406e-4	(A) Negative
ACSL1	4q35.1	1.29	0.89	0.97	1.04	0.40	1.452e-4	3.406e-4	(A) Negative
SEC22A	3q21.1	0.29	0.11	0.45	0.39	0.18	1.453e-4	3.407e-4	(A) Negative
GRM6	5q35.3	0.37	0.23	0.31	0.40	0.14	1.456e-4	3.413e-4	(A) Negative
FAM227B	15q21.2	0.16	0.49	0.81	0.85	-0.33	1.460e-4	3.423e-4	(B) Positive
MCM3AP-AS1	21q22.3	-1.30	-1.60	0.75	0.67	0.30	1.460e-4	3.423e-4	(A) Negative
ADAM32	8p11.22	1.63	1.13	1.23	1.22	0.50	1.461e-4	3.424e-4	(A) Negative
NFKB2	10q24.32	0.56	0.32	0.59	0.51	0.23	1.464e-4	3.431e-4	(A) Negative
ALDH18A1	10q24.1	0.69	0.41	0.69	0.65	0.28	1.465e-4	3.432e-4	(A) Negative
ATP5F1D	19p13.3	-0.47	-0.21	0.68	0.54	-0.26	1.468e-4	3.440e-4	(B) Positive
MMP23B	1p36.33	0.69	1.08	0.98	0.94	-0.39	1.471e-4	3.446e-4	(B) Positive
RCC1	1p35.3	0.68	0.53	0.36	0.33	0.14	1.477e-4	3.459e-4	(A) Negative
PEAK1	15q24.3	0.11	-0.04	0.35	0.37	0.14	1.478e-4	3.461e-4	(A) Negative
NCOR2	12q24.31	0.13	0.29	0.42	0.39	-0.17	1.481e-4	3.468e-4	(B) Positive
LMBRD2	5p13.2	-0.18	0.05	0.59	0.49	-0.23	1.484e-4	3.474e-4	(B) Positive
QARS1	3p21.31	-0.40	-0.18	0.55	0.50	-0.22	1.495e-4	3.500e-4	(B) Positive
PHACTR4	1p35.3	-0.25	-0.44	0.47	0.38	0.19	1.496e-4	3.502e-4	(A) Negative
PMS2P5	7q11.23	-0.52	-0.36	0.40	0.40	-0.16	1.496e-4	3.502e-4	(B) Positive
CYTH1	17q25.3	0.42	0.15	0.67	0.62	0.27	1.497e-4	3.502e-4	(A) Negative
TRAF3	14q32.32	0.27	0.03	0.61	0.52	0.24	1.507e-4	3.526e-4	(A) Negative
GARIN4	1q32.3	-0.03	-0.17	0.33	0.36	0.14	1.513e-4	3.540e-4	(A) Negative
CLDN6	16p13.3	-2.04	-2.46	1.13	0.61	0.42	1.515e-4	3.545e-4	(A) Negative
DTWD1	15q21.2	-0.92	-0.71	0.54	0.48	-0.21	1.517e-4	3.547e-4	(B) Positive
ZNF329	19q13.43	-0.34	-0.09	0.60	0.62	-0.24	1.522e-4	3.559e-4	(B) Positive
ARRDC1	9q34.3	0.31	0.54	0.57	0.51	-0.23	1.526e-4	3.567e-4	(B) Positive
C1ORF210	1p34.2	2.08	2.38	0.76	0.64	-0.30	1.527e-4	3.569e-4	(B) Positive
DIABLO	12q24.31	0.01	0.15	0.36	0.34	-0.14	1.531e-4	3.579e-4	(B) Positive
F8A1	Xq28	0.59	0.37	0.55	0.48	0.22	1.537e-4	3.591e-4	(A) Negative
ACTG2	2p13.1	1.28	0.65	1.64	1.23	0.63	1.537e-4	3.591e-4	(A) Negative
GPN3	12q24.11	-0.83	-0.61	0.56	0.48	-0.22	1.538e-4	3.594e-4	(B) Positive
CTNNBIP1	1p36.22	0.88	0.61	0.70	0.56	0.27	1.544e-4	3.607e-4	(A) Negative
TUBB2B	6p25.2	-1.84	-2.48	1.70	1.02	0.64	1.546e-4	3.611e-4	(A) Negative
BCAN	1q23.1	-0.26	-0.54	0.74	0.40	0.28	1.551e-4	3.623e-4	(A) Negative
GH2	17q23.3	0.36	0.25	0.28	0.31	0.12	1.552e-4	3.624e-4	(A) Negative
LRRC34	3q26.2	-1.05	-1.44	1.01	0.67	0.38	1.552e-4	3.624e-4	(A) Negative
IL36G	2q14.1	0.35	0.01	0.89	0.65	0.34	1.552e-4	3.624e-4	(A) Negative
DAND5	19p13.13	-1.23	-1.56	0.81	0.84	0.33	1.554e-4	3.626e-4	(A) Negative
STX1A	7q11.23	-0.64	-0.86	0.54	0.54	0.22	1.554e-4	3.626e-4	(A) Negative
TSKU	11q13.5	0.30	0.66	0.85	1.01	-0.36	1.561e-4	3.642e-4	(B) Positive
ARMC2	6q21	-0.48	-0.20	0.72	0.62	-0.28	1.561e-4	3.643e-4	(B) Positive
CYP26B1	2p13.2	0.37	-0.05	1.05	1.00	0.42	1.565e-4	3.651e-4	(A) Negative
ZNF467	7q36.1	0.79	1.06	0.68	0.56	-0.27	1.567e-4	3.656e-4	(B) Positive
ABCA12	2q35	-1.89	-0.98	2.29	2.14	-0.91	1.573e-4	3.668e-4	(B) Positive
RASSF5	1q32.1	-0.23	-0.58	0.88	0.81	0.35	1.574e-4	3.670e-4	(A) Negative
TSTD2	9q22.33	-0.31	-0.07	0.60	0.52	-0.24	1.576e-4	3.674e-4	(B) Positive
MBNL1	3q25.1-q25.2	0.08	-0.11	0.48	0.44	0.19	1.577e-4	3.678e-4	(A) Negative
ERO1A	14q22.1	-0.83	-1.22	1.05	0.65	0.39	1.579e-4	3.681e-4	(A) Negative
SLC39A2	14q11.2	1.23	0.78	1.17	0.93	0.45	1.583e-4	3.690e-4	(A) Negative
SLC2A4RG	20q13.33	0.17	0.38	0.53	0.49	-0.21	1.586e-4	3.697e-4	(B) Positive
HMBOX1	8p21.1-p12	-0.44	0.00	1.09	1.18	-0.45	1.593e-4	3.711e-4	(B) Positive
ASCC2	22q12.2	0.27	0.10	0.41	0.49	0.17	1.593e-4	3.711e-4	(A) Negative
BBX	3q13.12	0.03	0.22	0.47	0.50	-0.19	1.594e-4	3.713e-4	(B) Positive
FLACC1	2q33.1	-0.37	-0.08	0.69	0.81	-0.29	1.600e-4	3.728e-4	(B) Positive
RNF20	9q31.1	0.13	0.33	0.49	0.43	-0.19	1.602e-4	3.730e-4	(B) Positive
RAB27A	15q21.3	-1.23	-1.54	0.78	0.71	0.31	1.607e-4	3.741e-4	(A) Negative
DVL3	3q27.1	0.31	0.10	0.56	0.49	0.22	1.614e-4	3.759e-4	(A) Negative
BARHL1	9q34.13	0.13	-0.04	0.42	0.44	0.17	1.615e-4	3.759e-4	(A) Negative
LTBR	12p13.31	1.05	0.79	0.66	0.53	0.26	1.617e-4	3.763e-4	(A) Negative
DNAH17	17q25.3	-0.66	-0.98	0.83	0.64	0.32	1.619e-4	3.769e-4	(A) Negative
NDUFA6	22q13.2	0.23	0.01	0.58	0.49	0.23	1.621e-4	3.772e-4	(A) Negative
KRT2	12q13.13	0.55	0.30	0.64	0.56	0.25	1.622e-4	3.773e-4	(A) Negative
PTPN18	2q21.1	0.72	0.90	0.45	0.42	-0.18	1.624e-4	3.777e-4	(B) Positive
MT3	16q13	0.05	-0.29	0.83	0.85	0.34	1.625e-4	3.780e-4	(A) Negative
ZNF710	15q26.1	0.94	0.70	0.58	0.63	0.24	1.626e-4	3.782e-4	(A) Negative
CADPS	3p14.2	-1.57	-1.21	0.86	0.98	-0.36	1.632e-4	3.794e-4	(B) Positive
EFEMP2	11q13.1	0.18	0.50	0.80	0.78	-0.32	1.633e-4	3.796e-4	(B) Positive
TSPAN7	Xp11.4	-2.03	-1.65	0.93	1.02	-0.38	1.633e-4	3.796e-4	(B) Positive
PTDSS2	11p15.5	-0.27	-0.11	0.41	0.41	-0.17	1.634e-4	3.798e-4	(B) Positive
VPS26C	21q22.13	-0.14	-0.34	0.53	0.42	0.20	1.635e-4	3.800e-4	(A) Negative
RNF181	2p11.2	-0.00	0.21	0.54	0.40	-0.21	1.635e-4	3.800e-4	(B) Positive
NDUFV1	11q13.2	-0.45	-0.64	0.45	0.54	0.19	1.639e-4	3.808e-4	(A) Negative
RCAN2	6p12.3	-0.23	-0.57	0.90	0.62	0.34	1.639e-4	3.808e-4	(A) Negative
SLX4IP	20p12.2	0.25	0.57	0.79	0.78	-0.32	1.639e-4	3.808e-4	(B) Positive
RAB43	3q21.3	0.58	0.33	0.66	0.47	0.25	1.642e-4	3.814e-4	(A) Negative
SLC33A1	3q25.31	0.74	0.53	0.52	0.53	0.21	1.643e-4	3.816e-4	(A) Negative
CARHSP1	16p13.2	-0.68	-0.96	0.70	0.68	0.28	1.644e-4	3.817e-4	(A) Negative
SGSM1	22q11.23	0.74	1.09	0.87	0.85	-0.35	1.644e-4	3.817e-4	(B) Positive
YME1L1	10p12.1	0.21	0.02	0.50	0.34	0.19	1.654e-4	3.840e-4	(A) Negative
ERP27	12p12.3	3.24	2.64	1.44	1.66	0.60	1.674e-4	3.884e-4	(A) Negative
RGL4	22q11.23	-0.10	-0.58	1.23	1.07	0.48	1.677e-4	3.891e-4	(A) Negative
ESR2	14q23.2-q23.3	0.33	0.16	0.44	0.39	0.17	1.681e-4	3.900e-4	(A) Negative
LUM	12q21.33	1.50	1.98	1.20	1.17	-0.48	1.682e-4	3.902e-4	(B) Positive
GTSF1	12q13.13	-3.79	-4.37	1.55	0.87	0.58	1.682e-4	3.902e-4	(A) Negative
KRTAP17-1	17q21.2	1.00	0.58	1.12	0.73	0.42	1.687e-4	3.914e-4	(A) Negative
CLASP1	2q14.2-q14.3	0.15	-0.06	0.54	0.44	0.21	1.691e-4	3.921e-4	(A) Negative
CCDC42	17p13.1	0.34	0.14	0.53	0.40	0.20	1.692e-4	3.923e-4	(A) Negative
MTCH2	11p11.2	0.15	-0.03	0.45	0.40	0.18	1.692e-4	3.924e-4	(A) Negative
RNF10	12q24.31	0.17	0.35	0.46	0.40	-0.18	1.693e-4	3.925e-4	(B) Positive
SNRPB	20p13	-1.05	-1.29	0.59	0.61	0.24	1.699e-4	3.937e-4	(A) Negative
DIAPH1	5q31.3	-0.36	-0.53	0.45	0.40	0.18	1.701e-4	3.942e-4	(A) Negative
OR51A7	11p15.4	0.26	0.13	0.30	0.37	0.13	1.704e-4	3.948e-4	(A) Negative
BEST2	19p13.13	0.38	0.25	0.31	0.31	0.13	1.705e-4	3.951e-4	(A) Negative
DBH	9q34.2	-0.47	-0.78	0.85	0.42	0.31	1.709e-4	3.958e-4	(A) Negative
ABR	17p13.3	-0.02	0.24	0.66	0.55	-0.26	1.715e-4	3.973e-4	(B) Positive
PRSS53	16p11.2	-0.16	-0.29	0.30	0.33	0.12	1.716e-4	3.974e-4	(A) Negative
IL6R	1q21.3	0.45	0.10	0.93	0.72	0.36	1.716e-4	3.974e-4	(A) Negative
PCDH10	4q28.3	-0.88	-0.58	0.64	1.06	-0.30	1.719e-4	3.979e-4	(B) Positive
H2AC7	6p22.2	0.14	0.52	0.92	1.02	-0.38	1.724e-4	3.990e-4	(B) Positive
SSB	2q31.1	-0.57	-0.75	0.48	0.34	0.18	1.727e-4	3.997e-4	(A) Negative
MIDN	19p13.3	-0.07	0.12	0.50	0.45	-0.20	1.735e-4	4.017e-4	(B) Positive
USP53	4q26	0.32	0.60	0.72	0.66	-0.28	1.740e-4	4.028e-4	(B) Positive
N4BP2	4p14	-0.64	-0.33	0.79	0.76	-0.32	1.741e-4	4.029e-4	(B) Positive
ATP6V1C1	8q22.3	0.14	0.40	0.63	0.71	-0.26	1.745e-4	4.038e-4	(B) Positive
GLT8D2	12q23.3	1.78	2.20	1.03	1.10	-0.42	1.748e-4	4.043e-4	(B) Positive
CCDC97	19q13.2	0.64	0.84	0.54	0.33	-0.20	1.749e-4	4.045e-4	(B) Positive
NRBP2	8q24.3	0.19	-0.14	0.85	0.70	0.33	1.750e-4	4.047e-4	(A) Negative
TREX1	3p21.31	0.59	0.86	0.70	0.58	-0.27	1.751e-4	4.049e-4	(B) Positive
SLC10A4	4p11	-3.01	-3.50	1.32	0.82	0.49	1.753e-4	4.053e-4	(A) Negative
TGFBI	5q31.1	0.03	-0.33	0.89	0.82	0.35	1.754e-4	4.054e-4	(A) Negative
STT3A	11q24.2	0.24	-0.03	0.68	0.63	0.27	1.756e-4	4.058e-4	(A) Negative
PROKR1	2p13.3	0.42	0.25	0.45	0.34	0.17	1.760e-4	4.068e-4	(A) Negative
APOD	3q29	2.54	3.20	1.67	1.50	-0.66	1.761e-4	4.068e-4	(B) Positive
ALPL	1p36.12	0.50	0.21	0.76	0.60	0.29	1.764e-4	4.075e-4	(A) Negative
MICU1	10q22.1	0.22	0.42	0.52	0.46	-0.20	1.770e-4	4.088e-4	(B) Positive
SOX13	1q32.1	0.60	0.90	0.80	0.56	-0.30	1.781e-4	4.114e-4	(B) Positive
GYPC	2q14.3	-0.80	-1.10	0.78	0.63	0.30	1.781e-4	4.114e-4	(A) Negative
LGI2	4p15.2	1.36	0.97	0.96	0.97	0.38	1.783e-4	4.116e-4	(A) Negative
CHST1	11p11.2	1.66	2.01	0.92	0.74	-0.36	1.789e-4	4.130e-4	(B) Positive
VNN3P	6q23.2	0.99	0.54	1.17	0.89	0.45	1.794e-4	4.141e-4	(A) Negative
TFDP2	3q23	-0.62	-0.87	0.64	0.52	0.25	1.794e-4	4.142e-4	(A) Negative
MYO1G	7p13	-1.19	-1.47	0.73	0.67	0.29	1.796e-4	4.144e-4	(A) Negative
LBP	20q11.23	1.58	0.93	1.73	1.19	0.65	1.798e-4	4.150e-4	(A) Negative
ATN1	12p13.31	0.63	0.48	0.37	0.35	0.15	1.806e-4	4.167e-4	(A) Negative
LCE1C	1q21.3	0.67	0.49	0.46	0.41	0.18	1.816e-4	4.189e-4	(A) Negative
POLR2J2	7q22.1	-0.39	-0.54	0.40	0.30	0.15	1.816e-4	4.189e-4	(A) Negative
SRGN	10q22.1	1.35	0.94	1.06	0.93	0.41	1.818e-4	4.192e-4	(A) Negative
CT45A5	Xq26.3	-3.73	-4.45	1.92	1.27	0.72	1.827e-4	4.212e-4	(A) Negative
CIDEA	18p11.21	1.67	2.30	1.54	1.63	-0.62	1.829e-4	4.217e-4	(B) Positive
TRIM41	5q35.3	0.07	0.24	0.44	0.38	-0.17	1.829e-4	4.218e-4	(B) Positive
SRPK2	7q22.3	0.01	0.20	0.48	0.51	-0.19	1.831e-4	4.222e-4	(B) Positive
MYO7A	11q13.5	0.15	-0.09	0.62	0.55	0.24	1.832e-4	4.222e-4	(A) Negative
SDCBP	8q12.1	0.24	-0.08	0.82	0.60	0.31	1.834e-4	4.226e-4	(A) Negative
RASSF7	11p15.5	0.44	0.68	0.59	0.63	-0.24	1.837e-4	4.232e-4	(B) Positive
WNT7A	3p25.1	0.26	0.05	0.56	0.36	0.21	1.839e-4	4.236e-4	(A) Negative
HAS3	16q22.1	-0.80	-1.20	1.06	0.84	0.41	1.848e-4	4.258e-4	(A) Negative
TMEM51	1p36.21	0.57	0.28	0.77	0.63	0.30	1.849e-4	4.258e-4	(A) Negative
DAZL	3p24.3	-0.52	-0.87	0.93	0.68	0.35	1.851e-4	4.263e-4	(A) Negative
MAPK6	15q21.2	-0.79	-1.03	0.61	0.50	0.24	1.851e-4	4.263e-4	(A) Negative
CILP	15q22.31	4.55	5.07	1.37	1.02	-0.52	1.853e-4	4.266e-4	(B) Positive
HSPB3	5q11.2	-3.06	-3.69	1.64	1.21	0.62	1.856e-4	4.273e-4	(A) Negative
HMCN1	1q25.3-q31.1	-0.75	-0.37	0.95	0.92	-0.38	1.857e-4	4.273e-4	(B) Positive
SCYL3	1q24.2	1.26	1.49	0.59	0.53	-0.23	1.857e-4	4.275e-4	(B) Positive
CSF3R	1p34.3	1.08	1.39	0.80	0.73	-0.31	1.870e-4	4.304e-4	(B) Positive
TBX2	17q23.2	-2.11	-1.81	0.77	0.69	-0.30	1.874e-4	4.312e-4	(B) Positive
OR2C1	16p13.3	-0.15	0.01	0.42	0.42	-0.17	1.874e-4	4.312e-4	(B) Positive
GABRQ	Xq28	-0.25	-0.44	0.48	0.44	0.19	1.878e-4	4.319e-4	(A) Negative
UAP1	1q23.3	0.68	0.42	0.66	0.64	0.26	1.879e-4	4.320e-4	(A) Negative
PCDH20	13q21.2	1.78	2.42	1.59	1.61	-0.64	1.882e-4	4.329e-4	(B) Positive
SEC61A2	10p14	-0.01	-0.25	0.62	0.58	0.24	1.884e-4	4.333e-4	(A) Negative
DNAJB4	1p31.1	-0.06	-0.35	0.74	0.71	0.29	1.889e-4	4.342e-4	(A) Negative
CALY	10q26.3	0.29	0.46	0.35	0.61	-0.17	1.895e-4	4.355e-4	(B) Positive
TMEM165	4q12	0.44	0.23	0.55	0.42	0.21	1.899e-4	4.366e-4	(A) Negative
C2CD5	12p12.1	-0.16	0.07	0.58	0.50	-0.23	1.900e-4	4.367e-4	(B) Positive
OXNAD1	3p25.1-p24.3	-0.18	-0.40	0.57	0.41	0.22	1.904e-4	4.376e-4	(A) Negative
CCDC43	17q21.31	-0.62	-0.44	0.46	0.51	-0.19	1.914e-4	4.398e-4	(B) Positive
TMEM208	16q22.1	0.26	0.06	0.50	0.51	0.20	1.921e-4	4.413e-4	(A) Negative
PORCN	Xp11.23	-1.19	-0.98	0.56	0.43	-0.21	1.926e-4	4.424e-4	(B) Positive
LGR5	12q21.1	-1.48	-1.90	1.14	0.65	0.42	1.933e-4	4.439e-4	(A) Negative
RIPPLY3	21q22.13	0.18	0.80	1.56	1.57	-0.62	1.933e-4	4.439e-4	(B) Positive
TGDS	13q32.1	-1.23	-1.47	0.62	0.50	0.24	1.937e-4	4.446e-4	(A) Negative
UBE2A	Xq24	0.45	0.27	0.47	0.35	0.18	1.940e-4	4.454e-4	(A) Negative
ITK	5q33.3	-0.59	-1.05	1.17	1.07	0.46	1.943e-4	4.459e-4	(A) Negative
LILRA3	19q13.4 alternate reference locus	1.06	0.70	0.93	0.70	0.35	1.944e-4	4.462e-4	(A) Negative
PDGFRB	5q32	1.73	1.97	0.62	0.54	-0.24	1.945e-4	4.463e-4	(B) Positive
CD163	12p13.31	6.97	6.71	0.61	0.73	0.25	1.948e-4	4.471e-4	(A) Negative
SCGB2A1	11q12.3	4.22	5.16	2.40	2.09	-0.93	1.950e-4	4.475e-4	(B) Positive
FCER1G	1q23.3	2.15	1.92	0.61	0.57	0.24	1.965e-4	4.508e-4	(A) Negative
IL25	14q11.2	0.71	1.06	0.88	0.88	-0.35	1.966e-4	4.510e-4	(B) Positive
PLCG1	20q12	-0.85	-1.06	0.53	0.51	0.21	1.971e-4	4.521e-4	(A) Negative
SART3	12q23.3	-0.26	-0.12	0.35	0.35	-0.14	1.975e-4	4.528e-4	(B) Positive
TLR3	4q35.1	1.01	1.48	1.20	1.06	-0.46	1.975e-4	4.529e-4	(B) Positive
RPA1	17p13.3	-0.43	-0.64	0.53	0.50	0.21	1.981e-4	4.541e-4	(A) Negative
RAPGEF1	9q34.13	-0.16	-0.32	0.40	0.40	0.16	1.984e-4	4.547e-4	(A) Negative
PROM2	2q11.1	3.06	3.38	0.86	0.65	-0.33	1.986e-4	4.552e-4	(B) Positive
WFDC5	20q13.12	0.64	0.31	0.85	0.74	0.33	1.988e-4	4.556e-4	(A) Negative
TNFAIP2	14q32.32	1.21	0.85	0.94	0.62	0.35	1.990e-4	4.558e-4	(A) Negative
MYO3B	2q31.1	-0.02	-0.43	1.00	1.17	0.41	2.005e-4	4.592e-4	(A) Negative
NSUN2	5p15.31	-0.27	-0.49	0.58	0.47	0.22	2.009e-4	4.603e-4	(A) Negative
EIF4A1	17p13.1	-0.25	-0.41	0.41	0.43	0.16	2.018e-4	4.620e-4	(A) Negative
NCEH1	3q26.31	-0.45	-0.05	1.08	0.76	-0.40	2.018e-4	4.620e-4	(B) Positive
OSER1	20q13.12	-0.02	0.18	0.50	0.48	-0.20	2.019e-4	4.623e-4	(B) Positive
DNAL1	14q24.3	-0.39	-0.07	0.81	0.69	-0.31	2.024e-4	4.633e-4	(B) Positive
SLC12A3	16q13	-2.63	-2.78	0.37	0.45	0.15	2.032e-4	4.652e-4	(A) Negative
CDK3	17q25.1	-0.47	-0.64	0.43	0.48	0.17	2.035e-4	4.657e-4	(A) Negative
FRAS1	4q21.21	-1.29	-1.73	1.14	1.03	0.44	2.040e-4	4.668e-4	(A) Negative
ALOX15B	17p13.1	1.36	1.84	1.19	1.32	-0.48	2.049e-4	4.687e-4	(B) Positive
NOP56	20p13	-1.06	-1.25	0.47	0.48	0.19	2.049e-4	4.687e-4	(A) Negative
RAB18	10p12.1	1.11	1.32	0.54	0.50	-0.21	2.051e-4	4.691e-4	(B) Positive
SENP8	15q23	-0.40	-0.14	0.68	0.52	-0.26	2.056e-4	4.703e-4	(B) Positive
KPNA5	6q22.1	0.08	-0.23	0.81	0.65	0.31	2.063e-4	4.717e-4	(A) Negative
AFG1L	6q21	-0.13	-0.37	0.63	0.49	0.24	2.069e-4	4.731e-4	(A) Negative
ITGB6	2q24.2	3.34	2.73	1.53	1.46	0.60	2.071e-4	4.735e-4	(A) Negative
BIVM	13q33.1	-0.93	-1.33	1.03	0.93	0.40	2.086e-4	4.768e-4	(A) Negative
YIPF2	19p13.2	0.81	0.64	0.45	0.43	0.18	2.090e-4	4.777e-4	(A) Negative
FH	1q43	0.06	-0.18	0.60	0.53	0.23	2.090e-4	4.777e-4	(A) Negative
CIMAP1C	15q24.2	-0.04	0.12	0.40	0.41	-0.16	2.105e-4	4.809e-4	(B) Positive
FASLG	1q24.3	2.87	2.36	1.33	1.12	0.51	2.113e-4	4.828e-4	(A) Negative
SYT7	11q12.2	0.56	0.81	0.59	0.77	-0.25	2.121e-4	4.846e-4	(B) Positive
VKORC1L1	7q11.21	0.27	0.06	0.54	0.45	0.21	2.123e-4	4.850e-4	(A) Negative
KRT80	12q13.13	-0.64	-1.01	0.92	0.92	0.36	2.125e-4	4.853e-4	(A) Negative
GRB14	2q24.3	0.67	-0.12	1.99	2.08	0.79	2.130e-4	4.864e-4	(A) Negative
CUZD1	10q26.13	0.11	-0.33	1.20	0.78	0.44	2.135e-4	4.874e-4	(A) Negative
TNFAIP8	5q23.1	-0.36	-0.68	0.82	0.81	0.32	2.138e-4	4.880e-4	(A) Negative
ZNF160	19q13.42	-0.08	0.09	0.43	0.43	-0.17	2.142e-4	4.889e-4	(B) Positive
UBASH3A	21q22.3	-0.60	-1.07	1.21	1.09	0.47	2.146e-4	4.897e-4	(A) Negative
FAM24B	10q26.13	-0.71	-1.04	0.87	0.70	0.33	2.162e-4	4.934e-4	(A) Negative
FUT1	19q13.33	0.62	0.81	0.50	0.50	-0.20	2.164e-4	4.938e-4	(B) Positive
ZC3H7B	22q13.2	0.50	0.27	0.56	0.58	0.22	2.168e-4	4.947e-4	(A) Negative
SURF4	9q34.2	-0.09	-0.26	0.46	0.41	0.18	2.171e-4	4.953e-4	(A) Negative
GOT2	16q21	-0.38	-0.17	0.52	0.60	-0.21	2.174e-4	4.959e-4	(B) Positive
CHRAC1	8q24.3	-0.34	-0.63	0.75	0.59	0.29	2.179e-4	4.968e-4	(A) Negative
MTRES1	6q21	0.86	0.60	0.68	0.63	0.26	2.181e-4	4.973e-4	(A) Negative
NPY	7p15.3	-2.07	-2.64	1.57	0.72	0.57	2.186e-4	4.983e-4	(A) Negative
PNN	14q21.1	-0.88	-1.03	0.37	0.33	0.14	2.187e-4	4.984e-4	(A) Negative
BOD1L1	4p15.33	-0.05	0.20	0.65	0.59	-0.25	2.189e-4	4.988e-4	(B) Positive
PRR3	6p21.33	-0.14	-0.26	0.31	0.31	0.12	2.190e-4	4.990e-4	(A) Negative
SUMO1	2q33.1	0.63	0.46	0.47	0.34	0.18	2.194e-4	4.999e-4	(A) Negative
REM1	20q11.21	0.84	0.52	0.88	0.61	0.33	2.198e-4	5.008e-4	(A) Negative
ACAA2	18q21.1	-0.17	-0.47	0.75	0.69	0.29	2.202e-4	5.017e-4	(A) Negative
KCNS3	2p24.2	2.01	2.51	1.29	1.08	-0.49	2.204e-4	5.021e-4	(B) Positive
EPHA1	7q34-q35	0.53	0.27	0.67	0.57	0.26	2.205e-4	5.022e-4	(A) Negative
PLCB3	11q13.1	0.38	0.14	0.60	0.65	0.24	2.210e-4	5.033e-4	(A) Negative
CD160	1q21.1	0.65	0.40	0.66	0.53	0.25	2.213e-4	5.039e-4	(A) Negative
SLC46A2	9q32	0.76	1.01	0.62	0.72	-0.25	2.216e-4	5.045e-4	(B) Positive
LYPLA1	8q11.23	-0.21	0.09	0.74	0.84	-0.30	2.219e-4	5.051e-4	(B) Positive
IL17RE	3p25.3	0.52	0.33	0.50	0.49	0.20	2.222e-4	5.056e-4	(A) Negative
DVL2	17p13.1	-0.58	-0.74	0.42	0.39	0.16	2.231e-4	5.078e-4	(A) Negative
EIF4G3	1p36.12	-0.38	-0.18	0.52	0.45	-0.20	2.239e-4	5.094e-4	(B) Positive
SAP30L	5q33.2	0.16	0.32	0.43	0.37	-0.17	2.239e-4	5.094e-4	(B) Positive
ZNF646	16p11.2	0.17	0.34	0.44	0.42	-0.17	2.243e-4	5.102e-4	(B) Positive
FCRLB	1q23.3	0.35	0.69	0.82	1.04	-0.34	2.247e-4	5.111e-4	(B) Positive
SEC61A1	3q21.3	0.33	0.17	0.41	0.32	0.15	2.255e-4	5.129e-4	(A) Negative
TAB2	6q25.1	0.64	0.45	0.46	0.55	0.19	2.258e-4	5.133e-4	(A) Negative
C6ORF120	6q27	0.23	0.43	0.53	0.41	-0.20	2.266e-4	5.151e-4	(B) Positive
ARAP3	5q31.3	-1.03	-1.29	0.68	0.62	0.26	2.266e-4	5.151e-4	(A) Negative
KHDC1	6q13	-0.19	-0.60	1.08	0.88	0.41	2.272e-4	5.165e-4	(A) Negative
ZNF607	19q13.1	-0.32	-0.55	0.56	0.61	0.23	2.273e-4	5.166e-4	(A) Negative
MYEOV	11q13.3	-0.92	-1.43	1.34	1.00	0.50	2.274e-4	5.167e-4	(A) Negative
LMNA	1q22	0.33	0.08	0.65	0.55	0.25	2.275e-4	5.168e-4	(A) Negative
ANKRD6	6q15	0.96	0.67	0.74	0.75	0.29	2.278e-4	5.174e-4	(A) Negative
SKA2	17q23.2	-0.91	-1.18	0.68	0.74	0.27	2.278e-4	5.174e-4	(A) Negative
MED25	19q13.33	0.46	0.61	0.36	0.42	-0.15	2.287e-4	5.193e-4	(B) Positive
STRADB	2q33.1	-1.04	-0.86	0.45	0.45	-0.18	2.300e-4	5.223e-4	(B) Positive
CLP1	11q12.1	0.06	-0.11	0.43	0.40	0.17	2.305e-4	5.233e-4	(A) Negative
SLC25A16	10q21.3	0.09	0.36	0.70	0.67	-0.27	2.307e-4	5.238e-4	(B) Positive
ZCWPW1	7q22.1	0.28	0.56	0.71	0.70	-0.28	2.308e-4	5.238e-4	(B) Positive
RALY	20q11.22	-0.00	-0.17	0.43	0.42	0.17	2.308e-4	5.238e-4	(A) Negative
DAD1	14q11.2	0.07	0.25	0.49	0.39	-0.19	2.310e-4	5.241e-4	(B) Positive
PMFBP1	16q22.2	-0.45	-0.69	0.60	0.63	0.24	2.312e-4	5.246e-4	(A) Negative
LINC00312	3p25.3	0.42	0.79	0.94	0.92	-0.37	2.317e-4	5.257e-4	(B) Positive
KLF4	9q31.2	-0.80	-0.48	0.81	0.88	-0.32	2.319e-4	5.260e-4	(B) Positive
CRAMP1	16p13.3	-0.03	0.15	0.45	0.52	-0.18	2.322e-4	5.266e-4	(B) Positive
RAB4B	19q13.2	0.12	0.35	0.58	0.56	-0.23	2.326e-4	5.276e-4	(B) Positive
SEPTIN1	16p11.2	-0.29	-0.60	0.79	0.68	0.30	2.333e-4	5.290e-4	(A) Negative
DENND2B	11p15.4	1.09	0.84	0.64	0.64	0.25	2.338e-4	5.300e-4	(A) Negative
NOC3L	10q23.33	-0.36	-0.57	0.55	0.40	0.20	2.340e-4	5.305e-4	(A) Negative
HSD17B11	4q22.1	-1.85	-1.52	0.84	0.84	-0.33	2.344e-4	5.313e-4	(B) Positive
PAMR1	11p13	1.88	2.26	0.95	1.04	-0.38	2.344e-4	5.313e-4	(B) Positive
BCL6B	17p13.1	1.91	2.11	0.52	0.50	-0.20	2.351e-4	5.327e-4	(B) Positive
NABP2	12q13.3	-0.41	-0.21	0.51	0.40	-0.19	2.352e-4	5.330e-4	(B) Positive
LMAN1L	15q24.1	0.56	0.41	0.41	0.25	0.15	2.353e-4	5.331e-4	(A) Negative
SETD7	4q31.1	0.66	0.88	0.56	0.48	-0.22	2.355e-4	5.333e-4	(B) Positive
CHMP1B	18p11.21	0.28	0.08	0.51	0.44	0.20	2.367e-4	5.361e-4	(A) Negative
COL5A3	19p13.2	1.46	1.78	0.82	0.84	-0.32	2.373e-4	5.374e-4	(B) Positive
ETV3	1q23.1	0.04	-0.12	0.40	0.38	0.16	2.375e-4	5.377e-4	(A) Negative
CHMP4B	20q11.22	-0.23	-0.03	0.54	0.49	-0.21	2.388e-4	5.406e-4	(B) Positive
C20ORF96	20p13	-0.07	0.33	1.04	0.93	-0.40	2.389e-4	5.407e-4	(B) Positive
PLEKHG3	14q23.3	0.49	0.67	0.45	0.51	-0.18	2.389e-4	5.407e-4	(B) Positive
DNAAF10	2p14	0.01	-0.13	0.38	0.33	0.14	2.393e-4	5.415e-4	(A) Negative
OR4C6	11q11	0.21	0.03	0.46	0.52	0.19	2.396e-4	5.422e-4	(A) Negative
CUEDC2	10q24.32	-0.30	-0.12	0.48	0.40	-0.18	2.397e-4	5.422e-4	(B) Positive
TIMM13	19p13.3	-0.46	-0.28	0.46	0.43	-0.18	2.406e-4	5.442e-4	(B) Positive
ARHGEF2	1q22	0.37	0.07	0.77	0.70	0.30	2.406e-4	5.442e-4	(A) Negative
GUCD1	22q11.23	0.16	0.36	0.50	0.55	-0.20	2.408e-4	5.446e-4	(B) Positive
ARMCX1	Xq22.1	0.87	1.30	1.10	1.10	-0.43	2.411e-4	5.452e-4	(B) Positive
SPINK2	4q12	-0.33	-0.83	1.27	1.30	0.50	2.421e-4	5.474e-4	(A) Negative
RAD21	8q24.11	0.58	0.27	0.80	0.80	0.31	2.424e-4	5.480e-4	(A) Negative
SUN3	7p12.3	-1.22	-1.59	1.02	0.62	0.37	2.425e-4	5.481e-4	(A) Negative
TENM4	11q14.1	0.63	1.00	0.94	0.88	-0.36	2.426e-4	5.482e-4	(B) Positive
PARD3	10p11.22-p11.21	0.75	0.48	0.68	0.65	0.27	2.428e-4	5.486e-4	(A) Negative
ARIH1	15q24.1	-0.11	-0.36	0.66	0.55	0.25	2.438e-4	5.509e-4	(A) Negative
ZNF557	19p13.2	0.37	0.54	0.45	0.37	-0.17	2.467e-4	5.572e-4	(B) Positive
AICDA	12p13.31	1.00	0.54	1.23	1.01	0.47	2.467e-4	5.572e-4	(A) Negative
RALBP1	18p11.22	0.56	0.34	0.61	0.42	0.23	2.467e-4	5.572e-4	(A) Negative
ADH1A	4q23	2.06	2.65	1.55	1.35	-0.59	2.469e-4	5.577e-4	(B) Positive
MED26	19p13.11	0.28	0.13	0.39	0.34	0.15	2.475e-4	5.590e-4	(A) Negative
ADAM23	2q33.3	-3.52	-3.31	0.54	0.51	-0.21	2.488e-4	5.616e-4	(B) Positive
CD47	3q13.12	0.18	-0.14	0.82	0.72	0.31	2.499e-4	5.641e-4	(A) Negative
GPR183	13q32.3	3.79	3.29	1.29	1.24	0.50	2.500e-4	5.643e-4	(A) Negative
CAMK2G	10q22.2	-0.03	-0.23	0.51	0.41	0.19	2.501e-4	5.644e-4	(A) Negative
CACNB1	17q12	0.01	-0.12	0.35	0.34	0.14	2.506e-4	5.655e-4	(A) Negative
ZFX	Xp22.11	0.43	0.64	0.51	0.60	-0.21	2.509e-4	5.660e-4	(B) Positive
SEMA6B	19p13.3	-0.35	-0.14	0.52	0.55	-0.21	2.509e-4	5.661e-4	(B) Positive
NDUFA13	19p13.11	-0.12	0.07	0.48	0.44	-0.18	2.527e-4	5.700e-4	(B) Positive
SCIMP	17p13.2	1.73	1.42	0.82	0.68	0.31	2.528e-4	5.701e-4	(A) Negative
COX7B	Xq21.1	0.18	-0.05	0.60	0.57	0.23	2.530e-4	5.705e-4	(A) Negative
SH3D19	4q31.3	0.05	0.33	0.74	0.61	-0.28	2.536e-4	5.718e-4	(B) Positive
LDOC1	Xq27.1	0.75	0.44	0.78	0.79	0.30	2.540e-4	5.727e-4	(A) Negative
MBP	18q23	-0.12	-0.38	0.69	0.54	0.26	2.543e-4	5.732e-4	(A) Negative
WWC2-AS2	4q35.1	0.03	0.31	0.72	0.68	-0.28	2.543e-4	5.732e-4	(B) Positive
ZFAND2B	2q35	0.35	0.16	0.50	0.35	0.18	2.548e-4	5.741e-4	(A) Negative
NOL6	9p13.3	0.04	-0.12	0.38	0.40	0.15	2.551e-4	5.747e-4	(A) Negative
IPO9	1q32.1	-0.09	-0.26	0.43	0.39	0.16	2.556e-4	5.758e-4	(A) Negative
HDAC3	5q31.3	-0.29	-0.13	0.41	0.38	-0.16	2.563e-4	5.773e-4	(B) Positive
ELOC	8q21.11	0.18	-0.03	0.51	0.64	0.21	2.567e-4	5.782e-4	(A) Negative
ARHGEF26	3q25.2	0.83	1.25	1.09	0.95	-0.41	2.569e-4	5.785e-4	(B) Positive
PKHD1L1	8q23.1-q23.2	0.59	0.30	0.77	0.64	0.29	2.569e-4	5.785e-4	(A) Negative
DYM	18q21.1	0.43	0.22	0.56	0.44	0.21	2.575e-4	5.798e-4	(A) Negative
TMEM263	12q23.3	0.48	0.71	0.62	0.54	-0.23	2.585e-4	5.820e-4	(B) Positive
MAGEL2	15q11.2	-0.03	0.35	0.97	1.01	-0.38	2.586e-4	5.820e-4	(B) Positive
IDH3G	Xq28	0.22	0.07	0.40	0.34	0.15	2.591e-4	5.832e-4	(A) Negative
ZXDB	Xp11.21	0.54	0.72	0.47	0.43	-0.18	2.596e-4	5.841e-4	(B) Positive
CPO	2q33.3	0.45	0.72	0.67	0.77	-0.27	2.597e-4	5.844e-4	(B) Positive
C10ORF88	10q26.13	0.07	0.29	0.58	0.44	-0.22	2.603e-4	5.856e-4	(B) Positive
FUT7	9q34.3	0.62	0.39	0.62	0.51	0.23	2.606e-4	5.862e-4	(A) Negative
PVRIG	7q22.1	-0.75	-1.18	1.13	0.99	0.43	2.623e-4	5.898e-4	(A) Negative
COX15	10q24.2	-0.48	-0.30	0.50	0.39	-0.19	2.629e-4	5.911e-4	(B) Positive
ADGRF3	2p23.3	-0.05	-0.14	0.22	0.22	0.09	2.632e-4	5.918e-4	(A) Negative
IL21	4q27	0.51	0.22	0.76	0.64	0.29	2.645e-4	5.947e-4	(A) Negative
CFAP68	11q23.1	-0.32	-0.08	0.61	0.64	-0.24	2.647e-4	5.951e-4	(B) Positive
PELI3	11q13.2	0.87	1.08	0.54	0.59	-0.22	2.655e-4	5.967e-4	(B) Positive
TFAP2E	1p34.3	0.25	0.04	0.57	0.41	0.21	2.661e-4	5.980e-4	(A) Negative
AQR	15q14	0.17	0.33	0.41	0.36	-0.16	2.663e-4	5.983e-4	(B) Positive
YARS2	12p11.21	-0.38	-0.56	0.49	0.36	0.18	2.678e-4	6.016e-4	(A) Negative
MOXD1	6q23.2	-1.52	-2.06	1.47	1.06	0.54	2.686e-4	6.035e-4	(A) Negative
KLK1	19q13.33	-1.91	-2.28	0.99	0.74	0.37	2.690e-4	6.041e-4	(A) Negative
PIGN	18q21.33	0.62	0.86	0.64	0.48	-0.24	2.696e-4	6.055e-4	(B) Positive
SPATA9	5q15	-0.72	-0.50	0.56	0.57	-0.22	2.702e-4	6.066e-4	(B) Positive
PITPNC1	17q24.2	-0.74	-1.07	0.84	0.83	0.33	2.702e-4	6.066e-4	(A) Negative
SIX2	2p21	0.75	0.27	1.26	1.13	0.48	2.706e-4	6.076e-4	(A) Negative
FLRT1	11q13.1	-0.48	-0.64	0.44	0.38	0.17	2.725e-4	6.117e-4	(A) Negative
NFXL1	4p12	-0.26	-0.49	0.59	0.53	0.23	2.726e-4	6.118e-4	(A) Negative
CEP15	3p14.2	0.04	0.49	1.16	1.23	-0.46	2.728e-4	6.122e-4	(B) Positive
SARDH	9q34.2	-0.42	-0.26	0.39	0.47	-0.16	2.733e-4	6.132e-4	(B) Positive
TMEM79	1q22	1.59	1.23	0.96	0.75	0.36	2.736e-4	6.139e-4	(A) Negative
TGOLN2	2p11.2	0.66	0.83	0.45	0.40	-0.17	2.738e-4	6.142e-4	(B) Positive
MAP2K6	17q24.3	0.04	-0.31	0.95	0.78	0.35	2.752e-4	6.172e-4	(A) Negative
SPIDR	8q11.21	0.13	0.35	0.54	0.57	-0.21	2.772e-4	6.217e-4	(B) Positive
SPMIP4	7p15.3	-0.10	-0.34	0.62	0.63	0.24	2.773e-4	6.217e-4	(A) Negative
GUCY1B1	4q32.1	2.32	1.98	0.89	0.83	0.34	2.777e-4	6.227e-4	(A) Negative
PAFAH1B1	17p13.3	-0.25	-0.43	0.47	0.41	0.18	2.780e-4	6.232e-4	(A) Negative
OSR2	8q22.2	-0.23	0.32	1.43	1.34	-0.55	2.782e-4	6.236e-4	(B) Positive
RDH8	19p13.2	0.17	0.07	0.24	0.32	0.10	2.796e-4	6.266e-4	(A) Negative
G6PD	Xq28	-1.25	-1.55	0.79	0.62	0.29	2.797e-4	6.268e-4	(A) Negative
C14ORF119	14q11.2	-0.34	-0.17	0.47	0.34	-0.17	2.803e-4	6.279e-4	(B) Positive
MORC2-AS1	22q12.2	0.66	0.45	0.55	0.52	0.21	2.803e-4	6.279e-4	(A) Negative
HK2	2p12	-0.37	-0.61	0.63	0.63	0.24	2.803e-4	6.279e-4	(A) Negative
FAM83F	22q13.1	3.39	3.12	0.67	0.78	0.27	2.804e-4	6.281e-4	(A) Negative
ORMDL3	17q21.1	0.63	0.98	0.95	0.75	-0.35	2.812e-4	6.298e-4	(B) Positive
SCAF4	21q22.11	0.21	0.02	0.51	0.42	0.19	2.814e-4	6.300e-4	(A) Negative
HSFX1	Xq28	-0.03	0.16	0.48	0.46	-0.18	2.816e-4	6.304e-4	(B) Positive
UTF1	10q26.3	0.89	0.67	0.56	0.56	0.22	2.817e-4	6.307e-4	(A) Negative
ARL5A	2q23.3	0.28	0.09	0.49	0.41	0.18	2.822e-4	6.317e-4	(A) Negative
STARD6	18q21.2	0.44	0.22	0.61	0.41	0.22	2.826e-4	6.323e-4	(A) Negative
NKX2-1	14q13.3	0.17	-0.03	0.56	0.39	0.21	2.826e-4	6.323e-4	(A) Negative
EMC4	15q14	-0.03	0.12	0.40	0.42	-0.16	2.831e-4	6.333e-4	(B) Positive
RBFOX2	22q12.3	0.03	-0.19	0.57	0.52	0.22	2.831e-4	6.333e-4	(A) Negative
PRTN3	19p13.3	-0.57	-0.41	0.38	0.46	-0.15	2.831e-4	6.333e-4	(B) Positive
PFKM	12q13.11	-1.31	-1.01	0.78	0.68	-0.30	2.839e-4	6.350e-4	(B) Positive
PHB2	12p13.31	-0.49	-0.72	0.61	0.39	0.22	2.840e-4	6.352e-4	(A) Negative
RRN3	16p13.11	0.27	0.45	0.47	0.43	-0.18	2.845e-4	6.362e-4	(B) Positive
RUNX1-IT1	21q22.12	-1.88	-2.24	0.95	0.82	0.36	2.856e-4	6.384e-4	(A) Negative
AEN	15q26.1	-0.76	-0.97	0.52	0.53	0.20	2.874e-4	6.424e-4	(A) Negative
ACD	16q22.1	-0.79	-0.99	0.52	0.42	0.19	2.881e-4	6.439e-4	(A) Negative
WDR44	Xq24	-0.00	0.19	0.52	0.39	-0.19	2.894e-4	6.468e-4	(B) Positive
ECD	10q22.2	0.11	0.28	0.43	0.40	-0.16	2.908e-4	6.498e-4	(B) Positive
ASTE1	3q22.1	0.43	0.61	0.48	0.40	-0.18	2.915e-4	6.512e-4	(B) Positive
N4BP1	16q12.1	0.39	0.20	0.49	0.48	0.19	2.918e-4	6.518e-4	(A) Negative
FGFR1	8p11.23	-0.72	-0.40	0.80	0.98	-0.32	2.919e-4	6.519e-4	(B) Positive
ARHGAP23	17q12	-0.34	-0.59	0.62	0.79	0.25	2.923e-4	6.529e-4	(A) Negative
PRADC1	2p13.2	0.14	-0.08	0.58	0.48	0.22	2.930e-4	6.543e-4	(A) Negative
PSMA8	18q11.2	0.82	0.43	1.09	0.60	0.39	2.932e-4	6.546e-4	(A) Negative
PLEKHB2	2q21.1	-0.23	-0.03	0.50	0.53	-0.19	2.932e-4	6.546e-4	(B) Positive
POLR2C	16q21	-0.81	-0.97	0.42	0.44	0.16	2.935e-4	6.552e-4	(A) Negative
HERC3	4q22.1	0.08	0.27	0.50	0.47	-0.19	2.948e-4	6.579e-4	(B) Positive
SREBF2	22q13.2	-0.38	-0.61	0.60	0.53	0.23	2.948e-4	6.580e-4	(A) Negative
CLEC11A	19q13.33	0.76	1.02	0.68	0.64	-0.26	2.949e-4	6.581e-4	(B) Positive
AXL	19q13.2	-1.95	-1.62	0.91	0.74	-0.34	2.950e-4	6.583e-4	(B) Positive
RHBDD1	2q36.3	0.47	0.66	0.52	0.40	-0.19	2.963e-4	6.609e-4	(B) Positive
GOLGA8A	15q14	-2.86	-3.23	0.91	1.06	0.36	2.969e-4	6.622e-4	(A) Negative
APCDD1	18p11.22	1.64	1.24	1.05	0.93	0.40	2.972e-4	6.629e-4	(A) Negative
RXFP3	5p13.2	0.55	0.42	0.34	0.36	0.13	2.976e-4	6.637e-4	(A) Negative
FHIP2B	8p21.3	-0.34	-0.12	0.59	0.53	-0.22	2.995e-4	6.678e-4	(B) Positive
UBE4B	1p36.22	0.05	-0.14	0.52	0.44	0.19	3.003e-4	6.695e-4	(A) Negative
PMCH	12q23.2	0.31	0.02	0.70	0.84	0.28	3.011e-4	6.711e-4	(A) Negative
SPIC	12q23.2	0.78	0.44	0.96	0.61	0.35	3.015e-4	6.719e-4	(A) Negative
LINC00310	21q22.11	0.58	0.24	0.88	0.82	0.34	3.020e-4	6.729e-4	(A) Negative
SPRYD7	13q14.2	-0.23	-0.00	0.61	0.52	-0.23	3.020e-4	6.730e-4	(B) Positive
FRRS1	1p21.2	-0.01	-0.27	0.69	0.63	0.26	3.023e-4	6.734e-4	(A) Negative
STAT4	2q32.2-q32.3	1.32	0.94	1.00	0.94	0.38	3.026e-4	6.741e-4	(A) Negative
TRIM32	9q33.1	-0.07	0.13	0.57	0.42	-0.21	3.036e-4	6.761e-4	(B) Positive
ZSWIM1	20q13.12	0.29	0.47	0.48	0.41	-0.18	3.038e-4	6.765e-4	(B) Positive
RHOD	11q13.2	0.73	1.02	0.76	0.77	-0.29	3.041e-4	6.770e-4	(B) Positive
NAP1L5	4q22.1	-0.38	-0.10	0.78	0.51	-0.28	3.047e-4	6.783e-4	(B) Positive
SLC47A1	17p11.2	-2.32	-2.00	0.77	0.98	-0.32	3.051e-4	6.792e-4	(B) Positive
KIF25-AS1	6q27	0.33	-0.38	1.98	1.15	0.71	3.063e-4	6.817e-4	(A) Negative
CHRNB2	1q21.3	0.12	0.36	0.58	0.72	-0.24	3.066e-4	6.824e-4	(B) Positive
ACSM3	16p12.3	-4.13	-4.40	0.74	0.52	0.27	3.074e-4	6.840e-4	(A) Negative
OTP	5q14.1	0.28	0.09	0.51	0.44	0.19	3.076e-4	6.844e-4	(A) Negative
JHY	11q24.1	0.29	0.65	0.90	1.02	-0.36	3.077e-4	6.845e-4	(B) Positive
FGD1	Xp11.22	0.26	0.07	0.52	0.37	0.19	3.120e-4	6.939e-4	(A) Negative
AANAT	17q25.1	0.55	0.45	0.24	0.27	0.10	3.126e-4	6.953e-4	(A) Negative
CPNE6	14q11.2	0.17	0.09	0.19	0.22	0.08	3.152e-4	7.009e-4	(A) Negative
GDA	9q21.13	-4.46	-4.75	0.80	0.50	0.29	3.159e-4	7.024e-4	(A) Negative
NAGPA	16p13.3	-0.53	-0.34	0.52	0.44	-0.19	3.165e-4	7.036e-4	(B) Positive
IGSF9	1q23.2	2.31	2.04	0.68	0.77	0.27	3.166e-4	7.037e-4	(A) Negative
CSNK2A3	11p15.4	-0.39	-0.59	0.53	0.50	0.20	3.166e-4	7.037e-4	(A) Negative
OR6T1	11q24.1	0.56	0.45	0.28	0.32	0.11	3.167e-4	7.038e-4	(A) Negative
SERINC5	5q14.1	0.10	0.35	0.65	0.60	-0.25	3.167e-4	7.038e-4	(B) Positive
INTS14	15q22.31	0.06	0.21	0.39	0.36	-0.15	3.172e-4	7.047e-4	(B) Positive
SIPA1L2	1q42.2	0.30	-0.07	0.96	0.94	0.37	3.180e-4	7.063e-4	(A) Negative
SLC27A6	5q23.3	-0.47	-1.14	1.81	1.44	0.67	3.186e-4	7.076e-4	(A) Negative
TPST2	22q12.1	-0.03	0.24	0.72	0.68	-0.27	3.186e-4	7.077e-4	(B) Positive
PLS1	3q23	-0.39	0.08	1.26	1.02	-0.47	3.189e-4	7.082e-4	(B) Positive
COPS7A	12p13.31	-0.18	0.01	0.51	0.42	-0.19	3.205e-4	7.116e-4	(B) Positive
PEG10	7q21.3	-1.90	-2.61	1.83	1.92	0.71	3.209e-4	7.123e-4	(A) Negative
PNPLA3	22q13.31	-2.05	-2.71	1.71	1.74	0.66	3.214e-4	7.134e-4	(A) Negative
SLC16A14	2q36.3	0.40	0.86	1.23	1.05	-0.46	3.221e-4	7.149e-4	(B) Positive
ZBTB6	9q33.2	-0.21	0.06	0.72	0.58	-0.26	3.228e-4	7.163e-4	(B) Positive
MARCKSL1	1p35.1	1.03	0.80	0.62	0.59	0.24	3.238e-4	7.185e-4	(A) Negative
CRIP3	6p21.1	-1.20	-1.49	0.79	0.66	0.29	3.245e-4	7.200e-4	(A) Negative
GBX2	2q37.2	-1.36	-1.67	0.88	0.58	0.32	3.259e-4	7.229e-4	(A) Negative
CTAGE1	18q11.2	0.14	0.35	0.55	0.49	-0.21	3.265e-4	7.241e-4	(B) Positive
C11ORF65	11q22.3	-0.40	-0.12	0.71	0.70	-0.27	3.274e-4	7.262e-4	(B) Positive
ACTL6B	7q22.1	0.28	0.13	0.40	0.42	0.16	3.291e-4	7.299e-4	(A) Negative
EIF2B5	3q27.1	-0.04	0.14	0.47	0.46	-0.18	3.292e-4	7.299e-4	(B) Positive
NRIP2	12p13.33	-0.24	-0.10	0.37	0.36	-0.14	3.305e-4	7.327e-4	(B) Positive
SLC22A3	6q25.3	-0.98	-1.33	0.95	0.81	0.35	3.322e-4	7.364e-4	(A) Negative
IFT74	9p21.2	0.09	0.39	0.80	0.70	-0.30	3.328e-4	7.375e-4	(B) Positive
TTC9	14q24.2	1.93	2.25	0.87	0.72	-0.32	3.333e-4	7.387e-4	(B) Positive
DSEL	18q22.1	-1.37	-1.04	0.82	1.01	-0.33	3.341e-4	7.402e-4	(B) Positive
PIGF	2p21	-0.56	-0.32	0.65	0.57	-0.24	3.341e-4	7.402e-4	(B) Positive
BARX2	11q24.3	0.99	0.58	1.13	0.94	0.42	3.349e-4	7.418e-4	(A) Negative
TUB	11p15.4	-0.49	-0.83	0.93	0.75	0.34	3.350e-4	7.420e-4	(A) Negative
HOXB13	17q21.32	-0.94	-1.61	1.73	1.78	0.67	3.355e-4	7.430e-4	(A) Negative
SLAMF9	1q23.2	0.36	0.65	0.77	0.76	-0.29	3.375e-4	7.474e-4	(B) Positive
GFOD3P	1p36.32	-0.66	-0.42	0.60	0.67	-0.24	3.378e-4	7.480e-4	(B) Positive
PRRC2C	1q24.3	0.34	0.16	0.49	0.42	0.18	3.381e-4	7.486e-4	(A) Negative
ABCF2	7q36.1	-0.50	-0.69	0.51	0.35	0.18	3.392e-4	7.508e-4	(A) Negative
MAP1S	19p13.12	0.42	0.28	0.36	0.38	0.14	3.395e-4	7.515e-4	(A) Negative
RBM18	9q33.2	-0.20	-0.44	0.64	0.54	0.24	3.402e-4	7.527e-4	(A) Negative
RPS6KA1	1p36.11	0.72	0.50	0.57	0.60	0.22	3.405e-4	7.535e-4	(A) Negative
CLDN2	Xq22.3	0.34	0.12	0.64	0.31	0.22	3.413e-4	7.551e-4	(A) Negative
STAR	8p11.23	-3.92	-4.44	1.42	1.05	0.52	3.419e-4	7.562e-4	(A) Negative
KRT1	12q13.13	0.68	1.20	1.32	1.60	-0.53	3.427e-4	7.579e-4	(B) Positive
ASB16-AS1	17q21.31	-0.21	-0.10	0.28	0.32	-0.11	3.443e-4	7.614e-4	(B) Positive
ZNF780A	19q13.2	0.08	0.27	0.48	0.45	-0.18	3.452e-4	7.632e-4	(B) Positive
LEFTY2	1q42.12	-2.69	-3.14	1.25	0.77	0.45	3.460e-4	7.650e-4	(A) Negative
RAB9A	Xp22.2	0.25	0.02	0.64	0.54	0.24	3.481e-4	7.696e-4	(A) Negative
LSG1	3q29	0.38	0.21	0.46	0.38	0.17	3.482e-4	7.696e-4	(A) Negative
EMD	Xq28	-0.92	-1.09	0.45	0.43	0.17	3.485e-4	7.701e-4	(A) Negative
APOL6	22q12.3	0.80	0.43	1.00	0.83	0.37	3.485e-4	7.701e-4	(A) Negative
TPRKB	2p13.1	-0.21	-0.40	0.53	0.43	0.19	3.487e-4	7.704e-4	(A) Negative
PPP1R14D	15q15.1	0.09	0.28	0.47	0.64	-0.19	3.516e-4	7.768e-4	(B) Positive
MS4A1	11q12.2	0.37	-0.35	1.98	1.61	0.73	3.534e-4	7.807e-4	(A) Negative
GHRHR	7p14.3	0.31	0.14	0.48	0.30	0.17	3.539e-4	7.816e-4	(A) Negative
CHD8	14q11.2	-0.18	0.00	0.49	0.44	-0.18	3.545e-4	7.829e-4	(B) Positive
CT45A6	Xq26.3	-3.85	-4.66	2.27	1.44	0.81	3.547e-4	7.833e-4	(A) Negative
H2AC11	6p22.1	-0.00	0.29	0.71	0.90	-0.29	3.553e-4	7.843e-4	(B) Positive
GBF1	10q24.32	0.03	0.19	0.42	0.34	-0.15	3.553e-4	7.844e-4	(B) Positive
ZNF665	19q13.42	0.30	0.45	0.39	0.38	-0.15	3.568e-4	7.876e-4	(B) Positive
GET3	19p13.13	-0.25	-0.08	0.44	0.45	-0.17	3.569e-4	7.878e-4	(B) Positive
TBC1D23	3q12.1-q12.2	0.41	0.25	0.44	0.28	0.16	3.588e-4	7.917e-4	(A) Negative
ATP2B1	12q21.33	-0.64	-0.37	0.75	0.60	-0.28	3.590e-4	7.921e-4	(B) Positive
COL1A2	7q21.3	2.18	2.59	1.09	1.11	-0.42	3.593e-4	7.926e-4	(B) Positive
MAGED1	Xp11.22	0.77	0.48	0.74	0.77	0.28	3.596e-4	7.932e-4	(A) Negative
FKBP7	2q31.2	0.15	-0.12	0.72	0.69	0.27	3.598e-4	7.935e-4	(A) Negative
ACAT1	11q22.3	-0.95	-0.69	0.69	0.67	-0.26	3.599e-4	7.936e-4	(B) Positive
HS3ST5	6q21-q22.1	-1.73	-1.32	0.92	1.49	-0.41	3.603e-4	7.945e-4	(B) Positive
FXYD1	19q13.12	-0.42	-0.10	0.80	0.91	-0.31	3.604e-4	7.946e-4	(B) Positive
CRYGA	2q33.3	0.17	0.08	0.24	0.23	0.09	3.608e-4	7.952e-4	(A) Negative
PRRX2	9q34.11	0.30	-0.06	0.98	0.83	0.36	3.610e-4	7.957e-4	(A) Negative
CARM1	19p13.2	0.54	0.31	0.63	0.54	0.23	3.617e-4	7.970e-4	(A) Negative
SPTSSA	14q13.1	0.04	-0.29	0.91	0.70	0.33	3.631e-4	8.001e-4	(A) Negative
TMX4	20p12.3	0.39	-0.03	1.19	0.71	0.42	3.637e-4	8.013e-4	(A) Negative
CCDC178	18q12.1	1.45	1.82	0.90	1.21	-0.37	3.639e-4	8.018e-4	(B) Positive
ARHGAP28	18p11.31	0.00	-0.30	0.77	0.90	0.30	3.640e-4	8.019e-4	(A) Negative
SBK1	16p12.1	0.82	0.58	0.66	0.49	0.24	3.650e-4	8.038e-4	(A) Negative
THNSL1	10p12.1	0.20	-0.17	1.00	0.80	0.37	3.650e-4	8.038e-4	(A) Negative
BUD31	7q22.1	-0.29	-0.48	0.52	0.39	0.19	3.652e-4	8.042e-4	(A) Negative
MPRIP	17p11.2	0.11	-0.08	0.50	0.43	0.18	3.657e-4	8.050e-4	(A) Negative
BRINP3	1q31.1	-0.02	-0.80	2.13	1.76	0.78	3.657e-4	8.050e-4	(A) Negative
EIF5AL1	10q22.3	-0.74	-0.93	0.50	0.49	0.19	3.663e-4	8.062e-4	(A) Negative
CNPPD1	2q35	0.26	0.39	0.35	0.32	-0.13	3.667e-4	8.071e-4	(B) Positive
BCS1L	2q35	-0.35	-0.54	0.52	0.36	0.19	3.669e-4	8.073e-4	(A) Negative
PLLP	16q13	-1.06	-0.76	0.81	0.75	-0.30	3.669e-4	8.073e-4	(B) Positive
APLP1	19q13.12	-0.15	-0.48	0.85	0.85	0.32	3.676e-4	8.087e-4	(A) Negative
ATP4A	19q13.12	-0.89	-1.21	0.87	0.78	0.32	3.683e-4	8.101e-4	(A) Negative
FARS2	6p25.1	0.52	0.70	0.48	0.41	-0.18	3.688e-4	8.112e-4	(B) Positive
NCLN	19p13.3	-0.12	-0.27	0.41	0.40	0.16	3.690e-4	8.114e-4	(A) Negative
HDDC2	6q22.31	-0.43	-0.65	0.57	0.56	0.21	3.694e-4	8.123e-4	(A) Negative
DYNC1H1	14q32.31	0.78	0.61	0.46	0.39	0.17	3.701e-4	8.137e-4	(A) Negative
ARID1A	1p36.11	0.13	0.27	0.39	0.36	-0.15	3.702e-4	8.138e-4	(B) Positive
NTMT1	9q34.11	-0.73	-0.91	0.50	0.40	0.18	3.704e-4	8.142e-4	(A) Negative
CCNT2	2q21.3	-0.25	-0.07	0.51	0.43	-0.19	3.719e-4	8.173e-4	(B) Positive
KDM6A	Xp11.3	0.47	0.71	0.64	0.49	-0.23	3.722e-4	8.178e-4	(B) Positive
AGA	4q34.3	0.23	0.46	0.64	0.52	-0.23	3.723e-4	8.180e-4	(B) Positive
GGPS1	1q42.3	0.75	0.96	0.55	0.49	-0.20	3.725e-4	8.184e-4	(B) Positive
IFNL2	19q13.2	0.82	0.55	0.75	0.61	0.27	3.732e-4	8.198e-4	(A) Negative
BATF2	11q13.1	1.39	0.80	1.61	1.33	0.59	3.737e-4	8.208e-4	(A) Negative
MARCHF11	5p15.1	-1.45	-0.96	1.19	1.53	-0.48	3.740e-4	8.212e-4	(B) Positive
SOST	17q21.31	-0.97	-1.45	1.33	0.99	0.48	3.741e-4	8.215e-4	(A) Negative
CEMP1	16p13.3	-0.21	0.03	0.63	0.62	-0.24	3.753e-4	8.238e-4	(B) Positive
LMCD1	3p25.3	1.76	2.09	0.89	0.86	-0.33	3.757e-4	8.246e-4	(B) Positive
LPCAT1	5p15.33	-0.48	-0.75	0.75	0.62	0.28	3.785e-4	8.307e-4	(A) Negative
GPR37L1	1q32.1	0.34	0.25	0.23	0.27	0.09	3.798e-4	8.334e-4	(A) Negative
C1QTNF4	11p11.2	0.41	0.69	0.73	0.72	-0.28	3.798e-4	8.334e-4	(B) Positive
EIF3K	19q13.2	0.10	-0.09	0.52	0.34	0.19	3.800e-4	8.337e-4	(A) Negative
RAI1	17p11.2	-0.01	0.15	0.44	0.43	-0.16	3.805e-4	8.348e-4	(B) Positive
SP4	7p15.3	-0.02	-0.22	0.54	0.56	0.21	3.818e-4	8.375e-4	(A) Negative
STK32A	5q32	-2.44	-2.84	1.12	0.69	0.40	3.825e-4	8.388e-4	(A) Negative
TMEM167A	5q14.2	-0.41	-0.25	0.45	0.34	-0.16	3.837e-4	8.414e-4	(B) Positive
RABGEF1	7q11.21	-0.39	-0.55	0.44	0.36	0.16	3.854e-4	8.451e-4	(A) Negative
RBM4	11q13.2	0.04	0.18	0.39	0.40	-0.15	3.856e-4	8.453e-4	(B) Positive
FBLN5	14q32.12	1.76	1.44	0.86	0.80	0.32	3.860e-4	8.462e-4	(A) Negative
SLC24A5	15q21.1	-1.18	-0.74	1.17	1.05	-0.43	3.867e-4	8.476e-4	(B) Positive
SMCR8	17p11.2	0.34	0.49	0.39	0.37	-0.15	3.870e-4	8.480e-4	(B) Positive
CILP2	19p13.11	0.77	1.03	0.68	0.65	-0.26	3.870e-4	8.480e-4	(B) Positive
CNKSR1	1p36.11	0.80	0.98	0.46	0.51	-0.18	3.885e-4	8.512e-4	(B) Positive
PCDHA5	5q31.3	0.58	0.97	1.01	1.08	-0.39	3.907e-4	8.560e-4	(B) Positive
LCE2A	1q21.3	0.04	-0.11	0.40	0.33	0.14	3.911e-4	8.565e-4	(A) Negative
TP53AIP1	11q24.3	0.09	0.25	0.40	0.48	-0.16	3.911e-4	8.565e-4	(B) Positive
RPL35A	3q29	0.07	-0.13	0.56	0.42	0.20	3.913e-4	8.569e-4	(A) Negative
TMEM92	17q21.33	-0.83	-1.28	1.23	0.93	0.44	3.923e-4	8.590e-4	(A) Negative
KRT27	17q21.2	-0.40	-0.12	0.72	0.77	-0.28	3.932e-4	8.608e-4	(B) Positive
PSAPL1	4p16.1	-0.03	-0.35	0.90	0.59	0.32	3.935e-4	8.614e-4	(A) Negative
CDC42SE1	1q21.3	1.20	1.00	0.52	0.54	0.20	3.942e-4	8.627e-4	(A) Negative
OR14C36	1q44	0.58	0.48	0.25	0.31	0.10	3.942e-4	8.627e-4	(A) Negative
MRPL30	2q11.2	-0.46	-0.64	0.51	0.39	0.18	3.961e-4	8.666e-4	(A) Negative
NT5E	6q14.3	-2.64	-2.94	0.83	0.67	0.30	3.971e-4	8.689e-4	(A) Negative
CASQ2	1p13.1	1.08	1.45	0.95	1.05	-0.37	3.974e-4	8.693e-4	(B) Positive
MYLK2	20q11.21	-1.21	-1.46	0.62	0.78	0.25	3.996e-4	8.740e-4	(A) Negative
SRPX2	Xq22.1	1.39	1.77	1.03	0.96	-0.38	3.998e-4	8.744e-4	(B) Positive
MUC5B	11p15.5	0.52	0.16	0.93	1.00	0.36	3.999e-4	8.745e-4	(A) Negative
DPP9	19p13.3	-0.25	-0.05	0.53	0.53	-0.20	4.002e-4	8.750e-4	(B) Positive
CASP9	1p36.21	-1.10	-0.93	0.46	0.41	-0.17	4.006e-4	8.757e-4	(B) Positive
STAT5A	17q21.2	-0.74	-1.03	0.81	0.57	0.29	4.008e-4	8.761e-4	(A) Negative
PDZD2	5p13.3	1.37	0.96	1.10	1.01	0.41	4.011e-4	8.766e-4	(A) Negative
COIL	17q22	-0.22	-0.01	0.56	0.60	-0.21	4.022e-4	8.790e-4	(B) Positive
RNF4	4p16.3	-0.24	-0.07	0.48	0.39	-0.17	4.031e-4	8.808e-4	(B) Positive
KLHL6	3q27.1	-0.44	-0.85	1.11	1.00	0.41	4.043e-4	8.834e-4	(A) Negative
TRAIP	3p21.31	-1.07	-1.29	0.58	0.56	0.22	4.047e-4	8.842e-4	(A) Negative
STRC	15q15.3	-0.04	0.23	0.67	0.86	-0.27	4.049e-4	8.844e-4	(B) Positive
IL13RA1	Xq24	0.67	0.98	0.86	0.54	-0.30	4.053e-4	8.851e-4	(B) Positive
TEKT4	2q11.1	-0.42	-0.18	0.66	0.58	-0.24	4.055e-4	8.855e-4	(B) Positive
MYH3	17p13.1	-1.38	-1.73	0.94	0.85	0.35	4.062e-4	8.868e-4	(A) Negative
KCTD5	16p13.3	0.28	0.15	0.35	0.37	0.13	4.064e-4	8.871e-4	(A) Negative
NCOR1	17p12-p11.2	-0.26	-0.11	0.38	0.48	-0.15	4.064e-4	8.871e-4	(B) Positive
DCP1B	12p13.33	0.11	0.34	0.62	0.49	-0.22	4.068e-4	8.878e-4	(B) Positive
NDST1	5q33.1	0.56	0.74	0.49	0.48	-0.18	4.070e-4	8.881e-4	(B) Positive
KLHL23	2q31.1	-1.12	-1.48	1.01	0.82	0.37	4.076e-4	8.893e-4	(A) Negative
CDADC1	13q14.2	-0.01	0.21	0.60	0.44	-0.21	4.086e-4	8.915e-4	(B) Positive
NPPA	1p36.22	0.01	0.17	0.44	0.46	-0.17	4.087e-4	8.916e-4	(B) Positive
ABCB10	1q42.13	-0.53	-0.74	0.58	0.50	0.21	4.094e-4	8.930e-4	(A) Negative
EP400	12q24.33	-0.42	-0.30	0.34	0.29	-0.13	4.129e-4	9.005e-4	(B) Positive
CEP20	16p13.11	-0.53	-0.33	0.56	0.47	-0.21	4.131e-4	9.009e-4	(B) Positive
SIM1	6q16.3	0.68	0.44	0.67	0.43	0.24	4.133e-4	9.011e-4	(A) Negative
TDRD7	9q22.33	0.23	0.50	0.74	0.52	-0.26	4.151e-4	9.049e-4	(B) Positive
LDLRAD3	11p13	1.02	1.32	0.77	0.91	-0.30	4.156e-4	9.058e-4	(B) Positive
THOC2	Xq25	-0.41	-0.58	0.47	0.40	0.17	4.158e-4	9.063e-4	(A) Negative
KLHL29	2p24.1	-0.86	-1.31	1.22	1.09	0.45	4.169e-4	9.085e-4	(A) Negative
PRKAR2B	7q22.3	0.04	0.47	1.11	1.21	-0.43	4.171e-4	9.089e-4	(B) Positive
UBFD1	16p12.2	-0.37	-0.15	0.59	0.48	-0.21	4.174e-4	9.092e-4	(B) Positive
WNT10B	12q13.12	-1.49	-1.83	0.92	0.88	0.34	4.174e-4	9.092e-4	(A) Negative
ADORA1	1q32.1	1.29	0.86	1.17	1.12	0.44	4.177e-4	9.098e-4	(A) Negative
WDR76	15q15.3	-0.95	-1.22	0.70	0.70	0.26	4.190e-4	9.125e-4	(A) Negative
IGF2BP1	17q21.32	-3.74	-3.95	0.57	0.54	0.21	4.190e-4	9.125e-4	(A) Negative
LINC00574	6q27	-0.19	0.00	0.50	0.55	-0.19	4.195e-4	9.133e-4	(B) Positive
RPGRIP1	14q11.2	0.94	1.26	0.90	0.68	-0.32	4.198e-4	9.138e-4	(B) Positive
RAB9B	Xq22.2	0.25	-0.14	1.08	0.84	0.39	4.198e-4	9.138e-4	(A) Negative
PTPN12	7q11.23	0.29	0.09	0.55	0.49	0.20	4.198e-4	9.138e-4	(A) Negative
SLC25A43	Xq24	0.15	-0.11	0.72	0.58	0.26	4.201e-4	9.142e-4	(A) Negative
FITM2	20q13.12	-0.63	-0.31	0.88	0.74	-0.32	4.202e-4	9.144e-4	(B) Positive
FLRT2	14q31.3	-0.90	-0.53	0.97	0.99	-0.37	4.210e-4	9.160e-4	(B) Positive
RYBP	3p13	0.38	0.62	0.65	0.60	-0.24	4.217e-4	9.174e-4	(B) Positive
ABCB4	7q21.12	-0.59	-0.38	0.56	0.58	-0.21	4.220e-4	9.178e-4	(B) Positive
KLHL20	1q25.1	0.09	0.28	0.52	0.45	-0.19	4.223e-4	9.184e-4	(B) Positive
ACYP1	14q24.3	-1.10	-1.34	0.65	0.59	0.24	4.227e-4	9.191e-4	(A) Negative
TMEM54	1p35.1	1.10	0.87	0.61	0.58	0.23	4.235e-4	9.207e-4	(A) Negative
TLNRD1	15q25.1	0.11	0.33	0.57	0.58	-0.22	4.237e-4	9.210e-4	(B) Positive
DPY19L2P3	7p14.3	-0.72	-0.51	0.54	0.66	-0.21	4.238e-4	9.212e-4	(B) Positive
LILRB4	19q13.42	1.26	1.03	0.62	0.49	0.22	4.242e-4	9.221e-4	(A) Negative
INF2	14q32.33	-0.00	-0.15	0.41	0.39	0.15	4.258e-4	9.253e-4	(A) Negative
PER1	17p13.1	-0.60	-0.39	0.53	0.64	-0.21	4.259e-4	9.253e-4	(B) Positive
SUN5	20q11.21	0.24	0.10	0.36	0.39	0.14	4.264e-4	9.265e-4	(A) Negative
RAB33A	Xq26.1	-1.07	-1.40	0.91	0.81	0.33	4.270e-4	9.276e-4	(A) Negative
PTPN23	3p21.31	-0.02	0.10	0.34	0.33	-0.13	4.288e-4	9.314e-4	(B) Positive
GPRASP2	Xq22.1	0.43	0.76	0.90	0.75	-0.33	4.291e-4	9.319e-4	(B) Positive
SCD	10q24.31	-1.28	-0.82	1.22	1.16	-0.45	4.292e-4	9.321e-4	(B) Positive
OR51I2	11p15.4	0.81	0.65	0.43	0.42	0.16	4.311e-4	9.359e-4	(A) Negative
MCL1	1q21.2	0.80	0.59	0.56	0.55	0.21	4.313e-4	9.364e-4	(A) Negative
SND1	7q32.1	-0.29	-0.44	0.42	0.35	0.15	4.317e-4	9.371e-4	(A) Negative
CCL4	17q12	4.58	4.35	0.59	0.63	0.23	4.320e-4	9.376e-4	(A) Negative
MARCHF6	5p15.2	-0.16	0.03	0.53	0.43	-0.19	4.321e-4	9.377e-4	(B) Positive
NINL	20p11.21	-0.72	-1.06	0.93	0.76	0.34	4.335e-4	9.406e-4	(A) Negative
BRD2	6p21.32	-0.05	0.12	0.45	0.50	-0.17	4.336e-4	9.407e-4	(B) Positive
NME7	1q24.2	-0.51	-0.26	0.70	0.62	-0.26	4.338e-4	9.410e-4	(B) Positive
PIK3CA	3q26.32	0.41	0.16	0.72	0.44	0.25	4.342e-4	9.418e-4	(A) Negative
ACP6	1q21.2	-0.30	-0.03	0.73	0.74	-0.27	4.353e-4	9.440e-4	(B) Positive
TNRC6A	16p12.1	0.06	0.22	0.44	0.46	-0.17	4.353e-4	9.440e-4	(B) Positive
CHN1	2q31.1	0.55	0.30	0.69	0.61	0.25	4.382e-4	9.502e-4	(A) Negative
ZNF613	19q13.41	1.09	1.30	0.52	0.68	-0.21	4.389e-4	9.516e-4	(B) Positive
IZUMO2	19q13.33	0.21	-0.13	0.99	0.44	0.34	4.394e-4	9.526e-4	(A) Negative
ISL2	15q24.3	-1.25	-1.45	0.57	0.41	0.20	4.398e-4	9.531e-4	(A) Negative
ANKRD17	4q13.3	0.59	0.39	0.56	0.40	0.20	4.406e-4	9.549e-4	(A) Negative
ATP2B2	3p25.3	0.05	-0.14	0.56	0.34	0.20	4.422e-4	9.581e-4	(A) Negative
CSPG4	15q24.2	-1.16	-1.59	1.23	0.74	0.43	4.426e-4	9.589e-4	(A) Negative
MAMDC4	9q34.3	-1.44	-1.30	0.37	0.43	-0.14	4.427e-4	9.589e-4	(B) Positive
NIFK	2q14.3	0.03	-0.14	0.49	0.41	0.18	4.427e-4	9.589e-4	(A) Negative
ATP5MC3	2q31.1	-0.25	-0.42	0.47	0.39	0.17	4.428e-4	9.590e-4	(A) Negative
ZZZ3	1p31.1	0.19	-0.01	0.54	0.60	0.21	4.433e-4	9.599e-4	(A) Negative
IL12B	5q33.3	0.62	0.33	0.77	0.69	0.28	4.454e-4	9.645e-4	(A) Negative
DDX6	11q23.3	0.04	-0.18	0.60	0.52	0.22	4.459e-4	9.655e-4	(A) Negative
RNF26	11q23.3	-0.63	-0.80	0.46	0.40	0.17	4.463e-4	9.660e-4	(A) Negative
LILRB2	19q13.4	3.46	3.28	0.46	0.48	0.17	4.468e-4	9.670e-4	(A) Negative
LINGO2	9p21.2-p21.1	-1.87	-2.31	1.26	0.84	0.44	4.474e-4	9.682e-4	(A) Negative
MUC4	3q29	-0.77	-1.22	1.29	0.67	0.44	4.482e-4	9.699e-4	(A) Negative
SPOCK1	5q31.2	-0.53	-0.08	1.22	1.06	-0.45	4.484e-4	9.701e-4	(B) Positive
GBP6	1p22.2	1.01	0.63	1.06	0.84	0.38	4.485e-4	9.702e-4	(A) Negative
DDX47	12p13.1	-0.48	-0.70	0.61	0.37	0.21	4.503e-4	9.741e-4	(A) Negative
FABP6	5q33.3	-0.44	-1.07	1.74	1.50	0.63	4.511e-4	9.757e-4	(A) Negative
CGGBP1	3p11.1	-0.38	-0.22	0.46	0.36	-0.16	4.512e-4	9.757e-4	(B) Positive
ADAMTS7	15q25.1	0.36	0.23	0.35	0.34	0.13	4.518e-4	9.769e-4	(A) Negative
SSH1	12q24.11	-0.61	-0.76	0.41	0.33	0.15	4.548e-4	9.832e-4	(A) Negative
TRAF3IP2	6q21	1.21	0.95	0.72	0.64	0.26	4.551e-4	9.838e-4	(A) Negative
INKA2	1p13.2	-0.32	-0.55	0.62	0.50	0.22	4.565e-4	9.866e-4	(A) Negative
CDH11	16q21	2.43	2.85	1.10	1.11	-0.41	4.565e-4	9.866e-4	(B) Positive
NEUROD2	17q12	0.47	0.24	0.66	0.34	0.23	4.567e-4	9.869e-4	(A) Negative
TNNI3K	1p31.1	0.39	0.73	0.93	0.86	-0.34	4.569e-4	9.871e-4	(B) Positive
TATDN3	1q32.3	-0.70	-0.50	0.56	0.49	-0.20	4.571e-4	9.874e-4	(B) Positive
SLC30A7	1p21.2	0.88	0.69	0.51	0.43	0.18	4.575e-4	9.882e-4	(A) Negative
KLHDC7A	1p36.13	0.52	0.66	0.33	0.48	-0.14	4.577e-4	9.884e-4	(B) Positive
PAN3	13q12.2	0.47	0.65	0.47	0.51	-0.18	4.580e-4	9.890e-4	(B) Positive
PLEKHM2	1p36.21	-0.37	-0.53	0.43	0.43	0.16	4.584e-4	9.897e-4	(A) Negative
DTL	1q32.3	-1.25	-1.53	0.71	0.90	0.28	4.585e-4	9.897e-4	(A) Negative
SULT1B1	4q13.3	1.07	0.67	1.14	0.76	0.40	4.585e-4	9.897e-4	(A) Negative
SF1	11q13.1	-0.77	-0.61	0.40	0.45	-0.15	4.586e-4	9.899e-4	(B) Positive
DCAF12	9p13.3	0.72	0.53	0.53	0.41	0.19	4.588e-4	9.901e-4	(A) Negative
DOCK8-AS1	9p24.3	0.71	1.10	1.05	1.05	-0.39	4.594e-4	9.913e-4	(B) Positive
ACP5	19p13.2	2.00	2.37	1.00	0.87	-0.36	4.621e-4	9.970e-4	(B) Positive
VPS8	3q27.2	0.22	0.43	0.57	0.49	-0.21	4.626e-4	9.981e-4	(B) Positive
FAP	2q24.2	2.21	2.63	1.10	1.11	-0.41	4.628e-4	9.982e-4	(B) Positive
DRG1	22q12.2	-0.16	-0.37	0.57	0.50	0.21	4.628e-4	9.982e-4	(A) Negative
EVC	4p16.2	0.38	0.67	0.78	0.72	-0.29	4.642e-4	1.001e-3	(B) Positive
RNF19A	8q22.2	1.09	0.83	0.70	0.67	0.26	4.649e-4	1.003e-3	(A) Negative
TIMD4	5q33.3	2.09	1.54	1.52	1.23	0.55	4.666e-4	1.006e-3	(A) Negative
ZNF507	19q13.11	0.11	-0.04	0.40	0.31	0.14	4.679e-4	1.009e-3	(A) Negative
ZNF184	6p22.1	0.17	-0.05	0.61	0.44	0.22	4.681e-4	1.009e-3	(A) Negative
TGFB1I1	16p11.2	-0.24	0.04	0.77	0.74	-0.28	4.681e-4	1.009e-3	(B) Positive
LINC00052	15q25.3	-1.96	-1.74	0.50	0.79	-0.21	4.683e-4	1.009e-3	(B) Positive
POLDIP3	22q13.2	0.19	-0.00	0.55	0.43	0.20	4.684e-4	1.009e-3	(A) Negative
EEF1DP3	13q13.1	0.32	0.54	0.56	0.59	-0.21	4.694e-4	1.011e-3	(B) Positive
RYR2	1q43	-1.23	-1.72	1.40	0.84	0.49	4.695e-4	1.011e-3	(A) Negative
UHRF1	19p13.3	-0.70	-0.99	0.77	0.82	0.29	4.696e-4	1.011e-3	(A) Negative
TBC1D10C	11q13.2	-0.15	-0.67	1.43	1.21	0.52	4.703e-4	1.013e-3	(A) Negative
STK24	13q32.2	0.22	-0.03	0.70	0.47	0.25	4.705e-4	1.013e-3	(A) Negative
PDPR	16q22.1	-0.51	-0.74	0.64	0.56	0.23	4.710e-4	1.014e-3	(A) Negative
PRPS1L1	7p21.1	-1.58	-1.83	0.69	0.66	0.26	4.725e-4	1.017e-3	(A) Negative
RCOR2	11q13.1	0.51	0.32	0.53	0.51	0.19	4.729e-4	1.018e-3	(A) Negative
CLMP	11q24.1	-2.65	-2.93	0.77	0.78	0.29	4.740e-4	1.020e-3	(A) Negative
ZNF367	9q22.32	-0.76	-1.03	0.72	0.62	0.26	4.744e-4	1.021e-3	(A) Negative
ASB10	7q36.1	0.16	0.04	0.32	0.29	0.12	4.747e-4	1.021e-3	(A) Negative
PLA2G4C	19q13.33	1.81	2.17	0.99	0.84	-0.36	4.748e-4	1.022e-3	(B) Positive
MAGEA12	Xq28	-3.33	-3.91	1.66	1.07	0.58	4.765e-4	1.025e-3	(A) Negative
NR2F6	19p13.11	0.27	0.48	0.55	0.65	-0.22	4.772e-4	1.026e-3	(B) Positive
ARHGAP30	1q23.3	1.36	1.00	0.97	0.87	0.35	4.774e-4	1.027e-3	(A) Negative
TSSK3	1p35.1	-0.62	-0.76	0.39	0.33	0.14	4.776e-4	1.027e-3	(A) Negative
CORO1A	16p11.2	-0.26	-0.62	0.98	0.85	0.36	4.791e-4	1.030e-3	(A) Negative
ARHGAP20	11q22.3-q23.1	0.10	0.36	0.69	0.70	-0.26	4.798e-4	1.032e-3	(B) Positive
SHOX2	3q25.32	-0.21	-0.55	0.92	0.79	0.33	4.799e-4	1.032e-3	(A) Negative
PPARG	3p25.2	-1.30	-0.91	1.00	1.17	-0.39	4.801e-4	1.032e-3	(B) Positive
TENM2	5q34	-1.07	-0.43	1.71	1.78	-0.64	4.809e-4	1.033e-3	(B) Positive
CBLN3	14q12	0.27	0.36	0.20	0.26	-0.08	4.811e-4	1.034e-3	(B) Positive
OR1F1	16p13.3	0.18	0.02	0.46	0.42	0.17	4.815e-4	1.034e-3	(A) Negative
EIF5	14q32.32	-0.59	-0.38	0.56	0.50	-0.20	4.830e-4	1.038e-3	(B) Positive
OAZ1	19p13.3	0.03	0.18	0.40	0.36	-0.14	4.831e-4	1.038e-3	(B) Positive
TSC22D4	7q22.1	-0.04	-0.23	0.53	0.41	0.19	4.832e-4	1.038e-3	(A) Negative
HSP90B1	12q23.3	0.01	-0.19	0.56	0.49	0.20	4.846e-4	1.041e-3	(A) Negative
ZBTB48	1p36.31	-0.15	0.00	0.41	0.38	-0.15	4.849e-4	1.041e-3	(B) Positive
CPOX	3q11.2	-1.69	-1.90	0.60	0.49	0.22	4.862e-4	1.044e-3	(A) Negative
PLSCR3	17p13.1	0.36	0.19	0.44	0.40	0.16	4.879e-4	1.047e-3	(A) Negative
LORICRIN	1q21.3	0.71	0.46	0.75	0.41	0.26	4.886e-4	1.049e-3	(A) Negative
KLF9	9q21.12	0.02	0.25	0.63	0.63	-0.24	4.887e-4	1.049e-3	(B) Positive
PLAG1	8q12.1	-1.39	-1.75	0.99	0.77	0.35	4.891e-4	1.049e-3	(A) Negative
DCAF6	1q24.2	0.81	1.01	0.53	0.61	-0.20	4.914e-4	1.054e-3	(B) Positive
SNRPB2	20p12.1	-0.11	-0.29	0.50	0.48	0.18	4.923e-4	1.056e-3	(A) Negative
C6ORF141	6p12.3	-1.41	-0.96	1.13	1.42	-0.45	4.928e-4	1.057e-3	(B) Positive
ARHGAP33	19q13.12	0.10	-0.05	0.39	0.39	0.15	4.954e-4	1.062e-3	(A) Negative
MYL7	7p13	-1.63	-1.19	1.12	1.32	-0.43	4.958e-4	1.063e-3	(B) Positive
MGME1	20p11.23	-0.64	-0.86	0.59	0.55	0.22	4.963e-4	1.064e-3	(A) Negative
SLC49A4	3q21.1	0.35	0.55	0.55	0.50	-0.20	4.965e-4	1.064e-3	(B) Positive
SIX4	14q23.1	0.20	0.45	0.61	0.86	-0.25	4.978e-4	1.067e-3	(B) Positive
CXCL5	4q13.3	0.75	0.52	0.68	0.34	0.23	4.982e-4	1.068e-3	(A) Negative
CHST10	2q11.2	-0.53	-0.20	0.88	0.80	-0.32	4.989e-4	1.069e-3	(B) Positive
PNKP	19q13.33	0.14	0.30	0.43	0.46	-0.16	5.000e-4	1.071e-3	(B) Positive
GPM6A	4q34.2	0.10	0.48	0.94	1.23	-0.37	5.004e-4	1.072e-3	(B) Positive
DSG3	18q12.1	1.30	0.31	2.80	2.11	0.99	5.005e-4	1.072e-3	(A) Negative
PGM2L1	11q13.4	0.99	0.73	0.69	0.74	0.26	5.014e-4	1.074e-3	(A) Negative
MORC4	Xq22.3	1.27	0.99	0.81	0.58	0.28	5.029e-4	1.077e-3	(A) Negative
AHSA2P	2p15	-2.40	-2.14	0.65	0.82	-0.26	5.030e-4	1.077e-3	(B) Positive
STARD3NL	7p14-p13	-0.33	-0.14	0.53	0.44	-0.19	5.033e-4	1.078e-3	(B) Positive
KLRK1	12p13.2	-1.83	-2.15	0.90	0.79	0.32	5.033e-4	1.078e-3	(A) Negative
FCRL4	1q23.1	0.74	0.42	0.91	0.70	0.32	5.035e-4	1.078e-3	(A) Negative
KAT7	17q21.33	-0.11	0.12	0.62	0.65	-0.23	5.038e-4	1.078e-3	(B) Positive
CELF2	10p14	0.20	-0.21	1.16	0.97	0.42	5.045e-4	1.080e-3	(A) Negative
MRPL49	11q13.1	-0.05	0.12	0.44	0.50	-0.17	5.056e-4	1.082e-3	(B) Positive
AMPD1	1p13.2	0.40	-0.14	1.44	1.52	0.54	5.078e-4	1.086e-3	(A) Negative
STK11	19p13.3	0.24	0.40	0.45	0.42	-0.17	5.089e-4	1.089e-3	(B) Positive
EEIG2	1p13.3	-0.28	-0.02	0.67	0.73	-0.25	5.089e-4	1.089e-3	(B) Positive
CRISPLD1	8q21.13	1.59	0.90	1.91	1.75	0.69	5.092e-4	1.089e-3	(A) Negative
FKBPL	6p21.32	0.27	0.09	0.52	0.43	0.19	5.101e-4	1.091e-3	(A) Negative
YPEL1	22q11.21-q11.22	0.84	0.55	0.80	0.72	0.29	5.118e-4	1.094e-3	(A) Negative
PYHIN1	1q23.1	1.80	1.43	1.03	0.87	0.37	5.121e-4	1.095e-3	(A) Negative
MMP14	14q11.2	0.04	-0.22	0.67	0.83	0.26	5.147e-4	1.100e-3	(A) Negative
CEP131	17q25.3	0.01	-0.21	0.61	0.56	0.22	5.149e-4	1.101e-3	(A) Negative
GPKOW	Xp11.23	-0.03	0.10	0.36	0.29	-0.13	5.155e-4	1.102e-3	(B) Positive
WNT9A	1q42.13	0.21	-0.03	0.66	0.48	0.23	5.161e-4	1.103e-3	(A) Negative
MAPRE1	20q11.21	0.11	-0.04	0.42	0.37	0.15	5.161e-4	1.103e-3	(A) Negative
COL8A2	1p34.3	3.61	4.04	1.18	1.12	-0.43	5.165e-4	1.104e-3	(B) Positive
RHBG	1q22	-2.93	-2.65	0.71	0.92	-0.28	5.174e-4	1.105e-3	(B) Positive
LRAT	4q32.1	-0.60	-1.03	1.20	0.98	0.43	5.177e-4	1.106e-3	(A) Negative
LPCAT3	12p13.31	-0.10	0.16	0.73	0.64	-0.26	5.178e-4	1.106e-3	(B) Positive
DNAH1	3p21.1	-0.10	0.05	0.42	0.41	-0.15	5.180e-4	1.106e-3	(B) Positive
SLC25A29	14q32.2	-0.18	0.06	0.66	0.64	-0.24	5.192e-4	1.108e-3	(B) Positive
NIPA2	15q11.2	-0.23	-0.42	0.51	0.45	0.18	5.200e-4	1.110e-3	(A) Negative
SIGLEC11	19q13.33	1.07	0.81	0.72	0.67	0.26	5.208e-4	1.112e-3	(A) Negative
NT5C	17q25	-0.63	-0.44	0.52	0.50	-0.19	5.216e-4	1.113e-3	(B) Positive
KIR3DL2	19q13.42	0.59	0.33	0.72	0.68	0.26	5.241e-4	1.118e-3	(A) Negative
SRP9	1q42.12	0.49	0.71	0.62	0.57	-0.22	5.247e-4	1.120e-3	(B) Positive
CDH6	5p13.3	-1.00	-0.77	0.62	0.57	-0.23	5.249e-4	1.120e-3	(B) Positive
SC5D	11q23.3-q24.1	-0.42	-0.14	0.75	0.73	-0.28	5.252e-4	1.120e-3	(B) Positive
HOXA1	7p15.2	-0.36	-0.58	0.63	0.47	0.22	5.275e-4	1.125e-3	(A) Negative
RNASE3	14q11.2	0.03	-0.14	0.46	0.36	0.16	5.289e-4	1.128e-3	(A) Negative
SLC66A2	18q23	0.25	0.05	0.52	0.52	0.19	5.291e-4	1.128e-3	(A) Negative
SLC7A9	19q13.11	-1.07	-0.79	0.77	0.69	-0.28	5.292e-4	1.128e-3	(B) Positive
ZNF568	19q13.12	0.49	0.74	0.70	0.57	-0.25	5.295e-4	1.129e-3	(B) Positive
NFIA	1p31.3	1.78	2.31	1.50	1.06	-0.52	5.298e-4	1.129e-3	(B) Positive
GPR132	14q32.33	1.03	0.82	0.59	0.54	0.22	5.322e-4	1.134e-3	(A) Negative
ZNF275	Xq28	-0.00	-0.18	0.48	0.40	0.17	5.327e-4	1.135e-3	(A) Negative
BCL2L13	22q11.21	0.00	-0.14	0.38	0.37	0.14	5.327e-4	1.135e-3	(A) Negative
TTC23	15q26.3	-0.14	-0.38	0.66	0.66	0.24	5.336e-4	1.137e-3	(A) Negative
RAD54L2	3p21.2	-0.19	-0.35	0.46	0.35	0.16	5.343e-4	1.138e-3	(A) Negative
MEIG1	10p13	0.25	-0.10	0.95	0.92	0.35	5.378e-4	1.146e-3	(A) Negative
PGAP3	17q12	1.47	1.88	1.18	0.84	-0.41	5.380e-4	1.146e-3	(B) Positive
MRPL51	12p13.31	-0.25	-0.47	0.62	0.44	0.22	5.382e-4	1.146e-3	(A) Negative
VCPIP1	8q13.1	0.44	0.22	0.62	0.58	0.22	5.389e-4	1.148e-3	(A) Negative
ZNG1F	9p11.2	-0.03	0.16	0.52	0.55	-0.19	5.409e-4	1.152e-3	(B) Positive
TCN1	11q12.1	0.88	1.76	2.36	2.40	-0.87	5.417e-4	1.153e-3	(B) Positive
HMGB1	13q12.3	0.34	0.16	0.52	0.43	0.19	5.418e-4	1.153e-3	(A) Negative
USP2	11q23.3	-0.12	-0.36	0.68	0.61	0.25	5.422e-4	1.154e-3	(A) Negative
RCN3	19q13.33	2.18	1.89	0.78	0.75	0.29	5.423e-4	1.154e-3	(A) Negative
SERGEF	11p15.1	-0.05	0.17	0.60	0.63	-0.22	5.426e-4	1.155e-3	(B) Positive
SVIP	11p14.3	0.32	0.65	0.94	0.77	-0.34	5.428e-4	1.155e-3	(B) Positive
OR1E2	17p13.2	0.65	0.52	0.34	0.34	0.13	5.433e-4	1.156e-3	(A) Negative
LGALS2	22q13.1	-0.36	-0.99	1.73	1.66	0.63	5.438e-4	1.157e-3	(A) Negative
RGS9	17q24.1	1.12	0.68	1.23	1.07	0.44	5.446e-4	1.158e-3	(A) Negative
EDDM3B	14q11.2	0.43	0.74	0.78	1.00	-0.31	5.454e-4	1.160e-3	(B) Positive
CASZ1	1p36.22	0.40	0.56	0.43	0.47	-0.16	5.455e-4	1.160e-3	(B) Positive
NR1D1	17q21.1	-0.38	-0.13	0.69	0.71	-0.26	5.458e-4	1.160e-3	(B) Positive
NTSR2	2p25.1	0.09	-0.21	0.84	0.65	0.30	5.458e-4	1.160e-3	(A) Negative
CRHR2	7p14.3	0.51	0.41	0.26	0.28	0.10	5.459e-4	1.160e-3	(A) Negative
CTIF	18q21.1	0.68	0.45	0.61	0.60	0.23	5.464e-4	1.161e-3	(A) Negative
PLB1	2p23.2	1.17	0.88	0.83	0.59	0.29	5.476e-4	1.164e-3	(A) Negative
PNMA6A	Xq28	-0.34	-0.61	0.79	0.51	0.27	5.483e-4	1.165e-3	(A) Negative
CRYBG1	6q21	1.38	0.97	1.07	1.19	0.40	5.485e-4	1.165e-3	(A) Negative
WRN	8p12	-1.01	-1.26	0.69	0.59	0.25	5.499e-4	1.168e-3	(A) Negative
CACNA1C	12p13.33	-0.16	0.08	0.66	0.54	-0.24	5.500e-4	1.168e-3	(B) Positive
HS3ST3B1	17p12	-0.34	-0.56	0.58	0.57	0.21	5.500e-4	1.168e-3	(A) Negative
DCHS2	4q31.3	0.40	0.16	0.69	0.41	0.24	5.546e-4	1.178e-3	(A) Negative
VWA8	13q14.11	-0.21	-0.01	0.55	0.57	-0.20	5.548e-4	1.178e-3	(B) Positive
MANF	3p21.2	0.12	-0.10	0.61	0.50	0.22	5.572e-4	1.183e-3	(A) Negative
TMEM74B	20p13	-1.25	-1.58	0.87	1.03	0.33	5.584e-4	1.185e-3	(A) Negative
SERPINA1	14q32.13	-2.03	-1.71	0.75	1.21	-0.32	5.586e-4	1.185e-3	(B) Positive
PTPRJ	11p11.2	0.09	-0.12	0.57	0.55	0.21	5.598e-4	1.188e-3	(A) Negative
COL10A1	6q22.1	5.20	5.56	0.98	0.91	-0.36	5.617e-4	1.192e-3	(B) Positive
POMT1	9q34.13	0.08	0.25	0.47	0.36	-0.16	5.666e-4	1.202e-3	(B) Positive
NRROS	3q29	-0.76	-0.95	0.55	0.47	0.20	5.673e-4	1.203e-3	(A) Negative
BMX	Xp22.2	-0.64	-0.22	1.14	1.12	-0.42	5.678e-4	1.204e-3	(B) Positive
NAPG	18p11.22	0.17	-0.06	0.67	0.53	0.24	5.687e-4	1.206e-3	(A) Negative
DRD3	3q13.31	0.01	-0.08	0.25	0.30	0.10	5.717e-4	1.212e-3	(A) Negative
VMAC	19p13.3	1.22	1.44	0.64	0.53	-0.23	5.754e-4	1.220e-3	(B) Positive
AKAP1	17q22	0.56	0.30	0.69	0.66	0.25	5.757e-4	1.220e-3	(A) Negative
P2RX3	11q12.1	0.42	0.31	0.30	0.26	0.11	5.779e-4	1.225e-3	(A) Negative
ITIH6	Xp11.22	0.31	0.51	0.54	0.57	-0.20	5.779e-4	1.225e-3	(B) Positive
PRMT5	14q11.2	-0.90	-0.69	0.59	0.51	-0.21	5.787e-4	1.226e-3	(B) Positive
ST7	7q31.2	-0.10	0.06	0.44	0.44	-0.16	5.787e-4	1.226e-3	(B) Positive
THEM5	1q21.3	0.72	0.52	0.56	0.53	0.20	5.788e-4	1.226e-3	(A) Negative
TENT5A	6q14.1	-0.37	-0.67	0.79	0.92	0.30	5.788e-4	1.226e-3	(A) Negative
PDK3	Xp22.11	0.38	0.03	1.03	0.64	0.35	5.794e-4	1.227e-3	(A) Negative
MIF	22q11.23	0.26	0.03	0.63	0.69	0.23	5.803e-4	1.229e-3	(A) Negative
DOK3	5q35.3	0.92	0.66	0.71	0.62	0.25	5.837e-4	1.236e-3	(A) Negative
SLIT2	4p15.31	1.71	2.05	0.92	0.93	-0.34	5.842e-4	1.237e-3	(B) Positive
TUG1	22q12.2	0.53	0.34	0.53	0.49	0.19	5.879e-4	1.245e-3	(A) Negative
TRIM56	7q22.1	-0.42	-0.25	0.46	0.43	-0.17	5.885e-4	1.246e-3	(B) Positive
SMARCA4	19p13.2	-0.22	-0.41	0.57	0.45	0.20	5.902e-4	1.249e-3	(A) Negative
BRF2	8p11.23	0.44	0.70	0.64	0.90	-0.26	5.914e-4	1.251e-3	(B) Positive
ADAMTS8	11q24.3	-0.46	-0.14	0.82	1.01	-0.32	5.919e-4	1.252e-3	(B) Positive
SIX1	14q23.1	0.45	1.16	1.92	2.10	-0.72	5.920e-4	1.252e-3	(B) Positive
SHB	9p13.1	0.76	0.49	0.76	0.57	0.26	5.922e-4	1.253e-3	(A) Negative
H1-0	22q13.1	0.44	0.78	0.96	0.80	-0.34	5.927e-4	1.254e-3	(B) Positive
HACE1	6q16.3	-0.27	-0.52	0.69	0.60	0.25	5.936e-4	1.255e-3	(A) Negative
RPL14	3p22.1	-0.51	-0.32	0.50	0.47	-0.18	5.945e-4	1.257e-3	(B) Positive
UBE2L3	22q11.21	0.33	0.17	0.43	0.46	0.16	5.954e-4	1.259e-3	(A) Negative
UBA6	4q13.2	-0.27	-0.44	0.48	0.45	0.17	5.960e-4	1.260e-3	(A) Negative
BTN3A2	6p22.2	0.38	0.06	0.89	0.82	0.32	5.978e-4	1.264e-3	(A) Negative
RNLS	10q23.31	1.49	1.81	0.88	0.84	-0.32	5.981e-4	1.264e-3	(B) Positive
WDFY4	10q11.23	0.68	0.48	0.53	0.64	0.20	5.982e-4	1.264e-3	(A) Negative
SNRPF	12q23.1	-0.67	-0.88	0.57	0.51	0.20	5.996e-4	1.267e-3	(A) Negative
PAXIP1	7q36.2	-0.46	-0.30	0.42	0.46	-0.16	6.008e-4	1.269e-3	(B) Positive
MACO1	1p36.11	0.55	0.72	0.49	0.39	-0.17	6.012e-4	1.270e-3	(B) Positive
ZNF471	19q13.43	1.50	1.15	0.91	1.13	0.35	6.029e-4	1.273e-3	(A) Negative
UNC5A	5q35.2	0.28	0.40	0.33	0.36	-0.12	6.042e-4	1.276e-3	(B) Positive
CCDC25	8p21.1	-0.30	-0.10	0.55	0.59	-0.20	6.048e-4	1.277e-3	(B) Positive
EEF1B2	2q33.3	-0.54	-0.73	0.54	0.46	0.19	6.071e-4	1.282e-3	(A) Negative
NMD3	3q26.1	-0.70	-0.90	0.57	0.48	0.20	6.075e-4	1.283e-3	(A) Negative
ISLR2	15q24.1	0.94	1.22	0.79	0.69	-0.28	6.078e-4	1.283e-3	(B) Positive
ATAT1	6p21.33	0.60	0.34	0.74	0.67	0.27	6.096e-4	1.287e-3	(A) Negative
AGK	7q34	-0.37	-0.52	0.42	0.40	0.15	6.100e-4	1.287e-3	(A) Negative
ZC3H11A	1q32.1	0.04	0.20	0.44	0.46	-0.16	6.102e-4	1.288e-3	(B) Positive
HOXC9	12q13.13	0.45	0.82	1.04	0.98	-0.37	6.110e-4	1.289e-3	(B) Positive
SLC41A3	3q21.2-q21.3	0.57	0.38	0.53	0.41	0.18	6.111e-4	1.289e-3	(A) Negative
MCHR1	22q13.2	0.26	0.62	0.92	1.15	-0.36	6.116e-4	1.290e-3	(B) Positive
BMAL1	11p15.3	0.44	0.69	0.73	0.60	-0.26	6.120e-4	1.291e-3	(B) Positive
NSD3	8p11.23	0.46	0.71	0.63	0.81	-0.25	6.122e-4	1.291e-3	(B) Positive
CPZ	4p16.1	-0.96	-0.58	1.03	1.05	-0.38	6.148e-4	1.296e-3	(B) Positive
ARPC1B	7q22.1	-0.03	-0.32	0.84	0.56	0.29	6.158e-4	1.298e-3	(A) Negative
CHP1	15q15.1	0.15	0.31	0.46	0.41	-0.16	6.167e-4	1.300e-3	(B) Positive
SIX6	14q23.1	-2.94	-3.12	0.51	0.45	0.18	6.168e-4	1.300e-3	(A) Negative
FEV	2q35	0.18	0.02	0.45	0.40	0.16	6.181e-4	1.303e-3	(A) Negative
CLTA	9p13.3	0.36	0.23	0.38	0.28	0.13	6.181e-4	1.303e-3	(A) Negative
TUFM	16p11.2	-0.24	-0.07	0.47	0.44	-0.17	6.228e-4	1.312e-3	(B) Positive
SRI	7q21.12	0.61	0.81	0.54	0.65	-0.21	6.274e-4	1.322e-3	(B) Positive
TBC1D15	12q21.1	0.02	0.17	0.42	0.37	-0.15	6.279e-4	1.323e-3	(B) Positive
NRG1	8p12	-0.93	-1.29	1.04	0.70	0.36	6.298e-4	1.327e-3	(A) Negative
INSL3	19p13.11	0.56	0.36	0.58	0.51	0.21	6.328e-4	1.333e-3	(A) Negative
ANKRD13C-DT	1p31.1	0.05	-0.18	0.64	0.53	0.22	6.358e-4	1.339e-3	(A) Negative
RAB32	6q24.3	0.24	-0.06	0.84	0.67	0.29	6.378e-4	1.343e-3	(A) Negative
HSPH1	13q12.3	0.38	0.13	0.65	0.76	0.24	6.382e-4	1.344e-3	(A) Negative
ZCCHC8	12q24.31	-0.52	-0.36	0.41	0.44	-0.15	6.383e-4	1.344e-3	(B) Positive
CPA5	7q32.2	0.30	0.15	0.41	0.37	0.15	6.395e-4	1.346e-3	(A) Negative
DGKE	17q22	-0.81	-0.58	0.62	0.69	-0.23	6.402e-4	1.347e-3	(B) Positive
CIITA	16p13.13	2.78	2.48	0.87	0.64	0.30	6.406e-4	1.348e-3	(A) Negative
SAA2	11p15.1	2.93	2.42	1.39	1.51	0.52	6.406e-4	1.348e-3	(A) Negative
FMNL1	17q21.31	-0.43	-0.72	0.78	0.75	0.28	6.427e-4	1.352e-3	(A) Negative
VANGL1	1p13.1	0.31	0.11	0.52	0.57	0.19	6.449e-4	1.356e-3	(A) Negative
CPNE3	8q21.3	0.46	0.70	0.66	0.70	-0.24	6.460e-4	1.359e-3	(B) Positive
MAGT1	Xq21.1	0.64	0.45	0.56	0.48	0.20	6.472e-4	1.361e-3	(A) Negative
ERP29	12q24.13	-0.27	-0.11	0.46	0.43	-0.16	6.475e-4	1.361e-3	(B) Positive
NBPF1	1p36.13	-0.72	-0.41	0.83	0.94	-0.31	6.480e-4	1.362e-3	(B) Positive
C1ORF131	1q42.2	0.05	-0.14	0.54	0.50	0.19	6.489e-4	1.364e-3	(A) Negative
SCOC	4q31.1	0.23	0.48	0.71	0.63	-0.25	6.493e-4	1.365e-3	(B) Positive
EAF1	3p25.1	0.09	0.29	0.56	0.48	-0.20	6.500e-4	1.366e-3	(B) Positive
AMZ2	17q24.2	0.02	0.26	0.69	0.59	-0.24	6.501e-4	1.366e-3	(B) Positive
SPECC1	17p11.2	-0.30	-0.63	0.94	0.77	0.33	6.505e-4	1.367e-3	(A) Negative
TMEM182	2q12.1	0.24	-0.06	0.84	0.74	0.30	6.534e-4	1.373e-3	(A) Negative
ALPK2	18q21.31-q21.32	-1.98	-2.34	1.00	1.07	0.37	6.541e-4	1.374e-3	(A) Negative
LCP1	13q14.13	-0.08	-0.45	1.09	0.83	0.38	6.546e-4	1.375e-3	(A) Negative
WFDC11	20q13.12	0.31	0.09	0.60	0.64	0.22	6.549e-4	1.375e-3	(A) Negative
EDAR	2q13	0.71	0.32	1.13	0.77	0.39	6.554e-4	1.376e-3	(A) Negative
EDIL3	5q14.3	1.82	2.43	1.72	1.49	-0.61	6.613e-4	1.389e-3	(B) Positive
DSC1	18q12.1	1.42	1.05	1.02	1.07	0.37	6.632e-4	1.392e-3	(A) Negative
TSEN54	17q25.1	-0.15	-0.33	0.48	0.56	0.18	6.640e-4	1.394e-3	(A) Negative
BRD4	19p13.12	0.64	0.41	0.63	0.53	0.22	6.691e-4	1.404e-3	(A) Negative
GNL1	6p21.33	-0.52	-0.69	0.45	0.45	0.16	6.691e-4	1.404e-3	(A) Negative
STMN2	8q21.13	3.02	3.48	1.34	1.01	-0.46	6.693e-4	1.405e-3	(B) Positive
ICAM4	19p13.2	-2.24	-2.40	0.47	0.41	0.16	6.695e-4	1.405e-3	(A) Negative
CYCS	7p15.3	-1.20	-1.40	0.59	0.46	0.20	6.711e-4	1.408e-3	(A) Negative
PARD6A	16q22.1	0.05	0.34	0.83	0.70	-0.29	6.712e-4	1.408e-3	(B) Positive
TSPAN5	4q23	0.15	0.35	0.50	0.70	-0.20	6.716e-4	1.409e-3	(B) Positive
LEPR	1p31.3	-0.85	-0.58	0.69	0.92	-0.27	6.730e-4	1.411e-3	(B) Positive
SUDS3	12q24.23	0.46	0.66	0.55	0.47	-0.19	6.745e-4	1.414e-3	(B) Positive
BTC	4q13.3	1.85	1.41	1.26	1.03	0.44	6.753e-4	1.416e-3	(A) Negative
TMEM64	8q21.3	-1.72	-2.18	1.24	1.48	0.47	6.825e-4	1.431e-3	(A) Negative
NMUR1	2q37.1	0.77	0.36	1.17	0.96	0.41	6.840e-4	1.434e-3	(A) Negative
MGST3	1q24.1	1.28	1.05	0.61	0.64	0.22	6.847e-4	1.435e-3	(A) Negative
ALOX12	17p13.1	-0.87	-1.20	1.00	0.53	0.33	6.850e-4	1.435e-3	(A) Negative
CTSZ	20q13.32	2.35	2.02	0.91	0.84	0.32	6.870e-4	1.440e-3	(A) Negative
KIF22	16p11.2	-0.60	-0.42	0.48	0.52	-0.18	6.880e-4	1.441e-3	(B) Positive
C20ORF141	20p13	0.45	0.36	0.24	0.23	0.09	6.881e-4	1.441e-3	(A) Negative
DNAJC5	20q13.33	0.23	0.05	0.51	0.51	0.18	6.893e-4	1.444e-3	(A) Negative
IFITM1	11p15.5	0.89	1.27	1.09	0.97	-0.39	6.910e-4	1.447e-3	(B) Positive
PGAM2	7p13	0.53	0.79	0.69	0.90	-0.27	6.917e-4	1.449e-3	(B) Positive
METAP1	4q23	-0.58	-0.78	0.56	0.51	0.20	6.934e-4	1.452e-3	(A) Negative
CD9	12p13.31	0.85	1.12	0.77	0.68	-0.27	6.965e-4	1.458e-3	(B) Positive
SUPT3H	6p21.1	-0.52	-0.76	0.68	0.59	0.24	6.983e-4	1.462e-3	(A) Negative
TLX2	2p13.1	-0.74	-0.93	0.50	0.58	0.19	6.992e-4	1.463e-3	(A) Negative
RPL36AL	14q21.3	-0.14	0.03	0.51	0.35	-0.17	6.997e-4	1.464e-3	(B) Positive
AMT	3p21.31	-1.89	-1.66	0.61	0.69	-0.23	7.023e-4	1.470e-3	(B) Positive
PKM	15q23	-0.79	-0.97	0.51	0.46	0.18	7.030e-4	1.471e-3	(A) Negative
ARHGDIB	12p12.3	0.28	0.60	0.87	0.89	-0.32	7.057e-4	1.476e-3	(B) Positive
PRKCE	2p21	-0.12	0.08	0.55	0.63	-0.20	7.064e-4	1.478e-3	(B) Positive
IKZF4	12q13.2	0.14	0.27	0.35	0.31	-0.12	7.065e-4	1.478e-3	(B) Positive
DMBT1	10q26.13	0.31	-0.18	1.45	0.86	0.49	7.069e-4	1.478e-3	(A) Negative
GNA11	19p13.3	0.64	0.82	0.49	0.42	-0.17	7.141e-4	1.493e-3	(B) Positive
TERF2IP	16q23.1	-0.00	0.15	0.43	0.43	-0.15	7.142e-4	1.493e-3	(B) Positive
CCDC185	1q41	0.59	0.34	0.70	0.67	0.25	7.150e-4	1.495e-3	(A) Negative
FOXN1	17q11.2	0.05	0.18	0.36	0.37	-0.13	7.176e-4	1.500e-3	(B) Positive
DCUN1D4	4q12	-0.47	-0.63	0.44	0.40	0.16	7.201e-4	1.505e-3	(A) Negative
TGIF2	20q11.23	-0.10	-0.36	0.74	0.70	0.26	7.207e-4	1.506e-3	(A) Negative
PSMD11	17q11.2	-0.21	-0.42	0.57	0.61	0.21	7.214e-4	1.507e-3	(A) Negative
MPL	1p34.2	0.77	0.54	0.70	0.41	0.23	7.226e-4	1.510e-3	(A) Negative
POLB	8p11.21	0.27	0.54	0.74	0.80	-0.27	7.279e-4	1.521e-3	(B) Positive
GAS8-AS1	16q24.3	0.38	0.28	0.30	0.30	0.11	7.286e-4	1.522e-3	(A) Negative
TMEM167B	1p13.3	0.66	0.84	0.53	0.42	-0.18	7.289e-4	1.522e-3	(B) Positive
FBXL14	12p13.33	0.45	0.70	0.72	0.64	-0.25	7.302e-4	1.525e-3	(B) Positive
PGAM1	10q24.1	-0.81	-0.97	0.47	0.39	0.16	7.331e-4	1.531e-3	(A) Negative
SUN1	7p22.3	-0.30	-0.48	0.52	0.36	0.18	7.333e-4	1.531e-3	(A) Negative
TMEM187	Xq28	0.66	0.89	0.65	0.49	-0.22	7.336e-4	1.531e-3	(B) Positive
TMC1	9q21.13	0.42	0.17	0.72	0.59	0.25	7.337e-4	1.531e-3	(A) Negative
ZNF791	19p13.13	0.20	0.38	0.49	0.49	-0.18	7.381e-4	1.540e-3	(B) Positive
ANKRD33	12q13.13	0.45	0.37	0.23	0.23	0.08	7.424e-4	1.549e-3	(A) Negative
LTBP3	11q13.1	0.68	0.87	0.52	0.52	-0.19	7.439e-4	1.552e-3	(B) Positive
YTHDF2	1p35.3	0.73	0.57	0.48	0.38	0.16	7.454e-4	1.555e-3	(A) Negative
UQCRB	8q22.1	0.28	0.10	0.49	0.57	0.18	7.467e-4	1.557e-3	(A) Negative
NADK2	5p13.2	-0.55	-0.32	0.67	0.58	-0.23	7.467e-4	1.557e-3	(B) Positive
ERGIC3	20q11.22	-0.09	0.09	0.51	0.49	-0.18	7.487e-4	1.561e-3	(B) Positive
KREMEN2	16p13.3	-0.81	-1.49	1.86	2.00	0.68	7.497e-4	1.563e-3	(A) Negative
FNBP1L	1p22.1	1.71	1.48	0.64	0.59	0.23	7.500e-4	1.564e-3	(A) Negative
SRRD	22q12.1	-0.05	-0.22	0.47	0.48	0.17	7.508e-4	1.565e-3	(A) Negative
GAST	17q21.2	0.27	0.08	0.54	0.52	0.19	7.525e-4	1.568e-3	(A) Negative
SRPRB	3q22.1	0.41	0.23	0.52	0.51	0.19	7.530e-4	1.569e-3	(A) Negative
STX10	19p13.13	-0.28	-0.44	0.45	0.42	0.16	7.539e-4	1.571e-3	(A) Negative
LATS1	6q25.1	0.04	0.21	0.48	0.43	-0.17	7.560e-4	1.575e-3	(B) Positive
TASP1	20p12.1	-0.33	-0.15	0.50	0.52	-0.18	7.565e-4	1.576e-3	(B) Positive
SLC36A1	5q33.1	0.38	0.25	0.34	0.40	0.13	7.569e-4	1.577e-3	(A) Negative
CDHR1	10q23.1	-0.50	-0.68	0.50	0.50	0.18	7.580e-4	1.579e-3	(A) Negative
FUNDC2	Xq28	-0.08	0.13	0.61	0.59	-0.22	7.583e-4	1.579e-3	(B) Positive
SLF1	5q15	-2.57	-2.37	0.57	0.51	-0.20	7.588e-4	1.580e-3	(B) Positive
NGEF	2q37.1	-1.50	-1.94	1.25	1.10	0.44	7.589e-4	1.580e-3	(A) Negative
FAM86B1	8p23.1	-0.55	-0.36	0.54	0.45	-0.19	7.622e-4	1.587e-3	(B) Positive
HOXC12	12q13.13	1.11	0.24	2.51	2.07	0.87	7.627e-4	1.588e-3	(A) Negative
CUL5	11q22.3	0.58	0.40	0.53	0.48	0.19	7.651e-4	1.592e-3	(A) Negative
S100A7A	1q21.3	1.41	0.62	2.30	1.82	0.79	7.657e-4	1.594e-3	(A) Negative
SSTR3	22q13.1	0.51	0.44	0.19	0.25	0.07	7.667e-4	1.595e-3	(A) Negative
SCAND1	20q11.23	0.29	0.49	0.56	0.50	-0.20	7.673e-4	1.596e-3	(B) Positive
PPT2	6p21.32	-1.79	-1.61	0.50	0.52	-0.18	7.676e-4	1.597e-3	(B) Positive
BRWD1-AS2	21q22.2	0.69	0.52	0.48	0.41	0.17	7.678e-4	1.597e-3	(A) Negative
GLP1R	6p21.2	0.56	0.36	0.57	0.48	0.20	7.719e-4	1.605e-3	(A) Negative
GBGT1	9q34.2	0.31	0.07	0.68	0.57	0.24	7.719e-4	1.605e-3	(A) Negative
NPW	16p13.3	0.13	-0.37	1.36	1.51	0.50	7.727e-4	1.607e-3	(A) Negative
CTSS	1q21.3	1.66	1.30	1.04	0.91	0.36	7.735e-4	1.608e-3	(A) Negative
SERPINB9	6p25.2	-1.19	-1.48	0.85	0.71	0.30	7.737e-4	1.608e-3	(A) Negative
KLRC2	12p13.2	-3.67	-4.08	1.17	1.03	0.41	7.737e-4	1.608e-3	(A) Negative
ALPG	2q37.1	0.07	-0.11	0.54	0.26	0.18	7.739e-4	1.608e-3	(A) Negative
RPP14	3p14.3	-0.32	-0.20	0.33	0.33	-0.12	7.746e-4	1.610e-3	(B) Positive
ZNHIT2	11q13.1	0.49	0.68	0.51	0.52	-0.18	7.747e-4	1.610e-3	(B) Positive
AGAP1	2q37.2	0.17	0.39	0.62	0.57	-0.22	7.761e-4	1.612e-3	(B) Positive
COL5A1	9q34.3	0.60	0.96	1.02	1.02	-0.37	7.764e-4	1.613e-3	(B) Positive
RP1	8q11.23-q12.1	0.50	0.84	0.89	1.11	-0.34	7.782e-4	1.616e-3	(B) Positive
TMEM184C	4q31.23	0.16	0.34	0.52	0.36	-0.18	7.785e-4	1.617e-3	(B) Positive
BRINP1	9q33.1	-0.65	-1.15	1.46	1.16	0.50	7.788e-4	1.617e-3	(A) Negative
BORCS5	12p13.2	0.37	0.18	0.54	0.52	0.19	7.793e-4	1.618e-3	(A) Negative
RAB3C	5q11.2	-0.26	0.24	1.36	1.46	-0.49	7.815e-4	1.622e-3	(B) Positive
CNOT3	19q13.42	0.29	0.16	0.36	0.42	0.13	7.848e-4	1.629e-3	(A) Negative
WNT3	17q21.31-q21.32	0.05	0.44	1.04	1.22	-0.39	7.855e-4	1.630e-3	(B) Positive
PGD	1p36.22	-0.37	-0.61	0.68	0.66	0.24	7.861e-4	1.631e-3	(A) Negative
ZP2	16p12.3-p12.2	0.74	0.29	1.34	0.75	0.44	7.863e-4	1.632e-3	(A) Negative
RAB1A	2p14	0.75	0.56	0.56	0.43	0.19	7.874e-4	1.634e-3	(A) Negative
MAGEA9	Xq28	-3.37	-4.29	2.83	1.26	0.92	7.876e-4	1.634e-3	(A) Negative
IGFBP7	4q12	1.41	1.73	0.92	0.77	-0.32	7.883e-4	1.635e-3	(B) Positive
SLC16A9	10q21.2	-1.42	-0.89	1.55	1.33	-0.54	7.887e-4	1.636e-3	(B) Positive
TBC1D24	16p13.3	1.57	1.27	0.87	0.74	0.30	7.891e-4	1.637e-3	(A) Negative
RRS1	8q13.1	0.33	0.06	0.75	0.78	0.27	7.908e-4	1.640e-3	(A) Negative
HBEGF	5q31.3	0.56	0.31	0.69	0.74	0.25	7.913e-4	1.641e-3	(A) Negative
ZNF28	19q13.41	0.49	0.72	0.64	0.65	-0.23	7.941e-4	1.646e-3	(B) Positive
SYNJ2	6q25.3	-0.89	-0.62	0.79	0.59	-0.27	8.010e-4	1.660e-3	(B) Positive
NRP2	2q33.3	0.07	-0.19	0.74	0.56	0.25	8.030e-4	1.664e-3	(A) Negative
PXMP2	12q24.33	-0.34	-0.13	0.61	0.58	-0.22	8.043e-4	1.667e-3	(B) Positive
ELK3	12q23.1	0.22	0.40	0.54	0.45	-0.19	8.053e-4	1.669e-3	(B) Positive
RMC1	18q11.2	0.72	0.56	0.46	0.39	0.16	8.106e-4	1.679e-3	(A) Negative
CD164	6q21	0.63	0.86	0.64	0.55	-0.22	8.106e-4	1.679e-3	(B) Positive
PLAA	9p21.2	0.74	0.52	0.66	0.45	0.22	8.109e-4	1.680e-3	(A) Negative
DOP1B	21q22.12	1.09	1.36	0.79	0.66	-0.27	8.124e-4	1.683e-3	(B) Positive
CDKN2C	1p32.3	-1.18	-1.51	1.00	0.68	0.33	8.143e-4	1.686e-3	(A) Negative
GALNS	16q24.3	-0.13	-0.32	0.57	0.45	0.19	8.187e-4	1.695e-3	(A) Negative
PDGFRL	8p22	1.54	1.87	0.91	0.95	-0.33	8.203e-4	1.698e-3	(B) Positive
ENTPD3	3p22.1	2.48	2.97	1.37	1.38	-0.49	8.223e-4	1.702e-3	(B) Positive
EPS15	1p32.3	0.73	0.58	0.40	0.41	0.14	8.237e-4	1.705e-3	(A) Negative
TMEM50A	1p36.11	0.38	0.54	0.47	0.37	-0.16	8.252e-4	1.708e-3	(B) Positive
PLEKHA2	8p11.22	-0.78	-0.99	0.58	0.59	0.21	8.297e-4	1.717e-3	(A) Negative
SAMD5	6q24.3	0.02	-0.45	1.37	1.15	0.47	8.302e-4	1.718e-3	(A) Negative
ABHD18	4q28.2	-0.97	-0.79	0.52	0.55	-0.19	8.311e-4	1.719e-3	(B) Positive
GATB	4q31.3	-0.11	0.09	0.59	0.47	-0.20	8.332e-4	1.723e-3	(B) Positive
PI16	6p21.2	-0.01	0.57	1.58	1.80	-0.58	8.346e-4	1.726e-3	(B) Positive
PHLDB1	11q23.3	0.24	0.41	0.48	0.47	-0.17	8.348e-4	1.727e-3	(B) Positive
CFAP161	15q25.1	-2.87	-2.59	0.78	0.79	-0.28	8.351e-4	1.727e-3	(B) Positive
GLI1	12q13.3	-1.89	-1.54	0.96	1.08	-0.35	8.383e-4	1.733e-3	(B) Positive
BNC1	15q25.2	-1.41	-2.02	1.80	1.29	0.60	8.421e-4	1.741e-3	(A) Negative
KCNJ14	19q13.33	-0.60	-0.93	0.96	0.81	0.33	8.443e-4	1.745e-3	(A) Negative
RPS6	9p22.1	0.23	-0.03	0.76	0.54	0.26	8.449e-4	1.746e-3	(A) Negative
ASPHD1	16p11.2	-1.40	-1.86	1.34	1.16	0.46	8.467e-4	1.750e-3	(A) Negative
P2RY12	3q25.1	1.23	1.59	1.03	1.03	-0.37	8.475e-4	1.751e-3	(B) Positive
STAMBP	2p13.1	0.11	-0.08	0.55	0.41	0.19	8.498e-4	1.756e-3	(A) Negative
DUSP11	2p13.1	0.27	0.13	0.39	0.34	0.14	8.505e-4	1.757e-3	(A) Negative
H2AC4	6p22.2	0.45	0.71	0.70	0.86	-0.26	8.550e-4	1.766e-3	(B) Positive
BBS12	4q27	0.74	0.97	0.68	0.61	-0.23	8.578e-4	1.772e-3	(B) Positive
CXCR6	3p21.31	2.18	1.70	1.38	1.24	0.48	8.589e-4	1.774e-3	(A) Negative
EOMES	3p24.1	1.63	1.22	1.17	1.07	0.41	8.626e-4	1.781e-3	(A) Negative
NAA40	11q13.1	-0.85	-1.02	0.50	0.47	0.18	8.631e-4	1.782e-3	(A) Negative
NEIL2	8p23.1	0.16	0.39	0.67	0.60	-0.23	8.633e-4	1.782e-3	(B) Positive
EPS8	12p12.3	-0.36	-0.06	0.87	0.75	-0.30	8.686e-4	1.793e-3	(B) Positive
METTL27	7q11.23	-0.90	-0.53	1.04	1.00	-0.36	8.692e-4	1.794e-3	(B) Positive
QTRT2	3q13.31	-0.07	-0.21	0.42	0.36	0.15	8.733e-4	1.802e-3	(A) Negative
TMEM134	11q13.2	0.54	0.74	0.58	0.54	-0.20	8.755e-4	1.806e-3	(B) Positive
TMEM255A	Xq24	-2.14	-1.77	1.05	0.94	-0.36	8.761e-4	1.807e-3	(B) Positive
C22ORF46P	22q13.2	-0.09	-0.25	0.45	0.47	0.16	8.766e-4	1.808e-3	(A) Negative
FBXO27	19q13.2	0.80	0.45	1.01	0.78	0.34	8.787e-4	1.812e-3	(A) Negative
SSU72	1p36.33	0.40	0.20	0.59	0.44	0.20	8.813e-4	1.818e-3	(A) Negative
HSPA9	5q31.2	-0.16	0.01	0.50	0.43	-0.17	8.820e-4	1.819e-3	(B) Positive
HSD17B10	Xp11.22	-0.07	-0.23	0.46	0.39	0.16	8.821e-4	1.819e-3	(A) Negative
LMBRD1	6q13	0.52	0.72	0.57	0.51	-0.20	8.830e-4	1.820e-3	(B) Positive
PPP1R7	2q37.3	-0.10	0.06	0.48	0.37	-0.16	8.851e-4	1.824e-3	(B) Positive
DLK1	14q32.2	-3.67	-4.31	1.96	0.88	0.63	8.851e-4	1.824e-3	(A) Negative
PPP4R4	14q32.2	-1.32	-0.69	1.74	1.90	-0.63	8.855e-4	1.825e-3	(B) Positive
ATG2A	11q13.1	-0.09	0.07	0.43	0.46	-0.15	8.863e-4	1.826e-3	(B) Positive
DPEP3	16q22.1	0.68	0.56	0.32	0.36	0.12	8.869e-4	1.827e-3	(A) Negative
MACC1	7p21.1	1.45	0.99	1.33	1.28	0.47	8.871e-4	1.827e-3	(A) Negative
TENM3-AS1	4q34.3	-1.70	-1.51	0.47	0.70	-0.19	8.877e-4	1.829e-3	(B) Positive
SDAD1	4q21.1	0.39	0.21	0.54	0.40	0.18	8.881e-4	1.829e-3	(A) Negative
CDX2	13q12.2	-0.21	0.22	1.16	1.32	-0.42	8.902e-4	1.833e-3	(B) Positive
TMEM50B	21q22.11	0.53	0.76	0.68	0.55	-0.23	8.915e-4	1.836e-3	(B) Positive
FHL1	Xq26.3	-1.26	-0.87	1.08	1.14	-0.39	8.953e-4	1.843e-3	(B) Positive
APLP2	11q24.3	0.24	0.47	0.64	0.67	-0.23	9.012e-4	1.855e-3	(B) Positive
PDE10A	6q27	0.09	-0.38	1.41	0.90	0.47	9.017e-4	1.856e-3	(A) Negative
SH3RF1	4q32.3-q33	1.50	1.77	0.80	0.62	-0.27	9.050e-4	1.863e-3	(B) Positive
ATL1	14q22.1	2.12	1.82	0.85	0.87	0.30	9.058e-4	1.864e-3	(A) Negative
TMEM41A	3q27.2	0.39	0.21	0.51	0.41	0.17	9.067e-4	1.866e-3	(A) Negative
NPC2	14q24.3	1.01	0.82	0.53	0.61	0.19	9.075e-4	1.867e-3	(A) Negative
SLC26A5	7q22.1	0.45	0.59	0.38	0.49	-0.14	9.076e-4	1.867e-3	(B) Positive
LURAP1	1p34.1	-0.10	0.17	0.79	0.79	-0.28	9.080e-4	1.868e-3	(B) Positive
TMEM256	17p13.1	-0.47	-0.24	0.68	0.60	-0.23	9.094e-4	1.870e-3	(B) Positive
ARPP21	3p22.3	-3.08	-2.86	0.51	0.84	-0.21	9.114e-4	1.874e-3	(B) Positive
GATA4	8p23.1	-1.73	-1.53	0.46	0.79	-0.19	9.148e-4	1.881e-3	(B) Positive
TRA	14q11.2	1.13	0.93	0.59	0.51	0.20	9.207e-4	1.893e-3	(A) Negative
MKNK1	1p33	0.38	0.24	0.40	0.42	0.14	9.214e-4	1.894e-3	(A) Negative
FEZ1	11q24.2	-2.03	-1.78	0.74	0.69	-0.26	9.231e-4	1.898e-3	(B) Positive
TMTC1	12p11.22	-0.59	-0.16	1.19	1.30	-0.43	9.245e-4	1.900e-3	(B) Positive
SOD1	21q22.11	0.04	0.25	0.60	0.55	-0.21	9.257e-4	1.902e-3	(B) Positive
HECTD1	14q12	-0.46	-0.30	0.49	0.42	-0.17	9.271e-4	1.905e-3	(B) Positive
CELP	9q34.13	0.33	0.12	0.62	0.50	0.21	9.287e-4	1.908e-3	(A) Negative
H1-9P	17q21.33	-0.97	-1.43	1.45	0.68	0.47	9.342e-4	1.919e-3	(A) Negative
NHLH2	1p13.1	0.37	0.28	0.26	0.28	0.09	9.347e-4	1.920e-3	(A) Negative
CADPS2	7q31.32	0.95	1.40	1.34	1.02	-0.45	9.360e-4	1.922e-3	(B) Positive
TCF4	18q21.2	0.67	0.93	0.74	0.76	-0.26	9.367e-4	1.923e-3	(B) Positive
PRTG	15q21.3	-2.15	-1.90	0.70	0.71	-0.25	9.378e-4	1.925e-3	(B) Positive
GNG13	16p13.3	0.21	0.55	0.93	1.06	-0.34	9.383e-4	1.926e-3	(B) Positive
MYOC	1q24.3	0.47	0.79	0.83	1.16	-0.32	9.386e-4	1.927e-3	(B) Positive
ZNF384	12p13.31	-0.11	-0.27	0.47	0.32	0.16	9.394e-4	1.928e-3	(A) Negative
CDH26	20q13.33	-0.29	-0.60	0.88	0.84	0.31	9.435e-4	1.936e-3	(A) Negative
LSM8	7q31.31	-0.79	-0.98	0.54	0.64	0.20	9.450e-4	1.939e-3	(A) Negative
MMRN2	10q23.2	2.67	2.87	0.60	0.49	-0.20	9.509e-4	1.951e-3	(B) Positive
RAB28	4p15.33	-0.46	-0.27	0.53	0.47	-0.18	9.510e-4	1.951e-3	(B) Positive
CSHL1	17q23.3	0.28	0.18	0.27	0.34	0.10	9.538e-4	1.956e-3	(A) Negative
DNAJC28	21q22.11	0.19	0.42	0.66	0.64	-0.23	9.539e-4	1.957e-3	(B) Positive
LPP	3q27.3-q28	1.37	1.16	0.60	0.55	0.21	9.543e-4	1.957e-3	(A) Negative
UAP1L1	9q34.3	-0.68	-0.45	0.67	0.59	-0.23	9.552e-4	1.959e-3	(B) Positive
SORBS2	4q35.1	2.21	1.67	1.58	1.42	0.54	9.554e-4	1.959e-3	(A) Negative
PRAF2	Xp11.23	0.40	0.56	0.47	0.42	-0.16	9.589e-4	1.966e-3	(B) Positive
MRPL3	3q22.1	-0.08	-0.24	0.46	0.36	0.16	9.596e-4	1.967e-3	(A) Negative
GRIN2B	12p13.1	0.24	-0.03	0.76	0.82	0.27	9.603e-4	1.968e-3	(A) Negative
TSR2	Xp11.22	0.26	0.43	0.51	0.45	-0.18	9.606e-4	1.968e-3	(B) Positive
ZNF330	4q31.21	-0.86	-0.68	0.52	0.48	-0.18	9.607e-4	1.968e-3	(B) Positive
AMIGO1	1p13.3	0.27	0.47	0.57	0.56	-0.20	9.607e-4	1.968e-3	(B) Positive
SLC35D2	9q22.32	-0.46	-0.27	0.57	0.47	-0.19	9.616e-4	1.970e-3	(B) Positive
CLCN6	1p36.22	-0.95	-0.78	0.52	0.48	-0.18	9.625e-4	1.972e-3	(B) Positive
BTBD16	10q26.13	-2.50	-2.77	0.83	0.60	0.28	9.628e-4	1.972e-3	(A) Negative
SMYD5	2p13.2	-0.26	-0.40	0.42	0.40	0.15	9.637e-4	1.974e-3	(A) Negative
ZNF436	1p36.12	1.56	1.78	0.65	0.50	-0.22	9.644e-4	1.975e-3	(B) Positive
MAGEE2	Xq13.3	0.33	0.05	0.87	0.49	0.28	9.663e-4	1.978e-3	(A) Negative
PLN	6q22.31	2.24	2.63	1.13	1.01	-0.39	9.691e-4	1.984e-3	(B) Positive
PIN1P1	1p31.1	-0.15	-0.04	0.30	0.37	-0.11	9.700e-4	1.985e-3	(B) Positive
GIPR	19q13.32	0.86	0.72	0.39	0.39	0.14	9.728e-4	1.991e-3	(A) Negative
CNN2	19p13.3	0.53	0.26	0.79	0.73	0.27	9.738e-4	1.993e-3	(A) Negative
CDH15	16q24.3	-0.45	-0.75	0.85	0.83	0.30	9.741e-4	1.993e-3	(A) Negative
SEC23B	20p11.23	0.09	0.31	0.64	0.56	-0.22	9.745e-4	1.994e-3	(B) Positive
PCID2	13q34	-0.47	-0.66	0.58	0.39	0.19	9.746e-4	1.994e-3	(A) Negative
CTNNBL1	20q11.23	-0.38	-0.22	0.43	0.52	-0.16	9.769e-4	1.998e-3	(B) Positive
BANK1	4q24	3.03	2.51	1.52	1.40	0.52	9.794e-4	2.003e-3	(A) Negative
TDRP	8p23.3	-0.34	-0.68	1.00	0.87	0.34	9.805e-4	2.005e-3	(A) Negative
TMSB4XP8	4q22.1	1.57	1.30	0.76	0.77	0.27	9.819e-4	2.008e-3	(A) Negative
SPMIP8	16q21	0.33	0.12	0.63	0.52	0.21	9.860e-4	2.016e-3	(A) Negative
TNIP2	4p16.3	-0.02	0.18	0.58	0.55	-0.20	9.873e-4	2.018e-3	(B) Positive
EPGN	4q13.3	-0.74	-1.18	1.36	0.79	0.44	9.878e-4	2.019e-3	(A) Negative
OR2F1	7q35	0.32	0.18	0.35	0.46	0.13	9.908e-4	2.025e-3	(A) Negative
MAGEA1	Xq28	-3.62	-4.29	2.02	1.54	0.67	9.980e-4	2.039e-3	(A) Negative
NTN1	17p13.1	1.10	0.89	0.61	0.63	0.21	1.004e-3	2.051e-3	(A) Negative
FATE1	Xq28	0.52	0.35	0.49	0.58	0.18	1.004e-3	2.052e-3	(A) Negative
TMEM127	2q11.2	1.11	1.26	0.44	0.30	-0.15	1.004e-3	2.052e-3	(B) Positive
DAAM1	14q23.1	0.63	0.87	0.71	0.56	-0.24	1.006e-3	2.055e-3	(B) Positive
BAHD1	15q15.1	0.15	0.30	0.44	0.42	-0.15	1.007e-3	2.056e-3	(B) Positive
TPO	2p25.3	0.16	0.56	1.11	1.22	-0.40	1.009e-3	2.061e-3	(B) Positive
PER3	1p36.23	-0.23	0.06	0.84	0.72	-0.29	1.009e-3	2.061e-3	(B) Positive
CTAGE3P	13q14.3	0.19	0.39	0.61	0.50	-0.21	1.011e-3	2.064e-3	(B) Positive
SFTPC	8p21.3	-0.02	-0.19	0.53	0.27	0.17	1.013e-3	2.069e-3	(A) Negative
MLEC	12q24.31	0.02	0.17	0.44	0.47	-0.16	1.016e-3	2.074e-3	(B) Positive
CSE1L	20q13.13	-0.70	-0.89	0.56	0.59	0.20	1.017e-3	2.075e-3	(A) Negative
NOS3	7q36.1	0.17	-0.04	0.60	0.51	0.20	1.018e-3	2.077e-3	(A) Negative
DSG1	18q12.1	0.54	0.10	1.33	0.81	0.44	1.019e-3	2.079e-3	(A) Negative
DNAJC21	5p13.2	0.23	0.42	0.54	0.44	-0.18	1.020e-3	2.081e-3	(B) Positive
IFITM2	11p15.5	0.79	1.13	1.03	0.79	-0.34	1.022e-3	2.084e-3	(B) Positive
MAGEF1	3q27.1	0.56	0.33	0.69	0.60	0.24	1.022e-3	2.085e-3	(A) Negative
GGT1	22q11.23	0.28	-0.09	1.02	1.23	0.37	1.025e-3	2.091e-3	(A) Negative
MDM4	1q32.1	-0.45	-0.22	0.67	0.64	-0.23	1.029e-3	2.098e-3	(B) Positive
SFN	1p36.11	0.30	-0.04	1.01	0.81	0.34	1.029e-3	2.099e-3	(A) Negative
ZNF606	19q13.43	1.14	1.40	0.71	0.79	-0.25	1.033e-3	2.106e-3	(B) Positive
NDST4	4q26	-3.34	-3.04	0.71	1.22	-0.30	1.035e-3	2.109e-3	(B) Positive
ARMC3	10p12.2	1.86	2.45	1.64	1.86	-0.59	1.035e-3	2.110e-3	(B) Positive
GIGYF2	2q37.1	0.42	0.66	0.72	0.60	-0.24	1.036e-3	2.111e-3	(B) Positive
ATAD1	10q23.31	-0.44	-0.15	0.90	0.42	-0.29	1.037e-3	2.114e-3	(B) Positive
MEA1	6p21.1	0.16	-0.01	0.51	0.38	0.17	1.038e-3	2.116e-3	(A) Negative
MYADM	19q13.42	0.89	1.06	0.48	0.43	-0.16	1.041e-3	2.120e-3	(B) Positive
ALDH3A1	17p11.2	-1.90	-2.12	0.68	0.56	0.23	1.044e-3	2.127e-3	(A) Negative
ZBTB33	Xq24	0.35	0.15	0.61	0.47	0.20	1.046e-3	2.130e-3	(A) Negative
BEND6	6p12.1	-0.56	-0.82	0.75	0.72	0.26	1.051e-3	2.140e-3	(A) Negative
SV2B	15q26.1	1.52	1.02	1.45	1.26	0.49	1.060e-3	2.158e-3	(A) Negative
ERF	19q13.2	-0.47	-0.67	0.60	0.48	0.20	1.060e-3	2.159e-3	(A) Negative
ARPC3	12q24.11	0.13	0.28	0.46	0.42	-0.16	1.065e-3	2.168e-3	(B) Positive
PELP1	17p13.2	-0.25	-0.40	0.44	0.42	0.15	1.066e-3	2.170e-3	(A) Negative
POLR1H	6p22.1	-0.27	-0.42	0.43	0.37	0.15	1.067e-3	2.171e-3	(A) Negative
HOTAIR	12q13.13	1.17	0.51	1.83	2.06	0.65	1.068e-3	2.173e-3	(A) Negative
TFIP11	22q12.1	0.21	0.32	0.32	0.37	-0.12	1.072e-3	2.181e-3	(B) Positive
PDGFB	22q13.1	1.17	1.42	0.75	0.61	-0.25	1.072e-3	2.182e-3	(B) Positive
ARRDC3	5q14.3	-0.04	-0.24	0.56	0.62	0.20	1.075e-3	2.187e-3	(A) Negative
SPMAP2	19p13.3	0.12	-0.17	0.88	0.71	0.29	1.075e-3	2.187e-3	(A) Negative
CCM2	7p13	0.00	-0.17	0.50	0.43	0.17	1.077e-3	2.190e-3	(A) Negative
ATF3	1q32.3	0.37	0.10	0.69	1.01	0.27	1.077e-3	2.190e-3	(A) Negative
OR52M1	11p15.4	0.23	0.14	0.25	0.27	0.09	1.077e-3	2.191e-3	(A) Negative
SOCS5	2p21	0.45	0.23	0.65	0.52	0.22	1.080e-3	2.196e-3	(A) Negative
UPRT	Xq13.3	0.19	0.35	0.49	0.45	-0.17	1.081e-3	2.198e-3	(B) Positive
PIEZO1	16q24.3	-0.26	-0.42	0.48	0.45	0.16	1.084e-3	2.203e-3	(A) Negative
STK33	11p15.4	-2.11	-2.58	1.42	1.01	0.47	1.084e-3	2.203e-3	(A) Negative
CDHR5	11p15.5	0.17	0.04	0.40	0.35	0.14	1.085e-3	2.205e-3	(A) Negative
TCL6	14q32.13	0.23	0.16	0.21	0.24	0.07	1.087e-3	2.208e-3	(A) Negative
BRME1	19p13.12	-0.43	-0.80	1.10	0.89	0.37	1.091e-3	2.216e-3	(A) Negative
C20ORF144	20q11.22	0.57	0.41	0.46	0.46	0.16	1.091e-3	2.216e-3	(A) Negative
TPD52L1	6q22-q23	0.78	0.37	1.15	1.27	0.41	1.092e-3	2.217e-3	(A) Negative
GPX2	14q23.3	-3.18	-2.82	1.00	1.20	-0.36	1.092e-3	2.217e-3	(B) Positive
FOXL2	3q22.3	-2.71	-3.04	1.00	0.80	0.33	1.094e-3	2.222e-3	(A) Negative
CRB2	9q33.3	-0.08	0.05	0.38	0.41	-0.13	1.097e-3	2.228e-3	(B) Positive
HTRA4	8p11.22	2.02	1.61	1.20	1.11	0.41	1.101e-3	2.234e-3	(A) Negative
RSPO3	6q22.33	3.64	3.21	1.24	1.28	0.43	1.101e-3	2.235e-3	(A) Negative
SYPL1	7q22.2	-0.19	0.01	0.59	0.61	-0.21	1.101e-3	2.235e-3	(B) Positive
IGF2	11p15.5	-2.54	-2.20	1.04	0.75	-0.34	1.102e-3	2.237e-3	(B) Positive
GABARAPL2	16q23.1	-0.36	-0.15	0.60	0.55	-0.21	1.104e-3	2.240e-3	(B) Positive
PPP1R9A	7q21.3	1.11	0.74	1.04	1.19	0.37	1.106e-3	2.244e-3	(A) Negative
PSMD12	17q24.2	-0.10	-0.28	0.48	0.59	0.18	1.107e-3	2.247e-3	(A) Negative
ASNSD1	2q32.2	-0.08	-0.22	0.45	0.32	0.15	1.108e-3	2.249e-3	(A) Negative
KCNQ3	8q24.22	1.05	0.84	0.63	0.48	0.21	1.109e-3	2.250e-3	(A) Negative
SENP3	17p13	-0.48	-0.64	0.46	0.45	0.16	1.113e-3	2.257e-3	(A) Negative
SIPA1L3	19q13.13-q13.2	1.27	1.49	0.65	0.59	-0.22	1.115e-3	2.260e-3	(B) Positive
ZNF583	19q13.43	0.16	0.41	0.74	0.66	-0.25	1.116e-3	2.263e-3	(B) Positive
DGCR8	22q11.21	-1.19	-1.36	0.49	0.48	0.17	1.118e-3	2.267e-3	(A) Negative
SELENOH	11q12.1	0.27	0.43	0.48	0.49	-0.17	1.118e-3	2.267e-3	(B) Positive
CSNK2B	6p21.33	-0.32	-0.46	0.42	0.37	0.14	1.121e-3	2.272e-3	(A) Negative
DNMT3L	21q22.3	-1.14	-1.35	0.63	0.51	0.21	1.127e-3	2.283e-3	(A) Negative
SERTAD1	19q13.2	0.53	0.74	0.64	0.45	-0.21	1.128e-3	2.286e-3	(B) Positive
TMED4	7p13	0.01	0.16	0.42	0.38	-0.14	1.131e-3	2.291e-3	(B) Positive
KPNA3	13q14.2	0.32	0.07	0.75	0.54	0.25	1.131e-3	2.291e-3	(A) Negative
ZSCAN2	15q25.2	-0.00	-0.21	0.64	0.51	0.21	1.131e-3	2.291e-3	(A) Negative
GRAP2	22q13.1	-1.53	-1.77	0.71	0.69	0.24	1.132e-3	2.293e-3	(A) Negative
PGBD1	6p22.1	-0.83	-0.54	0.87	0.78	-0.30	1.132e-3	2.293e-3	(B) Positive
LUC7L3	17q21.33	-0.75	-0.60	0.44	0.47	-0.15	1.134e-3	2.296e-3	(B) Positive
SPRN	10q26.3	0.12	0.25	0.36	0.42	-0.13	1.137e-3	2.302e-3	(B) Positive
SP110	2q37.1	1.42	1.74	0.96	0.77	-0.32	1.137e-3	2.302e-3	(B) Positive
TNFRSF14	1p36.32	-0.24	0.06	0.92	0.65	-0.30	1.137e-3	2.302e-3	(B) Positive
LEPROTL1	8p12	-0.34	-0.15	0.54	0.59	-0.19	1.138e-3	2.304e-3	(B) Positive
ARHGEF16	1p36.32	0.32	0.61	0.88	0.63	-0.29	1.139e-3	2.306e-3	(B) Positive
GPATCH11	2p22.2	0.26	0.02	0.73	0.67	0.25	1.139e-3	2.306e-3	(A) Negative
TALDO1	11p15.5	0.21	0.04	0.51	0.45	0.17	1.141e-3	2.309e-3	(A) Negative
RIPOR1	16q22.1	0.16	0.25	0.26	0.23	-0.09	1.143e-3	2.313e-3	(B) Positive
NRL	14q11.2-q12	0.43	0.66	0.69	0.55	-0.23	1.147e-3	2.319e-3	(B) Positive
WDR55	5q31.3	-0.02	0.16	0.54	0.45	-0.18	1.147e-3	2.320e-3	(B) Positive
BTBD7	14q32.12	0.43	0.59	0.47	0.44	-0.16	1.148e-3	2.321e-3	(B) Positive
CYP27B1	12q14.1	0.05	-0.36	1.19	1.25	0.41	1.151e-3	2.328e-3	(A) Negative
NHLH1	1q23.2	0.56	0.41	0.45	0.42	0.15	1.152e-3	2.329e-3	(A) Negative
AGPAT1	6p21.32	0.14	0.00	0.43	0.35	0.14	1.153e-3	2.331e-3	(A) Negative
PKD1	16p13.3	-0.40	-0.27	0.36	0.40	-0.13	1.153e-3	2.331e-3	(B) Positive
RHOJ	14q23.2	0.26	0.53	0.77	0.76	-0.27	1.155e-3	2.335e-3	(B) Positive
SLC8A3	14q24.2	-0.80	-0.68	0.35	0.41	-0.13	1.156e-3	2.335e-3	(B) Positive
SERAC1	6q25.3	0.72	0.47	0.76	0.60	0.25	1.159e-3	2.342e-3	(A) Negative
PARP4	13q12.12	0.02	-0.18	0.57	0.60	0.20	1.160e-3	2.344e-3	(A) Negative
NPRL3	16p13.3	-0.30	-0.16	0.41	0.36	-0.14	1.165e-3	2.353e-3	(B) Positive
DENND5A	11p15.4	-0.29	-0.12	0.53	0.47	-0.18	1.165e-3	2.353e-3	(B) Positive
PHYHIPL	10q21.1	-1.90	-2.12	0.68	0.49	0.22	1.166e-3	2.356e-3	(A) Negative
TMPRSS2	21q22.3	2.50	1.98	1.51	1.45	0.52	1.167e-3	2.357e-3	(A) Negative
C8ORF76	8q24.13	0.24	0.03	0.60	0.66	0.21	1.169e-3	2.360e-3	(A) Negative
FBN1	15q21.1	-0.04	0.28	0.94	0.90	-0.32	1.169e-3	2.361e-3	(B) Positive
FAM3C	7q31.31	0.03	-0.22	0.73	0.61	0.24	1.171e-3	2.364e-3	(A) Negative
RAB19	7q34	0.30	0.49	0.50	0.62	-0.18	1.171e-3	2.364e-3	(B) Positive
ASH2L	8p11.23	-0.08	0.12	0.52	0.74	-0.20	1.172e-3	2.366e-3	(B) Positive
CER1	9p22.3	0.34	0.21	0.38	0.33	0.13	1.176e-3	2.373e-3	(A) Negative
CSNK1G2-AS1	19p13.3	0.04	-0.15	0.50	0.68	0.19	1.177e-3	2.375e-3	(A) Negative
KPNA6	1p35.2	-0.07	-0.19	0.36	0.32	0.12	1.181e-3	2.383e-3	(A) Negative
ABCD2	12q12	0.41	0.14	0.80	0.75	0.27	1.183e-3	2.386e-3	(A) Negative
CDR2L	17q25.1	0.70	0.45	0.77	0.61	0.25	1.184e-3	2.388e-3	(A) Negative
CENPBD2P	19q13.43	-0.14	0.02	0.46	0.49	-0.16	1.184e-3	2.389e-3	(B) Positive
KANSL2	12q13.11	-0.42	-0.22	0.60	0.52	-0.20	1.187e-3	2.394e-3	(B) Positive
RTP4	3q27.3	2.11	1.56	1.68	1.32	0.55	1.188e-3	2.396e-3	(A) Negative
ARL4A	7p21.3	-0.85	-1.17	0.95	0.85	0.32	1.190e-3	2.399e-3	(A) Negative
ALOX12P2	17p13.1	-0.61	-0.96	1.02	1.02	0.35	1.192e-3	2.403e-3	(A) Negative
CRIM1	2p22.2	0.27	0.52	0.72	0.70	-0.25	1.194e-3	2.407e-3	(B) Positive
GAS1	9q21.33	0.98	0.57	1.16	1.31	0.41	1.194e-3	2.407e-3	(A) Negative
GALNT17	7q11.22	-0.61	-0.98	1.19	0.65	0.38	1.195e-3	2.408e-3	(A) Negative
ADCY10	1q24.2	0.69	0.41	0.84	0.63	0.27	1.196e-3	2.410e-3	(A) Negative
MED31	17p13.1	-0.49	-0.33	0.46	0.50	-0.16	1.201e-3	2.420e-3	(B) Positive
ADGRG5	16q21	0.89	0.53	1.09	0.87	0.36	1.202e-3	2.422e-3	(A) Negative
ZNF831	20q13.32	3.31	2.80	1.49	1.38	0.51	1.202e-3	2.422e-3	(A) Negative
PLEK	2p14	2.57	2.24	0.97	0.86	0.33	1.203e-3	2.423e-3	(A) Negative
LINGO1	15q24.3	0.22	0.56	0.97	1.04	-0.34	1.205e-3	2.426e-3	(B) Positive
PARP15	3q21.1	0.73	0.44	0.89	0.71	0.29	1.208e-3	2.433e-3	(A) Negative
YIPF4	2p22.3	0.52	0.35	0.49	0.41	0.16	1.209e-3	2.434e-3	(A) Negative
GTF2H3	12q24.31	-0.77	-0.59	0.53	0.53	-0.18	1.213e-3	2.442e-3	(B) Positive
ZNF468	19q13.41	0.42	0.61	0.56	0.52	-0.19	1.221e-3	2.457e-3	(B) Positive
PSPN	19p13.3	0.27	0.39	0.36	0.36	-0.12	1.221e-3	2.458e-3	(B) Positive
MMP11	22q11.23	2.79	3.06	0.80	0.78	-0.27	1.222e-3	2.460e-3	(B) Positive
ERN2	16p12.2	0.70	0.52	0.51	0.52	0.18	1.230e-3	2.475e-3	(A) Negative
RNF7	3q23	0.20	0.36	0.49	0.39	-0.16	1.234e-3	2.483e-3	(B) Positive
TMEM86A	11p15.1	2.06	2.35	0.90	0.73	-0.30	1.236e-3	2.487e-3	(B) Positive
MYH15	3q13.13	0.12	-0.03	0.43	0.41	0.15	1.237e-3	2.488e-3	(A) Negative
MYH6	14q11.2	-1.69	-1.82	0.37	0.38	0.13	1.239e-3	2.492e-3	(A) Negative
RAI14	5p13.2	-0.07	-0.33	0.78	0.58	0.25	1.240e-3	2.494e-3	(A) Negative
TGFB1	19q13.2	-0.50	-0.34	0.48	0.47	-0.16	1.245e-3	2.504e-3	(B) Positive
ACSL3	2q36.1	-0.14	0.10	0.71	0.64	-0.24	1.250e-3	2.513e-3	(B) Positive
ABHD5	3p21.33	0.09	-0.10	0.58	0.49	0.19	1.254e-3	2.522e-3	(A) Negative
ZBTB10	8q21.13	0.77	0.54	0.66	0.73	0.23	1.255e-3	2.523e-3	(A) Negative
KIF20B	10q23.31	-1.14	-1.41	0.81	0.76	0.27	1.259e-3	2.530e-3	(A) Negative
SARS2	19q13.2	-0.30	-0.48	0.57	0.40	0.18	1.265e-3	2.542e-3	(A) Negative
RAB11FIP2	10q26.11	0.07	0.23	0.49	0.44	-0.16	1.268e-3	2.547e-3	(B) Positive
STAM	10p12.33	-0.01	-0.19	0.55	0.44	0.18	1.268e-3	2.547e-3	(A) Negative
L3MBTL3	6q23.1	0.25	0.03	0.64	0.68	0.22	1.268e-3	2.547e-3	(A) Negative
FAM91A1	8q24.13	0.40	0.21	0.56	0.58	0.19	1.268e-3	2.548e-3	(A) Negative
PQBP1	Xp11.23	-0.20	-0.31	0.33	0.30	0.11	1.275e-3	2.561e-3	(A) Negative
CCT6B	17q12	0.63	0.89	0.74	0.77	-0.25	1.277e-3	2.564e-3	(B) Positive
P2RY1	3q25.2	0.02	-0.31	1.03	0.75	0.33	1.278e-3	2.565e-3	(A) Negative
ZFAT	8q24.22	0.79	0.61	0.53	0.49	0.18	1.282e-3	2.574e-3	(A) Negative
ID2	2p25.1	0.56	0.33	0.68	0.68	0.23	1.289e-3	2.587e-3	(A) Negative
MIGA2	9q34.11	-0.46	-0.34	0.38	0.35	-0.13	1.291e-3	2.591e-3	(B) Positive
ZNF34	8q24.3	0.73	0.92	0.57	0.53	-0.19	1.294e-3	2.596e-3	(B) Positive
MATN1	1p35.2	-0.14	-0.31	0.53	0.43	0.18	1.294e-3	2.598e-3	(A) Negative
ZNF683	1p36.11	4.13	3.77	1.08	1.07	0.37	1.296e-3	2.599e-3	(A) Negative
SRSF10	1p36.11	-0.58	-0.70	0.36	0.29	0.12	1.296e-3	2.600e-3	(A) Negative
ITGA11	15q23	-0.34	0.10	1.29	1.27	-0.44	1.298e-3	2.604e-3	(B) Positive
MIXL1	1q42.12	-0.99	-1.11	0.35	0.39	0.12	1.299e-3	2.605e-3	(A) Negative
DNAJA1	9p21.1	0.08	-0.11	0.59	0.51	0.20	1.299e-3	2.605e-3	(A) Negative
STXBP1	9q34.11	-1.64	-1.47	0.49	0.48	-0.17	1.299e-3	2.606e-3	(B) Positive
ALDOC	17q11.2	-1.95	-2.22	0.80	0.77	0.27	1.304e-3	2.615e-3	(A) Negative
NDUFA4L2	12q13.3	-0.23	-0.56	1.02	0.68	0.33	1.306e-3	2.619e-3	(A) Negative
VIM	10p13	-0.59	-0.92	1.00	0.91	0.33	1.310e-3	2.627e-3	(A) Negative
RBM14	11q13.2	-0.13	-0.25	0.34	0.38	0.12	1.317e-3	2.639e-3	(A) Negative
ZNF41	Xp11.3	-0.07	0.10	0.51	0.47	-0.17	1.318e-3	2.641e-3	(B) Positive
CMKLR1	12q23.3	2.11	1.82	0.88	0.79	0.29	1.321e-3	2.646e-3	(A) Negative
ARMH4	14q23.1	1.42	1.73	0.90	0.90	-0.31	1.322e-3	2.649e-3	(B) Positive
FOXD4L1	2q14.1	0.67	0.48	0.55	0.57	0.19	1.325e-3	2.654e-3	(A) Negative
EIF2AK2	2p22.2	1.10	0.82	0.81	0.78	0.28	1.328e-3	2.660e-3	(A) Negative
LAGE3	Xq28	0.42	0.20	0.63	0.71	0.22	1.332e-3	2.667e-3	(A) Negative
ASCC1	10q22.1	-0.05	-0.19	0.41	0.42	0.14	1.333e-3	2.669e-3	(A) Negative
DOLPP1	9q34.11	-0.38	-0.22	0.50	0.40	-0.16	1.336e-3	2.675e-3	(B) Positive
SCN2A	2q24.3	0.67	0.27	1.25	0.80	0.40	1.336e-3	2.676e-3	(A) Negative
CDH23	10q22.1	0.70	0.87	0.48	0.57	-0.17	1.338e-3	2.678e-3	(B) Positive
MIR99AHG	21q21.1	0.05	-0.34	1.16	1.05	0.39	1.340e-3	2.683e-3	(A) Negative
TMPRSS7	3q13.2	0.25	0.05	0.59	0.67	0.21	1.341e-3	2.684e-3	(A) Negative
DACT2	6q27	-1.02	-1.56	1.62	1.43	0.54	1.347e-3	2.696e-3	(A) Negative
AFG3L2	18p11.21	-0.28	-0.51	0.70	0.60	0.23	1.347e-3	2.696e-3	(A) Negative
NDUFAB1	16p12.2	-0.67	-0.51	0.47	0.48	-0.16	1.348e-3	2.697e-3	(B) Positive
SLC35F6	2p23.3	0.79	0.96	0.51	0.38	-0.17	1.354e-3	2.710e-3	(B) Positive
CXCR3	Xq13.1	2.08	1.70	1.10	1.09	0.37	1.355e-3	2.710e-3	(A) Negative
FEM1A	19p13.3	0.30	0.46	0.49	0.41	-0.16	1.355e-3	2.710e-3	(B) Positive
ZNF333	19p13.12	0.20	0.35	0.46	0.37	-0.15	1.361e-3	2.721e-3	(B) Positive
ZNF777	7q36.1	0.24	0.08	0.49	0.43	0.16	1.362e-3	2.723e-3	(A) Negative
ZNF783	7q36.1	-0.29	-0.47	0.56	0.50	0.19	1.367e-3	2.733e-3	(A) Negative
CD1A	1q23.1	-1.85	-2.38	1.65	1.26	0.53	1.372e-3	2.742e-3	(A) Negative
COPRS	17q11.2	-0.32	-0.13	0.58	0.53	-0.19	1.383e-3	2.765e-3	(B) Positive
AMOT	Xq23	0.49	0.22	0.83	0.70	0.27	1.387e-3	2.772e-3	(A) Negative
TRMT112	11q13.1	-0.04	0.12	0.48	0.42	-0.16	1.395e-3	2.789e-3	(B) Positive
MEOX2	7p21.2	-0.41	-0.01	1.17	1.14	-0.40	1.398e-3	2.794e-3	(B) Positive
GPR156	3q13.33	1.10	0.85	0.72	0.76	0.25	1.404e-3	2.804e-3	(A) Negative
FNDC5	1p35.1	-0.27	0.03	0.93	0.79	-0.31	1.404e-3	2.805e-3	(B) Positive
C11ORF71	11q23.2	0.50	0.29	0.65	0.57	0.22	1.406e-3	2.809e-3	(A) Negative
BAP1	3p21.1	-0.69	-0.50	0.54	0.55	-0.18	1.407e-3	2.811e-3	(B) Positive
NOX4	11q14.3	2.00	2.40	1.19	1.07	-0.40	1.413e-3	2.821e-3	(B) Positive
SRPK3	Xq28	1.12	0.82	0.90	0.88	0.30	1.413e-3	2.822e-3	(A) Negative
FAM131B	7q34	-0.13	0.05	0.53	0.53	-0.18	1.415e-3	2.825e-3	(B) Positive
TSFM	12q14.1	-0.20	-0.05	0.43	0.47	-0.15	1.415e-3	2.825e-3	(B) Positive
NAP1L4	11p15.4	-0.26	-0.12	0.41	0.40	-0.14	1.417e-3	2.829e-3	(B) Positive
PSTPIP2	18q21.1	1.08	0.80	0.85	0.73	0.28	1.418e-3	2.830e-3	(A) Negative
POLE2	14q21.3	-1.48	-1.76	0.85	0.72	0.28	1.419e-3	2.832e-3	(A) Negative
TSPAN2	1p13.2	1.09	0.70	1.18	0.99	0.39	1.422e-3	2.837e-3	(A) Negative
SLC39A8	4q24	-0.11	-0.44	0.94	1.08	0.33	1.428e-3	2.849e-3	(A) Negative
ARHGAP45	19p13.3	-0.42	-0.07	1.08	0.75	-0.35	1.430e-3	2.853e-3	(B) Positive
RGS17	6q25.2	-3.03	-2.74	0.87	0.79	-0.29	1.431e-3	2.854e-3	(B) Positive
MRPL28	16p13.3	-0.55	-0.39	0.48	0.42	-0.16	1.431e-3	2.855e-3	(B) Positive
ARL14EP	11p14.1	0.36	0.53	0.51	0.47	-0.17	1.431e-3	2.855e-3	(B) Positive
GZMH	14q12	3.37	2.97	1.19	1.08	0.40	1.432e-3	2.856e-3	(A) Negative
ZNF674	Xp11.3	-0.17	-0.37	0.60	0.46	0.19	1.433e-3	2.857e-3	(A) Negative
ABCA7	19p13.3	-0.89	-0.62	0.85	0.70	-0.28	1.436e-3	2.864e-3	(B) Positive
GPR45	2q12.1	0.19	0.04	0.43	0.43	0.14	1.439e-3	2.869e-3	(A) Negative
ADD3	10q25.1-q25.2	-0.36	-0.65	0.81	1.03	0.29	1.442e-3	2.874e-3	(A) Negative
DAW1	2q36.3	-0.52	-0.79	0.83	0.63	0.27	1.446e-3	2.881e-3	(A) Negative
SLC13A4	7q33	-0.78	-0.54	0.66	0.91	-0.24	1.455e-3	2.900e-3	(B) Positive
TRIB3	20p13	-1.18	-0.85	1.04	0.80	-0.34	1.456e-3	2.902e-3	(B) Positive
SLC25A23	19p13.3	-0.62	-0.41	0.65	0.47	-0.21	1.457e-3	2.902e-3	(B) Positive
ZNF138	7q11.21	-0.35	-0.16	0.57	0.58	-0.19	1.457e-3	2.903e-3	(B) Positive
TERT	5p15.33	-1.53	-1.75	0.68	0.56	0.22	1.457e-3	2.903e-3	(A) Negative
TRIM27	6p22.1	-0.11	-0.26	0.44	0.44	0.15	1.460e-3	2.908e-3	(A) Negative
NFAT5	16q22.1	-0.44	-0.68	0.72	0.60	0.23	1.462e-3	2.912e-3	(A) Negative
UBAP1	9p13.3	0.36	0.19	0.50	0.38	0.16	1.463e-3	2.914e-3	(A) Negative
EXTL2	1p21.2	-0.82	-1.02	0.61	0.50	0.20	1.466e-3	2.918e-3	(A) Negative
COG4	16q22.1	-0.57	-0.73	0.46	0.46	0.16	1.471e-3	2.929e-3	(A) Negative
NDUFA12	12q22	-0.15	0.00	0.49	0.39	-0.16	1.474e-3	2.933e-3	(B) Positive
PHEX	Xp22.11	0.96	0.50	1.39	1.30	0.46	1.475e-3	2.936e-3	(A) Negative
TBC1D8	2q11.2	0.41	0.71	0.93	0.73	-0.30	1.475e-3	2.936e-3	(B) Positive
NOTCH3	19p13.12	1.93	1.70	0.68	0.63	0.23	1.478e-3	2.940e-3	(A) Negative
GORAB	1q24.2	0.47	0.26	0.64	0.53	0.21	1.483e-3	2.950e-3	(A) Negative
OSTF1	9q21.13	0.47	0.30	0.50	0.50	0.17	1.485e-3	2.955e-3	(A) Negative
OOEP	6q13	-1.27	-1.84	1.83	0.97	0.57	1.487e-3	2.958e-3	(A) Negative
CIAO2A	15q22.31	-0.73	-0.54	0.54	0.52	-0.18	1.489e-3	2.962e-3	(B) Positive
PLEKHN1	1p36.33	0.18	-0.19	1.14	0.92	0.37	1.496e-3	2.975e-3	(A) Negative
FAM9A	Xp22.31	0.63	0.25	1.20	0.84	0.38	1.497e-3	2.976e-3	(A) Negative
MID1IP1	Xp11.4	-0.50	-0.33	0.49	0.55	-0.17	1.500e-3	2.982e-3	(B) Positive
PLPP2	19p13.3	1.93	1.70	0.67	0.76	0.23	1.500e-3	2.982e-3	(A) Negative
CTSK	1q21.3	3.47	3.77	0.88	0.89	-0.30	1.501e-3	2.984e-3	(B) Positive
PPIB	15q22.31	-0.26	-0.44	0.53	0.54	0.18	1.503e-3	2.987e-3	(A) Negative
HSPB7	1p36.13	-1.12	-0.79	0.94	1.16	-0.33	1.503e-3	2.988e-3	(B) Positive
RBBP5	1q32.1	0.35	0.21	0.42	0.46	0.14	1.508e-3	2.996e-3	(A) Negative
LITAF	16p13.13	1.07	0.85	0.65	0.51	0.21	1.510e-3	3.000e-3	(A) Negative
OR51Q1	11p15.4	0.27	0.15	0.36	0.37	0.12	1.512e-3	3.003e-3	(A) Negative
TIE1	1p34.2	1.07	1.29	0.64	0.61	-0.21	1.518e-3	3.015e-3	(B) Positive
IFNAR1	21q22.11	0.40	0.22	0.56	0.41	0.18	1.518e-3	3.015e-3	(A) Negative
TAP1	6p21.32	1.71	1.31	1.24	0.97	0.40	1.521e-3	3.020e-3	(A) Negative
CD1B	1q23.1	-2.39	-2.72	1.02	0.78	0.33	1.524e-3	3.025e-3	(A) Negative
SEZ6L2	16p11.2	-0.25	0.14	1.15	1.24	-0.39	1.524e-3	3.025e-3	(B) Positive
MAP3K15	Xp22.12	-1.82	-1.98	0.49	0.49	0.16	1.525e-3	3.028e-3	(A) Negative
FADS6	17q25.1	0.35	0.14	0.68	0.33	0.21	1.531e-3	3.039e-3	(A) Negative
ANKRD36	2q11.2	-0.45	-0.72	0.82	0.75	0.27	1.533e-3	3.043e-3	(A) Negative
MYPN	10q21.3	-3.56	-3.83	0.83	0.70	0.27	1.534e-3	3.045e-3	(A) Negative
HILPDA	7q32.1	0.11	-0.19	0.92	0.74	0.30	1.540e-3	3.056e-3	(A) Negative
GOLGA2	9q34.11	0.05	0.24	0.58	0.50	-0.19	1.542e-3	3.059e-3	(B) Positive
CDKN2B	9p21.3	0.81	0.42	1.24	0.74	0.39	1.551e-3	3.078e-3	(A) Negative
THBS3	1q22	1.16	0.90	0.83	0.53	0.26	1.554e-3	3.082e-3	(A) Negative
OBI1	13q31.1	0.05	-0.14	0.57	0.47	0.18	1.555e-3	3.083e-3	(A) Negative
SUCO	1q24.3	0.93	1.18	0.80	0.61	-0.26	1.555e-3	3.084e-3	(B) Positive
CARD14	17q25.3	0.97	1.20	0.67	0.72	-0.23	1.561e-3	3.095e-3	(B) Positive
PI4K2A	10q24.2	0.05	0.17	0.35	0.35	-0.12	1.561e-3	3.095e-3	(B) Positive
DCAF1	3p21.2	0.04	0.20	0.47	0.45	-0.16	1.564e-3	3.100e-3	(B) Positive
PCBD1	10q22.1	0.36	0.56	0.61	0.55	-0.20	1.565e-3	3.102e-3	(B) Positive
RDH12	14q24.1	-0.09	-0.33	0.76	0.53	0.24	1.566e-3	3.103e-3	(A) Negative
AJAP1	1p36.32	-1.86	-1.98	0.35	0.39	0.12	1.574e-3	3.120e-3	(A) Negative
DDX17	22q13.1	-0.08	0.06	0.41	0.48	-0.14	1.576e-3	3.123e-3	(B) Positive
C4ORF19	4p14	0.74	0.14	1.78	1.82	0.60	1.577e-3	3.124e-3	(A) Negative
RPL26P30	11p15.5	-0.32	-0.17	0.48	0.37	-0.15	1.578e-3	3.126e-3	(B) Positive
OSTN	3q28	0.60	0.51	0.26	0.26	0.09	1.580e-3	3.130e-3	(A) Negative
NCOR1P1	20p11.1	-0.08	0.10	0.55	0.55	-0.18	1.580e-3	3.130e-3	(B) Positive
ST8SIA2	15q26.1	0.46	0.33	0.41	0.37	0.14	1.583e-3	3.134e-3	(A) Negative
SERPINA4	14q32.13	-2.51	-2.31	0.60	0.58	-0.20	1.585e-3	3.139e-3	(B) Positive
SPATA12	3p14.3	-0.17	-0.33	0.48	0.46	0.16	1.586e-3	3.140e-3	(A) Negative
VCL	10q22.2	0.11	-0.09	0.60	0.52	0.20	1.587e-3	3.141e-3	(A) Negative
AAMDC	11q14.1	0.80	1.05	0.74	0.85	-0.26	1.587e-3	3.141e-3	(B) Positive
ACSBG2	19p13.3	-0.12	-0.01	0.29	0.46	-0.11	1.591e-3	3.150e-3	(B) Positive
RPL30	8q22.2	0.64	0.45	0.57	0.55	0.19	1.600e-3	3.166e-3	(A) Negative
CIART	1q21.2	0.67	0.36	0.94	0.95	0.32	1.600e-3	3.167e-3	(A) Negative
YBX2	17p13.1	0.15	-0.20	1.06	0.99	0.35	1.602e-3	3.169e-3	(A) Negative
PTGFRN	1p13.1	1.09	0.87	0.65	0.61	0.21	1.604e-3	3.173e-3	(A) Negative
ABHD16A	6p21.33	0.54	0.69	0.45	0.41	-0.15	1.605e-3	3.174e-3	(B) Positive
TRPV2	17p11.2	-0.96	-1.21	0.76	0.73	0.25	1.606e-3	3.176e-3	(A) Negative
ADCK1	14q24.3	-0.32	-0.13	0.54	0.59	-0.19	1.606e-3	3.176e-3	(B) Positive
MEF2A	15q26.3	0.49	0.30	0.58	0.43	0.19	1.606e-3	3.176e-3	(A) Negative
MAGEA10	Xq28	-3.94	-4.43	1.60	0.79	0.49	1.616e-3	3.195e-3	(A) Negative
ZBTB22	6p21.3	0.83	0.97	0.42	0.44	-0.14	1.617e-3	3.197e-3	(B) Positive
CYSLTR1	Xq21.1	-0.42	-0.06	1.07	1.07	-0.36	1.620e-3	3.202e-3	(B) Positive
OR2B2	6p22.1	0.41	0.31	0.31	0.32	0.10	1.627e-3	3.217e-3	(A) Negative
OSGIN2	8q21.3	0.87	0.65	0.68	0.64	0.22	1.628e-3	3.217e-3	(A) Negative
JADE1	4q28.2	-1.12	-0.93	0.56	0.56	-0.19	1.633e-3	3.228e-3	(B) Positive
SP2	17q21.32	-0.08	0.04	0.36	0.38	-0.12	1.635e-3	3.230e-3	(B) Positive
GCSAM	3q13.2	0.40	0.13	0.83	0.69	0.27	1.638e-3	3.236e-3	(A) Negative
ZFP82	19q13.12	0.13	-0.15	0.85	0.75	0.28	1.639e-3	3.237e-3	(A) Negative
WIPF2	17q21.2	0.36	0.58	0.72	0.53	-0.23	1.640e-3	3.238e-3	(B) Positive
PARVA	11p15.3	0.89	1.03	0.43	0.44	-0.14	1.640e-3	3.238e-3	(B) Positive
BFAR	16p13.12	-0.55	-0.41	0.42	0.40	-0.14	1.647e-3	3.253e-3	(B) Positive
KLHDC4	16q24.2	-0.25	-0.45	0.59	0.65	0.20	1.655e-3	3.267e-3	(A) Negative
TNMD	Xq22.1	-1.43	-0.97	1.36	1.50	-0.46	1.656e-3	3.269e-3	(B) Positive
OCIAD2	4p11	1.29	1.09	0.64	0.50	0.21	1.656e-3	3.269e-3	(A) Negative
SAA1	11p15.1	3.15	2.60	1.59	1.77	0.54	1.657e-3	3.271e-3	(A) Negative
PTPRC	1q31.3-q32.1	1.04	0.65	1.18	1.05	0.38	1.661e-3	3.278e-3	(A) Negative
CLCN3	4q33	0.67	0.91	0.76	0.56	-0.24	1.663e-3	3.282e-3	(B) Positive
MAN2A2	15q25	-0.68	-0.50	0.55	0.49	-0.18	1.664e-3	3.283e-3	(B) Positive
ZFPM2	8q23	0.57	0.87	0.91	0.86	-0.30	1.664e-3	3.283e-3	(B) Positive
GP1BA	17p13.2	0.88	0.55	1.01	0.86	0.33	1.670e-3	3.294e-3	(A) Negative
CREBBP	16p13.3	0.58	0.76	0.57	0.40	-0.18	1.671e-3	3.296e-3	(B) Positive
NR4A3	9q31.1	0.17	-0.11	0.84	0.92	0.29	1.673e-3	3.299e-3	(A) Negative
MRPL36	5p15.33	-0.21	-0.36	0.47	0.41	0.15	1.678e-3	3.309e-3	(A) Negative
ATP6V1E1	22q11.21	0.30	0.48	0.53	0.53	-0.18	1.679e-3	3.311e-3	(B) Positive
TRIM44	11p13	-0.32	-0.16	0.50	0.39	-0.16	1.683e-3	3.318e-3	(B) Positive
CHD5	1p36.31	-0.29	-0.46	0.51	0.51	0.17	1.686e-3	3.323e-3	(A) Negative
CAMSAP3	19p13.2	0.91	1.11	0.60	0.60	-0.20	1.689e-3	3.330e-3	(B) Positive
DDX41	5q35.3	-0.42	-0.29	0.40	0.34	-0.13	1.690e-3	3.330e-3	(B) Positive
RIDA	8q22.2	0.07	-0.16	0.65	0.73	0.22	1.701e-3	3.353e-3	(A) Negative
SAE1	19q13.32	-0.32	-0.48	0.50	0.42	0.16	1.702e-3	3.353e-3	(A) Negative
GPHB5	14q23.2	0.29	0.15	0.43	0.38	0.14	1.707e-3	3.363e-3	(A) Negative
SELENOF	1p22.3	0.51	0.35	0.48	0.43	0.16	1.707e-3	3.363e-3	(A) Negative
HIPK1	1p13.2	-0.19	-0.06	0.39	0.41	-0.13	1.707e-3	3.363e-3	(B) Positive
SLC22A8	11q12.3	0.61	0.52	0.26	0.25	0.09	1.708e-3	3.364e-3	(A) Negative
DRG2	17p11.2	-0.42	-0.26	0.49	0.45	-0.16	1.709e-3	3.365e-3	(B) Positive
ADPRS	1p34.3	0.25	0.10	0.48	0.43	0.16	1.712e-3	3.371e-3	(A) Negative
PREB	2p23.3	-0.24	-0.37	0.42	0.36	0.13	1.713e-3	3.373e-3	(A) Negative
TOP3B	22q11.22	-0.73	-0.86	0.37	0.38	0.13	1.716e-3	3.377e-3	(A) Negative
SS18L1	20q13.33	-0.62	-0.80	0.54	0.62	0.19	1.720e-3	3.387e-3	(A) Negative
ARHGAP17	16p12.1	-0.00	-0.13	0.40	0.37	0.13	1.724e-3	3.393e-3	(A) Negative
KRTAP11-1	21q22.1	0.43	0.37	0.21	0.20	0.07	1.734e-3	3.413e-3	(A) Negative
SAP130	2q14.3	-0.31	-0.45	0.43	0.31	0.13	1.737e-3	3.418e-3	(A) Negative
VPS18	15q15.1	0.77	1.03	0.77	0.70	-0.25	1.739e-3	3.421e-3	(B) Positive
PCDHA1	5q31.3	0.53	0.93	1.20	1.24	-0.40	1.745e-3	3.432e-3	(B) Positive
PPP1R3D	20q13.33	1.08	1.39	0.94	0.91	-0.31	1.748e-3	3.438e-3	(B) Positive
PYGL	14q22.1	-1.23	-0.82	1.23	1.13	-0.40	1.761e-3	3.464e-3	(B) Positive
LEFTY1	1q42.12	-1.96	-1.55	1.24	1.17	-0.41	1.764e-3	3.470e-3	(B) Positive
CYB561	17q23.3	1.21	1.49	0.84	0.73	-0.27	1.771e-3	3.482e-3	(B) Positive
PTGES2	9q34.11	-0.62	-0.78	0.51	0.44	0.16	1.772e-3	3.483e-3	(A) Negative
CD44	11p13	0.05	-0.20	0.73	0.86	0.25	1.776e-3	3.491e-3	(A) Negative
PRKCB	16p12.2-p12.1	-2.36	-2.76	1.24	1.12	0.40	1.776e-3	3.492e-3	(A) Negative
ST6GALNAC5	1p31.1	1.80	1.28	1.58	1.53	0.52	1.779e-3	3.496e-3	(A) Negative
PARP8	5q11.1	0.54	0.25	0.88	0.92	0.30	1.784e-3	3.506e-3	(A) Negative
ARMC1	8q13.1	0.14	-0.07	0.60	0.64	0.20	1.785e-3	3.507e-3	(A) Negative
NXNL1	19p13.11	0.46	0.37	0.27	0.31	0.09	1.789e-3	3.514e-3	(A) Negative
MRM1	17q12	-0.78	-0.56	0.65	0.66	-0.22	1.798e-3	3.533e-3	(B) Positive
TRPC4AP	20q11.22	-0.55	-0.42	0.39	0.44	-0.13	1.806e-3	3.547e-3	(B) Positive
SSBP3	1p32.3	0.03	-0.16	0.56	0.54	0.18	1.808e-3	3.551e-3	(A) Negative
SLC25A2	5q31.3	0.05	0.18	0.38	0.41	-0.13	1.808e-3	3.551e-3	(B) Positive
HAPLN2	1q23.1	-0.22	-0.10	0.30	0.47	-0.11	1.816e-3	3.565e-3	(B) Positive
STRAP	12p12.3	-0.66	-0.88	0.71	0.49	0.22	1.816e-3	3.566e-3	(A) Negative
ZNF80	3q13.31	0.66	0.43	0.72	0.61	0.23	1.818e-3	3.569e-3	(A) Negative
ZNF485	10q11.21	0.19	-0.03	0.66	0.72	0.22	1.818e-3	3.569e-3	(A) Negative
OR9Q1	11q12.1	0.36	0.49	0.38	0.39	-0.13	1.819e-3	3.570e-3	(B) Positive
ARMCX5	Xq22.1	0.25	0.46	0.67	0.51	-0.21	1.821e-3	3.574e-3	(B) Positive
SMIM43	4q27	-0.52	-0.68	0.50	0.42	0.16	1.828e-3	3.587e-3	(A) Negative
ELSPBP1	19q13.33	-0.46	-0.23	0.68	0.72	-0.23	1.829e-3	3.588e-3	(B) Positive
CCR8	3p22.1	0.63	0.43	0.60	0.59	0.20	1.840e-3	3.610e-3	(A) Negative
ZNF70	22q11.23	0.12	-0.04	0.49	0.40	0.16	1.844e-3	3.618e-3	(A) Negative
RABGAP1L	1q25.1	0.27	0.07	0.62	0.55	0.20	1.846e-3	3.621e-3	(A) Negative
MT1H	16q13	-0.46	-0.82	1.13	0.97	0.36	1.850e-3	3.629e-3	(A) Negative
TBCE	1q42.3	-0.19	-0.38	0.61	0.52	0.20	1.853e-3	3.633e-3	(A) Negative
CLTCL1	22q11.21	-1.27	-1.49	0.67	0.67	0.22	1.856e-3	3.638e-3	(A) Negative
CRYBA2	2q35	0.03	-0.43	1.44	1.17	0.46	1.857e-3	3.641e-3	(A) Negative
NAIF1	9q34.11	-0.07	0.03	0.30	0.28	-0.10	1.858e-3	3.642e-3	(B) Positive
CLCA3P	1p22.3	-0.08	-0.29	0.65	0.66	0.22	1.873e-3	3.672e-3	(A) Negative
KCNH2	7q36.1	-1.62	-1.92	0.95	0.73	0.30	1.875e-3	3.674e-3	(A) Negative
DPY19L2P1	7p14.2	-1.11	-0.90	0.59	0.76	-0.21	1.875e-3	3.674e-3	(B) Positive
HES1	3q29	0.64	0.88	0.74	0.74	-0.24	1.876e-3	3.675e-3	(B) Positive
EXD1	15q15.1	0.12	-0.05	0.55	0.46	0.17	1.882e-3	3.687e-3	(A) Negative
TREH	11q23.3	-0.04	0.03	0.22	0.25	-0.07	1.882e-3	3.687e-3	(B) Positive
PIAS2	18q21.1	-0.04	-0.23	0.61	0.52	0.19	1.884e-3	3.690e-3	(A) Negative
PLCXD2	3q13.2	-0.04	-0.15	0.33	0.38	0.11	1.886e-3	3.693e-3	(A) Negative
RHAG	6p12.3	-3.96	-4.09	0.40	0.36	0.13	1.887e-3	3.696e-3	(A) Negative
PLCD3	17q21.31	-0.73	-0.61	0.36	0.41	-0.12	1.895e-3	3.710e-3	(B) Positive
FGD2	6p21.2	1.32	1.17	0.46	0.40	0.15	1.895e-3	3.710e-3	(A) Negative
PPP1R14A	19q13.1	0.21	-0.09	0.92	0.75	0.29	1.900e-3	3.719e-3	(A) Negative
TSPAN14	10q23.1	0.27	0.13	0.42	0.43	0.14	1.902e-3	3.723e-3	(A) Negative
CCDC90B	11q14.1	-0.57	-0.75	0.55	0.55	0.18	1.907e-3	3.733e-3	(A) Negative
TEP1	14q11.2	-0.38	-0.62	0.75	0.68	0.24	1.912e-3	3.742e-3	(A) Negative
DDAH2	6p21.33	0.98	1.17	0.57	0.58	-0.19	1.914e-3	3.746e-3	(B) Positive
ELOVL6	4q25	-1.09	-1.36	0.85	0.67	0.27	1.915e-3	3.746e-3	(A) Negative
MTMR3	22q12.2	0.70	0.82	0.37	0.38	-0.12	1.916e-3	3.749e-3	(B) Positive
CPVL	7p14.3	-0.56	-0.86	0.96	0.84	0.31	1.928e-3	3.771e-3	(A) Negative
SOCS6	18q22.2	0.80	1.02	0.66	0.67	-0.22	1.929e-3	3.772e-3	(B) Positive
PRB1	12p13.2	0.43	0.07	1.16	0.73	0.35	1.929e-3	3.772e-3	(A) Negative
IAPP	12p12.1	0.34	0.17	0.52	0.52	0.17	1.932e-3	3.778e-3	(A) Negative
SPN	16p11.2	-0.45	-0.65	0.63	0.54	0.20	1.945e-3	3.803e-3	(A) Negative
DCX	Xq23	0.93	0.17	2.46	1.65	0.76	1.951e-3	3.815e-3	(A) Negative
C2ORF27A	2q21.2	0.11	0.32	0.61	0.65	-0.20	1.954e-3	3.819e-3	(B) Positive
SAMD13	1p31.1	0.28	-0.17	1.21	1.80	0.45	1.957e-3	3.825e-3	(A) Negative
ACAD8	11q25	-0.25	-0.06	0.59	0.55	-0.19	1.959e-3	3.829e-3	(B) Positive
IZUMO1	19q13.33	-0.54	-0.73	0.62	0.48	0.20	1.963e-3	3.836e-3	(A) Negative
FOXO4	Xq13.1	0.23	0.35	0.37	0.38	-0.12	1.963e-3	3.836e-3	(B) Positive
NAALADL1	11q13.1	-0.02	0.19	0.63	0.61	-0.20	1.965e-3	3.840e-3	(B) Positive
ANKZF1	2q35	-1.24	-1.38	0.46	0.39	0.15	1.967e-3	3.842e-3	(A) Negative
TM4SF18	3q25.1	3.05	2.73	1.01	0.88	0.32	1.969e-3	3.845e-3	(A) Negative
RTF2	20q13.31	0.05	0.19	0.41	0.45	-0.14	1.971e-3	3.849e-3	(B) Positive
OAZ2	15q22.31	-0.19	-0.06	0.41	0.39	-0.13	1.973e-3	3.854e-3	(B) Positive
LRFN1	19q13.2	0.76	0.57	0.59	0.55	0.19	1.974e-3	3.854e-3	(A) Negative
ZFAS1	20q13.13	-1.04	-0.80	0.73	0.67	-0.24	1.975e-3	3.856e-3	(B) Positive
CST7	20p11.21	1.12	0.73	1.26	1.03	0.40	1.976e-3	3.857e-3	(A) Negative
C1QL1	17q21.31	-1.11	-1.39	0.90	0.68	0.28	1.976e-3	3.857e-3	(A) Negative
RGS13	1q31.2	1.46	1.80	1.03	1.13	-0.34	1.977e-3	3.859e-3	(B) Positive
TNFRSF18	1p36.33	-0.35	-0.05	0.84	1.07	-0.29	1.978e-3	3.860e-3	(B) Positive
SLC25A4	4q35.1	-0.57	-0.27	0.90	0.89	-0.30	1.979e-3	3.862e-3	(B) Positive
UTS2	1p36.23	-5.18	-5.59	1.29	1.09	0.41	1.983e-3	3.869e-3	(A) Negative
CCL27	9p13.3	-0.66	-0.88	0.68	0.56	0.21	1.983e-3	3.869e-3	(A) Negative
HABP4	9q22.32	-0.40	-0.62	0.68	0.65	0.22	1.986e-3	3.873e-3	(A) Negative
TMEM241	18q11.2	1.50	1.73	0.71	0.62	-0.23	1.994e-3	3.889e-3	(B) Positive
LCP2	5q35.1	0.84	0.55	0.92	0.79	0.29	1.998e-3	3.895e-3	(A) Negative
TIGAR	12p13.32	-0.30	-0.53	0.76	0.53	0.23	1.999e-3	3.898e-3	(A) Negative
F10	13q34	-2.73	-2.53	0.57	0.64	-0.19	2.000e-3	3.898e-3	(B) Positive
SLC25A21	14q13.3	-1.56	-1.21	1.13	0.91	-0.36	2.000e-3	3.898e-3	(B) Positive
ACOT11	1p32.3	0.11	-0.05	0.52	0.44	0.17	2.004e-3	3.906e-3	(A) Negative
ZNF707	8q24.3	0.60	0.42	0.56	0.61	0.19	2.006e-3	3.909e-3	(A) Negative
POLR3C	1q21.1	0.32	0.16	0.50	0.45	0.16	2.006e-3	3.909e-3	(A) Negative
SCG2	2q36.1	-2.74	-2.43	0.93	1.03	-0.31	2.008e-3	3.913e-3	(B) Positive
H2BC5	6p22.2	0.05	0.32	0.82	0.94	-0.28	2.010e-3	3.915e-3	(B) Positive
MBTPS2	Xp22.12	0.15	0.31	0.50	0.47	-0.16	2.011e-3	3.917e-3	(B) Positive
GUCA1B	6p21.1	-0.75	-0.99	0.74	0.69	0.24	2.013e-3	3.922e-3	(A) Negative
DCP2	5q22.2	-0.70	-0.56	0.44	0.40	-0.14	2.014e-3	3.922e-3	(B) Positive
CES3	16q22.1	-0.37	-0.65	0.89	0.77	0.28	2.015e-3	3.924e-3	(A) Negative
KCNB1	20q13.13	0.00	-0.45	1.47	1.04	0.46	2.024e-3	3.940e-3	(A) Negative
ZNF215	11p15.4	-1.42	-1.78	1.16	0.92	0.37	2.024e-3	3.941e-3	(A) Negative
STARD8	Xq13.1	-0.41	-0.27	0.42	0.40	-0.14	2.025e-3	3.943e-3	(B) Positive
TNC	9q33.1	-0.76	-1.15	1.20	1.09	0.39	2.027e-3	3.946e-3	(A) Negative
HYAL3	3p21.31	-0.04	-0.30	0.82	0.75	0.26	2.036e-3	3.962e-3	(A) Negative
TP73	1p36.32	-0.10	0.04	0.44	0.40	-0.14	2.037e-3	3.965e-3	(B) Positive
TRAF4	17q11.2	0.22	-0.04	0.80	0.76	0.26	2.042e-3	3.974e-3	(A) Negative
WSB2	12q24.23	0.22	0.01	0.66	0.55	0.21	2.047e-3	3.983e-3	(A) Negative
ATG5	6q21	0.58	0.38	0.62	0.62	0.20	2.050e-3	3.989e-3	(A) Negative
ARF5	7q32.1	0.39	0.24	0.48	0.43	0.15	2.051e-3	3.991e-3	(A) Negative
PPIL2	22q11.21	-0.38	-0.24	0.43	0.44	-0.14	2.055e-3	3.996e-3	(B) Positive
POPDC2	3q13.33	1.88	2.09	0.66	0.51	-0.21	2.062e-3	4.011e-3	(B) Positive
NINJ2	12p13.33	-0.24	-0.51	0.80	0.77	0.26	2.064e-3	4.013e-3	(A) Negative
CLUHP3	16p11.2	-0.76	-0.55	0.63	0.68	-0.21	2.066e-3	4.017e-3	(B) Positive
DACT3	19q13.32	0.54	0.81	0.85	0.72	-0.27	2.075e-3	4.034e-3	(B) Positive
AFG2A	4q28.1	-0.04	0.16	0.61	0.57	-0.20	2.078e-3	4.039e-3	(B) Positive
STK16	2q35	0.30	0.55	0.77	0.77	-0.25	2.085e-3	4.052e-3	(B) Positive
MAIP1	2q33.1	0.03	-0.12	0.49	0.35	0.15	2.087e-3	4.057e-3	(A) Negative
CCSER2	10q23.1	1.24	1.08	0.50	0.44	0.16	2.093e-3	4.066e-3	(A) Negative
SCGN	6p22.2	-0.26	0.32	1.81	1.76	-0.59	2.093e-3	4.067e-3	(B) Positive
ABHD6	3p14.3	-0.46	-0.20	0.80	0.70	-0.26	2.094e-3	4.068e-3	(B) Positive
COG5	7q22.3	-0.20	-0.38	0.54	0.50	0.17	2.097e-3	4.073e-3	(A) Negative
GUCY2F	Xq22.3-q23	-0.18	-0.39	0.64	0.64	0.21	2.097e-3	4.074e-3	(A) Negative
HSPE1	2q33.1	-0.39	-0.58	0.59	0.59	0.19	2.100e-3	4.078e-3	(A) Negative
CACNA1B	9q34.3	0.58	0.43	0.44	0.44	0.14	2.100e-3	4.078e-3	(A) Negative
ST6GAL2	2q12.3	0.44	0.77	1.01	0.94	-0.33	2.107e-3	4.092e-3	(B) Positive
MFSD14B	9q22.32	0.12	-0.05	0.54	0.45	0.17	2.113e-3	4.102e-3	(A) Negative
NOL3	16q22.1	-0.69	-0.43	0.81	0.73	-0.26	2.113e-3	4.102e-3	(B) Positive
CD151	11p15.5	-0.37	-0.16	0.64	0.66	-0.21	2.114e-3	4.103e-3	(B) Positive
AP1S1	7q22.1	-1.02	-1.22	0.62	0.61	0.20	2.121e-3	4.116e-3	(A) Negative
RSAD2	2p25.2	3.55	3.12	1.35	1.22	0.43	2.124e-3	4.121e-3	(A) Negative
HS3ST4	16p12.1	-0.91	-1.26	1.15	0.75	0.35	2.126e-3	4.125e-3	(A) Negative
TMTC4	13q32.3	0.08	-0.18	0.83	0.65	0.26	2.138e-3	4.148e-3	(A) Negative
FADS3	11q12.2	-0.63	-0.86	0.74	0.55	0.23	2.141e-3	4.154e-3	(A) Negative
MAP3K20	2q31.1	-0.05	0.19	0.75	0.71	-0.24	2.142e-3	4.156e-3	(B) Positive
ZNF503	10q22.2	-0.36	-0.68	1.01	1.01	0.33	2.149e-3	4.168e-3	(A) Negative
HTN3	4q13.3	0.08	-0.29	1.22	0.62	0.37	2.152e-3	4.173e-3	(A) Negative
TMEM94	17q25.1	-0.46	-0.28	0.52	0.65	-0.18	2.154e-3	4.177e-3	(B) Positive
CENPQ	6p12.3	-1.21	-1.41	0.63	0.58	0.20	2.155e-3	4.178e-3	(A) Negative
LHFPL2	5q14.1	0.70	0.52	0.54	0.58	0.18	2.159e-3	4.186e-3	(A) Negative
TUBGCP6	22q13.33	-0.35	-0.21	0.43	0.45	-0.14	2.165e-3	4.198e-3	(B) Positive
LY9	1q23.3	0.71	0.43	0.89	0.75	0.28	2.170e-3	4.205e-3	(A) Negative
ADM2	22q13.33	1.09	0.80	0.89	0.90	0.29	2.174e-3	4.214e-3	(A) Negative
G2E3	14q12	-0.87	-1.06	0.62	0.51	0.20	2.175e-3	4.215e-3	(A) Negative
PRB3	12p13.2	0.43	0.29	0.45	0.43	0.14	2.180e-3	4.225e-3	(A) Negative
FOXE1	9q22.33	-0.51	-0.65	0.42	0.45	0.14	2.185e-3	4.232e-3	(A) Negative
ZNF239	10q11.22-q11.23	1.05	1.32	0.85	0.79	-0.27	2.188e-3	4.238e-3	(B) Positive
NOP10	15q14	-0.15	-0.31	0.52	0.41	0.16	2.188e-3	4.239e-3	(A) Negative
CSPG5	3p21.31	-0.26	-0.48	0.71	0.61	0.22	2.192e-3	4.244e-3	(A) Negative
CEP72	5p15.33	-1.19	-1.46	0.86	0.61	0.26	2.196e-3	4.252e-3	(A) Negative
TBX15	1p12	1.00	1.21	0.66	0.67	-0.21	2.196e-3	4.252e-3	(B) Positive
CYP2F1	19q13.2	-1.47	-1.71	0.81	0.45	0.24	2.202e-3	4.263e-3	(A) Negative
TARS3	15q26.3	0.22	0.39	0.54	0.53	-0.18	2.204e-3	4.267e-3	(B) Positive
MRPL33	2p23.2	-0.18	-0.35	0.52	0.41	0.16	2.205e-3	4.267e-3	(A) Negative
TATDN1	8q24.13	-0.20	-0.44	0.75	0.66	0.24	2.207e-3	4.271e-3	(A) Negative
USP3	15q22.31	-0.37	-0.20	0.51	0.53	-0.17	2.208e-3	4.272e-3	(B) Positive
AGMO	7p21.2	-0.65	-1.02	1.18	0.85	0.36	2.208e-3	4.272e-3	(A) Negative
HLA-F	6p22.1	2.22	1.95	0.86	0.72	0.27	2.210e-3	4.275e-3	(A) Negative
EXOSC6	16q22.1	-0.39	-0.52	0.41	0.42	0.13	2.212e-3	4.279e-3	(A) Negative
FMO1	1q24.3	3.59	3.23	1.13	1.12	0.37	2.220e-3	4.293e-3	(A) Negative
MN1	22q12.1	-1.04	-0.78	0.83	0.69	-0.26	2.225e-3	4.304e-3	(B) Positive
MLLT3	9p21.3	0.04	0.33	0.93	0.79	-0.29	2.226e-3	4.304e-3	(B) Positive
SLC35D1	1p31.3	-0.42	-0.19	0.73	0.62	-0.23	2.227e-3	4.306e-3	(B) Positive
CMTM6	3p22.3	0.63	0.84	0.64	0.61	-0.21	2.231e-3	4.313e-3	(B) Positive
CLEC12B	12p13.2	-0.19	-0.39	0.60	0.71	0.20	2.235e-3	4.322e-3	(A) Negative
GADD45GIP1	19p13.13	-0.35	-0.51	0.51	0.46	0.16	2.239e-3	4.328e-3	(A) Negative
MRPL32	7p14.1	-0.28	-0.14	0.45	0.36	-0.14	2.242e-3	4.333e-3	(B) Positive
CFAP418	8q22.1	-0.30	-0.08	0.68	0.69	-0.22	2.246e-3	4.341e-3	(B) Positive
TSPAN9	12p13.33-p13.32	1.36	1.53	0.56	0.45	-0.18	2.248e-3	4.343e-3	(B) Positive
FAM110A	20p13	1.52	1.74	0.67	0.61	-0.21	2.252e-3	4.351e-3	(B) Positive
CD4	12p13.31	1.33	1.17	0.51	0.43	0.16	2.255e-3	4.357e-3	(A) Negative
RNF31	14q12	0.11	0.26	0.46	0.40	-0.15	2.256e-3	4.357e-3	(B) Positive
PPIF	10q22.3	-0.22	-0.37	0.46	0.56	0.16	2.259e-3	4.363e-3	(A) Negative
IMPACT	18q11.2	0.63	0.81	0.57	0.50	-0.18	2.262e-3	4.369e-3	(B) Positive
GGTLC2	22q11.22	0.48	0.18	0.88	1.00	0.29	2.264e-3	4.372e-3	(A) Negative
DCTN1	2p13.1	0.05	0.20	0.46	0.47	-0.15	2.265e-3	4.373e-3	(B) Positive
RHOXF1	Xq24	0.48	0.75	0.84	0.89	-0.28	2.265e-3	4.373e-3	(B) Positive
QRFPR	4q27	-0.72	-1.14	1.42	0.76	0.42	2.266e-3	4.374e-3	(A) Negative
SIRT2	19q13.2	0.71	0.56	0.48	0.33	0.15	2.267e-3	4.376e-3	(A) Negative
RPL26L1	5q35.1	-0.28	-0.10	0.56	0.43	-0.17	2.272e-3	4.385e-3	(B) Positive
MIS18BP1	14q21.2	0.01	-0.18	0.59	0.57	0.19	2.274e-3	4.388e-3	(A) Negative
PRMT7	16q22.1	-0.34	-0.20	0.41	0.45	-0.14	2.275e-3	4.389e-3	(B) Positive
RPS4X	Xq13.1	0.11	0.28	0.54	0.51	-0.17	2.276e-3	4.391e-3	(B) Positive
RHPN2	19q13.11	0.55	0.27	0.89	0.76	0.28	2.277e-3	4.393e-3	(A) Negative
LAMA1	18p11.31	-1.92	-2.12	0.63	0.46	0.19	2.279e-3	4.395e-3	(A) Negative
MAP7D1	1p34.3	0.31	0.15	0.48	0.46	0.15	2.282e-3	4.400e-3	(A) Negative
GPR18	13q32.3	2.84	2.38	1.44	1.26	0.45	2.286e-3	4.408e-3	(A) Negative
IFITM3	11p15.5	0.73	0.95	0.71	0.61	-0.22	2.291e-3	4.418e-3	(B) Positive
ASB15	7q31.32	0.25	0.43	0.54	0.60	-0.18	2.294e-3	4.423e-3	(B) Positive
KRTAP4-11	17q21.2	0.65	0.50	0.44	0.50	0.15	2.301e-3	4.437e-3	(A) Negative
ZNF202	11q23.3	-0.57	-0.75	0.59	0.51	0.19	2.304e-3	4.442e-3	(A) Negative
PPP2R2B	5q32	-0.72	-1.01	0.87	0.93	0.29	2.305e-3	4.443e-3	(A) Negative
NTNG1	1p13.3	-1.58	-1.26	0.86	1.38	-0.32	2.308e-3	4.448e-3	(B) Positive
ATP2B3	Xq28	0.27	0.10	0.57	0.37	0.17	2.315e-3	4.461e-3	(A) Negative
ZKSCAN3	6p22.1	-0.03	0.12	0.49	0.44	-0.16	2.317e-3	4.464e-3	(B) Positive
RARS2	6q15	-0.10	-0.28	0.59	0.42	0.18	2.317e-3	4.464e-3	(A) Negative
ARHGAP4	Xq28	-0.74	-1.00	0.81	0.83	0.26	2.321e-3	4.470e-3	(A) Negative
CAT	11p13	0.21	0.42	0.64	0.56	-0.20	2.328e-3	4.483e-3	(B) Positive
RIMS2	8q22.3	-0.05	-0.45	1.19	1.33	0.40	2.328e-3	4.484e-3	(A) Negative
B4GALNT4	11p15.5	-0.51	-0.24	0.84	0.85	-0.27	2.328e-3	4.484e-3	(B) Positive
PXMP4	20q11.22	0.39	0.80	1.30	1.12	-0.41	2.329e-3	4.484e-3	(B) Positive
IPMK	10q21.1	0.53	0.31	0.69	0.68	0.22	2.342e-3	4.508e-3	(A) Negative
BMPER	7p14.3	-1.23	-1.01	0.62	0.79	-0.21	2.343e-3	4.510e-3	(B) Positive
KLF8	Xp11.21	2.60	2.23	1.19	0.94	0.37	2.344e-3	4.512e-3	(A) Negative
ALKAL1	8q11.23	-0.02	-0.32	0.99	0.67	0.30	2.349e-3	4.521e-3	(A) Negative
RICTOR	5p13.1	-1.00	-0.85	0.45	0.43	-0.14	2.352e-3	4.526e-3	(B) Positive
FGFR1OP2	12p11.23	-0.19	-0.37	0.61	0.38	0.18	2.360e-3	4.541e-3	(A) Negative
LINC00638	14q32.33	-0.41	-0.18	0.71	0.70	-0.23	2.368e-3	4.555e-3	(B) Positive
SLC36A3	5q33.1	0.23	0.11	0.37	0.36	0.12	2.368e-3	4.556e-3	(A) Negative
KIAA1614	1q25.3	0.20	0.03	0.58	0.38	0.17	2.372e-3	4.562e-3	(A) Negative
PPOX	1q23.3	-0.47	-0.31	0.48	0.50	-0.16	2.383e-3	4.582e-3	(B) Positive
TRMT44	4p16.1	0.28	0.42	0.44	0.45	-0.14	2.384e-3	4.584e-3	(B) Positive
WIPI2	7p22.1	0.28	0.15	0.43	0.33	0.13	2.387e-3	4.589e-3	(A) Negative
PCDHB17P	5q31.3	0.41	0.03	1.24	0.92	0.38	2.387e-3	4.589e-3	(A) Negative
HBB	11p15.4	3.27	3.49	0.70	0.68	-0.22	2.391e-3	4.597e-3	(B) Positive
IGSF8	1q23.2	0.83	0.99	0.51	0.48	-0.16	2.399e-3	4.611e-3	(B) Positive
LAT	16p11.2	-1.24	-1.53	0.92	0.80	0.29	2.409e-3	4.630e-3	(A) Negative
WDR37	10p15.3	0.57	0.40	0.54	0.45	0.17	2.410e-3	4.631e-3	(A) Negative
HACD4	9p21.3	2.08	2.48	1.24	1.24	-0.40	2.416e-3	4.642e-3	(B) Positive
OSCAR	19q13.42	0.45	0.25	0.63	0.60	0.20	2.417e-3	4.645e-3	(A) Negative
OR10J5	1q23.2	0.16	-0.02	0.58	0.53	0.18	2.419e-3	4.647e-3	(A) Negative
GABARAP	17p13.1	0.44	0.58	0.41	0.40	-0.13	2.420e-3	4.650e-3	(B) Positive
ZDHHC3	3p21.31	0.12	0.26	0.46	0.40	-0.14	2.423e-3	4.653e-3	(B) Positive
ATP5F1B	12q13.3	-1.15	-0.94	0.68	0.60	-0.21	2.428e-3	4.662e-3	(B) Positive
DTX2P1-UPK3BP1-PMS2P11	7q11.23	-0.47	-0.34	0.41	0.40	-0.13	2.433e-3	4.671e-3	(B) Positive
HUS1B	6p25.3	-0.23	0.03	0.61	1.37	-0.27	2.434e-3	4.673e-3	(B) Positive
KLHL21	1p36.31	0.07	-0.11	0.57	0.47	0.18	2.436e-3	4.676e-3	(A) Negative
SPINK7	5q32	0.47	0.39	0.22	0.25	0.07	2.436e-3	4.676e-3	(A) Negative
CFAP298	21q22.11	-0.21	-0.01	0.62	0.51	-0.19	2.441e-3	4.685e-3	(B) Positive
C1ORF50	1p34.2	0.22	0.09	0.41	0.35	0.13	2.442e-3	4.686e-3	(A) Negative
TJAP1	6p21.1	-0.10	-0.26	0.50	0.39	0.16	2.447e-3	4.695e-3	(A) Negative
GALNT18	11p15.4	2.12	1.86	0.86	0.75	0.27	2.447e-3	4.695e-3	(A) Negative
ENHO	9p13.3	0.57	0.37	0.56	0.75	0.19	2.448e-3	4.696e-3	(A) Negative
CDKN2AIP	4q35.1	-0.16	-0.01	0.48	0.41	-0.15	2.451e-3	4.702e-3	(B) Positive
MAPKAPK3	3p21.2	-0.36	-0.20	0.51	0.47	-0.16	2.453e-3	4.705e-3	(B) Positive
HNRNPR	1p36.12	-0.09	-0.19	0.32	0.31	0.10	2.463e-3	4.723e-3	(A) Negative
TRBV3-1	7q34	-0.98	-1.18	0.62	0.62	0.20	2.463e-3	4.724e-3	(A) Negative
CNP	17q21.2	-0.02	-0.19	0.53	0.49	0.17	2.466e-3	4.729e-3	(A) Negative
ANKRD40	17q21.33	-0.10	0.12	0.69	0.68	-0.22	2.470e-3	4.735e-3	(B) Positive
TCERG1	5q32	-1.26	-1.39	0.41	0.38	0.13	2.474e-3	4.742e-3	(A) Negative
TRIM25	17q22	0.06	-0.07	0.41	0.46	0.14	2.475e-3	4.745e-3	(A) Negative
ALDH16A1	19q13.33	0.02	0.19	0.57	0.51	-0.18	2.479e-3	4.751e-3	(B) Positive
DRD5	4p16.1	-1.70	-2.00	0.94	0.78	0.29	2.482e-3	4.757e-3	(A) Negative
HNRNPH3	10q21.3	-0.86	-0.99	0.42	0.40	0.13	2.484e-3	4.760e-3	(A) Negative
PEX2	8q21.13	0.66	0.85	0.59	0.59	-0.19	2.486e-3	4.763e-3	(B) Positive
CDKN1A	6p21.2	-0.09	0.18	0.87	0.76	-0.27	2.488e-3	4.766e-3	(B) Positive
TRMT5	14q23.1	-0.45	-0.27	0.58	0.48	-0.18	2.489e-3	4.768e-3	(B) Positive
GPATCH4	1q22-q23.1	-0.12	-0.27	0.47	0.44	0.15	2.499e-3	4.786e-3	(A) Negative
PACSIN3	11p11.2	0.14	-0.10	0.77	0.75	0.25	2.501e-3	4.789e-3	(A) Negative
FSCN3	7q32.1	0.36	0.26	0.31	0.28	0.10	2.503e-3	4.793e-3	(A) Negative
TPM2	9p13.3	0.39	0.07	1.02	0.90	0.32	2.512e-3	4.809e-3	(A) Negative
LIG4	13q33.3	-0.08	-0.29	0.69	0.56	0.21	2.519e-3	4.823e-3	(A) Negative
NANOS3	19p13.12	0.45	0.24	0.66	0.59	0.21	2.523e-3	4.831e-3	(A) Negative
KLHL4	Xq21.31	-0.66	-0.48	0.57	0.50	-0.18	2.525e-3	4.833e-3	(B) Positive
ACAP1	17p13.1	0.08	-0.15	0.75	0.63	0.23	2.530e-3	4.842e-3	(A) Negative
SPRY1	4q28.1	0.60	0.88	0.88	0.91	-0.28	2.531e-3	4.843e-3	(B) Positive
RASIP1	19q13.33	-0.90	-1.12	0.71	0.58	0.22	2.539e-3	4.858e-3	(A) Negative
RTP1	3q27.3	-0.12	-0.36	0.82	0.37	0.24	2.539e-3	4.858e-3	(A) Negative
JAKMIP1	4p16.1	-1.45	-1.92	1.41	1.58	0.46	2.541e-3	4.860e-3	(A) Negative
FBXO9	6p12.1	-0.20	-0.05	0.48	0.49	-0.15	2.542e-3	4.863e-3	(B) Positive
CD86	3q13.33	1.97	1.74	0.71	0.80	0.23	2.547e-3	4.871e-3	(A) Negative
LPAR4	Xq21.1	-0.89	-0.65	0.71	0.83	-0.24	2.556e-3	4.887e-3	(B) Positive
SIVA1	14q32.33	0.13	-0.04	0.53	0.49	0.17	2.560e-3	4.895e-3	(A) Negative
DSN1	20q11.23	-0.88	-1.07	0.56	0.69	0.19	2.561e-3	4.896e-3	(A) Negative
CD177	19q13.31	-0.25	0.02	0.78	1.07	-0.27	2.565e-3	4.903e-3	(B) Positive
PSMB5	14q11.2	0.08	-0.07	0.48	0.44	0.15	2.567e-3	4.906e-3	(A) Negative
FPR1	19q13.41	3.43	3.21	0.68	0.70	0.22	2.567e-3	4.906e-3	(A) Negative
LRIG2	1p13.2	-0.55	-0.71	0.53	0.42	0.16	2.571e-3	4.913e-3	(A) Negative
OR2F2	7q35	0.43	0.29	0.43	0.42	0.14	2.574e-3	4.919e-3	(A) Negative
PTAFR	1p35.3	2.14	1.86	0.91	0.75	0.28	2.575e-3	4.920e-3	(A) Negative
CST13P	20p11.21	0.19	0.32	0.40	0.46	-0.13	2.578e-3	4.925e-3	(B) Positive
SPON1	11p15.2	2.66	3.09	1.35	1.35	-0.43	2.580e-3	4.928e-3	(B) Positive
HAL	12q23.1	-2.18	-1.98	0.59	0.81	-0.21	2.581e-3	4.929e-3	(B) Positive
AMMECR1	Xq23	-0.28	-0.48	0.65	0.64	0.21	2.586e-3	4.938e-3	(A) Negative
IL15	4q31.21	1.00	0.62	1.24	0.89	0.37	2.586e-3	4.938e-3	(A) Negative
GNB3	12p13.31	-1.12	-1.25	0.41	0.42	0.13	2.588e-3	4.941e-3	(A) Negative
ANKRD36B	2q11.2	-0.66	-0.93	0.89	0.78	0.28	2.590e-3	4.944e-3	(A) Negative
MRGPRX2	11p15.1	0.32	0.42	0.32	0.34	-0.10	2.593e-3	4.950e-3	(B) Positive
RWDD4	4q35.1	0.10	0.28	0.56	0.54	-0.18	2.594e-3	4.952e-3	(B) Positive
SNAPIN	1q21.3	0.51	0.67	0.51	0.47	-0.16	2.597e-3	4.957e-3	(B) Positive
WFIKKN2	17q21.33	0.26	0.15	0.37	0.33	0.12	2.598e-3	4.958e-3	(A) Negative
UNC13B	9p13.3	0.21	0.40	0.58	0.70	-0.19	2.598e-3	4.958e-3	(B) Positive
MYBBP1A	17p13.2	-0.67	-0.85	0.56	0.47	0.17	2.601e-3	4.963e-3	(A) Negative
ZFC3H1	12q21.1	-0.70	-0.54	0.51	0.52	-0.16	2.604e-3	4.967e-3	(B) Positive
KCNIP3	2q11.1	-0.62	-0.87	0.84	0.59	0.25	2.604e-3	4.968e-3	(A) Negative
ADAMTS18	16q23.1	0.70	1.07	1.15	1.23	-0.37	2.605e-3	4.968e-3	(B) Positive
PSD	10q24.32	-0.08	0.04	0.37	0.35	-0.12	2.608e-3	4.974e-3	(B) Positive
SERP1	3q25.1	0.67	0.88	0.69	0.62	-0.22	2.610e-3	4.977e-3	(B) Positive
HOXC4	12q13.13	-0.01	0.22	0.74	0.68	-0.23	2.615e-3	4.985e-3	(B) Positive
SPATA2L	16q24.3	0.42	0.28	0.42	0.50	0.14	2.617e-3	4.989e-3	(A) Negative
CITED4	1p34.2	1.74	1.33	1.26	1.42	0.42	2.619e-3	4.992e-3	(A) Negative
TJP2	9q21.11	-0.14	-0.33	0.64	0.55	0.20	2.625e-3	5.003e-3	(A) Negative
POLR3A	10q22.3	-0.31	-0.45	0.46	0.43	0.14	2.628e-3	5.009e-3	(A) Negative
MESD	15q25.1	-0.28	-0.13	0.49	0.41	-0.15	2.629e-3	5.009e-3	(B) Positive
CCDC3	10p13	2.50	2.22	0.88	0.82	0.28	2.639e-3	5.029e-3	(A) Negative
LARP6	15q23	-0.87	-1.17	0.94	0.95	0.30	2.646e-3	5.041e-3	(A) Negative
ADAM10	15q21.3	0.12	-0.08	0.67	0.50	0.20	2.648e-3	5.044e-3	(A) Negative
DCTPP1	16p11.2	-0.08	0.12	0.64	0.67	-0.21	2.649e-3	5.046e-3	(B) Positive
ATP5PD	17q25.1	-0.06	0.11	0.56	0.55	-0.18	2.654e-3	5.054e-3	(B) Positive
USP54	10q22.2	0.76	0.58	0.59	0.51	0.18	2.669e-3	5.082e-3	(A) Negative
CNIH1	14q22.2	-0.23	-0.05	0.59	0.48	-0.18	2.672e-3	5.088e-3	(B) Positive
FHL5	6q16.1	1.06	1.28	0.67	0.85	-0.23	2.672e-3	5.088e-3	(B) Positive
SPAG1	8q22.2	0.70	0.97	0.86	0.84	-0.27	2.676e-3	5.094e-3	(B) Positive
NEUROD6	7p14.3	0.21	0.11	0.31	0.37	0.10	2.679e-3	5.099e-3	(A) Negative
TBC1D14	4p16.1	0.03	0.20	0.52	0.53	-0.17	2.680e-3	5.100e-3	(B) Positive
TMEM161A	19p13.11	-0.35	-0.51	0.50	0.48	0.16	2.682e-3	5.104e-3	(A) Negative
UBE2G2	21q22.3	-0.70	-0.86	0.53	0.42	0.16	2.683e-3	5.105e-3	(A) Negative
TMEM42	3p21.31	-0.19	-0.01	0.57	0.58	-0.18	2.685e-3	5.109e-3	(B) Positive
DEGS1	1q42.11	0.31	0.05	0.82	0.90	0.27	2.692e-3	5.122e-3	(A) Negative
HSF4	16q22.1	-1.49	-1.33	0.48	0.56	-0.16	2.700e-3	5.136e-3	(B) Positive
DNM2	19p13.2	-0.16	-0.28	0.35	0.39	0.11	2.705e-3	5.145e-3	(A) Negative
IGSF1	Xq26.1	-2.76	-2.46	0.82	1.32	-0.30	2.712e-3	5.158e-3	(B) Positive
BRD3	9q34.2	0.02	0.24	0.67	0.70	-0.22	2.717e-3	5.167e-3	(B) Positive
PPP2CB	8p12	-0.09	0.12	0.63	0.67	-0.20	2.721e-3	5.173e-3	(B) Positive
URB1-AS1	21q22.11	0.07	-0.14	0.65	0.65	0.21	2.721e-3	5.173e-3	(A) Negative
OR2G3	1q44	0.22	0.36	0.44	0.49	-0.14	2.728e-3	5.186e-3	(B) Positive
PHYH	10p13	0.77	0.60	0.55	0.44	0.17	2.729e-3	5.186e-3	(A) Negative
IL13	5q31.1	0.27	0.14	0.41	0.36	0.13	2.731e-3	5.190e-3	(A) Negative
A4GALT	22q13.2	0.61	0.86	0.81	0.71	-0.25	2.733e-3	5.193e-3	(B) Positive
KCNK16	6p21.2	0.13	0.24	0.32	0.38	-0.11	2.733e-3	5.193e-3	(B) Positive
SCN5A	3p22.2	-0.34	-0.45	0.36	0.30	0.11	2.734e-3	5.195e-3	(A) Negative
OFCC1	6p24.3	0.23	0.01	0.71	0.50	0.21	2.735e-3	5.195e-3	(A) Negative
CYBB	Xp21.1-p11.4	1.28	0.90	1.24	1.01	0.38	2.735e-3	5.195e-3	(A) Negative
LCE3A	1q21.3	-0.16	-0.33	0.55	0.48	0.17	2.739e-3	5.203e-3	(A) Negative
SLC49A3	4p16.3	3.00	3.17	0.54	0.50	-0.17	2.742e-3	5.208e-3	(B) Positive
RAPGEF5	7p15.3	1.68	1.40	0.88	0.75	0.27	2.747e-3	5.217e-3	(A) Negative
CNOT11	2q11.2	-0.31	-0.46	0.50	0.37	0.15	2.749e-3	5.219e-3	(A) Negative
MRE11	11q21	-0.18	-0.28	0.32	0.29	0.10	2.752e-3	5.224e-3	(A) Negative
SIGLEC6	19q13.41	0.16	0.24	0.23	0.32	-0.08	2.752e-3	5.224e-3	(B) Positive
KCTD18	2q33.1	0.61	0.75	0.46	0.42	-0.14	2.756e-3	5.231e-3	(B) Positive
EXOC1	4q12	0.13	0.27	0.46	0.37	-0.14	2.763e-3	5.243e-3	(B) Positive
THOC1	18p11.32	-0.41	-0.60	0.63	0.51	0.19	2.764e-3	5.245e-3	(A) Negative
GPR35	2q37.3	-1.25	-1.42	0.57	0.49	0.18	2.767e-3	5.248e-3	(A) Negative
C9ORF43	9q32	0.31	0.55	0.77	0.74	-0.24	2.767e-3	5.248e-3	(B) Positive
MYBPC1	12q23.2	2.24	1.58	2.07	2.04	0.65	2.767e-3	5.248e-3	(A) Negative
LRFN5	14q21.1	-0.48	-0.23	0.73	0.87	-0.24	2.772e-3	5.258e-3	(B) Positive
SGCE	7q21.3	-0.37	-0.75	1.16	1.31	0.38	2.772e-3	5.258e-3	(A) Negative
ZZEF1	17p13.2	0.10	0.22	0.38	0.40	-0.12	2.774e-3	5.260e-3	(B) Positive
PCSK5	9q21.13	1.16	1.46	0.96	0.96	-0.30	2.774e-3	5.261e-3	(B) Positive
GPATCH2	1q41	0.73	0.95	0.68	0.79	-0.22	2.776e-3	5.263e-3	(B) Positive
LRRC25	19p13.11	2.65	2.40	0.81	0.71	0.25	2.779e-3	5.268e-3	(A) Negative
EEFSEC	3q21.3	-0.46	-0.27	0.62	0.56	-0.19	2.783e-3	5.275e-3	(B) Positive
TTYH2	17q25.1	0.26	0.03	0.73	0.63	0.22	2.788e-3	5.285e-3	(A) Negative
KCNK9	8q24.3	0.55	0.66	0.36	0.39	-0.12	2.795e-3	5.296e-3	(B) Positive
PECR	2q35	-1.27	-1.07	0.64	0.56	-0.20	2.802e-3	5.309e-3	(B) Positive
ARHGEF10L	1p36.13	1.14	0.92	0.73	0.55	0.22	2.806e-3	5.316e-3	(A) Negative
TBL3	16p13.3	-0.41	-0.26	0.46	0.54	-0.15	2.806e-3	5.316e-3	(B) Positive
AACS	12q24.31	0.25	0.46	0.69	0.56	-0.21	2.808e-3	5.320e-3	(B) Positive
ZIK1	19q13.43	-0.80	-1.22	1.40	1.09	0.42	2.813e-3	5.328e-3	(A) Negative
LNPEP	5q15	0.10	0.32	0.73	0.57	-0.22	2.816e-3	5.333e-3	(B) Positive
ITPKB	1q42.12	0.47	0.24	0.78	0.51	0.23	2.818e-3	5.337e-3	(A) Negative
PRB2	12p13.2	0.17	0.03	0.45	0.40	0.14	2.821e-3	5.340e-3	(A) Negative
CAV1	7q31.2	-2.17	-1.92	0.79	0.80	-0.25	2.824e-3	5.346e-3	(B) Positive
GCH1	14q22.2	0.48	0.23	0.85	0.67	0.26	2.825e-3	5.348e-3	(A) Negative
PPP2R5C	14q32.31	-0.05	-0.17	0.39	0.34	0.12	2.829e-3	5.355e-3	(A) Negative
SLC35F5	2q14.1	0.33	0.54	0.69	0.53	-0.21	2.830e-3	5.355e-3	(B) Positive
SLC35D3	6q23.3	0.24	0.31	0.18	0.23	-0.06	2.844e-3	5.382e-3	(B) Positive
HMGN4	6p22.2	-0.05	-0.30	0.84	0.49	0.25	2.853e-3	5.398e-3	(A) Negative
PARN	16p13.12	0.17	0.30	0.44	0.40	-0.14	2.853e-3	5.398e-3	(B) Positive
FKBP11	12q13.12	-0.50	-0.80	0.96	0.85	0.30	2.854e-3	5.398e-3	(A) Negative
CCDC7	10p11.22	0.92	1.18	0.84	0.75	-0.26	2.854e-3	5.399e-3	(B) Positive
SCGB3A2	5q32	-1.19	-1.44	0.85	0.56	0.25	2.856e-3	5.402e-3	(A) Negative
UBB	17p11.2	0.16	0.30	0.44	0.39	-0.14	2.876e-3	5.439e-3	(B) Positive
RPS17	15q25.2	-0.72	-0.89	0.57	0.50	0.17	2.878e-3	5.441e-3	(A) Negative
CCR2	3p21.31	-0.63	-1.08	1.45	1.25	0.44	2.879e-3	5.443e-3	(A) Negative
VAMP3	1p36.23	-0.28	-0.11	0.56	0.45	-0.17	2.891e-3	5.465e-3	(B) Positive
PRPSAP1	17q25.1	-0.17	-0.39	0.73	0.54	0.22	2.891e-3	5.465e-3	(A) Negative
ZBED5	11p15.4	-0.66	-0.48	0.60	0.52	-0.18	2.893e-3	5.469e-3	(B) Positive
BEST3	12q15	-1.38	-1.21	0.50	0.57	-0.16	2.894e-3	5.469e-3	(B) Positive
SRXN1	20p13	-0.12	0.09	0.68	0.50	-0.20	2.895e-3	5.471e-3	(B) Positive
C18ORF54	18q21.2	-0.84	-1.08	0.71	0.82	0.23	2.913e-3	5.504e-3	(A) Negative
TMEM176B	7q36.1	3.49	3.32	0.50	0.56	0.16	2.913e-3	5.504e-3	(A) Negative
SFT2D1	6q27	0.08	-0.08	0.52	0.49	0.16	2.933e-3	5.540e-3	(A) Negative
GEMIN5	5q33.2	-0.40	-0.25	0.48	0.38	-0.14	2.936e-3	5.545e-3	(B) Positive
PEBP1	12q24.23	0.59	0.77	0.58	0.51	-0.18	2.949e-3	5.570e-3	(B) Positive
NAT9	17q25.2	-0.30	-0.47	0.54	0.53	0.17	2.950e-3	5.571e-3	(A) Negative
NIBAN1	1q25.3	0.70	1.06	1.05	1.34	-0.35	2.957e-3	5.583e-3	(B) Positive
GADD45B	19p13.3	1.04	1.29	0.80	0.76	-0.25	2.976e-3	5.619e-3	(B) Positive
HAUS5	19q13.12	-0.57	-0.78	0.68	0.55	0.21	2.980e-3	5.626e-3	(A) Negative
HNRNPUL2	11q12.3	0.49	0.32	0.53	0.48	0.16	2.982e-3	5.630e-3	(A) Negative
FAM111A	11q12.1	-0.45	-0.25	0.65	0.64	-0.20	2.994e-3	5.651e-3	(B) Positive
VPS13D	1p36.22-p36.21	0.56	0.70	0.49	0.36	-0.15	3.003e-3	5.667e-3	(B) Positive
SPG21	15q22.31	0.27	0.15	0.38	0.36	0.12	3.008e-3	5.676e-3	(A) Negative
WFDC12	20q13.12	0.35	0.17	0.60	0.56	0.19	3.008e-3	5.676e-3	(A) Negative
PNLDC1	6q25.3	0.91	0.56	1.19	0.86	0.35	3.009e-3	5.677e-3	(A) Negative
FILIP1L	3q12.1	0.84	1.10	0.84	0.79	-0.26	3.010e-3	5.677e-3	(B) Positive
SLC16A4	1p13.3	-0.17	0.10	0.85	0.91	-0.27	3.017e-3	5.690e-3	(B) Positive
NDUFB3	2q33.1	-0.03	-0.19	0.53	0.44	0.16	3.025e-3	5.706e-3	(A) Negative
USP33	1p31.1	0.15	0.29	0.49	0.43	-0.15	3.038e-3	5.728e-3	(B) Positive
DEFB103A	8p23.1	-0.19	-0.51	1.10	0.59	0.32	3.042e-3	5.737e-3	(A) Negative
GTSF1L	20q13.12	0.38	0.24	0.44	0.46	0.14	3.044e-3	5.738e-3	(A) Negative
BRPF1	3p25.3	0.04	-0.09	0.45	0.41	0.14	3.047e-3	5.743e-3	(A) Negative
CYP27A1	2q35	-0.10	-0.37	0.82	0.93	0.27	3.049e-3	5.748e-3	(A) Negative
MLF1	3q25.32	1.26	0.96	0.98	0.85	0.30	3.053e-3	5.753e-3	(A) Negative
CASP4	11q22.3	0.19	-0.05	0.77	0.73	0.24	3.055e-3	5.758e-3	(A) Negative
ABLIM2	4p16.1	1.02	1.27	0.82	0.74	-0.25	3.058e-3	5.762e-3	(B) Positive
FRZB	2q32.1	2.76	3.12	1.20	0.86	-0.36	3.059e-3	5.763e-3	(B) Positive
MRPL13	8q24.12	0.05	-0.16	0.65	0.74	0.21	3.060e-3	5.765e-3	(A) Negative
SNX27	1q21.3	0.69	0.85	0.53	0.52	-0.17	3.063e-3	5.769e-3	(B) Positive
CFAP100	3q21.3	-0.86	-1.11	0.86	0.56	0.25	3.065e-3	5.773e-3	(A) Negative
PAPSS2	10q23.2-q23.31	1.28	0.88	1.28	1.33	0.40	3.065e-3	5.773e-3	(A) Negative
RP1L1	8p23.1	0.15	0.05	0.35	0.29	0.11	3.068e-3	5.778e-3	(A) Negative
GRHPR	9p13.2	0.23	0.38	0.49	0.44	-0.15	3.071e-3	5.781e-3	(B) Positive
RSPH3	6q25.3	0.96	1.16	0.61	0.59	-0.19	3.074e-3	5.787e-3	(B) Positive
PTHLH	12p11.22	0.86	1.26	1.26	1.41	-0.41	3.078e-3	5.793e-3	(B) Positive
KIAA0930	22q13.31	0.43	0.59	0.55	0.42	-0.16	3.081e-3	5.799e-3	(B) Positive
EYA2	20q13.12	2.70	2.25	1.44	1.49	0.45	3.089e-3	5.813e-3	(A) Negative
QRICH2	17q25.1	0.01	-0.22	0.75	0.54	0.22	3.113e-3	5.858e-3	(A) Negative
GPR78	4p16.1	1.35	1.09	0.84	0.76	0.26	3.119e-3	5.869e-3	(A) Negative
DCAF17	2q31.1	0.54	0.37	0.55	0.51	0.17	3.143e-3	5.912e-3	(A) Negative
URM1	9q34.11	-0.44	-0.31	0.42	0.36	-0.13	3.160e-3	5.945e-3	(B) Positive
HGSNAT	8p11.21-p11.1	1.00	1.20	0.65	0.59	-0.20	3.165e-3	5.954e-3	(B) Positive
MON1A	3p21.31	-0.04	-0.18	0.48	0.40	0.14	3.167e-3	5.955e-3	(A) Negative
PCOLCE	7q22.1	-0.80	-0.54	0.82	0.84	-0.26	3.167e-3	5.956e-3	(B) Positive
ADAMTS6	5q12.3	-0.40	-0.19	0.66	0.61	-0.20	3.168e-3	5.957e-3	(B) Positive
GNAI3	1p13.3	0.22	0.07	0.49	0.41	0.15	3.172e-3	5.964e-3	(A) Negative
GNAI2	3p21.31	-0.13	0.06	0.63	0.61	-0.20	3.175e-3	5.970e-3	(B) Positive
KCNQ2	20q13.33	-1.19	-1.37	0.62	0.43	0.18	3.176e-3	5.970e-3	(A) Negative
IHO1	3p21.31	-0.78	-0.65	0.42	0.45	-0.13	3.185e-3	5.986e-3	(B) Positive
TRAT1	3q13.13	-0.61	-1.08	1.51	1.39	0.46	3.187e-3	5.990e-3	(A) Negative
PEPD	19q13.11	0.25	0.07	0.57	0.53	0.18	3.192e-3	5.998e-3	(A) Negative
MSI2	17q22	-0.24	0.01	0.83	0.76	-0.25	3.194e-3	6.001e-3	(B) Positive
NDUFB1	14q31.3	0.04	0.26	0.71	0.61	-0.22	3.196e-3	6.004e-3	(B) Positive
MARVELD3	16q22.2	2.44	2.23	0.69	0.70	0.22	3.197e-3	6.006e-3	(A) Negative
TBRG1	11q24.2	-0.85	-0.70	0.48	0.46	-0.15	3.198e-3	6.007e-3	(B) Positive
ZKSCAN4	6p22.1	0.13	0.26	0.46	0.35	-0.14	3.199e-3	6.008e-3	(B) Positive
MCTS1	Xq24	-0.36	-0.52	0.56	0.42	0.17	3.201e-3	6.010e-3	(A) Negative
ARFRP1	20q13.33	-0.49	-0.64	0.47	0.53	0.15	3.202e-3	6.012e-3	(A) Negative
ATR	3q23	-0.08	-0.21	0.46	0.35	0.14	3.205e-3	6.016e-3	(A) Negative
PSMC4	19q13.11-q13.13	-0.01	-0.16	0.50	0.42	0.15	3.205e-3	6.016e-3	(A) Negative
SLC50A1	1q22	0.65	0.86	0.66	0.68	-0.21	3.206e-3	6.017e-3	(B) Positive
MZT1	13q21.33	-0.92	-1.11	0.62	0.56	0.19	3.215e-3	6.035e-3	(A) Negative
NOS2	17q11.2	0.60	0.35	0.83	0.70	0.25	3.228e-3	6.058e-3	(A) Negative
CCDC120	Xp11.23	0.57	0.47	0.33	0.25	0.10	3.229e-3	6.059e-3	(A) Negative
KHDRBS1	1p35.2	0.14	0.06	0.29	0.24	0.09	3.229e-3	6.059e-3	(A) Negative
TELO2	16p13.3	-0.41	-0.25	0.50	0.50	-0.16	3.230e-3	6.059e-3	(B) Positive
CUL4B	Xq24	0.20	0.07	0.46	0.32	0.14	3.230e-3	6.059e-3	(A) Negative
SNRPE	1q32.1	-0.33	-0.51	0.56	0.57	0.18	3.243e-3	6.083e-3	(A) Negative
LRCH3	3q29	0.10	-0.02	0.37	0.30	0.11	3.245e-3	6.085e-3	(A) Negative
DDX31	9q34.13	-0.39	-0.53	0.47	0.40	0.14	3.245e-3	6.085e-3	(A) Negative
QPRT	16p11.2	-1.66	-2.00	1.09	1.05	0.34	3.246e-3	6.086e-3	(A) Negative
HAPLN4	19p13.11	-0.12	-0.21	0.28	0.24	0.08	3.253e-3	6.099e-3	(A) Negative
PAX2	10q24.31	0.05	-0.10	0.42	0.58	0.14	3.254e-3	6.101e-3	(A) Negative
PYCR3	8q24.3	0.53	0.73	0.61	0.69	-0.20	3.256e-3	6.103e-3	(B) Positive
RASGRP2	11q13.1	0.10	-0.21	1.04	0.87	0.32	3.257e-3	6.103e-3	(A) Negative
SETD2	3p21.31	0.19	0.34	0.49	0.47	-0.15	3.260e-3	6.109e-3	(B) Positive
LINC00189	21q21.3	-1.00	-1.17	0.51	0.56	0.16	3.267e-3	6.121e-3	(A) Negative
GBP4	1p22.2	3.71	3.36	1.14	1.09	0.35	3.276e-3	6.137e-3	(A) Negative
ENTPD2	9q34.3	0.90	0.66	0.78	0.64	0.24	3.278e-3	6.141e-3	(A) Negative
ARHGAP25	2p13.3	1.35	1.15	0.65	0.61	0.20	3.278e-3	6.141e-3	(A) Negative
ATRAID	2p23.3	-0.13	0.02	0.50	0.38	-0.15	3.289e-3	6.160e-3	(B) Positive
RALB	2q14.2	0.54	0.75	0.71	0.53	-0.21	3.290e-3	6.161e-3	(B) Positive
NIN	14q22.1	0.21	0.09	0.38	0.38	0.12	3.292e-3	6.165e-3	(A) Negative
MSANTD4	11q22.3	-0.20	-0.41	0.66	0.68	0.21	3.293e-3	6.165e-3	(A) Negative
EDNRB	13q22.3	-1.50	-1.17	1.11	0.92	-0.33	3.293e-3	6.165e-3	(B) Positive
CSPG4P1Y	Yq11.23	-0.27	-0.36	0.29	0.28	0.09	3.293e-3	6.165e-3	(A) Negative
VPS29	12q24.11	-0.15	0.01	0.51	0.43	-0.15	3.304e-3	6.184e-3	(B) Positive
LRRTM2	5q31.2	-0.14	-0.02	0.38	0.38	-0.12	3.311e-3	6.197e-3	(B) Positive
TPT1P8	8p11.23	0.58	0.76	0.57	0.60	-0.18	3.315e-3	6.204e-3	(B) Positive
PPFIA2	12q21.31	0.12	0.34	0.71	0.72	-0.22	3.317e-3	6.207e-3	(B) Positive
RAD18	3p25.3	-0.37	-0.58	0.69	0.56	0.21	3.320e-3	6.212e-3	(A) Negative
KLK13	19q13.41	-0.40	-0.78	1.23	1.09	0.37	3.338e-3	6.243e-3	(A) Negative
PTGS1	9q33.2	-1.30	-1.03	0.85	0.83	-0.26	3.338e-3	6.243e-3	(B) Positive
HBQ1	16p13.3	-2.06	-2.24	0.55	0.58	0.17	3.338e-3	6.243e-3	(A) Negative
FYTTD1	3q29	0.21	0.04	0.57	0.44	0.17	3.344e-3	6.252e-3	(A) Negative
IPCEF1	6q25.2	0.69	0.40	0.98	0.73	0.29	3.344e-3	6.252e-3	(A) Negative
MLYCD	16q23.3	0.03	0.19	0.51	0.55	-0.16	3.350e-3	6.263e-3	(B) Positive
PPP6R3	11q13	0.29	0.44	0.44	0.55	-0.14	3.351e-3	6.264e-3	(B) Positive
NEMF	14q21.3	-0.15	-0.02	0.40	0.38	-0.12	3.354e-3	6.269e-3	(B) Positive
CDKN2D	19p13.2	0.26	0.03	0.73	0.68	0.22	3.354e-3	6.269e-3	(A) Negative
CNGB1	16q21	0.10	0.03	0.24	0.23	0.07	3.357e-3	6.273e-3	(A) Negative
NOTCH2	1p12	0.64	0.46	0.58	0.56	0.18	3.357e-3	6.273e-3	(A) Negative
ITGB1	10p11.22	0.49	0.29	0.66	0.51	0.20	3.358e-3	6.275e-3	(A) Negative
INTS1	7p22.3	-0.38	-0.53	0.49	0.41	0.15	3.363e-3	6.282e-3	(A) Negative
F2	11p11.2	-3.70	-3.81	0.37	0.34	0.11	3.374e-3	6.303e-3	(A) Negative
ZAR1	4p11	-0.63	-0.83	0.65	0.54	0.20	3.378e-3	6.310e-3	(A) Negative
TNFRSF19	13q12.12	-1.97	-1.61	1.19	1.09	-0.36	3.388e-3	6.327e-3	(B) Positive
TULP4	6q25.3	1.22	1.40	0.59	0.59	-0.18	3.393e-3	6.336e-3	(B) Positive
CNST	1q44	-0.16	-0.03	0.44	0.45	-0.14	3.394e-3	6.338e-3	(B) Positive
HRH1	3p25.3	-0.34	-0.62	0.90	0.85	0.28	3.396e-3	6.340e-3	(A) Negative
UBE2D2	5q31.2	-0.14	-0.02	0.43	0.34	-0.13	3.405e-3	6.356e-3	(B) Positive
ITPR2	12p11.23	0.32	0.64	1.01	1.05	-0.32	3.409e-3	6.363e-3	(B) Positive
CHL1	3p26.3	1.08	1.41	1.03	1.20	-0.33	3.423e-3	6.389e-3	(B) Positive
KRT38	17q21.2	0.62	0.46	0.52	0.44	0.16	3.431e-3	6.403e-3	(A) Negative
PRELID2	5q32	-0.84	-0.62	0.73	0.66	-0.22	3.445e-3	6.428e-3	(B) Positive
COL4A1	13q34	2.34	2.16	0.58	0.62	0.18	3.449e-3	6.435e-3	(A) Negative
PHF20L1	8q24.22	0.53	0.34	0.65	0.57	0.20	3.453e-3	6.443e-3	(A) Negative
KDSR	18q21.33	0.41	0.56	0.48	0.39	-0.14	3.458e-3	6.450e-3	(B) Positive
SQLE	8q24.13	-0.49	-0.82	1.06	1.11	0.33	3.464e-3	6.461e-3	(A) Negative
HLA-DPB2	6p21.32	-0.34	-0.73	1.32	0.99	0.39	3.469e-3	6.470e-3	(A) Negative
NIBAN2	9q34.11	0.43	0.27	0.52	0.47	0.16	3.478e-3	6.486e-3	(A) Negative
ZNF761	19q13.42	0.13	0.30	0.54	0.51	-0.17	3.483e-3	6.494e-3	(B) Positive
ATP5F1A	18q21.1	-0.36	-0.18	0.58	0.56	-0.18	3.489e-3	6.505e-3	(B) Positive
TBC1D25	Xp11.23	0.02	0.19	0.54	0.54	-0.17	3.511e-3	6.546e-3	(B) Positive
PRSS36	16p11.2	-0.30	0.07	1.24	1.06	-0.37	3.515e-3	6.552e-3	(B) Positive
FRK	6q22.1	1.80	1.46	1.13	1.01	0.34	3.527e-3	6.573e-3	(A) Negative
LOC389199	4p16.1	0.98	0.75	0.74	0.76	0.23	3.531e-3	6.580e-3	(A) Negative
HOXA4	7p15.2	-1.01	-1.42	1.39	0.97	0.41	3.534e-3	6.584e-3	(A) Negative
BRWD3	Xq21.1	0.02	-0.20	0.70	0.64	0.21	3.534e-3	6.584e-3	(A) Negative
PUDP	Xp22.31	-0.51	-0.31	0.68	0.55	-0.20	3.539e-3	6.594e-3	(B) Positive
NKAPD1	11q23.1	0.08	-0.12	0.66	0.58	0.20	3.541e-3	6.596e-3	(A) Negative
EPHA7	6q16.1	0.12	-0.16	0.98	0.59	0.28	3.546e-3	6.604e-3	(A) Negative
NT5M	17p11.2	-0.62	-0.40	0.70	0.69	-0.22	3.550e-3	6.611e-3	(B) Positive
RBAKDN	7p22.1	0.16	-0.21	1.27	1.03	0.38	3.550e-3	6.611e-3	(A) Negative
NDUFB8	10q24.31	-0.38	-0.25	0.43	0.39	-0.13	3.553e-3	6.615e-3	(B) Positive
CACNG6	19q13.42	-1.32	-1.01	0.86	1.31	-0.30	3.555e-3	6.619e-3	(B) Positive
RASGRP4	19q13.2	0.39	0.49	0.34	0.32	-0.10	3.562e-3	6.631e-3	(B) Positive
KLF13	15q13.3	0.46	0.27	0.63	0.56	0.19	3.564e-3	6.633e-3	(A) Negative
MAB21L4	2q37.3	1.79	1.21	1.86	1.92	0.58	3.567e-3	6.639e-3	(A) Negative
H3C12	6p22.1	0.85	0.68	0.58	0.52	0.17	3.576e-3	6.654e-3	(A) Negative
ZMYM1	1p34.3	-0.25	-0.41	0.53	0.38	0.16	3.582e-3	6.664e-3	(A) Negative
GCA	2q24.2	0.81	0.61	0.66	0.68	0.20	3.582e-3	6.664e-3	(A) Negative
EXOC8	1q42.2	0.66	0.81	0.49	0.47	-0.15	3.584e-3	6.669e-3	(B) Positive
COBL	7p12.1	0.48	0.23	0.84	0.68	0.25	3.591e-3	6.680e-3	(A) Negative
HMGN2P46	15q21.1	-0.46	-0.28	0.62	0.51	-0.18	3.598e-3	6.692e-3	(B) Positive
TENT4B	16q12.1	0.06	0.26	0.62	0.75	-0.20	3.599e-3	6.694e-3	(B) Positive
WASF2	1p36.11	-0.84	-1.03	0.60	0.60	0.19	3.603e-3	6.700e-3	(A) Negative
CLEC4F	2p13.3	0.55	0.31	0.79	0.62	0.23	3.607e-3	6.707e-3	(A) Negative
ZNF569	19q13.12	0.05	-0.15	0.68	0.58	0.20	3.609e-3	6.709e-3	(A) Negative
NEFM	8p21.2	-2.17	-1.89	0.88	0.99	-0.28	3.610e-3	6.711e-3	(B) Positive
TOP3A	17p11.2	-0.46	-0.61	0.47	0.44	0.14	3.611e-3	6.713e-3	(A) Negative
YWHAH	22q12.3	0.71	0.54	0.57	0.58	0.18	3.617e-3	6.723e-3	(A) Negative
DEDD2	19q13.2	0.27	0.41	0.45	0.43	-0.14	3.625e-3	6.737e-3	(B) Positive
SLA	8q24.22	1.87	1.63	0.77	0.76	0.24	3.630e-3	6.746e-3	(A) Negative
NEURL2	20q13.12	-0.31	-0.16	0.47	0.55	-0.15	3.631e-3	6.747e-3	(B) Positive
CASP1	11q22.3	0.97	0.63	1.13	1.05	0.34	3.633e-3	6.750e-3	(A) Negative
RIN1	11q13.2	-1.69	-1.52	0.54	0.63	-0.17	3.635e-3	6.752e-3	(B) Positive
CCDC80	3q13.2	1.55	1.86	1.00	1.05	-0.31	3.645e-3	6.770e-3	(B) Positive
XXYLT1	3q29	-0.22	-0.42	0.67	0.45	0.19	3.662e-3	6.801e-3	(A) Negative
HELZ	17q24.2	0.18	0.34	0.53	0.51	-0.16	3.663e-3	6.802e-3	(B) Positive
GOSR1	17q11.2	0.37	0.48	0.35	0.36	-0.11	3.666e-3	6.807e-3	(B) Positive
AP5M1	14q22.3	0.20	0.37	0.57	0.42	-0.17	3.668e-3	6.809e-3	(B) Positive
MRPL38	17q25.1	0.18	0.04	0.44	0.47	0.14	3.669e-3	6.812e-3	(A) Negative
VSIR	10q22.1	1.74	1.52	0.77	0.62	0.23	3.676e-3	6.823e-3	(A) Negative
CHRM5	15q14	0.26	0.16	0.33	0.35	0.10	3.680e-3	6.831e-3	(A) Negative
HMHB1	5q31.3	0.27	0.18	0.30	0.26	0.09	3.690e-3	6.848e-3	(A) Negative
ITGB2	21q22.3	1.78	1.51	0.91	0.87	0.28	3.707e-3	6.879e-3	(A) Negative
EMC6	17p13.2	-0.25	-0.38	0.42	0.42	0.13	3.708e-3	6.880e-3	(A) Negative
SSUH2	3p25.3	-2.84	-2.62	0.73	0.74	-0.23	3.717e-3	6.896e-3	(B) Positive
TMEM106C	12q13.11	-0.46	-0.23	0.75	0.70	-0.23	3.720e-3	6.901e-3	(B) Positive
RBMX2	Xq26.1	0.12	-0.01	0.45	0.34	0.13	3.721e-3	6.902e-3	(A) Negative
PCCB	3q22.3	-0.49	-0.29	0.67	0.67	-0.20	3.723e-3	6.904e-3	(B) Positive
TSPAN3	15q24.3	-0.19	0.05	0.79	0.79	-0.24	3.725e-3	6.908e-3	(B) Positive
ADAM29	4q34.1	0.29	0.39	0.32	0.37	-0.10	3.728e-3	6.912e-3	(B) Positive
HSDL1	16q24.1	-0.47	-0.28	0.61	0.61	-0.19	3.741e-3	6.937e-3	(B) Positive
PIDD1	11p15.5	-1.30	-1.14	0.53	0.52	-0.16	3.747e-3	6.946e-3	(B) Positive
PCNT	21q22.3	-0.47	-0.66	0.62	0.56	0.19	3.779e-3	7.005e-3	(A) Negative
KRT25	17q21.2	0.06	-0.08	0.41	0.59	0.14	3.786e-3	7.017e-3	(A) Negative
ZNF780B	19q13.2	0.03	0.24	0.73	0.60	-0.22	3.793e-3	7.029e-3	(B) Positive
SP140	2q37.1	0.86	0.57	0.96	0.81	0.29	3.799e-3	7.040e-3	(A) Negative
TULP3	12p13.33	-0.54	-0.75	0.72	0.45	0.21	3.806e-3	7.051e-3	(A) Negative
ACSS2	20q11.22	-0.47	-0.65	0.64	0.44	0.19	3.808e-3	7.054e-3	(A) Negative
MED12L	3q25.1	-0.81	-0.60	0.67	0.63	-0.20	3.808e-3	7.054e-3	(B) Positive
CDK15	2q33.1	0.33	0.45	0.37	0.45	-0.12	3.811e-3	7.058e-3	(B) Positive
NEPRO	3q13.2	-0.08	-0.19	0.38	0.27	0.11	3.811e-3	7.059e-3	(A) Negative
RNF114	20q13.13	-0.14	-0.31	0.58	0.56	0.18	3.824e-3	7.082e-3	(A) Negative
ZFP36L2	2p21	1.39	1.07	1.04	1.03	0.32	3.831e-3	7.094e-3	(A) Negative
TRUB2	9q34.11	-0.27	-0.09	0.59	0.48	-0.17	3.832e-3	7.094e-3	(B) Positive
MYH1	17p13.1	0.38	0.62	0.69	0.93	-0.23	3.840e-3	7.108e-3	(B) Positive
COX5B	2q11.2	-0.01	-0.17	0.56	0.38	0.16	3.842e-3	7.112e-3	(A) Negative
ZBTB3	11q12.3	0.17	0.28	0.36	0.38	-0.11	3.848e-3	7.122e-3	(B) Positive
ISM2	14q24.3	-2.62	-2.75	0.41	0.41	0.13	3.849e-3	7.124e-3	(A) Negative
CENPH	5q13.2	-2.36	-2.56	0.65	0.71	0.20	3.853e-3	7.129e-3	(A) Negative
SLC11A1	2q35	1.59	1.37	0.71	0.65	0.21	3.856e-3	7.134e-3	(A) Negative
VPS9D1	16q24.3	0.07	-0.06	0.47	0.37	0.14	3.856e-3	7.134e-3	(A) Negative
CLDN19	1p34.2	-0.66	-0.42	0.72	1.04	-0.25	3.863e-3	7.146e-3	(B) Positive
BRD1	22q13.33	0.43	0.27	0.50	0.48	0.15	3.875e-3	7.168e-3	(A) Negative
ZBTB44	11q24.3	0.30	0.13	0.56	0.51	0.17	3.877e-3	7.169e-3	(A) Negative
MYCL	1p34.2	-0.03	-0.27	0.76	0.85	0.24	3.889e-3	7.191e-3	(A) Negative
GBP3	1p22.2	1.06	1.48	1.37	1.32	-0.42	3.889e-3	7.191e-3	(B) Positive
PHF11	13q14.2	1.37	1.57	0.68	0.54	-0.20	3.890e-3	7.191e-3	(B) Positive
MEIS2	15q14	-1.33	-1.66	1.15	0.82	0.33	3.896e-3	7.202e-3	(A) Negative
CEACAM3	19q13.2	0.57	0.92	1.15	1.17	-0.35	3.904e-3	7.216e-3	(B) Positive
ZNF493	19p12	-0.43	-0.25	0.63	0.51	-0.18	3.906e-3	7.220e-3	(B) Positive
SAMD3	6q23.1	2.16	1.77	1.31	1.16	0.39	3.910e-3	7.226e-3	(A) Negative
TNFSF4	1q25.1	0.79	1.08	0.94	1.01	-0.29	3.911e-3	7.227e-3	(B) Positive
KLHL11	17q21.2	0.23	0.43	0.62	0.64	-0.19	3.917e-3	7.237e-3	(B) Positive
KIAA1217	10p12.2-p12.1	2.25	2.46	0.68	0.64	-0.21	3.934e-3	7.267e-3	(B) Positive
DUSP19	2q32.1	-0.26	-0.42	0.55	0.47	0.16	3.934e-3	7.267e-3	(A) Negative
ELF4	Xq26.1	0.38	0.22	0.59	0.36	0.17	3.936e-3	7.270e-3	(A) Negative
RWDD2A	6q14.1	0.16	0.34	0.57	0.64	-0.18	3.939e-3	7.274e-3	(B) Positive
ETV2	19q13.12	0.16	0.28	0.42	0.36	-0.12	3.944e-3	7.283e-3	(B) Positive
CCR7	17q21.2	2.93	2.47	1.52	1.43	0.46	3.945e-3	7.284e-3	(A) Negative
FAM215A	17q21.31	-0.59	-0.48	0.36	0.39	-0.11	3.954e-3	7.301e-3	(B) Positive
PFDN6	6p21.32	-1.03	-1.24	0.70	0.71	0.22	3.965e-3	7.319e-3	(A) Negative
SLC16A11	17p13.1	0.48	0.56	0.25	0.37	-0.09	3.973e-3	7.333e-3	(B) Positive
CAV2	7q31.2	-0.25	-0.54	0.98	0.92	0.30	3.979e-3	7.343e-3	(A) Negative
DUSP12	1q23.3	-0.75	-0.93	0.63	0.53	0.19	3.984e-3	7.352e-3	(A) Negative
TEX101	19q13.31	0.42	0.17	0.88	0.51	0.25	3.986e-3	7.355e-3	(A) Negative
RNASE1	14q11.2	3.44	3.27	0.56	0.56	0.17	3.987e-3	7.355e-3	(A) Negative
VSTM2L	20q11.23	1.61	1.17	1.47	1.43	0.45	3.990e-3	7.362e-3	(A) Negative
UBL5	19p13.2	0.06	0.20	0.48	0.43	-0.14	3.996e-3	7.371e-3	(B) Positive
GPR12	13q12.13	0.83	0.72	0.38	0.33	0.11	3.999e-3	7.375e-3	(A) Negative
SPRR1B	1q21.3	-1.07	-1.52	1.58	1.12	0.45	4.002e-3	7.380e-3	(A) Negative
LIN28B	6q16.3-q21	-3.35	-3.66	1.08	0.79	0.31	4.005e-3	7.385e-3	(A) Negative
CAPZA3	12p12.3	0.64	0.40	0.81	0.70	0.24	4.011e-3	7.396e-3	(A) Negative
SYT3	19q13.33	-0.57	-0.76	0.64	0.58	0.19	4.019e-3	7.410e-3	(A) Negative
ESAM	11q24.2	2.15	2.31	0.52	0.47	-0.16	4.042e-3	7.451e-3	(B) Positive
TTN	2q31.2	-1.03	-1.25	0.74	0.74	0.22	4.043e-3	7.453e-3	(A) Negative
ZNF229	19q13.31	0.16	-0.25	1.36	1.35	0.41	4.050e-3	7.464e-3	(A) Negative
CA10	17q21.33-q22	0.28	-0.07	1.20	0.93	0.35	4.058e-3	7.478e-3	(A) Negative
SCN1A	2q24.3	-0.40	-0.61	0.68	0.64	0.20	4.059e-3	7.479e-3	(A) Negative
PLSCR2	3q24	0.61	0.46	0.50	0.44	0.15	4.061e-3	7.482e-3	(A) Negative
PDCL3	2q11.2	0.56	0.41	0.54	0.39	0.16	4.063e-3	7.484e-3	(A) Negative
MAP2K7	19p13.2	-0.00	-0.12	0.41	0.36	0.12	4.063e-3	7.484e-3	(A) Negative
PHF12	17q11.2	0.29	0.40	0.36	0.34	-0.11	4.064e-3	7.486e-3	(B) Positive
DUOX2	15q21.1	0.74	0.59	0.51	0.45	0.15	4.065e-3	7.486e-3	(A) Negative
RAP1BL	5q13.3	-0.53	-0.30	0.77	0.69	-0.23	4.066e-3	7.487e-3	(B) Positive
SLC15A4	12q24.33	0.12	0.00	0.40	0.37	0.12	4.075e-3	7.504e-3	(A) Negative
DYRK1A	21q22.13	0.52	0.41	0.38	0.28	0.11	4.081e-3	7.513e-3	(A) Negative
CNTROB	17p13.1	-0.27	-0.17	0.32	0.37	-0.10	4.081e-3	7.513e-3	(B) Positive
ADCY2	5p15.31	0.72	0.33	1.31	1.12	0.39	4.082e-3	7.514e-3	(A) Negative
EPHX4	1p22.1	0.83	0.35	1.60	1.60	0.49	4.114e-3	7.572e-3	(A) Negative
UNG	12q24.11	-0.18	-0.37	0.66	0.53	0.19	4.115e-3	7.572e-3	(A) Negative
OLA1	2q31.1	-0.67	-0.49	0.62	0.57	-0.18	4.117e-3	7.575e-3	(B) Positive
TPD52L2	20q13.33	-0.61	-0.77	0.53	0.53	0.16	4.119e-3	7.578e-3	(A) Negative
UCMA	10p13	0.35	0.17	0.64	0.42	0.18	4.119e-3	7.578e-3	(A) Negative
ASB16	17q21.31	0.26	0.35	0.26	0.33	-0.08	4.125e-3	7.588e-3	(B) Positive
DOP1A	6q14.1	1.42	1.26	0.55	0.51	0.16	4.127e-3	7.590e-3	(A) Negative
KDM3A	2p11.2	-0.63	-0.78	0.51	0.43	0.15	4.127e-3	7.590e-3	(A) Negative
PAPPA	9q33.1	-1.11	-1.30	0.64	0.51	0.19	4.135e-3	7.604e-3	(A) Negative
MON1B	16q23.1	0.32	0.21	0.36	0.39	0.11	4.143e-3	7.617e-3	(A) Negative
CTAGE7P	10q26.3	0.22	0.38	0.53	0.44	-0.16	4.147e-3	7.625e-3	(B) Positive
CDK12	17q12	0.33	0.08	0.84	0.69	0.25	4.162e-3	7.651e-3	(A) Negative
PRPS1	Xq22.3	-1.85	-2.05	0.63	0.69	0.20	4.170e-3	7.666e-3	(A) Negative
USP48	1p36.12	-0.45	-0.57	0.44	0.35	0.13	4.173e-3	7.669e-3	(A) Negative
ZNF223	19q13.31	0.14	0.32	0.61	0.50	-0.18	4.199e-3	7.717e-3	(B) Positive
SPEN	1p36.21-p36.13	0.01	-0.10	0.35	0.34	0.10	4.204e-3	7.725e-3	(A) Negative
CCND3	6p21.1	-0.62	-0.76	0.46	0.42	0.14	4.206e-3	7.727e-3	(A) Negative
IQCE	7p22.3	0.34	0.48	0.49	0.36	-0.14	4.211e-3	7.736e-3	(B) Positive
DENND4C	9p22.1	0.31	0.48	0.59	0.47	-0.17	4.225e-3	7.762e-3	(B) Positive
SMAD5-AS1	5q31.1	0.22	0.03	0.68	0.49	0.19	4.230e-3	7.770e-3	(A) Negative
NR2C2AP	19p13.11	0.21	0.05	0.54	0.45	0.16	4.231e-3	7.770e-3	(A) Negative
ZNF502	3p21.31	1.21	0.89	1.06	1.05	0.32	4.231e-3	7.770e-3	(A) Negative
MPP3	17q21.31	-0.66	-0.34	1.06	0.93	-0.31	4.247e-3	7.797e-3	(B) Positive
ADCY4	14q12	3.35	3.54	0.65	0.58	-0.19	4.251e-3	7.805e-3	(B) Positive
MRPS23	17q22	-0.66	-0.45	0.68	0.72	-0.21	4.259e-3	7.819e-3	(B) Positive
ANKRD54	22q13.1	0.49	0.36	0.44	0.44	0.13	4.261e-3	7.821e-3	(A) Negative
MRPS6	21q22.11	-0.34	-0.52	0.62	0.57	0.18	4.264e-3	7.825e-3	(A) Negative
SRSF2	17q25.2	-0.50	-0.62	0.41	0.42	0.13	4.264e-3	7.825e-3	(A) Negative
LSM4	19p13.11	-0.40	-0.54	0.46	0.49	0.14	4.268e-3	7.833e-3	(A) Negative
UBAC1	9q34.3	-0.55	-0.68	0.41	0.38	0.12	4.271e-3	7.836e-3	(A) Negative
MATK	19p13.3	-1.76	-2.04	0.94	0.85	0.28	4.272e-3	7.837e-3	(A) Negative
ZC3H12D	6q25.1	-0.52	-0.67	0.50	0.44	0.15	4.286e-3	7.862e-3	(A) Negative
LYPD4	19q13.2	0.28	0.48	0.68	0.56	-0.20	4.286e-3	7.862e-3	(B) Positive
ACER3	11q13.5	0.24	-0.03	0.87	0.94	0.27	4.287e-3	7.862e-3	(A) Negative
MLF2	12p13.31	0.10	-0.04	0.49	0.40	0.14	4.293e-3	7.872e-3	(A) Negative
PABIR2	Xq26.3	-1.23	-1.05	0.63	0.53	-0.18	4.296e-3	7.878e-3	(B) Positive
TRIM36	5q22.3	-0.41	0.03	1.38	1.60	-0.43	4.300e-3	7.884e-3	(B) Positive
BUD23	7q11.23	-0.13	-0.29	0.55	0.45	0.16	4.302e-3	7.886e-3	(A) Negative
COMMD1	2p15	0.44	0.31	0.46	0.34	0.13	4.305e-3	7.892e-3	(A) Negative
ATP5MJ	14q32.33	-0.15	-0.31	0.55	0.49	0.16	4.317e-3	7.913e-3	(A) Negative
HOXB4	17q21.32	0.49	0.73	0.79	0.86	-0.24	4.328e-3	7.932e-3	(B) Positive
ADGRL4	1p31.1	4.48	4.74	0.86	0.83	-0.26	4.339e-3	7.951e-3	(B) Positive
ACTL10	20q11.22	1.48	1.74	0.89	0.87	-0.27	4.340e-3	7.952e-3	(B) Positive
PRDX6	1q25.1	-0.61	-0.77	0.56	0.47	0.16	4.343e-3	7.956e-3	(A) Negative
ZNF574	19q13.2	0.61	0.52	0.30	0.32	0.09	4.344e-3	7.957e-3	(A) Negative
ARHGEF15	17p13.1	0.58	0.67	0.31	0.35	-0.10	4.346e-3	7.960e-3	(B) Positive
NLRP14	11p15.4	0.08	-0.07	0.51	0.48	0.15	4.347e-3	7.961e-3	(A) Negative
MAP3K11	11q13.1	0.27	0.13	0.46	0.43	0.14	4.351e-3	7.967e-3	(A) Negative
RTP3	3p21.31	-0.24	-0.67	1.52	0.94	0.43	4.355e-3	7.975e-3	(A) Negative
KCTD11	17p13.1	0.06	0.24	0.61	0.49	-0.18	4.364e-3	7.990e-3	(B) Positive
AFG3L1P	16q24.3	-1.45	-1.64	0.64	0.59	0.19	4.365e-3	7.990e-3	(A) Negative
SGK1	6q23.2	-1.21	-1.49	0.95	0.92	0.28	4.369e-3	7.998e-3	(A) Negative
MOGAT2	11q13.5	0.59	0.05	1.81	1.70	0.54	4.371e-3	8.001e-3	(A) Negative
OR7A10	19p13.12	0.37	0.23	0.48	0.50	0.15	4.376e-3	8.009e-3	(A) Negative
NDUFV3	21q22.3	-0.21	-0.34	0.46	0.37	0.13	4.388e-3	8.030e-3	(A) Negative
ATIC	2q35	-0.66	-0.51	0.53	0.43	-0.15	4.396e-3	8.044e-3	(B) Positive
ZNF766	19q13.41	0.35	0.56	0.72	0.67	-0.21	4.401e-3	8.053e-3	(B) Positive
EFNA2	19p13.3	0.06	-0.02	0.26	0.24	0.08	4.416e-3	8.078e-3	(A) Negative
MYL11	16p11.2	-0.62	-0.50	0.32	0.60	-0.12	4.418e-3	8.081e-3	(B) Positive
TNFRSF1B	1p36.22	0.90	0.66	0.82	0.74	0.24	4.423e-3	8.089e-3	(A) Negative
ZBTB37	1q25.1	0.40	0.58	0.63	0.60	-0.19	4.433e-3	8.107e-3	(B) Positive
ZDHHC23	3q13.31	-0.43	-0.67	0.81	0.68	0.24	4.439e-3	8.116e-3	(A) Negative
PDP2	16q22.1	-0.24	-0.42	0.60	0.50	0.17	4.441e-3	8.120e-3	(A) Negative
ZBTB9	6p21.32	0.45	0.59	0.45	0.50	-0.14	4.442e-3	8.121e-3	(B) Positive
OR2H2	6p22.1	0.29	0.23	0.19	0.22	0.06	4.450e-3	8.134e-3	(A) Negative
DHX9	1q25.3	-0.11	-0.21	0.34	0.28	0.10	4.452e-3	8.138e-3	(A) Negative
PXDNL	8q11.22-q11.23	2.29	1.85	1.49	1.33	0.44	4.456e-3	8.143e-3	(A) Negative
KCNJ16	17q24.3	0.99	0.55	1.55	1.15	0.44	4.498e-3	8.219e-3	(A) Negative
PPL	16p13.3	1.24	0.96	0.93	0.80	0.27	4.499e-3	8.220e-3	(A) Negative
ZDHHC19	3q29	0.31	0.22	0.30	0.36	0.10	4.505e-3	8.231e-3	(A) Negative
PRAP1	10q26.3	-1.35	-1.48	0.44	0.39	0.13	4.509e-3	8.236e-3	(A) Negative
TIMMDC1	3q13.33	0.26	0.13	0.43	0.39	0.13	4.513e-3	8.243e-3	(A) Negative
RSRC2	12q24.31	-0.15	-0.05	0.35	0.30	-0.10	4.518e-3	8.253e-3	(B) Positive
ZNF518A	10q24.1	-0.05	-0.20	0.52	0.49	0.15	4.527e-3	8.267e-3	(A) Negative
RWDD2B	21q21.3	-0.06	-0.21	0.50	0.43	0.15	4.530e-3	8.271e-3	(A) Negative
KRT79	12q13.13	0.40	0.17	0.79	0.67	0.23	4.533e-3	8.277e-3	(A) Negative
TGIF1	18p11.31	0.28	0.46	0.62	0.56	-0.18	4.548e-3	8.304e-3	(B) Positive
TMC7	16p12.3	-0.33	-0.57	0.80	0.73	0.24	4.558e-3	8.320e-3	(A) Negative
POLR2E	19p13.3	-0.62	-0.48	0.48	0.46	-0.14	4.562e-3	8.327e-3	(B) Positive
VWA5A	11q24.2	0.29	0.56	0.90	0.80	-0.26	4.573e-3	8.346e-3	(B) Positive
HSD11B1L	19p13.3	0.46	0.26	0.66	0.65	0.20	4.574e-3	8.347e-3	(A) Negative
PCSK7	11q23.3	0.30	0.14	0.53	0.49	0.16	4.589e-3	8.373e-3	(A) Negative
SGSM3	22q13.1	0.35	0.18	0.57	0.50	0.17	4.591e-3	8.377e-3	(A) Negative
RHOV	15q15.1	0.95	0.62	1.06	1.13	0.32	4.599e-3	8.389e-3	(A) Negative
CYP26C1	10q23.33	0.36	0.20	0.54	0.44	0.16	4.612e-3	8.413e-3	(A) Negative
HAPLN1	5q14.3	0.22	-0.41	2.15	1.88	0.63	4.616e-3	8.419e-3	(A) Negative
LINC00260	1q32.1	-1.45	-1.66	0.71	0.64	0.21	4.623e-3	8.431e-3	(A) Negative
NDUFV1-DT	11q13.2	0.36	0.29	0.24	0.28	0.08	4.632e-3	8.447e-3	(A) Negative
CABIN1	22q11.23	-0.07	-0.22	0.49	0.46	0.14	4.636e-3	8.452e-3	(A) Negative
ARHGAP24	4q21.23-q21.3	0.52	0.72	0.69	0.70	-0.21	4.654e-3	8.484e-3	(B) Positive
KDM5C	Xp11.22	0.16	0.01	0.51	0.43	0.15	4.656e-3	8.487e-3	(A) Negative
ARHGAP9	12q13.3	1.30	0.98	1.12	0.92	0.32	4.657e-3	8.489e-3	(A) Negative
RITA1	12q24.13	-0.10	0.01	0.39	0.34	-0.11	4.663e-3	8.499e-3	(B) Positive
VSIG1	Xq22.3	0.60	0.46	0.47	0.47	0.14	4.667e-3	8.505e-3	(A) Negative
PRR7	5q35.3	0.03	-0.19	0.76	0.68	0.22	4.670e-3	8.509e-3	(A) Negative
KRT76	12q13.13	0.18	0.08	0.32	0.35	0.10	4.673e-3	8.515e-3	(A) Negative
KBTBD7	13q14.11	0.83	1.00	0.59	0.55	-0.17	4.676e-3	8.519e-3	(B) Positive
CCDC28B	1p35.2	-0.49	-0.78	1.02	0.69	0.29	4.677e-3	8.519e-3	(A) Negative
AAMP	2q35	0.07	0.21	0.48	0.42	-0.14	4.688e-3	8.539e-3	(B) Positive
SNPH	20p13	-0.34	0.04	1.27	1.25	-0.38	4.689e-3	8.540e-3	(B) Positive
WWP2	16q22.1	0.34	0.19	0.52	0.43	0.15	4.697e-3	8.552e-3	(A) Negative
PEX11B	1q21.1	1.01	1.16	0.50	0.45	-0.15	4.708e-3	8.573e-3	(B) Positive
FCGR1A	1q21.2	3.59	3.45	0.47	0.50	0.14	4.712e-3	8.578e-3	(A) Negative
TFB2M	1q44	0.09	-0.08	0.57	0.55	0.17	4.712e-3	8.578e-3	(A) Negative
UBA5	3q22.1	-0.74	-0.89	0.50	0.49	0.15	4.715e-3	8.583e-3	(A) Negative
PLA2G2D	1p36.12	0.18	0.02	0.58	0.43	0.16	4.736e-3	8.620e-3	(A) Negative
OR10S1	11q24.1	0.28	0.37	0.30	0.36	-0.09	4.754e-3	8.651e-3	(B) Positive
HTN1	4q13.3	0.05	-0.36	1.51	0.51	0.41	4.755e-3	8.653e-3	(A) Negative
NUDT11	Xp11.22	-1.83	-2.28	1.61	0.97	0.45	4.760e-3	8.661e-3	(A) Negative
ERCC4	16p13.12	0.11	0.26	0.52	0.39	-0.15	4.761e-3	8.661e-3	(B) Positive
CHRNE	17p13.2	0.61	0.52	0.29	0.24	0.08	4.763e-3	8.664e-3	(A) Negative
LARS2	3p21.31	-0.87	-0.75	0.41	0.38	-0.12	4.769e-3	8.675e-3	(B) Positive
UBE2N	12q22	-0.06	0.07	0.46	0.43	-0.13	4.774e-3	8.682e-3	(B) Positive
C1QA	1p36.12	3.57	3.44	0.43	0.39	0.13	4.776e-3	8.685e-3	(A) Negative
DISP2	15q15.1	-0.25	0.14	1.28	1.46	-0.39	4.788e-3	8.706e-3	(B) Positive
CALML3	10p15.1	0.45	0.91	1.51	1.65	-0.46	4.797e-3	8.721e-3	(B) Positive
THUMPD3	3p25.3	-0.72	-0.87	0.55	0.41	0.16	4.808e-3	8.740e-3	(A) Negative
BCL9L	11q23.3	0.14	-0.01	0.49	0.48	0.15	4.826e-3	8.772e-3	(A) Negative
LANCL1	2q34	-0.34	-0.18	0.54	0.47	-0.16	4.839e-3	8.795e-3	(B) Positive
HMCES	3q21.3	0.13	-0.02	0.54	0.43	0.16	4.842e-3	8.799e-3	(A) Negative
PWP1	12q23.3	-0.33	-0.47	0.50	0.35	0.14	4.854e-3	8.821e-3	(A) Negative
UQCRFS1	19q12	-0.08	-0.27	0.68	0.48	0.19	4.870e-3	8.848e-3	(A) Negative
NKIRAS2	17q21.2	0.16	0.01	0.50	0.46	0.15	4.872e-3	8.851e-3	(A) Negative
FERMT3	11q13.1	0.41	0.16	0.86	0.81	0.25	4.883e-3	8.871e-3	(A) Negative
CTRB2	16q23.1	0.39	0.31	0.27	0.29	0.08	4.886e-3	8.874e-3	(A) Negative
SH3YL1	2p25.3	1.26	1.04	0.80	0.63	0.23	4.889e-3	8.880e-3	(A) Negative
AURKC	19q13.43	-1.33	-1.16	0.54	0.74	-0.18	4.892e-3	8.883e-3	(B) Positive
SRSF7	2p22.1	-0.15	-0.24	0.31	0.28	0.09	4.910e-3	8.916e-3	(A) Negative
PHYHIP	8p21.3	-0.22	0.04	0.91	0.84	-0.27	4.926e-3	8.943e-3	(B) Positive
COPS6	7q22.1	-0.54	-0.42	0.40	0.37	-0.12	4.930e-3	8.949e-3	(B) Positive
FAM138F	19p13.3	-0.16	-0.28	0.42	0.42	0.13	4.934e-3	8.955e-3	(A) Negative
CD55	1q32.2	-0.63	-0.81	0.62	0.63	0.19	4.934e-3	8.955e-3	(A) Negative
CLEC5A	7q34	2.11	1.84	0.93	0.85	0.27	4.957e-3	8.996e-3	(A) Negative
PRB4	12p13.2	0.24	0.13	0.35	0.42	0.11	4.970e-3	9.018e-3	(A) Negative
TIMM23	10q11.22	0.28	0.15	0.44	0.40	0.13	4.977e-3	9.030e-3	(A) Negative
LINC00315	21q22.3	0.42	0.32	0.34	0.32	0.10	4.993e-3	9.058e-3	(A) Negative
SNX16	8q21.13	0.70	0.50	0.66	0.64	0.20	4.998e-3	9.066e-3	(A) Negative
ZNF592	15q25.3	0.15	0.03	0.42	0.38	0.12	4.998e-3	9.066e-3	(A) Negative
HNF1A	12q24.31	-1.47	-1.33	0.45	0.51	-0.14	4.999e-3	9.067e-3	(B) Positive
PCDHB18P	5q31.3	0.01	0.19	0.62	0.57	-0.18	5.009e-3	9.084e-3	(B) Positive
PEF1	1p35.2	0.82	0.96	0.49	0.44	-0.14	5.009e-3	9.084e-3	(B) Positive
RUVBL1	3q21.3	-0.33	-0.49	0.53	0.47	0.15	5.014e-3	9.090e-3	(A) Negative
FTSJ1	Xp11.23	-0.57	-0.69	0.40	0.39	0.12	5.015e-3	9.092e-3	(A) Negative
VGLL3	3p12.1	0.08	-0.06	0.48	0.46	0.14	5.022e-3	9.103e-3	(A) Negative
NAA16	13q14.11	-0.55	-0.42	0.44	0.36	-0.13	5.028e-3	9.114e-3	(B) Positive
ORC4	2q23.1	-0.08	0.06	0.49	0.43	-0.14	5.044e-3	9.142e-3	(B) Positive
TOE1	1p34.1	-0.69	-0.81	0.40	0.39	0.12	5.052e-3	9.155e-3	(A) Negative
SHLD2P1	10q11.22	0.15	0.31	0.58	0.45	-0.16	5.066e-3	9.180e-3	(B) Positive
EZR	6q25.3	0.82	1.01	0.66	0.63	-0.19	5.067e-3	9.181e-3	(B) Positive
PASD1	Xq28	-4.32	-4.46	0.49	0.40	0.14	5.072e-3	9.188e-3	(A) Negative
PGM3	6q14.1	-0.18	-0.37	0.65	0.65	0.19	5.073e-3	9.189e-3	(A) Negative
SGPP1	14q23.2	-1.00	-0.73	0.90	1.00	-0.27	5.077e-3	9.195e-3	(B) Positive
BCL2L2	14q11.2	-0.32	-0.21	0.37	0.36	-0.11	5.106e-3	9.247e-3	(B) Positive
OR2B11	1q44	0.47	0.40	0.21	0.24	0.06	5.111e-3	9.255e-3	(A) Negative
HOXD3	2q31.1	-0.54	-0.27	0.98	0.79	-0.28	5.119e-3	9.268e-3	(B) Positive
OR4D1	17q22	0.53	0.46	0.24	0.27	0.07	5.121e-3	9.271e-3	(A) Negative
RAB33B	4q31.1	0.80	0.95	0.54	0.47	-0.16	5.126e-3	9.280e-3	(B) Positive
AADACL4	1p36.21	-0.15	-0.32	0.57	0.62	0.17	5.156e-3	9.333e-3	(A) Negative
TDRD12	19q13.11	-2.51	-3.07	2.03	1.32	0.56	5.161e-3	9.341e-3	(A) Negative
CHD4	12p13.31	-0.09	0.02	0.38	0.37	-0.11	5.167e-3	9.350e-3	(B) Positive
MERTK	2q13	0.35	0.10	0.85	0.74	0.24	5.175e-3	9.364e-3	(A) Negative
TDRD3	13q21.2	-0.15	-0.01	0.49	0.46	-0.14	5.176e-3	9.366e-3	(B) Positive
HAT1	2q31.1	-0.58	-0.43	0.50	0.44	-0.15	5.178e-3	9.366e-3	(B) Positive
ZNF774	15q26.1	0.41	0.17	0.85	0.64	0.24	5.178e-3	9.366e-3	(A) Negative
CLDN18	3q22.3	0.20	0.11	0.29	0.33	0.09	5.184e-3	9.376e-3	(A) Negative
SUMF2	7p11.2	0.23	-0.02	0.89	0.54	0.24	5.195e-3	9.395e-3	(A) Negative
IRS4	Xq22.3	0.57	0.30	0.94	0.86	0.27	5.214e-3	9.428e-3	(A) Negative
DSP	6p24.3	1.43	1.16	0.86	1.14	0.27	5.214e-3	9.428e-3	(A) Negative
STK4	20q13.12	-0.11	-0.23	0.44	0.40	0.13	5.216e-3	9.430e-3	(A) Negative
AP2M1	3q27.1	-0.33	-0.49	0.56	0.55	0.16	5.218e-3	9.433e-3	(A) Negative
PRPH2	6p21.1	2.16	2.52	1.19	1.27	-0.36	5.222e-3	9.440e-3	(B) Positive
RBFOX1	16p13.3	-1.51	-1.37	0.43	0.67	-0.15	5.249e-3	9.487e-3	(B) Positive
NARS2	11q14.1	-0.62	-0.81	0.61	0.70	0.19	5.252e-3	9.492e-3	(A) Negative
NSUN5	7q11.23	-0.46	-0.59	0.47	0.39	0.13	5.258e-3	9.501e-3	(A) Negative
RPL22	1p36.31	0.12	-0.03	0.53	0.42	0.15	5.263e-3	9.509e-3	(A) Negative
IMP4	2q21.1	0.19	0.06	0.45	0.36	0.13	5.271e-3	9.523e-3	(A) Negative
ZKSCAN5	7q22.1	-0.73	-0.63	0.35	0.33	-0.10	5.274e-3	9.527e-3	(B) Positive
ANO7	2q37.3	-0.78	-0.99	0.69	0.76	0.21	5.278e-3	9.534e-3	(A) Negative
VPS4B	18q21.33	0.55	0.73	0.61	0.54	-0.18	5.279e-3	9.534e-3	(B) Positive
MT1JP	16q13	-0.16	-0.46	1.06	0.85	0.30	5.282e-3	9.539e-3	(A) Negative
FBXO33	14q21.1	0.05	-0.08	0.44	0.49	0.13	5.294e-3	9.559e-3	(A) Negative
CABS1	4q13.3	0.26	0.18	0.27	0.30	0.08	5.294e-3	9.559e-3	(A) Negative
SLBP	4p16.3	-0.72	-0.90	0.60	0.53	0.17	5.305e-3	9.576e-3	(A) Negative
SRSF1	17q22	-0.49	-0.60	0.39	0.35	0.11	5.310e-3	9.585e-3	(A) Negative
IFNW1	9p21.3	0.37	0.14	0.76	0.83	0.23	5.331e-3	9.623e-3	(A) Negative
PHF2	9q22.31	0.91	1.07	0.56	0.44	-0.16	5.337e-3	9.632e-3	(B) Positive
EMG1	12p13.31	-0.28	-0.47	0.69	0.52	0.19	5.340e-3	9.636e-3	(A) Negative
DDX1	2p24.3	-0.12	-0.24	0.45	0.34	0.13	5.341e-3	9.637e-3	(A) Negative
HOOK1	1p32.1	1.32	1.53	0.71	0.74	-0.21	5.347e-3	9.647e-3	(B) Positive
STIM2	4p15.2	0.12	0.29	0.58	0.51	-0.17	5.398e-3	9.739e-3	(B) Positive
TRPV1	17p13.2	-0.11	0.03	0.46	0.50	-0.14	5.401e-3	9.742e-3	(B) Positive
EEF1AKMT1	13q12.11	0.49	0.64	0.52	0.48	-0.15	5.414e-3	9.764e-3	(B) Positive
FOXD4	9p24.3	0.32	0.48	0.55	0.59	-0.16	5.414e-3	9.764e-3	(B) Positive
CTBS	1p22.3	0.31	0.50	0.64	0.59	-0.19	5.416e-3	9.765e-3	(B) Positive
ZNF830	17q12	0.34	0.48	0.46	0.50	-0.14	5.425e-3	9.782e-3	(B) Positive
CADM1	11q23.3	-0.52	-0.87	1.21	1.12	0.35	5.428e-3	9.785e-3	(A) Negative
THAP3	1p36.31	0.21	0.34	0.47	0.33	-0.13	5.436e-3	9.800e-3	(B) Positive
UBR4	1p36.13	-0.29	-0.40	0.38	0.32	0.11	5.437e-3	9.800e-3	(A) Negative
AEBP2	12p12.3	-0.06	-0.23	0.64	0.43	0.18	5.447e-3	9.817e-3	(A) Negative
SERPINA7	Xq22.3	-5.45	-5.59	0.46	0.44	0.14	5.455e-3	9.830e-3	(A) Negative
NDUFB11	Xp11.3	-0.36	-0.51	0.50	0.41	0.14	5.456e-3	9.832e-3	(A) Negative
DAP	5p15.2	0.37	0.19	0.61	0.52	0.17	5.473e-3	9.860e-3	(A) Negative
IFT81	12q24.11	-0.39	-0.24	0.54	0.43	-0.15	5.480e-3	9.873e-3	(B) Positive
CALHM5	6q22.1	1.01	1.25	0.81	0.76	-0.24	5.498e-3	9.903e-3	(B) Positive
SNAPC3	9p22.3	0.15	-0.03	0.65	0.52	0.18	5.500e-3	9.906e-3	(A) Negative
IRAG2	12p12.1	-0.98	-1.27	1.06	0.73	0.29	5.513e-3	9.929e-3	(A) Negative
WFDC10B	20q13.12	0.40	0.22	0.62	0.56	0.18	5.523e-3	9.946e-3	(A) Negative
RAVER1	19p13.2	0.41	0.28	0.43	0.47	0.13	5.529e-3	9.955e-3	(A) Negative
WFDC2	20q13.12	1.63	2.16	1.80	1.74	-0.53	5.539e-3	9.972e-3	(B) Positive
ARHGEF7	13q34	0.06	-0.12	0.64	0.44	0.18	5.543e-3	9.979e-3	(A) Negative
TVP23C	17p12	-0.21	-0.03	0.62	0.52	-0.18	5.553e-3	9.994e-3	(B) Positive
PPA2	4q24	-0.04	0.11	0.51	0.46	-0.15	5.553e-3	9.994e-3	(B) Positive
JMJD1C	10q21.3	0.19	0.01	0.63	0.52	0.18	5.558e-3	0.0100	(A) Negative
FAM222A	12q24.11	0.75	1.02	0.97	0.77	-0.27	5.567e-3	0.0100	(B) Positive
WFDC3	20q13.12	1.16	0.94	0.79	0.63	0.22	5.585e-3	0.0100	(A) Negative
TMC6	17q25.3	-0.93	-1.12	0.65	0.65	0.19	5.585e-3	0.0100	(A) Negative
STAMBPL1	10q23.31	-1.15	-1.34	0.68	0.57	0.19	5.589e-3	0.0101	(A) Negative
TMEM52	1p36.33	-0.11	-0.35	0.84	0.67	0.24	5.597e-3	0.0101	(A) Negative
CA8	8q12.1	-0.73	-0.09	2.26	1.90	-0.64	5.620e-3	0.0101	(B) Positive
ZNF112	19q13.31	0.74	0.95	0.74	0.60	-0.21	5.622e-3	0.0101	(B) Positive
TGFBR3	1p22.1	-0.55	-0.11	1.51	1.53	-0.44	5.623e-3	0.0101	(B) Positive
PCDH12	5q31.3	3.23	3.40	0.61	0.53	-0.17	5.624e-3	0.0101	(B) Positive
EXOSC5	19q13.2	0.01	-0.16	0.61	0.51	0.17	5.635e-3	0.0101	(A) Negative
RPAP3	12q13.11	-0.49	-0.35	0.48	0.44	-0.14	5.641e-3	0.0101	(B) Positive
MSRA	8p23.1	0.15	0.02	0.48	0.45	0.14	5.654e-3	0.0102	(A) Negative
TEX55	3q13.32	0.27	0.16	0.38	0.34	0.11	5.666e-3	0.0102	(A) Negative
GNAS	20q13.32	0.28	0.07	0.72	0.66	0.21	5.671e-3	0.0102	(A) Negative
MARCHF4	2q35	-0.80	-0.51	0.94	1.18	-0.29	5.678e-3	0.0102	(B) Positive
ENTPD1	10q24.1	1.91	1.78	0.43	0.44	0.13	5.690e-3	0.0102	(A) Negative
NTRK1	1q23.1	-1.63	-1.46	0.54	0.68	-0.17	5.693e-3	0.0102	(B) Positive
GSTT1	22q11.23 alternate reference locus	-0.34	0.11	1.52	1.59	-0.45	5.714e-3	0.0103	(B) Positive
CLDND1	3q11.2	0.14	0.03	0.39	0.36	0.11	5.725e-3	0.0103	(A) Negative
TPRX1	19q13.33	0.08	-0.03	0.37	0.32	0.10	5.726e-3	0.0103	(A) Negative
GFRA4	20p13	0.51	0.38	0.46	0.45	0.14	5.726e-3	0.0103	(A) Negative
SLC25A15	13q14.11	-0.53	-0.69	0.54	0.57	0.16	5.728e-3	0.0103	(A) Negative
CD300E	17q25.1	0.27	0.16	0.39	0.38	0.11	5.734e-3	0.0103	(A) Negative
ATG12	5q22.3	-0.51	-0.40	0.39	0.35	-0.11	5.744e-3	0.0103	(B) Positive
CIBAR2	16q24.1	1.44	1.10	1.21	1.11	0.35	5.753e-3	0.0103	(A) Negative
CCL21	9p13.3	1.31	1.06	0.88	0.75	0.25	5.767e-3	0.0104	(A) Negative
GABRA3	Xq28	-0.19	-0.36	0.60	0.57	0.17	5.772e-3	0.0104	(A) Negative
FAM83G	17p11.2	0.18	0.07	0.37	0.39	0.11	5.792e-3	0.0104	(A) Negative
CDH18	5p14.3	-4.50	-4.17	0.84	1.75	-0.32	5.803e-3	0.0104	(B) Positive
SPESP1	15q23	-0.95	-0.41	1.86	1.74	-0.54	5.812e-3	0.0104	(B) Positive
SPTSSB	3q26.1	-4.61	-4.02	2.04	2.02	-0.59	5.827e-3	0.0105	(B) Positive
SLC16A12	10q23.31	-0.81	-0.53	0.98	0.87	-0.28	5.831e-3	0.0105	(B) Positive
EAF2	3q13.33	0.39	0.09	1.03	1.07	0.30	5.834e-3	0.0105	(A) Negative
MEF2B	19p13.11	0.24	0.13	0.38	0.35	0.11	5.836e-3	0.0105	(A) Negative
ZCCHC2	18q21.33	0.42	0.25	0.59	0.52	0.17	5.848e-3	0.0105	(A) Negative
MYH8	17p13.1	0.21	0.32	0.35	0.48	-0.11	5.850e-3	0.0105	(B) Positive
EI24	11q24.2	0.07	-0.08	0.51	0.46	0.15	5.855e-3	0.0105	(A) Negative
TMEM184A	7p22.3	0.03	0.35	1.14	0.84	-0.31	5.857e-3	0.0105	(B) Positive
CAPN5	11q13.5	0.01	-0.09	0.35	0.34	0.10	5.863e-3	0.0105	(A) Negative
FKBP9	7p14.3	0.02	-0.16	0.66	0.56	0.19	5.865e-3	0.0105	(A) Negative
SALL1	16q12.1	-3.62	-3.33	1.01	0.91	-0.29	5.869e-3	0.0105	(B) Positive
KCNG2	18q23	0.10	0.29	0.67	0.72	-0.20	5.869e-3	0.0105	(B) Positive
LAMC3	9q34.12	-0.58	-0.84	0.90	0.88	0.26	5.872e-3	0.0105	(A) Negative
KMT2E	7q22.3	0.08	0.23	0.53	0.43	-0.15	5.874e-3	0.0105	(B) Positive
SPACA3	17q11.2	0.26	0.10	0.52	0.51	0.15	5.889e-3	0.0105	(A) Negative
TMED2	12q24.31	0.41	0.61	0.70	0.65	-0.20	5.895e-3	0.0106	(B) Positive
PROCR	20q11.22	-1.22	-0.97	0.83	0.85	-0.24	5.897e-3	0.0106	(B) Positive
NUDT10	Xp11.22	-1.26	-0.81	1.56	1.43	-0.45	5.910e-3	0.0106	(B) Positive
NSG1	4p16.3	-1.79	-2.21	1.50	1.03	0.41	5.912e-3	0.0106	(A) Negative
CTAG2	Xq28	-0.07	-0.37	1.09	0.76	0.30	5.922e-3	0.0106	(A) Negative
SPINT2	19q13.2	2.21	2.39	0.62	0.48	-0.17	5.934e-3	0.0106	(B) Positive
CMIP	16q23.2-q23.3	0.33	0.18	0.48	0.51	0.14	5.936e-3	0.0106	(A) Negative
OSTC	4q25	-0.13	-0.28	0.54	0.44	0.15	5.951e-3	0.0107	(A) Negative
RCL1	9p24.1	0.03	-0.19	0.77	0.54	0.21	5.954e-3	0.0107	(A) Negative
RPL10A	6p21.31	-0.29	-0.15	0.50	0.48	-0.14	5.960e-3	0.0107	(B) Positive
PLCXD3	5p13.1	-0.92	-0.58	1.19	1.18	-0.35	5.964e-3	0.0107	(B) Positive
SURF2	9q34.2	-0.03	-0.17	0.49	0.46	0.14	5.965e-3	0.0107	(A) Negative
DDX27	20q13.13	0.09	-0.07	0.57	0.55	0.16	5.967e-3	0.0107	(A) Negative
EPHX1	1q42.12	0.90	1.16	0.91	0.81	-0.26	5.973e-3	0.0107	(B) Positive
NONO	Xq13.1	-0.58	-0.70	0.43	0.37	0.12	5.988e-3	0.0107	(A) Negative
SCGB1A1	11q12.3	0.51	0.36	0.57	0.37	0.16	5.995e-3	0.0107	(A) Negative
KIAA1586	6p12.1	-0.84	-1.03	0.67	0.57	0.19	5.996e-3	0.0107	(A) Negative
LYST	1q42.3	0.44	0.68	0.83	0.68	-0.23	5.998e-3	0.0107	(B) Positive
TMEM185A	Xq28	0.45	0.55	0.35	0.32	-0.10	5.999e-3	0.0107	(B) Positive
IMMP2L	7q31.1	-0.53	-0.33	0.66	0.68	-0.19	6.000e-3	0.0107	(B) Positive
DR1	1p22.1	0.04	-0.12	0.57	0.50	0.16	6.031e-3	0.0108	(A) Negative
GMFB	14q22.2	-0.06	0.11	0.62	0.46	-0.17	6.038e-3	0.0108	(B) Positive
NPY2R	4q32.1	0.92	1.27	1.11	1.57	-0.36	6.047e-3	0.0108	(B) Positive
WHAMM	15q25.2	0.13	0.24	0.39	0.32	-0.11	6.055e-3	0.0108	(B) Positive
TRPC4	13q13.3	0.94	0.72	0.81	0.56	0.22	6.059e-3	0.0108	(A) Negative
FAM43B	1p36.12	-0.28	-0.15	0.48	0.47	-0.14	6.067e-3	0.0108	(B) Positive
SDHD	11q23.1	-0.41	-0.57	0.54	0.48	0.15	6.072e-3	0.0108	(A) Negative
SPATA3	2q37.1	0.31	0.23	0.29	0.35	0.09	6.073e-3	0.0108	(A) Negative
SUSD5	3p22.3	1.14	0.65	1.79	1.23	0.49	6.079e-3	0.0109	(A) Negative
ARHGEF25	12q13.3	-1.30	-1.12	0.63	0.59	-0.18	6.082e-3	0.0109	(B) Positive
H2BC15	6p22.1	-0.35	-0.58	0.78	0.83	0.23	6.082e-3	0.0109	(A) Negative
DPY30	2p22.3	0.03	-0.10	0.48	0.38	0.13	6.087e-3	0.0109	(A) Negative
TWIST1	7p21.1	0.14	0.40	0.84	0.97	-0.25	6.088e-3	0.0109	(B) Positive
COL3A1	2q32.2	5.40	5.58	0.61	0.66	-0.18	6.101e-3	0.0109	(B) Positive
DPYSL4	10q26.3	-1.85	-2.24	1.39	1.05	0.38	6.101e-3	0.0109	(A) Negative
MYNN	3q26.2	0.60	0.47	0.50	0.38	0.14	6.107e-3	0.0109	(A) Negative
SEPTIN14P20	20q13.33	-0.34	-0.18	0.52	0.61	-0.16	6.107e-3	0.0109	(B) Positive
MAP1B	5q13.2	-0.64	-0.93	1.02	0.97	0.29	6.119e-3	0.0109	(A) Negative
SLC13A5	17p13.1	-2.70	-2.84	0.48	0.47	0.14	6.121e-3	0.0109	(A) Negative
ADGRL1	19p13.12	-0.26	-0.04	0.77	0.60	-0.21	6.136e-3	0.0109	(B) Positive
ANKRD13A	12q24.11	0.06	-0.10	0.58	0.44	0.16	6.140e-3	0.0110	(A) Negative
DPYSL3	5q32	0.84	0.55	0.98	1.01	0.29	6.183e-3	0.0110	(A) Negative
TLL2	10q24.1	0.28	0.47	0.68	0.67	-0.20	6.190e-3	0.0110	(B) Positive
PHTF2	7q11.23-q21.11	0.02	-0.09	0.39	0.42	0.12	6.194e-3	0.0110	(A) Negative
H2AC18	1q21.2	0.34	0.70	1.25	1.34	-0.37	6.198e-3	0.0111	(B) Positive
CLEC2A	12p13.31	-1.47	-1.21	0.89	0.88	-0.26	6.200e-3	0.0111	(B) Positive
TTLL3	3p25.3	-1.05	-1.19	0.52	0.44	0.15	6.204e-3	0.0111	(A) Negative
ST8SIA4	5q21.1	-0.10	-0.29	0.68	0.56	0.19	6.206e-3	0.0111	(A) Negative
ZNF385D	3p24.3	-0.47	-0.12	1.16	1.46	-0.36	6.221e-3	0.0111	(B) Positive
SAMD11	1p36.33	-0.88	-0.67	0.75	0.78	-0.22	6.228e-3	0.0111	(B) Positive
NDUFS1	2q33.3	-0.50	-0.62	0.46	0.38	0.13	6.231e-3	0.0111	(A) Negative
DLL4	15q15.1	1.77	1.98	0.69	0.74	-0.20	6.234e-3	0.0111	(B) Positive
CLEC4C	12p13.31	0.71	0.49	0.77	0.70	0.22	6.236e-3	0.0111	(A) Negative
CRYBB1	22q12.1	-1.19	-1.01	0.64	0.58	-0.18	6.236e-3	0.0111	(B) Positive
SOX21	13q32.1	-1.31	-1.43	0.44	0.35	0.12	6.250e-3	0.0111	(A) Negative
NLGN3	Xq13.1	-0.67	-0.52	0.55	0.47	-0.16	6.251e-3	0.0111	(B) Positive
KMT2D	12q13.12	0.24	0.32	0.24	0.25	-0.07	6.259e-3	0.0111	(B) Positive
ADAMTSL2	9q34.2	0.91	1.08	0.60	0.55	-0.17	6.273e-3	0.0112	(B) Positive
GABPA	21q21.3	0.14	-0.02	0.54	0.50	0.15	6.278e-3	0.0112	(A) Negative
CD302	2q24.2	0.95	1.20	0.89	0.84	-0.25	6.291e-3	0.0112	(B) Positive
BLTP2	17q11.2	-0.26	-0.10	0.56	0.54	-0.16	6.307e-3	0.0112	(B) Positive
ABCB1	7q21.12	-0.98	-0.72	0.86	0.93	-0.25	6.308e-3	0.0112	(B) Positive
ACSBG1	15q25.1	-1.42	-1.67	0.92	0.53	0.25	6.311e-3	0.0112	(A) Negative
CNTFR	9p13.3	0.27	0.08	0.68	0.56	0.19	6.311e-3	0.0112	(A) Negative
ZNF358	19p13.2	0.75	0.61	0.49	0.49	0.14	6.324e-3	0.0113	(A) Negative
EXOC3L1	16q22.1	1.72	1.55	0.62	0.56	0.18	6.335e-3	0.0113	(A) Negative
VTA1	6q24.1-q24.2	-0.05	-0.22	0.62	0.49	0.17	6.336e-3	0.0113	(A) Negative
GRM8	7q31.33	0.17	0.43	0.95	0.82	-0.27	6.344e-3	0.0113	(B) Positive
OR1A2	17p13.3	0.21	0.11	0.36	0.34	0.10	6.356e-3	0.0113	(A) Negative
PCDHB3	5q31.3	0.29	-0.11	1.42	1.27	0.40	6.356e-3	0.0113	(A) Negative
RAP1B	12q15	0.33	0.50	0.59	0.51	-0.17	6.360e-3	0.0113	(B) Positive
NAT10	11p13	-0.22	-0.38	0.59	0.44	0.16	6.363e-3	0.0113	(A) Negative
COL5A2	2q32.2	2.00	2.32	1.11	1.12	-0.32	6.377e-3	0.0113	(B) Positive
COMT	22q11.21	0.20	0.04	0.55	0.58	0.16	6.380e-3	0.0113	(A) Negative
TDRD1	10q25.3	-0.25	-0.65	1.48	0.93	0.40	6.381e-3	0.0113	(A) Negative
CCDC177	14q24.1	1.03	1.19	0.55	0.60	-0.16	6.383e-3	0.0113	(B) Positive
RAB11FIP4	17q11.2	0.14	0.31	0.62	0.61	-0.18	6.386e-3	0.0113	(B) Positive
RRP9	3p21.2	-0.62	-0.74	0.42	0.38	0.12	6.395e-3	0.0114	(A) Negative
SMIM12	1p34.3	-0.06	-0.18	0.43	0.35	0.12	6.397e-3	0.0114	(A) Negative
CHTOP	1q21.3	0.11	0.02	0.32	0.29	0.09	6.405e-3	0.0114	(A) Negative
STK35	20p13	-0.30	-0.41	0.40	0.36	0.11	6.408e-3	0.0114	(A) Negative
DLG2	11q14.1	-0.22	0.01	0.82	0.69	-0.23	6.408e-3	0.0114	(B) Positive
TLE5	19p13.3	0.22	0.37	0.55	0.48	-0.16	6.408e-3	0.0114	(B) Positive
ARL6IP1	16p12.3	0.59	0.75	0.56	0.55	-0.16	6.414e-3	0.0114	(B) Positive
MS4A5	11q12.2	0.17	0.28	0.32	0.53	-0.11	6.417e-3	0.0114	(B) Positive
TRIM48	11q11	0.20	0.07	0.47	0.47	0.13	6.433e-3	0.0114	(A) Negative
FHAD1	1p36.21	0.80	1.02	0.78	0.66	-0.22	6.439e-3	0.0114	(B) Positive
GPATCH2L	14q24.3	-0.09	0.05	0.48	0.49	-0.14	6.447e-3	0.0114	(B) Positive
STRN4	19q13.32	0.31	0.21	0.37	0.34	0.11	6.453e-3	0.0115	(A) Negative
TEX29	13q34	0.37	0.20	0.62	0.52	0.17	6.457e-3	0.0115	(A) Negative
PSMB9	6p21.32	0.60	0.20	1.45	1.09	0.40	6.469e-3	0.0115	(A) Negative
HS6ST2	Xq26.2	-0.96	-1.26	1.08	0.94	0.30	6.476e-3	0.0115	(A) Negative
SCARB1	12q24.31	-0.61	-0.81	0.76	0.53	0.21	6.485e-3	0.0115	(A) Negative
DDX19B	16q22.1	-0.17	-0.31	0.49	0.42	0.14	6.495e-3	0.0115	(A) Negative
EIF2B2	14q24.3	-0.58	-0.45	0.43	0.39	-0.12	6.495e-3	0.0115	(B) Positive
SLC35A2	Xp11.23	0.66	0.55	0.41	0.38	0.12	6.500e-3	0.0115	(A) Negative
TLR5	1q41	3.30	3.11	0.69	0.61	0.19	6.507e-3	0.0115	(A) Negative
HCFC2	12q23.3	0.46	0.30	0.57	0.45	0.16	6.509e-3	0.0115	(A) Negative
OMP	11q13.5	0.15	0.05	0.36	0.37	0.11	6.511e-3	0.0115	(A) Negative
OR51L1	11p15.4	0.47	0.38	0.30	0.31	0.09	6.543e-3	0.0116	(A) Negative
MSRB1	16p13.3	0.22	0.42	0.72	0.54	-0.20	6.550e-3	0.0116	(B) Positive
RPS6KB2	11q13.2	-0.67	-0.91	0.82	0.77	0.23	6.562e-3	0.0116	(A) Negative
ADAMTSL4	1q21.2	-1.65	-1.90	0.91	0.71	0.25	6.565e-3	0.0116	(A) Negative
RAB39B	Xq28	-1.01	-0.65	1.20	1.54	-0.37	6.571e-3	0.0116	(B) Positive
UBE2H	7q32.2	0.71	0.87	0.58	0.46	-0.16	6.590e-3	0.0117	(B) Positive
WNT5A	3p14.3	-1.58	-1.22	1.19	1.38	-0.36	6.597e-3	0.0117	(B) Positive
APOM	6p21.33	-3.61	-3.47	0.46	0.53	-0.14	6.599e-3	0.0117	(B) Positive
BET1	7q21.3	-0.39	-0.53	0.46	0.47	0.13	6.614e-3	0.0117	(A) Negative
MOSMO	16p12.2	-1.27	-1.43	0.60	0.49	0.17	6.651e-3	0.0118	(A) Negative
DYRK1B	19q13.2	0.90	1.03	0.47	0.40	-0.13	6.659e-3	0.0118	(B) Positive
ZNF300	5q33.1	-0.94	-1.34	1.43	1.07	0.39	6.688e-3	0.0118	(A) Negative
WWOX	16q23.1-q23.2	-0.18	0.02	0.62	0.98	-0.20	6.689e-3	0.0118	(B) Positive
NPL	1q25.3	1.36	1.13	0.78	0.81	0.23	6.695e-3	0.0119	(A) Negative
PEX1	7q21.2	-0.12	0.03	0.50	0.53	-0.15	6.704e-3	0.0119	(B) Positive
FABP1	2p11.2	-6.21	-6.46	0.90	0.76	0.25	6.704e-3	0.0119	(A) Negative
TLN1	9p13.3	0.40	0.27	0.44	0.42	0.12	6.714e-3	0.0119	(A) Negative
DNAJC8	1p35.3	-0.47	-0.37	0.38	0.34	-0.11	6.717e-3	0.0119	(B) Positive
COL25A1	4q25	-1.00	-1.18	0.68	0.43	0.18	6.722e-3	0.0119	(A) Negative
ZNF418	19q13.43	0.85	1.02	0.60	0.56	-0.17	6.736e-3	0.0119	(B) Positive
SAFB	19p13.3	-0.04	-0.15	0.41	0.33	0.11	6.740e-3	0.0119	(A) Negative
DIPK1C	18q22.3	-1.64	-2.00	1.33	0.88	0.36	6.744e-3	0.0119	(A) Negative
HOXA2	7p15.2	0.23	0.03	0.75	0.65	0.21	6.748e-3	0.0119	(A) Negative
FJX1	11p13	0.33	0.08	0.87	0.96	0.25	6.749e-3	0.0119	(A) Negative
TBX4	17q23.2	-0.12	-0.36	0.89	0.67	0.24	6.751e-3	0.0119	(A) Negative
NUP35	2q32.1	-0.36	-0.50	0.54	0.37	0.15	6.757e-3	0.0119	(A) Negative
CES1	16q12.2	-1.46	-1.22	0.84	0.84	-0.24	6.758e-3	0.0119	(B) Positive
AKAP7	6q23.2	-0.34	-0.59	0.93	0.69	0.25	6.798e-3	0.0120	(A) Negative
PIGY	4q22.1	0.32	0.16	0.60	0.47	0.16	6.802e-3	0.0120	(A) Negative
TBC1D10B	16p11.2	0.24	0.34	0.35	0.32	-0.10	6.817e-3	0.0120	(B) Positive
ANKRD53	2p13.3	0.59	0.68	0.31	0.35	-0.09	6.821e-3	0.0121	(B) Positive
C9ORF72	9p21.2	0.17	-0.02	0.67	0.58	0.19	6.825e-3	0.0121	(A) Negative
GSDMB	17q21.1	-0.45	-0.77	1.13	1.05	0.32	6.862e-3	0.0121	(A) Negative
PPP2R2C	4p16.1	-0.13	0.41	1.86	1.94	-0.54	6.865e-3	0.0121	(B) Positive
RENBP	Xq28	0.78	0.57	0.75	0.64	0.21	6.865e-3	0.0121	(A) Negative
IRF7	11p15.5	1.20	1.40	0.73	0.55	-0.20	6.868e-3	0.0121	(B) Positive
NBPF15	1q21.1	-0.44	-0.27	0.57	0.58	-0.16	6.880e-3	0.0122	(B) Positive
C9ORF50	9q34.11	0.01	0.15	0.50	0.56	-0.15	6.904e-3	0.0122	(B) Positive
NRCAM	7q31.1	-1.97	-1.66	1.08	1.20	-0.32	6.907e-3	0.0122	(B) Positive
TFAP2B	6p12.3	0.80	1.65	2.93	3.08	-0.85	6.910e-3	0.0122	(B) Positive
VDR	12q13.11	2.46	2.26	0.71	0.68	0.20	6.923e-3	0.0122	(A) Negative
CADM4	19q13.31	0.97	0.76	0.75	0.60	0.21	6.930e-3	0.0122	(A) Negative
VGLL4	3p25.3-p25.2	1.11	0.98	0.48	0.34	0.13	6.933e-3	0.0122	(A) Negative
SPPL2C	17q21.31	0.03	0.13	0.39	0.36	-0.11	6.939e-3	0.0122	(B) Positive
ESYT1	12q13.2	0.01	0.12	0.41	0.38	-0.12	6.943e-3	0.0123	(B) Positive
ANO10	3p22.1-p21.33	-0.23	-0.04	0.69	0.56	-0.19	6.973e-3	0.0123	(B) Positive
CPA1	7q32.2	0.05	0.17	0.39	0.46	-0.12	6.997e-3	0.0123	(B) Positive
ZNF549	19q13.43	0.27	0.52	0.87	0.90	-0.25	7.020e-3	0.0124	(B) Positive
NR2C1	12q22	-0.99	-1.15	0.54	0.55	0.16	7.027e-3	0.0124	(A) Negative
OGT	Xq13.1	-0.63	-0.76	0.46	0.44	0.13	7.040e-3	0.0124	(A) Negative
AP5S1	20p13	0.10	0.27	0.61	0.53	-0.17	7.042e-3	0.0124	(B) Positive
KRTDAP	19q13.12	-0.49	-0.94	1.69	1.07	0.45	7.076e-3	0.0125	(A) Negative
GDF3	12p13.31	-3.64	-3.77	0.46	0.39	0.13	7.079e-3	0.0125	(A) Negative
TP53RK	20q13.12	0.57	0.44	0.45	0.50	0.13	7.104e-3	0.0125	(A) Negative
PPFIA1	11q13.3	-0.03	0.15	0.58	0.83	-0.18	7.107e-3	0.0125	(B) Positive
DOK6	18q22.2	-1.69	-1.40	1.08	0.92	-0.30	7.113e-3	0.0125	(B) Positive
NDUFS7	19p13.3	-0.15	-0.01	0.50	0.41	-0.14	7.128e-3	0.0126	(B) Positive
TRIM72	16p11.2	0.33	0.42	0.32	0.38	-0.09	7.129e-3	0.0126	(B) Positive
SNTA1	20q11.21	-0.10	0.11	0.76	0.62	-0.21	7.139e-3	0.0126	(B) Positive
OR10AD1	12q13.11	0.14	0.32	0.63	0.59	-0.18	7.144e-3	0.0126	(B) Positive
OR2D2	11p15.4	0.47	0.34	0.47	0.49	0.13	7.148e-3	0.0126	(A) Negative
N4BP2L2	13q13.1	-0.23	-0.03	0.69	0.59	-0.19	7.154e-3	0.0126	(B) Positive
TMEM119	12q23.3	1.35	1.56	0.77	0.71	-0.22	7.160e-3	0.0126	(B) Positive
KRTAP12-1	21q22.3	0.04	0.12	0.26	0.28	-0.08	7.185e-3	0.0127	(B) Positive
AZIN1	8q22.3	0.39	0.22	0.60	0.58	0.17	7.190e-3	0.0127	(A) Negative
NRBP1	2p23.3	0.21	0.06	0.54	0.47	0.15	7.191e-3	0.0127	(A) Negative
HGS	17q25.3	0.17	0.06	0.39	0.42	0.11	7.210e-3	0.0127	(A) Negative
GAP43	3q13.31	-2.90	-2.68	0.78	0.76	-0.22	7.254e-3	0.0128	(B) Positive
SET	9q34.11	-0.39	-0.56	0.63	0.50	0.17	7.292e-3	0.0128	(A) Negative
UNC119B	12q24.31	-0.36	-0.23	0.44	0.45	-0.13	7.321e-3	0.0129	(B) Positive
SKAP2	7p15.2	0.20	-0.02	0.77	0.70	0.22	7.335e-3	0.0129	(A) Negative
PABPC1L2B	Xq13.2	0.21	0.10	0.37	0.34	0.10	7.341e-3	0.0129	(A) Negative
USH1C	11p15.1	-1.01	-1.21	0.77	0.46	0.20	7.395e-3	0.0130	(A) Negative
SRPRA	11q24.2	0.06	-0.08	0.52	0.46	0.14	7.411e-3	0.0130	(A) Negative
JPH1	8q21.11	0.29	0.05	0.80	0.90	0.23	7.414e-3	0.0130	(A) Negative
SERPINF1	17p13.3	0.25	0.53	0.99	1.08	-0.29	7.422e-3	0.0131	(B) Positive
ITGA2B	17q21.31	-0.57	-0.71	0.52	0.39	0.14	7.425e-3	0.0131	(A) Negative
DHRS13	17q11.2	-0.36	-0.14	0.80	0.75	-0.22	7.429e-3	0.0131	(B) Positive
TUT7	9q21.33	0.41	0.27	0.54	0.42	0.15	7.440e-3	0.0131	(A) Negative
GMCL1	2p13.3	0.05	-0.09	0.52	0.49	0.15	7.451e-3	0.0131	(A) Negative
PARP2	14q11.2	-0.65	-0.81	0.58	0.46	0.16	7.455e-3	0.0131	(A) Negative
HSF5	17q22	0.40	0.28	0.46	0.45	0.13	7.463e-3	0.0131	(A) Negative
OR5L1	11q12.1	0.88	0.66	0.78	0.67	0.22	7.472e-3	0.0131	(A) Negative
KCNAB2	1p36.31	-0.45	-0.55	0.35	0.36	0.10	7.472e-3	0.0131	(A) Negative
RAB8A	19p13.11	0.18	0.33	0.52	0.50	-0.15	7.499e-3	0.0132	(B) Positive
NRG4	15q24.2	-2.07	-2.31	0.88	0.62	0.23	7.508e-3	0.0132	(A) Negative
RGS3	9q32	0.21	0.35	0.53	0.49	-0.15	7.509e-3	0.0132	(B) Positive
GREM2	1q43	-0.56	-0.26	1.07	0.92	-0.29	7.510e-3	0.0132	(B) Positive
PABIR3	Xq26.3	-0.61	-0.83	0.80	0.74	0.22	7.522e-3	0.0132	(A) Negative
KLF1	19p13.13	-2.47	-2.57	0.36	0.30	0.10	7.525e-3	0.0132	(A) Negative
FIBIN	11p14.2	2.44	2.71	0.94	0.98	-0.27	7.533e-3	0.0132	(B) Positive
LSS	21q22.3	-0.91	-1.09	0.63	0.58	0.18	7.551e-3	0.0133	(A) Negative
AK1	9q34.11	0.11	0.26	0.57	0.47	-0.15	7.561e-3	0.0133	(B) Positive
TNFSF14	19p13.3	-0.31	-0.50	0.67	0.63	0.19	7.578e-3	0.0133	(A) Negative
ACOX1	17q25.1	0.42	0.26	0.62	0.47	0.17	7.583e-3	0.0133	(A) Negative
PLP2	Xp11.23	0.13	-0.05	0.65	0.58	0.18	7.585e-3	0.0133	(A) Negative
SRMS	20q13.33	0.32	0.42	0.34	0.41	-0.10	7.595e-3	0.0133	(B) Positive
IFNGR2	21q22.11	1.18	1.02	0.57	0.45	0.15	7.618e-3	0.0134	(A) Negative
REV1	2q11.2	-0.06	-0.17	0.41	0.32	0.11	7.626e-3	0.0134	(A) Negative
ACOT12	5q14.1	-0.14	-0.06	0.30	0.33	-0.09	7.669e-3	0.0135	(B) Positive
SMG6	17p13.3	0.15	0.27	0.44	0.35	-0.12	7.672e-3	0.0135	(B) Positive
PRPF38B	1p13.3	-0.55	-0.66	0.38	0.34	0.10	7.697e-3	0.0135	(A) Negative
HLA-G	6p22.1	1.46	1.26	0.72	0.58	0.20	7.698e-3	0.0135	(A) Negative
TVP23B	17p11.2	0.06	0.22	0.59	0.56	-0.17	7.720e-3	0.0135	(B) Positive
HTRA2	2p13.1	-0.13	-0.22	0.35	0.35	0.10	7.725e-3	0.0135	(A) Negative
LIPN	10q23.31	0.24	0.12	0.45	0.46	0.13	7.726e-3	0.0135	(A) Negative
SH2D3C	9q34.11	1.23	1.42	0.65	0.64	-0.18	7.731e-3	0.0136	(B) Positive
ZNF529	19q13.12	-0.32	-0.48	0.58	0.44	0.16	7.740e-3	0.0136	(A) Negative
SMG8	17q22	-0.32	-0.16	0.56	0.60	-0.16	7.745e-3	0.0136	(B) Positive
VAMP4	1q24.3	0.36	0.54	0.64	0.54	-0.18	7.746e-3	0.0136	(B) Positive
DNAH9	17p12	-0.80	-0.53	0.94	1.06	-0.27	7.793e-3	0.0137	(B) Positive
TMX1	14q22.1	-0.66	-0.49	0.63	0.49	-0.17	7.793e-3	0.0137	(B) Positive
OR56B1	11p15.4	0.41	0.34	0.25	0.31	0.07	7.793e-3	0.0137	(A) Negative
ATP6V1B1	2p13.3	0.60	0.84	0.80	1.01	-0.24	7.800e-3	0.0137	(B) Positive
ZNG1A	9p24.3	-0.10	0.08	0.65	0.66	-0.18	7.801e-3	0.0137	(B) Positive
COX6B1	19q13.12	0.41	0.27	0.53	0.45	0.15	7.832e-3	0.0137	(A) Negative
H3C2	6p22.2	-0.18	-0.33	0.52	0.66	0.16	7.836e-3	0.0137	(A) Negative
HMG20A	15q24.3	-0.60	-0.49	0.38	0.36	-0.11	7.843e-3	0.0137	(B) Positive
GJB7	6q14.3-q15	-0.91	-1.27	1.21	1.49	0.36	7.844e-3	0.0137	(A) Negative
FYB1	5p13.1	0.77	0.47	1.08	0.93	0.30	7.858e-3	0.0138	(A) Negative
SYT16	14q23.2	0.18	-0.01	0.65	0.75	0.19	7.860e-3	0.0138	(A) Negative
ADARB1	21q22.3	-0.67	-0.82	0.55	0.49	0.15	7.866e-3	0.0138	(A) Negative
TRIM24	7q33-q34	-0.64	-0.81	0.58	0.57	0.16	7.878e-3	0.0138	(A) Negative
TUBG2	17q21.2	-0.88	-0.74	0.49	0.52	-0.14	7.880e-3	0.0138	(B) Positive
RGS7	1q43	-1.56	-1.33	0.76	1.00	-0.23	7.884e-3	0.0138	(B) Positive
HEYL	1p34.2	2.88	3.03	0.55	0.53	-0.15	7.887e-3	0.0138	(B) Positive
MCRIP2	16p13.3	-0.44	-0.28	0.56	0.56	-0.16	7.899e-3	0.0138	(B) Positive
MAST2	1p34.1	0.29	0.14	0.53	0.46	0.15	7.904e-3	0.0138	(A) Negative
DOCK11	Xq24	-0.73	-0.97	0.90	0.84	0.25	7.911e-3	0.0138	(A) Negative
MT1M	16q13	0.22	-0.09	1.17	0.96	0.32	7.915e-3	0.0138	(A) Negative
METTL22	16p13.2	-0.78	-0.65	0.47	0.40	-0.13	7.939e-3	0.0139	(B) Positive
AP4M1	7q22.1	0.22	0.11	0.42	0.40	0.12	7.948e-3	0.0139	(A) Negative
JAZF1	7p15.2-p15.1	0.16	-0.02	0.63	0.57	0.17	7.949e-3	0.0139	(A) Negative
IRF6	1q32.2	4.18	4.01	0.56	0.65	0.16	7.966e-3	0.0139	(A) Negative
THAP11	16q22.1	0.10	-0.03	0.48	0.39	0.13	8.002e-3	0.0140	(A) Negative
TMEM17	2p15	1.26	1.06	0.70	0.64	0.19	8.005e-3	0.0140	(A) Negative
DNAAF2	14q21.3	-0.07	-0.21	0.53	0.46	0.14	8.009e-3	0.0140	(A) Negative
ZNF469	16q24.2	3.13	2.81	1.16	1.05	0.32	8.018e-3	0.0140	(A) Negative
SRP72	4q12	-0.01	-0.14	0.46	0.38	0.12	8.025e-3	0.0140	(A) Negative
SCYL2	12q23.1	0.42	0.30	0.46	0.41	0.13	8.050e-3	0.0141	(A) Negative
TTC32	2p24.1	-0.94	-1.15	0.75	0.82	0.21	8.051e-3	0.0141	(A) Negative
MKRN1	7q34	0.13	0.25	0.41	0.38	-0.11	8.066e-3	0.0141	(B) Positive
EMB	5q11.1	-0.86	-0.55	1.13	1.12	-0.32	8.069e-3	0.0141	(B) Positive
C11ORF16	11p15.4	1.10	0.79	1.17	0.84	0.31	8.075e-3	0.0141	(A) Negative
DOK2	8p21.3	1.85	1.57	1.02	0.90	0.28	8.080e-3	0.0141	(A) Negative
PLXNA2	1q32.2	1.13	0.92	0.78	0.61	0.21	8.089e-3	0.0141	(A) Negative
GPSM3	6p21.32	0.72	0.55	0.63	0.60	0.17	8.099e-3	0.0141	(A) Negative
TNS1	2q35	0.24	0.13	0.41	0.34	0.11	8.103e-3	0.0142	(A) Negative
WNT7B	22q13.31	0.75	1.08	1.20	1.03	-0.33	8.105e-3	0.0142	(B) Positive
EFNA3	1q21.3	0.26	0.01	0.89	0.93	0.25	8.118e-3	0.0142	(A) Negative
ZNF672	1q44	0.29	0.14	0.55	0.42	0.15	8.127e-3	0.0142	(A) Negative
FIG4	6q21	0.72	0.94	0.79	0.78	-0.22	8.130e-3	0.0142	(B) Positive
CLPTM1L	5p15.33	0.11	-0.03	0.55	0.45	0.15	8.130e-3	0.0142	(A) Negative
DHX37	12q24.31	-0.54	-0.66	0.47	0.43	0.13	8.150e-3	0.0142	(A) Negative
PIK3C2A	11p15.1	-0.05	0.14	0.67	0.66	-0.19	8.167e-3	0.0143	(B) Positive
BDNF	11p14.1	-3.39	-3.09	0.92	1.39	-0.29	8.215e-3	0.0143	(B) Positive
DPP4	2q24.2	0.00	-0.32	1.19	1.02	0.32	8.216e-3	0.0143	(A) Negative
NIBAN3	19p13.11	0.67	0.42	0.93	0.77	0.25	8.219e-3	0.0143	(A) Negative
CASC3	17q21.1	0.13	0.33	0.73	0.64	-0.20	8.234e-3	0.0144	(B) Positive
ACOT8	20q13.12	-0.07	0.09	0.55	0.54	-0.15	8.237e-3	0.0144	(B) Positive
GAS2L2	17q12	0.21	0.41	0.71	0.73	-0.20	8.245e-3	0.0144	(B) Positive
ITPR3	6p21.31	-0.42	-0.62	0.76	0.56	0.20	8.255e-3	0.0144	(A) Negative
COL16A1	1p35.2	0.95	1.22	1.01	0.92	-0.28	8.264e-3	0.0144	(B) Positive
OPLAH	8q24.3	0.31	0.63	1.19	0.94	-0.32	8.283e-3	0.0144	(B) Positive
GRIN2A	16p13.2	-0.71	-0.85	0.52	0.36	0.14	8.294e-3	0.0145	(A) Negative
PPP1R16B	20q11.23	0.30	0.13	0.62	0.54	0.17	8.296e-3	0.0145	(A) Negative
ALG13	Xq23	-1.13	-0.95	0.67	0.67	-0.19	8.297e-3	0.0145	(B) Positive
SCFD2	4q12	0.11	-0.02	0.47	0.40	0.13	8.306e-3	0.0145	(A) Negative
C1QB	1p36.12	3.36	3.21	0.56	0.53	0.15	8.307e-3	0.0145	(A) Negative
ISY1	3q21.3	-0.09	-0.22	0.49	0.37	0.13	8.313e-3	0.0145	(A) Negative
OR4X2	11p11.2	0.38	0.31	0.22	0.23	0.06	8.318e-3	0.0145	(A) Negative
B3GALT5	21q22.2	0.22	0.42	0.70	0.82	-0.20	8.327e-3	0.0145	(B) Positive
SH3GL2	9p22.2	-1.20	-1.72	1.94	1.52	0.52	8.335e-3	0.0145	(A) Negative
PRSS8	16p11.2	2.30	2.50	0.70	0.77	-0.20	8.336e-3	0.0145	(B) Positive
RBM41	Xq22.3	-0.80	-0.94	0.52	0.51	0.14	8.340e-3	0.0145	(A) Negative
OSMR	5p13.1	-0.51	-0.78	1.04	0.71	0.27	8.342e-3	0.0145	(A) Negative
IL10RA	11q23.3	1.03	0.81	0.82	0.70	0.22	8.354e-3	0.0145	(A) Negative
NRGN	11q24.2	-0.80	-0.95	0.54	0.49	0.15	8.355e-3	0.0145	(A) Negative
PROKR2	20p12.3	0.23	0.34	0.39	0.36	-0.11	8.359e-3	0.0146	(B) Positive
FAM53C	5q31.2	0.02	-0.09	0.44	0.34	0.12	8.363e-3	0.0146	(A) Negative
MYORG	9p13.3	0.35	0.12	0.85	0.72	0.23	8.370e-3	0.0146	(A) Negative
BRAP	12q24.12	0.03	-0.08	0.38	0.35	0.10	8.373e-3	0.0146	(A) Negative
HSF1	8q24.3	0.50	0.34	0.59	0.58	0.16	8.374e-3	0.0146	(A) Negative
AIRE	21q22.3	0.29	0.21	0.27	0.30	0.08	8.387e-3	0.0146	(A) Negative
JUNB	19p13.13	0.99	1.16	0.60	0.75	-0.18	8.390e-3	0.0146	(B) Positive
LAYN	11q23.1	1.07	1.29	0.81	0.76	-0.22	8.420e-3	0.0146	(B) Positive
LGALS8	1q43	-0.07	0.18	0.96	0.75	-0.26	8.429e-3	0.0147	(B) Positive
KCNJ6	21q22.13	0.82	0.48	1.21	1.22	0.34	8.439e-3	0.0147	(A) Negative
NFATC2IP	16p11.2	-0.50	-0.39	0.37	0.40	-0.11	8.440e-3	0.0147	(B) Positive
UTP3	4q13.3	-0.19	-0.04	0.57	0.45	-0.15	8.457e-3	0.0147	(B) Positive
ZNF586	19q13.43	-0.16	0.02	0.66	0.54	-0.18	8.462e-3	0.0147	(B) Positive
GTPBP3	19p13.11	-0.47	-0.66	0.70	0.63	0.19	8.507e-3	0.0148	(A) Negative
SOX6	11p15.2	0.32	0.07	0.88	0.80	0.24	8.531e-3	0.0148	(A) Negative
ISOC2	19q13.42	-0.19	-0.35	0.58	0.58	0.16	8.535e-3	0.0148	(A) Negative
S100A13	1q21.3	0.21	0.43	0.81	0.72	-0.22	8.542e-3	0.0148	(B) Positive
RAB40B	17q25.3	1.25	1.04	0.76	0.57	0.20	8.559e-3	0.0149	(A) Negative
OR8J3	11q12.1	0.12	0.27	0.50	0.67	-0.15	8.568e-3	0.0149	(B) Positive
POLR2K	8q22.2	0.81	0.64	0.59	0.66	0.17	8.590e-3	0.0149	(A) Negative
SNCG	10q23.2	0.67	1.01	1.24	1.21	-0.34	8.591e-3	0.0149	(B) Positive
MT1B	16q13	-0.67	-0.97	1.12	0.96	0.30	8.591e-3	0.0149	(A) Negative
TAFAZZIN	Xq28	-0.71	-0.83	0.42	0.49	0.12	8.606e-3	0.0149	(A) Negative
EIF1B	3p22.1	-0.65	-0.49	0.58	0.52	-0.16	8.616e-3	0.0150	(B) Positive
PON3	7q21.3	0.07	-0.49	1.90	2.45	0.56	8.633e-3	0.0150	(A) Negative
SAFB2	19p13.3	-0.14	-0.02	0.43	0.39	-0.12	8.656e-3	0.0150	(B) Positive
SZT2	1p34.2	0.11	-0.01	0.43	0.41	0.12	8.663e-3	0.0150	(A) Negative
ITGA10	1q21.1	0.43	0.22	0.77	0.56	0.20	8.666e-3	0.0150	(A) Negative
ZC3HC1	7q32.2	-0.78	-0.90	0.47	0.33	0.12	8.692e-3	0.0151	(A) Negative
SPATA13	13q12.12	0.69	0.97	1.01	0.98	-0.28	8.693e-3	0.0151	(B) Positive
LACTB2	8q13.3	-0.43	-0.63	0.69	0.78	0.20	8.711e-3	0.0151	(A) Negative
C2CD4C	19p13.3	-0.85	-0.52	1.22	1.10	-0.33	8.723e-3	0.0151	(B) Positive
XKR4	8q12.1	-0.32	-0.56	0.92	0.65	0.24	8.736e-3	0.0152	(A) Negative
LTF	3p21.31	3.18	2.69	1.71	1.97	0.49	8.745e-3	0.0152	(A) Negative
KRTCAP3	2p23.3	2.69	2.31	1.39	1.33	0.38	8.748e-3	0.0152	(A) Negative
ADPRM	17p13.1	-0.32	-0.17	0.55	0.53	-0.15	8.749e-3	0.0152	(B) Positive
EHD3	2p23.1	-0.05	0.10	0.56	0.55	-0.15	8.752e-3	0.0152	(B) Positive
TET2	4q24	0.43	0.26	0.62	0.46	0.16	8.764e-3	0.0152	(A) Negative
SH3PXD2A	10q24.33	0.15	-0.05	0.71	0.69	0.20	8.764e-3	0.0152	(A) Negative
ZSCAN20	1p35.1	-0.40	-0.59	0.70	0.53	0.19	8.776e-3	0.0152	(A) Negative
CA3	8q21.2	1.68	1.16	1.90	1.76	0.52	8.784e-3	0.0152	(A) Negative
CCL23	17q12	1.13	0.91	0.83	0.79	0.23	8.842e-3	0.0153	(A) Negative
HTR1B	6q14.1	0.27	0.19	0.29	0.29	0.08	8.855e-3	0.0153	(A) Negative
BCL3	19q13.32	1.30	1.50	0.74	0.58	-0.20	8.864e-3	0.0154	(B) Positive
SLC39A7	6p21.32	-0.52	-0.71	0.66	0.71	0.19	8.865e-3	0.0154	(A) Negative
DPM2	9q34.11	0.03	0.15	0.44	0.40	-0.12	8.868e-3	0.0154	(B) Positive
POU4F2	4q31.22	0.21	0.33	0.43	0.45	-0.12	8.887e-3	0.0154	(B) Positive
CCDC6	10q21.2	1.56	1.37	0.72	0.54	0.19	8.891e-3	0.0154	(A) Negative
HDLBP	2q37.3	0.68	0.56	0.45	0.36	0.12	8.894e-3	0.0154	(A) Negative
SBNO2	19p13.3	0.52	0.38	0.52	0.56	0.15	8.896e-3	0.0154	(A) Negative
WT1-AS	11p13	-1.58	-1.95	1.36	1.34	0.37	8.908e-3	0.0154	(A) Negative
RPS18	6p21.32	0.20	0.05	0.54	0.51	0.15	8.928e-3	0.0155	(A) Negative
NSMCE3	15q13.1	0.38	0.50	0.45	0.46	-0.13	8.932e-3	0.0155	(B) Positive
LMO7	13q22.2	-0.56	-0.79	0.89	0.69	0.23	8.935e-3	0.0155	(A) Negative
WFDC1	16q24.1	-1.01	-1.38	1.46	0.96	0.38	8.953e-3	0.0155	(A) Negative
CLN6	15q23	-0.12	-0.26	0.50	0.49	0.14	8.956e-3	0.0155	(A) Negative
SLK	10q24.33-q25.1	0.17	0.31	0.55	0.41	-0.14	8.979e-3	0.0155	(B) Positive
TNPO3	7q32.1	-0.51	-0.67	0.62	0.54	0.17	8.992e-3	0.0156	(A) Negative
CD300LB	17q25.1	0.66	0.73	0.26	0.34	-0.08	9.033e-3	0.0156	(B) Positive
KCNT2	1q31.3	0.17	0.02	0.51	0.53	0.14	9.039e-3	0.0156	(A) Negative
NRG3	10q23.1	0.49	0.25	0.87	0.75	0.23	9.042e-3	0.0156	(A) Negative
ITFG1	16q12.1	-0.27	-0.09	0.65	0.58	-0.18	9.044e-3	0.0156	(B) Positive
FAM131C	1p36.13	0.85	0.70	0.52	0.56	0.15	9.080e-3	0.0157	(A) Negative
PDE1B	12q13.2	0.76	0.91	0.55	0.57	-0.15	9.092e-3	0.0157	(B) Positive
CCNL1	3q25.31	-0.88	-1.03	0.53	0.49	0.14	9.103e-3	0.0157	(A) Negative
SYCP2	20q13.33	0.06	0.48	1.55	1.43	-0.42	9.122e-3	0.0158	(B) Positive
CACNA1A	19p13.13	0.39	0.32	0.25	0.30	0.07	9.135e-3	0.0158	(A) Negative
MBD4	3q21.3	0.03	-0.10	0.48	0.36	0.13	9.150e-3	0.0158	(A) Negative
LGALS9	17q11.2	2.09	1.87	0.80	0.66	0.21	9.153e-3	0.0158	(A) Negative
NUP58	13q12.13	-0.42	-0.55	0.49	0.46	0.13	9.163e-3	0.0158	(A) Negative
RAB3IL1	11q12.2-q12.3	0.49	0.29	0.73	0.59	0.19	9.217e-3	0.0159	(A) Negative
ADO	10q21.3	0.28	0.42	0.54	0.48	-0.15	9.217e-3	0.0159	(B) Positive
PTPN11	12q24.13	0.06	-0.07	0.48	0.41	0.13	9.238e-3	0.0160	(A) Negative
CLIP1	12q24.31	0.66	0.82	0.60	0.58	-0.16	9.248e-3	0.0160	(B) Positive
OR13F1	9q31.1	0.44	0.36	0.31	0.30	0.09	9.300e-3	0.0161	(A) Negative
ZNF326	1p22.2	0.04	-0.08	0.44	0.48	0.12	9.301e-3	0.0161	(A) Negative
UTP25	1q32.2	0.76	0.59	0.61	0.54	0.16	9.311e-3	0.0161	(A) Negative
PACSIN2	22q13.2	0.12	-0.06	0.66	0.62	0.18	9.316e-3	0.0161	(A) Negative
MLC1	22q13.33	-0.99	-1.50	1.99	1.31	0.51	9.354e-3	0.0162	(A) Negative
XCR1	3p21.31	0.40	0.50	0.35	0.47	-0.11	9.363e-3	0.0162	(B) Positive
ACTL7A	9q31.3	0.37	0.29	0.29	0.30	0.08	9.372e-3	0.0162	(A) Negative
PCDHB2	5q31.3	0.15	-0.41	2.15	1.71	0.57	9.379e-3	0.0162	(A) Negative
GPNMB	7p15.3	1.05	0.76	1.06	0.99	0.29	9.391e-3	0.0162	(A) Negative
LMOD1	1q32.1	2.69	2.90	0.79	0.69	-0.21	9.394e-3	0.0162	(B) Positive
OR4K15	14q11.2	0.35	0.48	0.43	0.59	-0.13	9.394e-3	0.0162	(B) Positive
PLCL2	3p24.3	-0.28	-0.56	1.03	0.86	0.27	9.406e-3	0.0162	(A) Negative
PAK2	3q29	0.01	-0.12	0.48	0.41	0.13	9.421e-3	0.0163	(A) Negative
NODAL	10q22.1	-0.05	-0.13	0.29	0.29	0.08	9.435e-3	0.0163	(A) Negative
RHOG	11p15.4	0.29	0.16	0.47	0.38	0.12	9.454e-3	0.0163	(A) Negative
FCRL1	1q23.1	0.40	0.23	0.61	0.60	0.17	9.463e-3	0.0163	(A) Negative
GJB1	Xq13.1	-2.26	-1.92	1.21	1.32	-0.34	9.466e-3	0.0163	(B) Positive
DEFB106B	8p23.1	0.17	0.10	0.25	0.28	0.07	9.472e-3	0.0163	(A) Negative
SELE	1q24.2	4.20	3.75	1.67	1.59	0.45	9.481e-3	0.0164	(A) Negative
FAM131A	3q27.1	-0.00	-0.13	0.48	0.40	0.13	9.486e-3	0.0164	(A) Negative
ZNF510	9q22.33	-0.14	-0.02	0.41	0.44	-0.11	9.491e-3	0.0164	(B) Positive
MYH9	22q12.3	1.23	1.06	0.64	0.53	0.17	9.493e-3	0.0164	(A) Negative
TIGD4	4q31.3	-0.22	-0.03	0.71	0.62	-0.19	9.494e-3	0.0164	(B) Positive
SH3GL1	19p13.3	-0.25	-0.35	0.35	0.37	0.10	9.511e-3	0.0164	(A) Negative
MYOM2	8p23.3	-0.59	-0.25	1.25	1.12	-0.34	9.521e-3	0.0164	(B) Positive
PI4KAP2	22q11.21	-2.10	-1.95	0.53	0.62	-0.15	9.522e-3	0.0164	(B) Positive
HEY1	8q21.13	-1.98	-1.72	0.96	0.97	-0.26	9.536e-3	0.0164	(B) Positive
SLC39A13	11p11.2	0.69	0.83	0.51	0.43	-0.13	9.548e-3	0.0165	(B) Positive
GNGT2	17q21.32	1.34	1.18	0.61	0.49	0.16	9.552e-3	0.0165	(A) Negative
SPTA1	1q23.1	-4.60	-4.78	0.68	0.63	0.18	9.595e-3	0.0165	(A) Negative
TTTY9A	Yq11.222	0.15	0.28	0.41	0.59	-0.13	9.596e-3	0.0165	(B) Positive
FKBP5	6p21.31	0.42	0.14	1.05	1.03	0.29	9.610e-3	0.0166	(A) Negative
SMARCD3	7q36.1	0.62	0.93	1.17	0.88	-0.30	9.624e-3	0.0166	(B) Positive
EEF1E1	6p24.3	-1.19	-1.35	0.59	0.54	0.16	9.627e-3	0.0166	(A) Negative
ZFP36	19q13.2	1.07	1.33	0.92	0.96	-0.25	9.631e-3	0.0166	(B) Positive
TMEM138	11q12.2	-0.06	-0.21	0.56	0.45	0.15	9.641e-3	0.0166	(A) Negative
SLC7A5P2	16p12.2	-2.38	-2.57	0.67	0.68	0.18	9.663e-3	0.0166	(A) Negative
SEC31B	10q24.31	-2.24	-2.06	0.63	0.71	-0.18	9.667e-3	0.0166	(B) Positive
IFT80	3q25.33	-0.32	-0.44	0.47	0.41	0.12	9.676e-3	0.0167	(A) Negative
TRAF6	11p12	0.73	0.60	0.47	0.39	0.12	9.678e-3	0.0167	(A) Negative
SERPINA12	14q32.13	0.23	0.05	0.68	0.48	0.18	9.679e-3	0.0167	(A) Negative
RSBN1L	7q11.23	-0.02	0.09	0.41	0.45	-0.11	9.692e-3	0.0167	(B) Positive
LY96	8q21.11	0.21	-0.02	0.87	0.79	0.23	9.700e-3	0.0167	(A) Negative
FBXO31	16q24.2	-0.36	-0.47	0.38	0.37	0.10	9.708e-3	0.0167	(A) Negative
JUP	17q21.2	1.22	1.39	0.63	0.57	-0.17	9.732e-3	0.0167	(B) Positive
EFHC2	Xp11.3	0.39	0.66	1.00	1.08	-0.28	9.736e-3	0.0167	(B) Positive
ATP6V1F	7q32.1	0.21	0.11	0.38	0.33	0.10	9.752e-3	0.0168	(A) Negative
USP36	17q25.3	-0.03	-0.22	0.73	0.66	0.20	9.756e-3	0.0168	(A) Negative
DPY19L4	8q22.1	0.56	0.72	0.59	0.59	-0.16	9.778e-3	0.0168	(B) Positive
ZKSCAN8	6p21	0.03	-0.10	0.49	0.49	0.13	9.781e-3	0.0168	(A) Negative
LY86	6p25.1	0.67	0.90	0.88	0.68	-0.23	9.782e-3	0.0168	(B) Positive
TSPOAP1	17q22	0.79	1.06	1.00	0.95	-0.27	9.783e-3	0.0168	(B) Positive
ANO3	11p14.2	0.38	0.86	1.61	2.24	-0.48	9.804e-3	0.0169	(B) Positive
SHE	1q21.3	1.44	1.63	0.71	0.70	-0.19	9.820e-3	0.0169	(B) Positive
KRTAP13-4	21q22.11	0.59	0.51	0.30	0.26	0.08	9.831e-3	0.0169	(A) Negative
TMCO3	13q34	-0.29	-0.07	0.82	0.69	-0.22	9.831e-3	0.0169	(B) Positive
GNB2	7q22.1	0.15	0.29	0.51	0.52	-0.14	9.835e-3	0.0169	(B) Positive
DMAC1	9p24.1	0.17	0.01	0.61	0.53	0.16	9.859e-3	0.0169	(A) Negative
TNFRSF10A	8p21.3	0.24	0.03	0.73	0.78	0.20	9.872e-3	0.0170	(A) Negative
GAA	17q25.3	0.55	0.73	0.68	0.59	-0.18	9.908e-3	0.0170	(B) Positive
NFAM1	22q13.2	0.42	0.35	0.23	0.25	0.06	9.925e-3	0.0170	(A) Negative
SGCA	17q21.33	0.44	0.64	0.73	0.78	-0.20	9.926e-3	0.0170	(B) Positive
SMARCC1	3p21.31	0.03	-0.16	0.73	0.52	0.19	9.926e-3	0.0170	(A) Negative
KIF2B	17q22	-0.06	0.07	0.44	0.46	-0.12	9.928e-3	0.0170	(B) Positive
PYGM	11q13.1	-0.48	-0.35	0.42	0.62	-0.13	9.933e-3	0.0171	(B) Positive
GJA4	1p34.3	3.12	3.29	0.64	0.58	-0.17	9.949e-3	0.0171	(B) Positive
UFM1	13q13.3	0.59	0.74	0.55	0.45	-0.15	9.960e-3	0.0171	(B) Positive
RASA4	7q22.1	0.09	0.26	0.64	0.64	-0.17	9.980e-3	0.0171	(B) Positive
SLC7A10	19q13.11	1.31	0.98	1.19	1.36	0.34	9.980e-3	0.0171	(A) Negative
NPPB	1p36.22	-2.64	-2.81	0.69	0.47	0.18	9.981e-3	0.0171	(A) Negative
HYLS1	11q24.2	-0.18	-0.36	0.66	0.54	0.17	0.0100	0.0172	(A) Negative
RFTN2	2q33.1	1.81	2.07	0.96	0.89	-0.26	0.0100	0.0172	(B) Positive
ARMC10	7q22.1	-0.05	-0.17	0.48	0.41	0.13	0.0100	0.0172	(A) Negative
SIPA1L1	14q24.2	0.17	0.03	0.50	0.46	0.13	0.0100	0.0172	(A) Negative
CWC27	5q12.3	-0.77	-0.66	0.40	0.36	-0.11	0.0101	0.0173	(B) Positive
LRIT2	10q23.1	0.15	0.33	0.60	0.79	-0.18	0.0101	0.0173	(B) Positive
GAS6	13q34	0.14	0.42	1.08	0.86	-0.28	0.0101	0.0174	(B) Positive
TTLL10	1p36.33	0.20	0.04	0.61	0.54	0.16	0.0101	0.0174	(A) Negative
SSPOP	7q36.1	-0.68	-0.45	0.86	0.95	-0.24	0.0102	0.0174	(B) Positive
CYP24A1	20q13.2	-2.84	-3.12	1.01	1.10	0.28	0.0102	0.0174	(A) Negative
ZSCAN25	7q22.1	-0.31	-0.41	0.38	0.37	0.10	0.0102	0.0174	(A) Negative
POLR2B	4q12	0.08	-0.07	0.58	0.48	0.15	0.0102	0.0175	(A) Negative
ACP2	11p11.2	0.38	0.56	0.62	0.67	-0.17	0.0102	0.0175	(B) Positive
ZSCAN12	6p22.1	-0.04	0.11	0.53	0.52	-0.14	0.0102	0.0176	(B) Positive
WDR70	5p13.2	-0.14	-0.27	0.50	0.38	0.13	0.0103	0.0176	(A) Negative
SEMA4A	1q22	1.41	1.27	0.49	0.52	0.13	0.0103	0.0176	(A) Negative
VIP	6q25.2	0.35	0.46	0.41	0.47	-0.12	0.0103	0.0177	(B) Positive
TMEM234	1p35.2	0.33	0.22	0.42	0.35	0.11	0.0103	0.0177	(A) Negative
DDX59	1q32.1	0.32	0.45	0.48	0.40	-0.13	0.0103	0.0177	(B) Positive
HCK	20q11.21	3.57	3.34	0.87	0.74	0.23	0.0104	0.0177	(A) Negative
UBIAD1	1p36.22	-0.08	0.07	0.59	0.41	-0.15	0.0104	0.0178	(B) Positive
SDS	12q24.13	2.85	3.01	0.57	0.67	-0.16	0.0104	0.0178	(B) Positive
CREM	10p11.21	-0.26	-0.40	0.52	0.42	0.14	0.0104	0.0179	(A) Negative
MNX1	7q36.3	-1.25	-1.67	1.56	1.48	0.42	0.0104	0.0179	(A) Negative
POU2F3	11q23.3	1.91	1.61	1.16	0.85	0.30	0.0105	0.0179	(A) Negative
TRPA1	8q21.11	-3.54	-3.16	1.20	2.04	-0.39	0.0105	0.0179	(B) Positive
FLCN	17p11.2	-0.43	-0.56	0.47	0.48	0.13	0.0105	0.0179	(A) Negative
ELAVL4	1p33-p32.3	1.05	0.80	1.01	0.64	0.25	0.0105	0.0179	(A) Negative
PRR14	16p11.2	0.12	0.22	0.36	0.42	-0.10	0.0105	0.0179	(B) Positive
OR10A5	11p15.4	0.43	0.39	0.16	0.19	0.05	0.0105	0.0180	(A) Negative
ZMYM6	1p34.3	0.02	0.11	0.36	0.30	-0.09	0.0105	0.0180	(B) Positive
KLF7	2q33.3	0.88	0.69	0.69	0.76	0.19	0.0105	0.0180	(A) Negative
ABHD17C	15q25.1	0.03	0.24	0.77	0.84	-0.21	0.0105	0.0180	(B) Positive
ST7L	1p13.2	0.38	0.51	0.49	0.45	-0.13	0.0106	0.0181	(B) Positive
DENND6A	3p14.3	-0.08	0.04	0.44	0.44	-0.12	0.0106	0.0181	(B) Positive
GDF10	10q11.22	-0.23	0.16	1.38	1.54	-0.38	0.0106	0.0181	(B) Positive
IGF2-AS	11p15.5	-0.54	-0.33	0.82	0.60	-0.21	0.0106	0.0181	(B) Positive
CACYBP	1q25.1	-0.30	-0.44	0.52	0.50	0.14	0.0106	0.0181	(A) Negative
ZBTB49	4p16.3	0.17	0.31	0.51	0.53	-0.14	0.0106	0.0182	(B) Positive
CHCHD7	8q12.1	-0.08	-0.27	0.67	0.73	0.18	0.0107	0.0182	(A) Negative
WNT2	7q31.2	4.63	4.25	1.39	1.46	0.38	0.0107	0.0182	(A) Negative
LRRN2	1q32.1	1.23	1.60	1.41	1.24	-0.37	0.0107	0.0182	(B) Positive
CELF5	19p13.3	-0.06	-0.16	0.38	0.32	0.10	0.0107	0.0183	(A) Negative
ITLN2	1q23.3	-0.65	-0.88	0.90	0.69	0.23	0.0107	0.0183	(A) Negative
DDIT4L	4q24	1.86	1.48	1.44	1.31	0.38	0.0107	0.0183	(A) Negative
PDCL	9q33.2	0.25	0.14	0.42	0.36	0.11	0.0107	0.0183	(A) Negative
PHF21A	11p11.2	0.24	0.13	0.41	0.37	0.11	0.0108	0.0184	(A) Negative
CTPS2	Xp22.2	0.47	0.69	0.83	0.80	-0.22	0.0108	0.0184	(B) Positive
H3C11	6p22.1	0.46	0.36	0.38	0.41	0.11	0.0108	0.0185	(A) Negative
TAX1BP1	7p15.2	0.44	0.58	0.55	0.43	-0.14	0.0108	0.0185	(B) Positive
RABL2A	2q14.1	0.62	0.72	0.39	0.43	-0.11	0.0109	0.0185	(B) Positive
ITIH1	3p21.1	-1.02	-1.10	0.26	0.31	0.07	0.0109	0.0185	(A) Negative
TRAPPC8	18q12.1	0.11	0.25	0.53	0.51	-0.14	0.0109	0.0186	(B) Positive
ITPA	20p13	-0.12	-0.25	0.50	0.44	0.13	0.0109	0.0186	(A) Negative
SMAP2	1p34.2	-0.22	-0.08	0.53	0.43	-0.14	0.0109	0.0186	(B) Positive
MTFR1L	1p36.11	-0.05	0.05	0.40	0.38	-0.11	0.0109	0.0186	(B) Positive
LZTS1	8p21.3	-0.49	-0.69	0.75	0.73	0.20	0.0110	0.0187	(A) Negative
DNAH10	12q24.31	0.59	0.33	0.99	0.82	0.26	0.0110	0.0187	(A) Negative
HSD17B13	4q22.1	-0.60	-0.46	0.48	0.63	-0.14	0.0110	0.0187	(B) Positive
MED13	17q23.2	-0.14	-0.01	0.49	0.59	-0.14	0.0110	0.0188	(B) Positive
UBE2R2	9p13.3	0.47	0.33	0.54	0.44	0.14	0.0110	0.0188	(A) Negative
PARVG	22q13.31	1.00	0.76	0.92	0.77	0.24	0.0110	0.0188	(A) Negative
HORMAD2	22q12.2	0.23	0.09	0.55	0.38	0.14	0.0110	0.0188	(A) Negative
HOXD9	2q31.1	0.64	0.76	0.43	0.43	-0.12	0.0110	0.0188	(B) Positive
IL1B	2q14.1	1.04	0.73	1.18	1.06	0.31	0.0110	0.0188	(A) Negative
CDK5R2	2q35	0.68	0.59	0.33	0.36	0.09	0.0111	0.0188	(A) Negative
ADAD1	4q27	0.48	0.32	0.60	0.45	0.15	0.0111	0.0189	(A) Negative
CREBZF	11q14.1	-0.40	-0.22	0.71	0.54	-0.18	0.0111	0.0189	(B) Positive
SHISAL1	22q13.31	-1.68	-1.80	0.48	0.36	0.12	0.0111	0.0189	(A) Negative
CDH2	18q12.1	-2.96	-3.30	1.29	1.27	0.35	0.0111	0.0189	(A) Negative
OR52W1	11p15.4	0.13	0.22	0.33	0.29	-0.09	0.0111	0.0189	(B) Positive
GET1	21q22.2	-0.01	0.15	0.63	0.55	-0.16	0.0111	0.0189	(B) Positive
DLGAP1	18p11.31	0.88	0.46	1.61	1.39	0.42	0.0111	0.0189	(A) Negative
BSDC1	1p35.1	0.36	0.49	0.51	0.44	-0.13	0.0111	0.0189	(B) Positive
WDR38	9q33.3	0.21	0.34	0.45	0.65	-0.13	0.0111	0.0190	(B) Positive
WFDC6	20q13.12	0.68	1.00	1.15	1.30	-0.32	0.0111	0.0190	(B) Positive
TREML1	6p21.1	0.37	0.30	0.27	0.24	0.07	0.0111	0.0190	(A) Negative
KIF2A	5q12.1	-1.08	-1.24	0.59	0.53	0.16	0.0111	0.0190	(A) Negative
TNRC6B	22q13.1	0.53	0.40	0.48	0.44	0.13	0.0112	0.0190	(A) Negative
AHRR	5p15.33	-2.85	-3.06	0.76	0.73	0.20	0.0112	0.0190	(A) Negative
MMP13	11q22.2	2.74	3.32	2.19	2.07	-0.58	0.0112	0.0191	(B) Positive
AMBP	9q32	-4.88	-4.72	0.52	0.73	-0.15	0.0112	0.0191	(B) Positive
MAU2	19p13.11	-0.19	-0.03	0.58	0.56	-0.15	0.0112	0.0191	(B) Positive
ADAT3	19p13.3	0.61	0.48	0.53	0.45	0.14	0.0113	0.0192	(A) Negative
TMEM277P	19q13.33	0.89	0.69	0.72	0.72	0.19	0.0113	0.0192	(A) Negative
CAPN3	15q15.1	-1.49	-1.60	0.45	0.37	0.12	0.0113	0.0192	(A) Negative
FBXL18	7p22.1	-0.39	-0.53	0.54	0.51	0.14	0.0113	0.0192	(A) Negative
TBC1D10A	22q12.2	0.49	0.62	0.49	0.44	-0.13	0.0113	0.0192	(B) Positive
BCAR3	1p22.1	-0.88	-1.22	1.26	1.30	0.34	0.0113	0.0192	(A) Negative
ZNF302	19q13.11	0.03	0.20	0.67	0.52	-0.17	0.0113	0.0192	(B) Positive
PTCD1	7q22.1	-0.11	-0.23	0.45	0.42	0.12	0.0113	0.0193	(A) Negative
PPP1R17	7p14.3	-2.36	-2.62	1.04	0.71	0.26	0.0114	0.0193	(A) Negative
TAF10	11p15.4	-0.11	0.03	0.54	0.43	-0.14	0.0114	0.0193	(B) Positive
SUGT1	13q14.3	-0.29	-0.43	0.51	0.42	0.13	0.0114	0.0193	(A) Negative
RIPPLY1	Xq22.3	0.17	0.01	0.63	0.48	0.16	0.0114	0.0193	(A) Negative
ACAD11	3q22.1	-1.36	-1.21	0.57	0.52	-0.15	0.0114	0.0194	(B) Positive
CAPN7	3p25.1	-0.08	0.06	0.54	0.42	-0.14	0.0114	0.0194	(B) Positive
FBXO25	8p23.3	0.32	0.51	0.75	0.66	-0.20	0.0114	0.0194	(B) Positive
TAF1L	9p21.1	-0.22	-0.10	0.49	0.46	-0.13	0.0114	0.0194	(B) Positive
FAM180A	7q33	-0.49	-0.40	0.35	0.31	-0.09	0.0115	0.0195	(B) Positive
DAPL1	2q24.1	1.26	0.69	2.12	2.17	0.57	0.0115	0.0195	(A) Negative
KATNBL1	15q14	0.22	0.34	0.45	0.43	-0.12	0.0115	0.0195	(B) Positive
LINC00301	11q12.2	0.10	0.03	0.25	0.30	0.07	0.0115	0.0195	(A) Negative
SIX5	19q13.32	0.13	0.26	0.45	0.51	-0.12	0.0115	0.0195	(B) Positive
ACSM2B	16p12.3	-2.76	-2.61	0.55	0.58	-0.15	0.0115	0.0195	(B) Positive
VPREB1	22q11.22	-0.56	-0.67	0.39	0.45	0.11	0.0115	0.0195	(A) Negative
XPNPEP3	22q13.2	-0.15	-0.27	0.44	0.43	0.12	0.0115	0.0195	(A) Negative
FBXL13	7q22.1	-0.15	-0.57	1.74	0.69	0.42	0.0115	0.0195	(A) Negative
BPIFB3	20q11.21	0.10	-0.03	0.51	0.39	0.13	0.0115	0.0196	(A) Negative
GFPT2	5q35.3	0.27	0.05	0.81	0.80	0.22	0.0116	0.0196	(A) Negative
PTK2	8q24.3	0.51	0.34	0.64	0.57	0.17	0.0116	0.0197	(A) Negative
UBL7	15q24.1	-0.68	-0.57	0.43	0.41	-0.11	0.0116	0.0197	(B) Positive
SPRR2D	1q21.3	-1.15	-1.37	0.84	0.70	0.22	0.0116	0.0197	(A) Negative
TMEM18	2p25.3	-0.40	-0.24	0.64	0.45	-0.16	0.0116	0.0198	(B) Positive
H2AC1	6p22.2	0.30	0.42	0.44	0.52	-0.12	0.0117	0.0198	(B) Positive
AQP4	18q11.2	0.50	0.27	0.95	0.52	0.23	0.0117	0.0198	(A) Negative
POLA1	Xp22.11-p21.3	-0.31	-0.46	0.56	0.46	0.14	0.0117	0.0198	(A) Negative
MRGPRE	11p15.4	0.53	0.46	0.26	0.27	0.07	0.0117	0.0198	(A) Negative
ATP5PB	1p13.2	-0.20	-0.31	0.39	0.34	0.10	0.0117	0.0198	(A) Negative
IFNE	9p21.3	-0.89	-1.11	0.88	0.57	0.22	0.0117	0.0199	(A) Negative
ZNF230	19q13.31	-0.13	0.03	0.61	0.53	-0.16	0.0118	0.0199	(B) Positive
DNAH8	6p21.2	-1.82	-1.99	0.64	0.54	0.16	0.0118	0.0200	(A) Negative
PIGU	20q11.22	-0.49	-0.34	0.54	0.54	-0.14	0.0118	0.0200	(B) Positive
PIN4	Xq13.1	0.21	0.40	0.72	0.66	-0.19	0.0118	0.0200	(B) Positive
SNX11	17q21.32	0.35	0.49	0.56	0.51	-0.15	0.0118	0.0200	(B) Positive
SECTM1	17q25.3	1.12	0.86	1.01	0.84	0.26	0.0118	0.0200	(A) Negative
PITX3	10q24.32	0.76	0.64	0.43	0.43	0.11	0.0118	0.0200	(A) Negative
ZNF664	12q24.31	0.66	0.81	0.58	0.45	-0.15	0.0118	0.0200	(B) Positive
MYO5A	15q21.2	-0.71	-0.87	0.62	0.58	0.16	0.0118	0.0201	(A) Negative
INTS9	8p21.1	0.01	0.14	0.46	0.53	-0.13	0.0118	0.0201	(B) Positive
DIRC1	2q32.2	0.01	0.20	0.72	0.64	-0.19	0.0119	0.0201	(B) Positive
OR52R1	11p15.4	0.11	0.24	0.50	0.52	-0.13	0.0119	0.0201	(B) Positive
HMGA2	12q14.3	-5.21	-5.45	0.96	0.64	0.24	0.0119	0.0202	(A) Negative
PRRG3	Xq28	0.57	0.41	0.64	0.37	0.16	0.0119	0.0202	(A) Negative
ILVBL	19p13.12	-0.51	-0.34	0.64	0.62	-0.17	0.0119	0.0202	(B) Positive
ZNF668	16p11.2	0.36	0.45	0.34	0.40	-0.09	0.0120	0.0203	(B) Positive
GTF3C3	2q33.1	-0.68	-0.80	0.48	0.38	0.12	0.0120	0.0204	(A) Negative
THY1	11q23.3	0.37	0.57	0.77	0.73	-0.20	0.0121	0.0204	(B) Positive
NRXN2	11q13.1	0.28	0.42	0.51	0.47	-0.13	0.0121	0.0204	(B) Positive
PMS2CL	7p22.1	-0.54	-0.43	0.42	0.35	-0.11	0.0121	0.0204	(B) Positive
ELMOD1	11q22.3	-1.99	-1.81	0.70	0.71	-0.19	0.0121	0.0204	(B) Positive
MED20	6p21.1	0.09	-0.04	0.51	0.43	0.13	0.0121	0.0205	(A) Negative
FOXB1	15q22.2	0.99	0.81	0.71	0.72	0.19	0.0121	0.0205	(A) Negative
ZC3H14	14q31.3	-0.34	-0.44	0.38	0.32	0.10	0.0121	0.0205	(A) Negative
NTRK3	15q25.3	1.18	0.90	1.07	0.93	0.28	0.0121	0.0205	(A) Negative
BCL10	1p22.3	0.55	0.42	0.49	0.45	0.13	0.0121	0.0205	(A) Negative
RXFP2	13q13.1	0.20	0.38	0.68	0.69	-0.18	0.0121	0.0205	(B) Positive
SPATA6	1p33	0.74	0.94	0.76	0.68	-0.20	0.0122	0.0206	(B) Positive
POMP	13q12.3	0.20	0.08	0.41	0.46	0.11	0.0122	0.0206	(A) Negative
RANBP10	16q22	-0.07	-0.18	0.44	0.40	0.12	0.0122	0.0206	(A) Negative
ARHGEF19	1p36.13	0.93	0.73	0.73	0.72	0.19	0.0122	0.0206	(A) Negative
ZDHHC13	11p15.1	0.73	0.51	0.84	0.80	0.22	0.0122	0.0206	(A) Negative
GPR151	5q32	0.94	0.77	0.64	0.57	0.16	0.0122	0.0206	(A) Negative
CCL28	5p12	-0.73	-1.23	1.97	1.66	0.51	0.0122	0.0206	(A) Negative
WDR26	1q42.11-q42.12	0.47	0.60	0.50	0.43	-0.13	0.0122	0.0206	(B) Positive
IGDCC4	15q22.31	-0.50	-0.35	0.61	0.56	-0.16	0.0122	0.0207	(B) Positive
OTUD6A	Xq13.1	0.31	0.23	0.29	0.33	0.08	0.0123	0.0207	(A) Negative
INHBC	12q13.3	0.16	0.12	0.15	0.19	0.04	0.0123	0.0207	(A) Negative
GPR6	6q21	0.34	0.45	0.39	0.46	-0.11	0.0123	0.0207	(B) Positive
PSMD1	2q37.1	-0.22	-0.33	0.42	0.36	0.11	0.0123	0.0207	(A) Negative
FCAMR	1q32.1	0.38	0.20	0.70	0.60	0.18	0.0123	0.0207	(A) Negative
MRPL44	2q36.1	-0.24	-0.35	0.43	0.38	0.11	0.0123	0.0207	(A) Negative
MID2	Xq22.3	1.29	1.46	0.68	0.58	-0.17	0.0123	0.0207	(B) Positive
TEAD1	11p15.3	-0.79	-0.62	0.64	0.69	-0.17	0.0123	0.0207	(B) Positive
RINT1	7q22.3	-0.57	-0.76	0.76	0.67	0.20	0.0123	0.0207	(A) Negative
EXTL1	1p36.11	-0.09	-0.55	1.88	1.12	0.46	0.0123	0.0208	(A) Negative
HPF1	4q33	-0.28	-0.41	0.50	0.43	0.13	0.0123	0.0208	(A) Negative
RHPN1-AS1	8q24.3	1.27	1.04	0.89	0.87	0.23	0.0123	0.0208	(A) Negative
CACTIN	19p13.3	-0.16	-0.25	0.36	0.33	0.09	0.0123	0.0208	(A) Negative
TMED3	15q25.1	0.59	0.76	0.66	0.59	-0.17	0.0123	0.0208	(B) Positive
FLG2	1q21.3	0.49	0.29	0.77	0.68	0.20	0.0123	0.0208	(A) Negative
SYNE1	6q25.2	0.11	0.26	0.57	0.52	-0.15	0.0124	0.0209	(B) Positive
BMP5	6p12.1	-2.16	-2.47	1.21	1.01	0.31	0.0124	0.0209	(A) Negative
ANKRD13B	17q11.2	-0.02	-0.26	0.93	0.72	0.23	0.0124	0.0209	(A) Negative
SPAG16	2q34	0.01	0.24	0.79	1.10	-0.23	0.0124	0.0209	(B) Positive
PLP1	Xq22.2	-2.97	-3.35	1.57	0.93	0.38	0.0124	0.0209	(A) Negative
FAM124B	2q36.2	-0.20	0.03	0.88	0.87	-0.23	0.0124	0.0209	(B) Positive
KMT2C	7q36.1	-0.35	-0.19	0.65	0.42	-0.16	0.0124	0.0210	(B) Positive
INSL6	9p24.1	0.52	0.26	1.05	0.63	0.26	0.0125	0.0210	(A) Negative
STAT1	2q32.2	1.74	1.45	1.12	0.98	0.29	0.0125	0.0210	(A) Negative
GON7	14q32.12	0.13	0.28	0.60	0.48	-0.15	0.0125	0.0210	(B) Positive
SEC24D	4q26	0.26	0.46	0.78	0.63	-0.20	0.0125	0.0211	(B) Positive
SLC44A3	1p21.3	1.86	1.61	0.97	0.94	0.25	0.0125	0.0211	(A) Negative
GRM5	11q14.2-q14.3	0.28	0.21	0.26	0.26	0.07	0.0125	0.0211	(A) Negative
CPT2	1p32.3	0.02	0.18	0.61	0.52	-0.16	0.0126	0.0212	(B) Positive
MAPK8IP1	11p11.2	-0.36	-0.20	0.60	0.66	-0.16	0.0126	0.0212	(B) Positive
CNGA2	Xq28	0.43	0.28	0.55	0.61	0.15	0.0126	0.0212	(A) Negative
BPY2C	Yq11.23	0.33	0.15	0.69	0.67	0.18	0.0126	0.0212	(A) Negative
RBM42	19q13.12	0.30	0.15	0.60	0.47	0.15	0.0126	0.0212	(A) Negative
HBA2	16p13.3	-2.41	-2.23	0.67	0.66	-0.18	0.0126	0.0212	(B) Positive
SLC52A3	20p13	3.16	3.38	0.84	0.89	-0.22	0.0126	0.0212	(B) Positive
COPA	1q23.2	0.66	0.55	0.40	0.35	0.10	0.0126	0.0213	(A) Negative
SNX15	11q13.1	-0.28	-0.17	0.39	0.40	-0.10	0.0127	0.0213	(B) Positive
RPL27AP6	6q25.2	0.16	0.02	0.57	0.49	0.15	0.0127	0.0213	(A) Negative
SLC26A1	4p16.3	0.24	0.33	0.33	0.31	-0.09	0.0127	0.0213	(B) Positive
SPATA31H1	2p23.3	0.02	-0.06	0.33	0.28	0.09	0.0127	0.0213	(A) Negative
IL22RA1	1p36.11	-0.81	-1.06	1.00	0.76	0.25	0.0127	0.0214	(A) Negative
IL10RB	21q22.11	0.17	0.03	0.56	0.45	0.14	0.0127	0.0214	(A) Negative
CORIN	4p12	1.72	2.03	1.20	1.16	-0.31	0.0127	0.0214	(B) Positive
DRAM1	12q23.2	0.97	0.74	0.88	0.78	0.23	0.0127	0.0214	(A) Negative
DDX5	17q23.3	-0.30	-0.16	0.51	0.53	-0.14	0.0127	0.0214	(B) Positive
STAP2	19p13.3	1.05	0.86	0.73	0.66	0.19	0.0127	0.0214	(A) Negative
ADISSP	20p13	-0.87	-1.03	0.61	0.57	0.16	0.0127	0.0214	(A) Negative
RPSA	3p22.1	-0.27	-0.42	0.59	0.45	0.15	0.0128	0.0215	(A) Negative
DSE	6q22.1	1.64	1.45	0.69	0.71	0.18	0.0128	0.0215	(A) Negative
BTBD2	19p13.3	-0.05	0.07	0.46	0.47	-0.12	0.0128	0.0215	(B) Positive
CAMSAP2	1q32.1	0.64	0.47	0.65	0.54	0.17	0.0128	0.0215	(A) Negative
CIDEB	14q12	0.16	-0.03	0.70	0.73	0.19	0.0128	0.0215	(A) Negative
KCNN2	5q22.3	0.12	0.28	0.58	0.59	-0.15	0.0128	0.0215	(B) Positive
ZNF155	19q13.31	0.10	0.23	0.53	0.42	-0.13	0.0128	0.0216	(B) Positive
DNAAF9	20p13	0.02	0.15	0.50	0.46	-0.13	0.0128	0.0216	(B) Positive
SF3B4	1q21.2	0.23	0.09	0.53	0.54	0.14	0.0128	0.0216	(A) Negative
CISD2	4q24	-0.26	-0.40	0.55	0.46	0.14	0.0129	0.0216	(A) Negative
EXOC3	5p15.33	-0.29	-0.17	0.49	0.36	-0.12	0.0129	0.0216	(B) Positive
ZNF414	19p13.2	0.23	0.35	0.45	0.43	-0.12	0.0129	0.0217	(B) Positive
RAD51C	17q22	-1.56	-1.36	0.77	0.75	-0.20	0.0129	0.0217	(B) Positive
POLR1F	7p21.1	-0.29	-0.42	0.51	0.45	0.13	0.0129	0.0217	(A) Negative
TMEM107	17p13.1	-0.59	-0.46	0.49	0.60	-0.14	0.0129	0.0217	(B) Positive
WDR1	4p16.1	0.33	0.45	0.47	0.42	-0.12	0.0130	0.0218	(B) Positive
ZIM2	19q13.43	-0.03	-0.41	1.51	1.26	0.38	0.0130	0.0218	(A) Negative
HSD17B3	9q22.32	-0.08	0.03	0.44	0.45	-0.12	0.0130	0.0218	(B) Positive
TAAR5	6q23.2	0.42	0.37	0.20	0.22	0.05	0.0130	0.0219	(A) Negative
C16ORF78	16q12.1	0.10	0.02	0.32	0.35	0.08	0.0130	0.0219	(A) Negative
PLXNC1	12q22	0.48	0.71	0.91	0.78	-0.23	0.0130	0.0219	(B) Positive
CFAP300	11q22.1	0.17	0.50	1.23	1.39	-0.33	0.0131	0.0219	(B) Positive
SOX15	17p13.1	0.05	-0.12	0.67	0.60	0.17	0.0131	0.0219	(A) Negative
GNA12	7p22.3-p22.2	0.00	-0.12	0.47	0.38	0.12	0.0131	0.0219	(A) Negative
PCYT1B	Xp22.11	-1.15	-1.36	0.82	0.61	0.21	0.0131	0.0220	(A) Negative
MGAT5B	17q25.2	-1.74	-1.96	0.82	0.82	0.21	0.0131	0.0220	(A) Negative
CDC40	6q21	0.20	0.06	0.54	0.47	0.14	0.0131	0.0220	(A) Negative
U2AF1L4	19q13.12	0.21	0.05	0.65	0.50	0.16	0.0131	0.0220	(A) Negative
BROX	1q41	0.74	0.58	0.65	0.59	0.17	0.0132	0.0221	(A) Negative
FLT1	13q12.3	0.99	0.80	0.73	0.70	0.19	0.0132	0.0221	(A) Negative
UBALD1	16p13.3	0.15	0.27	0.46	0.41	-0.12	0.0132	0.0221	(B) Positive
TRAPPC5	19p13.2	0.52	0.67	0.56	0.50	-0.14	0.0132	0.0221	(B) Positive
ALKBH2	12q24.11	-0.09	-0.25	0.62	0.42	0.15	0.0132	0.0221	(A) Negative
NYNRIN	14q12	1.27	1.05	0.88	0.69	0.22	0.0132	0.0221	(A) Negative
WDR49	3q26.1	0.11	0.26	0.57	0.59	-0.15	0.0132	0.0222	(B) Positive
IFNL3	19q13.2	0.53	0.29	0.93	0.80	0.24	0.0132	0.0222	(A) Negative
TBP	6q27	-0.44	-0.56	0.49	0.39	0.12	0.0133	0.0222	(A) Negative
MDM2	12q15	-0.28	-0.12	0.62	0.64	-0.16	0.0133	0.0222	(B) Positive
HIGD2A	5q35.2	-0.09	0.05	0.56	0.44	-0.14	0.0133	0.0223	(B) Positive
GTF2A2	15q22.2	-0.39	-0.51	0.46	0.39	0.12	0.0133	0.0223	(A) Negative
IDE	10q23.33	-0.17	-0.32	0.61	0.53	0.15	0.0133	0.0223	(A) Negative
SELP	1q24.2	2.84	3.23	1.51	1.48	-0.39	0.0134	0.0224	(B) Positive
TEX35	1q25.2	0.49	0.35	0.53	0.40	0.13	0.0134	0.0224	(A) Negative
SCAP	3p21.31	-0.24	-0.14	0.41	0.39	-0.11	0.0134	0.0224	(B) Positive
SFT2D3	2q14.3	0.22	0.10	0.50	0.36	0.12	0.0134	0.0224	(A) Negative
KRT87P	12q13.13	-2.34	-2.13	0.82	0.80	-0.21	0.0134	0.0224	(B) Positive
CYP46A1	14q32.2	0.19	0.25	0.22	0.22	-0.06	0.0134	0.0224	(B) Positive
PCDHB4	5q31.3	1.17	1.50	1.28	1.07	-0.32	0.0134	0.0224	(B) Positive
CLPTM1	19q13.32	-0.04	0.11	0.55	0.59	-0.15	0.0134	0.0224	(B) Positive
ACADL	2q34	0.70	0.31	1.59	1.24	0.40	0.0134	0.0224	(A) Negative
CAPG	2p11.2	2.11	1.96	0.58	0.59	0.15	0.0134	0.0225	(A) Negative
RPS25	11q23.3	-0.56	-0.70	0.54	0.52	0.14	0.0134	0.0225	(A) Negative
HIP1	7q11.23	0.18	0.33	0.60	0.54	-0.15	0.0134	0.0225	(B) Positive
PRODH2	19q13.12	-3.15	-3.25	0.37	0.35	0.10	0.0135	0.0225	(A) Negative
RSPH10B	7p22.1	0.14	-0.05	0.72	0.67	0.19	0.0135	0.0225	(A) Negative
CLXN	8q11.21	1.32	1.59	1.00	1.17	-0.27	0.0135	0.0226	(B) Positive
WHAMMP3	15q11.2	-0.03	0.13	0.65	0.53	-0.16	0.0135	0.0226	(B) Positive
PALMD	1p21.2	1.18	0.94	0.93	0.84	0.24	0.0135	0.0226	(A) Negative
GBP7	1p22.2	0.28	0.46	0.66	0.68	-0.17	0.0135	0.0226	(B) Positive
RPL38	17q25.1	0.12	-0.03	0.58	0.54	0.15	0.0136	0.0227	(A) Negative
HVCN1	12q24.11	1.32	1.13	0.76	0.60	0.19	0.0136	0.0227	(A) Negative
PYCR1	17q25.3	-0.27	-0.45	0.68	0.69	0.18	0.0136	0.0227	(A) Negative
ATP9A	20q13.2	0.08	0.23	0.54	0.62	-0.15	0.0136	0.0228	(B) Positive
ZMPSTE24	1p34.2	0.67	0.80	0.47	0.44	-0.12	0.0136	0.0228	(B) Positive
SAMHD1	20q11.23	1.30	1.06	0.97	0.76	0.24	0.0136	0.0228	(A) Negative
ZNF628	19q13.42	0.40	0.31	0.35	0.38	0.09	0.0136	0.0228	(A) Negative
ZNF440	19p13.2	-0.11	0.05	0.64	0.47	-0.16	0.0137	0.0228	(B) Positive
PRPF4	9q32	-0.20	-0.32	0.48	0.40	0.12	0.0137	0.0229	(A) Negative
PDCD10	3q26.1	-0.05	-0.22	0.67	0.55	0.17	0.0137	0.0229	(A) Negative
PPP4C	16p11.2	0.12	0.27	0.52	0.62	-0.14	0.0137	0.0230	(B) Positive
LRRC7	1p31.1	-0.45	-0.62	0.67	0.73	0.18	0.0138	0.0230	(A) Negative
NFE2L1	17q21.32	-0.09	0.06	0.56	0.50	-0.14	0.0138	0.0230	(B) Positive
MEF2D	1q22	0.74	0.65	0.35	0.33	0.09	0.0138	0.0230	(A) Negative
GIT1	17q11.2	0.27	0.12	0.57	0.55	0.15	0.0138	0.0230	(A) Negative
GRM1	6q24.3	0.31	0.43	0.45	0.55	-0.12	0.0138	0.0230	(B) Positive
B4GALT6	18q12.1	-0.69	-0.88	0.72	0.69	0.19	0.0138	0.0230	(A) Negative
TSPAN4	11p15.5	-0.67	-0.50	0.63	0.65	-0.17	0.0138	0.0231	(B) Positive
SERPINE1	7q22.1	-1.73	-1.51	0.82	0.94	-0.22	0.0138	0.0231	(B) Positive
VIPAS39	14q24.3	-0.00	0.10	0.38	0.44	-0.10	0.0138	0.0231	(B) Positive
PDE5A	4q26	-0.06	0.12	0.64	0.91	-0.19	0.0139	0.0231	(B) Positive
SAR1A	10q22.1	0.55	0.67	0.46	0.43	-0.12	0.0139	0.0232	(B) Positive
TTPA	8q12.3	0.42	0.22	0.78	0.74	0.20	0.0139	0.0233	(A) Negative
MMP15	16q21	-0.16	-0.43	1.07	0.77	0.26	0.0140	0.0233	(A) Negative
PIANP	12p13.31	-0.97	-0.84	0.50	0.44	-0.13	0.0140	0.0233	(B) Positive
KLF6	10p15.2	1.16	0.97	0.74	0.65	0.19	0.0140	0.0234	(A) Negative
ROS1	6q22.1	-2.28	-2.55	1.09	0.84	0.27	0.0140	0.0234	(A) Negative
C17ORF75	17q11.2	-1.03	-0.87	0.60	0.70	-0.16	0.0141	0.0235	(B) Positive
GUCY1B2	13q14.3	-0.88	-1.20	1.24	1.34	0.33	0.0141	0.0235	(A) Negative
STIP1	11q13.1	-0.30	-0.44	0.55	0.59	0.14	0.0141	0.0236	(A) Negative
UFL1	6q16.1	0.34	0.47	0.48	0.49	-0.12	0.0141	0.0236	(B) Positive
TMOD4	1q21.3	-0.03	-0.17	0.55	0.54	0.14	0.0142	0.0236	(A) Negative
KCNJ5-AS1	11q24.3	0.73	0.49	0.97	0.74	0.24	0.0142	0.0237	(A) Negative
ZNF787	19q13.43	0.58	0.43	0.60	0.60	0.16	0.0142	0.0237	(A) Negative
DCD	12q13.2	2.41	1.66	3.00	2.57	0.75	0.0142	0.0237	(A) Negative
HHATL	3p22.1	-1.68	-1.55	0.48	0.64	-0.14	0.0143	0.0238	(B) Positive
RLN3	19p13.12	0.31	0.24	0.24	0.31	0.07	0.0143	0.0238	(A) Negative
DCT	13q32.1	-4.20	-4.31	0.42	0.36	0.11	0.0143	0.0238	(A) Negative
ST3GAL3	1p34.1	-0.49	-0.62	0.51	0.43	0.13	0.0143	0.0238	(A) Negative
TRIM37	17q22	-1.81	-1.62	0.72	0.74	-0.19	0.0143	0.0239	(B) Positive
ATP13A2	1p36.13	0.30	0.42	0.45	0.52	-0.12	0.0143	0.0239	(B) Positive
LGALS3BP	17q25	0.56	0.83	1.07	0.86	-0.27	0.0143	0.0239	(B) Positive
ASIC1	12q13.12	-1.12	-1.40	1.07	1.06	0.28	0.0144	0.0239	(A) Negative
ITGA2	5q11.2	-0.24	0.05	1.14	1.04	-0.29	0.0144	0.0239	(B) Positive
SOCS3	17q25.3	1.10	0.91	0.71	0.77	0.19	0.0144	0.0240	(A) Negative
HCLS1	3q13.33	0.45	0.20	0.98	0.80	0.24	0.0144	0.0240	(A) Negative
UBXN7	3q29	0.03	-0.11	0.58	0.45	0.14	0.0144	0.0240	(A) Negative
VWA3A	16p12.2	0.17	0.30	0.51	0.53	-0.13	0.0144	0.0240	(B) Positive
ZHX2	8q24.13	0.98	1.14	0.65	0.50	-0.16	0.0145	0.0241	(B) Positive
IFNA1	9p21.3	0.31	0.22	0.33	0.37	0.09	0.0145	0.0242	(A) Negative
FUBP1	1p31.1	-0.06	-0.19	0.54	0.44	0.13	0.0145	0.0242	(A) Negative
NLRP13	19q13.43	-0.13	0.07	0.69	0.99	-0.20	0.0145	0.0242	(B) Positive
ADAM8	10q26.3	2.07	1.80	1.03	1.09	0.27	0.0146	0.0242	(A) Negative
SLC29A2	11q13.2	-0.20	-0.30	0.34	0.38	0.09	0.0146	0.0242	(A) Negative
TCF25	16q24.3	0.08	-0.04	0.48	0.42	0.12	0.0146	0.0242	(A) Negative
RSPH14	22q11.22-q11.23	0.58	0.37	0.83	0.80	0.21	0.0146	0.0243	(A) Negative
GPR32	19q13.33	0.52	0.63	0.44	0.43	-0.11	0.0146	0.0243	(B) Positive
CARNMT1	9q21.13	-0.48	-0.64	0.68	0.47	0.17	0.0146	0.0243	(A) Negative
SERPINB10	18q21.3	0.48	0.38	0.43	0.40	0.11	0.0146	0.0243	(A) Negative
SLC39A10	2q32.3	-0.40	-0.27	0.55	0.50	-0.14	0.0147	0.0244	(B) Positive
ABCA5	17q24.3	-0.87	-0.62	1.01	0.99	-0.26	0.0147	0.0244	(B) Positive
UPK3B	7q11.23	-0.12	-0.21	0.38	0.31	0.09	0.0147	0.0244	(A) Negative
H1-7	12q13.11	0.43	0.34	0.36	0.29	0.09	0.0147	0.0244	(A) Negative
C16ORF46	16q23.2	0.19	0.34	0.57	0.58	-0.15	0.0147	0.0244	(B) Positive
RPL13	16q24.3	-0.40	-0.55	0.60	0.50	0.15	0.0147	0.0244	(A) Negative
IQCA1	2q37.2-q37.3	1.31	1.72	1.59	1.47	-0.40	0.0147	0.0245	(B) Positive
HEXA	15q23	0.01	0.13	0.47	0.42	-0.12	0.0147	0.0245	(B) Positive
ASGR2	17p13.1	-3.96	-4.07	0.43	0.38	0.11	0.0148	0.0246	(A) Negative
DNAJB1	19p13.12	0.70	0.83	0.49	0.50	-0.13	0.0148	0.0246	(B) Positive
BAAT	9q31.1	-2.62	-2.72	0.41	0.45	0.11	0.0148	0.0246	(A) Negative
CNDP2	18q22.3	0.67	0.82	0.60	0.50	-0.15	0.0148	0.0247	(B) Positive
RGS7BP	5q12.3	0.39	0.20	0.79	0.49	0.19	0.0149	0.0247	(A) Negative
TWSG1	18p11.22	0.02	0.20	0.72	0.63	-0.18	0.0149	0.0247	(B) Positive
STK3	8q22.2	1.07	0.92	0.60	0.64	0.16	0.0149	0.0247	(A) Negative
CCDC28A	6q24.1	0.35	0.50	0.58	0.62	-0.15	0.0149	0.0247	(B) Positive
PXYLP1	3q23	0.27	0.45	0.71	0.56	-0.17	0.0149	0.0248	(B) Positive
SLC4A10	2q24.2	-0.82	-0.69	0.45	0.73	-0.14	0.0149	0.0248	(B) Positive
ZNF366	5q13.1	2.62	2.85	0.88	0.90	-0.23	0.0149	0.0248	(B) Positive
RAP1GAP	1p36.12	0.14	0.35	0.84	0.69	-0.21	0.0149	0.0248	(B) Positive
CPXCR1	Xq21.31	0.17	-0.00	0.67	0.66	0.17	0.0150	0.0248	(A) Negative
SNX17	2p23.3	-0.30	-0.13	0.70	0.64	-0.18	0.0150	0.0248	(B) Positive
TRAPPC1	17p13.1	-0.02	0.08	0.39	0.47	-0.11	0.0150	0.0249	(B) Positive
TUBE1	6q21	-0.69	-0.89	0.80	0.62	0.20	0.0150	0.0249	(A) Negative
SPATA25	20q13.12	-0.07	-0.14	0.24	0.29	0.06	0.0150	0.0249	(A) Negative
ARL2	11q13.1	-0.63	-0.74	0.43	0.41	0.11	0.0151	0.0250	(A) Negative
ZNF542P	19q13.43	-0.21	0.02	0.91	0.82	-0.23	0.0151	0.0251	(B) Positive
UROS	10q26.2	0.23	0.37	0.56	0.49	-0.14	0.0151	0.0251	(B) Positive
B3GALT4	6p21.32	2.32	2.51	0.77	0.61	-0.19	0.0152	0.0252	(B) Positive
PKD1L1	7p12.3	0.39	0.52	0.47	0.65	-0.13	0.0152	0.0252	(B) Positive
KIR2DL3	19q13.42	0.69	0.82	0.51	0.47	-0.13	0.0152	0.0252	(B) Positive
S100PBP	1p35.1	-0.83	-0.94	0.45	0.38	0.11	0.0152	0.0252	(A) Negative
AFAP1	4p16.1	0.84	0.67	0.66	0.59	0.17	0.0152	0.0253	(A) Negative
TRIM35	8p21.2	0.75	0.62	0.51	0.52	0.13	0.0152	0.0253	(A) Negative
TMEM266	15q24.2	-1.96	-2.19	0.93	0.71	0.23	0.0153	0.0253	(A) Negative
TUBAL3	10p15.1	-0.22	0.15	1.41	1.49	-0.37	0.0153	0.0253	(B) Positive
CZIB	1p32.3	-0.20	-0.10	0.36	0.37	-0.09	0.0153	0.0253	(B) Positive
METTL18	1q24.2	0.49	0.64	0.55	0.59	-0.14	0.0153	0.0254	(B) Positive
CD40LG	Xq26.3	0.76	0.53	0.93	0.68	0.23	0.0153	0.0254	(A) Negative
AMN	14q32.32	0.35	0.20	0.61	0.65	0.16	0.0154	0.0255	(A) Negative
SPI1	11p11.2	1.37	1.17	0.79	0.72	0.20	0.0154	0.0255	(A) Negative
SERTAD4	1q32.2	2.21	1.89	1.32	1.03	0.32	0.0154	0.0255	(A) Negative
TEFM	17q11.2	-0.54	-0.39	0.61	0.57	-0.15	0.0154	0.0256	(B) Positive
CLIP3	19q13.12	0.07	0.21	0.59	0.53	-0.15	0.0155	0.0256	(B) Positive
NIPAL2	8q22.2	0.96	0.77	0.75	0.73	0.19	0.0155	0.0256	(A) Negative
COMMD9	11p13	0.47	0.36	0.47	0.35	0.11	0.0155	0.0257	(A) Negative
GPATCH1	19q13.11	0.38	0.25	0.53	0.37	0.13	0.0155	0.0257	(A) Negative
BIRC7	20q13.33	-0.82	-0.96	0.56	0.47	0.14	0.0156	0.0258	(A) Negative
SAT1	Xp22.11	1.26	0.99	1.13	0.71	0.27	0.0156	0.0258	(A) Negative
OR5AS1	11q12.1	0.26	0.16	0.40	0.45	0.10	0.0156	0.0258	(A) Negative
STKLD1	9q34.2	0.13	0.02	0.45	0.41	0.11	0.0156	0.0258	(A) Negative
C1QBP	17p13.2	-0.55	-0.69	0.56	0.56	0.14	0.0156	0.0258	(A) Negative
ZNF630	Xp11.23	1.13	1.29	0.57	0.66	-0.15	0.0156	0.0258	(B) Positive
GABRD	1p36.33	0.68	0.78	0.40	0.40	-0.10	0.0156	0.0259	(B) Positive
AQP7	9p13.3	-0.39	-0.17	0.81	1.06	-0.22	0.0157	0.0259	(B) Positive
AFDN	6q27	0.59	0.36	0.95	0.73	0.23	0.0157	0.0259	(A) Negative
DICER1	14q32.13	0.71	0.86	0.56	0.59	-0.15	0.0157	0.0259	(B) Positive
GAS2	11p14.3	-3.17	-3.54	1.52	1.15	0.37	0.0157	0.0259	(A) Negative
AP1M1	19p13.11	-0.51	-0.61	0.39	0.43	0.10	0.0157	0.0259	(A) Negative
PTGDS	9q34.3	2.70	2.47	0.89	0.93	0.23	0.0157	0.0260	(A) Negative
COL20A1	20q13.33	-0.13	-0.22	0.37	0.39	0.10	0.0157	0.0260	(A) Negative
IMPDH1	7q32.1	-0.04	-0.20	0.69	0.58	0.17	0.0157	0.0260	(A) Negative
TLR8	Xp22.2	2.82	2.53	1.18	1.07	0.30	0.0157	0.0260	(A) Negative
DDX55	12q24.31	-0.99	-1.12	0.51	0.43	0.13	0.0157	0.0260	(A) Negative
MYH11	16p13.11	3.98	4.24	1.05	0.71	-0.25	0.0158	0.0260	(B) Positive
PEG3	19q13.43	-2.15	-2.68	2.24	1.56	0.54	0.0158	0.0261	(A) Negative
DUSP10	1q41	0.55	0.81	1.07	0.85	-0.26	0.0158	0.0262	(B) Positive
UBE2O	17q25.1	-0.15	-0.27	0.48	0.43	0.12	0.0158	0.0262	(A) Negative
SPOCK3	4q32.3	-0.03	0.13	0.62	0.59	-0.16	0.0159	0.0262	(B) Positive
MAPKAPK2	1q32.1	0.65	0.76	0.41	0.49	-0.11	0.0159	0.0263	(B) Positive
CLCA4	1p22.3	0.64	0.43	0.83	0.70	0.21	0.0159	0.0263	(A) Negative
CFAP251	12q24.31	0.36	0.64	1.08	1.21	-0.28	0.0160	0.0263	(B) Positive
USP43	17p13.1	1.21	0.96	0.99	0.79	0.24	0.0160	0.0264	(A) Negative
TRIO	5p15.2	-0.17	-0.01	0.67	0.45	-0.16	0.0160	0.0264	(B) Positive
WFDC13	20q13.11	-0.57	-0.43	0.52	0.75	-0.15	0.0160	0.0264	(B) Positive
LILRB1	19q13.42	1.96	1.72	0.96	0.81	0.24	0.0160	0.0264	(A) Negative
EXOC7	17q25.1	0.13	0.23	0.41	0.39	-0.10	0.0161	0.0265	(B) Positive
CDKN1C	11p15.4	-0.32	-0.56	1.00	0.78	0.24	0.0161	0.0266	(A) Negative
RBM26	13q31.1	-0.28	-0.36	0.34	0.30	0.08	0.0161	0.0266	(A) Negative
KLK2	19q13.33	-0.03	0.05	0.28	0.39	-0.08	0.0161	0.0266	(B) Positive
MIR4435-2HG	2q13	-0.23	-0.41	0.75	0.64	0.19	0.0161	0.0266	(A) Negative
GLIPR1L1	12q21.2	0.21	0.10	0.40	0.54	0.11	0.0161	0.0266	(A) Negative
KIAA1328	18q12.2	-0.05	0.09	0.58	0.47	-0.14	0.0161	0.0266	(B) Positive
PRUNE1	1q21.3	0.68	0.85	0.68	0.65	-0.17	0.0161	0.0266	(B) Positive
IL27	16p12.1-p11.2	-0.34	-0.04	1.20	1.06	-0.30	0.0161	0.0266	(B) Positive
PENK	8q12.1	-0.46	-0.19	1.05	1.19	-0.28	0.0161	0.0266	(B) Positive
RORB	9q21.13	-2.75	-2.57	0.71	0.73	-0.18	0.0161	0.0266	(B) Positive
CAMTA1	1p36.31-p36.23	0.86	0.67	0.75	0.73	0.19	0.0162	0.0267	(A) Negative
SLC35C2	20q13.12	-0.33	-0.19	0.51	0.54	-0.13	0.0162	0.0267	(B) Positive
ZNF527	19q13.12	0.70	0.83	0.51	0.41	-0.12	0.0162	0.0267	(B) Positive
BMP1	8p21.3	-0.18	-0.33	0.59	0.65	0.15	0.0162	0.0268	(A) Negative
SYNPO	5q33.1	0.83	0.73	0.36	0.39	0.09	0.0163	0.0268	(A) Negative
DBX2	12q12	0.60	0.79	0.73	0.80	-0.19	0.0163	0.0268	(B) Positive
IFNA16	9p21.3	0.14	0.03	0.43	0.38	0.11	0.0163	0.0268	(A) Negative
RDH14	2p24.2	0.60	0.71	0.46	0.42	-0.11	0.0163	0.0268	(B) Positive
PIGK	1p31.1	0.15	0.27	0.47	0.50	-0.12	0.0163	0.0269	(B) Positive
BCL9	1q21.2	0.50	0.64	0.56	0.48	-0.14	0.0163	0.0269	(B) Positive
EDC4	16q22.1	-0.34	-0.46	0.46	0.44	0.12	0.0164	0.0270	(A) Negative
LRTM2	12p13.33	0.57	0.85	1.08	1.18	-0.28	0.0164	0.0270	(B) Positive
CHCHD1	10q22.2	0.37	0.48	0.47	0.41	-0.12	0.0164	0.0270	(B) Positive
CA2	8q21.2	0.22	0.56	1.17	1.85	-0.34	0.0164	0.0270	(B) Positive
SEMA3E	7q21.11	1.61	2.14	2.17	1.82	-0.53	0.0164	0.0270	(B) Positive
CFAP65	2q35	0.32	0.42	0.37	0.47	-0.10	0.0165	0.0271	(B) Positive
ZNF415	19q13.42	0.59	0.83	0.96	0.97	-0.24	0.0165	0.0271	(B) Positive
MAGEA11	Xq28	-1.33	-1.61	1.15	0.75	0.27	0.0165	0.0271	(A) Negative
HS6ST1	2q14.3	0.86	0.73	0.53	0.49	0.13	0.0165	0.0272	(A) Negative
ZIC5	13q32.3	-1.36	-1.54	0.75	0.57	0.18	0.0165	0.0272	(A) Negative
ELMO1	7p14.2-p14.1	0.19	0.04	0.61	0.52	0.15	0.0165	0.0272	(A) Negative
PHB1P19	12q13.13	-0.46	-0.60	0.55	0.61	0.14	0.0166	0.0273	(A) Negative
GPR174	Xq21.1	-1.08	-1.31	0.96	0.85	0.24	0.0166	0.0273	(A) Negative
HNRNPU	1q44	0.21	0.12	0.37	0.34	0.09	0.0166	0.0273	(A) Negative
OR51E2	11p15.4	0.96	1.08	0.48	0.54	-0.13	0.0166	0.0274	(B) Positive
CRH	8q13.1	-0.48	-0.29	0.67	0.99	-0.19	0.0166	0.0274	(B) Positive
IL18	11q23.1	0.69	0.40	1.15	1.08	0.29	0.0167	0.0275	(A) Negative
FAM3B	21q22.3	-0.65	-0.10	2.04	2.58	-0.55	0.0167	0.0275	(B) Positive
BABAM1	19p13.11	0.02	-0.08	0.43	0.35	0.10	0.0167	0.0275	(A) Negative
LMOD3	3p14.1	0.08	0.21	0.45	0.62	-0.12	0.0168	0.0275	(B) Positive
VIT	2p22.2	-0.58	-1.09	2.12	1.63	0.51	0.0168	0.0276	(A) Negative
CPSF1	8q24.3	-0.22	-0.37	0.59	0.61	0.15	0.0168	0.0276	(A) Negative
CCDC63	12q24.11	-2.02	-2.15	0.49	0.54	0.13	0.0168	0.0276	(A) Negative
GEMIN7	19q13.32	-0.30	-0.40	0.39	0.43	0.10	0.0168	0.0276	(A) Negative
KLRC3	12p13.2	-3.12	-3.44	1.27	1.20	0.32	0.0168	0.0276	(A) Negative
ZNF577	19q13.41	-0.02	0.19	0.84	0.88	-0.21	0.0168	0.0277	(B) Positive
CDK2	12q13.2	-1.36	-1.52	0.68	0.62	0.17	0.0168	0.0277	(A) Negative
USP44	12q22	-3.81	-3.98	0.70	0.59	0.17	0.0168	0.0277	(A) Negative
SPTB	14q23.3	-0.31	-0.39	0.35	0.29	0.09	0.0169	0.0277	(A) Negative
MAP3K7CL	21q21.3	-0.01	0.15	0.66	0.62	-0.16	0.0169	0.0277	(B) Positive
LINC00469	17q25.1	-0.02	-0.11	0.35	0.37	0.09	0.0169	0.0277	(A) Negative
DCC	18q21.2	0.36	0.23	0.54	0.49	0.13	0.0169	0.0277	(A) Negative
FAM210A	18p11.21	-0.67	-0.81	0.54	0.47	0.13	0.0169	0.0278	(A) Negative
CCDC91	12p11.22	0.58	0.73	0.63	0.54	-0.15	0.0170	0.0279	(B) Positive
PDZD7	10q24.31	-0.92	-0.83	0.37	0.42	-0.10	0.0170	0.0280	(B) Positive
RXRA	9q34.2	0.09	0.22	0.52	0.45	-0.13	0.0171	0.0280	(B) Positive
C4ORF33	4q28.2	0.19	0.39	0.78	0.75	-0.20	0.0171	0.0280	(B) Positive
IL17A	6p12.2	0.16	0.09	0.25	0.25	0.06	0.0171	0.0280	(A) Negative
TRIM54	2p23.3	-0.20	-0.29	0.35	0.36	0.09	0.0171	0.0281	(A) Negative
H1-8	3q22.1	0.55	0.44	0.43	0.45	0.11	0.0171	0.0281	(A) Negative
HOXA11	7p15.2	-1.43	-1.70	1.15	0.74	0.27	0.0171	0.0281	(A) Negative
UBE2Q2	15q24.2	0.41	0.59	0.71	0.65	-0.18	0.0171	0.0281	(B) Positive
TAF1	Xq13.1	-0.18	-0.06	0.49	0.47	-0.12	0.0171	0.0281	(B) Positive
ZG16	16p11.2	-1.10	-0.83	0.95	1.41	-0.27	0.0172	0.0281	(B) Positive
LATS2	13q12.11	0.51	0.34	0.66	0.67	0.17	0.0172	0.0282	(A) Negative
PHTF1	1p13.2	-0.34	-0.49	0.60	0.50	0.15	0.0172	0.0283	(A) Negative
LINC02910	20q13.33	-0.29	-0.38	0.37	0.32	0.09	0.0172	0.0283	(A) Negative
ABHD17AP1	1q21.2	0.39	0.50	0.45	0.42	-0.11	0.0172	0.0283	(B) Positive
ELL	19p13.11	0.36	0.26	0.39	0.33	0.10	0.0172	0.0283	(A) Negative
ST3GAL2	16q22.1	-0.97	-1.08	0.45	0.44	0.11	0.0172	0.0283	(A) Negative
SHANK2	11q13.3-q13.4	1.10	1.30	0.82	0.70	-0.20	0.0172	0.0283	(B) Positive
DNAJA2	16q11.2	-0.04	-0.18	0.57	0.56	0.14	0.0173	0.0283	(A) Negative
ATXN2L	16p11.2	-0.93	-1.01	0.33	0.35	0.08	0.0173	0.0283	(A) Negative
NCKAP1	2q32.1	0.65	0.50	0.64	0.54	0.16	0.0173	0.0283	(A) Negative
NDUFA4	7p21.3	0.02	-0.11	0.57	0.49	0.14	0.0173	0.0283	(A) Negative
TFAP2A	6p24.3	1.13	1.32	0.79	0.73	-0.20	0.0173	0.0283	(B) Positive
CD300A	17q25.1	0.58	0.42	0.63	0.60	0.16	0.0173	0.0283	(A) Negative
GOT1	10q24.2	-0.09	-0.23	0.58	0.45	0.14	0.0173	0.0284	(A) Negative
USP25	21q21.1	-0.01	-0.16	0.61	0.59	0.15	0.0173	0.0284	(A) Negative
ZNF714	19p12	-0.89	-0.72	0.71	0.63	-0.18	0.0173	0.0284	(B) Positive
ASCL2	11p15.5	0.84	0.56	1.06	1.22	0.28	0.0173	0.0284	(A) Negative
LINC02870	10q26.3	-0.15	-0.07	0.30	0.40	-0.08	0.0173	0.0284	(B) Positive
PROK1	1p13.3	0.26	0.35	0.33	0.48	-0.09	0.0173	0.0284	(B) Positive
CASC2	10q26.11	0.28	0.42	0.54	0.50	-0.13	0.0174	0.0284	(B) Positive
CTSL	9q21.33	-0.21	-0.40	0.76	0.74	0.19	0.0174	0.0284	(A) Negative
C1QTNF2	5q33.3	-0.57	-0.86	1.17	0.90	0.28	0.0174	0.0284	(A) Negative
KRTAP1-5	17q21.2	-3.17	-3.36	0.80	0.69	0.20	0.0174	0.0285	(A) Negative
TOR4A	9q34.3	-1.55	-1.72	0.67	0.54	0.16	0.0175	0.0286	(A) Negative
ANXA13	8q24.13	0.85	1.12	1.07	1.04	-0.27	0.0175	0.0286	(B) Positive
DNM1	9q34.11	-0.23	-0.07	0.64	0.64	-0.16	0.0175	0.0286	(B) Positive
DPPA2	3q13.13	-2.72	-2.98	1.11	0.70	0.26	0.0175	0.0286	(A) Negative
HRH2	5q35.2	0.29	0.23	0.22	0.28	0.06	0.0175	0.0286	(A) Negative
OPHN1	Xq12	-0.12	-0.22	0.43	0.37	0.10	0.0175	0.0286	(A) Negative
SUPT4H1	17q22	-0.05	0.12	0.65	0.63	-0.16	0.0175	0.0286	(B) Positive
RNASE9	14q11.2	0.29	0.13	0.62	0.68	0.16	0.0175	0.0287	(A) Negative
UBE2Z	17q21.32	0.22	0.36	0.54	0.53	-0.13	0.0176	0.0287	(B) Positive
SIRT7	17q25.3	0.16	0.03	0.54	0.56	0.14	0.0176	0.0288	(A) Negative
HINT1	5q23.3	-0.58	-0.42	0.64	0.58	-0.16	0.0176	0.0288	(B) Positive
SLIT1	10q24.1	-1.76	-1.60	0.52	0.99	-0.16	0.0176	0.0288	(B) Positive
TCEAL8	Xq22.1	0.43	0.58	0.61	0.59	-0.15	0.0177	0.0289	(B) Positive
EVA1C	21q22.11	0.92	0.64	1.15	0.94	0.28	0.0177	0.0289	(A) Negative
RPP30	10q23.31	-0.27	-0.38	0.43	0.33	0.10	0.0177	0.0290	(A) Negative
ADNP	20q13.13	-0.02	0.11	0.54	0.52	-0.13	0.0177	0.0290	(B) Positive
HBS1L	6q23.3	-0.30	-0.46	0.69	0.53	0.16	0.0178	0.0290	(A) Negative
DMGDH	5q14.1	-0.21	0.02	0.88	0.95	-0.22	0.0178	0.0290	(B) Positive
RB1CC1	8q11.23	0.42	0.27	0.62	0.57	0.15	0.0178	0.0291	(A) Negative
LINC02145	5p15.31	0.43	0.50	0.27	0.32	-0.07	0.0178	0.0291	(B) Positive
F8	Xq28	0.88	1.05	0.69	0.68	-0.17	0.0178	0.0291	(B) Positive
RPL26	17p13.1	-0.20	-0.07	0.52	0.54	-0.13	0.0179	0.0292	(B) Positive
TM4SF5	17p13.2	-3.86	-3.97	0.46	0.42	0.11	0.0179	0.0292	(A) Negative
PPP1R15A	19q13.2	-0.05	-0.19	0.53	0.60	0.14	0.0179	0.0292	(A) Negative
SCRN1	7p14.3	-0.91	-1.15	0.98	1.00	0.25	0.0179	0.0292	(A) Negative
OR8B4	11q24.2	0.29	0.44	0.59	0.69	-0.15	0.0179	0.0293	(B) Positive
HOXC8	12q13.13	0.48	0.67	0.75	0.84	-0.19	0.0179	0.0293	(B) Positive
HGFAC	4p16.3	-2.22	-2.34	0.47	0.39	0.11	0.0180	0.0293	(A) Negative
RIOX1	14q24.3	0.95	1.10	0.56	0.60	-0.14	0.0180	0.0293	(B) Positive
TTC4	1p32.3	-0.34	-0.48	0.57	0.46	0.14	0.0180	0.0293	(A) Negative
SCRT2	20p13	1.07	0.82	1.00	1.02	0.25	0.0180	0.0293	(A) Negative
ATOSB	9p13.3	0.50	0.42	0.33	0.31	0.08	0.0180	0.0294	(A) Negative
FMO3	1q24.3	2.97	2.61	1.53	0.97	0.36	0.0180	0.0294	(A) Negative
SSTR1	14q13	-3.62	-3.34	1.14	0.91	-0.27	0.0181	0.0295	(B) Positive
HSP90B3P	1p22.1	-0.13	-0.27	0.57	0.54	0.14	0.0181	0.0295	(A) Negative
PLA2G1B	12q24.31	0.48	0.67	0.76	0.74	-0.19	0.0181	0.0295	(B) Positive
SEMA6A	5q23.1	-1.22	-1.02	0.78	0.93	-0.20	0.0181	0.0296	(B) Positive
OR5AU1	14q11.2	0.38	0.28	0.41	0.34	0.10	0.0182	0.0296	(A) Negative
NCKAP1L	12q13.13-q13.2	-0.23	-0.47	0.99	0.84	0.24	0.0182	0.0296	(A) Negative
ST6GALNAC4	9q34.11	-0.37	-0.18	0.73	0.74	-0.18	0.0182	0.0297	(B) Positive
SPTLC2	14q24.3	1.02	1.20	0.75	0.60	-0.18	0.0182	0.0297	(B) Positive
UBE2F	2q37.3	0.03	0.15	0.49	0.51	-0.12	0.0182	0.0297	(B) Positive
CSGALNACT2	10q11.21	0.61	0.47	0.58	0.49	0.14	0.0183	0.0298	(A) Negative
MFF	2q36.3	-0.15	-0.24	0.39	0.32	0.09	0.0183	0.0298	(A) Negative
SENP1	12q13.11	-0.42	-0.32	0.40	0.39	-0.10	0.0183	0.0299	(B) Positive
SPP1	4q22.1	0.40	0.00	1.58	1.67	0.40	0.0183	0.0299	(A) Negative
ADGRF4	6p12.3	-0.68	-0.94	1.11	0.82	0.26	0.0184	0.0299	(A) Negative
TBCC	6p21.1	0.33	0.21	0.48	0.40	0.12	0.0184	0.0299	(A) Negative
IL37	2q14.1	-0.36	-0.50	0.58	0.46	0.14	0.0184	0.0300	(A) Negative
DENND3	8q24.3	0.43	0.23	0.84	0.62	0.20	0.0184	0.0300	(A) Negative
GABRA2	4p12	-2.32	-2.05	1.10	1.10	-0.27	0.0184	0.0300	(B) Positive
ZMYM2	13q12.11	-0.49	-0.35	0.55	0.58	-0.14	0.0184	0.0300	(B) Positive
JCAD	10p11.23	0.18	0.34	0.59	0.68	-0.15	0.0184	0.0300	(B) Positive
BLTP3A	6p21.31	-0.06	-0.17	0.44	0.41	0.11	0.0185	0.0300	(A) Negative
PPCDC	15q24.2	-0.54	-0.44	0.41	0.36	-0.10	0.0185	0.0301	(B) Positive
PPIL3	2q33.1	-0.77	-0.61	0.67	0.54	-0.16	0.0185	0.0301	(B) Positive
NOS1	12q24.22	0.40	0.33	0.27	0.23	0.07	0.0185	0.0301	(A) Negative
BRPF3	6p21.31	0.27	0.36	0.38	0.38	-0.09	0.0185	0.0301	(B) Positive
PLA1A	3q13.33	0.29	0.57	1.16	1.04	-0.28	0.0185	0.0302	(B) Positive
LRRC37B	17q11.2	-0.37	-0.51	0.57	0.50	0.14	0.0185	0.0302	(A) Negative
EIF4A2	3q27.3	-0.58	-0.42	0.69	0.66	-0.17	0.0186	0.0302	(B) Positive
PLXND1	3q22.1	-0.15	-0.01	0.51	0.59	-0.13	0.0186	0.0303	(B) Positive
ZFP3	17p13.2	0.50	0.40	0.41	0.45	0.10	0.0187	0.0303	(A) Negative
ADGRE1	19p13.3-p13.2	-1.77	-1.98	0.91	0.62	0.21	0.0187	0.0303	(A) Negative
RGS19	20q13.33	0.16	0.02	0.57	0.59	0.14	0.0187	0.0304	(A) Negative
MEP1A	6p12.3	-0.83	-0.98	0.61	0.58	0.15	0.0187	0.0304	(A) Negative
AGRP	16q22.1	0.28	0.16	0.47	0.43	0.12	0.0187	0.0304	(A) Negative
SSNA1	9q34.3	0.11	0.22	0.45	0.43	-0.11	0.0187	0.0304	(B) Positive
C19ORF44	19p13.11	0.29	0.42	0.49	0.51	-0.12	0.0187	0.0304	(B) Positive
SYNGR3	16p13.3	-1.06	-0.90	0.61	0.73	-0.16	0.0187	0.0304	(B) Positive
SEC11A	15q25.2	-0.41	-0.29	0.50	0.38	-0.12	0.0187	0.0304	(B) Positive
SLC25A11	17p13.2	-0.61	-0.49	0.48	0.50	-0.12	0.0188	0.0305	(B) Positive
ITIH5	10p14	0.78	0.95	0.68	0.79	-0.17	0.0188	0.0305	(B) Positive
ELOVL7	5q12.1	-0.20	-0.45	1.00	1.02	0.25	0.0188	0.0305	(A) Negative
PFN4	2p23.3	0.17	0.37	0.83	0.66	-0.20	0.0188	0.0305	(B) Positive
ZFHX2	14q11.2	0.72	0.93	0.86	0.75	-0.21	0.0188	0.0305	(B) Positive
ACP4	19q13.33	0.23	0.18	0.19	0.21	0.05	0.0188	0.0306	(A) Negative
RSL1D1	16p13.13	-0.26	-0.15	0.44	0.40	-0.11	0.0188	0.0306	(B) Positive
LCE1F	1q21.3	0.54	0.45	0.37	0.31	0.09	0.0189	0.0306	(A) Negative
AKAP13	15q25.3	1.25	1.13	0.51	0.41	0.12	0.0189	0.0307	(A) Negative
CPT1B	22q13.33	-0.51	-0.39	0.51	0.53	-0.13	0.0189	0.0307	(B) Positive
DAGLB	7p22.1	-0.28	-0.17	0.45	0.40	-0.11	0.0189	0.0307	(B) Positive
MICB	6p21.33	-0.84	-0.71	0.55	0.53	-0.14	0.0189	0.0307	(B) Positive
RHOU	1q42.13	0.30	0.04	1.03	1.09	0.26	0.0189	0.0308	(A) Negative
PITPNM1	11q13.2	-1.05	-1.22	0.65	0.73	0.17	0.0190	0.0308	(A) Negative
ADORA3	1p13.2	3.14	3.34	0.84	0.72	-0.20	0.0190	0.0308	(B) Positive
ZNF334	20q13.12	-0.69	-1.07	1.56	1.43	0.38	0.0190	0.0308	(A) Negative
HMGCS1	5p12	-1.28	-1.48	0.84	0.62	0.20	0.0190	0.0309	(A) Negative
ENDOG	9q34.11	-0.62	-0.48	0.58	0.46	-0.14	0.0191	0.0309	(B) Positive
ANO2	12p13.31	-0.62	-0.28	1.36	1.34	-0.34	0.0191	0.0310	(B) Positive
B3GNTL1	17q25.3	-0.10	-0.26	0.67	0.57	0.16	0.0191	0.0310	(A) Negative
PKN2	1p22.2	0.61	0.47	0.58	0.53	0.14	0.0191	0.0311	(A) Negative
HCP5	6p21.33	1.71	1.53	0.78	0.70	0.19	0.0192	0.0311	(A) Negative
IFT52	20q13.12	-0.13	0.05	0.76	0.68	-0.18	0.0192	0.0312	(B) Positive
RPS2	16p13.3	-1.10	-1.21	0.48	0.43	0.12	0.0193	0.0313	(A) Negative
C7ORF33	7q36.1	0.83	0.64	0.81	0.65	0.19	0.0193	0.0313	(A) Negative
INSIG2	2q14.1-q14.2	-0.81	-0.97	0.66	0.62	0.16	0.0193	0.0313	(A) Negative
SLC14A2	18q12.3	0.36	0.30	0.22	0.24	0.05	0.0193	0.0313	(A) Negative
ACVR2B	3p22.2	-1.24	-1.11	0.55	0.52	-0.13	0.0193	0.0313	(B) Positive
TAF8	6p21.1	-0.40	-0.50	0.42	0.40	0.10	0.0193	0.0314	(A) Negative
GCDH	19p13.13	-0.08	0.03	0.46	0.49	-0.12	0.0194	0.0314	(B) Positive
HSPA13	21q11.2	-0.55	-0.72	0.66	0.71	0.16	0.0194	0.0314	(A) Negative
KRT8P12	3q25.33	-0.28	-0.12	0.62	0.73	-0.16	0.0194	0.0314	(B) Positive
CFHR3	1q31.3	1.23	1.49	1.06	1.11	-0.26	0.0194	0.0314	(B) Positive
KIF5A	12q13.3	-0.80	-0.70	0.37	0.54	-0.10	0.0194	0.0315	(B) Positive
HSD11B1	1q32.2	1.79	1.49	1.20	1.27	0.30	0.0194	0.0315	(A) Negative
ST20-AS1	15q25.1	-0.15	-0.26	0.47	0.36	0.11	0.0195	0.0315	(A) Negative
ARID5A	2q11.2	0.72	0.51	0.84	0.82	0.21	0.0195	0.0315	(A) Negative
DHFR2	3q11.2	-0.42	-0.33	0.36	0.40	-0.09	0.0195	0.0316	(B) Positive
ARK2C	18q21.1	-0.38	-0.74	1.47	1.22	0.35	0.0195	0.0316	(A) Negative
PCLAF	15q22.31	-1.45	-1.62	0.67	0.77	0.17	0.0195	0.0317	(A) Negative
ADCYAP1	18p11.32	0.88	0.50	1.67	1.11	0.39	0.0196	0.0317	(A) Negative
ITPRID2	2q31.3	-0.50	-0.27	0.84	1.16	-0.23	0.0196	0.0317	(B) Positive
PAQR7	1p36.11	0.24	0.33	0.35	0.32	-0.09	0.0196	0.0317	(B) Positive
ZMAT5	22q12.2	-0.03	0.09	0.52	0.49	-0.13	0.0196	0.0318	(B) Positive
CCDC88B	11q13.1	-0.49	-0.68	0.76	0.72	0.18	0.0197	0.0318	(A) Negative
SH2B1	16p11.2	-0.32	-0.22	0.41	0.48	-0.10	0.0197	0.0318	(B) Positive
PDE4D	5q11.2-q12.1	-0.96	-1.12	0.64	0.68	0.16	0.0197	0.0319	(A) Negative
NDUFS2	1q23.3	0.10	0.25	0.60	0.63	-0.15	0.0197	0.0319	(B) Positive
PDC	1q31.1	-0.04	-0.14	0.42	0.46	0.11	0.0197	0.0320	(A) Negative
RIMKLA	1p34.2	-0.89	-0.52	1.50	1.48	-0.37	0.0198	0.0320	(B) Positive
MRPS18C	4q21.23	-0.43	-0.56	0.54	0.41	0.13	0.0198	0.0320	(A) Negative
CCN4	8q24.22	2.07	2.30	0.95	0.98	-0.23	0.0198	0.0320	(B) Positive
BANF1	11q13.1	-0.20	-0.31	0.48	0.46	0.12	0.0198	0.0321	(A) Negative
EID2	19q13.2	0.07	-0.06	0.56	0.44	0.13	0.0198	0.0321	(A) Negative
MCU	10q22.1	-0.01	-0.14	0.52	0.46	0.13	0.0199	0.0321	(A) Negative
ZNF512B	20q13.33	-0.63	-0.76	0.54	0.53	0.13	0.0199	0.0322	(A) Negative
YBEY	21q22.3	-0.37	-0.15	0.94	0.81	-0.22	0.0199	0.0322	(B) Positive
FAM78A	9q34.13	-0.55	-0.76	0.89	0.74	0.21	0.0199	0.0322	(A) Negative
KIAA0408	6q22.33	-1.55	-1.74	0.79	0.63	0.19	0.0200	0.0323	(A) Negative
RPAP1	15q15.1	-0.83	-0.72	0.46	0.40	-0.11	0.0200	0.0323	(B) Positive
MXD3	5q35.3	-0.74	-0.87	0.50	0.56	0.13	0.0200	0.0323	(A) Negative
IQSEC3	12p13.33	0.43	0.35	0.34	0.30	0.08	0.0200	0.0323	(A) Negative
SEMA4D	9q22.2	1.02	1.18	0.69	0.63	-0.17	0.0200	0.0324	(B) Positive
MYH13	17p13.1	0.10	-0.07	0.74	0.56	0.17	0.0201	0.0324	(A) Negative
CD48	1q23.3	1.86	1.52	1.42	1.23	0.34	0.0201	0.0324	(A) Negative
IRF2BP1	19q13.32	0.72	0.84	0.48	0.47	-0.12	0.0201	0.0324	(B) Positive
SLC37A2	11q24.2	0.16	0.35	0.75	0.85	-0.19	0.0201	0.0325	(B) Positive
SLC7A7	14q11.2	3.46	3.26	0.87	0.71	0.20	0.0201	0.0325	(A) Negative
RIN2	20p11.23	1.82	2.00	0.74	0.76	-0.18	0.0202	0.0326	(B) Positive
SIGLEC5	19q13.41	1.73	1.52	0.86	0.78	0.21	0.0202	0.0326	(A) Negative
HMGN2	1p36.11	-0.27	-0.15	0.53	0.43	-0.13	0.0202	0.0326	(B) Positive
PTGER2	14q22.1	-0.84	-0.56	1.03	1.40	-0.27	0.0202	0.0326	(B) Positive
LCE3B	1q21.3	0.29	0.21	0.32	0.32	0.08	0.0202	0.0326	(A) Negative
ZNF709	19p13.2	-0.03	0.09	0.49	0.53	-0.12	0.0202	0.0327	(B) Positive
MPZ	1q23.3	0.12	-0.03	0.65	0.48	0.15	0.0202	0.0327	(A) Negative
ZNF431	19p12	-0.59	-0.45	0.60	0.49	-0.14	0.0202	0.0327	(B) Positive
APPL1	3p14.3	0.49	0.62	0.52	0.56	-0.13	0.0202	0.0327	(B) Positive
RPS5	19q13.43	-0.81	-0.66	0.65	0.58	-0.15	0.0202	0.0327	(B) Positive
NEXN	1p31.1	0.64	0.40	0.98	0.98	0.24	0.0203	0.0327	(A) Negative
CFL2	14q13.1	-1.61	-1.78	0.69	0.65	0.17	0.0203	0.0327	(A) Negative
PNCK	Xq28	-1.16	-0.98	0.72	0.85	-0.18	0.0203	0.0327	(B) Positive
GTF3C4	9q34.13	-0.10	-0.24	0.59	0.45	0.14	0.0203	0.0327	(A) Negative
RPL18	19q13.33	-0.27	-0.16	0.45	0.45	-0.11	0.0203	0.0327	(B) Positive
NTN3	16p13.3	0.26	0.19	0.29	0.29	0.07	0.0203	0.0327	(A) Negative
CFL1	11q13.1	-0.31	-0.44	0.53	0.55	0.13	0.0203	0.0327	(A) Negative
CACNG7	19q13.42	-0.02	0.08	0.39	0.36	-0.09	0.0204	0.0328	(B) Positive
WFDC10A	20q13.12	-0.17	0.01	0.66	1.00	-0.18	0.0204	0.0329	(B) Positive
HEMGN	9q22.33	-5.36	-5.48	0.52	0.47	0.12	0.0204	0.0329	(A) Negative
STAU2	8q21.11	0.31	0.44	0.53	0.52	-0.13	0.0204	0.0329	(B) Positive
TARBP1	1q42.2	-0.28	-0.48	0.85	0.72	0.20	0.0204	0.0329	(A) Negative
GINS2	16q24.1	-1.34	-1.55	0.84	1.02	0.22	0.0204	0.0329	(A) Negative
FTO	16q12.2	-0.01	0.15	0.67	0.70	-0.17	0.0204	0.0330	(B) Positive
TSPYL2	Xp11.22	-0.44	-0.32	0.44	0.51	-0.11	0.0205	0.0330	(B) Positive
CSN2	4q13.3	0.42	0.20	0.98	0.44	0.22	0.0205	0.0330	(A) Negative
SSR3	3q25.31	-0.22	-0.34	0.50	0.45	0.12	0.0205	0.0331	(A) Negative
NLRC3	16p13.3	0.51	0.35	0.68	0.57	0.16	0.0206	0.0331	(A) Negative
ALB	4q13.3	-4.30	-4.09	0.75	1.16	-0.21	0.0206	0.0332	(B) Positive
ELOVL3	10q24.32	0.41	0.11	1.30	0.94	0.30	0.0206	0.0332	(A) Negative
WDR83OS	19p13.13	-0.20	-0.10	0.42	0.42	-0.10	0.0206	0.0332	(B) Positive
CBLN1	16q12.1	-2.41	-2.14	1.11	1.15	-0.27	0.0206	0.0332	(B) Positive
CD53	1p13.3	0.57	0.29	1.17	1.04	0.28	0.0207	0.0333	(A) Negative
ALOXE3	17p13.1	0.14	0.20	0.26	0.31	-0.07	0.0208	0.0334	(B) Positive
RNPS1	16p13.3	-0.36	-0.47	0.43	0.40	0.10	0.0208	0.0334	(A) Negative
STX1B	16p11.2	-0.46	-0.33	0.52	0.59	-0.13	0.0208	0.0335	(B) Positive
DES	2q35	0.25	0.04	0.86	0.83	0.21	0.0208	0.0335	(A) Negative
MRPS16	10q22.2	-0.47	-0.37	0.41	0.39	-0.10	0.0208	0.0335	(B) Positive
DDI2	1p36.21	-0.07	0.00	0.31	0.34	-0.08	0.0208	0.0335	(B) Positive
NOA1	4q12	0.03	-0.08	0.50	0.35	0.12	0.0208	0.0335	(A) Negative
AGBL3	7q33	0.99	0.85	0.57	0.58	0.14	0.0208	0.0335	(A) Negative
ING1	13q34	0.41	0.26	0.58	0.70	0.15	0.0208	0.0335	(A) Negative
CCAR2	8p21.3	-0.05	0.09	0.53	0.58	-0.13	0.0209	0.0336	(B) Positive
MAOB	Xp11.3	1.50	1.98	1.97	2.02	-0.48	0.0210	0.0337	(B) Positive
EPO	7q22.1	-2.52	-2.24	1.09	1.40	-0.28	0.0210	0.0337	(B) Positive
CHRNB1	17p13.1	-0.25	-0.14	0.49	0.47	-0.12	0.0210	0.0338	(B) Positive
ATP12A	13q12.12	0.06	-0.15	0.86	0.81	0.21	0.0210	0.0338	(A) Negative
TBKBP1	17q21.32	0.50	0.40	0.43	0.46	0.11	0.0211	0.0339	(A) Negative
LAIR1	19q13.42	1.33	1.10	0.97	0.85	0.23	0.0211	0.0339	(A) Negative
CTNND1	11q12.1	0.87	0.98	0.46	0.46	-0.11	0.0211	0.0339	(B) Positive
SEPTIN14	7p11.2	0.35	0.44	0.34	0.44	-0.09	0.0212	0.0340	(B) Positive
GYG1	3q24	0.30	0.17	0.56	0.50	0.13	0.0212	0.0340	(A) Negative
ALG2	9q22.33	0.23	0.35	0.53	0.37	-0.12	0.0213	0.0342	(B) Positive
TFG	3q12.2	0.11	-0.01	0.52	0.41	0.12	0.0213	0.0342	(A) Negative
NRP1	10p11.22	0.29	0.13	0.68	0.57	0.16	0.0213	0.0342	(A) Negative
NOG	17q22	-1.57	-1.70	0.55	0.60	0.14	0.0213	0.0343	(A) Negative
SPPL2A	15q21.2	-0.10	0.06	0.67	0.58	-0.16	0.0214	0.0343	(B) Positive
METTL6	3p25.1	-0.49	-0.36	0.56	0.48	-0.13	0.0214	0.0343	(B) Positive
AK2	1p35.1	-0.25	-0.37	0.52	0.37	0.12	0.0214	0.0343	(A) Negative
CD81	11p15.5	1.03	1.15	0.51	0.42	-0.12	0.0214	0.0344	(B) Positive
CDK14	7q21.13	0.33	0.51	0.74	0.85	-0.19	0.0215	0.0345	(B) Positive
VPS33B	15q26.1	-0.41	-0.29	0.50	0.40	-0.12	0.0215	0.0345	(B) Positive
IFI44L	1p31.1	3.45	3.08	1.55	1.32	0.37	0.0215	0.0345	(A) Negative
NDOR1	9q34.3	0.70	0.57	0.55	0.55	0.13	0.0216	0.0346	(A) Negative
DLEU1	13q14.2-q14.3	-1.16	-1.32	0.65	0.68	0.16	0.0216	0.0346	(A) Negative
IFNA10	9p21.3	0.52	0.32	0.79	0.89	0.20	0.0216	0.0347	(A) Negative
AFP	4q13.3	-4.82	-4.66	0.58	0.85	-0.16	0.0216	0.0347	(B) Positive
ARRDC1-AS1	9q34.3	-1.13	-1.03	0.40	0.41	-0.10	0.0216	0.0347	(B) Positive
PAGE5	Xp11.21	-2.53	-2.90	1.58	1.24	0.37	0.0217	0.0348	(A) Negative
EYA1	8q13.3	-2.69	-2.42	1.08	1.21	-0.27	0.0217	0.0348	(B) Positive
LY6G5B	6p21.33	-0.70	-0.80	0.45	0.47	0.11	0.0217	0.0348	(A) Negative
DSG4	18q12.1	0.37	0.28	0.32	0.38	0.08	0.0217	0.0348	(A) Negative
KLF10	8q22.3	0.00	0.17	0.69	0.65	-0.17	0.0217	0.0348	(B) Positive
TRIM49	11q14.3	-1.33	-1.56	0.97	0.74	0.22	0.0217	0.0349	(A) Negative
PDS5A	4p14	-0.31	-0.19	0.52	0.41	-0.12	0.0218	0.0349	(B) Positive
CEL	9q34.13	0.21	0.11	0.46	0.30	0.10	0.0218	0.0350	(A) Negative
PCDHGA3	5q31.3	-0.05	-0.30	1.01	1.09	0.25	0.0219	0.0351	(A) Negative
NR2F1	5q15	-1.27	-0.89	1.62	1.42	-0.38	0.0219	0.0351	(B) Positive
RPLP2	11p15.5	0.17	0.04	0.55	0.47	0.13	0.0219	0.0352	(A) Negative
PTPRS	19p13.3	0.36	0.23	0.52	0.54	0.13	0.0220	0.0353	(A) Negative
GTF2B	1p22.2	0.12	0.02	0.43	0.39	0.10	0.0220	0.0353	(A) Negative
MEX3D	19p13.3	0.44	0.33	0.45	0.43	0.11	0.0220	0.0353	(A) Negative
MAP3K8	10p11.23	0.79	0.52	1.12	1.07	0.27	0.0220	0.0353	(A) Negative
SCRIB	8q24.3	0.26	0.11	0.59	0.58	0.14	0.0221	0.0353	(A) Negative
TNFSF10	3q26	3.39	3.65	1.09	1.03	-0.26	0.0221	0.0354	(B) Positive
SYPL2	1p13.3	0.22	0.30	0.31	0.34	-0.08	0.0221	0.0354	(B) Positive
ATCAY	19p13.3	-0.35	-0.44	0.37	0.32	0.09	0.0221	0.0354	(A) Negative
PHF13	1p36.31	0.34	0.45	0.46	0.40	-0.11	0.0221	0.0355	(B) Positive
KLRF1	12p13.31	0.74	0.49	1.08	0.86	0.25	0.0222	0.0355	(A) Negative
CDO1	5q22.3	-0.07	0.32	1.65	1.57	-0.39	0.0222	0.0355	(B) Positive
DUS3L	19p13.3	-0.63	-0.74	0.48	0.43	0.11	0.0222	0.0356	(A) Negative
OR1S2	11q12.1	0.42	0.35	0.26	0.25	0.06	0.0223	0.0356	(A) Negative
SELENOI	2p23.3	0.40	0.25	0.63	0.57	0.15	0.0224	0.0358	(A) Negative
TRAPPC14	7q22.1	0.33	0.25	0.34	0.32	0.08	0.0224	0.0358	(A) Negative
ZNF669	1q44	0.19	0.03	0.69	0.69	0.17	0.0224	0.0359	(A) Negative
CCN3	8q24.12	-0.02	-0.29	1.16	1.03	0.27	0.0224	0.0359	(A) Negative
UBE2D4	7p13	0.30	0.40	0.45	0.39	-0.11	0.0224	0.0359	(B) Positive
CTXN1	19p13.2	0.89	0.75	0.58	0.49	0.14	0.0225	0.0359	(A) Negative
ZPBP	7p12.2	0.39	0.26	0.58	0.47	0.13	0.0225	0.0360	(A) Negative
HLA-A	6p22.1	1.68	1.46	0.92	0.84	0.22	0.0225	0.0360	(A) Negative
ANKS3	16p13.3	-0.54	-0.40	0.57	0.57	-0.14	0.0225	0.0360	(B) Positive
MIB2	1p36.33	-0.18	-0.27	0.37	0.35	0.09	0.0225	0.0361	(A) Negative
ACTG1P17	15q25.2	-0.58	-0.48	0.41	0.46	-0.10	0.0225	0.0361	(B) Positive
HARBI1	11p11.2	0.66	0.54	0.51	0.47	0.12	0.0226	0.0362	(A) Negative
COL19A1	6q13	-0.07	-0.21	0.60	0.52	0.14	0.0226	0.0362	(A) Negative
ATG9B	7q36.1	-0.27	-0.35	0.33	0.35	0.08	0.0227	0.0362	(A) Negative
GYS2	12p12.1	0.36	0.24	0.48	0.41	0.11	0.0227	0.0363	(A) Negative
GDF11	12q13.2	-1.55	-1.72	0.74	0.68	0.18	0.0227	0.0363	(A) Negative
ACAD9	3q21.3	0.25	0.14	0.48	0.32	0.11	0.0227	0.0363	(A) Negative
PDRG1	20q11.21	-0.16	-0.04	0.49	0.55	-0.12	0.0227	0.0363	(B) Positive
SIRPB2	20p13	0.21	0.32	0.46	0.54	-0.12	0.0227	0.0363	(B) Positive
AHSG	3q27.3	-6.13	-6.26	0.57	0.48	0.13	0.0227	0.0363	(A) Negative
PITHD1	1p36.11	0.17	0.05	0.52	0.46	0.12	0.0228	0.0364	(A) Negative
TSPAN12	7q31.31	1.02	0.80	0.88	0.93	0.22	0.0228	0.0364	(A) Negative
GGA2	16p12.2	-0.14	-0.02	0.47	0.51	-0.11	0.0228	0.0365	(B) Positive
RNF213	17q25.3	-0.22	-0.04	0.75	0.74	-0.18	0.0229	0.0366	(B) Positive
IRX4	5p15.33	0.56	0.23	1.45	1.18	0.33	0.0229	0.0366	(A) Negative
TRAPPC10	21q22.3	0.08	-0.01	0.43	0.34	0.10	0.0229	0.0366	(A) Negative
LHFPL1	Xq23	-0.49	-0.72	0.98	0.86	0.23	0.0229	0.0367	(A) Negative
CRIPTO	3p21.31	-4.26	-4.39	0.60	0.47	0.14	0.0230	0.0367	(A) Negative
ITGA8	10p13	0.31	0.54	0.99	0.86	-0.23	0.0230	0.0367	(B) Positive
IMMT	2p11.2	-0.42	-0.52	0.41	0.35	0.10	0.0230	0.0367	(A) Negative
GNAT1	3p21.31	0.12	0.00	0.51	0.48	0.12	0.0230	0.0367	(A) Negative
PAQR4	16p13.3	0.02	-0.11	0.51	0.65	0.13	0.0230	0.0367	(A) Negative
TMED10	14q24.3	0.44	0.55	0.46	0.40	-0.11	0.0230	0.0367	(B) Positive
ANAPC7	12q24.11	-0.47	-0.36	0.51	0.45	-0.12	0.0232	0.0370	(B) Positive
HSPBP1	19q13.42	0.11	0.01	0.40	0.45	0.10	0.0232	0.0370	(A) Negative
CCDC121	2p23.3	0.85	0.99	0.62	0.55	-0.14	0.0232	0.0370	(B) Positive
NFATC1	18q23	0.85	0.62	1.01	0.74	0.23	0.0232	0.0371	(A) Negative
SMC3	10q25.2	-0.55	-0.66	0.51	0.38	0.12	0.0232	0.0371	(A) Negative
IDI1	10p15.3	-1.05	-1.27	0.92	0.81	0.21	0.0233	0.0372	(A) Negative
NCOA5	20q13.12	0.70	0.78	0.34	0.35	-0.08	0.0233	0.0372	(B) Positive
OBSL1	2q35	-0.61	-0.79	0.77	0.73	0.18	0.0233	0.0372	(A) Negative
ASIC4	2q35	-1.61	-1.69	0.32	0.33	0.08	0.0234	0.0373	(A) Negative
OR2L13	1q44	0.31	0.41	0.39	0.42	-0.09	0.0234	0.0374	(B) Positive
DBNL	7p13	-0.30	-0.17	0.53	0.56	-0.13	0.0234	0.0374	(B) Positive
TPH1	11p15.1	0.10	0.29	0.76	0.94	-0.19	0.0234	0.0374	(B) Positive
OR1S1	11q12.1	0.19	0.28	0.35	0.35	-0.08	0.0234	0.0374	(B) Positive
ERBB2	17q12	2.01	2.34	1.46	1.03	-0.33	0.0235	0.0374	(B) Positive
USF3	3q13.2	0.56	0.66	0.42	0.37	-0.10	0.0235	0.0374	(B) Positive
SAMM50	22q13.31	-0.32	-0.43	0.48	0.42	0.11	0.0235	0.0375	(A) Negative
MAGEH1	Xp11.21	1.34	1.52	0.75	0.81	-0.18	0.0235	0.0375	(B) Positive
STK25	2q37.3	-0.21	-0.33	0.51	0.44	0.12	0.0235	0.0375	(A) Negative
MYOCD	17p12	0.23	0.31	0.32	0.33	-0.08	0.0236	0.0375	(B) Positive
SYT6	1p13.2	-1.55	-1.38	0.77	0.58	-0.18	0.0236	0.0376	(B) Positive
TCAP	17q12	0.06	-0.24	1.29	1.16	0.30	0.0236	0.0376	(A) Negative
HSD3B2	1p12	0.15	0.05	0.40	0.41	0.10	0.0236	0.0376	(A) Negative
CDRT15	17p12	0.14	0.29	0.60	0.68	-0.15	0.0237	0.0377	(B) Positive
OR5A2	11q12.1	0.27	0.15	0.47	0.55	0.12	0.0237	0.0377	(A) Negative
BASP1	5p15.1	-1.54	-1.34	0.82	0.88	-0.20	0.0237	0.0377	(B) Positive
ADGRG7	3q12.2	0.43	0.15	1.24	0.77	0.27	0.0237	0.0378	(A) Negative
KLHL22	22q11.21	-0.09	0.04	0.54	0.62	-0.13	0.0237	0.0378	(B) Positive
KSR1	17q11.2	0.07	-0.01	0.37	0.29	0.08	0.0237	0.0378	(A) Negative
LLGL2	17q25.1	-0.07	0.10	0.71	0.69	-0.17	0.0237	0.0378	(B) Positive
ANKRD34B	5q14.1	0.09	-0.06	0.61	0.72	0.15	0.0238	0.0378	(A) Negative
SLC44A2	19p13.2	1.63	1.51	0.54	0.45	0.12	0.0238	0.0379	(A) Negative
BRF1	14q32.33	0.11	0.21	0.40	0.37	-0.09	0.0238	0.0379	(B) Positive
MPEG1	11q12.1	3.11	2.95	0.67	0.64	0.16	0.0238	0.0379	(A) Negative
HPGD	4q34.1	0.01	0.26	1.03	1.04	-0.25	0.0238	0.0379	(B) Positive
LEMD3	12q14.3	0.17	0.30	0.53	0.47	-0.12	0.0239	0.0380	(B) Positive
OPCML	11q25	0.60	0.80	0.83	0.74	-0.19	0.0239	0.0380	(B) Positive
HYCC2	2q33.1	0.70	0.54	0.70	0.59	0.16	0.0240	0.0381	(A) Negative
HSD17B1	17q21.2	0.62	0.79	0.75	0.75	-0.18	0.0240	0.0382	(B) Positive
LIPH	3q27.2	1.78	2.12	1.50	1.16	-0.34	0.0241	0.0383	(B) Positive
VPS26B	11q25	0.11	0.22	0.48	0.43	-0.11	0.0241	0.0383	(B) Positive
SLC39A5	12q13.3	-1.75	-1.66	0.36	0.38	-0.09	0.0241	0.0384	(B) Positive
PARD3B	2q33.3	0.73	0.90	0.74	0.55	-0.17	0.0242	0.0385	(B) Positive
PAM	5q21.1	0.43	0.22	0.88	0.88	0.21	0.0242	0.0385	(A) Negative
GCKR	2p23.3	-3.23	-3.35	0.49	0.49	0.12	0.0242	0.0385	(A) Negative
ZNF200	16p13.3	-0.51	-0.41	0.45	0.41	-0.10	0.0242	0.0385	(B) Positive
BOK	2q37.3	0.57	0.75	0.78	0.76	-0.18	0.0242	0.0385	(B) Positive
KLK3	19q13.33	0.46	0.54	0.31	0.46	-0.08	0.0242	0.0385	(B) Positive
UBQLNL	11p15.4	-0.03	0.26	1.23	1.17	-0.29	0.0243	0.0386	(B) Positive
IL36A	2q14.1	0.05	0.16	0.46	0.44	-0.11	0.0244	0.0387	(B) Positive
DOCK2	5q35.1	-0.59	-0.79	0.86	0.75	0.20	0.0244	0.0387	(A) Negative
SLC25A42	19p13.11	-0.44	-0.36	0.34	0.31	-0.08	0.0244	0.0388	(B) Positive
SCO2	22q13.33	0.57	0.43	0.61	0.51	0.14	0.0245	0.0389	(A) Negative
TBATA	10q22.1	0.50	0.59	0.35	0.36	-0.08	0.0245	0.0389	(B) Positive
PIP4K2B	17q12	0.02	0.17	0.63	0.56	-0.15	0.0245	0.0390	(B) Positive
GCAT	22q13.1	-0.05	-0.24	0.78	0.76	0.18	0.0246	0.0390	(A) Negative
ARID5B	10q21.2	0.82	0.67	0.58	0.75	0.15	0.0246	0.0390	(A) Negative
FZR1	19p13.3	0.19	0.29	0.42	0.38	-0.10	0.0246	0.0391	(B) Positive
SAT2	17p13.1	-0.15	-0.03	0.51	0.55	-0.12	0.0246	0.0391	(B) Positive
GPR42	19q13.12	0.22	0.15	0.31	0.26	0.07	0.0247	0.0392	(A) Negative
MADCAM1	19p13.3	-0.04	-0.15	0.43	0.48	0.10	0.0247	0.0393	(A) Negative
OR51T1	11p15.4	0.23	0.15	0.29	0.39	0.07	0.0248	0.0393	(A) Negative
CELA3A	1p36.12	-2.23	-2.33	0.40	0.44	0.10	0.0248	0.0394	(A) Negative
ZFPM1	16q24.2	0.66	0.52	0.59	0.55	0.14	0.0249	0.0395	(A) Negative
SMS	Xp22.11	-0.37	-0.51	0.60	0.60	0.14	0.0249	0.0395	(A) Negative
PRM2	16p13.13	0.51	0.42	0.36	0.30	0.08	0.0249	0.0395	(A) Negative
C1QTNF8	16p13.3	0.20	0.12	0.34	0.36	0.08	0.0249	0.0395	(A) Negative
ATP8A2	13q12.13	-0.50	-0.21	1.23	1.34	-0.30	0.0249	0.0396	(B) Positive
NLE1	17q12	-0.75	-0.87	0.52	0.50	0.12	0.0250	0.0396	(A) Negative
WNT11	11q13.5	0.61	0.37	1.00	1.06	0.24	0.0250	0.0396	(A) Negative
PLEKHS1	10q25.3	4.60	4.17	1.81	1.84	0.43	0.0250	0.0396	(A) Negative
MAFA	8q24.3	1.01	0.83	0.76	0.77	0.18	0.0250	0.0396	(A) Negative
CBARP	19p13.3	0.21	0.14	0.28	0.23	0.06	0.0250	0.0396	(A) Negative
OR4K5	14q11.2	0.02	-0.03	0.20	0.23	0.05	0.0250	0.0397	(A) Negative
NDUFA11	19p13.3	-0.09	-0.18	0.40	0.35	0.09	0.0250	0.0397	(A) Negative
TIAM1	21q22.11	0.56	0.40	0.70	0.74	0.17	0.0250	0.0397	(A) Negative
PCSK2	20p12.1	-0.37	-0.18	0.72	0.97	-0.19	0.0250	0.0397	(B) Positive
EPDR1	7p14.1	-1.60	-1.38	0.92	0.93	-0.22	0.0250	0.0397	(B) Positive
PRUNE2	9q21.2	-1.64	-1.87	1.03	0.80	0.23	0.0251	0.0397	(A) Negative
SWI5	9q34.11	0.21	0.32	0.45	0.40	-0.10	0.0251	0.0397	(B) Positive
GNG12	1p31.3	-0.51	-0.26	1.09	0.95	-0.25	0.0251	0.0398	(B) Positive
VSTM4	10q11.23	-0.26	-0.16	0.46	0.44	-0.11	0.0251	0.0398	(B) Positive
EIF6	20q11.22	-0.30	-0.39	0.38	0.41	0.09	0.0251	0.0398	(A) Negative
TECTA	11q23.3	0.18	0.30	0.49	0.53	-0.12	0.0251	0.0398	(B) Positive
CREG1	1q24.2	-0.02	-0.19	0.76	0.57	0.17	0.0251	0.0398	(A) Negative
OR4L1	14q11.2	0.40	0.34	0.27	0.29	0.06	0.0252	0.0399	(A) Negative
ZNF653	19p13.2	0.34	0.43	0.40	0.39	-0.09	0.0252	0.0399	(B) Positive
TDRD5	1q25.2	1.11	0.90	0.90	0.95	0.21	0.0252	0.0399	(A) Negative
SCG3	15q21.2	-2.95	-3.18	0.99	1.05	0.24	0.0252	0.0399	(A) Negative
MAP4K5	14q22.1	0.18	0.07	0.49	0.39	0.11	0.0252	0.0400	(A) Negative
NEUROG3	10q22.1	1.06	0.80	1.09	1.14	0.26	0.0253	0.0400	(A) Negative
PCDH17	13q21.1	3.13	2.96	0.76	0.73	0.18	0.0253	0.0400	(A) Negative
CDKL2	4q21.1	0.29	0.54	1.05	1.02	-0.25	0.0253	0.0401	(B) Positive
STK31	7p15.3	1.56	1.16	1.79	1.46	0.41	0.0253	0.0401	(A) Negative
BPIFB4	20q11.21	0.19	0.08	0.48	0.45	0.11	0.0253	0.0401	(A) Negative
UGT1A8	2q37.1	-0.12	-0.27	0.62	0.51	0.14	0.0254	0.0401	(A) Negative
OR1C1	1q44	0.42	0.34	0.31	0.27	0.07	0.0254	0.0401	(A) Negative
SLC34A3	9q34.3	0.82	0.68	0.59	0.58	0.14	0.0254	0.0402	(A) Negative
SLC35A5	3q13.2	-0.16	-0.01	0.64	0.60	-0.15	0.0254	0.0402	(B) Positive
IFRD2	3p21.31	-0.49	-0.60	0.49	0.39	0.11	0.0255	0.0403	(A) Negative
PADI3	1p36.13	0.15	-0.13	1.26	0.81	0.28	0.0255	0.0403	(A) Negative
ARL4D	17q21.31	-0.77	-0.62	0.66	0.64	-0.15	0.0255	0.0403	(B) Positive
KDM4C	9p24.1	-0.20	-0.36	0.71	0.49	0.16	0.0255	0.0403	(A) Negative
RNF216P1	7p22.1	-0.26	-0.37	0.49	0.39	0.11	0.0255	0.0404	(A) Negative
P4HB	17q25.3	0.59	0.45	0.58	0.58	0.14	0.0255	0.0404	(A) Negative
TMEM61	1p32.3	0.44	0.14	1.36	1.00	0.30	0.0256	0.0405	(A) Negative
SEC16B	1q25.2	0.57	0.45	0.51	0.46	0.12	0.0256	0.0405	(A) Negative
ADORA2A	22q11.23	0.31	0.51	0.81	1.08	-0.21	0.0257	0.0406	(B) Positive
BRSK2	11p15.5	-0.52	-0.72	0.85	0.73	0.19	0.0258	0.0407	(A) Negative
CCT2	12q15	-0.81	-0.66	0.60	0.67	-0.15	0.0260	0.0411	(B) Positive
FGF13	Xq26.3-q27.1	1.04	0.68	1.56	1.37	0.36	0.0261	0.0412	(A) Negative
SFMBT2	10p14	-0.17	-0.29	0.53	0.41	0.12	0.0261	0.0412	(A) Negative
GNG7	19p13.3	0.55	0.34	0.94	0.66	0.21	0.0261	0.0413	(A) Negative
POLE	12q24.33	-0.85	-0.94	0.42	0.39	0.10	0.0262	0.0413	(A) Negative
SPATA31G1	9p13.3	0.13	0.02	0.47	0.31	0.10	0.0262	0.0413	(A) Negative
SYNE2	14q23.2	0.46	0.29	0.75	0.63	0.17	0.0262	0.0414	(A) Negative
WASL	7q31.32	0.32	0.45	0.58	0.47	-0.13	0.0262	0.0414	(B) Positive
CBX1	17q21.32	0.34	0.12	0.94	0.76	0.21	0.0263	0.0415	(A) Negative
PKD2L2	5q31.2	0.05	0.14	0.35	0.36	-0.08	0.0263	0.0415	(B) Positive
TTC7B	14q32.11	-0.45	-0.58	0.55	0.53	0.13	0.0263	0.0416	(A) Negative
MCF2	Xq27.1	-0.68	-0.88	0.89	0.83	0.20	0.0264	0.0416	(A) Negative
C7ORF50	7p22.3	-0.18	-0.05	0.59	0.49	-0.13	0.0264	0.0416	(B) Positive
MAN1A2	1p12	0.90	0.75	0.65	0.57	0.15	0.0264	0.0416	(A) Negative
CEBPD	8q11.21	2.21	2.45	1.02	1.05	-0.24	0.0264	0.0417	(B) Positive
SCNN1B	16p12.2-p12.1	0.54	0.30	1.04	1.03	0.24	0.0264	0.0417	(A) Negative
TUBB1	20q13.32	-1.40	-1.27	0.52	0.71	-0.13	0.0264	0.0417	(B) Positive
HSPB2	11q23.1	3.73	3.50	1.02	0.84	0.23	0.0264	0.0417	(A) Negative
TRIM55	8q13.1	-0.08	-0.42	1.57	1.11	0.35	0.0264	0.0417	(A) Negative
S1PR5	19p13.2	0.18	-0.07	1.12	0.93	0.25	0.0265	0.0418	(A) Negative
DDX56	7p13	-0.68	-0.56	0.52	0.46	-0.12	0.0265	0.0418	(B) Positive
ACRBP	12p13.31	-1.49	-1.34	0.61	0.61	-0.14	0.0265	0.0419	(B) Positive
REXO5	16p12.3	-0.96	-0.78	0.75	0.69	-0.17	0.0265	0.0419	(B) Positive
ELK1	Xp11.23	-0.08	-0.20	0.48	0.51	0.11	0.0266	0.0419	(A) Negative
OASL	12q24.31	2.33	2.01	1.41	1.21	0.32	0.0266	0.0419	(A) Negative
TAS2R4	7q34	-0.28	-0.19	0.37	0.42	-0.09	0.0266	0.0420	(B) Positive
FST	5q11.2	-3.60	-3.37	0.96	1.01	-0.23	0.0266	0.0420	(B) Positive
GPX5	6p22.1	0.30	0.24	0.26	0.24	0.06	0.0266	0.0420	(A) Negative
PDGFRA	4q12	-0.28	-0.49	0.90	0.90	0.21	0.0267	0.0421	(A) Negative
PHC1	12p13.31	-1.78	-1.94	0.73	0.50	0.16	0.0267	0.0421	(A) Negative
DHH	12q13.12	0.15	0.08	0.29	0.30	0.07	0.0267	0.0421	(A) Negative
ERG28	14q24.3	0.05	0.15	0.44	0.40	-0.10	0.0267	0.0421	(B) Positive
TTC3	21q22.13	0.51	0.66	0.67	0.53	-0.15	0.0267	0.0421	(B) Positive
EPB42	15q15.2	-0.66	-0.55	0.46	0.54	-0.11	0.0268	0.0422	(B) Positive
MEG3	14q32.2	-1.48	-1.36	0.50	0.45	-0.11	0.0268	0.0423	(B) Positive
SND1-IT1	7q32.1	-0.37	-0.50	0.56	0.47	0.13	0.0269	0.0424	(A) Negative
FKRP	19q13.32	0.32	0.20	0.50	0.44	0.11	0.0269	0.0424	(A) Negative
SLC16A7	12q14.1	-0.65	-0.84	0.73	0.94	0.18	0.0269	0.0424	(A) Negative
TMCC1	3q22.1	0.25	0.35	0.48	0.35	-0.11	0.0270	0.0426	(B) Positive
TAOK3	12q24.23	0.61	0.72	0.46	0.46	-0.11	0.0271	0.0426	(B) Positive
NACC1	19p13.13	0.55	0.47	0.34	0.33	0.08	0.0271	0.0427	(A) Negative
C2CD4B	15q22.2	1.05	0.87	0.77	0.77	0.18	0.0271	0.0427	(A) Negative
ADGRE3	19p13.12	0.66	0.53	0.54	0.61	0.13	0.0272	0.0428	(A) Negative
PITX2	4q25	-1.04	-1.43	1.73	1.44	0.39	0.0272	0.0428	(A) Negative
MRPL57	13q12.11	-0.00	0.12	0.51	0.44	-0.12	0.0272	0.0429	(B) Positive
BDKRB1	14q32.2	-1.92	-1.68	1.03	0.95	-0.24	0.0272	0.0429	(B) Positive
VEGFD	Xp22.2	0.86	1.19	1.33	1.60	-0.32	0.0273	0.0429	(B) Positive
SETDB1	1q21.3	0.35	0.24	0.49	0.44	0.11	0.0273	0.0430	(A) Negative
KCNA3	1p13.3	0.09	-0.09	0.76	0.85	0.18	0.0273	0.0430	(A) Negative
TXNDC11	16p13.13	0.25	0.37	0.55	0.43	-0.12	0.0273	0.0430	(B) Positive
ZNF77	19p13.3	0.11	-0.06	0.77	0.50	0.17	0.0273	0.0430	(A) Negative
PPIG	2q31.1	0.06	-0.08	0.63	0.46	0.14	0.0274	0.0431	(A) Negative
NEB	2q23.3	0.71	0.42	1.27	1.09	0.29	0.0274	0.0432	(A) Negative
DHX32	10q26.2	0.28	0.41	0.57	0.57	-0.13	0.0275	0.0433	(B) Positive
PXDN	2p25.3	0.61	0.38	1.04	0.80	0.23	0.0276	0.0434	(A) Negative
ANKRD23	2q11.2	-1.31	-1.45	0.59	0.66	0.14	0.0276	0.0434	(A) Negative
MRPL50	9q31.1	-0.78	-0.88	0.45	0.41	0.10	0.0276	0.0434	(A) Negative
SMARCAL1	2q35	0.40	0.32	0.40	0.31	0.09	0.0276	0.0434	(A) Negative
ACLY	17q21.2	-0.30	-0.17	0.53	0.55	-0.12	0.0276	0.0434	(B) Positive
SRP68	17q25.1	0.23	0.12	0.46	0.52	0.11	0.0277	0.0435	(A) Negative
EEF2K	16p12.2	-0.05	0.07	0.50	0.51	-0.12	0.0277	0.0435	(B) Positive
CALHM3	10q24.33	-1.22	-1.44	1.02	0.73	0.22	0.0277	0.0435	(A) Negative
REEP4	8p21.3	-0.49	-0.63	0.59	0.58	0.14	0.0277	0.0436	(A) Negative
TOP2B	3p24.2	-0.13	-0.00	0.59	0.44	-0.13	0.0280	0.0439	(B) Positive
HNRNPA1L2	13q14.3	-1.07	-0.94	0.56	0.50	-0.13	0.0280	0.0439	(B) Positive
FGF3	11q13.3	0.20	0.27	0.31	0.30	-0.07	0.0280	0.0439	(B) Positive
BARD1	2q35	-0.30	-0.44	0.61	0.61	0.14	0.0280	0.0439	(A) Negative
PSPC1	13q12.11	0.05	-0.08	0.63	0.40	0.14	0.0280	0.0440	(A) Negative
HYAL2	3p21.31	0.26	0.38	0.52	0.45	-0.12	0.0280	0.0440	(B) Positive
IGSF11	3q13.32	-2.14	-2.30	0.69	0.62	0.16	0.0281	0.0441	(A) Negative
ACVR1C	2q24.1	-0.22	0.04	1.03	1.38	-0.26	0.0281	0.0441	(B) Positive
WFDC8	20q13.12	0.18	0.09	0.38	0.41	0.09	0.0281	0.0441	(A) Negative
HSD17B14	19q13.33	1.36	1.54	0.73	0.79	-0.17	0.0281	0.0441	(B) Positive
LPIN3	20q12	-0.12	-0.04	0.32	0.37	-0.08	0.0282	0.0442	(B) Positive
ZDHHC15	Xq13.3	-0.06	-0.34	1.23	1.05	0.28	0.0282	0.0442	(A) Negative
ANK2	4q25-q26	-0.15	0.00	0.61	0.73	-0.15	0.0282	0.0443	(B) Positive
WDR81	17p13.3	0.32	0.44	0.52	0.44	-0.12	0.0282	0.0443	(B) Positive
ARMCX2	Xq22.1	0.07	0.33	1.15	1.11	-0.27	0.0282	0.0443	(B) Positive
ZBTB11	3q12.3	-0.30	-0.20	0.44	0.36	-0.10	0.0283	0.0444	(B) Positive
AVP	20p13	1.05	0.82	1.00	0.90	0.23	0.0284	0.0445	(A) Negative
LRRC4B	19q13.33	-0.32	-0.46	0.63	0.55	0.14	0.0284	0.0445	(A) Negative
PLEKHM1	17q21.31	0.23	0.31	0.36	0.35	-0.08	0.0284	0.0446	(B) Positive
GGCT	7p14.3	0.61	0.43	0.79	0.77	0.18	0.0284	0.0446	(A) Negative
FAM230I	22q11.23	-0.08	-0.18	0.41	0.50	0.10	0.0285	0.0447	(A) Negative
HPCAL4	1p34.2	-0.48	-0.61	0.55	0.42	0.12	0.0285	0.0447	(A) Negative
LINC00905	19p13.12	0.21	0.13	0.32	0.31	0.07	0.0285	0.0447	(A) Negative
PADI1	1p36.13	0.24	0.12	0.49	0.62	0.12	0.0286	0.0449	(A) Negative
TOR1A	9q34.11	-0.16	-0.06	0.43	0.36	-0.10	0.0286	0.0449	(B) Positive
TESK1	9p13.3	1.16	1.06	0.46	0.34	0.10	0.0286	0.0449	(A) Negative
LIX1	5q15	-1.84	-2.03	0.87	0.54	0.19	0.0287	0.0450	(A) Negative
MPV17L2	19p13.11	-0.15	-0.28	0.57	0.46	0.13	0.0287	0.0451	(A) Negative
SYT11	1q22	0.47	0.33	0.64	0.59	0.15	0.0288	0.0451	(A) Negative
GGA1	22q13.1	-0.52	-0.62	0.42	0.46	0.10	0.0288	0.0451	(A) Negative
TMEM147	19q13.12	0.66	0.54	0.55	0.42	0.12	0.0289	0.0452	(A) Negative
PIGC	1q24.3	0.69	0.56	0.55	0.52	0.13	0.0289	0.0452	(A) Negative
ZBTB14	18p11.31	0.21	0.30	0.39	0.38	-0.09	0.0289	0.0453	(B) Positive
MITF	3p13	-1.72	-1.57	0.70	0.63	-0.16	0.0289	0.0453	(B) Positive
UQCC2	6p21.31	-0.12	-0.25	0.54	0.54	0.12	0.0289	0.0453	(A) Negative
ZMYM4	1p34.3	0.28	0.16	0.53	0.37	0.12	0.0289	0.0453	(A) Negative
LINC00334	21q22.3	0.48	0.41	0.32	0.27	0.07	0.0290	0.0454	(A) Negative
PPBP	4q13.3	0.68	0.51	0.76	0.70	0.17	0.0290	0.0454	(A) Negative
PPP1CA	11q13.2	-0.07	0.05	0.48	0.64	-0.12	0.0290	0.0454	(B) Positive
ATXN1	6p22.3	0.35	0.48	0.61	0.48	-0.13	0.0291	0.0455	(B) Positive
GNA15	19p13.3	-0.66	-0.87	0.95	0.79	0.21	0.0291	0.0455	(A) Negative
GLYCTK	3p21.2	-1.05	-0.95	0.43	0.39	-0.10	0.0291	0.0456	(B) Positive
GULP1	2q32.1-q32.2	-0.89	-1.12	1.03	0.97	0.23	0.0291	0.0456	(A) Negative
CNTRL	9q33.2	-0.65	-0.80	0.66	0.55	0.15	0.0291	0.0456	(A) Negative
PPP1R3F	Xp11.23	0.08	0.17	0.42	0.40	-0.10	0.0292	0.0456	(B) Positive
PIAS4	19p13.3	0.31	0.44	0.56	0.53	-0.13	0.0292	0.0457	(B) Positive
TERF1	8q21.11	-0.12	-0.00	0.51	0.53	-0.12	0.0292	0.0458	(B) Positive
XKR3	22q11.1	-2.35	-2.49	0.63	0.57	0.14	0.0293	0.0458	(A) Negative
PPIA	7p13	-0.08	-0.18	0.47	0.36	0.10	0.0293	0.0459	(A) Negative
MFSD10	4p16.3	0.32	0.46	0.61	0.58	-0.14	0.0294	0.0459	(B) Positive
TSPEAR-AS2	21q22.3	-1.90	-2.06	0.75	0.60	0.17	0.0294	0.0459	(A) Negative
MED28	4p15.32	-0.28	-0.39	0.48	0.39	0.11	0.0294	0.0459	(A) Negative
PDE12	3p14.3	0.15	0.24	0.42	0.38	-0.09	0.0294	0.0460	(B) Positive
ZNF165	6p22.1	0.48	0.27	0.96	0.72	0.21	0.0295	0.0461	(A) Negative
DTYMK	2q37.3	-0.57	-0.70	0.57	0.48	0.13	0.0295	0.0462	(A) Negative
TSPYL4	6q22.1	0.06	0.22	0.71	0.58	-0.16	0.0295	0.0462	(B) Positive
CPM	12q15	-0.10	-0.36	1.19	0.95	0.26	0.0295	0.0462	(A) Negative
TMEM156	4p14	-0.14	-0.37	1.01	0.96	0.23	0.0296	0.0462	(A) Negative
CMTR1	6p21.2	-0.25	-0.35	0.41	0.50	0.10	0.0296	0.0462	(A) Negative
RAD23A	19p13.13	-0.20	-0.32	0.54	0.45	0.12	0.0296	0.0463	(A) Negative
TRADD	16q22.1	0.29	0.16	0.57	0.52	0.13	0.0296	0.0463	(A) Negative
CACNA1E	1q25.3	1.15	0.94	0.92	0.95	0.21	0.0296	0.0463	(A) Negative
CEP95	17q23.3	-0.78	-0.93	0.65	0.61	0.15	0.0296	0.0463	(A) Negative
MLX	17q21.2	0.15	0.06	0.43	0.39	0.10	0.0297	0.0464	(A) Negative
UCP2	11q13.4	0.11	0.34	1.04	1.00	-0.24	0.0297	0.0464	(B) Positive
EVC2	4p16.2	0.41	0.19	1.02	0.83	0.23	0.0297	0.0464	(A) Negative
KLRC4	12p13.2	-1.91	-2.06	0.66	0.73	0.16	0.0297	0.0465	(A) Negative
FAM216A	12q24.11	-2.40	-2.62	0.99	0.82	0.22	0.0298	0.0465	(A) Negative
LINC00852	3p25.3	-0.27	-0.17	0.39	0.54	-0.10	0.0298	0.0465	(B) Positive
THAP1	8p11.21	0.40	0.51	0.46	0.52	-0.11	0.0298	0.0465	(B) Positive
RPL23A	17q11.2	-0.62	-0.46	0.71	0.58	-0.16	0.0298	0.0466	(B) Positive
PPP5C	19q13.32	-0.47	-0.60	0.56	0.62	0.13	0.0298	0.0466	(A) Negative
FECH	18q21.31	-0.25	-0.09	0.68	0.63	-0.15	0.0298	0.0466	(B) Positive
PRDM10	11q24.3	-0.34	-0.26	0.36	0.33	-0.08	0.0299	0.0466	(B) Positive
ZNF331	19q13.42	0.41	0.53	0.50	0.53	-0.12	0.0299	0.0466	(B) Positive
FOXS1	20q11.21	0.69	0.59	0.45	0.45	0.10	0.0299	0.0467	(A) Negative
RABIF	1q32.1	0.65	0.54	0.48	0.47	0.11	0.0300	0.0468	(A) Negative
SLC38A4	12q13.11	-0.54	-0.40	0.61	0.66	-0.14	0.0300	0.0468	(B) Positive
ZNF16	8q24.3	1.11	1.23	0.57	0.53	-0.13	0.0301	0.0469	(B) Positive
CLU	8p21.1	0.40	0.69	1.36	0.93	-0.29	0.0301	0.0470	(B) Positive
SENP6	6q14.1	0.57	0.71	0.62	0.59	-0.14	0.0301	0.0470	(B) Positive
CT55	Xq26.3	-4.70	-4.94	1.06	1.08	0.24	0.0301	0.0470	(A) Negative
TTLL6	17q21.32	-0.43	-0.34	0.35	0.49	-0.09	0.0301	0.0470	(B) Positive
RFFL	17q12	0.33	0.43	0.44	0.47	-0.10	0.0302	0.0470	(B) Positive
GSN	9q33.2	1.31	1.14	0.70	0.80	0.17	0.0302	0.0471	(A) Negative
SSMEM1	7q32.2	-0.35	-0.47	0.55	0.47	0.12	0.0302	0.0471	(A) Negative
MAFK	7p22.3	0.03	-0.04	0.32	0.31	0.07	0.0302	0.0471	(A) Negative
PRDX1	1p34.1	0.11	-0.04	0.67	0.60	0.15	0.0303	0.0472	(A) Negative
DIP2A	21q22.3	-0.42	-0.52	0.43	0.43	0.10	0.0303	0.0473	(A) Negative
MAGEB18	Xp21.3	-0.52	-0.33	0.76	0.98	-0.19	0.0303	0.0473	(B) Positive
ABCC12	16q12.1	0.75	1.04	1.28	1.15	-0.29	0.0303	0.0473	(B) Positive
DPP6	7q36.2	-0.59	-0.72	0.58	0.32	0.12	0.0304	0.0473	(A) Negative
FANCM	14q21.2	-0.89	-0.77	0.51	0.49	-0.12	0.0304	0.0474	(B) Positive
GPR142	17q25.1	0.75	0.67	0.38	0.32	0.08	0.0304	0.0474	(A) Negative
GOLPH3	5p13.3	0.92	0.81	0.55	0.39	0.12	0.0305	0.0475	(A) Negative
CD28	2q33.2	-2.63	-2.89	1.17	1.11	0.26	0.0305	0.0475	(A) Negative
BTN3A1	6p22.2	0.30	0.10	0.89	0.75	0.20	0.0305	0.0475	(A) Negative
AP4S1	14q12	-0.22	-0.10	0.58	0.46	-0.13	0.0305	0.0476	(B) Positive
PDLIM1	10q23.33	0.35	0.50	0.62	0.81	-0.15	0.0306	0.0476	(B) Positive
GALR2	17q25.1	-0.13	-0.20	0.30	0.33	0.07	0.0306	0.0477	(A) Negative
PLA2G15	16q22.1	0.09	0.17	0.34	0.38	-0.08	0.0306	0.0477	(B) Positive
C11ORF54	11q21	-0.17	-0.04	0.58	0.62	-0.14	0.0307	0.0478	(B) Positive
MTDH	8q22.1	0.45	0.32	0.54	0.60	0.13	0.0307	0.0478	(A) Negative
BPTF	17q24.2	-0.25	-0.14	0.46	0.49	-0.11	0.0308	0.0479	(B) Positive
CD52	1p36.11	1.19	0.86	1.46	1.36	0.33	0.0308	0.0479	(A) Negative
UTY	Yq11.221	-1.23	-1.14	0.37	0.56	-0.10	0.0308	0.0480	(B) Positive
OTUD6B	8q21.3	-0.30	-0.47	0.75	0.69	0.17	0.0308	0.0480	(A) Negative
ADGRA2	8p11.23	0.29	0.45	0.69	0.68	-0.16	0.0308	0.0480	(B) Positive
ADGRB3	6q12-q13	-0.04	0.13	0.77	0.81	-0.18	0.0309	0.0480	(B) Positive
TUBA1A	12q13.12	-0.70	-0.84	0.61	0.58	0.14	0.0309	0.0481	(A) Negative
SPANXN3	Xq27.3	0.36	0.22	0.64	0.51	0.14	0.0310	0.0482	(A) Negative
SMR3B	4q13.3	0.96	0.50	2.19	1.17	0.46	0.0310	0.0482	(A) Negative
ERI1	8p23.1	-0.51	-0.72	0.90	0.91	0.21	0.0310	0.0482	(A) Negative
LAMB4	7q31.1	-0.03	-0.14	0.49	0.46	0.11	0.0311	0.0484	(A) Negative
CCDC198	14q22.3	-0.20	-0.08	0.55	0.56	-0.13	0.0311	0.0484	(B) Positive
RNF2	1q25.3	0.22	0.37	0.62	0.69	-0.14	0.0311	0.0484	(B) Positive
FBXL6	8q24.3	0.13	-0.02	0.67	0.78	0.16	0.0311	0.0484	(A) Negative
CALCRL	2q32.1	2.59	2.82	1.02	0.86	-0.22	0.0312	0.0485	(B) Positive
SLC35F1	6q22.2-q22.31	-1.25	-1.42	0.80	0.49	0.17	0.0312	0.0485	(A) Negative
FGF11	17p13.1	0.00	-0.09	0.40	0.38	0.09	0.0312	0.0486	(A) Negative
TFEC	7q31.2	2.98	2.70	1.30	1.11	0.29	0.0313	0.0486	(A) Negative
GLB1L3	11q25	-0.82	-1.02	0.95	0.61	0.20	0.0313	0.0486	(A) Negative
DOCK6	19p13.2	-0.60	-0.46	0.61	0.57	-0.14	0.0313	0.0486	(B) Positive
UBR3	2q31.1	0.36	0.47	0.48	0.43	-0.11	0.0313	0.0486	(B) Positive
TBC1D20	20p13	0.17	0.28	0.48	0.43	-0.11	0.0313	0.0486	(B) Positive
ZNF354B	5q35.3	-0.36	-0.24	0.54	0.43	-0.12	0.0313	0.0486	(B) Positive
TRIM60	4q32.3	0.12	0.27	0.66	0.71	-0.15	0.0313	0.0486	(B) Positive
GATD1-DT	11p15.5	-1.57	-1.43	0.61	0.74	-0.15	0.0313	0.0486	(B) Positive
CST6	11q13.1	4.52	4.31	0.86	1.20	0.21	0.0313	0.0487	(A) Negative
LHFPL3	7q22.2-q22.3	0.25	0.11	0.63	0.40	0.13	0.0314	0.0488	(A) Negative
CNNM2	10q24.32	-0.71	-0.60	0.47	0.56	-0.11	0.0314	0.0488	(B) Positive
FRRS1L	9q31.3	0.23	0.09	0.65	0.51	0.14	0.0315	0.0489	(A) Negative
IL31RA	5q11.2	-0.47	-0.57	0.44	0.45	0.10	0.0315	0.0489	(A) Negative
ZNF445	3p21.31	-0.39	-0.31	0.37	0.31	-0.08	0.0315	0.0489	(B) Positive
MLLT6	17q12	0.13	0.24	0.50	0.49	-0.11	0.0316	0.0490	(B) Positive
GABRB2	5q34	0.28	0.21	0.32	0.37	0.08	0.0316	0.0490	(A) Negative
CPB2	13q14.13	-5.02	-5.20	0.85	0.74	0.19	0.0316	0.0490	(A) Negative
SUSD2	22q11.23	1.78	1.56	1.02	0.84	0.22	0.0316	0.0491	(A) Negative
GJA5	1q21.2	2.72	2.57	0.66	0.60	0.15	0.0316	0.0491	(A) Negative
ARID3A	19p13.3	-1.89	-1.77	0.54	0.53	-0.12	0.0317	0.0492	(B) Positive
EFL1	15q25.2	-0.16	-0.06	0.48	0.34	-0.10	0.0317	0.0493	(B) Positive
AGTR2	Xq23	0.12	0.25	0.58	0.52	-0.13	0.0318	0.0493	(B) Positive
NPHP4	1p36.31	-0.69	-0.80	0.48	0.44	0.11	0.0318	0.0493	(A) Negative
C2CD6	2q33.1	-1.34	-1.56	1.05	0.78	0.23	0.0318	0.0493	(A) Negative
H3C1	6p22.2	0.98	0.85	0.57	0.50	0.13	0.0318	0.0494	(A) Negative
CYTL1	4p16.2	-3.02	-2.80	0.98	0.90	-0.22	0.0319	0.0495	(B) Positive
RBMY2FP	Yq11.223	-1.09	-0.92	0.73	0.75	-0.17	0.0319	0.0495	(B) Positive
FCHSD2	11q13.4	0.28	0.17	0.51	0.45	0.11	0.0320	0.0496	(A) Negative
OR2M5	1q44	0.19	0.08	0.53	0.47	0.12	0.0320	0.0496	(A) Negative
CSDC2	22q13.2	0.50	0.61	0.45	0.49	-0.10	0.0320	0.0496	(B) Positive
NSFL1C	20p13	0.02	0.13	0.46	0.43	-0.10	0.0320	0.0496	(B) Positive
IL3	5q31.1	0.25	0.19	0.27	0.28	0.06	0.0321	0.0497	(A) Negative
CCNT1	12q13.11-q13.12	-0.11	-0.00	0.48	0.44	-0.11	0.0321	0.0498	(B) Positive
MPPED2	11p14.1	-0.59	-0.26	1.51	1.24	-0.33	0.0321	0.0498	(B) Positive
NFASC	1q32.1	0.55	0.40	0.71	0.46	0.15	0.0321	0.0498	(A) Negative
UBE2L6	11q12.1	1.06	1.26	0.93	0.76	-0.20	0.0322	0.0499	(B) Positive
